data_6f9a_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6f9a _Structure_validation_residue.Date_analyzed 2019-01-25 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 CA--C 1.534 0.346 0 CA-C-O 119.013 -0.518 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.18 -45.26 77.5 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.03 -39.41 81.89 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.1 mt -63.72 -52.83 58.76 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 19.6 m -54.71 -44.96 73.91 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.876 -0.515 . . . . 0.0 109.618 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -63.77 -51.67 63.79 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.195 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.0 m -58.47 -39.96 81.4 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 120.325 1.42 . . . . 0.0 111.317 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.3 tp -64.67 -55.48 19.87 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 119.016 0.825 . . . . 0.0 110.072 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -59.65 -46.98 87.38 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -57.58 -44.23 85.21 Favored 'General case' 0 C--O 1.225 -0.204 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.73 -53.39 46.62 Favored Glycine 0 N--CA 1.438 -1.228 0 CA-C-O 118.473 -1.181 . . . . 0.0 111.11 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 5.0 t -55.19 -52.96 39.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 119.132 1.466 . . . . 0.0 111.142 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -33.76 76.19 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 118.816 -0.612 . . . . 0.0 111.274 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.0 m -70.04 -45.83 66.33 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 32.9 mt -56.27 -54.67 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 123.94 0.896 . . . . 0.0 109.814 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.76 -39.64 92.34 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 123.614 0.571 . . . . 0.0 110.266 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -62.86 -44.48 95.99 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.166 0.894 . . . . 0.0 110.526 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -20.32 62.29 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 118.266 -0.873 . . . . 0.0 112.765 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.8 mt -98.77 -28.85 13.31 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 120.34 1.427 . . . . 0.0 111.651 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -59.35 -37.43 77.83 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.91 0.484 . . . . 0.0 110.618 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -64.03 -46.76 83.02 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -156.94 148.32 22.22 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.013 0.925 . . . . 0.0 110.245 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 85.7 m -75.26 174.48 9.45 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 41.4 pt -130.71 148.6 33.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 123.476 0.71 . . . . 0.0 110.074 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.54 168.23 20.26 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.218 0.607 . . . . 0.0 110.038 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -151.43 129.59 11.91 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.906 1.682 . . . . 0.0 109.67 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -95.0 102.33 14.13 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.53 67.41 2.86 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 126.573 1.949 . . . . 0.0 109.384 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.15 -116.85 5.69 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 124.5 1.048 . . . . 0.0 110.803 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -70.2 -30.62 67.77 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.144 0.978 . . . . 0.0 111.443 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -107.33 160.39 15.65 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.865 0.841 . . . . 0.0 110.051 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.6 mt -125.86 151.66 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -123.18 131.56 53.73 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 126.456 1.902 . . . . 0.0 106.749 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -126.35 131.54 51.78 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.849 1.659 . . . . 0.0 108.325 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -128.52 123.65 34.06 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.952 1.301 . . . . 0.0 109.869 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 4.6 m -109.91 160.35 28.43 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.236 1.414 . . . . 0.0 113.718 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.96 90.41 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.13 3.22 . . . . 0.0 113.324 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 59.19 52.07 55.45 Favored Glycine 0 CA--C 1.519 0.34 0 O-C-N 120.957 -1.089 . . . . 0.0 111.743 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.6 mt -127.31 -67.17 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.09 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.42 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 8.7 pt-20 -173.09 167.31 4.94 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 126.13 1.772 . . . . 0.0 109.281 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.22 117.24 24.13 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.0 m -130.57 156.19 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 124.386 1.074 . . . . 0.0 112.706 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -124.79 135.46 52.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 177.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -146.45 157.41 43.75 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.079 0.952 . . . . 0.0 113.35 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 33.5 t60 -88.79 119.72 29.54 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 103.581 -2.748 . . . . 0.0 103.581 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -165.25 -163.14 17.9 Favored Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 111.666 -0.573 . . . . 0.0 111.666 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.3 154.31 51.58 Favored 'General case' 0 CA--C 1.526 0.039 0 C-N-CA 123.505 0.722 . . . . 0.0 109.486 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.4 t . . . . . 0 C--O 1.24 0.603 0 C-N-CA 124.087 0.955 . . . . 0.0 110.716 -179.047 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 . . . . . 0 C--O 1.235 0.299 0 CA-C-O 120.69 0.281 . . . . 0.0 110.363 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 23.4 mt . . . . . 0 CA--C 1.54 0.59 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -179.888 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 89.9 mt . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.3 t -137.17 143.83 33.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 125.745 1.618 . . . . 0.0 106.788 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -140.44 162.63 34.88 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.907 0.883 . . . . 0.0 111.56 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.3 ptp85 -108.34 143.21 37.54 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.926 1.291 . . . . 0.0 110.076 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.3 mp -120.03 -70.2 0.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.375 1.47 . . . . 0.0 107.788 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -132.6 152.98 20.43 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 123.547 0.594 . . . . 0.0 112.589 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -124.43 91.07 50.05 Favored Pre-proline 0 N--CA 1.452 -0.352 0 C-N-CA 126.028 1.731 . . . . 0.0 109.434 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 97.2 Cg_endo -73.55 177.22 8.27 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.014 2.476 . . . . 0.0 111.37 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -91.09 169.13 11.11 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -82.48 -42.67 18.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.948 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -93.27 149.76 20.99 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 122.969 0.508 . . . . 0.0 110.065 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.2 p -69.79 -20.05 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 123.33 0.652 . . . . 0.0 112.45 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -88.96 -20.0 25.03 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.661 1.184 . . . . 0.0 111.656 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -77.34 -19.31 56.51 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.094 0.558 . . . . 0.0 109.793 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -103.56 171.11 7.55 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.15 1.38 . . . . 0.0 109.788 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -137.81 134.6 35.38 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.89 1.276 . . . . 0.0 107.788 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -115.5 164.59 14.08 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.959 1.304 . . . . 0.0 110.672 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -131.67 122.03 25.28 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 124.621 1.168 . . . . 0.0 112.0 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 15.7 tp -85.76 104.34 15.36 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 38.8 mt -114.49 177.03 4.79 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 122.139 0.971 . . . . 0.0 110.939 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -156.76 155.67 32.0 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.037 1.335 . . . . 0.0 107.463 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -138.59 -177.15 4.73 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -49.25 -31.33 8.59 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.079 1.352 . . . . 0.0 113.218 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 89.8 t -74.28 -74.37 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -166.53 -162.34 17.81 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -78.31 161.87 26.91 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.293 0.637 . . . . 0.0 112.06 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -163.15 175.25 11.2 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.854 2.062 . . . . 0.0 108.302 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 7.2 mt -127.01 121.51 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 39.9 t -91.35 137.81 32.07 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -139.18 120.51 14.87 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.8 tt -114.72 139.81 38.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.3 mt -133.51 112.53 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 123.4 0.68 . . . . 0.0 112.284 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -105.78 -167.69 23.42 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 124.604 1.097 . . . . 0.0 110.956 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.5 t 80.69 47.27 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.307 1.843 . . . . 0.0 110.39 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -97.76 -112.02 3.02 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 105.645 -2.982 . . . . 0.0 105.645 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -141.36 122.61 14.81 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 104.265 -2.494 . . . . 0.0 104.265 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.5 mm -60.17 134.38 25.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 98.8 m -81.58 100.81 9.59 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.98 -19.27 51.35 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.33 0.652 . . . . 0.0 111.325 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.32 -30.24 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 126.141 1.776 . . . . 0.0 110.767 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.3 p -125.01 -36.2 2.57 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 119.601 1.091 . . . . 0.0 112.416 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 96.54 33.81 6.03 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.084 1.326 . . . . 0.0 110.581 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -124.95 171.05 10.51 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.376 1.47 . . . . 0.0 112.058 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -89.1 141.85 28.15 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.558 0.743 . . . . 0.0 112.006 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.17 29.14 0.22 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 128.455 2.702 . . . . 0.0 110.764 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -73.52 142.38 46.73 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 122.282 1.039 . . . . 0.0 109.489 -176.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -104.81 149.58 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 CA-C-N 113.399 -1.728 . . . . 0.0 111.417 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -118.2 124.96 49.2 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.2 mp -115.86 129.86 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 125.806 1.642 . . . . 0.0 106.638 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -114.57 108.97 17.55 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -85.27 119.49 25.7 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.593 0.757 . . . . 0.0 110.602 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 32.0 m -131.43 171.57 17.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 C-N-CA 125.026 1.33 . . . . 0.0 111.796 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.37 133.55 39.91 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -89.7 149.13 20.31 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 123.557 0.599 . . . . 0.0 111.811 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -60.67 -45.02 97.18 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 47.1 t -87.21 98.58 11.4 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -72.21 8.04 1.48 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.385 0.674 . . . . 0.0 109.381 177.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 60.2 m -130.84 38.44 3.69 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.241 1.817 . . . . 0.0 113.267 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.2 165.7 28.16 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 121.475 -0.766 . . . . 0.0 112.161 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.66 168.24 20.57 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.969 2.446 . . . . 0.0 112.492 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 81.0 p -77.26 150.0 35.37 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.78 162.73 23.98 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.174 1.39 . . . . 0.0 107.446 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.1 mp -76.68 141.77 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -84.63 -59.65 2.3 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 -141.58 166.56 24.42 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.171 1.388 . . . . 0.0 108.484 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 47.7 t -145.84 136.39 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 C-N-CA 126.142 1.777 . . . . 0.0 106.391 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.46 121.09 3.71 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.375 0.607 . . . . 0.0 109.862 177.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -81.05 88.14 5.98 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 14.7 p -58.02 -56.8 17.36 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.587 1.555 . . . . 0.0 112.095 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt -99.76 -172.55 2.26 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.239 -1.764 . . . . 0.0 106.239 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 31.2 mm -75.5 -35.22 31.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 O-C-N 121.081 -1.012 . . . . 0.0 109.392 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.98 -54.05 2.54 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.912 0.885 . . . . 0.0 110.861 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 29.2 t -62.56 137.44 24.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 121.41 0.624 . . . . 0.0 109.391 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -133.08 139.92 47.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.147 1.779 . . . . 0.0 107.048 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -120.6 140.52 51.41 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 125.409 1.484 . . . . 0.0 108.945 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.84 161.41 39.36 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 126.132 1.773 . . . . 0.0 109.745 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -133.02 146.11 51.44 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 99.0 t -131.65 134.14 60.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 124.68 1.192 . . . . 0.0 108.376 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.08 142.06 35.13 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.624 0.77 . . . . 0.0 109.812 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 61.7 mt -139.72 135.68 16.92 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.73 -41.84 0.68 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.881 1.721 . . . . 0.0 112.367 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -62.99 -20.46 65.31 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 16.2 mt -68.52 -33.04 73.42 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 118.174 -0.917 . . . . 0.0 109.882 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 21.0 m -62.88 -13.4 33.64 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -70.37 -36.71 74.32 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.827 0.822 . . . . 0.0 109.152 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 24.0 mt -70.52 114.02 8.21 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -48.16 -33.77 8.91 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 16.6 mt -61.49 -37.05 82.25 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.257 -0.902 . . . . 0.0 109.817 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 13.0 mt -95.74 9.69 39.55 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 127.505 2.322 . . . . 0.0 113.491 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.761 0 O-C-N 121.564 -0.71 . . . . 0.0 110.457 179.315 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 118.799 -0.619 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.88 -49.55 75.77 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.584 0.707 . . . . 0.0 109.516 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 62.3 tp -55.15 -43.63 74.38 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 125.3 1.44 . . . . 0.0 109.666 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.2 mt -62.52 -53.67 51.23 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.553 1.07 . . . . 0.0 109.506 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 85.2 m -54.36 -52.7 60.8 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.013 0.525 . . . . 0.0 109.826 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -61.9 -42.14 98.72 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 118.488 -0.768 . . . . 0.0 110.801 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.1 m -55.8 -47.8 76.5 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 119.318 0.963 . . . . 0.0 109.771 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 26.6 tp -59.28 -55.8 30.28 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 118.373 0.533 . . . . 0.0 109.765 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -51.21 -52.42 44.65 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 124.778 1.231 . . . . 0.0 110.997 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -55.83 -44.59 78.08 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 125.088 1.355 . . . . 0.0 109.711 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.62 -53.24 39.86 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 125.117 1.341 . . . . 0.0 111.785 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 59.1 t -55.25 -52.92 40.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 119.018 1.409 . . . . 0.0 110.998 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -31.07 72.01 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 118.51 0.596 . . . . 0.0 110.703 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.2 m -69.05 -42.62 76.05 Favored 'General case' 0 CA--C 1.523 -0.093 0 CA-C-N 118.682 0.674 . . . . 0.0 109.403 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 34.1 mt -58.09 -51.16 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 107.103 -1.444 . . . . 0.0 107.103 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.88 -40.03 94.0 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 118.762 -0.637 . . . . 0.0 111.095 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -59.32 -47.48 85.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.875 0.762 . . . . 0.0 109.375 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -73.51 -19.3 60.96 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.6 mt -102.67 -28.29 12.21 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 119.901 1.228 . . . . 0.0 112.124 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -58.03 -32.46 67.99 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -65.84 -45.58 81.69 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 119.036 -0.507 . . . . 0.0 110.504 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -158.4 156.38 30.34 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.662 1.119 . . . . 0.0 111.203 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 59.9 m -76.09 176.04 8.36 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 34.0 pt -135.7 155.49 36.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.49 163.3 38.18 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.126 0.488 . . . . 0.0 112.137 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -150.92 129.01 11.83 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.22 1.408 . . . . 0.0 110.638 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -92.23 107.6 19.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.57 73.09 3.73 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.627 1.571 . . . . 0.0 107.545 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.59 -115.43 5.93 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -74.15 -27.22 60.74 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.322 1.049 . . . . 0.0 112.638 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -107.13 157.6 17.73 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 118.718 0.69 . . . . 0.0 110.299 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 58.7 mt -123.99 149.41 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -126.15 129.3 48.77 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.219 2.208 . . . . 0.0 107.424 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -127.03 130.96 50.99 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.722 1.609 . . . . 0.0 107.644 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -122.3 115.44 22.34 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.814 1.246 . . . . 0.0 108.594 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 15.6 m -105.02 154.86 38.41 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 123.48 0.712 . . . . 0.0 110.588 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -61.05 90.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.589 1 C-N-CA 125.887 4.391 . . . . 0.0 116.091 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 60.05 33.96 81.58 Favored Glycine 0 CA--C 1.528 0.853 0 O-C-N 121.682 -0.636 . . . . 0.0 112.323 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.0 mt -111.23 -66.36 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.405 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 5.3 pt-20 -180.0 162.52 1.01 Allowed 'General case' 0 C--O 1.24 0.586 0 C-N-CA 126.468 1.907 . . . . 0.0 108.901 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -115.52 122.29 45.26 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 102.544 -3.132 . . . . 0.0 102.544 178.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.4 m -130.32 156.17 42.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 123.358 0.663 . . . . 0.0 111.228 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -125.62 126.43 44.73 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -146.33 158.95 43.94 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.435 1.094 . . . . 0.0 112.435 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -88.39 154.64 20.22 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 177.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 166.0 -163.97 37.15 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -127.82 144.32 51.09 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.624 1.97 . . . . 0.0 106.7 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 C--O 1.236 0.348 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.98 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 . . . . . 0 N--CA 1.447 -0.623 0 CA-C-O 121.199 0.524 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 74.6 mt . . . . . 0 N--CA 1.447 -0.618 0 N-CA-C 103.167 -2.901 . . . . 0.0 103.167 177.65 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 83.7 mt . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 39.6 t -136.78 143.14 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.384 1.074 . . . . 0.0 108.568 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -143.59 147.36 34.28 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.191 1.397 . . . . 0.0 111.714 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.92 123.63 40.68 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 124.809 1.244 . . . . 0.0 108.073 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.5 mp -95.28 -72.47 0.62 Allowed 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -125.76 148.14 16.87 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -128.44 91.97 42.33 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 42.5 Cg_endo -77.01 176.57 9.97 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.615 2.877 . . . . 0.0 110.698 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -83.76 167.73 16.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.177 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.43 -33.62 23.65 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.488 1.115 . . . . 0.0 112.001 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -90.9 142.2 28.02 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 126.402 1.881 . . . . 0.0 106.258 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.3 p -72.96 -28.35 26.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 118.224 0.465 . . . . 0.0 110.078 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -73.1 0.51 11.34 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 127.479 2.311 . . . . 0.0 113.059 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -114.76 -13.12 12.06 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.329 1.852 . . . . 0.0 110.227 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 36.1 mmm-85 -77.25 163.68 26.29 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.824 1.25 . . . . 0.0 108.358 177.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -131.03 95.89 3.92 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.301 0.572 . . . . 0.0 110.134 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -108.53 148.94 29.53 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 125.774 1.629 . . . . 0.0 108.279 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -138.37 134.92 34.79 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.358 1.063 . . . . 0.0 109.791 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.95 98.51 10.41 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.29 1.036 . . . . 0.0 109.515 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 35.4 mt -103.77 172.01 7.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.761 0.791 . . . . 0.0 110.195 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -157.37 157.09 33.43 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.246 -0.909 . . . . 0.0 109.503 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -138.83 -179.23 5.71 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -56.79 -11.75 1.56 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.788 2.035 . . . . 0.0 113.026 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 54.8 t -94.07 -67.07 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 126.484 1.914 . . . . 0.0 107.873 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -169.63 -174.11 37.69 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -81.05 158.76 24.98 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 114.606 -0.797 . . . . 0.0 109.044 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -162.61 176.55 10.26 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.546 1.538 . . . . 0.0 108.469 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 14.3 mt -123.93 133.75 68.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.3 t -109.19 122.49 47.42 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -125.58 112.93 16.76 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.9 tt -100.86 130.93 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 11.0 mt -123.36 109.7 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.088 1.355 . . . . 0.0 109.053 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -104.36 -153.04 22.59 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 107.559 -2.217 . . . . 0.0 107.559 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.3 m 74.43 46.07 0.17 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.34 1.456 . . . . 0.0 109.444 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -111.95 -126.95 4.84 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -130.42 124.91 33.18 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.441 1.096 . . . . 0.0 110.986 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 46.1 mm -61.08 137.28 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.82 0.848 . . . . 0.0 112.296 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 74.1 m -94.66 95.36 8.7 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 102.866 -3.013 . . . . 0.0 102.866 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -55.07 -17.79 4.47 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.888 1.275 . . . . 0.0 113.537 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 73.4 t -59.73 -38.18 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 124.878 1.271 . . . . 0.0 109.567 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 20.9 p -125.32 -15.9 6.07 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 78.52 32.94 40.36 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -103.48 159.9 15.19 Favored 'General case' 0 CA--C 1.52 -0.189 0 O-C-N 121.435 -1.038 . . . . 0.0 110.651 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -91.71 142.4 27.64 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.903 1.281 . . . . 0.0 107.725 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -73.46 28.96 0.07 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 127.854 2.461 . . . . 0.0 111.82 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.3 ptt? -73.2 141.0 47.35 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 122.58 1.181 . . . . 0.0 110.04 -175.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 1.5 p -113.06 144.35 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.33 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -112.26 125.25 53.96 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.6 mp -109.67 119.11 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -102.38 106.39 17.14 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -85.36 115.17 22.95 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.37 1.068 . . . . 0.0 110.46 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.8 m -127.93 172.83 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 126.14 1.776 . . . . 0.0 112.277 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.3 t -85.5 133.09 34.1 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.445 1.498 . . . . 0.0 107.313 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -89.67 161.86 29.94 Favored Glycine 0 N--CA 1.47 0.95 0 CA-C-N 119.555 1.071 . . . . 0.0 112.032 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -47.22 -79.61 0.07 OUTLIER Glycine 0 C--N 1.341 0.824 0 C-N-CA 126.315 1.912 . . . . 0.0 110.997 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 25.3 m -70.42 126.3 29.24 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -98.28 35.98 1.68 Allowed 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 8.6 m -143.24 33.19 1.34 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -129.52 179.15 16.95 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 120.361 1.437 . . . . 0.0 113.122 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -75.09 170.06 21.22 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.949 2.432 . . . . 0.0 109.273 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 98.3 p -81.72 156.36 25.04 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.853 -0.529 . . . . 0.0 109.692 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.85 164.69 7.85 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 126.143 1.777 . . . . 0.0 109.276 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.9 mt -79.75 136.09 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.164 1.386 . . . . 0.0 107.37 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -81.21 -54.84 5.16 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 124.574 1.15 . . . . 0.0 109.753 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 19.0 p-90 -148.59 166.54 27.96 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 124.794 1.237 . . . . 0.0 108.761 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 45.3 t -145.28 126.58 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.01 122.05 10.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -75.02 97.92 3.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 2.1 p -66.14 -51.79 54.52 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 118.311 -0.852 . . . . 0.0 111.715 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -120.72 179.11 4.45 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.437 0.695 . . . . 0.0 109.781 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.8 mp -55.19 -37.82 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 C-N-CA 125.908 1.683 . . . . 0.0 110.666 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.75 -21.04 5.29 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 56.4 t -85.21 124.51 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -123.68 142.9 50.63 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -129.79 139.95 51.15 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -138.83 160.85 38.69 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.086 1.354 . . . . 0.0 109.505 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -127.28 143.71 51.18 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.0 t -128.53 143.75 40.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 125.084 1.354 . . . . 0.0 107.683 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.45 134.13 55.32 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 124.29 1.036 . . . . 0.0 110.408 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 93.9 mt -136.72 138.36 26.08 Favored Pre-proline 0 C--O 1.236 0.355 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.638 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.08 -43.29 0.25 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.312 2.008 . . . . 0.0 111.944 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -57.32 -26.82 61.52 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.794 0.837 . . . . 0.0 111.278 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 16.9 mt -66.17 -38.72 88.74 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 120.947 -1.096 . . . . 0.0 110.189 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 42.8 m -55.21 -21.85 15.53 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.6 1.56 . . . . 0.0 113.921 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -64.98 -34.44 78.43 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 123.393 0.677 . . . . 0.0 111.192 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 29.9 mt -71.95 117.27 13.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -48.67 -36.11 15.34 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.82 -36.17 78.37 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.527 -0.733 . . . . 0.0 110.254 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -97.84 3.58 49.83 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.389 1.875 . . . . 0.0 113.271 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 178.902 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.9 m . . . . . 0 CA--C 1.537 0.445 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.34 -48.31 82.12 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 119.633 1.106 . . . . 0.0 108.409 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 58.9 tp -56.97 -44.83 83.04 Favored 'General case' 0 C--N 1.343 0.322 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.1 mt -61.4 -50.52 72.52 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.955 0.798 . . . . 0.0 110.577 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 54.9 m -54.97 -52.44 63.06 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.815 1.246 . . . . 0.0 110.669 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -63.96 -42.78 97.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.575 0.75 . . . . 0.0 110.62 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.2 m -54.1 -49.14 69.78 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.155 0.982 . . . . 0.0 109.007 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 41.1 tp -57.38 -54.24 49.09 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.929 0.331 . . . . 0.0 110.72 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -52.65 -50.99 62.08 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 124.428 1.091 . . . . 0.0 111.654 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -56.11 -52.2 65.18 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.393 1.077 . . . . 0.0 108.604 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -55.29 -51.04 56.97 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 96.4 t -57.2 -52.79 51.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 C-N-CA 125.206 1.402 . . . . 0.0 111.809 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -32.3 73.57 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 119.289 0.95 . . . . 0.0 110.313 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.1 m -66.3 -42.02 88.89 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 34.0 mt -61.49 -50.72 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.51 -40.92 72.4 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 117.9 -1.048 . . . . 0.0 110.809 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -62.61 -55.01 31.01 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.305 1.042 . . . . 0.0 110.436 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -62.7 -25.92 68.4 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 11.0 mp -98.07 -26.99 14.42 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.543 1.52 . . . . 0.0 110.848 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -53.88 -29.54 41.97 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.184 0.994 . . . . 0.0 111.233 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -74.49 -46.83 36.97 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 117.965 0.348 . . . . 0.0 110.709 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.2 mmt85 -157.03 151.46 25.33 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.201 -0.937 . . . . 0.0 111.819 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 51.5 m -76.43 160.55 29.44 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 32.8 pt -118.1 152.83 20.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 124.889 1.275 . . . . 0.0 108.592 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -146.16 168.87 19.94 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 122.853 0.461 . . . . 0.0 111.909 -178.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -154.51 127.69 8.37 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.572 1.549 . . . . 0.0 111.286 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -91.52 104.37 16.88 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.52 66.77 5.46 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.424 1.489 . . . . 0.0 107.034 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 66.84 -115.96 7.76 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -66.12 -34.03 77.13 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -107.32 152.76 23.71 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 119.165 0.893 . . . . 0.0 110.247 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.7 mt -121.16 151.97 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -126.93 136.72 52.68 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.714 1.605 . . . . 0.0 108.202 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -131.38 132.45 44.41 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.542 1.537 . . . . 0.0 108.955 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -126.04 117.27 22.87 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.607 1.163 . . . . 0.0 109.737 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 21.9 m -104.22 158.17 32.49 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 124.197 0.999 . . . . 0.0 111.502 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -63.67 84.91 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.621 1 C-N-CA 125.413 4.076 . . . . 0.0 116.101 -178.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.41 29.02 74.24 Favored Glycine 0 CA--C 1.529 0.938 0 O-C-N 121.394 -0.816 . . . . 0.0 111.542 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.1 mt -106.77 -67.25 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.414 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 7.8 pt-20 -172.56 165.31 5.58 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.713 1.205 . . . . 0.0 108.954 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.23 119.87 30.59 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 103.7 -2.704 . . . . 0.0 103.7 177.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.43 156.63 42.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 124.53 1.132 . . . . 0.0 112.02 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -123.81 133.67 53.76 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -146.11 158.25 43.87 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.71 1.204 . . . . 0.0 111.629 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 50.3 t60 -87.94 154.86 20.18 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 157.9 -162.19 31.98 Favored Glycine 0 C--N 1.333 0.409 0 O-C-N 121.21 -0.931 . . . . 0.0 111.28 -178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.61 145.9 49.07 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 54.2 t . . . . . 0 C--O 1.237 0.413 0 C-N-CA 124.971 1.308 . . . . 0.0 108.3 179.825 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 . . . . . 0 C--O 1.242 0.676 0 CA-C-O 121.009 0.433 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 26.2 mt . . . . . 0 N--CA 1.449 -0.507 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 178.913 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 84.5 mt . . . . . 0 N--CA 1.463 0.175 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.78 147.14 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -142.41 153.04 43.4 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.717 1.207 . . . . 0.0 110.538 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 37.5 mtm105 -101.1 126.32 47.78 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 22.7 mt -101.68 -62.4 1.26 Allowed 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -134.15 153.49 20.97 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -129.22 86.25 57.26 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 126.872 2.069 . . . . 0.0 109.239 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 41.5 Cg_endo -80.47 176.7 8.9 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 123.672 2.915 . . . . 0.0 110.788 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.2 mmmt -92.64 156.45 17.07 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.49 -25.03 41.92 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.015 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -107.29 126.89 53.01 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.58 1.152 . . . . 0.0 108.042 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.4 p -52.9 -34.23 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.834 1.254 . . . . 0.0 111.195 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -61.09 -18.26 56.98 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 129.722 3.209 . . . . 0.0 113.521 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -112.32 -4.08 14.39 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.024 1.73 . . . . 0.0 111.736 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 61.2 mtp180 -91.3 176.87 6.42 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.821 0.82 . . . . 0.0 109.777 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -142.68 134.76 27.27 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -144.0 150.07 37.7 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.782 1.633 . . . . 0.0 107.864 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -133.11 131.73 40.87 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.643 1.177 . . . . 0.0 108.5 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 28.1 tp -86.2 99.65 11.68 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 44.0 mt -101.19 175.04 5.72 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.166 0.986 . . . . 0.0 109.613 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.413 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 5.7 p90 -155.93 156.6 34.85 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.866 0.841 . . . . 0.0 109.648 177.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -135.16 -179.73 5.81 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -54.18 -32.09 54.6 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 125.598 1.559 . . . . 0.0 112.298 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 58.2 t -73.9 -59.06 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.222 1.009 . . . . 0.0 109.13 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -178.96 -168.7 38.5 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 124.552 1.072 . . . . 0.0 111.726 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.413 ' CD2' ' HB3' ' A' ' 176' ' ' TYR . 24.4 m-85 -83.35 161.25 21.45 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.681 1.193 . . . . 0.0 112.36 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -168.03 168.97 11.58 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.78 2.032 . . . . 0.0 109.026 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 15.9 mt -114.28 138.37 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.0 t -111.25 123.54 50.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.902 1.281 . . . . 0.0 108.102 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.4 109.94 11.49 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 177.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 2.3 tt -100.82 126.09 54.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.2 mt -116.44 112.37 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.144 0.978 . . . . 0.0 110.989 -177.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -108.57 -161.27 20.26 Favored Glycine 0 CA--C 1.522 0.492 0 C-N-CA 124.784 1.183 . . . . 0.0 111.126 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 74.44 31.86 0.99 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.411 1.485 . . . . 0.0 110.386 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -87.97 -102.18 0.91 Allowed Glycine 0 C--N 1.336 0.548 1 N-CA-C 102.788 -4.125 . . . . 0.0 102.788 177.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -145.88 160.54 41.66 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 24.2 mm -92.49 132.71 36.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 125.026 1.33 . . . . 0.0 109.141 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 59.3 m -88.4 93.86 9.67 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 100.329 -3.952 . . . . 0.0 100.329 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -53.42 -24.45 12.6 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -177.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -51.11 -34.32 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 125.99 1.716 . . . . 0.0 111.334 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.1 p -126.08 -25.63 3.53 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.879 0.872 . . . . 0.0 112.36 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 92.57 19.5 37.7 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.803 1.192 . . . . 0.0 111.722 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -95.79 165.18 12.42 Favored 'General case' 0 N--CA 1.454 -0.225 0 O-C-N 121.269 -1.136 . . . . 0.0 110.285 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.437 ' C ' ' H ' ' A' ' 201' ' ' MET . 4.1 mt-10 -96.25 147.22 24.0 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.812 0.845 . . . . 0.0 109.163 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -75.56 28.3 0.1 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.971 2.108 . . . . 0.0 110.286 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' MET . . . . . 0.437 ' H ' ' C ' ' A' ' 199' ' ' GLU . 4.9 ptm -72.62 146.19 46.8 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.507 1.146 . . . . 0.0 108.299 -176.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.3 p -120.1 140.03 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 113.901 -1.5 . . . . 0.0 112.549 -176.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -105.13 131.74 52.23 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.1 mp -115.91 113.98 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -97.31 109.08 21.91 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -85.53 118.05 24.81 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.54 0.736 . . . . 0.0 109.585 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.79 172.89 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 125.732 1.613 . . . . 0.0 112.184 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.6 t -86.38 136.58 33.07 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.108 1.763 . . . . 0.0 108.405 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.93 158.05 32.88 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -63.52 -68.29 1.72 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 108.266 -1.934 . . . . 0.0 108.266 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 17.0 p -81.6 91.5 6.4 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 104.084 -2.561 . . . . 0.0 104.084 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -72.51 37.44 0.07 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.753 2.421 . . . . 0.0 113.487 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.4 m -138.22 46.12 2.06 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 115.097 1.518 . . . . 0.0 115.097 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -156.9 175.08 34.51 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -71.66 165.65 31.86 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.071 1.847 . . . . 0.0 110.733 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 52.0 p -72.93 153.89 40.78 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.338 1.055 . . . . 0.0 110.519 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -169.27 160.71 9.71 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.261 1.424 . . . . 0.0 108.652 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.8 127.83 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -72.24 -60.95 1.97 Allowed 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.868 1.667 . . . . 0.0 109.8 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 40.7 p-90 -143.03 168.46 19.66 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.859 2.064 . . . . 0.0 109.091 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 55.9 t -144.2 145.3 21.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 126.283 1.833 . . . . 0.0 106.42 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.34 118.8 1.44 Allowed 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -75.64 92.2 2.93 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 102.285 -3.228 . . . . 0.0 102.285 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 4.8 p -56.09 -55.2 35.83 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.853 1.261 . . . . 0.0 112.408 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -111.59 -172.54 2.06 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.8 mp -62.23 -38.67 81.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 O-C-N 121.396 -0.815 . . . . 0.0 110.214 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.76 -41.05 3.26 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.877 0.871 . . . . 0.0 112.285 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 10.0 t -64.49 132.25 30.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -130.82 141.7 50.35 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.335 1.454 . . . . 0.0 107.288 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -127.01 141.83 51.69 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.75 161.8 38.34 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.445 1.498 . . . . 0.0 108.854 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -138.95 147.46 42.28 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 123.583 0.753 . . . . 0.0 109.99 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.4 m -132.76 151.65 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.127 0.571 . . . . 0.0 109.487 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.1 p -113.42 131.87 55.85 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 122.802 0.441 . . . . 0.0 109.814 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 85.3 mt -129.63 136.12 28.61 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.34 -40.34 0.85 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.207 1.938 . . . . 0.0 112.639 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -61.45 -26.22 67.74 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.38 0.672 . . . . 0.0 111.721 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 3.8 mp -66.29 -35.17 79.71 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.762 0.71 . . . . 0.0 109.309 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 44.0 m -59.51 -19.63 49.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.725 1.21 . . . . 0.0 113.234 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -62.85 -34.52 77.52 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.567 0.747 . . . . 0.0 110.581 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 47.9 mt -73.1 118.92 16.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.218 1.407 . . . . 0.0 107.654 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -49.91 -39.75 41.0 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.0 mp -59.98 -34.32 73.15 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.191 -0.943 . . . . 0.0 111.19 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -101.13 5.54 42.82 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 126.583 1.953 . . . . 0.0 112.495 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.461 0 C-N-CA 123.946 0.898 . . . . 0.0 109.646 179.441 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.1 p . . . . . 0 C--O 1.235 0.31 0 CA-C-O 119.676 -0.202 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.83 -43.61 92.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 48.6 tp -60.65 -48.36 82.13 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 124.034 0.934 . . . . 0.0 108.607 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.9 mt -58.58 -52.05 67.32 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.209 1.004 . . . . 0.0 110.016 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 97.3 m -56.64 -50.28 72.52 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.292 1.037 . . . . 0.0 110.662 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -64.23 -50.94 66.04 Favored 'General case' 0 C--O 1.224 -0.244 0 O-C-N 121.455 -0.778 . . . . 0.0 110.118 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.4 m -51.97 -43.24 63.47 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.411 1.084 . . . . 0.0 111.026 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.6 tt -58.47 -57.08 14.54 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 119.368 0.986 . . . . 0.0 110.122 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -63.64 -38.02 89.52 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -59.9 -36.03 76.12 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -66.93 -51.4 40.2 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.1 t -56.07 -52.97 44.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 118.483 1.142 . . . . 0.0 112.4 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.16 -32.66 68.42 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.907 0.776 . . . . 0.0 111.213 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.1 m -75.63 -46.71 30.02 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 122.845 0.458 . . . . 0.0 110.917 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 24.8 mt -55.75 -52.42 48.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.07 -41.38 83.26 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 123.778 0.674 . . . . 0.0 110.88 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -62.1 -50.63 71.15 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 118.376 0.534 . . . . 0.0 110.929 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.1 -3.55 7.72 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.058 0.943 . . . . 0.0 113.444 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.9 mt -115.22 -28.89 6.78 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.676 1.59 . . . . 0.0 110.075 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -62.18 -26.14 68.17 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.238 0.615 . . . . 0.0 110.612 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.09 -46.89 60.93 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.706 0.802 . . . . 0.0 109.289 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -160.85 147.71 15.29 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 125.703 1.601 . . . . 0.0 108.495 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 67.7 m -75.71 173.21 11.38 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.7 pt -128.61 146.75 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 C-N-CA 123.639 0.775 . . . . 0.0 110.59 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -142.01 162.14 36.22 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.549 0.74 . . . . 0.0 111.057 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -146.9 125.03 12.11 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.441 1.096 . . . . 0.0 109.715 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -87.93 102.35 14.63 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.5 67.04 7.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 66.13 -115.09 7.11 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -63.61 -36.96 85.54 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.099 -0.953 . . . . 0.0 113.146 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -107.31 154.2 21.62 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 120.499 1.5 . . . . 0.0 111.613 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 30.2 mt -118.45 135.23 59.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -110.12 127.61 54.99 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 105.55 -2.018 . . . . 0.0 105.55 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -123.11 119.9 31.66 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.408 1.883 . . . . 0.0 111.718 -177.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -119.87 126.07 50.05 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.034 1.334 . . . . 0.0 110.947 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 3.3 m -111.13 160.84 27.52 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.685 1.594 . . . . 0.0 114.624 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -65.6 87.1 0.21 Allowed 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 124.794 3.663 . . . . 0.0 112.417 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 55.93 56.47 23.8 Favored Glycine 0 C--N 1.331 0.29 0 O-C-N 121.216 -0.927 . . . . 0.0 111.727 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.2 mt -128.05 -66.18 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.425 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 17.3 pt-20 -178.89 173.56 1.2 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.532 1.933 . . . . 0.0 110.982 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.72 118.74 28.77 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 176.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.43 154.97 41.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.984 0.913 . . . . 0.0 111.016 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -117.87 136.2 53.6 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -146.45 156.44 43.29 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.45 1.1 . . . . 0.0 112.413 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -92.19 147.44 22.93 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 162.9 -163.9 35.58 Favored Glycine 0 C--N 1.336 0.554 0 CA-C-N 120.126 1.33 . . . . 0.0 113.231 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -123.24 135.61 54.34 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.922 1.689 . . . . 0.0 110.095 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 CA--C 1.53 0.184 0 C-N-CA 124.502 1.121 . . . . 0.0 108.726 -179.824 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 . . . . . 0 N--CA 1.443 -0.798 0 CA-C-O 121.95 0.881 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 72.2 mt . . . . . 0 C--N 1.326 -0.443 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 179.684 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 49.1 mt . . . . . 0 CA--C 1.515 -0.37 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.6 t -143.4 129.3 16.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -119.74 157.35 28.77 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 122.871 0.468 . . . . 0.0 112.013 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 26.6 mmm-85 -105.58 129.78 53.76 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.152 1.381 . . . . 0.0 107.907 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.9 mp -110.2 -65.66 1.14 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.516 0.726 . . . . 0.0 110.712 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -125.71 154.06 18.52 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -129.72 96.73 25.89 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.228 1.811 . . . . 0.0 108.913 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 44.6 Cg_endo -74.35 -170.41 0.73 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.638 2.892 . . . . 0.0 108.796 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -100.88 165.38 11.38 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -81.46 -34.09 31.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.668 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -98.95 133.7 42.85 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 118.589 0.631 . . . . 0.0 110.355 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.6 p -58.26 -28.3 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.277 1.031 . . . . 0.0 109.611 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -69.01 -19.11 64.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 128.192 2.597 . . . . 0.0 112.84 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -99.62 -9.8 22.75 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.878 0.871 . . . . 0.0 110.476 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -70.3 161.5 30.26 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -140.35 95.64 2.91 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -101.37 167.38 10.21 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.539 1.136 . . . . 0.0 109.934 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -137.05 132.48 34.25 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.311 1.044 . . . . 0.0 110.12 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.4 tp -90.87 98.56 11.85 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 16.4 mt -107.19 -178.92 3.78 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.629 1.172 . . . . 0.0 109.494 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -155.47 161.66 40.9 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -136.6 -178.3 5.11 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 124.567 1.147 . . . . 0.0 108.437 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -56.34 -23.04 34.68 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.876 1.27 . . . . 0.0 111.511 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 58.6 t -81.67 -66.81 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -174.71 -164.22 29.18 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -77.22 160.03 29.23 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.299 0.64 . . . . 0.0 111.205 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -168.2 161.39 12.31 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.653 1.581 . . . . 0.0 109.381 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 4.1 mt -106.6 133.47 51.03 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 178.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 4.1 t -108.55 131.68 54.6 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -134.59 124.85 26.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.0 tt -115.38 140.15 38.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.3 mt -135.2 115.7 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 O-C-N 121.699 -0.626 . . . . 0.0 110.971 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -105.33 -168.0 23.83 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.683 1.611 . . . . 0.0 110.015 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.5 t 78.16 58.05 0.03 OUTLIER 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.452 1.901 . . . . 0.0 110.713 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -110.53 -104.21 2.81 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 106.941 -2.464 . . . . 0.0 106.941 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -153.97 119.61 5.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 42.6 mm -60.66 133.95 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 123.963 0.905 . . . . 0.0 109.108 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 58.9 m -86.36 106.52 17.46 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.11 -15.68 5.96 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.307 0.958 . . . . 0.0 112.964 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 49.0 t -58.28 -46.4 88.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.983 1.313 . . . . 0.0 110.34 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.6 p -119.89 -20.88 7.38 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.553 1.141 . . . . 0.0 111.71 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 81.95 13.25 79.83 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 127.14 2.305 . . . . 0.0 112.139 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -85.77 170.59 12.3 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.549 1.54 . . . . 0.0 110.823 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.09 153.54 22.63 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 122.104 0.954 . . . . 0.0 111.536 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 29.9 ttm-85 -92.76 29.97 1.67 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 127.769 2.428 . . . . 0.0 109.463 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.0 ptt? -73.93 154.58 39.31 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.6 p -122.61 144.4 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.453 -177.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -111.57 131.91 54.92 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.7 mp -123.48 119.5 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 125.097 1.359 . . . . 0.0 108.835 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -100.84 120.64 40.43 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.68 0.792 . . . . 0.0 108.951 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -99.4 123.1 43.38 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.838 0.745 . . . . 0.0 110.137 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 14.8 m -135.12 170.08 20.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.9 1.28 . . . . 0.0 111.389 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.1 136.04 41.14 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -92.59 108.17 3.61 Favored Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 107.548 -2.221 . . . . 0.0 107.548 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -34.99 -54.3 0.87 Allowed Glycine 0 C--N 1.338 0.647 0 C-N-CA 126.728 2.109 . . . . 0.0 113.473 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 14.9 m -79.56 71.27 6.15 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -50.15 23.1 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.647 1 C-N-CA 133.767 4.827 . . . . 0.0 118.406 -178.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 7.9 t -145.96 47.39 1.24 Allowed 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.154 -1.591 . . . . 0.0 110.891 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -140.46 166.98 25.68 Favored Glycine 0 C--N 1.336 0.571 0 O-C-N 120.508 -1.37 . . . . 0.0 110.405 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.34 168.92 23.68 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 CA-C-N 119.623 1.711 . . . . 0.0 108.915 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 99.1 p -72.23 153.42 41.59 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.9 p -160.44 165.16 31.54 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.561 1.545 . . . . 0.0 108.18 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.2 mp -84.92 132.08 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -78.95 -55.33 5.22 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 124.804 1.242 . . . . 0.0 111.297 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 33.2 p-90 -146.24 165.45 29.17 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.408 HG12 ' CE1' ' A' ' 229' ' ' TYR . 52.6 t -144.38 139.19 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 126.259 1.824 . . . . 0.0 106.19 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.22 134.86 11.69 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.606 0.717 . . . . 0.0 110.621 178.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -90.54 90.35 7.96 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.3 p -75.32 -46.05 35.76 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.227 1.011 . . . . 0.0 111.584 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -103.52 -179.61 4.0 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.2 mp -78.16 -27.8 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.5 t -118.27 -56.81 2.13 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.288 1.435 . . . . 0.0 111.24 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 3.7 t -60.02 141.42 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . 0.408 ' CE1' HG12 ' A' ' 221' ' ' VAL . 1.2 t80 -125.85 150.5 47.82 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.905 2.082 . . . . 0.0 109.035 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -131.44 138.7 49.16 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.777 1.631 . . . . 0.0 108.837 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.71 162.22 40.19 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.091 1.757 . . . . 0.0 111.745 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -132.38 147.66 52.39 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 89.3 t -129.59 139.07 52.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 126.065 1.746 . . . . 0.0 108.377 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.92 140.77 46.3 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 124.134 0.974 . . . . 0.0 109.678 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 56.9 mt -137.83 140.4 29.42 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.53 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.85 -45.04 0.31 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.049 2.499 . . . . 0.0 112.284 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -61.08 -25.69 67.12 Favored 'General case' 0 N--CA 1.461 0.124 0 O-C-N 121.235 -0.916 . . . . 0.0 111.914 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.2 mp -60.1 -37.66 80.64 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 118.336 -0.84 . . . . 0.0 109.905 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 32.6 m -54.47 -26.7 32.71 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.819 1.648 . . . . 0.0 113.181 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -62.08 -30.15 70.8 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 41.7 mt -76.19 116.21 16.67 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.578 1.151 . . . . 0.0 112.151 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -48.19 -39.96 22.6 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.636 1.974 . . . . 0.0 114.853 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 13.4 mt -61.53 -34.08 74.91 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.183 -0.948 . . . . 0.0 112.968 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 1.9 mp -104.95 7.72 34.28 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.317 0 C-N-CA 129.084 2.954 . . . . 0.0 110.047 -178.523 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.534 0.331 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.8 90.04 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 118.616 0.644 . . . . 0.0 110.683 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 47.6 tp -61.53 -45.75 92.86 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.0 mt -64.5 -52.16 59.31 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.543 0.737 . . . . 0.0 110.484 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 53.3 m -54.89 -51.75 65.02 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.654 -0.654 . . . . 0.0 110.188 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -60.21 -46.59 89.23 Favored 'General case' 0 C--N 1.339 0.116 0 O-C-N 121.656 -0.652 . . . . 0.0 110.64 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.1 m -53.34 -45.96 69.3 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.093 0.957 . . . . 0.0 110.2 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 27.4 tp -59.45 -56.64 19.43 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.611 0.641 . . . . 0.0 110.721 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -56.56 -51.47 68.46 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 118.436 0.562 . . . . 0.0 111.723 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -55.2 -38.92 69.01 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.415 0.686 . . . . 0.0 109.674 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -67.04 -52.79 30.27 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 87.8 t -55.03 -53.32 35.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.734 1.214 . . . . 0.0 111.276 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -31.52 72.68 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 118.64 0.654 . . . . 0.0 110.822 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.0 m -69.71 -46.7 65.41 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 25.0 mt -57.33 -52.21 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.35 -41.02 88.24 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 119.171 -0.442 . . . . 0.0 111.466 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -60.54 -50.77 72.22 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.19 0.45 . . . . 0.0 110.79 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -71.32 -19.92 62.25 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.2 mp -102.8 -25.72 13.41 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.125 1.329 . . . . 0.0 111.526 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -55.12 -39.21 69.14 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 121.551 -0.718 . . . . 0.0 110.802 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.96 -42.73 89.58 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.487 -0.768 . . . . 0.0 111.184 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 -153.63 147.21 25.07 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 120.224 1.375 . . . . 0.0 112.403 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 60.7 m -76.14 167.88 21.06 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 36.3 pt -128.15 148.42 32.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.74 167.92 20.94 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.222 0.609 . . . . 0.0 112.141 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -151.04 127.43 10.66 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.318 1.447 . . . . 0.0 109.758 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -91.07 102.73 15.49 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.704 0.802 . . . . 0.0 109.176 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.27 66.75 8.53 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.89 -114.96 7.04 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -63.84 -32.87 74.53 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.036 0.934 . . . . 0.0 112.594 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -107.68 159.43 16.48 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 119.663 1.119 . . . . 0.0 111.094 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.6 mt -127.92 147.05 32.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -123.05 128.62 50.4 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.295 1.838 . . . . 0.0 108.776 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -122.2 130.52 53.28 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.619 1.968 . . . . 0.0 110.01 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -124.21 119.41 29.28 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.398 1.479 . . . . 0.0 108.256 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 14.9 m -108.52 157.71 35.86 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 123.45 0.7 . . . . 0.0 111.274 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -65.69 87.41 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.552 1 C-N-CA 125.67 4.246 . . . . 0.0 115.55 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.58 34.42 89.85 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 119.479 -0.623 . . . . 0.0 111.851 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.5 mt -112.44 -67.22 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.446 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 11.7 pt-20 -173.26 168.21 4.7 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.73 1.612 . . . . 0.0 109.379 -178.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.63 120.38 29.37 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 177.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.2 m -138.33 156.56 30.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 124.832 1.253 . . . . 0.0 111.553 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -132.64 127.05 34.05 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.958 0.903 . . . . 0.0 108.835 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -136.93 159.25 42.44 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 126.909 2.084 . . . . 0.0 113.283 -178.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -87.36 153.3 21.56 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 159.75 -164.98 34.42 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.83 147.35 49.46 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 89.8 t . . . . . 0 C--O 1.235 0.311 0 C-N-CA 124.398 1.079 . . . . 0.0 110.604 -178.895 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 . . . . . 0 N--CA 1.442 -0.832 0 CA-C-O 121.366 0.603 . . . . 0.0 111.479 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 48.7 mt . . . . . 0 N--CA 1.442 -0.84 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 179.41 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 19.2 tp . . . . . 0 CA--C 1.531 0.242 0 CA-C-O 120.681 0.277 . . . . 0.0 110.607 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 3.9 p -134.95 154.97 37.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.666 1.586 . . . . 0.0 110.002 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -143.32 151.38 40.42 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.125 1.37 . . . . 0.0 109.846 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 13.9 ptt-85 -99.18 135.49 40.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 125.513 1.525 . . . . 0.0 109.315 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.25 -65.67 1.1 Allowed 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 123.377 0.671 . . . . 0.0 109.722 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -130.73 150.21 19.25 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.75 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 6.5 ttpp -123.25 90.36 50.48 Favored Pre-proline 0 N--CA 1.451 -0.386 0 C-N-CA 125.932 1.693 . . . . 0.0 108.388 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 93.1 Cg_endo -70.59 175.14 9.19 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.956 2.438 . . . . 0.0 109.275 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -91.28 166.06 13.12 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.334 0.653 . . . . 0.0 110.531 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -77.61 -27.79 51.33 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.987 0.915 . . . . 0.0 113.316 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -112.99 137.89 50.71 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.725 1.21 . . . . 0.0 109.094 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.5 p -60.4 -27.34 39.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.22 1.008 . . . . 0.0 111.823 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -71.93 -8.32 53.78 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 129.128 2.971 . . . . 0.0 112.287 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -112.97 -5.13 13.81 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.676 1.99 . . . . 0.0 110.425 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 45.2 mmm-85 -82.55 165.73 19.87 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -134.24 96.59 3.64 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -111.3 139.57 46.6 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.283 1.833 . . . . 0.0 107.459 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -131.03 137.11 49.03 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.272 1.029 . . . . 0.0 109.029 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 43.8 tp -88.52 103.3 15.76 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.468 1.107 . . . . 0.0 109.717 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 7.2 mt -119.63 177.64 4.87 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.845 1.258 . . . . 0.0 108.342 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -157.49 166.85 31.87 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.579 0.751 . . . . 0.0 110.019 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.505 ' CG ' ' H ' ' A' ' 178' ' ' ASP . 31.6 t70 -136.6 -178.46 5.18 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.505 ' H ' ' CG ' ' A' ' 177' ' ' ASP . 0.5 OUTLIER -54.51 -30.67 54.22 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 125.491 1.516 . . . . 0.0 111.36 179.647 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 20.2 t -77.52 -64.25 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.491 1.116 . . . . 0.0 110.012 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -169.67 -170.83 34.61 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 119.059 0.845 . . . . 0.0 112.491 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -87.67 154.77 20.32 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 123.637 0.775 . . . . 0.0 110.816 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -159.72 172.83 17.01 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.719 1.208 . . . . 0.0 107.977 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.1 mt -117.41 137.96 49.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.2 t -106.0 118.29 36.23 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 124.916 1.385 . . . . 0.0 107.437 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.82 107.78 11.77 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 2.1 tt -101.99 128.33 54.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.1 mt -120.4 111.1 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.955 1.302 . . . . 0.0 111.551 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -104.75 -159.01 23.65 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 125.7 1.619 . . . . 0.0 110.042 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 74.82 36.94 0.53 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.772 1.629 . . . . 0.0 109.735 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -89.89 -126.91 3.18 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 107.576 -2.21 . . . . 0.0 107.576 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -137.35 127.95 26.85 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.9 mm -61.45 129.36 24.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 123.499 0.719 . . . . 0.0 111.784 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 5.1 m -90.0 94.07 9.65 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 101.198 -3.63 . . . . 0.0 101.198 176.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -57.67 -17.72 16.52 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.4 m -53.05 -33.04 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.466 1.507 . . . . 0.0 109.854 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 1.4 p -122.35 -34.01 3.36 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 123.25 0.62 . . . . 0.0 111.33 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 95.46 22.79 20.85 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.284 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -111.1 165.59 11.76 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.299 1.84 . . . . 0.0 109.159 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -87.21 145.48 26.38 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.355 1.462 . . . . 0.0 111.954 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -79.05 29.81 0.21 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.638 2.775 . . . . 0.0 111.06 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.8 ptm -73.12 149.44 43.04 Favored 'General case' 0 C--O 1.239 0.512 0 O-C-N 121.124 -0.985 . . . . 0.0 109.504 -177.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -116.73 146.88 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.607 -177.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -115.05 127.98 55.96 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.7 mp -117.06 116.53 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.109 0.964 . . . . 0.0 108.412 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -100.32 113.69 26.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -92.2 116.78 29.24 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 28.3 m -125.31 169.84 16.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 125.789 1.636 . . . . 0.0 111.806 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -81.37 137.41 35.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -101.24 122.46 7.6 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 107.364 -2.294 . . . . 0.0 107.364 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -45.32 -46.13 11.13 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.37 1.462 . . . . 0.0 113.238 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 8.3 t -81.62 65.2 6.65 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -57.14 28.19 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 130.099 3.36 . . . . 0.0 117.538 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.1 t -138.78 47.1 1.95 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 120.637 1.562 . . . . 0.0 112.486 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -153.24 172.68 32.15 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -73.28 167.1 28.18 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.276 1.984 . . . . 0.0 109.799 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.19 155.71 34.28 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.66 159.77 12.21 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.241 1.416 . . . . 0.0 107.373 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.86 128.89 37.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -72.9 -61.01 1.96 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 124.08 0.952 . . . . 0.0 109.184 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . 0.435 ' CE3' ' HD2' ' A' ' 222' ' ' ARG . 28.6 p-90 -139.64 167.2 22.65 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.595 1.558 . . . . 0.0 109.443 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 24.9 t -144.01 129.15 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.435 ' HD2' ' CE3' ' A' ' 220' ' ' TRP . 0.1 OUTLIER -145.51 118.03 8.55 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.99 0.9 . . . . 0.0 109.417 178.053 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -76.36 94.58 3.64 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 102.714 -3.069 . . . . 0.0 102.714 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 17.4 p -61.45 -66.41 0.54 Allowed 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.274 0.629 . . . . 0.0 109.669 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -101.38 179.12 4.45 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 34.7 mm -62.07 -21.47 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 123.535 0.734 . . . . 0.0 111.871 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.01 -45.57 1.26 Allowed 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.243 0.617 . . . . 0.0 111.228 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 25.2 t -67.29 133.58 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -130.09 144.63 51.45 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.752 1.621 . . . . 0.0 108.661 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -123.74 138.38 54.53 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 126.363 1.865 . . . . 0.0 107.944 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.1 156.51 43.94 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.868 1.267 . . . . 0.0 109.91 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -130.9 143.3 50.63 Favored 'General case' 0 CA--C 1.52 -0.211 0 O-C-N 121.344 -0.847 . . . . 0.0 110.673 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 61.1 t -125.61 140.89 47.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.44 1.496 . . . . 0.0 107.419 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.72 136.81 52.44 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 96.6 mt -133.02 143.47 48.67 Favored Pre-proline 0 C--O 1.236 0.385 0 CA-C-O 118.192 -0.909 . . . . 0.0 109.112 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.39 -44.2 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.34 2.026 . . . . 0.0 111.445 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -62.36 -20.3 64.26 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.721 1.208 . . . . 0.0 113.291 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 14.9 mt -69.63 -38.11 77.07 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.047 0.839 . . . . 0.0 109.982 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 34.5 m -54.31 -21.58 9.71 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.433 1.493 . . . . 0.0 113.61 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -61.94 -30.66 71.06 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.391 1.076 . . . . 0.0 110.835 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 52.8 mt -79.09 124.08 27.96 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -48.02 -45.41 31.94 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 126.267 1.827 . . . . 0.0 112.824 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 6.1 mp -60.7 -28.91 68.99 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.271 -0.893 . . . . 0.0 111.512 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -99.91 -0.68 39.05 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.596 1.558 . . . . 0.0 111.627 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.457 0 C-N-CA 125.744 1.618 . . . . 0.0 109.493 -179.808 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.4 p . . . . . 0 C--O 1.237 0.408 0 CA-C-O 119.545 -0.264 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.5 -45.59 93.24 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.415 0.686 . . . . 0.0 110.262 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.1 tp -62.74 -42.86 99.87 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 117.895 -1.05 . . . . 0.0 110.482 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.7 mt -58.99 -53.82 54.12 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.441 1.019 . . . . 0.0 109.123 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.6 m -56.1 -42.03 76.15 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.816 0.447 . . . . 0.0 110.129 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -65.72 -51.07 62.2 Favored 'General case' 0 CA--C 1.527 0.09 0 O-C-N 120.97 -1.082 . . . . 0.0 110.044 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.7 m -53.02 -43.19 66.34 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.182 1.393 . . . . 0.0 110.323 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 19.9 tp -60.08 -55.55 32.57 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.943 0.792 . . . . 0.0 111.489 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -65.46 -40.07 92.77 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 118.867 0.758 . . . . 0.0 112.124 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -61.59 -41.46 97.46 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 124.052 0.941 . . . . 0.0 109.851 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -66.26 -49.47 57.09 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 62.6 t -54.52 -53.05 34.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 126.036 1.734 . . . . 0.0 111.412 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -32.99 74.77 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 118.133 0.424 . . . . 0.0 110.463 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.09 -42.78 72.28 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 118.324 0.511 . . . . 0.0 110.492 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 16.6 mt -53.4 -53.5 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.97 -42.36 98.16 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 118.643 -0.694 . . . . 0.0 110.422 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -61.44 -30.04 70.33 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.948 0.794 . . . . 0.0 111.174 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -91.96 -3.81 55.42 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.67 1.188 . . . . 0.0 112.511 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.9 mt -119.75 -29.28 5.05 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.041 1.291 . . . . 0.0 112.586 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -62.07 -24.77 67.3 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.46 0.704 . . . . 0.0 111.313 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -73.45 -46.62 47.29 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.657 1.183 . . . . 0.0 108.565 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -161.33 145.16 13.01 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.034 1.733 . . . . 0.0 108.951 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 33.9 m -76.19 173.73 10.99 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.322 0.649 . . . . 0.0 109.778 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 42.1 pt -125.55 151.56 31.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 123.794 0.838 . . . . 0.0 109.209 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.89 160.89 41.76 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 122.849 0.46 . . . . 0.0 109.901 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -150.95 125.13 9.35 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.568 -0.708 . . . . 0.0 111.278 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -84.58 101.73 12.34 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 178.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.21 67.2 9.55 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.32 -115.68 6.94 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -66.85 -33.74 76.28 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -106.78 160.37 15.53 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.464 1.029 . . . . 0.0 110.363 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 21.3 mt -125.07 133.52 69.25 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 N-CA-C 104.894 -2.262 . . . . 0.0 104.894 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -110.63 131.64 54.88 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -121.49 128.36 52.0 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 125.245 1.418 . . . . 0.0 109.368 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -127.24 108.85 11.23 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 124.288 0.992 . . . . 0.0 112.096 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 1.7 m -98.23 159.28 31.07 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.038 0.935 . . . . 0.0 112.858 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.06 96.34 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.562 1 C-N-CA 125.925 4.417 . . . . 0.0 113.62 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 55.54 49.78 63.42 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-O 119.076 -0.847 . . . . 0.0 111.18 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 5.1 mt -125.95 -68.01 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.613 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -172.64 162.57 5.11 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -123.73 119.76 30.73 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 103.011 -2.959 . . . . 0.0 103.011 177.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.8 m -131.38 155.87 42.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 124.123 0.969 . . . . 0.0 111.166 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -122.51 131.63 53.94 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 177.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -146.11 157.41 43.84 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.972 0.909 . . . . 0.0 111.102 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -89.39 154.4 20.09 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 157.05 -163.62 32.41 Favored Glycine 0 C--N 1.33 0.231 0 O-C-N 120.175 -1.578 . . . . 0.0 110.768 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.09 144.3 51.06 Favored 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.4 p . . . . . 0 C--N 1.328 -0.368 0 C-N-CA 126.106 1.762 . . . . 0.0 106.454 -179.693 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 34.5 mm . . . . . 0 CA--C 1.547 0.832 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.414 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 47.3 mt . . . . . 0 C--O 1.233 0.206 0 N-CA-C 110.713 -0.106 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.9 p -142.8 141.69 27.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -132.5 157.83 43.65 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.605 1.562 . . . . 0.0 109.484 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -107.71 130.66 54.92 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.495 1.118 . . . . 0.0 109.746 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.4 -75.98 0.51 Allowed 'General case' 0 N--CA 1.458 -0.052 0 C-N-CA 124.434 1.093 . . . . 0.0 109.68 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -127.72 153.76 19.41 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -129.45 90.97 42.65 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -74.87 173.67 14.06 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.965 2.444 . . . . 0.0 110.984 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -83.16 164.52 20.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.825 0.821 . . . . 0.0 109.493 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -81.92 -24.02 35.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.307 -1.315 . . . . 0.0 113.592 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -102.03 144.1 31.04 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.8 p -72.95 -31.53 36.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 121.426 0.631 . . . . 0.0 110.199 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.55 -21.93 66.65 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.822 2.049 . . . . 0.0 110.571 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -83.48 -18.41 38.65 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.288 -0.883 . . . . 0.0 112.302 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.45 ' HD3' ' CE1' ' A' ' 172' ' ' PHE . 3.0 mtt180 -76.36 172.34 13.07 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.175 0.59 . . . . 0.0 112.304 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -136.75 95.03 3.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.254 1.422 . . . . 0.0 107.988 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.45 ' CE1' ' HD3' ' A' ' 170' ' ' ARG . 85.7 m-85 -99.09 161.61 13.53 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.64 1.176 . . . . 0.0 109.535 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -141.51 129.51 21.97 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 118.671 0.669 . . . . 0.0 110.155 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 21.5 tp -87.88 99.66 12.29 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 26.5 mt -106.84 -179.67 4.0 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.758 1.223 . . . . 0.0 109.556 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -159.72 159.88 33.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -140.81 -173.53 3.73 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -50.87 -34.03 26.4 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.953 1.701 . . . . 0.0 112.631 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 41.3 t -79.16 -73.47 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -165.65 -169.05 28.75 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 119.366 0.984 . . . . 0.0 111.959 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -78.49 156.37 29.35 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.269 0.628 . . . . 0.0 110.789 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -159.55 167.53 28.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.431 1.492 . . . . 0.0 107.616 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.3 mt -114.88 125.13 72.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.3 t -99.18 130.08 45.47 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -137.99 107.06 6.01 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 103.72 -2.696 . . . . 0.0 103.72 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.0 tt -99.65 140.45 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 15.2 mt -129.59 112.28 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 123.291 0.636 . . . . 0.0 110.092 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.34 -159.07 26.07 Favored Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.1 m 72.05 57.99 0.15 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.557 1.543 . . . . 0.0 109.286 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -116.4 -118.78 3.08 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 125.589 1.566 . . . . 0.0 109.501 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -140.59 122.81 15.8 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.366 1.466 . . . . 0.0 109.79 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.6 mm -61.15 119.29 4.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 126.065 1.746 . . . . 0.0 110.497 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 35.2 m -77.58 100.9 6.29 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -48.56 -29.7 4.51 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.737 1.615 . . . . 0.0 113.476 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 27.1 t -53.36 -40.84 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.186 1.394 . . . . 0.0 111.585 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 37.9 p -124.07 -18.4 5.92 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.694 0.759 . . . . 0.0 111.554 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 77.56 15.84 80.92 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 128.68 3.038 . . . . 0.0 111.994 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -86.45 168.9 13.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.068 1.347 . . . . 0.0 110.801 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -85.32 148.15 26.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.252 1.025 . . . . 0.0 108.443 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.91 29.93 0.99 Allowed 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 127.933 2.493 . . . . 0.0 111.232 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 11.9 ptt? -73.18 156.26 38.78 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.18 143.53 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.978 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -106.78 133.23 51.76 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.73 111.81 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 C-N-CA 124.378 1.071 . . . . 0.0 108.373 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -97.12 114.56 26.24 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -91.28 122.92 34.32 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.488 0.715 . . . . 0.0 110.142 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.82 176.49 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 125.864 1.666 . . . . 0.0 110.728 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.9 t -88.09 143.15 27.24 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -107.07 151.84 16.88 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -51.66 -61.55 6.3 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.843 1.687 . . . . 0.0 113.952 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 11.7 m -78.03 92.57 4.36 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 118.568 1.184 . . . . 0.0 108.669 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -66.42 17.36 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.041 2.536 . . . . 0.0 114.166 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 3.8 m -132.78 47.04 2.55 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 -177.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -157.88 175.51 35.12 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 120.647 -1.283 . . . . 0.0 111.552 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.44 162.6 37.89 Favored 'Trans proline' 0 C--O 1.239 0.562 0 C-N-CA 122.661 2.241 . . . . 0.0 110.959 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 12.4 p -69.38 162.09 28.03 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.875 0.87 . . . . 0.0 109.366 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.21 157.25 9.22 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.16 1.384 . . . . 0.0 107.927 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.83 132.32 33.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -81.25 -53.17 6.58 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 125.59 1.556 . . . . 0.0 111.377 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 41.3 p-90 -148.94 165.85 30.35 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 124.135 0.974 . . . . 0.0 108.446 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 49.1 t -145.67 136.39 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 127.146 2.179 . . . . 0.0 105.504 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.02 130.57 10.65 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -78.69 87.93 4.59 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 2.6 p -60.45 -53.45 57.41 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.423 0.689 . . . . 0.0 110.989 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 17.5 mmtp -114.81 179.33 3.98 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.6 mp -66.22 -33.04 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -108.83 -65.05 1.17 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.871 0.868 . . . . 0.0 109.88 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 5.5 t -55.35 138.88 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 124.892 1.277 . . . . 0.0 109.749 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -133.49 151.03 51.71 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.698 1.999 . . . . 0.0 108.341 -178.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -132.22 141.06 48.91 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 126.109 1.764 . . . . 0.0 108.793 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.01 162.31 37.26 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.429 2.292 . . . . 0.0 111.177 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -134.48 147.64 50.41 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.746 0.818 . . . . 0.0 108.898 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 93.3 t -134.66 135.5 53.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 C-N-CA 124.687 1.195 . . . . 0.0 108.689 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.7 p -102.75 142.19 34.31 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.706 0.802 . . . . 0.0 108.979 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 34.0 mt -139.48 137.61 19.13 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 123.693 0.797 . . . . 0.0 109.9 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.34 -34.66 2.63 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.914 2.41 . . . . 0.0 113.029 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -67.81 -26.46 66.09 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.224 -0.922 . . . . 0.0 110.595 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 3.9 mp -65.9 -34.47 78.21 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 28.3 m -59.13 -11.16 3.35 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.252 1.421 . . . . 0.0 112.98 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -81.96 -30.34 31.76 Favored 'General case' 0 CA--C 1.528 0.098 0 O-C-N 120.16 -1.587 . . . . 0.0 111.142 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 23.8 mt -78.78 111.88 15.35 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.41 -27.87 1.86 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 116.404 2.001 . . . . 0.0 116.404 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 5.2 mp -63.68 -45.03 91.92 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.466 0.706 . . . . 0.0 110.445 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -82.21 3.59 26.76 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 127.002 2.121 . . . . 0.0 113.3 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.32 0 C-N-CA 127.949 2.5 . . . . 0.0 110.584 -177.546 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.9 m . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 118.79 -0.624 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.59 -46.06 84.48 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.662 1.119 . . . . 0.0 110.064 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.9 tp -66.39 -39.74 89.24 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.112 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.2 mt -60.95 -51.75 67.94 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.403 1.002 . . . . 0.0 110.392 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 90.1 m -55.12 -56.45 19.75 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.26 1.424 . . . . 0.0 109.906 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.04 -48.91 78.66 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-O 119.043 -0.503 . . . . 0.0 111.332 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 54.9 m -52.84 -50.39 63.82 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.439 0.695 . . . . 0.0 111.41 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.9 tp -58.59 -54.12 50.7 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.766 -0.635 . . . . 0.0 110.138 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -55.12 -51.54 66.1 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.555 0.742 . . . . 0.0 112.071 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -59.09 -40.08 84.19 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.24 -52.48 52.45 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-O 118.146 -1.363 . . . . 0.0 110.973 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 29.5 t -55.72 -53.19 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 119.255 1.528 . . . . 0.0 111.289 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -35.04 79.13 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.863 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.2 m -64.91 -45.24 86.7 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 41.0 mt -56.66 -54.36 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -56.7 -43.23 80.34 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 123.278 0.361 . . . . 0.0 110.466 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -67.56 -37.63 82.94 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.823 -0.548 . . . . 0.0 112.294 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.86 -1.97 41.45 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.935 0.894 . . . . 0.0 113.235 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.2 mt -119.39 -26.16 5.89 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 119.645 1.111 . . . . 0.0 111.744 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -58.7 -23.57 59.83 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -74.22 -43.17 58.19 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 117.946 -1.026 . . . . 0.0 111.383 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -156.23 150.21 25.19 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.523 1.129 . . . . 0.0 112.376 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 57.4 m -76.02 171.58 14.21 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 23.0 pt -129.38 156.12 41.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 123.955 0.902 . . . . 0.0 109.018 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -151.21 154.03 36.06 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 122.059 -0.401 . . . . 0.0 111.196 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -141.37 127.42 19.51 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 124.118 0.967 . . . . 0.0 110.699 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -87.22 118.13 26.43 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -109.84 67.41 0.65 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.045 2.138 . . . . 0.0 106.105 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.14 -120.8 8.03 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -66.46 -33.07 74.87 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.531 1.132 . . . . 0.0 112.508 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -106.92 145.31 32.37 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 118.737 0.699 . . . . 0.0 109.847 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 10.6 mt -116.06 151.16 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -118.7 135.92 54.22 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 126.057 1.743 . . . . 0.0 106.447 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.63 131.43 48.07 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 125.661 1.584 . . . . 0.0 108.516 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -128.2 109.35 11.41 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.183 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 2.5 m -89.45 160.04 42.97 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 117.832 -1.08 . . . . 0.0 108.709 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -61.49 70.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 125.15 3.9 . . . . 0.0 116.145 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.46 48.74 65.6 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 125.257 1.408 . . . . 0.0 111.772 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.2 mt -114.65 -66.29 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -160.14 160.95 33.57 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.462 1.905 . . . . 0.0 107.915 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -123.46 120.81 34.02 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 102.525 -3.139 . . . . 0.0 102.525 177.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.94 155.52 27.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 123.593 0.757 . . . . 0.0 111.751 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -121.24 135.74 55.08 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -145.97 157.69 43.88 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 125.206 1.402 . . . . 0.0 111.144 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -88.78 151.44 22.39 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 164.68 -163.33 36.21 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.4 139.24 50.63 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.706 2.002 . . . . 0.0 106.268 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 91.5 t . . . . . 0 C--N 1.328 -0.335 0 C-N-CA 125.189 1.396 . . . . 0.0 109.594 -178.81 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 . . . . . 0 N--CA 1.454 -0.257 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 20.2 mt . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 179.784 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 93.3 mt . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.8 t -140.99 141.48 31.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -132.78 144.86 50.53 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.222 1.409 . . . . 0.0 110.084 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.3 mmt85 -93.39 114.19 26.54 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.937 1.295 . . . . 0.0 110.215 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.0 mp -89.85 -79.82 0.33 Allowed 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -118.58 157.23 15.33 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -133.63 88.63 33.18 Favored Pre-proline 0 N--CA 1.454 -0.258 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -77.37 172.2 16.36 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.069 2.513 . . . . 0.0 112.18 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -89.63 165.25 14.35 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 125.1 1.36 . . . . 0.0 111.659 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.95 -43.55 21.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.712 0.768 . . . . 0.0 110.708 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -78.96 130.0 35.1 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.666 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.7 p -64.88 -32.97 60.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 O-C-N 123.286 0.366 . . . . 0.0 110.149 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -67.72 -28.44 67.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.54 1.136 . . . . 0.0 112.049 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -71.81 -33.3 68.41 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -75.06 174.47 9.33 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.835 1.254 . . . . 0.0 109.251 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -143.53 149.28 37.23 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -136.76 146.58 45.93 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.933 1.293 . . . . 0.0 107.966 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.99 123.35 40.18 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.816 1.246 . . . . 0.0 110.115 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 tt -86.6 106.31 17.47 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 45.2 mt -113.45 177.99 4.44 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.597 1.159 . . . . 0.0 110.689 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -152.66 159.28 43.19 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -140.65 -178.42 5.51 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.43 -28.47 68.3 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 41.0 t -71.63 -56.66 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.256 1.022 . . . . 0.0 109.754 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 178.24 -173.69 46.11 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -78.05 164.13 25.31 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.068 0.547 . . . . 0.0 109.726 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -164.19 170.55 16.19 Favored 'General case' 0 N--CA 1.461 0.095 0 C-N-CA 125.434 1.493 . . . . 0.0 109.076 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 5.9 mt -118.2 134.67 61.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 103.816 -2.661 . . . . 0.0 103.816 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 21.1 t -110.57 139.61 45.66 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -137.3 112.71 9.3 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 6.3 tt -101.52 140.3 20.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.8 mt -131.46 110.7 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.201 1.0 . . . . 0.0 109.853 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -101.32 -157.68 27.03 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 49.6 m 70.57 55.76 0.27 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.562 1.145 . . . . 0.0 112.205 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -114.42 -126.31 4.24 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -130.01 123.67 31.12 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.911 1.684 . . . . 0.0 107.508 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.0 mm -60.94 146.18 11.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 124.805 1.242 . . . . 0.0 111.371 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 64.4 m -105.92 91.31 3.68 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 103.776 -2.675 . . . . 0.0 103.776 177.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -49.8 -30.78 10.28 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.614 1.166 . . . . 0.0 113.11 -178.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 60.6 t -45.96 -40.2 3.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 127.168 2.187 . . . . 0.0 110.276 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 7.1 p -120.4 -27.36 5.21 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.002 0.521 . . . . 0.0 110.963 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 92.31 22.57 29.18 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.898 1.714 . . . . 0.0 110.724 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -101.6 164.49 11.73 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.666 1.233 . . . . 0.0 112.388 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -89.49 146.47 24.6 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.541 -1.209 . . . . 0.0 107.866 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -77.35 30.84 0.15 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 127.522 2.329 . . . . 0.0 111.203 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -73.61 145.01 45.74 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 1.4 p -112.4 142.3 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 C-N-CA 124.468 1.107 . . . . 0.0 110.058 -177.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -109.51 123.59 49.65 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.2 mp -115.34 121.55 67.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 124.444 1.098 . . . . 0.0 108.822 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -102.37 116.67 33.12 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.47 0.708 . . . . 0.0 109.683 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -96.02 117.94 31.65 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.918 1.287 . . . . 0.0 109.625 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 22.2 m -133.21 167.85 25.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 124.565 1.146 . . . . 0.0 112.035 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.6 t -81.19 128.49 33.83 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 177.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.6 137.11 13.07 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -51.43 -41.84 49.35 Favored Glycine 0 C--N 1.336 0.528 0 CA-C-O 119.014 -0.881 . . . . 0.0 112.385 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.402 ' C ' ' H ' ' A' ' 213' ' ' SER . 4.7 m -80.71 74.9 7.63 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 178.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -71.33 30.88 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.218 2.207 . . . . 0.0 112.939 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' SER . . . . . 0.402 ' H ' ' C ' ' A' ' 211' ' ' SER . 37.8 m -143.96 47.33 1.43 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.208 2.203 . . . . 0.0 108.242 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -155.11 164.2 31.77 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -78.25 172.76 14.88 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.874 2.382 . . . . 0.0 112.354 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 24.2 m -62.25 147.63 47.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.485 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -165.92 156.29 12.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.8 mt -87.6 127.81 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -72.43 -52.95 13.68 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.783 1.233 . . . . 0.0 110.996 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 39.9 p-90 -150.58 166.6 29.76 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.002 1.321 . . . . 0.0 109.395 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 40.4 t -146.46 128.42 7.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 C-N-CA 126.015 1.726 . . . . 0.0 106.795 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.26 124.8 12.43 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.361 0.6 . . . . 0.0 109.898 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -79.42 93.06 5.3 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 103.08 -2.933 . . . . 0.0 103.08 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.0 p -68.8 -53.59 20.81 Favored 'General case' 0 C--O 1.237 0.424 0 O-C-N 121.667 -0.646 . . . . 0.0 110.348 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -103.33 174.54 5.82 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 25.1 mm -62.94 -27.62 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 O-C-N 121.89 -0.506 . . . . 0.0 111.144 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.89 -52.68 1.99 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.778 0.831 . . . . 0.0 110.697 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 1.7 t -64.94 132.33 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.737 0.815 . . . . 0.0 109.187 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -124.49 154.77 40.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.327 1.851 . . . . 0.0 109.187 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -131.23 137.77 49.05 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 125.937 1.695 . . . . 0.0 108.784 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -143.61 161.62 38.04 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 126.274 1.83 . . . . 0.0 110.544 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -137.63 143.76 41.57 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.9 m -133.69 146.59 31.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 123.808 0.843 . . . . 0.0 108.97 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.87 143.78 33.54 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.454 0.701 . . . . 0.0 110.08 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 22.9 mt -140.33 134.49 15.46 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.876 0.871 . . . . 0.0 109.135 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.12 -45.63 0.64 Allowed 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.176 1.917 . . . . 0.0 110.9 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -61.73 -21.43 64.5 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.4 mp -64.57 -36.32 83.84 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.685 1.13 . . . . 0.0 109.993 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 50.8 m -56.75 -23.53 43.49 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.022 1.729 . . . . 0.0 113.208 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -64.24 -26.98 68.74 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 121.236 -0.915 . . . . 0.0 112.769 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 28.9 mt -83.19 122.79 28.86 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -48.26 -41.27 27.26 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.95 2.1 . . . . 0.0 113.84 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 49.6 mt -63.52 -37.17 86.26 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.76 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 24.0 mt -97.29 6.67 47.98 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 127.19 2.196 . . . . 0.0 112.788 -177.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.311 0 C-N-CA 126.356 1.863 . . . . 0.0 108.644 179.777 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.9 p . . . . . 0 CA--C 1.532 0.27 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.49 -46.21 89.5 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 59.9 tp -59.65 -49.04 79.31 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.09 0.956 . . . . 0.0 109.098 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.9 mt -59.05 -50.49 73.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.363 1.065 . . . . 0.0 109.778 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 75.0 m -55.77 -52.48 63.83 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.225 1.41 . . . . 0.0 110.231 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -64.47 -41.9 96.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.214 1.006 . . . . 0.0 110.784 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 23.9 m -55.52 -51.69 66.19 Favored 'General case' 0 CA--C 1.523 -0.089 0 C-N-CA 125.284 1.434 . . . . 0.0 109.41 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.5 tp -56.98 -52.37 65.49 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 118.669 -0.682 . . . . 0.0 109.933 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -56.79 -50.86 71.06 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.478 0.581 . . . . 0.0 111.303 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -55.76 -38.89 70.46 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.546 1.138 . . . . 0.0 109.443 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.64 -53.26 36.17 Favored Glycine 0 N--CA 1.437 -1.25 0 CA-C-O 118.323 -1.265 . . . . 0.0 110.181 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.1 t -55.88 -53.13 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 119.297 1.548 . . . . 0.0 110.348 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -32.55 72.46 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 118.561 0.618 . . . . 0.0 112.007 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.3 m -68.2 -51.51 44.74 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 25.4 mt -55.1 -54.26 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.97 -39.14 80.84 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.648 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -61.89 -42.05 98.61 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 118.814 0.734 . . . . 0.0 111.257 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -82.0 -8.22 59.66 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 117.586 -1.197 . . . . 0.0 113.405 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.8 mp -111.65 -33.11 6.45 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 120.941 1.7 . . . . 0.0 110.87 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -53.67 -36.64 62.37 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 122.943 0.497 . . . . 0.0 110.876 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -61.94 -42.57 99.26 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 117.627 -1.178 . . . . 0.0 113.566 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -162.38 150.18 14.18 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 126.696 1.998 . . . . 0.0 111.261 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 31.5 m -75.96 167.27 22.17 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.713 0.805 . . . . 0.0 109.554 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.8 pt -125.55 157.27 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 125.256 1.423 . . . . 0.0 108.592 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.21 168.48 22.36 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.289 0.636 . . . . 0.0 111.667 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -151.68 119.94 6.35 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 124.883 1.273 . . . . 0.0 108.433 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -87.98 102.63 14.93 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.87 67.73 6.19 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.23 -116.2 9.02 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 107.815 -2.114 . . . . 0.0 107.815 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -65.51 -33.42 75.89 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -107.59 121.62 45.04 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 119.081 0.855 . . . . 0.0 111.128 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.5 mt -95.03 150.21 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -119.61 137.87 53.59 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 126.149 1.78 . . . . 0.0 106.354 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.19 132.19 41.26 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 125.288 1.435 . . . . 0.0 109.11 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -130.3 112.28 13.17 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 124.893 1.37 . . . . 0.0 109.859 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 6.8 m -96.04 159.38 32.36 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.006 0.922 . . . . 0.0 111.018 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -64.87 88.02 0.18 Allowed 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 123.714 2.942 . . . . 0.0 114.046 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 56.98 54.56 35.96 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.3 mt -126.49 -66.52 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.401 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 8.6 pt-20 -167.5 163.37 14.78 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.178 1.791 . . . . 0.0 108.193 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -124.62 115.75 21.3 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 101.473 -3.529 . . . . 0.0 101.473 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.4 m -130.23 155.55 41.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 123.456 0.702 . . . . 0.0 111.849 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -119.26 126.68 52.07 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 104.961 -2.236 . . . . 0.0 104.961 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -144.91 157.67 44.07 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.885 0.874 . . . . 0.0 112.339 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -89.29 154.59 19.97 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 177.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 166.25 -162.86 36.42 Favored Glycine 0 CA--C 1.521 0.426 0 O-C-N 120.282 -1.511 . . . . 0.0 111.723 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.1 131.72 45.84 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 177.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.4 p . . . . . 0 C--O 1.239 0.529 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 179.952 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 . . . . . 0 N--CA 1.45 -0.459 0 CA-C-O 121.281 0.563 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 47.6 mt . . . . . 0 C--N 1.329 -0.286 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 179.607 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 C--O 1.232 0.174 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.8 t -142.63 132.76 23.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 124.983 1.313 . . . . 0.0 108.452 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -121.7 150.18 42.17 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.926 1.69 . . . . 0.0 109.872 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -101.42 117.07 34.2 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 35.0 mt -89.35 -72.92 0.53 Allowed 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -133.69 152.45 20.49 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -122.7 94.77 47.25 Favored Pre-proline 0 N--CA 1.447 -0.584 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.406 ' HB2' HH22 ' A' ' 170' ' ' ARG . 41.8 Cg_endo -79.13 179.53 6.37 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 122.559 2.173 . . . . 0.0 109.723 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -92.09 173.03 8.04 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -90.59 -41.44 11.35 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.769 0.668 . . . . 0.0 110.268 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -83.35 138.29 33.59 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 125.666 1.586 . . . . 0.0 108.504 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.44 -24.3 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -77.56 -20.73 53.63 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.834 0.853 . . . . 0.0 113.059 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -76.64 -37.28 56.59 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.787 0.804 . . . . 0.0 110.547 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.406 HH22 ' HB2' ' A' ' 163' ' ' PRO . 0.3 OUTLIER -84.72 174.4 9.94 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.531 0.732 . . . . 0.0 110.192 179.563 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -147.6 120.56 8.77 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -96.75 160.01 14.61 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -131.62 122.04 25.36 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.982 0.913 . . . . 0.0 110.966 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 22.0 tp -84.65 103.53 13.84 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 36.0 mt -109.75 -179.84 3.92 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.134 1.374 . . . . 0.0 108.854 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.415 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 5.0 p90 -159.03 164.56 35.37 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.19 -0.944 . . . . 0.0 109.918 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -140.71 -178.29 5.46 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.1 -20.63 64.24 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.675 1.19 . . . . 0.0 110.641 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 74.0 t -79.65 -65.74 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -173.29 -172.27 38.65 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.122 1.344 . . . . 0.0 110.01 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.415 ' CD2' ' HB3' ' A' ' 176' ' ' TYR . 29.3 m-85 -83.69 164.47 19.62 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.538 0.735 . . . . 0.0 111.433 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -168.08 165.92 13.22 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.638 1.575 . . . . 0.0 109.247 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 4.8 mt -112.46 128.97 68.83 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 40.3 t -97.11 130.78 44.34 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 126.155 1.782 . . . . 0.0 108.205 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -138.15 107.48 6.12 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 7.6 tt -100.53 140.53 19.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 5.6 mt -131.76 111.26 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 123.72 0.808 . . . . 0.0 110.532 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.72 -161.21 25.85 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 178.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 50.6 m 71.38 50.08 0.29 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.234 1.814 . . . . 0.0 112.206 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -105.5 -95.2 2.38 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 107.514 -2.234 . . . . 0.0 107.514 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -154.48 123.78 6.45 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.553 1.541 . . . . 0.0 110.854 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.4 mm -65.6 116.87 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 119.616 1.098 . . . . 0.0 108.886 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 19.8 p -69.83 119.84 14.66 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 122.524 0.33 . . . . 0.0 110.908 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -70.72 -8.47 52.36 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.581 -0.699 . . . . 0.0 110.145 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 23.1 t -65.23 -42.93 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 126.359 1.864 . . . . 0.0 109.042 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 6.7 p -125.88 -27.88 3.27 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.948 0.795 . . . . 0.0 112.814 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 97.74 19.28 25.16 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 126.801 2.143 . . . . 0.0 110.036 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -107.25 168.3 9.31 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 119.2 1.5 . . . . 0.0 112.45 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.45 163.0 27.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 122.289 1.042 . . . . 0.0 111.401 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -99.3 29.09 4.12 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 126.514 1.926 . . . . 0.0 108.059 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -73.08 148.08 44.36 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.781 0.8 . . . . 0.0 110.433 -175.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.2 p -116.02 141.53 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.542 -177.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -110.65 124.52 52.06 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.6 mp -113.3 128.03 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 125.649 1.58 . . . . 0.0 109.059 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -108.4 107.7 18.36 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.581 1.152 . . . . 0.0 108.578 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -84.0 122.47 28.81 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 107.886 -1.154 . . . . 0.0 107.886 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 23.0 m -131.45 169.86 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 125.767 1.627 . . . . 0.0 112.527 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -83.11 144.05 30.13 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.633 -1.292 . . . . 0.0 107.735 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -113.39 123.62 6.23 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -32.04 -62.2 0.29 Allowed Glycine 0 CA--C 1.523 0.55 0 C-N-CA 128.954 3.169 . . . . 0.0 114.765 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 2.0 p -78.02 89.79 4.18 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -67.33 35.09 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.107 2.163 . . . . 0.0 115.488 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.4 m -148.5 45.82 1.04 Allowed 'General case' 0 CA--C 1.54 0.559 0 O-C-N 119.837 -1.789 . . . . 0.0 111.161 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.54 162.59 28.48 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.02 169.86 20.34 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.849 2.366 . . . . 0.0 112.036 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 10.3 m -70.7 156.09 39.93 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -168.45 155.88 7.87 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.8 mt -77.73 134.17 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -74.14 -61.43 1.86 Allowed 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 41.7 p-90 -140.25 166.47 24.61 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 125.812 1.645 . . . . 0.0 109.121 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.446 HG13 ' CE1' ' A' ' 229' ' ' TYR . 53.3 t -147.5 134.6 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.19 131.35 11.08 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -85.69 86.37 7.37 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 101.629 -3.471 . . . . 0.0 101.629 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 8.6 p -61.2 -58.09 9.73 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.88 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 56.3 mmtt -91.61 -172.82 3.35 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.7 mp -74.54 -36.61 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 121.021 -1.049 . . . . 0.0 109.492 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 4.6 m -120.91 -43.08 2.47 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.468 0.707 . . . . 0.0 111.835 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 1.1 t -67.7 136.11 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . 0.446 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.7 OUTLIER -124.11 148.02 47.48 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.41 2.284 . . . . 0.0 110.011 -178.01 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -126.18 138.21 53.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.369 2.268 . . . . 0.0 106.655 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.95 161.98 38.84 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.943 1.697 . . . . 0.0 111.065 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -138.35 149.67 45.82 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.453 0.701 . . . . 0.0 109.962 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 72.2 t -133.18 135.96 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.593 1.157 . . . . 0.0 109.306 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.37 130.0 53.57 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.171 1.389 . . . . 0.0 111.26 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 33.4 mt -133.56 138.49 31.29 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-O 118.612 -0.708 . . . . 0.0 110.522 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.76 -43.9 1.63 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.213 2.609 . . . . 0.0 112.467 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -63.57 -20.44 65.64 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 37.1 mt -72.01 -35.28 69.38 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-O 118.828 -0.606 . . . . 0.0 110.037 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 48.2 m -56.3 -21.67 25.53 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.393 1.477 . . . . 0.0 113.149 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -65.98 -31.39 72.27 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.626 0.77 . . . . 0.0 112.115 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 64.4 mt -77.02 116.46 17.7 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -48.1 -37.12 14.56 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.5 mp -63.73 -36.76 84.94 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.01 -1.056 . . . . 0.0 110.028 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -91.87 3.21 55.69 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.746 2.019 . . . . 0.0 112.704 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.714 0 C-N-CA 123.779 0.832 . . . . 0.0 111.002 179.688 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 43.4 p . . . . . 0 CA--C 1.528 0.114 0 CA-C-O 119.395 -0.336 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.94 -48.81 75.05 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.908 0.883 . . . . 0.0 108.774 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 41.6 tp -57.71 -46.76 83.95 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.9 mt -59.1 -53.22 60.79 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.458 0.703 . . . . 0.0 109.704 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 38.6 m -55.1 -43.64 74.21 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.132 1.373 . . . . 0.0 110.803 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.75 -51.52 33.38 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 117.843 -1.075 . . . . 0.0 109.013 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 42.0 m -54.36 -44.26 72.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 119.701 1.137 . . . . 0.0 110.971 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.3 tp -60.12 -55.51 32.96 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 118.686 0.675 . . . . 0.0 109.612 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -56.72 -49.55 74.84 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.779 1.232 . . . . 0.0 110.598 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -57.35 -49.81 74.95 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.722 1.209 . . . . 0.0 108.543 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.78 -46.45 94.48 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 49.9 t -58.8 -52.23 62.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 C-N-CA 126.096 1.758 . . . . 0.0 111.133 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -32.66 74.45 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 119.552 1.069 . . . . 0.0 109.732 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.5 m -66.85 -43.27 84.11 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 34.7 mt -59.16 -51.89 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -35.68 72.27 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.98 -0.533 . . . . 0.0 111.297 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -66.89 -56.56 9.73 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.244 0.929 . . . . 0.0 109.953 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.89 -24.12 66.74 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -178.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 80.5 mt -94.31 -27.93 15.84 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 119.045 0.839 . . . . 0.0 109.955 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -64.1 -27.33 69.02 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 121.663 -0.648 . . . . 0.0 109.709 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -63.74 -46.89 83.3 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.346 1.058 . . . . 0.0 109.012 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -163.37 156.46 18.87 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 126.073 1.749 . . . . 0.0 110.487 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 76.8 m -75.84 176.2 8.03 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 34.1 pt -135.58 149.78 28.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.69 168.13 20.92 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.091 0.556 . . . . 0.0 111.337 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -154.96 128.54 8.55 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.339 1.056 . . . . 0.0 112.16 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -92.45 102.61 15.07 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.4 0.68 . . . . 0.0 109.35 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.92 67.63 8.23 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.461 1.904 . . . . 0.0 106.558 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 67.21 -115.36 7.08 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -68.25 -33.22 73.98 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 118.789 -0.624 . . . . 0.0 112.188 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -106.25 154.18 21.1 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 119.794 1.179 . . . . 0.0 111.603 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.7 mt -121.36 149.94 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -126.76 129.08 47.66 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 127.014 2.125 . . . . 0.0 107.993 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -125.3 125.21 43.16 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 127.104 2.162 . . . . 0.0 109.13 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -122.68 126.67 48.05 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.978 1.311 . . . . 0.0 109.637 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 17.8 m -113.72 157.24 42.19 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.641 0.776 . . . . 0.0 112.77 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -60.29 90.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.354 0.845 1 C-N-CA 126.163 4.575 . . . . 0.0 115.976 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 62.21 31.05 77.71 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.874 -0.491 . . . . 0.0 111.874 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.9 mt -110.64 -66.08 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.252 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.443 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 9.4 pt-20 179.67 164.74 1.08 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.753 1.621 . . . . 0.0 109.689 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.35 123.12 38.7 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.2 m -131.23 155.85 42.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 124.385 1.074 . . . . 0.0 111.747 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -123.29 122.72 39.04 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.908 1.683 . . . . 0.0 108.144 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -146.45 156.71 43.49 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.364 1.066 . . . . 0.0 111.404 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -93.15 153.53 18.59 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 168.18 -163.71 37.39 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -116.18 142.9 46.21 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.234 0.25 0 C-N-CA 124.004 0.922 . . . . 0.0 108.886 -179.141 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 . . . . . 0 C--O 1.237 0.397 0 CA-C-O 120.641 0.257 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.3 mt . . . . . 0 C--N 1.328 -0.349 0 N-CA-C 103.66 -2.719 . . . . 0.0 103.66 178.339 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 76.9 mt . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 41.9 t -137.96 138.12 44.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -141.56 153.51 44.88 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.364 1.465 . . . . 0.0 108.33 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -109.88 127.92 55.02 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.508 1.523 . . . . 0.0 110.513 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -90.66 -71.16 0.64 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -133.59 160.66 24.08 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 124.137 0.875 . . . . 0.0 111.759 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -130.36 90.6 40.91 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 126.167 1.787 . . . . 0.0 107.879 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 54.6 Cg_endo -75.95 -175.55 2.56 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 124.471 3.447 . . . . 0.0 110.288 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -110.75 161.19 16.03 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.915 0.886 . . . . 0.0 110.314 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.15 -29.55 57.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.731 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -99.11 133.79 42.89 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.6 p -67.18 -26.43 36.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 122.917 0.487 . . . . 0.0 110.349 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -74.0 -16.19 61.07 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.145 1.778 . . . . 0.0 112.548 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -91.94 -13.69 30.74 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.63 1.572 . . . . 0.0 108.744 177.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -107.15 175.25 5.56 Favored 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 126.961 2.104 . . . . 0.0 107.786 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -148.07 152.34 37.2 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -138.6 165.52 26.68 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.784 1.234 . . . . 0.0 107.819 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -139.37 122.59 16.97 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.477 1.111 . . . . 0.0 109.296 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 25.7 tp -88.89 100.16 12.96 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 54.1 mt -106.29 -179.55 3.97 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.281 2.233 . . . . 0.0 110.504 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -156.54 151.8 26.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.137 0.975 . . . . 0.0 109.035 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -134.32 -174.54 3.59 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.066 1.746 . . . . 0.0 106.621 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -54.87 -31.4 59.7 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.997 2.119 . . . . 0.0 112.035 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 73.0 t -69.81 -67.53 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -177.61 -163.6 29.71 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -78.19 160.95 27.68 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.421 0.688 . . . . 0.0 109.397 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -165.84 168.4 15.97 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.27 1.428 . . . . 0.0 109.453 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.0 mt -117.45 124.85 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.3 t -102.16 133.44 47.01 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -137.04 111.57 8.63 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.6 tt -101.1 127.82 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 5.8 mt -120.39 114.13 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.29 1.036 . . . . 0.0 111.522 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.0 -172.81 27.64 Favored Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 125.17 1.367 . . . . 0.0 111.455 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.2 t 84.57 58.52 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 128.242 2.617 . . . . 0.0 110.808 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -110.23 -127.4 5.28 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 107.656 -2.178 . . . . 0.0 107.656 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -126.82 118.79 25.34 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 19.1 mm -59.82 134.53 25.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 18.9 p -89.25 106.73 18.63 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -63.66 -12.22 32.18 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 119.104 0.865 . . . . 0.0 110.385 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 29.0 t -60.73 -42.01 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 126.937 2.095 . . . . 0.0 109.767 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 3.5 p -125.23 -24.06 4.05 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.856 0.753 . . . . 0.0 112.504 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 87.51 29.31 22.08 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 108.499 -1.84 . . . . 0.0 108.499 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -108.15 164.55 12.2 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 122.545 1.165 . . . . 0.0 111.283 178.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -91.51 138.41 31.59 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 1.8 mtt85 -70.69 29.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 129.921 3.288 . . . . 0.0 112.784 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 16.0 ptt? -72.46 148.81 44.77 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.018 0.913 . . . . 0.0 110.552 -174.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -115.91 143.39 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.369 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -108.26 133.61 52.25 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.41 110.17 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -95.21 108.4 20.53 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.656 0.782 . . . . 0.0 109.814 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -84.68 126.85 33.73 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.054 0.542 . . . . 0.0 109.726 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 32.3 m -139.27 175.65 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 125.877 1.671 . . . . 0.0 112.315 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.9 t -93.0 126.16 37.94 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.533 1.533 . . . . 0.0 107.563 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.12 164.82 44.57 Favored Glycine 0 N--CA 1.467 0.756 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -54.12 -76.12 0.2 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 125.094 1.33 . . . . 0.0 110.394 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 47.8 m -70.85 145.73 50.08 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 34.0 p30 -117.26 33.26 5.71 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 29.6 m -134.78 47.33 2.38 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.733 1.213 . . . . 0.0 113.433 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -153.54 165.71 31.53 Favored Glycine 0 CA--C 1.524 0.615 0 O-C-N 120.451 -1.405 . . . . 0.0 110.333 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -70.82 163.99 37.18 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.038 1.825 . . . . 0.0 110.327 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 14.1 p -67.24 155.83 37.86 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.236 1.014 . . . . 0.0 109.137 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -169.02 159.42 9.25 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.67 1.188 . . . . 0.0 108.711 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.6 mp -76.74 134.03 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -78.11 -55.34 5.36 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 125.973 1.709 . . . . 0.0 109.934 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . 0.402 ' CE3' ' CD ' ' A' ' 222' ' ' ARG . 27.9 p-90 -145.69 165.05 29.9 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 124.755 1.222 . . . . 0.0 108.686 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 39.0 t -144.47 127.39 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.402 ' CD ' ' CE3' ' A' ' 220' ' ' TRP . 0.3 OUTLIER -153.82 118.69 5.01 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 124.107 0.879 . . . . 0.0 109.189 179.355 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -74.64 95.2 2.79 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 102.626 -3.102 . . . . 0.0 102.626 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.7 p -63.73 -57.77 8.95 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.81 0.844 . . . . 0.0 111.69 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -100.87 -178.51 3.79 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.4 mp -58.2 -41.55 81.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 O-C-N 121.79 -0.569 . . . . 0.0 110.022 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -123.52 -10.1 7.93 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -177.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 59.0 t -91.74 130.5 40.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -123.38 143.51 50.07 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.218 1.007 . . . . 0.0 108.354 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -127.3 140.92 51.87 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 125.609 1.564 . . . . 0.0 107.451 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -139.7 159.04 43.09 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.272 1.829 . . . . 0.0 108.042 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -131.48 144.62 51.28 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 99.6 t -132.55 133.44 59.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.2 p -104.66 141.0 37.22 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 43.6 mt -137.36 137.12 21.55 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -72.99 -39.28 2.35 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.065 1.843 . . . . 0.0 112.127 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -60.52 -34.61 74.35 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.587 0.63 . . . . 0.0 111.338 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 5.1 mp -59.45 -29.95 68.15 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-O 118.745 -0.645 . . . . 0.0 111.428 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 57.2 m -63.57 -19.35 64.75 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.935 0.894 . . . . 0.0 112.618 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -67.46 -38.58 84.66 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.169 0.588 . . . . 0.0 111.086 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 49.6 mt -67.0 117.45 9.08 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.352 1.061 . . . . 0.0 108.539 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -48.36 -37.87 17.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.347 1.459 . . . . 0.0 114.874 -178.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 17.9 mt -62.72 -33.55 75.35 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.578 -0.702 . . . . 0.0 110.015 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -98.21 2.42 48.35 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.986 2.115 . . . . 0.0 113.064 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.517 0 C-N-CA 124.534 1.134 . . . . 0.0 107.998 179.036 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.9 p . . . . . 0 CA--C 1.535 0.376 0 CA-C-O 119.726 -0.178 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.68 -45.21 91.13 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.479 -0.763 . . . . 0.0 108.971 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 45.8 tp -58.42 -44.79 89.22 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.707 1.203 . . . . 0.0 108.434 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 11.5 mt -64.05 -54.92 26.59 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.238 1.015 . . . . 0.0 110.184 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.3 m -57.14 -44.24 83.19 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.03 -1.044 . . . . 0.0 110.784 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -62.31 -50.46 71.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 120.977 -1.077 . . . . 0.0 108.441 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.0 m -56.0 -40.77 73.85 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.144 0.977 . . . . 0.0 110.477 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 13.6 tp -62.29 -53.33 56.64 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.726 0.694 . . . . 0.0 109.136 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.34 -48.33 80.9 Favored 'General case' 0 C--N 1.335 -0.064 0 C-N-CA 123.43 0.692 . . . . 0.0 110.616 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -60.86 -42.88 98.73 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.374 1.47 . . . . 0.0 110.269 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.11 -47.11 85.13 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 94.5 t -57.87 -53.07 50.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 118.566 1.183 . . . . 0.0 110.125 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -31.4 72.55 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 119.177 0.899 . . . . 0.0 110.488 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.6 m -65.75 -48.11 72.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 40.8 mt -58.78 -53.02 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 C-N-CA 123.886 0.875 . . . . 0.0 108.805 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.47 -36.57 73.92 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.326 0.512 . . . . 0.0 111.31 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -63.58 -54.5 35.0 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.536 1.062 . . . . 0.0 108.318 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.21 10.59 0.55 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 128.399 2.68 . . . . 0.0 114.825 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.6 mt -132.68 -32.85 1.25 Allowed 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 124.636 1.174 . . . . 0.0 108.278 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -61.39 -34.43 75.33 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -59.14 -45.05 91.95 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.92 1.688 . . . . 0.0 111.922 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -166.72 153.04 8.52 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.593 1.957 . . . . 0.0 109.683 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.0 m -76.48 174.76 9.9 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 27.5 pt -131.66 152.16 36.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -146.75 165.05 30.82 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 122.91 0.484 . . . . 0.0 110.786 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -150.34 128.48 11.95 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.539 1.536 . . . . 0.0 110.595 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -94.27 102.8 14.82 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.463 1.105 . . . . 0.0 109.707 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.77 66.87 6.16 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.52 -115.47 7.67 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -63.6 -35.26 79.92 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.325 1.05 . . . . 0.0 112.213 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -107.14 153.45 22.63 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 119.211 0.914 . . . . 0.0 110.502 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.2 mt -119.92 152.68 22.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -124.97 132.47 53.27 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 127.182 2.193 . . . . 0.0 107.31 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -126.96 132.93 50.71 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 125.87 1.668 . . . . 0.0 107.376 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -129.49 111.52 12.84 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 6.6 m -100.37 159.0 30.92 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 123.814 0.846 . . . . 0.0 111.236 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -61.46 92.97 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 124.442 3.428 . . . . 0.0 114.121 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 54.95 39.28 67.97 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.062 -0.854 . . . . 0.0 112.217 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.4 mt -109.9 -66.94 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -171.32 161.34 6.47 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.982 1.713 . . . . 0.0 106.917 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -119.91 121.7 39.6 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 101.625 -3.472 . . . . 0.0 101.625 177.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.1 m -137.39 155.06 31.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 123.506 0.722 . . . . 0.0 111.725 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -119.91 132.6 55.59 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 177.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -146.34 158.19 43.86 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.235 1.014 . . . . 0.0 113.032 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -88.8 148.46 23.9 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 165.64 -162.93 36.3 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.95 147.04 50.81 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 124.497 1.119 . . . . 0.0 108.186 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 C--N 1.325 -0.478 0 C-N-CA 124.988 1.315 . . . . 0.0 107.813 179.78 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 . . . . . 0 N--CA 1.448 -0.551 0 CA-C-O 120.471 0.177 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 56.3 mt . . . . . 0 CA--C 1.549 0.928 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 177.414 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 43.3 mt . . . . . 0 C--O 1.231 0.096 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 12.2 t -140.91 135.44 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.924 1.29 . . . . 0.0 109.351 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -119.64 176.27 5.46 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.735 1.214 . . . . 0.0 110.972 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -128.31 120.31 26.82 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 26.2 mt -96.77 -67.37 0.85 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.738 1.215 . . . . 0.0 109.807 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -127.25 149.2 17.73 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.406 ' HB3' ' HB3' ' A' ' 189' ' ' SER . 26.7 tttp -124.89 83.54 59.59 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 125.969 1.708 . . . . 0.0 108.261 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -75.58 173.61 14.2 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.403 2.069 . . . . 0.0 109.928 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -92.89 161.57 14.43 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.554 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -80.68 -22.98 39.91 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.742 0.817 . . . . 0.0 112.929 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -112.35 147.51 36.22 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.157 0.983 . . . . 0.0 108.456 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.2 p -71.25 -32.14 46.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -74.14 -12.87 60.72 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -177.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -84.68 -18.67 34.56 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.474 0.309 . . . . 0.0 110.289 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -111.84 171.84 7.25 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.662 1.185 . . . . 0.0 111.983 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -138.69 117.14 12.03 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.445 1.098 . . . . 0.0 109.471 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -96.76 158.29 15.5 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -130.55 126.6 37.18 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.081 0.553 . . . . 0.0 112.159 -177.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.2 tt -90.28 101.8 14.52 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.332 0.653 . . . . 0.0 110.504 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 5.2 mt -115.03 174.81 5.79 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.87 1.668 . . . . 0.0 108.333 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -143.02 163.96 31.37 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 120.345 -1.472 . . . . 0.0 109.069 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -137.94 -176.38 4.41 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.902 1.681 . . . . 0.0 110.388 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -69.39 5.28 1.37 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.401 1.88 . . . . 0.0 115.076 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 41.5 t -118.9 -63.98 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -162.51 -160.86 11.47 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 119.812 1.187 . . . . 0.0 111.888 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -91.13 160.85 15.36 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -164.84 171.88 13.61 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 7.4 mt -121.07 133.57 67.28 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 4.4 t -111.13 132.11 54.55 Favored 'General case' 0 N--CA 1.439 -1.002 0 O-C-N 124.579 1.175 . . . . 0.0 108.752 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -133.64 111.57 10.72 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.8 tt -96.79 132.78 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.5 mt -124.32 111.4 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 124.501 1.121 . . . . 0.0 111.03 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -103.34 -158.54 25.01 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 162' ' ' LYS . 1.6 t 70.69 28.29 3.5 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 127.062 2.145 . . . . 0.0 112.286 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -81.28 -90.45 0.56 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 103.611 -3.796 . . . . 0.0 103.611 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -157.14 165.97 34.54 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 29.2 mm -94.36 145.5 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 126.235 1.814 . . . . 0.0 108.448 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.8 p -107.71 98.41 8.01 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 106.114 -1.809 . . . . 0.0 106.114 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -63.22 -7.62 6.42 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 120.28 1.4 . . . . 0.0 112.444 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 86.0 t -63.65 -38.43 82.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 126.499 1.92 . . . . 0.0 108.147 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 21.0 p -119.45 -32.5 4.32 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.213 1.005 . . . . 0.0 110.539 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 88.72 32.95 10.47 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -118.01 -176.93 3.15 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.643 1.577 . . . . 0.0 109.116 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -102.89 148.34 25.77 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.878 0.871 . . . . 0.0 110.228 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.04 29.62 0.08 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 129.317 3.047 . . . . 0.0 111.312 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -72.74 151.48 42.12 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 120.819 -1.176 . . . . 0.0 110.967 -174.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.3 p -121.95 149.12 25.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.771 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -114.95 130.35 56.9 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.6 mp -117.63 111.91 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -96.04 108.39 20.8 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.651 1.18 . . . . 0.0 108.835 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -87.83 121.15 29.9 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.115 0.966 . . . . 0.0 111.677 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.71 163.86 36.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 126.085 1.754 . . . . 0.0 111.002 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.17 139.8 40.01 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -94.85 178.23 36.11 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -89.77 -39.14 6.29 Favored Glycine 0 CA--C 1.525 0.699 0 O-C-N 121.909 -0.759 . . . . 0.0 111.513 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.8 t -82.62 94.8 7.61 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -77.64 39.8 0.28 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.066 0.546 . . . . 0.0 111.246 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 41.0 p -156.7 26.26 0.33 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -138.18 176.99 20.39 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 118.676 0.671 . . . . 0.0 112.562 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.47 164.33 28.7 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.298 2.666 . . . . 0.0 112.098 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 8.6 t -70.91 159.58 34.41 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.89 161.85 7.22 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 126.079 1.752 . . . . 0.0 107.452 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.8 mp -82.2 130.08 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -71.15 -59.22 2.89 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.539 1.135 . . . . 0.0 110.351 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 29.6 p-90 -143.55 166.04 25.92 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 125.244 1.418 . . . . 0.0 108.552 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 42.7 t -145.55 127.74 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.82 118.23 8.48 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 177.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -77.81 91.27 4.1 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 101.002 -3.703 . . . . 0.0 101.002 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.7 p -56.75 -53.13 61.37 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.871 1.669 . . . . 0.0 113.513 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.453 ' HB2' ' H ' ' A' ' 228' ' ' VAL . 71.6 mmtt -116.14 176.63 5.01 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 16.9 mm -61.72 -30.52 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -122.69 -24.28 4.92 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.453 ' H ' ' HB2' ' A' ' 225' ' ' LYS . 21.8 t -90.28 135.67 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -131.81 142.13 49.64 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -127.17 140.04 52.53 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 125.111 1.364 . . . . 0.0 108.615 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -140.72 159.12 42.88 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.462 1.505 . . . . 0.0 109.042 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -130.56 139.63 50.46 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 79.7 t -122.06 146.74 26.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 124.503 1.121 . . . . 0.0 108.313 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.52 130.4 54.23 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 123.122 0.569 . . . . 0.0 109.98 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 63.4 mt -132.19 137.94 31.18 Favored Pre-proline 0 C--O 1.236 0.383 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.193 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -74.89 -44.88 0.32 Allowed 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.188 1.926 . . . . 0.0 112.478 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.84 -25.76 21.15 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.681 1.192 . . . . 0.0 113.261 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 88.6 mt -67.49 -34.38 77.02 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-N 118.651 0.659 . . . . 0.0 112.762 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 19.0 m -57.66 -17.75 16.6 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.879 1.272 . . . . 0.0 114.312 -178.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -64.12 -29.02 70.17 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.941 -0.475 . . . . 0.0 110.363 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 30.0 mt -80.29 113.44 18.47 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -49.61 -30.74 9.31 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 17.5 mt -62.74 -36.18 82.18 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.756 -0.59 . . . . 0.0 109.535 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -95.28 2.96 54.96 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 126.888 2.075 . . . . 0.0 114.586 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.597 0 C-N-CA 126.58 1.952 . . . . 0.0 109.101 179.551 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.4 p . . . . . 0 CA--C 1.531 0.237 0 CA-C-O 118.858 -0.591 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.48 -45.56 92.48 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.001 0.819 . . . . 0.0 110.03 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.7 tp -60.95 -40.66 94.16 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 118.947 0.794 . . . . 0.0 109.449 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.4 mt -60.65 -54.38 46.02 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 55.9 m -54.2 -44.88 72.0 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.499 1.12 . . . . 0.0 111.534 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.2 ttmt -62.78 -50.99 68.85 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 m -56.88 -42.91 80.68 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 117.815 -1.088 . . . . 0.0 111.156 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 20.9 tp -62.66 -53.48 53.93 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 119.881 1.219 . . . . 0.0 109.504 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -55.38 -52.41 63.62 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 123.91 0.884 . . . . 0.0 111.198 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -55.22 -50.48 69.31 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 125.008 1.323 . . . . 0.0 108.496 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.05 -50.27 67.57 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 123.91 0.767 . . . . 0.0 112.081 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 89.9 t -59.18 -53.23 50.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 124.215 1.006 . . . . 0.0 110.136 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -30.86 71.9 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 118.983 0.811 . . . . 0.0 110.6 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.4 m -66.49 -45.15 80.6 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 31.0 mt -58.28 -53.84 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.21 -37.59 83.53 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.183 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -60.74 -44.46 96.63 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.215 1.006 . . . . 0.0 109.472 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.86 -19.29 44.81 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 71.0 mt -100.74 -25.06 14.26 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 121.132 1.787 . . . . 0.0 112.793 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -59.36 -21.12 59.37 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -71.2 -46.09 61.98 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.77 2.428 . . . . 0.0 110.542 179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -162.28 153.29 17.68 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 125.558 1.543 . . . . 0.0 112.456 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.6 m -76.36 159.92 30.06 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 175.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 24.7 pt -117.63 154.64 19.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -147.09 165.86 28.66 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.294 0.569 . . . . 0.0 111.217 -178.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -151.1 134.56 16.23 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.094 1.357 . . . . 0.0 109.555 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -97.45 105.39 17.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 123.52 0.728 . . . . 0.0 109.813 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.84 67.33 9.79 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.104 1.361 . . . . 0.0 107.609 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 69.76 -115.18 6.07 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -66.83 -32.4 73.66 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.028 1.331 . . . . 0.0 112.679 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -106.09 162.84 13.26 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 119.036 0.835 . . . . 0.0 111.89 -177.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 45.3 mt -130.66 149.43 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -125.49 129.81 50.53 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.182 2.193 . . . . 0.0 108.255 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -125.98 129.6 49.54 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.333 1.853 . . . . 0.0 109.392 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -124.03 117.16 24.08 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.941 1.696 . . . . 0.0 109.666 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 19.8 m -99.35 159.7 29.43 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.574 1.15 . . . . 0.0 111.056 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -62.78 87.24 0.11 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 124.797 3.665 . . . . 0.0 113.687 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 57.61 45.77 92.85 Favored Glycine 0 CA--C 1.527 0.814 0 O-C-N 121.201 -0.937 . . . . 0.0 112.0 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.5 mt -118.26 -66.74 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 118.607 1.203 . . . . 0.0 108.435 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -166.02 159.81 15.93 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 126.954 2.102 . . . . 0.0 107.885 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -123.92 117.65 25.27 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 102.072 -3.307 . . . . 0.0 102.072 177.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.0 m -128.9 156.24 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.43 1.092 . . . . 0.0 111.979 -178.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -127.26 127.51 44.5 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 178.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -146.4 159.4 43.43 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.201 1.4 . . . . 0.0 113.04 -178.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -88.7 153.58 20.98 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 177.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 163.2 -163.81 35.7 Favored Glycine 0 C--O 1.241 0.579 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.53 139.28 53.33 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 126.102 1.761 . . . . 0.0 106.607 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 C--N 1.323 -0.569 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 179.358 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 N--CA 1.445 -0.675 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.8 mt . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 178.493 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.5 mt . . . . . 0 N--CA 1.464 0.26 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.3 t -142.73 142.41 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 123.508 0.723 . . . . 0.0 109.88 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -139.95 159.26 42.59 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.367 1.467 . . . . 0.0 109.197 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.2 124.99 51.64 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.99 -62.54 1.54 Allowed 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 124.631 1.172 . . . . 0.0 109.557 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -139.92 158.29 25.66 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.9 ttpp -126.03 89.7 51.79 Favored Pre-proline 0 N--CA 1.452 -0.334 0 C-N-CA 124.875 1.27 . . . . 0.0 108.467 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -75.4 177.36 8.75 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.982 2.455 . . . . 0.0 109.502 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -91.63 155.57 18.24 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 121.788 -0.57 . . . . 0.0 111.588 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.42 -24.15 61.19 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 125.036 1.334 . . . . 0.0 113.277 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -109.61 148.49 31.21 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.753 1.621 . . . . 0.0 108.777 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.1 p -73.32 -32.87 39.16 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 C-N-CA 121.987 0.115 . . . . 0.0 111.267 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -72.95 -21.98 60.78 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 120.454 -1.404 . . . . 0.0 113.465 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -79.68 -17.72 53.01 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.295 0.638 . . . . 0.0 111.626 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.96 176.56 5.23 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.245 1.018 . . . . 0.0 111.15 178.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -146.76 137.1 23.67 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.712 1.205 . . . . 0.0 108.612 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -127.05 159.67 33.44 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.706 2.803 . . . . 0.0 106.777 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -136.08 131.65 35.12 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.276 0.63 . . . . 0.0 112.165 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 35.2 tp -85.23 101.65 12.68 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.613 1.565 . . . . 0.0 108.413 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 27.8 mt -113.55 -179.15 3.56 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.605 1.562 . . . . 0.0 109.603 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -153.46 158.07 40.82 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 52.4 p30 -134.8 -173.37 3.28 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 127.596 2.358 . . . . 0.0 107.094 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.55 -22.76 66.15 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.107 -1.621 . . . . 0.0 113.469 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 74.6 t -78.31 -53.48 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 178.3 -163.09 30.9 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-O 122.023 0.791 . . . . 0.0 112.368 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -82.7 159.9 22.49 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -167.43 165.83 14.68 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.939 0.896 . . . . 0.0 109.684 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 5.8 mt -109.92 136.47 45.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 177.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -110.96 116.74 31.73 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 125.106 1.362 . . . . 0.0 107.818 -179.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -116.3 108.67 16.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.2 tt -99.65 140.19 19.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.5 mt -135.66 107.43 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 124.335 1.054 . . . . 0.0 111.153 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -101.45 -157.19 26.87 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 18.1 m 68.23 34.26 3.98 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.759 0.424 . . . . 0.0 112.075 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -89.84 -96.34 1.12 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 103.812 -3.715 . . . . 0.0 103.812 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -150.54 170.58 18.79 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.99 1.716 . . . . 0.0 107.575 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 23.5 mm -100.64 123.06 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 126.365 1.866 . . . . 0.0 107.946 178.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 8.1 m -88.1 94.39 9.79 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 101.505 -3.517 . . . . 0.0 101.505 177.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -57.89 -15.63 9.26 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 3.1 m -55.91 -35.62 41.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.003 0.921 . . . . 0.0 108.87 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 75.0 p -114.87 -24.45 8.65 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.569 1.148 . . . . 0.0 110.275 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 81.91 34.44 24.39 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -129.85 169.68 14.87 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.052 1.341 . . . . 0.0 110.939 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -83.02 145.76 29.12 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 12.2 ttt85 -76.82 29.17 0.13 Allowed 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 129.913 3.285 . . . . 0.0 112.384 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -72.19 144.1 48.64 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 122.351 1.072 . . . . 0.0 111.959 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -110.8 155.67 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 113.489 -1.687 . . . . 0.0 111.493 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -123.87 128.46 49.52 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.021 1.728 . . . . 0.0 106.972 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.5 mp -118.09 119.79 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 124.968 1.307 . . . . 0.0 107.723 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -102.5 113.81 27.48 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -94.1 116.75 29.21 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 33.6 m -126.4 169.35 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 125.298 1.439 . . . . 0.0 112.096 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -85.48 135.78 33.7 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 177.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -101.56 156.08 18.91 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 118.936 0.789 . . . . 0.0 111.608 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -51.01 -68.21 1.6 Allowed Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.902 1.715 . . . . 0.0 112.145 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 13.3 p -75.66 80.24 2.64 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 117.913 0.856 . . . . 0.0 108.776 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -67.46 36.23 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.132 2.573 . . . . 0.0 115.777 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 14.3 m -148.05 46.65 1.08 Allowed 'General case' 0 CA--C 1.536 0.408 0 O-C-N 119.932 -1.73 . . . . 0.0 113.093 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -148.28 -178.58 23.54 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.63 164.9 32.79 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.862 2.375 . . . . 0.0 110.417 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 60.6 p -81.42 151.95 27.65 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.934 0.894 . . . . 0.0 108.706 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.32 163.6 17.57 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.274 1.429 . . . . 0.0 107.454 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.3 mp -77.36 130.07 36.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -72.38 -61.07 1.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.968 1.707 . . . . 0.0 110.222 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -142.26 167.85 21.14 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 125.689 1.596 . . . . 0.0 108.804 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.404 HG12 ' CE1' ' A' ' 229' ' ' TYR . 28.7 t -145.69 137.63 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.97 117.8 3.3 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -77.16 92.7 3.83 Favored 'General case' 0 C--N 1.328 -0.357 1 N-CA-C 99.715 -4.18 . . . . 0.0 99.715 177.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 2.0 p -58.42 -61.38 2.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.875 1.27 . . . . 0.0 112.348 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -98.78 -172.72 2.36 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 28.2 mm -63.25 -46.1 96.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 O-C-N 121.256 -0.902 . . . . 0.0 111.089 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 9.1 t -109.72 -16.89 13.81 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 16.2 t -87.32 140.56 15.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 123.928 0.891 . . . . 0.0 108.874 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . 0.404 ' CE1' HG12 ' A' ' 221' ' ' VAL . 2.3 t80 -133.78 140.64 47.07 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.126 0.971 . . . . 0.0 109.038 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -127.98 138.48 52.63 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.02 161.44 39.39 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.524 1.529 . . . . 0.0 109.71 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -133.46 149.85 51.75 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 123.334 0.654 . . . . 0.0 110.355 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 60.5 t -128.29 144.98 36.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 125.511 1.524 . . . . 0.0 107.554 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.66 133.03 56.43 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 83.0 mt -134.75 137.58 27.76 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.056 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.34 -43.19 1.1 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.169 2.579 . . . . 0.0 112.708 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -57.76 -33.78 68.85 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.072 0.549 . . . . 0.0 111.081 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 55.6 mt -61.81 -33.79 74.76 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.891 0.769 . . . . 0.0 111.898 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 53.1 m -61.84 -17.16 55.32 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.017 0.927 . . . . 0.0 113.133 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -69.31 -17.98 63.77 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 123.923 0.889 . . . . 0.0 112.896 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 45.1 mt -90.74 120.73 32.02 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 126.235 1.814 . . . . 0.0 107.017 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.14 -41.79 49.53 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.898 1.279 . . . . 0.0 113.055 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 31.7 mt -56.39 -34.8 67.04 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.416 0.687 . . . . 0.0 110.193 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -100.88 4.53 42.8 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 126.791 2.036 . . . . 0.0 113.84 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.463 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.787 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.6 m . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.7 -39.11 87.33 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-N 118.622 0.646 . . . . 0.0 109.841 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.9 tp -64.6 -44.89 89.16 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mt -59.11 -51.07 71.62 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.0 m -55.17 -44.75 75.52 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.34 1.056 . . . . 0.0 111.083 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -67.23 -51.17 56.48 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 121.548 -0.72 . . . . 0.0 110.232 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 21.8 m -54.82 -42.07 71.43 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 118.153 -0.927 . . . . 0.0 110.506 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.8 tp -61.01 -56.15 24.43 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 120.051 1.296 . . . . 0.0 110.034 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -57.23 -49.49 75.85 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.987 0.812 . . . . 0.0 111.602 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -56.85 -44.48 82.2 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.334 0.654 . . . . 0.0 109.269 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.52 -47.2 89.25 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 79.7 t -58.18 -52.99 51.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.671 1.189 . . . . 0.0 109.838 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -31.1 72.05 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.14 0.882 . . . . 0.0 110.315 178.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -68.53 -47.96 65.56 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 24.3 mt -57.06 -54.72 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 123.075 0.55 . . . . 0.0 109.583 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.52 -41.24 80.45 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 124.188 0.93 . . . . 0.0 110.23 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -64.64 -43.98 91.96 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.079 0.466 . . . . 0.0 111.894 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.31 -13.08 61.05 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 73.9 mt -106.75 -26.85 11.12 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 119.488 1.04 . . . . 0.0 111.945 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -57.15 -28.19 62.52 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.178 0.591 . . . . 0.0 111.625 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -68.52 -45.88 71.07 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.342 1.457 . . . . 0.0 111.096 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -161.07 149.55 16.08 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.978 1.311 . . . . 0.0 109.896 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 60.3 m -75.38 163.16 27.72 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 177.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 28.2 pt -118.24 148.7 20.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.8 154.58 44.34 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 122.673 0.389 . . . . 0.0 110.689 -177.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -143.13 124.96 15.07 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 124.439 1.096 . . . . 0.0 110.143 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -87.63 102.86 15.03 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.6 67.32 6.41 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.52 -115.95 6.26 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -66.4 -33.15 75.08 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.479 0.712 . . . . 0.0 112.59 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -106.64 160.29 15.56 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 122.153 0.977 . . . . 0.0 110.947 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.0 mt -124.57 147.99 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 178.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -121.64 134.53 54.99 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -130.49 125.25 33.88 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 126.629 1.972 . . . . 0.0 108.221 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -126.39 119.07 26.35 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 125.043 1.337 . . . . 0.0 109.799 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 12.5 m -102.88 160.52 25.97 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 124.76 1.224 . . . . 0.0 113.229 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.88 80.64 0.64 Allowed 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 124.47 3.447 . . . . 0.0 113.506 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.76 52.19 35.66 Favored Glycine 0 C--O 1.237 0.324 0 O-C-N 121.546 -0.721 . . . . 0.0 111.505 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.3 mt -129.17 -67.09 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -174.41 160.19 3.17 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.17 1.388 . . . . 0.0 108.987 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.91 120.23 38.51 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 176.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.18 154.86 40.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 118.758 0.708 . . . . 0.0 111.083 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -123.04 130.32 52.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 127.897 2.479 . . . . 0.0 106.579 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -146.37 156.92 43.67 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.357 1.063 . . . . 0.0 110.198 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 56.3 t60 -89.2 153.83 20.62 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 156.21 -164.14 32.26 Favored Glycine 0 CA--C 1.523 0.537 0 O-C-N 120.829 -1.169 . . . . 0.0 111.59 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.16 150.05 45.61 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 124.388 1.075 . . . . 0.0 110.517 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 CA--C 1.535 0.392 0 C-N-CA 125.091 1.357 . . . . 0.0 108.205 179.285 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.5 mt . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 179.172 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 84.3 mt . . . . . 0 C--O 1.23 0.061 0 CA-C-O 119.399 -0.334 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 9.8 t -136.69 152.8 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.802 1.241 . . . . 0.0 108.585 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -145.44 171.8 14.12 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 126.286 1.835 . . . . 0.0 110.112 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -125.9 125.59 43.04 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.118 1.767 . . . . 0.0 109.55 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 22.1 mt -102.89 -72.83 0.68 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.227 1.011 . . . . 0.0 109.395 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -124.0 149.18 16.88 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -132.37 89.14 37.6 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.01 0.924 . . . . 0.0 110.443 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -77.5 -179.15 5.16 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 125.049 3.833 . . . . 0.0 113.293 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -90.05 161.67 15.71 Favored 'General case' 0 C--O 1.231 0.084 0 C-N-CA 124.069 0.948 . . . . 0.0 110.211 178.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.19 -24.81 57.87 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -118.99 157.91 26.82 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 123.629 0.771 . . . . 0.0 109.331 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 5.2 p -73.97 -33.02 35.21 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 C-N-CA 124.633 1.173 . . . . 0.0 112.095 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -75.13 -7.05 52.69 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.22 1.808 . . . . 0.0 112.93 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -94.2 -14.99 25.0 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.115 1.366 . . . . 0.0 109.708 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -124.35 179.32 4.96 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 128.665 2.786 . . . . 0.0 112.811 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -138.17 166.76 23.35 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.414 2.286 . . . . 0.0 107.817 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -141.06 159.34 42.42 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.864 2.066 . . . . 0.0 107.612 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -124.38 124.54 42.58 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.755 1.222 . . . . 0.0 111.309 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 21.6 tp -90.02 100.77 13.53 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 22.6 mt -107.21 -178.72 3.72 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.308 1.843 . . . . 0.0 108.754 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -158.81 159.89 35.62 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.61 -175.67 4.03 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -48.2 -35.78 12.48 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.979 1.711 . . . . 0.0 111.307 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 60.0 t -77.77 -67.63 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 126.193 1.797 . . . . 0.0 111.27 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -167.46 -170.22 32.0 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -178.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -78.81 152.79 31.15 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.469 1.108 . . . . 0.0 112.037 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -162.49 156.56 21.15 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.005 1.322 . . . . 0.0 109.971 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 7.4 mt -102.04 140.08 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 4.3 t -121.98 136.35 54.92 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -142.62 119.18 11.01 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 176.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.8 tt -97.28 140.39 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.7 mt -130.51 112.59 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 O-C-N 120.742 -1.224 . . . . 0.0 110.161 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.18 -155.57 25.83 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 107.89 -2.084 . . . . 0.0 107.89 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 49.1 m 73.16 44.43 0.33 Allowed 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.095 1.358 . . . . 0.0 108.586 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -99.91 -121.9 4.74 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 125.158 1.361 . . . . 0.0 110.026 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -136.29 122.61 20.58 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.368 1.867 . . . . 0.0 108.774 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 14.1 mm -60.95 136.57 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 119.736 1.153 . . . . 0.0 110.155 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 28.5 p -90.58 111.58 22.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -68.13 -10.69 56.02 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 120.475 1.489 . . . . 0.0 110.391 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 40.6 t -60.33 -45.33 96.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 126.709 2.004 . . . . 0.0 108.808 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 1.3 p -125.41 -20.57 4.75 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 92.49 10.31 60.69 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.75 2.119 . . . . 0.0 112.255 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -94.32 169.66 10.06 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.544 1.138 . . . . 0.0 112.157 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -88.28 156.08 19.38 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 122.159 0.981 . . . . 0.0 109.707 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -79.52 30.21 0.24 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 128.97 2.908 . . . . 0.0 111.286 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 1.9 ptm -72.39 150.46 43.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.958 0.885 . . . . 0.0 110.428 -175.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.1 p -120.23 149.01 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 114.341 -1.3 . . . . 0.0 111.699 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -112.77 127.92 56.28 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.945 1.698 . . . . 0.0 106.853 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.1 mp -119.93 115.97 49.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.248 1.019 . . . . 0.0 108.454 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -101.19 116.43 32.79 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.338 0.655 . . . . 0.0 110.64 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -92.4 114.41 26.95 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.047 1.339 . . . . 0.0 110.104 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 27.4 m -127.38 172.28 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 126.197 1.799 . . . . 0.0 111.801 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -85.7 142.65 28.87 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -113.55 144.88 18.27 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-O 118.583 -1.12 . . . . 0.0 110.878 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -32.94 -73.98 0.07 OUTLIER Glycine 0 C--N 1.337 0.631 0 C-N-CA 128.724 3.059 . . . . 0.0 113.233 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 39.6 t -70.72 94.09 0.99 Allowed 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -74.39 21.12 0.11 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.312 1.845 . . . . 0.0 111.667 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 37.5 m -135.82 40.48 2.74 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.909 1.684 . . . . 0.0 112.578 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -150.94 166.95 30.5 Favored Glycine 0 CA--C 1.526 0.748 0 O-C-N 120.682 -1.261 . . . . 0.0 111.505 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.46 167.03 25.21 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.492 2.128 . . . . 0.0 112.128 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 51.0 m -76.87 155.19 33.1 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.979 178.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.0 p -162.05 163.63 28.63 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 126.55 1.94 . . . . 0.0 107.216 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.3 mp -81.45 129.23 37.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -79.23 -47.08 16.59 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.493 0.717 . . . . 0.0 112.635 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 40.0 p-90 -151.99 166.98 29.87 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 46.8 t -144.77 138.92 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 C-N-CA 125.719 1.608 . . . . 0.0 106.808 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.96 134.34 4.27 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.621 0.724 . . . . 0.0 112.104 177.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -86.96 93.11 9.25 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 78.2 p -67.53 -56.42 9.57 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.576 0.703 . . . . 0.0 110.693 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -95.03 -175.04 3.41 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.983 1.713 . . . . 0.0 107.591 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.6 mp -74.71 -39.17 46.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 O-C-N 121.713 -0.617 . . . . 0.0 109.706 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 5.4 m -115.69 -18.91 10.73 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 3.5 t -85.13 152.82 3.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -135.41 139.85 44.48 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.604 1.162 . . . . 0.0 108.585 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -120.84 135.43 55.17 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.035 1.334 . . . . 0.0 108.57 -178.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -138.46 161.13 37.8 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.93 1.692 . . . . 0.0 109.751 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -138.53 144.13 39.8 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 66.6 t -131.72 133.55 61.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 125.624 1.57 . . . . 0.0 109.449 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.9 p -99.49 146.6 26.19 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 13.4 mt -142.99 136.18 13.96 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.277 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -72.55 -44.69 0.68 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.433 2.089 . . . . 0.0 111.492 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -58.93 -20.82 55.61 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.13 0.972 . . . . 0.0 112.289 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 2.2 mp -71.69 -39.16 70.39 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.783 0.833 . . . . 0.0 108.987 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 29.2 m -58.3 -30.5 66.7 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.453 1.501 . . . . 0.0 111.979 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -60.2 -38.17 82.5 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.577 0.351 . . . . 0.0 110.788 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 23.8 mt -72.64 117.04 13.83 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -47.92 -34.34 8.91 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -177.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 20.1 mt -64.13 -40.86 97.08 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.941 0.792 . . . . 0.0 110.661 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 4.8 mp -99.58 9.38 43.28 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 125.295 1.438 . . . . 0.0 113.798 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.723 0 C-N-CA 126.533 1.933 . . . . 0.0 111.231 179.623 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.534 0.345 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.57 -40.57 95.8 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.2 tp -62.22 -45.69 92.2 Favored 'General case' 0 C--O 1.221 -0.396 0 C-N-CA 124.31 1.044 . . . . 0.0 109.148 178.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 mt -59.66 -51.3 70.37 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.173 0.989 . . . . 0.0 109.457 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.1 m -55.0 -55.48 30.43 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.553 1.141 . . . . 0.0 109.626 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -61.23 -46.33 90.87 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.12 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.1 m -52.23 -51.71 56.69 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 119.608 1.095 . . . . 0.0 110.196 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.2 tp -56.56 -55.31 35.5 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 119.229 0.922 . . . . 0.0 108.826 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.61 -49.6 67.48 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.803 1.241 . . . . 0.0 113.507 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -42.2 93.36 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.914 1.686 . . . . 0.0 108.525 179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.39 -50.23 69.91 Favored Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.84 -53.14 49.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 118.793 1.297 . . . . 0.0 111.109 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -31.78 72.0 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.206 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 m -66.08 -48.23 71.65 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 27.1 mt -58.36 -54.64 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.733 0.813 . . . . 0.0 110.318 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.77 -31.8 71.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 123.036 0.21 . . . . 0.0 111.525 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -73.64 -46.62 45.6 Favored 'General case' 0 C--O 1.225 -0.211 0 O-C-N 121.526 -0.734 . . . . 0.0 109.059 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.18 5.18 5.74 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.692 1.997 . . . . 0.0 113.887 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.3 mt -123.42 -30.43 3.66 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 125.516 1.526 . . . . 0.0 109.199 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -62.01 -28.5 69.62 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.158 0.435 . . . . 0.0 109.961 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -62.89 -47.16 84.51 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.706 0.802 . . . . 0.0 109.262 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -164.35 150.29 10.7 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.275 1.83 . . . . 0.0 109.883 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 64.2 m -75.27 171.75 13.65 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.3 pt -128.39 147.66 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 O-C-N 121.395 -0.815 . . . . 0.0 110.318 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.84 167.91 20.96 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.565 0.746 . . . . 0.0 110.894 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -153.71 124.88 7.41 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.65 1.58 . . . . 0.0 110.594 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -87.04 102.31 14.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.14 67.36 6.91 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.149 1.78 . . . . 0.0 109.608 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.8 -115.26 4.66 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -73.29 -27.77 61.73 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.245 1.818 . . . . 0.0 112.883 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -107.66 161.85 14.5 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 118.945 0.793 . . . . 0.0 110.293 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 24.1 mt -128.23 141.01 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 104.154 -2.535 . . . . 0.0 104.154 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -116.73 135.18 53.98 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 124.786 1.234 . . . . 0.0 107.776 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.38 130.44 46.03 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.625 1.57 . . . . 0.0 108.488 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -128.24 121.73 30.05 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.615 1.166 . . . . 0.0 110.622 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 4.2 m -108.73 159.19 31.85 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 123.956 0.902 . . . . 0.0 112.231 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -65.7 95.13 0.28 Allowed 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 125.259 3.973 . . . . 0.0 114.562 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 57.94 39.69 92.15 Favored Glycine 0 CA--C 1.525 0.67 0 O-C-N 121.554 -0.716 . . . . 0.0 111.636 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.8 mt -115.16 -65.17 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.43 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 5.7 pt-20 179.4 169.51 1.05 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.894 2.078 . . . . 0.0 108.695 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.45 124.6 40.5 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.9 m -135.01 156.95 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 125.479 1.511 . . . . 0.0 111.189 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -124.03 133.63 53.61 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 103.327 -2.842 . . . . 0.0 103.327 176.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -146.25 156.62 43.51 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.902 0.881 . . . . 0.0 110.575 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -89.47 153.82 20.51 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 155.68 -162.82 31.4 Favored Glycine 0 CA--C 1.519 0.292 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.95 152.59 50.1 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.251 1.02 . . . . 0.0 108.355 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 93.3 t . . . . . 0 C--O 1.237 0.411 0 C-N-CA 124.408 1.083 . . . . 0.0 109.559 179.556 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 . . . . . 0 C--O 1.234 0.255 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 38.0 mm . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 179.124 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.7 mt . . . . . 0 CA--C 1.521 -0.14 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.2 143.26 28.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 124.74 1.216 . . . . 0.0 108.186 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -134.88 155.65 50.32 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.785 1.234 . . . . 0.0 109.256 178.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 28.9 ttp180 -97.06 130.23 44.39 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 128.021 2.528 . . . . 0.0 108.331 -178.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 27.5 mt -112.54 -69.88 0.84 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.415 1.007 . . . . 0.0 108.666 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -139.58 141.8 12.08 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-O 121.446 0.47 . . . . 0.0 112.979 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -110.88 92.9 15.71 Favored Pre-proline 0 N--CA 1.447 -0.582 0 C-N-CA 127.366 2.266 . . . . 0.0 110.637 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 75.5 Cg_endo -75.53 -177.16 3.36 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.646 2.897 . . . . 0.0 109.358 178.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -96.81 157.96 15.65 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.14 -26.51 56.39 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 124.901 1.376 . . . . 0.0 114.15 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -108.97 139.63 43.57 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 124.164 0.986 . . . . 0.0 108.466 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.4 p -62.97 -31.04 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -61.88 -26.7 68.31 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.727 1.611 . . . . 0.0 112.542 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -94.6 -2.33 51.62 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -79.62 163.56 24.5 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.434 -0.791 . . . . 0.0 110.297 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -137.58 95.1 3.0 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -102.35 160.2 14.75 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -135.63 143.86 45.77 Favored 'General case' 0 C--O 1.227 -0.11 0 C-N-CA 124.304 1.042 . . . . 0.0 110.221 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 36.3 tp -110.07 97.85 7.26 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.48 174.23 5.96 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.411 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 6.1 p90 -150.67 162.63 40.31 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 121.401 -0.812 . . . . 0.0 110.486 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -140.71 -175.3 4.24 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.4 1.062 . . . . 0.0 109.185 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -57.04 -20.3 23.84 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.155 1.382 . . . . 0.0 113.991 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 97.4 t -81.09 -65.66 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 178.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 175.57 -170.16 43.09 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.411 ' CD2' ' HB3' ' A' ' 176' ' ' TYR . 15.6 m-85 -78.52 159.13 28.35 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.721 0.772 . . . . 0.0 109.911 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -156.21 176.2 12.98 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.53 1.932 . . . . 0.0 106.805 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 18.8 mt -121.1 114.46 43.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 4.7 t -90.46 141.58 28.6 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.423 ' HG2' ' HH ' ' A' ' 206' ' ' TYR . 1.8 tp10 -146.29 107.01 4.09 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.6 tt -98.68 140.44 18.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.9 mt -133.97 113.71 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 123.869 0.868 . . . . 0.0 110.847 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -107.85 -156.73 19.5 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 124.754 1.169 . . . . 0.0 110.275 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 68.5 m 73.09 37.55 0.76 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.775 1.23 . . . . 0.0 109.983 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -94.16 -108.35 2.04 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 126.858 2.17 . . . . 0.0 108.336 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -140.07 120.99 14.54 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.638 1.175 . . . . 0.0 107.921 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 17.7 mm -60.58 121.59 8.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 124.336 1.054 . . . . 0.0 109.272 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 77.6 m -82.22 96.42 7.85 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 125.735 1.614 . . . . 0.0 109.923 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.09 -18.47 58.09 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -59.3 -31.48 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.674 1.189 . . . . 0.0 110.76 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 44.8 p -125.07 -35.0 2.7 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.777 0.831 . . . . 0.0 111.799 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.92 32.93 5.7 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 126.43 1.966 . . . . 0.0 110.779 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -124.13 171.12 10.05 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.372 1.869 . . . . 0.0 112.174 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -83.33 148.7 27.19 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 122.322 1.058 . . . . 0.0 110.439 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -82.98 30.77 0.44 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 130.8 3.64 . . . . 0.0 109.251 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.5 ptt? -74.28 150.83 40.03 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.688 1.195 . . . . 0.0 110.334 -175.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -113.32 146.79 17.49 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.355 -177.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -114.42 116.39 28.81 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.8 mp -106.26 130.66 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -117.85 103.76 10.28 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.719 0.807 . . . . 0.0 110.108 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . 0.423 ' HH ' ' HG2' ' A' ' 185' ' ' GLU . 43.4 m-85 -83.02 125.31 31.3 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 15.5 m -135.96 171.09 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.44 1.496 . . . . 0.0 110.974 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 2.1 t -81.61 140.5 34.39 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -118.43 109.21 1.73 Allowed Glycine 0 C--N 1.34 0.752 0 CA-C-O 117.836 -1.536 . . . . 0.0 113.217 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 4.71 -92.15 0.0 OUTLIER Glycine 0 C--N 1.34 0.803 0 C-N-CA 129.626 3.489 . . . . 0.0 114.07 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.0 100.0 0.39 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -72.11 29.13 0.05 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.486 1.914 . . . . 0.0 113.169 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 14.8 t -119.29 47.2 1.73 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.685 1.994 . . . . 0.0 114.19 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -166.08 162.99 36.5 Favored Glycine 0 C--N 1.339 0.717 0 C-N-CA 118.014 -2.041 . . . . 0.0 117.523 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -66.64 164.81 27.59 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.355 2.704 . . . . 0.0 110.321 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 28.8 m -64.47 155.46 32.66 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.473 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -168.88 157.16 7.94 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 126.025 1.73 . . . . 0.0 108.111 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.9 mt -83.38 133.81 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -74.95 -55.27 5.94 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 125.061 1.345 . . . . 0.0 111.772 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 52.1 p-90 -149.94 165.93 31.15 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.218 1.407 . . . . 0.0 108.347 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.401 ' CG2' ' HH ' ' A' ' 229' ' ' TYR . 39.6 t -148.34 130.42 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 125.198 1.399 . . . . 0.0 107.62 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.37 140.65 16.59 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -92.16 90.23 7.24 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 102.365 -3.198 . . . . 0.0 102.365 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 2.0 p -61.31 -65.15 0.74 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.767 1.627 . . . . 0.0 110.747 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -86.88 -172.59 4.06 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.6 mp -58.97 -41.53 83.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 118.322 -0.846 . . . . 0.0 110.163 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 7.3 m -129.86 -8.91 4.45 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 25.1 t -71.87 121.72 22.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 103.927 -2.62 . . . . 0.0 103.927 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . 0.401 ' HH ' ' CG2' ' A' ' 221' ' ' VAL . 1.0 OUTLIER -110.17 124.63 51.9 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 179.323 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -114.33 135.16 54.38 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -139.79 158.29 44.33 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.04 1.736 . . . . 0.0 109.621 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -130.69 146.21 52.12 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 85.1 t -131.95 135.48 58.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.77 138.25 40.65 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.726 0.81 . . . . 0.0 110.376 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 48.4 mt -139.81 137.05 17.91 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 124.052 0.941 . . . . 0.0 109.594 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.59 -32.77 2.67 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.722 2.948 . . . . 0.0 113.11 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -69.19 -23.81 63.96 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.717 1.207 . . . . 0.0 112.146 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 37.4 mt -66.28 -36.54 83.24 Favored 'General case' 0 C--O 1.226 -0.139 0 O-C-N 121.238 -0.914 . . . . 0.0 110.292 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 3.7 m -56.39 -19.23 13.85 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.893 1.277 . . . . 0.0 113.553 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -62.85 -31.98 73.12 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.23 1.412 . . . . 0.0 110.358 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 26.8 mt -84.11 120.14 25.82 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.44 -37.8 57.74 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.715 0.689 . . . . 0.0 112.072 -178.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 6.0 mp -57.6 -38.84 75.59 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.485 -0.76 . . . . 0.0 111.248 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -97.35 6.08 48.85 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.071 1.748 . . . . 0.0 111.675 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.259 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 179.27 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 CA--C 1.535 0.383 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.93 -45.81 89.48 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 66.7 tp -62.62 -41.34 98.95 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.413 0.685 . . . . 0.0 110.272 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.8 mt -60.08 -54.28 47.8 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.983 0.913 . . . . 0.0 109.762 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 45.2 m -56.21 -51.79 66.78 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.228 1.011 . . . . 0.0 110.748 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -58.03 -49.55 76.47 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.7 m -53.94 -49.55 68.45 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 118.425 -0.798 . . . . 0.0 110.598 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.2 tp -56.77 -54.91 40.83 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.967 0.803 . . . . 0.0 109.579 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -55.29 -53.64 53.62 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.684 0.793 . . . . 0.0 111.492 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -57.37 -33.51 67.88 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.315 1.446 . . . . 0.0 110.363 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -69.43 -53.38 17.41 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.4 t -56.55 -52.1 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 118.799 1.3 . . . . 0.0 111.706 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -37.24 79.76 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 118.89 -0.576 . . . . 0.0 110.779 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.4 m -67.43 -48.11 68.23 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 43.8 mt -53.5 -52.97 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 123.978 0.911 . . . . 0.0 109.575 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.54 -39.45 83.99 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 122.187 0.195 . . . . 0.0 111.234 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -69.73 -33.93 73.17 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.294 -0.879 . . . . 0.0 111.461 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.24 10.25 15.25 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.569 1.548 . . . . 0.0 112.239 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.3 mt -133.35 -33.35 1.12 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.841 1.256 . . . . 0.0 110.557 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -56.26 -31.23 63.39 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 123.693 0.797 . . . . 0.0 111.57 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -69.47 -45.96 67.79 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 118.668 -0.682 . . . . 0.0 112.465 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -157.26 143.65 18.0 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 125.336 1.454 . . . . 0.0 108.244 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 30.5 m -75.87 172.08 13.31 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 122.906 0.482 . . . . 0.0 110.959 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 25.6 pt -125.9 154.91 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.591 1.156 . . . . 0.0 111.418 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.62 167.69 21.64 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.738 0.815 . . . . 0.0 109.956 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -150.53 117.75 6.0 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.772 1.629 . . . . 0.0 109.935 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -82.54 102.14 11.19 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.0 66.8 3.62 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.474 -0.766 . . . . 0.0 110.472 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.19 -113.06 3.74 Favored Glycine 0 C--N 1.339 0.697 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -77.39 -38.33 50.11 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -106.65 126.44 52.28 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.874 1.215 . . . . 0.0 113.503 -178.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.0 mt -90.6 147.8 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -115.11 135.8 53.81 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 178.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.72 123.91 27.14 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.789 1.236 . . . . 0.0 109.337 -177.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -126.8 119.51 27.05 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.824 1.249 . . . . 0.0 111.743 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 1.4 m -100.62 160.81 25.85 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 125.391 1.477 . . . . 0.0 112.477 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -64.13 88.86 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 124.249 3.299 . . . . 0.0 112.288 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 53.48 57.46 15.49 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 123.934 0.778 . . . . 0.0 111.274 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 15.6 mt -124.94 -65.67 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.445 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 15.6 pt-20 -176.15 168.92 2.86 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 127.621 2.368 . . . . 0.0 109.677 177.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -123.52 124.15 42.2 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.5 155.76 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.301 1.041 . . . . 0.0 112.256 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -119.82 126.24 50.51 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -146.48 157.67 43.78 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.093 0.861 . . . . 0.0 112.065 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -88.68 148.63 23.91 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 160.32 -162.17 33.09 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 108.871 -1.691 . . . . 0.0 108.871 -177.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.4 ttm-85 -125.63 164.15 21.22 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.34 1.456 . . . . 0.0 111.104 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 84.5 t . . . . . 0 C--O 1.24 0.571 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.749 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 . . . . . 0 N--CA 1.46 0.04 0 CA-C-O 121.202 0.525 . . . . 0.0 111.461 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.6 mp . . . . . 0 C--O 1.236 0.382 0 C-N-CA 123.853 0.861 . . . . 0.0 108.801 178.654 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 76.6 mt . . . . . 0 N--CA 1.456 -0.172 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.8 t -135.84 142.54 38.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.534 1.134 . . . . 0.0 108.054 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -137.61 158.62 43.99 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 126.348 1.859 . . . . 0.0 109.049 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -113.01 130.43 56.14 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.437 1.095 . . . . 0.0 110.196 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.96 -75.19 0.53 Allowed 'General case' 0 C--O 1.226 -0.153 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -134.68 152.39 20.68 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 116.255 -0.43 . . . . 0.0 112.73 -178.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -116.49 94.39 42.93 Favored Pre-proline 0 N--CA 1.453 -0.32 0 C-N-CA 125.271 1.428 . . . . 0.0 108.601 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 88.1 Cg_endo -73.48 -175.82 2.21 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.343 2.695 . . . . 0.0 109.555 178.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.442 ' HE2' ' OE2' ' A' ' 169' ' ' GLU . 25.3 mmmt -97.53 161.1 13.94 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.16 0.584 . . . . 0.0 112.238 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -78.26 -24.21 46.96 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.87 1.668 . . . . 0.0 113.362 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -116.37 147.75 41.3 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.5 p -73.06 -27.23 24.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -79.68 -12.73 59.8 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.296 0.639 . . . . 0.0 112.445 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.442 ' OE2' ' HE2' ' A' ' 164' ' ' LYS . 4.3 mm-40 -79.62 -21.5 44.84 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.865 0.466 . . . . 0.0 110.864 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -107.3 172.1 7.01 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.744 1.618 . . . . 0.0 110.652 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -134.29 131.31 38.26 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 124.186 0.994 . . . . 0.0 109.434 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -107.86 162.29 14.14 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -130.11 120.86 25.28 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.056 -1.028 . . . . 0.0 109.738 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 48.4 tp -87.24 100.6 12.81 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 39.5 mt -105.32 -179.21 3.88 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 126.207 1.803 . . . . 0.0 109.972 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -157.09 157.07 33.87 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 124.458 1.103 . . . . 0.0 109.596 177.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -137.51 -179.36 5.69 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.143 2.177 . . . . 0.0 108.604 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -58.53 -26.41 63.49 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.445 1.098 . . . . 0.0 113.533 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 59.8 t -79.62 -62.81 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -172.99 -164.41 28.34 Favored Glycine 0 C--N 1.339 0.725 0 CA-C-N 119.031 0.832 . . . . 0.0 111.366 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -78.21 166.38 22.8 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.193 -0.593 . . . . 0.0 109.982 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -167.62 162.09 13.97 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.508 1.523 . . . . 0.0 108.145 178.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 3.6 mt -113.97 121.43 66.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.154 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.2 t -95.96 135.03 38.25 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -138.57 133.63 32.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 178.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.9 tt -121.45 141.37 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 124.679 1.191 . . . . 0.0 109.072 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.4 mt -137.14 115.14 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 122.596 0.358 . . . . 0.0 111.705 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -103.74 -166.96 25.28 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 126.497 1.999 . . . . 0.0 110.125 178.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 69.3 m 73.23 60.41 0.1 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.624 1.569 . . . . 0.0 109.056 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -108.13 -95.58 2.4 Favored Glycine 0 CA--C 1.519 0.286 0 N-CA-C 104.513 -3.435 . . . . 0.0 104.513 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -155.59 125.23 6.41 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 18.0 mm -60.25 121.29 7.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.2 99.94 10.27 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 125.839 1.656 . . . . 0.0 110.153 -178.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -60.94 -20.49 62.28 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.364 0.602 . . . . 0.0 111.51 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.5 m -57.18 -32.64 41.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.642 1.577 . . . . 0.0 112.235 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 67.0 p -125.17 -29.22 3.32 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.078 1.351 . . . . 0.0 112.017 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 88.22 32.37 12.34 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -178.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -126.82 -179.72 4.96 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.915 1.686 . . . . 0.0 111.322 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -91.86 148.15 22.44 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.298 0.639 . . . . 0.0 109.496 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 45.2 ttm-85 -79.32 30.12 0.23 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.287 2.635 . . . . 0.0 109.729 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.7 ptm -72.87 153.96 40.8 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 122.064 0.935 . . . . 0.0 110.075 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 6.0 p -122.97 148.93 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 113.876 -1.511 . . . . 0.0 113.696 -176.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -114.09 137.46 51.7 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.5 mp -126.03 118.41 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 127.516 2.326 . . . . 0.0 107.921 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -106.88 104.28 13.92 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.554 1.141 . . . . 0.0 110.42 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -80.95 129.53 34.58 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 120.523 -1.361 . . . . 0.0 111.8 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 33.9 m -137.8 172.15 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.643 1.177 . . . . 0.0 112.634 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.4 137.64 37.35 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.176 0.991 . . . . 0.0 108.352 178.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -105.38 117.95 5.69 Favored Glycine 0 C--N 1.332 0.352 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -42.34 -46.8 5.56 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 126.239 1.876 . . . . 0.0 113.283 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.463 ' C ' ' H ' ' A' ' 213' ' ' SER . 1.8 p -76.45 80.73 3.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -65.02 21.46 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 130.317 3.447 . . . . 0.0 113.329 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 211' ' ' SER . 23.4 t -142.49 47.24 1.58 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 129.567 3.147 . . . . 0.0 107.642 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -149.61 159.3 28.02 Favored Glycine 0 C--N 1.34 0.771 0 O-C-N 119.668 -1.895 . . . . 0.0 114.6 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.93 173.47 13.51 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.851 3.034 . . . . 0.0 111.015 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 49.0 m -75.28 152.13 38.26 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -168.39 152.59 5.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 178.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.1 mt -78.66 134.68 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -77.63 -51.81 10.03 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.007 0.923 . . . . 0.0 111.794 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 55.9 p-90 -149.66 165.55 31.99 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.244 1.418 . . . . 0.0 108.439 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 24.5 t -147.42 134.16 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 126.228 1.811 . . . . 0.0 106.883 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.68 124.75 6.15 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 177.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -78.96 86.99 4.79 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 103.517 -2.771 . . . . 0.0 103.517 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 8.6 p -53.14 -52.55 58.34 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.904 1.682 . . . . 0.0 112.606 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -107.05 -177.36 3.34 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . 0.253 2.6 mp -68.24 -18.95 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 118.882 -1.127 . . . . 0.0 110.603 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -132.31 -39.6 1.03 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.519 1.054 . . . . 0.0 112.614 178.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 11.8 t -63.47 135.3 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.34 139.65 46.96 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.43 1.092 . . . . 0.0 109.9 -178.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -121.03 140.57 51.74 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.478 1.511 . . . . 0.0 111.755 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -142.94 161.31 38.46 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 128.183 2.593 . . . . 0.0 109.723 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -137.22 146.67 45.12 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.034 1.334 . . . . 0.0 107.496 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 98.5 t -131.92 134.68 59.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 125.294 1.438 . . . . 0.0 107.862 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.64 134.56 45.8 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.234 1.014 . . . . 0.0 110.577 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 69.6 mt -131.74 138.47 32.64 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.71 -46.2 0.89 Allowed 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.542 2.828 . . . . 0.0 111.553 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.98 -27.48 66.88 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.947 1.299 . . . . 0.0 111.79 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 3.5 mp -61.68 -31.62 71.77 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 117.871 -1.061 . . . . 0.0 110.477 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 8.3 m -65.64 -19.16 65.8 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.978 1.263 . . . . 0.0 113.158 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -63.54 -29.82 71.02 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.051 0.941 . . . . 0.0 111.419 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 50.7 mt -82.34 113.78 20.36 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -48.2 -31.2 5.47 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 21.2 mt -67.58 -36.5 81.02 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.162 -0.961 . . . . 0.0 110.338 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 17.9 mt -100.06 8.89 43.63 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 127.341 2.256 . . . . 0.0 111.204 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 178.574 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 CA--C 1.536 0.418 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.15 -45.04 96.3 Favored 'General case' 0 C--N 1.337 0.06 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 67.7 tp -58.3 -44.01 88.37 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.081 -0.961 . . . . 0.0 108.87 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.2 mt -61.24 -53.92 50.66 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.243 0.929 . . . . 0.0 109.388 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 51.6 m -55.13 -48.58 73.48 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.806 0.842 . . . . 0.0 111.198 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -62.87 -46.3 88.51 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 120.403 -1.436 . . . . 0.0 110.214 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 52.9 m -54.18 -46.04 72.28 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.576 1.15 . . . . 0.0 109.915 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 22.0 tp -58.6 -54.08 51.14 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.761 0.709 . . . . 0.0 110.452 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 25.4 t30 -57.47 -46.93 83.12 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.263 0.483 . . . . 0.0 111.526 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -55.52 -46.64 77.01 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.974 0.91 . . . . 0.0 109.169 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.04 -46.47 91.21 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 93.2 t -59.01 -53.22 51.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.047 1.339 . . . . 0.0 110.393 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -32.52 73.49 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.775 1.17 . . . . 0.0 110.16 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.2 m -67.22 -46.46 73.77 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 33.8 mt -59.64 -51.6 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.99 -35.72 77.56 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 118.659 -0.686 . . . . 0.0 110.217 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.27 -48.42 75.79 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 119.708 1.14 . . . . 0.0 110.357 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.14 -27.65 60.95 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 -178.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.8 mp -85.72 -28.37 24.67 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 120.19 1.359 . . . . 0.0 109.336 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -60.53 -19.47 57.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.127 0.571 . . . . 0.0 111.452 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.36 -46.64 54.53 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.19 0.596 . . . . 0.0 110.868 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -165.54 155.63 13.0 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.586 1.554 . . . . 0.0 108.258 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 33.5 m -75.77 162.85 27.83 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.3 pt -117.68 156.23 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.22 163.23 38.23 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 120.712 0.292 . . . . 0.0 111.191 -177.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -152.31 127.63 9.9 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.739 1.616 . . . . 0.0 109.816 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -89.14 104.43 16.98 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.17 67.66 5.9 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.43 -115.03 4.92 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.491 -1.043 . . . . 0.0 110.491 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -73.82 -34.26 64.5 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -106.38 138.2 42.98 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 119.355 0.98 . . . . 0.0 110.976 -178.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.2 mt -102.89 149.69 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -122.24 133.79 54.7 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 126.406 1.882 . . . . 0.0 106.223 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.47 132.72 44.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.101 1.761 . . . . 0.0 107.945 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -126.46 117.84 23.72 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.424 1.089 . . . . 0.0 110.959 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 8.7 m -102.64 155.99 35.84 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.008 0.923 . . . . 0.0 112.924 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.34 92.21 0.28 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 125.069 3.846 . . . . 0.0 116.164 -178.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 62.64 36.27 93.01 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.3 mt -116.68 -66.99 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.418 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 7.2 pt-20 176.96 166.62 0.53 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.075 1.75 . . . . 0.0 109.58 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -117.62 129.63 55.87 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 104.278 -2.49 . . . . 0.0 104.278 177.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.1 m -138.32 155.46 28.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.922 0.889 . . . . 0.0 110.725 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -121.12 131.44 54.25 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -145.96 157.84 43.88 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.418 1.087 . . . . 0.0 111.479 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -88.61 154.27 20.46 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 165.34 -163.66 36.7 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.64 142.04 50.81 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.235 0.341 0 CA-C-N 118.777 0.717 . . . . 0.0 109.709 -178.803 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 14.1 mt . . . . . 0 C--N 1.326 -0.433 0 C-N-CA 127.504 2.322 . . . . 0.0 106.672 -179.323 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 23.5 mt . . . . . 0 CA--C 1.515 -0.377 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.5 p -143.18 152.52 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.848 0.859 . . . . 0.0 109.872 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -142.38 145.56 33.99 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.913 1.685 . . . . 0.0 108.124 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -95.58 135.15 37.62 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.522 1.129 . . . . 0.0 108.676 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.4 mp -102.15 -69.69 0.78 Allowed 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 123.122 0.569 . . . . 0.0 110.486 -178.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -127.96 165.83 20.82 Favored Glycine 0 C--O 1.243 0.681 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -132.32 89.12 37.87 Favored Pre-proline 0 N--CA 1.448 -0.569 0 C-N-CA 125.428 1.491 . . . . 0.0 109.52 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 90.9 Cg_endo -74.93 176.63 9.63 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 123.201 2.601 . . . . 0.0 108.02 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -94.8 155.37 16.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.916 0.865 . . . . 0.0 111.443 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.28 -20.25 61.55 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 126.074 1.75 . . . . 0.0 113.317 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -122.97 136.83 55.01 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.466 1.506 . . . . 0.0 109.91 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.9 p -61.37 -27.76 42.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.536 0.684 . . . . 0.0 110.691 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -71.06 -6.44 39.09 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 127.755 2.422 . . . . 0.0 113.013 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -112.35 -20.11 11.94 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.561 1.144 . . . . 0.0 112.721 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.27 165.78 13.26 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -145.79 112.71 6.04 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -101.56 170.14 8.38 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.999 1.32 . . . . 0.0 110.522 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -131.81 125.82 32.8 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.481 1.512 . . . . 0.0 110.836 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 24.4 tp -86.51 104.46 15.99 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 61.2 mt -107.47 177.0 4.96 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.21 1.404 . . . . 0.0 110.78 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.445 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 12.0 p90 -162.37 166.53 25.03 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 122.813 1.292 . . . . 0.0 110.766 178.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.483 ' CG ' ' H ' ' A' ' 178' ' ' ASP . 27.4 t70 -140.85 177.42 8.05 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 126.125 1.77 . . . . 0.0 106.759 178.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.483 ' H ' ' CG ' ' A' ' 177' ' ' ASP . 6.7 m-20 -59.28 -31.67 69.33 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 125.379 1.471 . . . . 0.0 107.948 177.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 38.7 t -66.1 -62.11 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 125.756 1.623 . . . . 0.0 107.791 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 178.9 -171.97 44.15 Favored Glycine 0 C--N 1.339 0.745 0 C-N-CA 124.392 0.996 . . . . 0.0 113.158 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.445 ' CD2' ' HB3' ' A' ' 176' ' ' TYR . 32.9 m-85 -90.27 155.05 19.27 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.692 1.197 . . . . 0.0 111.789 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -164.87 162.05 20.61 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.416 1.887 . . . . 0.0 109.171 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 8.6 mt -106.3 141.68 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 5.3 t -122.77 132.75 54.36 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -132.9 120.55 21.63 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 177.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.9 tt -105.91 128.0 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 5.5 mt -120.71 107.28 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 124.312 1.045 . . . . 0.0 110.653 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -99.7 -156.62 28.48 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 107.146 -2.382 . . . . 0.0 107.146 177.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 46.8 m 70.22 51.72 0.38 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.547 0.689 . . . . 0.0 110.757 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -115.71 -119.93 3.26 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 107.244 -2.342 . . . . 0.0 107.244 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -129.39 141.75 50.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.544 1.138 . . . . 0.0 108.793 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 24.5 mm -79.55 128.89 38.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 16.7 m -90.53 104.42 17.0 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 101.908 -3.367 . . . . 0.0 101.908 176.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -55.45 -16.04 3.31 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -177.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 3.0 m -59.05 -39.7 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.207 1.003 . . . . 0.0 110.246 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 1.2 p -125.21 -17.95 5.54 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.627 1.103 . . . . 0.0 111.551 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 85.94 5.48 83.52 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.685 0.659 . . . . 0.0 113.549 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -83.93 160.83 21.0 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.271 1.429 . . . . 0.0 108.351 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.415 ' C ' ' H ' ' A' ' 201' ' ' MET . 36.6 mt-10 -86.61 152.11 22.87 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -74.96 29.84 0.09 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 127.415 2.286 . . . . 0.0 109.962 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' MET . . . . . 0.415 ' H ' ' C ' ' A' ' 199' ' ' GLU . 6.3 ptt? -72.1 149.3 44.91 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 122.025 0.917 . . . . 0.0 109.838 -175.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.6 p -123.08 144.12 33.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.252 -176.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -108.35 130.18 55.21 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 178.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.1 mp -118.38 112.42 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 124.744 1.217 . . . . 0.0 108.225 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -95.33 116.79 29.25 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -94.53 116.38 28.7 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.326 0.65 . . . . 0.0 110.305 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 32.2 m -126.57 171.61 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 125.518 1.527 . . . . 0.0 111.955 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -85.86 135.8 33.56 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.783 1.633 . . . . 0.0 106.991 177.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -91.57 154.66 22.84 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 119.195 0.907 . . . . 0.0 111.406 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -62.61 -60.79 7.26 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 27.5 p -78.58 74.1 5.12 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -70.23 57.95 0.17 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.94 2.496 . . . . 0.0 112.011 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.36 47.51 0.35 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.984 1.714 . . . . 0.0 110.761 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -165.19 174.25 41.05 Favored Glycine 0 CA--C 1.527 0.788 0 O-C-N 119.736 -1.852 . . . . 0.0 112.159 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -71.73 162.06 43.22 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.438 2.092 . . . . 0.0 110.57 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 7.8 m -73.95 151.04 40.46 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 126.414 1.886 . . . . 0.0 111.034 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -164.85 165.15 20.72 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.735 1.614 . . . . 0.0 108.267 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.4 mp -79.15 128.02 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 177.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . 0.492 ' NE2' ' HG1' ' A' ' 234' ' ' THR . 18.9 mm-40 -72.09 -60.56 2.17 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.847 1.659 . . . . 0.0 109.867 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 28.7 p-90 -140.24 166.56 24.35 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.242 1.417 . . . . 0.0 109.807 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 49.9 t -145.85 133.03 15.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 125.585 1.554 . . . . 0.0 107.012 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.7 127.48 12.56 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.63 0.729 . . . . 0.0 109.362 178.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -79.99 87.88 5.38 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.9 p -57.42 -53.94 52.47 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.227 1.011 . . . . 0.0 112.622 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -119.31 -179.23 3.79 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.7 mp -61.27 -27.18 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.244 1.018 . . . . 0.0 110.838 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.8 t -131.64 -30.89 1.61 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.364 0.666 . . . . 0.0 111.765 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 16.7 t -76.31 135.42 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -129.02 148.35 50.97 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.72 1.608 . . . . 0.0 108.681 -179.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -132.2 136.76 47.26 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 126.524 1.93 . . . . 0.0 107.564 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.72 161.61 38.78 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.751 1.62 . . . . 0.0 110.191 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -134.87 145.19 48.03 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.521 0.729 . . . . 0.0 109.998 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.1 t -124.2 146.12 30.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 125.657 1.583 . . . . 0.0 108.263 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' THR . . . . . 0.492 ' HG1' ' NE2' ' A' ' 219' ' ' GLN . 0.7 OUTLIER -115.87 133.14 56.34 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.924 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 87.9 mt -134.74 135.99 24.47 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 123.828 0.851 . . . . 0.0 108.911 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.29 -42.38 2.0 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.662 2.241 . . . . 0.0 112.554 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -60.64 -24.9 65.91 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.308 0.643 . . . . 0.0 112.113 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 54.6 mt -68.19 -28.14 67.01 Favored 'General case' 0 C--O 1.225 -0.194 0 O-C-N 121.099 -1.0 . . . . 0.0 110.844 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 39.3 m -63.74 -15.76 59.4 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.763 1.225 . . . . 0.0 113.39 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -68.54 -24.08 64.59 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 41.0 mt -85.38 121.99 28.9 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.693 1.597 . . . . 0.0 107.882 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -50.5 -37.21 37.63 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.6 mp -61.02 -38.59 86.62 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.415 -0.803 . . . . 0.0 109.994 178.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -91.89 3.04 56.07 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 127.567 2.347 . . . . 0.0 113.226 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.673 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.569 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.4 p . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.307 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.69 -44.61 81.65 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 119.346 0.975 . . . . 0.0 109.71 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 52.0 tp -62.49 -44.89 95.28 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 118.52 -0.752 . . . . 0.0 109.036 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.7 mt -60.78 -48.27 82.57 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.272 0.942 . . . . 0.0 110.539 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 33.0 m -56.46 -56.5 20.39 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.676 1.19 . . . . 0.0 109.335 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.9 ttpp -58.69 -48.22 81.84 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-O 118.948 -0.548 . . . . 0.0 110.4 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.1 m -52.88 -52.95 55.57 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.231 1.012 . . . . 0.0 110.933 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 17.1 tp -57.81 -53.59 56.47 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 118.882 0.765 . . . . 0.0 110.099 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -58.69 -46.72 86.63 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -59.17 -43.44 92.12 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 125.049 1.339 . . . . 0.0 107.832 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.27 -50.53 65.64 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 15.7 t -57.32 -53.49 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 118.69 1.245 . . . . 0.0 110.684 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -32.8 74.22 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.044 0.838 . . . . 0.0 110.979 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.3 m -66.21 -45.71 79.81 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 34.1 mt -60.56 -51.43 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 123.848 0.859 . . . . 0.0 108.79 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.19 -38.97 69.06 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 123.521 0.513 . . . . 0.0 109.978 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -67.58 -54.51 19.22 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 118.808 0.731 . . . . 0.0 110.669 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.11 -17.5 7.32 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 125.874 1.67 . . . . 0.0 114.537 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.6 mp -111.59 -27.86 8.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 119.388 0.995 . . . . 0.0 109.509 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -59.71 -31.07 69.26 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.447 0.567 . . . . 0.0 110.919 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -64.38 -46.04 85.1 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 122.901 0.48 . . . . 0.0 111.348 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -162.95 152.6 15.56 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.996 1.719 . . . . 0.0 110.094 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 55.9 m -75.68 166.79 23.01 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 23.6 pt -125.12 153.29 32.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 124.426 1.091 . . . . 0.0 109.108 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -146.3 168.27 21.5 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.996 -0.44 . . . . 0.0 112.149 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -154.11 121.38 5.74 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.072 0.949 . . . . 0.0 109.665 178.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -81.71 103.96 11.77 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.5 0.72 . . . . 0.0 109.634 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.94 70.83 2.92 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 178.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 67.66 -121.15 14.1 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -69.11 -28.13 66.2 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -107.13 137.5 45.07 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 119.482 1.037 . . . . 0.0 110.056 -178.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.8 mt -112.74 134.13 56.33 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -100.68 129.01 46.53 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 125.124 1.37 . . . . 0.0 107.977 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -123.57 132.5 53.9 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.897 1.279 . . . . 0.0 108.712 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -129.62 112.91 14.17 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.447 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 19.8 m -97.42 159.74 30.44 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-O 118.402 -0.809 . . . . 0.0 111.214 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.2 90.34 0.1 OUTLIER 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 123.989 3.126 . . . . 0.0 113.622 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 56.07 44.69 88.3 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 123.827 0.727 . . . . 0.0 112.751 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 6.5 mt -113.58 -66.89 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.413 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 13.6 pt-20 -171.41 167.56 6.76 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.894 1.278 . . . . 0.0 109.354 178.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.61 122.22 38.32 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 178.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.8 m -137.84 156.5 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -122.09 125.99 47.41 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 177.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -146.91 157.95 43.78 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.442 1.497 . . . . 0.0 110.13 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -88.56 153.25 21.29 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 178.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 174.08 -163.53 34.46 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.241 -1.943 . . . . 0.0 108.241 -178.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.12 137.84 46.45 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.325 -0.488 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 . . . . . 0 C--O 1.235 0.292 0 CA-C-O 120.818 0.342 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 65.2 mt . . . . . 0 C--N 1.328 -0.365 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 179.376 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.7 tp . . . . . 0 C--O 1.233 0.187 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 22.1 t -137.06 140.5 42.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.377 1.071 . . . . 0.0 108.23 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -126.14 134.46 51.31 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -85.91 120.88 27.79 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 126.531 1.932 . . . . 0.0 108.576 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 50.7 mt -94.08 -89.03 0.23 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -114.63 145.7 18.64 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -114.9 92.57 30.91 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 83.5 Cg_endo -71.9 179.67 4.62 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.682 2.922 . . . . 0.0 111.387 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -104.08 160.45 14.83 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 124.656 1.182 . . . . 0.0 111.676 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -77.37 -26.53 52.0 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -110.75 136.71 49.41 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.0 p -63.39 -24.11 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 124.147 0.979 . . . . 0.0 112.237 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -81.45 -18.5 45.05 Favored 'General case' 0 C--N 1.335 -0.038 0 C-N-CA 123.314 0.645 . . . . 0.0 112.258 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -71.55 -23.63 61.8 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 122.818 0.447 . . . . 0.0 110.3 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -113.62 168.6 9.63 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.01 1.724 . . . . 0.0 108.352 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -142.12 134.77 28.3 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 8.7 m-30 -101.03 170.86 7.99 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.07 0.948 . . . . 0.0 109.1 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -137.61 129.66 28.98 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 24.8 tp -100.79 98.35 8.88 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.12 -179.73 3.98 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 126.561 1.944 . . . . 0.0 108.775 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -149.64 162.74 39.61 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 122.23 1.014 . . . . 0.0 110.254 178.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -133.14 -179.67 5.64 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.997 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -58.66 -35.7 72.97 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 125.103 1.361 . . . . 0.0 109.092 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 44.7 t -72.05 -62.11 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -177.64 -169.14 38.3 Favored Glycine 0 C--N 1.338 0.679 0 CA-C-N 119.178 0.899 . . . . 0.0 111.234 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -78.4 158.4 28.75 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.997 0.427 . . . . 0.0 111.149 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -158.1 166.36 32.67 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.056 1.343 . . . . 0.0 107.894 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 3.5 mt -114.63 136.09 52.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 7.1 t -110.98 145.34 38.59 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -140.27 120.32 13.69 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 178.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 2.6 tt -114.85 134.55 57.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 178.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.5 mt -129.32 112.42 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 124.063 0.945 . . . . 0.0 110.289 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -104.29 -160.39 24.27 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 126.343 1.925 . . . . 0.0 111.292 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 40.0 m 67.55 60.12 0.48 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.465 1.506 . . . . 0.0 112.633 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -112.24 -119.47 3.73 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -126.28 115.57 19.9 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.496 1.518 . . . . 0.0 107.893 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 46.1 mm -60.26 114.59 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 54.3 m -72.8 100.07 2.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.73 -15.55 20.72 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.833 0.742 . . . . 0.0 112.7 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.46 -36.71 42.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.514 1.526 . . . . 0.0 107.513 177.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 5.0 p -126.49 -30.76 2.81 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 96.57 17.13 34.47 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 127.317 2.389 . . . . 0.0 111.116 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -92.46 166.18 12.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.35 1.075 . . . . 0.0 111.98 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -87.49 146.74 25.68 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.603 178.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -76.8 30.22 0.13 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.367 2.267 . . . . 0.0 110.744 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -74.6 140.93 44.69 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.964 0.888 . . . . 0.0 110.719 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.3 p -109.47 150.04 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.252 -1.34 . . . . 0.0 109.377 -178.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -120.62 130.44 54.15 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.9 mp -120.19 110.01 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 124.929 1.291 . . . . 0.0 108.2 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -96.46 107.07 19.42 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -84.19 124.45 31.18 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.099 0.96 . . . . 0.0 109.426 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 27.9 m -134.9 173.22 14.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 125.1 1.36 . . . . 0.0 110.645 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 2.4 t -86.86 127.55 35.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 177.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -85.44 171.85 46.2 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 118.61 0.641 . . . . 0.0 112.991 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -68.02 -16.13 68.14 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.831 1.205 . . . . 0.0 112.418 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 40.0 t -118.17 119.33 34.4 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -97.22 18.21 15.53 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.796 0.438 . . . . 0.0 111.253 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 91.2 p -138.41 48.33 1.95 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.045 1.738 . . . . 0.0 110.927 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.83 168.08 28.15 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 120.762 -1.211 . . . . 0.0 111.617 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.68 169.96 21.38 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.865 2.377 . . . . 0.0 111.041 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 78.9 p -68.54 155.05 40.71 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -169.64 154.05 5.32 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 121.66 -0.65 . . . . 0.0 109.611 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.9 mt -82.06 130.23 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -75.98 -59.42 2.77 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.364 1.065 . . . . 0.0 111.441 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 45.1 p-90 -142.23 165.32 27.76 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.775 1.63 . . . . 0.0 108.222 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 46.3 t -145.24 127.01 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.75 133.76 17.07 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 122.051 0.929 . . . . 0.0 110.801 178.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -82.39 86.52 6.71 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 6.7 p -57.59 -64.76 0.79 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.587 1.155 . . . . 0.0 108.915 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -98.76 -174.49 2.8 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 178.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 34.3 mm -69.71 -43.93 79.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 O-C-N 121.347 -0.846 . . . . 0.0 110.486 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -103.81 -39.72 6.53 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.006 0.522 . . . . 0.0 112.308 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 15.5 t -72.56 130.82 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.5 148.88 50.32 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.915 1.686 . . . . 0.0 108.693 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -129.02 144.23 51.12 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.804 1.242 . . . . 0.0 109.258 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.67 161.48 40.48 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.269 1.828 . . . . 0.0 108.698 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -131.05 144.88 51.78 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 86.8 t -130.94 135.23 60.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 4.6 p -102.64 142.58 33.56 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 72.9 mt -141.87 131.75 12.6 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-O 118.748 -0.644 . . . . 0.0 109.714 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -71.54 -32.97 11.38 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.514 2.143 . . . . 0.0 112.128 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -69.38 -22.02 63.74 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.029 0.932 . . . . 0.0 111.246 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.6 mp -68.91 -41.2 78.52 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 22.4 m -57.63 -19.76 28.52 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.137 1.375 . . . . 0.0 112.469 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -64.98 -26.38 68.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.247 0.619 . . . . 0.0 110.643 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 25.1 mt -88.03 133.8 33.88 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.704 2.401 . . . . 0.0 108.477 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -54.9 -47.37 74.43 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.935 2.094 . . . . 0.0 113.937 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 8.1 mp -58.91 -34.63 71.92 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.225 -0.922 . . . . 0.0 111.925 -178.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -92.66 3.88 54.75 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.046 1.338 . . . . 0.0 111.476 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.37 0 C-N-CA 126.259 1.823 . . . . 0.0 110.491 -179.479 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.89 95.69 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 40.7 tp -65.61 -44.83 85.32 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.981 0.912 . . . . 0.0 110.041 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 21.4 mt -62.24 -49.02 77.37 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 79.0 m -54.46 -54.22 43.75 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.638 0.775 . . . . 0.0 109.092 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -58.0 -51.36 69.97 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 122.835 0.454 . . . . 0.0 109.989 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 28.3 m -56.52 -42.61 78.7 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.819 0.847 . . . . 0.0 112.548 -178.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.6 tp -66.98 -55.66 13.52 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 119.328 0.967 . . . . 0.0 110.136 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -60.21 -47.15 87.19 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 118.749 0.704 . . . . 0.0 111.971 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -57.79 -49.79 75.43 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.31 -47.18 91.1 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 42.5 t -59.74 -53.55 46.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 126.238 1.815 . . . . 0.0 110.783 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -32.56 74.17 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 119.776 -0.769 . . . . 0.0 109.68 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.6 m -65.36 -44.92 86.14 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.284 0.947 . . . . 0.0 108.63 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.9 mt -53.02 -53.16 23.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.33 -46.87 79.73 Favored 'General case' 0 N--CA 1.436 -1.15 0 O-C-N 124.688 1.243 . . . . 0.0 111.99 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.21 -50.83 71.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.809 0.814 . . . . 0.0 110.023 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -68.46 -8.96 45.52 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.721 1.208 . . . . 0.0 114.059 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.4 mt -115.27 -25.15 8.14 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.416 1.007 . . . . 0.0 111.861 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -61.87 -29.27 70.08 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.125 0.42 . . . . 0.0 110.347 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -69.62 -46.35 66.43 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.883 1.273 . . . . 0.0 109.546 178.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 -160.15 147.45 16.28 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.641 1.576 . . . . 0.0 110.218 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 65.9 m -75.58 177.57 6.66 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 34.0 pt -131.86 150.32 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 O-C-N 121.432 -0.793 . . . . 0.0 109.556 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.59 164.91 28.94 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.961 0.504 . . . . 0.0 110.604 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -147.08 129.13 15.5 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.057 1.743 . . . . 0.0 109.237 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -91.33 102.76 15.46 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.97 66.64 3.62 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.959 1.303 . . . . 0.0 107.791 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.16 -120.28 11.77 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -63.34 -34.9 78.7 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.809 0.844 . . . . 0.0 112.558 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -107.44 148.85 28.61 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 118.743 0.701 . . . . 0.0 110.637 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.0 mt -112.06 151.03 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -125.22 128.4 48.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.246 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -126.33 130.69 51.31 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.846 1.658 . . . . 0.0 108.544 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -125.76 120.97 32.02 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.35 1.46 . . . . 0.0 109.33 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 6.5 m -105.53 160.02 27.51 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.755 1.222 . . . . 0.0 113.89 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.02 86.12 0.49 Allowed 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 124.585 3.524 . . . . 0.0 113.208 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 61.93 54.95 31.11 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.0 mt -130.02 -67.46 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.408 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 20.9 pt-20 -170.29 166.57 8.72 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 126.337 1.855 . . . . 0.0 108.05 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.58 119.07 27.12 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 102.472 -3.159 . . . . 0.0 102.472 177.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.6 m -139.24 148.39 23.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -178.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -113.69 138.02 50.8 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -145.76 158.5 43.85 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.753 1.221 . . . . 0.0 111.158 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -87.81 154.48 20.51 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 152.34 -164.14 30.48 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -132.13 161.29 33.68 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.173 1.389 . . . . 0.0 108.01 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 53.7 t . . . . . 0 N--CA 1.467 0.397 0 C-N-CA 124.579 1.152 . . . . 0.0 109.928 -179.309 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 . . . . . 0 C--O 1.235 0.303 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.7 mt . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 179.516 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 46.8 mt . . . . . 0 C--O 1.234 0.258 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.2 t -142.67 138.95 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 126.145 1.778 . . . . 0.0 108.933 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -132.04 153.48 50.36 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 125.215 1.406 . . . . 0.0 110.673 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -95.39 135.96 36.35 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.658 1.583 . . . . 0.0 108.2 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 63.7 mt -115.89 -78.85 0.58 Allowed 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -121.38 154.05 16.6 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt -132.84 90.57 31.74 Favored Pre-proline 0 N--CA 1.456 -0.148 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 48.6 Cg_endo -76.27 -178.99 4.83 Favored 'Trans proline' 0 C--O 1.239 0.529 0 C-N-CA 123.194 2.596 . . . . 0.0 111.951 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -85.59 166.97 15.8 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.24 -37.03 39.03 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -105.33 152.0 23.47 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.375 -0.828 . . . . 0.0 111.67 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.1 p -68.25 -24.68 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.575 0.75 . . . . 0.0 112.393 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -82.82 -8.24 59.6 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.909 1.284 . . . . 0.0 112.372 -178.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -96.79 -11.72 24.58 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.466 1.107 . . . . 0.0 110.258 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -120.53 177.91 4.87 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.83 2.452 . . . . 0.0 111.552 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -142.85 165.78 26.44 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.02 1.728 . . . . 0.0 109.786 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -140.94 168.42 19.84 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.885 1.674 . . . . 0.0 109.28 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -129.97 122.0 27.65 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.638 0.775 . . . . 0.0 109.488 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.0 tt -81.28 105.0 12.12 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 45.7 mt -115.78 -179.89 3.78 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.944 0.897 . . . . 0.0 110.995 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -161.91 156.15 22.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -138.42 -172.83 3.38 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -54.16 -24.2 17.18 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.487 1.915 . . . . 0.0 113.626 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 45.7 t -80.85 -75.5 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -166.68 -168.97 29.67 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -78.16 154.78 30.88 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.249 1.02 . . . . 0.0 111.177 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -160.85 175.38 12.61 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.149 1.78 . . . . 0.0 108.74 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 15.8 mt -120.01 137.85 52.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 103.063 -2.94 . . . . 0.0 103.063 177.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.4 t -124.88 125.85 44.61 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -128.55 146.02 50.95 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 5.8 tt -121.53 138.2 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 13.8 mt -126.06 109.54 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 125.65 1.58 . . . . 0.0 109.512 -178.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.34 -153.26 24.9 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 41.7 m 75.95 31.67 0.68 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.866 1.267 . . . . 0.0 111.357 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -91.62 -138.22 7.92 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 108.266 -1.934 . . . . 0.0 108.266 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -117.47 121.71 41.77 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 127.229 2.212 . . . . 0.0 110.04 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 10.6 mm -60.79 125.63 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 123.378 0.671 . . . . 0.0 109.839 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 56.6 m -84.64 101.96 12.56 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 103.922 -2.621 . . . . 0.0 103.922 177.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -58.61 -17.79 24.91 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.579 0.627 . . . . 0.0 110.762 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 24.9 t -50.69 -41.56 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 125.526 1.53 . . . . 0.0 109.098 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 7.5 p -125.45 -24.23 3.96 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 96.1 6.21 59.13 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 126.713 2.101 . . . . 0.0 112.441 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -86.23 166.82 15.4 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.038 0.935 . . . . 0.0 110.965 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -90.39 150.87 21.68 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 2.6 tpt85 -76.88 30.69 0.13 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 128.216 2.606 . . . . 0.0 110.789 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.1 ptt? -72.44 149.13 44.5 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -176.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.3 p -121.74 140.78 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 114.616 -1.174 . . . . 0.0 112.218 -176.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -112.57 123.09 49.51 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.365 1.066 . . . . 0.0 110.394 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 2.3 mp -109.04 128.67 64.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 126.115 1.766 . . . . 0.0 111.098 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -106.23 118.69 37.29 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.36 1.064 . . . . 0.0 108.724 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -97.27 115.33 27.43 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.91 0.884 . . . . 0.0 109.61 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 32.8 m -125.54 165.42 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.647 1.579 . . . . 0.0 112.106 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.13 137.33 37.43 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -107.06 128.03 9.08 Favored Glycine 0 C--N 1.334 0.471 0 N-CA-C 108.265 -1.934 . . . . 0.0 108.265 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -42.91 -41.63 4.63 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.592 1.568 . . . . 0.0 113.656 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.4 t -79.49 85.37 5.27 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -72.66 9.15 1.17 Allowed 'General case' 0 CA--C 1.549 0.908 0 O-C-N 121.276 -0.89 . . . . 0.0 113.115 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.95 46.51 1.65 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.43 1.892 . . . . 0.0 112.906 -178.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -166.83 159.89 33.38 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 120.299 -1.5 . . . . 0.0 111.993 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.25 166.59 22.82 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.135 2.557 . . . . 0.0 111.825 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 5.2 p -66.22 158.62 28.38 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.827 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.0 p -161.6 165.31 28.58 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.125 1.77 . . . . 0.0 107.376 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.8 mt -85.61 132.1 32.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -78.2 -53.03 7.79 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.787 1.635 . . . . 0.0 110.542 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . 0.434 ' CE3' ' HD2' ' A' ' 222' ' ' ARG . 37.9 p-90 -152.16 167.4 28.66 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.38 1.472 . . . . 0.0 108.685 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 47.0 t -146.29 133.88 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 126.253 1.821 . . . . 0.0 106.923 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.434 ' HD2' ' CE3' ' A' ' 220' ' ' TRP . 0.1 OUTLIER -153.75 130.47 10.81 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.912 0.778 . . . . 0.0 111.12 178.082 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -81.73 86.88 6.36 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' THR . . . . . 0.597 ' HG1' ' CD ' ' A' ' 230' ' ' GLU . 6.6 p -65.32 -55.02 20.61 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 127.022 2.129 . . . . 0.0 110.599 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -98.38 -176.51 3.42 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.5 mp -78.79 -29.98 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.8 t -111.61 -54.34 2.62 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.511 0.725 . . . . 0.0 110.898 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.94 149.4 10.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 123.639 0.776 . . . . 0.0 109.283 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.24 139.56 39.29 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.213 1.805 . . . . 0.0 109.453 -178.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . 0.597 ' CD ' ' HG1' ' A' ' 224' ' ' THR . 0.6 OUTLIER -117.3 140.34 49.68 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.03 1.332 . . . . 0.0 108.553 179.703 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.39 162.32 38.46 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.394 1.877 . . . . 0.0 109.12 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -131.79 149.4 52.48 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 94.3 t -132.55 132.77 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 125.836 1.654 . . . . 0.0 108.887 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.25 144.29 27.2 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 32.7 mt -141.28 136.97 16.21 Favored Pre-proline 0 N--CA 1.454 -0.262 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.75 -40.88 0.46 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.627 1.551 . . . . 0.0 112.338 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -68.27 -17.67 64.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 120.768 -1.208 . . . . 0.0 111.944 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 17.0 mt -66.04 -30.77 71.36 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 176.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 28.9 m -61.11 -13.78 19.71 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.024 1.33 . . . . 0.0 111.167 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -75.37 -32.37 60.81 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 120.142 -1.599 . . . . 0.0 111.534 178.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 40.5 mt -81.31 111.47 17.72 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 126.5 1.92 . . . . 0.0 109.0 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -47.08 -34.11 5.58 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 128.847 2.859 . . . . 0.0 114.878 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 12.5 mt -62.82 -39.62 94.88 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.355 -0.841 . . . . 0.0 111.531 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 4.8 mp -91.51 10.33 28.27 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 127.058 2.143 . . . . 0.0 113.5 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.164 0 C-N-CA 126.462 1.905 . . . . 0.0 110.694 -178.289 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.9 p . . . . . 0 CA--C 1.528 0.115 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.49 -48.17 82.94 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 118.293 0.497 . . . . 0.0 110.096 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 47.1 tp -67.53 -40.2 85.06 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 118.218 -0.896 . . . . 0.0 109.445 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.7 mt -59.35 -52.49 65.43 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.864 1.211 . . . . 0.0 109.266 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.4 m -57.3 -49.57 75.68 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 121.648 -0.657 . . . . 0.0 109.47 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -57.89 -49.1 77.86 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 118.238 0.472 . . . . 0.0 109.776 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 59.6 m -53.05 -52.57 58.09 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.71 1.604 . . . . 0.0 110.422 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 19.0 tp -59.83 -54.3 47.88 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 118.802 -0.618 . . . . 0.0 110.603 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.86 -47.67 79.88 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 118.262 0.483 . . . . 0.0 111.708 -178.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -60.06 -39.74 87.05 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.285 1.034 . . . . 0.0 108.512 178.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.89 -52.83 50.53 Favored Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 40.3 t -56.39 -52.99 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 118.661 1.231 . . . . 0.0 111.165 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -29.67 70.87 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.405 1.002 . . . . 0.0 111.54 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.1 m -75.41 -42.69 53.09 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 118.79 -0.624 . . . . 0.0 110.459 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 22.6 mt -56.12 -50.87 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.03 -43.19 91.57 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -65.77 -20.51 66.29 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.72 1.208 . . . . 0.0 112.81 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.16 10.36 33.84 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.003 1.321 . . . . 0.0 112.583 178.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.7 mt -135.59 -29.15 1.07 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.497 1.119 . . . . 0.0 113.555 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -51.7 -37.16 49.61 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -178.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -65.45 -40.07 92.79 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 116.069 1.878 . . . . 0.0 116.069 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.9 mmt180 -159.12 147.87 18.25 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.395 1.478 . . . . 0.0 109.243 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 32.2 m -75.72 172.3 12.87 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 32.9 pt -126.31 146.24 32.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -144.96 152.65 40.51 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 122.84 0.456 . . . . 0.0 110.889 -178.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -137.08 127.71 26.98 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 124.046 0.938 . . . . 0.0 110.455 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -89.15 102.86 15.52 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.57 70.75 4.24 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.08 -115.51 5.5 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -77.27 -28.03 53.37 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.322 1.049 . . . . 0.0 111.794 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -106.65 135.56 47.96 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 119.327 0.967 . . . . 0.0 111.215 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.4 mt -106.82 145.82 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -121.27 128.33 52.26 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.409 1.484 . . . . 0.0 107.627 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -122.94 128.24 50.0 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.676 1.59 . . . . 0.0 110.255 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -121.06 109.97 15.68 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.074 0.95 . . . . 0.0 108.612 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 11.6 m -95.23 158.8 34.15 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 123.226 0.61 . . . . 0.0 110.972 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.5 83.55 0.39 Allowed 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 123.903 3.069 . . . . 0.0 115.658 -178.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.32 51.68 50.47 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 124.205 0.907 . . . . 0.0 111.085 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.8 mt -126.8 -67.17 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -170.64 163.35 8.11 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 126.414 1.885 . . . . 0.0 108.362 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.67 121.12 36.64 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 102.154 -3.276 . . . . 0.0 102.154 177.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.4 m -131.5 156.95 43.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 124.548 1.139 . . . . 0.0 111.13 -178.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -125.83 126.39 44.41 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 178.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -143.99 157.53 44.28 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.489 1.115 . . . . 0.0 111.926 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -89.29 153.24 21.05 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 178.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 161.84 -163.03 34.51 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.38 140.86 50.58 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.6 t . . . . . 0 C--N 1.332 -0.186 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.829 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 . . . . . 0 C--O 1.234 0.258 0 CA-C-O 121.408 0.623 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 39.7 mt . . . . . 0 N--CA 1.45 -0.438 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.822 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 80.6 mt . . . . . 0 C--O 1.233 0.235 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.3 t -142.5 135.12 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.071 1.348 . . . . 0.0 107.838 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -124.31 151.38 44.35 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.087 1.355 . . . . 0.0 111.051 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -96.99 112.64 24.3 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 127.068 2.147 . . . . 0.0 107.449 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.3 mp -93.82 -78.53 0.43 Allowed 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -120.49 144.23 16.95 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -121.52 89.35 47.19 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -77.58 173.35 14.32 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.793 2.995 . . . . 0.0 111.608 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -87.88 161.88 17.25 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.184 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -82.97 -37.84 23.51 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.066 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -93.34 132.59 37.42 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 15.0 p -60.65 -31.74 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 123.85 0.86 . . . . 0.0 112.086 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -68.03 -21.36 65.02 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.704 0.684 . . . . 0.0 112.01 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -84.31 -20.31 32.3 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.838 0.455 . . . . 0.0 110.614 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 32.9 mmm-85 -70.72 165.93 21.95 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.748 0.819 . . . . 0.0 109.904 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -134.86 95.98 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.086 0.955 . . . . 0.0 109.241 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -106.68 156.65 18.4 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.946 1.298 . . . . 0.0 108.932 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -140.92 147.49 38.92 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.759 1.224 . . . . 0.0 107.888 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 25.1 tp -107.94 102.64 11.81 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 125.705 1.602 . . . . 0.0 106.875 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.81 179.0 4.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.28 1.432 . . . . 0.0 107.837 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -154.07 163.66 39.74 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -133.81 173.9 11.04 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -63.78 -11.43 26.69 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.403 -0.81 . . . . 0.0 110.61 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 83.7 t -83.76 -66.16 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -176.32 -174.54 42.91 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -81.41 156.57 25.33 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 124.798 1.239 . . . . 0.0 111.842 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -162.79 169.96 19.08 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.228 1.011 . . . . 0.0 111.258 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 7.9 mt -116.57 121.78 68.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 11.8 t -97.69 131.61 44.08 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.704 1.202 . . . . 0.0 110.321 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -137.93 110.14 7.34 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.114 1.766 . . . . 0.0 109.075 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 2.7 tt -103.22 140.23 22.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.2 mt -132.83 113.79 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 123.647 0.779 . . . . 0.0 110.289 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -106.55 -156.87 21.33 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 125.293 1.425 . . . . 0.0 110.897 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 65.69 60.79 0.7 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.109 1.763 . . . . 0.0 111.554 -178.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -116.84 -124.01 3.52 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 104.633 -3.387 . . . . 0.0 104.633 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -127.95 123.58 35.22 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.759 1.224 . . . . 0.0 110.754 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 31.0 mm -64.25 116.96 4.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 71.8 m -73.71 102.09 3.86 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -53.18 -28.8 28.24 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.5 m -52.41 -33.28 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 C-N-CA 125.025 1.33 . . . . 0.0 111.384 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 73.1 p -123.0 -45.79 2.12 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.74 12.43 20.88 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.994 2.235 . . . . 0.0 111.32 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -92.56 169.97 10.11 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.942 1.297 . . . . 0.0 111.488 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -85.17 148.51 26.07 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.589 0.709 . . . . 0.0 111.792 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 18.3 tpt85 -84.05 28.56 0.6 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.676 2.39 . . . . 0.0 109.157 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 3.5 ptt? -73.47 158.77 34.3 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -177.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 1.9 p -125.93 140.1 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.155 -178.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -105.96 115.54 30.4 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 125.84 1.656 . . . . 0.0 107.083 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.6 mp -107.12 131.65 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -118.1 120.15 36.88 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 125.435 1.494 . . . . 0.0 108.511 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -101.05 119.4 38.69 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.42 1.488 . . . . 0.0 112.368 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 17.2 m -127.05 176.34 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.808 1.243 . . . . 0.0 111.8 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.6 t -91.0 124.32 35.15 Favored 'General case' 0 C--N 1.337 0.053 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 178.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.34 155.24 34.03 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.258 -0.496 . . . . 0.0 113.043 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -57.44 -27.22 57.98 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.305 0.955 . . . . 0.0 111.594 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 6.0 m -114.68 93.69 4.44 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -77.55 25.03 0.19 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.967 1.707 . . . . 0.0 112.552 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 27.2 t -131.98 45.48 2.77 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.343 1.857 . . . . 0.0 110.005 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -161.35 166.03 35.69 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-O 118.619 -1.101 . . . . 0.0 111.27 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -71.09 166.75 28.16 Favored 'Trans proline' 0 C--O 1.24 0.589 0 C-N-CA 122.821 2.347 . . . . 0.0 112.413 -178.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 96.7 p -70.38 155.58 40.49 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -166.01 156.11 12.5 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.0 mt -78.87 127.03 39.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -72.01 -51.25 22.71 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.743 1.617 . . . . 0.0 112.139 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 20.7 p-90 -152.76 164.92 36.86 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.183 1.393 . . . . 0.0 109.334 -178.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 51.3 t -147.36 120.75 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.15 127.42 21.19 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -80.68 92.26 5.97 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 104.101 -2.555 . . . . 0.0 104.101 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 5.7 p -65.69 -65.65 0.65 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.35 1.46 . . . . 0.0 109.786 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -88.71 -172.83 3.88 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.052 0.941 . . . . 0.0 108.489 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.4 mp -78.71 -40.99 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -106.07 -49.41 3.38 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.106 1.363 . . . . 0.0 112.539 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 2.4 t -68.26 145.54 13.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.2 136.1 37.86 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.716 1.606 . . . . 0.0 109.177 -178.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.42 139.93 43.78 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 125.047 1.339 . . . . 0.0 108.577 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -142.06 155.1 45.38 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 126.088 1.755 . . . . 0.0 110.136 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -136.25 146.42 46.7 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 1.6 m -137.34 154.56 30.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.1 p -109.08 148.67 30.46 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 123.469 0.708 . . . . 0.0 110.33 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 41.6 mt -142.27 133.35 12.94 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.27 -46.56 0.65 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.772 2.315 . . . . 0.0 112.324 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -62.03 -22.73 65.96 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.953 0.901 . . . . 0.0 113.375 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.8 mp -63.26 -40.06 96.35 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.223 0.92 . . . . 0.0 108.974 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 30.2 m -54.59 -22.53 13.58 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.84 1.656 . . . . 0.0 113.152 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -62.7 -31.47 72.38 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 121.1 -1.0 . . . . 0.0 110.841 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 26.4 mt -79.4 118.88 21.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.7 -35.52 31.52 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.9 mp -58.93 -45.19 90.99 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.336 -0.852 . . . . 0.0 109.599 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.76 5.45 36.31 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.125 1.77 . . . . 0.0 112.62 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.526 0 CA-C-N 119.68 1.127 . . . . 0.0 111.261 -179.549 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.6 m . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.05 -38.31 70.44 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.373 0.669 . . . . 0.0 110.659 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.3 tp -60.57 -38.11 83.5 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 119.003 -0.523 . . . . 0.0 110.457 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.4 mt -67.23 -49.51 64.2 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 58.7 m -54.6 -44.57 73.16 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.919 0.888 . . . . 0.0 109.904 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -66.31 -50.78 62.45 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 121.104 -0.998 . . . . 0.0 110.246 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 58.4 m -53.99 -47.43 71.44 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.287 1.435 . . . . 0.0 111.145 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 28.5 tp -63.31 -54.79 31.51 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 119.051 0.841 . . . . 0.0 110.911 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -54.01 -48.99 69.86 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.414 0.686 . . . . 0.0 110.52 -178.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -57.37 -50.79 71.85 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 124.07 0.948 . . . . 0.0 109.051 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -57.04 -49.38 72.13 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-O 119.178 -0.79 . . . . 0.0 111.687 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 72.6 t -58.88 -53.2 50.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 125.343 1.457 . . . . 0.0 110.867 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -31.23 72.34 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 118.573 0.624 . . . . 0.0 110.531 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.8 m -70.44 -46.13 64.47 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.9 mt -53.56 -54.31 19.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.37 -44.04 84.09 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 124.035 0.834 . . . . 0.0 110.81 -178.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -60.41 -52.53 64.82 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.163 0.506 . . . . 0.0 111.6 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -22.19 66.8 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.8 mt -96.04 -27.37 15.14 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 118.823 0.738 . . . . 0.0 110.311 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -61.79 -28.44 69.46 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.186 0.594 . . . . 0.0 110.178 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -66.53 -46.93 74.52 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -165.44 152.75 10.64 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.908 2.083 . . . . 0.0 109.431 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 57.5 m -75.44 171.82 13.58 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 41.6 pt -125.78 147.55 30.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 123.801 0.84 . . . . 0.0 108.981 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.73 156.42 45.01 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 122.78 0.432 . . . . 0.0 110.375 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -142.91 128.02 18.58 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 124.167 0.987 . . . . 0.0 110.195 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -88.71 106.12 18.14 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.29 67.23 0.92 Allowed 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.35 -120.53 7.11 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.173 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -66.73 -32.06 73.12 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.64 1.176 . . . . 0.0 111.345 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -107.64 135.84 48.41 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.463 0.649 . . . . 0.0 111.626 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.409 HD11 ' H ' ' A' ' 140' ' ' GLY . 33.1 mt -105.8 149.72 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 177.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -119.08 134.8 54.98 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.334 -1.757 . . . . 0.0 108.205 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -128.91 130.74 47.19 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.751 1.22 . . . . 0.0 108.495 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -129.4 118.82 22.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.585 1.154 . . . . 0.0 109.219 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 10.6 m -105.41 160.32 26.46 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.668 1.187 . . . . 0.0 113.57 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -63.79 92.82 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 124.858 3.706 . . . . 0.0 113.157 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 52.17 53.06 32.7 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-O 119.579 -0.567 . . . . 0.0 111.846 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.1 mt -124.92 -67.36 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.434 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 22.2 pt-20 -177.38 174.73 1.55 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.98 1.712 . . . . 0.0 109.203 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.82 124.55 39.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 177.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.9 m -134.42 156.94 41.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 124.379 1.072 . . . . 0.0 110.879 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -124.09 124.12 41.82 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -146.17 156.37 43.37 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.323 1.049 . . . . 0.0 111.615 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -102.21 119.59 39.06 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.409 ' H ' HD11 ' A' ' 126' ' ' ILE . . . -154.44 -165.14 13.54 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.921 1.724 . . . . 0.0 108.962 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.66 136.89 50.28 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 C--O 1.237 0.417 0 C-N-CA 123.902 0.881 . . . . 0.0 112.319 -179.193 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 . . . . . 0 N--CA 1.445 -0.715 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 88.1 mt . . . . . 0 C--N 1.326 -0.442 0 N-CA-C 102.744 -3.058 . . . . 0.0 102.744 178.863 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 N--CA 1.456 -0.144 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.8 t -134.95 133.95 53.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.044 0.838 . . . . 0.0 108.965 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -130.3 163.4 26.88 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.492 1.517 . . . . 0.0 110.792 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -112.9 143.38 44.28 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 18.5 mt -116.32 -72.92 0.67 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -128.67 148.88 18.19 Favored Glycine 0 C--O 1.241 0.564 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -130.78 91.83 36.0 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.718 1.207 . . . . 0.0 109.286 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 43.5 Cg_endo -74.46 -166.09 0.31 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 125.06 3.84 . . . . 0.0 111.051 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -95.98 168.1 10.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.114 1.366 . . . . 0.0 109.395 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -81.79 -28.45 33.2 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -113.98 162.56 16.27 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 123.328 0.651 . . . . 0.0 110.324 -179.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.8 p -73.63 -34.58 41.96 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 C-N-CA 123.364 0.665 . . . . 0.0 110.379 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -74.37 -16.03 60.91 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.404 -0.81 . . . . 0.0 112.182 -177.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -81.57 -19.66 41.53 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.183 0.993 . . . . 0.0 110.603 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -117.33 177.91 4.56 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.608 1.563 . . . . 0.0 110.985 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -140.51 156.86 46.2 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -133.83 166.99 21.37 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.308 1.843 . . . . 0.0 107.977 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -133.74 123.7 25.38 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 120.498 1.499 . . . . 0.0 112.614 -179.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.77 99.08 9.45 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.005 1.322 . . . . 0.0 109.442 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 24.7 mt -108.21 174.02 6.06 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 122.394 1.092 . . . . 0.0 109.516 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -154.52 163.11 40.7 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -141.25 -178.44 5.59 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -52.55 -34.25 49.3 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 125.335 1.454 . . . . 0.0 110.523 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 56.1 t -70.79 -67.78 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 127.005 2.122 . . . . 0.0 109.191 178.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -175.77 -174.69 42.54 Favored Glycine 0 N--CA 1.446 -0.66 0 O-C-N 121.817 -0.552 . . . . 0.0 111.931 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -80.06 158.32 26.49 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.515 1.126 . . . . 0.0 111.973 -178.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -165.69 177.0 7.58 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.457 1.503 . . . . 0.0 108.531 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 8.9 mt -121.92 126.28 74.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 101.609 -3.478 . . . . 0.0 101.609 177.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.2 t -106.4 107.8 19.0 Favored 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 124.325 1.016 . . . . 0.0 109.248 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -111.22 118.78 36.85 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 118.5 -0.762 . . . . 0.0 110.699 -179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.8 tt -108.95 140.27 28.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.5 mt -133.87 113.47 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 C-N-CA 123.997 0.919 . . . . 0.0 110.637 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.68 -162.41 26.01 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 177.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.0 m 84.45 29.19 0.07 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.251 2.221 . . . . 0.0 112.959 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -87.4 -109.15 0.92 Allowed Glycine 0 C--N 1.338 0.649 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -139.11 126.6 21.7 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.337 1.455 . . . . 0.0 109.053 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.5 mm -68.19 122.54 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 120.503 1.501 . . . . 0.0 109.453 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 30.5 p -82.01 117.76 22.46 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 123.156 0.583 . . . . 0.0 111.622 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -71.89 -3.52 22.95 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.115 -0.991 . . . . 0.0 110.718 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 39.6 t -66.98 -42.06 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 125.127 1.371 . . . . 0.0 108.278 178.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.9 p -124.34 -28.57 3.64 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 122.898 0.479 . . . . 0.0 111.613 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.77 30.62 10.22 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -116.55 169.28 9.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.74 1.216 . . . . 0.0 112.289 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -83.83 139.91 32.36 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.351 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 2.9 tpp85 -77.13 30.75 0.14 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 130.013 3.325 . . . . 0.0 109.371 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 12.2 ptt? -73.11 157.11 37.9 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 122.008 0.909 . . . . 0.0 109.329 -176.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.5 p -125.19 146.05 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 114.37 -1.287 . . . . 0.0 111.317 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -112.7 138.6 49.27 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 1.8 mp -125.94 114.38 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 126.455 1.902 . . . . 0.0 107.579 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -99.69 116.28 31.43 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -93.54 118.17 31.01 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 125.242 1.417 . . . . 0.0 111.506 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 32.5 m -129.49 172.21 15.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 124.266 1.026 . . . . 0.0 111.312 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.2 t -78.59 134.96 37.16 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -93.21 122.01 6.79 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -37.68 -61.73 1.06 Allowed Glycine 0 C--N 1.336 0.538 0 C-N-CA 126.74 2.114 . . . . 0.0 111.343 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.8 p -77.66 83.09 4.05 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 37.2 p-10 -76.64 66.78 2.66 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.9 p -149.47 19.45 0.94 Allowed 'General case' 0 C--O 1.238 0.458 0 N-CA-C 116.539 2.052 . . . . 0.0 116.539 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -163.95 173.65 40.01 Favored Glycine 0 N--CA 1.47 0.941 0 O-C-N 121.189 -0.945 . . . . 0.0 115.197 -178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -64.77 164.24 24.97 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.036 2.49 . . . . 0.0 112.535 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 15.8 p -67.31 157.59 33.59 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.368 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 1.7 p -161.27 163.72 30.75 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.417 2.287 . . . . 0.0 106.923 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.5 mt -82.75 134.57 26.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 178.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -81.57 -55.22 4.81 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.052 1.341 . . . . 0.0 111.097 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 26.2 p-90 -147.92 166.54 27.36 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.259 1.424 . . . . 0.0 108.541 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 49.6 t -146.1 131.76 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.43 133.65 15.25 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.73 0.776 . . . . 0.0 111.223 177.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -81.72 89.3 6.27 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.2 p -66.01 -51.91 54.03 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.082 0.953 . . . . 0.0 111.734 -178.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -103.18 -173.83 2.4 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.0 mp -72.17 -43.54 66.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 3.4 m -111.94 -28.55 7.99 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -177.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 2.1 t -81.78 143.1 12.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -129.04 145.5 51.24 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.31 1.444 . . . . 0.0 110.09 -177.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -129.33 142.02 50.93 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 125.442 1.497 . . . . 0.0 108.39 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.28 163.2 37.16 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.296 1.839 . . . . 0.0 110.786 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -126.89 149.15 49.91 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 88.7 t -132.77 134.37 58.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 125.525 1.53 . . . . 0.0 107.803 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.41 143.48 32.63 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.922 0.889 . . . . 0.0 108.877 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 33.8 mt -139.85 138.13 19.36 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 118.251 -0.88 . . . . 0.0 109.215 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.22 -46.16 0.31 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.647 2.231 . . . . 0.0 110.838 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.71 -25.41 62.88 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.996 1.318 . . . . 0.0 110.816 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 15.3 mt -65.52 -41.33 93.26 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 24.7 m -58.01 -16.1 11.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.604 1.562 . . . . 0.0 113.061 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -63.19 -43.84 97.07 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.006 0.923 . . . . 0.0 109.143 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.8 mt -71.87 120.04 16.9 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 128.809 2.844 . . . . 0.0 107.049 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -52.67 -35.21 54.75 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.4 mp -58.73 -36.7 74.72 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.602 -0.686 . . . . 0.0 110.897 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -94.41 3.88 54.6 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 125.046 1.338 . . . . 0.0 111.949 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.718 0 O-C-N 121.506 -0.746 . . . . 0.0 112.384 -179.346 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.446 -0.672 0 CA-C-O 118.375 -0.821 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.53 -35.97 77.27 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.715 1.143 . . . . 0.0 110.34 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.22 -45.34 88.69 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.6 mt -63.46 -53.93 44.47 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.494 1.118 . . . . 0.0 109.538 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 55.2 m -54.87 -44.51 74.1 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.637 1.175 . . . . 0.0 110.648 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.1 ttmm -65.97 -49.79 66.6 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.813 -0.613 . . . . 0.0 109.945 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 79.9 m -51.92 -43.28 63.35 Favored 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 124.523 1.129 . . . . 0.0 111.157 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tt -61.79 -56.88 14.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.299 0.5 . . . . 0.0 111.898 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -60.69 -45.71 93.16 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.744 0.817 . . . . 0.0 111.42 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -57.72 -44.28 85.87 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.861 0.864 . . . . 0.0 108.851 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.98 -52.03 54.87 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 94.8 t -55.1 -53.2 36.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 124.977 1.311 . . . . 0.0 111.711 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.04 -33.36 75.58 Favored 'General case' 0 C--N 1.335 -0.052 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.741 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.2 m -67.63 -46.22 73.13 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 27.9 mt -55.64 -54.31 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 124.606 1.163 . . . . 0.0 108.855 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.02 -43.73 82.13 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.468 -178.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -60.99 -52.96 62.81 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-N 118.78 0.718 . . . . 0.0 110.637 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.68 -15.65 53.48 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.2 mt -101.54 -28.11 12.73 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 119.358 0.981 . . . . 0.0 109.174 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -65.5 -26.22 67.82 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -66.6 -46.23 76.61 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 -161.77 148.56 14.1 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.307 1.843 . . . . 0.0 109.297 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 71.0 m -74.99 164.42 26.57 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 178.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 33.3 pt -119.36 154.98 21.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -145.21 165.39 28.48 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.031 -178.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -151.25 125.34 9.26 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.194 1.397 . . . . 0.0 109.369 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -88.76 117.38 27.7 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -108.41 67.49 0.67 Allowed 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.722 1.209 . . . . 0.0 109.0 178.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.0 -114.09 3.88 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 107.917 -2.073 . . . . 0.0 107.917 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -83.99 -26.5 29.14 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.162 1.385 . . . . 0.0 112.463 179.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -106.38 115.44 30.22 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.409 1.484 . . . . 0.0 112.638 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 51.2 mt -92.57 146.74 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 C-N-CA 125.559 1.543 . . . . 0.0 108.219 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -118.04 135.23 54.3 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.499 -1.228 . . . . 0.0 107.74 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -133.14 126.43 31.69 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.311 1.044 . . . . 0.0 108.772 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.599 ' HH ' HD13 ' A' ' 187' ' ' ILE . 18.5 t80 -122.85 127.07 48.53 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.595 1.158 . . . . 0.0 111.677 -179.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 17.6 m -114.21 158.66 39.06 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 123.428 0.691 . . . . 0.0 112.351 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.28 92.78 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.625 1 C-N-CA 125.614 4.21 . . . . 0.0 113.858 -178.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 58.91 47.49 90.37 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.1 mt -125.37 -66.86 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.215 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.449 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 20.8 pt-20 -178.13 167.11 1.99 Allowed 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.415 1.486 . . . . 0.0 109.117 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.32 119.28 29.65 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 178.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.6 m -127.2 156.67 38.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 125.252 1.421 . . . . 0.0 110.765 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.36 124.07 41.57 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 103.638 -2.726 . . . . 0.0 103.638 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -146.29 158.79 43.91 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -178.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -89.37 153.64 20.7 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 169.48 -168.46 41.3 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -125.62 138.22 53.91 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.563 1.545 . . . . 0.0 107.075 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.467 0.402 0 CA-C-N 119.244 0.929 . . . . 0.0 110.907 -178.857 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 . . . . . 0 C--O 1.236 0.365 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 23.0 mt . . . . . 0 C--O 1.237 0.434 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 179.111 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 15.9 mt . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -136.2 135.18 50.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -134.49 154.82 51.23 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.96 1.704 . . . . 0.0 108.689 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -107.68 143.19 36.52 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.874 0.87 . . . . 0.0 109.236 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 35.5 mt -113.6 -69.96 0.83 Allowed 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 124.255 0.972 . . . . 0.0 109.432 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -133.57 156.51 22.3 Favored Glycine 0 C--O 1.239 0.422 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -126.78 93.7 41.67 Favored Pre-proline 0 C--O 1.231 0.102 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 57.3 Cg_endo -76.73 174.69 12.43 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 122.421 2.08 . . . . 0.0 110.068 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -81.32 162.03 23.62 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.47 -28.96 24.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.937 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -103.44 135.48 44.96 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.39 -22.54 28.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -83.28 -14.44 53.08 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 124.865 1.266 . . . . 0.0 111.448 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -84.55 -13.74 50.93 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.404 0.682 . . . . 0.0 110.864 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -117.51 174.56 6.08 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.345 1.858 . . . . 0.0 111.524 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -142.68 154.4 44.29 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.104 1.361 . . . . 0.0 109.511 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -128.96 169.41 14.69 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.874 2.469 . . . . 0.0 108.759 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -131.78 135.84 47.08 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.663 1.185 . . . . 0.0 109.514 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 17.4 tp -89.15 98.76 11.95 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.444 1.097 . . . . 0.0 108.343 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 20.6 mt -105.32 178.37 4.58 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.95 0.881 . . . . 0.0 111.341 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -158.58 162.66 37.38 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -138.62 -178.39 5.28 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 125.346 1.459 . . . . 0.0 109.827 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -58.92 -15.59 13.56 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 45.4 t -98.58 -56.32 5.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 C-N-CA 125.569 1.548 . . . . 0.0 108.768 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -169.21 -167.42 29.77 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 119.324 0.966 . . . . 0.0 113.172 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -88.64 156.09 19.23 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 122.192 -0.593 . . . . 0.0 110.848 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -157.64 173.98 16.04 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.162 1.385 . . . . 0.0 107.934 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 18.9 mt -118.27 140.22 42.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 102.908 -2.997 . . . . 0.0 102.908 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 36.1 t -117.94 131.26 56.52 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.6 127.05 18.81 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 178.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.6 tt -115.19 134.74 57.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.599 HD13 ' HH ' ' A' ' 129' ' ' TYR . 4.5 mt -125.04 111.08 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.681 1.192 . . . . 0.0 111.823 -177.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -100.42 -158.32 27.95 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 108.328 -1.909 . . . . 0.0 108.328 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 9.1 m 69.53 56.95 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 123.93 0.892 . . . . 0.0 109.467 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -114.79 -116.06 3.11 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 105.678 -2.969 . . . . 0.0 105.678 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -135.24 129.05 33.05 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.902 1.681 . . . . 0.0 107.375 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 25.8 mm -67.28 132.73 32.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 29.3 p -80.31 113.48 18.52 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.22 -24.46 66.37 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.863 1.211 . . . . 0.0 111.86 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 3.6 m -57.34 -41.5 78.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 117.251 -1.357 . . . . 0.0 112.634 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 1.3 p -125.41 -21.43 4.54 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 120.612 1.551 . . . . 0.0 112.591 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 89.31 13.45 61.72 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.875 1.702 . . . . 0.0 110.923 -178.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -90.2 169.6 11.0 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.61 1.205 . . . . 0.0 108.98 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.47 ' C ' ' H ' ' A' ' 201' ' ' MET . 17.6 mt-10 -86.31 149.66 24.89 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -78.44 31.08 0.18 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.112 2.165 . . . . 0.0 107.775 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' MET . . . . . 0.47 ' H ' ' C ' ' A' ' 199' ' ' GLU . 11.5 ptt? -71.37 152.14 43.44 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -175.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.7 p -119.47 146.38 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 114.207 -1.361 . . . . 0.0 111.57 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -111.76 132.24 54.79 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 125.145 1.378 . . . . 0.0 107.391 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 2.4 mp -118.13 139.77 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 178.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -122.74 100.21 6.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -81.06 126.53 31.54 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 118.817 0.735 . . . . 0.0 110.198 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 33.0 m -134.79 172.24 16.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 126.014 1.726 . . . . 0.0 111.144 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.7 t -78.75 139.47 38.43 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -107.33 146.87 16.21 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -40.96 -66.14 0.94 Allowed Glycine 0 CA--C 1.522 0.514 0 C-N-CA 126.49 1.995 . . . . 0.0 112.469 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.7 t -70.75 103.72 2.66 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 117.845 0.822 . . . . 0.0 110.557 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -71.59 6.8 1.7 Allowed 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.68 -0.637 . . . . 0.0 111.018 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 73.9 p -126.95 30.72 5.41 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.335 1.854 . . . . 0.0 110.283 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -120.64 170.32 14.38 Favored Glycine 0 N--CA 1.47 0.925 0 CA-C-N 119.675 1.125 . . . . 0.0 115.159 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -79.91 165.75 21.75 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.583 2.188 . . . . 0.0 110.477 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 90.5 p -78.74 152.31 31.58 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.38 164.18 7.01 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.558 1.543 . . . . 0.0 108.215 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.1 mt -84.82 134.53 26.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -79.59 -54.27 6.05 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 125.224 1.409 . . . . 0.0 111.443 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 41.1 p-90 -146.94 162.65 38.28 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.71 1.204 . . . . 0.0 108.7 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 44.0 t -148.41 135.34 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 125.943 1.697 . . . . 0.0 107.062 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.07 138.4 10.26 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 177.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -82.51 87.3 6.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 102.564 -3.125 . . . . 0.0 102.564 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.1 p -63.13 -49.65 73.56 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.692 1.597 . . . . 0.0 111.913 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -95.2 -172.37 2.65 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.6 mp -71.51 -46.4 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 4.9 m -113.37 -36.55 4.95 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 2.7 t -70.17 144.63 13.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.56 139.76 52.55 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.079 1.752 . . . . 0.0 108.141 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -121.94 142.99 49.73 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.895 1.278 . . . . 0.0 109.425 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.69 162.71 36.92 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.624 1.57 . . . . 0.0 110.019 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -129.11 142.93 50.73 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 93.5 t -129.25 137.88 55.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 124.891 1.277 . . . . 0.0 108.192 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.97 139.85 41.99 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 123.849 0.859 . . . . 0.0 111.153 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 26.6 mt -140.33 139.07 19.91 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.259 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.05 -43.98 0.29 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.683 2.256 . . . . 0.0 111.983 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -59.22 -21.21 59.16 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.807 0.843 . . . . 0.0 111.373 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 14.1 mt -69.85 -39.92 76.12 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 117.383 -1.294 . . . . 0.0 109.032 177.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 9.1 m -58.44 -22.13 53.38 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 119.657 1.117 . . . . 0.0 113.386 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -60.78 -32.03 71.37 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.362 0.665 . . . . 0.0 110.301 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 23.7 mt -79.86 118.84 21.99 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -48.33 -35.15 11.82 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 3.6 mp -57.61 -41.4 81.21 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 121.093 -1.004 . . . . 0.0 111.148 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -89.42 1.83 55.31 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.87 1.668 . . . . 0.0 112.905 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.418 0 C-N-CA 125.418 1.487 . . . . 0.0 108.6 -179.876 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.221 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -150.94 177.54 10.04 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.172 1.789 . . . . 0.0 106.867 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 m -117.3 165.32 13.6 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.997 1.319 . . . . 0.0 108.457 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -126.26 36.6 4.47 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.645 0.778 . . . . 0.0 109.267 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.1 m -52.5 -50.63 62.39 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.671 1.188 . . . . 0.0 111.872 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -55.97 -31.8 63.32 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.317 1.047 . . . . 0.0 113.079 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.45 -44.13 89.1 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 123.478 0.711 . . . . 0.0 109.765 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.7 m -66.54 -36.21 82.11 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.781 -0.575 . . . . 0.0 110.248 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.18 -45.26 77.5 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.03 -39.41 81.89 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.1 mt -63.72 -52.83 58.76 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 19.6 m -54.71 -44.96 73.91 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.876 -0.515 . . . . 0.0 109.618 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -63.77 -51.67 63.79 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.195 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.0 m -58.47 -39.96 81.4 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 120.325 1.42 . . . . 0.0 111.317 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.3 tp -64.67 -55.48 19.87 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 119.016 0.825 . . . . 0.0 110.072 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -59.65 -46.98 87.38 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -57.58 -44.23 85.21 Favored 'General case' 0 C--O 1.225 -0.204 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.73 -53.39 46.62 Favored Glycine 0 N--CA 1.438 -1.228 0 CA-C-O 118.473 -1.181 . . . . 0.0 111.11 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 5.0 t -55.19 -52.96 39.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 119.132 1.466 . . . . 0.0 111.142 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -33.76 76.19 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 118.816 -0.612 . . . . 0.0 111.274 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.0 m -70.04 -45.83 66.33 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 32.9 mt -56.27 -54.67 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 123.94 0.896 . . . . 0.0 109.814 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.76 -39.64 92.34 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 123.614 0.571 . . . . 0.0 110.266 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -62.86 -44.48 95.99 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.166 0.894 . . . . 0.0 110.526 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -20.32 62.29 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 118.266 -0.873 . . . . 0.0 112.765 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.8 mt -98.77 -28.85 13.31 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 120.34 1.427 . . . . 0.0 111.651 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -59.35 -37.43 77.83 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.91 0.484 . . . . 0.0 110.618 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -64.03 -46.76 83.02 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -156.94 148.32 22.22 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.013 0.925 . . . . 0.0 110.245 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 85.7 m -75.26 174.48 9.45 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 41.4 pt -130.71 148.6 33.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 123.476 0.71 . . . . 0.0 110.074 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.54 168.23 20.26 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.218 0.607 . . . . 0.0 110.038 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -151.43 129.59 11.91 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.906 1.682 . . . . 0.0 109.67 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -95.0 102.33 14.13 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.53 67.41 2.86 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 126.573 1.949 . . . . 0.0 109.384 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.15 -116.85 5.69 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 124.5 1.048 . . . . 0.0 110.803 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -70.2 -30.62 67.77 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.144 0.978 . . . . 0.0 111.443 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -107.33 160.39 15.65 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.865 0.841 . . . . 0.0 110.051 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.6 mt -125.86 151.66 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -123.18 131.56 53.73 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 126.456 1.902 . . . . 0.0 106.749 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -126.35 131.54 51.78 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.849 1.659 . . . . 0.0 108.325 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -128.52 123.65 34.06 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.952 1.301 . . . . 0.0 109.869 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 4.6 m -109.91 160.35 28.43 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.236 1.414 . . . . 0.0 113.718 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.96 90.41 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.13 3.22 . . . . 0.0 113.324 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 59.19 52.07 55.45 Favored Glycine 0 CA--C 1.519 0.34 0 O-C-N 120.957 -1.089 . . . . 0.0 111.743 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.6 mt -127.31 -67.17 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.09 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.42 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 8.7 pt-20 -173.09 167.31 4.94 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 126.13 1.772 . . . . 0.0 109.281 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.22 117.24 24.13 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.0 m -130.57 156.19 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 124.386 1.074 . . . . 0.0 112.706 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -124.79 135.46 52.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 177.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -146.45 157.41 43.75 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.079 0.952 . . . . 0.0 113.35 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 33.5 t60 -88.79 119.72 29.54 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 103.581 -2.748 . . . . 0.0 103.581 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -165.25 -163.14 17.9 Favored Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 111.666 -0.573 . . . . 0.0 111.666 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.3 154.31 51.58 Favored 'General case' 0 CA--C 1.526 0.039 0 C-N-CA 123.505 0.722 . . . . 0.0 109.486 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.4 t -128.59 154.36 39.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 124.087 0.955 . . . . 0.0 110.716 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -102.41 93.83 5.37 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 127.6 2.36 . . . . 0.0 105.851 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.2 t -48.75 -27.38 2.91 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.953 1.301 . . . . 0.0 113.875 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -55.89 -26.57 47.93 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.4 t -146.47 -18.21 0.43 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.682 0.674 . . . . 0.0 111.621 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 97.87 3.72 58.04 Favored Glycine 0 C--O 1.22 -0.729 0 C-N-CA 124.998 1.285 . . . . 0.0 111.738 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -64.21 147.81 51.52 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.018 1.409 . . . . 0.0 110.363 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 23.4 mt -87.45 158.75 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 84.5 t -103.44 143.24 15.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 124.565 1.146 . . . . 0.0 107.939 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -58.0 110.35 0.91 Allowed 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -137.06 164.63 27.95 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.42 1.088 . . . . 0.0 110.272 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.65 137.54 58.17 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.038 1.735 . . . . 0.0 109.866 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -95.59 15.06 20.88 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.881 2.073 . . . . 0.0 113.196 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.22 -10.17 58.73 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 120.224 -1.547 . . . . 0.0 112.553 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 89.9 mt -120.62 72.7 0.97 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.767 1.627 . . . . 0.0 106.636 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.3 t -137.17 143.83 33.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 125.745 1.618 . . . . 0.0 106.788 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -140.44 162.63 34.88 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.907 0.883 . . . . 0.0 111.56 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.3 ptp85 -108.34 143.21 37.54 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.926 1.291 . . . . 0.0 110.076 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.3 mp -120.03 -70.2 0.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.375 1.47 . . . . 0.0 107.788 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -132.6 152.98 20.43 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 123.547 0.594 . . . . 0.0 112.589 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -124.43 91.07 50.05 Favored Pre-proline 0 N--CA 1.452 -0.352 0 C-N-CA 126.028 1.731 . . . . 0.0 109.434 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 97.2 Cg_endo -73.55 177.22 8.27 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.014 2.476 . . . . 0.0 111.37 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -91.09 169.13 11.11 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -82.48 -42.67 18.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.948 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -93.27 149.76 20.99 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 122.969 0.508 . . . . 0.0 110.065 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.2 p -69.79 -20.05 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 123.33 0.652 . . . . 0.0 112.45 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -88.96 -20.0 25.03 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.661 1.184 . . . . 0.0 111.656 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -77.34 -19.31 56.51 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.094 0.558 . . . . 0.0 109.793 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -103.56 171.11 7.55 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.15 1.38 . . . . 0.0 109.788 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -137.81 134.6 35.38 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.89 1.276 . . . . 0.0 107.788 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -115.5 164.59 14.08 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.959 1.304 . . . . 0.0 110.672 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -131.67 122.03 25.28 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 124.621 1.168 . . . . 0.0 112.0 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 15.7 tp -85.76 104.34 15.36 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 38.8 mt -114.49 177.03 4.79 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 122.139 0.971 . . . . 0.0 110.939 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -156.76 155.67 32.0 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.037 1.335 . . . . 0.0 107.463 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -138.59 -177.15 4.73 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -49.25 -31.33 8.59 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.079 1.352 . . . . 0.0 113.218 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 89.8 t -74.28 -74.37 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -166.53 -162.34 17.81 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -78.31 161.87 26.91 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.293 0.637 . . . . 0.0 112.06 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -163.15 175.25 11.2 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.854 2.062 . . . . 0.0 108.302 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 7.2 mt -127.01 121.51 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 39.9 t -91.35 137.81 32.07 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -139.18 120.51 14.87 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.8 tt -114.72 139.81 38.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.3 mt -133.51 112.53 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 123.4 0.68 . . . . 0.0 112.284 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -105.78 -167.69 23.42 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 124.604 1.097 . . . . 0.0 110.956 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.5 t 80.69 47.27 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.307 1.843 . . . . 0.0 110.39 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -97.76 -112.02 3.02 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 105.645 -2.982 . . . . 0.0 105.645 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -141.36 122.61 14.81 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 104.265 -2.494 . . . . 0.0 104.265 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.5 mm -60.17 134.38 25.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 98.8 m -81.58 100.81 9.59 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.98 -19.27 51.35 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.33 0.652 . . . . 0.0 111.325 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.32 -30.24 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 126.141 1.776 . . . . 0.0 110.767 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.3 p -125.01 -36.2 2.57 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 119.601 1.091 . . . . 0.0 112.416 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 96.54 33.81 6.03 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.084 1.326 . . . . 0.0 110.581 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -124.95 171.05 10.51 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.376 1.47 . . . . 0.0 112.058 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -89.1 141.85 28.15 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.558 0.743 . . . . 0.0 112.006 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.17 29.14 0.22 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 128.455 2.702 . . . . 0.0 110.764 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -73.52 142.38 46.73 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 122.282 1.039 . . . . 0.0 109.489 -176.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -104.81 149.58 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 CA-C-N 113.399 -1.728 . . . . 0.0 111.417 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -118.2 124.96 49.2 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.2 mp -115.86 129.86 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 125.806 1.642 . . . . 0.0 106.638 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -114.57 108.97 17.55 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -85.27 119.49 25.7 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.593 0.757 . . . . 0.0 110.602 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 32.0 m -131.43 171.57 17.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 C-N-CA 125.026 1.33 . . . . 0.0 111.796 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.37 133.55 39.91 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -89.7 149.13 20.31 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 123.557 0.599 . . . . 0.0 111.811 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -60.67 -45.02 97.18 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 47.1 t -87.21 98.58 11.4 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -72.21 8.04 1.48 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.385 0.674 . . . . 0.0 109.381 177.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 60.2 m -130.84 38.44 3.69 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.241 1.817 . . . . 0.0 113.267 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.2 165.7 28.16 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 121.475 -0.766 . . . . 0.0 112.161 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.66 168.24 20.57 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.969 2.446 . . . . 0.0 112.492 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 81.0 p -77.26 150.0 35.37 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.78 162.73 23.98 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.174 1.39 . . . . 0.0 107.446 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.1 mp -76.68 141.77 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -84.63 -59.65 2.3 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 -141.58 166.56 24.42 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.171 1.388 . . . . 0.0 108.484 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 47.7 t -145.84 136.39 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 C-N-CA 126.142 1.777 . . . . 0.0 106.391 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.46 121.09 3.71 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.375 0.607 . . . . 0.0 109.862 177.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -81.05 88.14 5.98 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 14.7 p -58.02 -56.8 17.36 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.587 1.555 . . . . 0.0 112.095 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt -99.76 -172.55 2.26 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.239 -1.764 . . . . 0.0 106.239 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 31.2 mm -75.5 -35.22 31.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 O-C-N 121.081 -1.012 . . . . 0.0 109.392 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.98 -54.05 2.54 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.912 0.885 . . . . 0.0 110.861 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 29.2 t -62.56 137.44 24.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 121.41 0.624 . . . . 0.0 109.391 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -133.08 139.92 47.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.147 1.779 . . . . 0.0 107.048 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -120.6 140.52 51.41 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 125.409 1.484 . . . . 0.0 108.945 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.84 161.41 39.36 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 126.132 1.773 . . . . 0.0 109.745 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -133.02 146.11 51.44 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 99.0 t -131.65 134.14 60.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 124.68 1.192 . . . . 0.0 108.376 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.08 142.06 35.13 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.624 0.77 . . . . 0.0 109.812 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 61.7 mt -139.72 135.68 16.92 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.73 -41.84 0.68 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.881 1.721 . . . . 0.0 112.367 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -62.99 -20.46 65.31 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 16.2 mt -68.52 -33.04 73.42 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 118.174 -0.917 . . . . 0.0 109.882 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 21.0 m -62.88 -13.4 33.64 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -70.37 -36.71 74.32 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.827 0.822 . . . . 0.0 109.152 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 24.0 mt -70.52 114.02 8.21 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -48.16 -33.77 8.91 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 16.6 mt -61.49 -37.05 82.25 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.257 -0.902 . . . . 0.0 109.817 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 13.0 mt -95.74 9.69 39.55 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 127.505 2.322 . . . . 0.0 113.491 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -77.21 41.4 0.3 Allowed 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.564 -0.71 . . . . 0.0 110.457 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -150.38 130.53 13.57 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.158 1.383 . . . . 0.0 110.206 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . 0.4 ' CG ' ' H ' ' A' ' 248' ' ' GLU . 41.0 t30 -172.54 -179.41 2.18 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.944 2.898 . . . . 0.0 106.716 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . 0.4 ' H ' ' CG ' ' A' ' 247' ' ' ASN . 69.7 mm-40 62.24 7.68 2.35 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.029 2.131 . . . . 0.0 114.105 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 7.9 t70 . . . . . 0 C--O 1.25 1.12 0 C-N-CA 124.645 1.178 . . . . 0.0 112.613 -179.255 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.588 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -130.04 -169.09 2.06 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.603 1.161 . . . . 0.0 110.384 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.5 t -153.81 -160.11 1.06 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.853 1.261 . . . . 0.0 108.512 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -62.54 118.95 8.28 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.962 1.305 . . . . 0.0 108.619 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.8 m -46.02 -51.67 13.21 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.041 1.737 . . . . 0.0 114.039 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -58.56 -50.31 74.27 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 122.334 0.254 . . . . 0.0 110.393 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -58.78 -47.72 83.72 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 118.092 -0.956 . . . . 0.0 110.387 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p -60.12 -43.78 95.39 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 119.944 1.247 . . . . 0.0 111.875 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.88 -49.55 75.77 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.584 0.707 . . . . 0.0 109.516 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 62.3 tp -55.15 -43.63 74.38 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 125.3 1.44 . . . . 0.0 109.666 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.2 mt -62.52 -53.67 51.23 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.553 1.07 . . . . 0.0 109.506 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 85.2 m -54.36 -52.7 60.8 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.013 0.525 . . . . 0.0 109.826 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -61.9 -42.14 98.72 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 118.488 -0.768 . . . . 0.0 110.801 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.1 m -55.8 -47.8 76.5 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 119.318 0.963 . . . . 0.0 109.771 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 26.6 tp -59.28 -55.8 30.28 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 118.373 0.533 . . . . 0.0 109.765 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -51.21 -52.42 44.65 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 124.778 1.231 . . . . 0.0 110.997 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -55.83 -44.59 78.08 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 125.088 1.355 . . . . 0.0 109.711 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.62 -53.24 39.86 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 125.117 1.341 . . . . 0.0 111.785 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 59.1 t -55.25 -52.92 40.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 119.018 1.409 . . . . 0.0 110.998 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -31.07 72.01 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 118.51 0.596 . . . . 0.0 110.703 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.2 m -69.05 -42.62 76.05 Favored 'General case' 0 CA--C 1.523 -0.093 0 CA-C-N 118.682 0.674 . . . . 0.0 109.403 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 34.1 mt -58.09 -51.16 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 107.103 -1.444 . . . . 0.0 107.103 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.88 -40.03 94.0 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 118.762 -0.637 . . . . 0.0 111.095 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -59.32 -47.48 85.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.875 0.762 . . . . 0.0 109.375 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -73.51 -19.3 60.96 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.6 mt -102.67 -28.29 12.21 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 119.901 1.228 . . . . 0.0 112.124 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -58.03 -32.46 67.99 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -65.84 -45.58 81.69 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 119.036 -0.507 . . . . 0.0 110.504 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -158.4 156.38 30.34 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.662 1.119 . . . . 0.0 111.203 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 59.9 m -76.09 176.04 8.36 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 34.0 pt -135.7 155.49 36.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.49 163.3 38.18 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.126 0.488 . . . . 0.0 112.137 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -150.92 129.01 11.83 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.22 1.408 . . . . 0.0 110.638 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -92.23 107.6 19.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.57 73.09 3.73 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.627 1.571 . . . . 0.0 107.545 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.59 -115.43 5.93 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -74.15 -27.22 60.74 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.322 1.049 . . . . 0.0 112.638 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -107.13 157.6 17.73 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 118.718 0.69 . . . . 0.0 110.299 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 58.7 mt -123.99 149.41 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -126.15 129.3 48.77 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.219 2.208 . . . . 0.0 107.424 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -127.03 130.96 50.99 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.722 1.609 . . . . 0.0 107.644 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -122.3 115.44 22.34 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.814 1.246 . . . . 0.0 108.594 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 15.6 m -105.02 154.86 38.41 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 123.48 0.712 . . . . 0.0 110.588 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -61.05 90.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.589 1 C-N-CA 125.887 4.391 . . . . 0.0 116.091 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 60.05 33.96 81.58 Favored Glycine 0 CA--C 1.528 0.853 0 O-C-N 121.682 -0.636 . . . . 0.0 112.323 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.0 mt -111.23 -66.36 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.405 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 5.3 pt-20 -180.0 162.52 1.01 Allowed 'General case' 0 C--O 1.24 0.586 0 C-N-CA 126.468 1.907 . . . . 0.0 108.901 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -115.52 122.29 45.26 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 102.544 -3.132 . . . . 0.0 102.544 178.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.4 m -130.32 156.17 42.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 123.358 0.663 . . . . 0.0 111.228 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -125.62 126.43 44.73 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -146.33 158.95 43.94 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.435 1.094 . . . . 0.0 112.435 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -88.39 154.64 20.22 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 177.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 166.0 -163.97 37.15 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -127.82 144.32 51.09 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.624 1.97 . . . . 0.0 106.7 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.9 p -155.16 148.2 12.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -97.13 91.05 5.37 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 103.564 -2.754 . . . . 0.0 103.564 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.9 t -51.2 -27.37 8.73 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -52.17 -28.45 18.18 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.553 1.541 . . . . 0.0 113.138 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 t -131.49 -28.02 1.9 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.265 1.426 . . . . 0.0 109.499 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 98.56 7.55 55.6 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 126.095 1.807 . . . . 0.0 109.427 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -65.54 113.57 4.28 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 119.067 1.433 . . . . 0.0 110.849 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 74.6 mt -73.53 138.06 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 103.167 -2.901 . . . . 0.0 103.167 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 78.2 t -93.82 162.87 2.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 125.008 1.323 . . . . 0.0 107.644 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -52.63 122.19 8.53 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.73 -175.47 3.97 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.248 0.619 . . . . 0.0 112.083 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -106.31 129.87 54.25 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -88.72 24.16 2.09 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.696 1.198 . . . . 0.0 111.093 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -81.54 -14.34 56.99 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 121.304 -0.873 . . . . 0.0 111.271 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 83.7 mt -124.2 82.27 2.01 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.776 1.631 . . . . 0.0 107.619 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 39.6 t -136.78 143.14 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.384 1.074 . . . . 0.0 108.568 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -143.59 147.36 34.28 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.191 1.397 . . . . 0.0 111.714 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.92 123.63 40.68 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 124.809 1.244 . . . . 0.0 108.073 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.5 mp -95.28 -72.47 0.62 Allowed 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -125.76 148.14 16.87 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -128.44 91.97 42.33 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 42.5 Cg_endo -77.01 176.57 9.97 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.615 2.877 . . . . 0.0 110.698 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -83.76 167.73 16.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.177 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.43 -33.62 23.65 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.488 1.115 . . . . 0.0 112.001 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -90.9 142.2 28.02 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 126.402 1.881 . . . . 0.0 106.258 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.3 p -72.96 -28.35 26.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 118.224 0.465 . . . . 0.0 110.078 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -73.1 0.51 11.34 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 127.479 2.311 . . . . 0.0 113.059 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -114.76 -13.12 12.06 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.329 1.852 . . . . 0.0 110.227 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 36.1 mmm-85 -77.25 163.68 26.29 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.824 1.25 . . . . 0.0 108.358 177.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -131.03 95.89 3.92 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.301 0.572 . . . . 0.0 110.134 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -108.53 148.94 29.53 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 125.774 1.629 . . . . 0.0 108.279 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -138.37 134.92 34.79 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.358 1.063 . . . . 0.0 109.791 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.95 98.51 10.41 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.29 1.036 . . . . 0.0 109.515 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 35.4 mt -103.77 172.01 7.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.761 0.791 . . . . 0.0 110.195 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -157.37 157.09 33.43 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.246 -0.909 . . . . 0.0 109.503 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -138.83 -179.23 5.71 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -56.79 -11.75 1.56 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.788 2.035 . . . . 0.0 113.026 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 54.8 t -94.07 -67.07 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 126.484 1.914 . . . . 0.0 107.873 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -169.63 -174.11 37.69 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -81.05 158.76 24.98 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 114.606 -0.797 . . . . 0.0 109.044 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -162.61 176.55 10.26 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.546 1.538 . . . . 0.0 108.469 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 14.3 mt -123.93 133.75 68.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.3 t -109.19 122.49 47.42 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -125.58 112.93 16.76 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.9 tt -100.86 130.93 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 11.0 mt -123.36 109.7 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.088 1.355 . . . . 0.0 109.053 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -104.36 -153.04 22.59 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 107.559 -2.217 . . . . 0.0 107.559 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.3 m 74.43 46.07 0.17 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.34 1.456 . . . . 0.0 109.444 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -111.95 -126.95 4.84 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -130.42 124.91 33.18 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.441 1.096 . . . . 0.0 110.986 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 46.1 mm -61.08 137.28 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.82 0.848 . . . . 0.0 112.296 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 74.1 m -94.66 95.36 8.7 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 102.866 -3.013 . . . . 0.0 102.866 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -55.07 -17.79 4.47 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.888 1.275 . . . . 0.0 113.537 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 73.4 t -59.73 -38.18 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 124.878 1.271 . . . . 0.0 109.567 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 20.9 p -125.32 -15.9 6.07 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 78.52 32.94 40.36 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -103.48 159.9 15.19 Favored 'General case' 0 CA--C 1.52 -0.189 0 O-C-N 121.435 -1.038 . . . . 0.0 110.651 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -91.71 142.4 27.64 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.903 1.281 . . . . 0.0 107.725 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -73.46 28.96 0.07 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 127.854 2.461 . . . . 0.0 111.82 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.3 ptt? -73.2 141.0 47.35 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 122.58 1.181 . . . . 0.0 110.04 -175.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 1.5 p -113.06 144.35 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.33 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -112.26 125.25 53.96 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.6 mp -109.67 119.11 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -102.38 106.39 17.14 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -85.36 115.17 22.95 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.37 1.068 . . . . 0.0 110.46 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.8 m -127.93 172.83 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 126.14 1.776 . . . . 0.0 112.277 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.3 t -85.5 133.09 34.1 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.445 1.498 . . . . 0.0 107.313 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -89.67 161.86 29.94 Favored Glycine 0 N--CA 1.47 0.95 0 CA-C-N 119.555 1.071 . . . . 0.0 112.032 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -47.22 -79.61 0.07 OUTLIER Glycine 0 C--N 1.341 0.824 0 C-N-CA 126.315 1.912 . . . . 0.0 110.997 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 25.3 m -70.42 126.3 29.24 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -98.28 35.98 1.68 Allowed 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 8.6 m -143.24 33.19 1.34 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -129.52 179.15 16.95 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 120.361 1.437 . . . . 0.0 113.122 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -75.09 170.06 21.22 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.949 2.432 . . . . 0.0 109.273 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 98.3 p -81.72 156.36 25.04 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.853 -0.529 . . . . 0.0 109.692 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.85 164.69 7.85 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 126.143 1.777 . . . . 0.0 109.276 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.9 mt -79.75 136.09 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.164 1.386 . . . . 0.0 107.37 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -81.21 -54.84 5.16 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 124.574 1.15 . . . . 0.0 109.753 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 19.0 p-90 -148.59 166.54 27.96 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 124.794 1.237 . . . . 0.0 108.761 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 45.3 t -145.28 126.58 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.01 122.05 10.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -75.02 97.92 3.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 2.1 p -66.14 -51.79 54.52 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 118.311 -0.852 . . . . 0.0 111.715 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -120.72 179.11 4.45 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.437 0.695 . . . . 0.0 109.781 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.8 mp -55.19 -37.82 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 C-N-CA 125.908 1.683 . . . . 0.0 110.666 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.75 -21.04 5.29 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 56.4 t -85.21 124.51 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -123.68 142.9 50.63 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -129.79 139.95 51.15 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -138.83 160.85 38.69 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.086 1.354 . . . . 0.0 109.505 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -127.28 143.71 51.18 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.0 t -128.53 143.75 40.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 125.084 1.354 . . . . 0.0 107.683 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.45 134.13 55.32 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 124.29 1.036 . . . . 0.0 110.408 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 93.9 mt -136.72 138.36 26.08 Favored Pre-proline 0 C--O 1.236 0.355 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.638 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.08 -43.29 0.25 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.312 2.008 . . . . 0.0 111.944 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -57.32 -26.82 61.52 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.794 0.837 . . . . 0.0 111.278 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 16.9 mt -66.17 -38.72 88.74 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 120.947 -1.096 . . . . 0.0 110.189 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 42.8 m -55.21 -21.85 15.53 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.6 1.56 . . . . 0.0 113.921 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -64.98 -34.44 78.43 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 123.393 0.677 . . . . 0.0 111.192 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 29.9 mt -71.95 117.27 13.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -48.67 -36.11 15.34 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.82 -36.17 78.37 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.527 -0.733 . . . . 0.0 110.254 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -97.84 3.58 49.83 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.389 1.875 . . . . 0.0 113.271 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -79.02 47.64 0.79 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -157.78 144.34 17.8 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 127.811 2.444 . . . . 0.0 107.35 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -171.35 159.45 5.72 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 128.768 2.827 . . . . 0.0 105.88 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.6 68.55 1.28 Allowed 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.4 t70 . . . . . 0 C--O 1.25 1.13 0 CA-C-N 113.856 -1.52 . . . . 0.0 108.806 179.38 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.919 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -151.97 150.21 29.76 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.6 p -165.96 166.78 17.17 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.429 1.092 . . . . 0.0 108.947 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -111.63 175.85 5.26 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.219 1.408 . . . . 0.0 110.702 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.5 m -72.88 -45.85 56.03 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.875 1.27 . . . . 0.0 114.109 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -57.83 -34.59 69.85 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.816 0.735 . . . . 0.0 110.784 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -59.13 -47.43 85.31 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.9 m -65.92 -35.68 81.29 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.34 -48.31 82.12 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 119.633 1.106 . . . . 0.0 108.409 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 58.9 tp -56.97 -44.83 83.04 Favored 'General case' 0 C--N 1.343 0.322 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.1 mt -61.4 -50.52 72.52 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.955 0.798 . . . . 0.0 110.577 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 54.9 m -54.97 -52.44 63.06 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.815 1.246 . . . . 0.0 110.669 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -63.96 -42.78 97.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.575 0.75 . . . . 0.0 110.62 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.2 m -54.1 -49.14 69.78 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.155 0.982 . . . . 0.0 109.007 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 41.1 tp -57.38 -54.24 49.09 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.929 0.331 . . . . 0.0 110.72 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -52.65 -50.99 62.08 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 124.428 1.091 . . . . 0.0 111.654 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -56.11 -52.2 65.18 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.393 1.077 . . . . 0.0 108.604 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -55.29 -51.04 56.97 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 96.4 t -57.2 -52.79 51.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 C-N-CA 125.206 1.402 . . . . 0.0 111.809 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -32.3 73.57 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 119.289 0.95 . . . . 0.0 110.313 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.1 m -66.3 -42.02 88.89 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 34.0 mt -61.49 -50.72 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.51 -40.92 72.4 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 117.9 -1.048 . . . . 0.0 110.809 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -62.61 -55.01 31.01 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.305 1.042 . . . . 0.0 110.436 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -62.7 -25.92 68.4 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 11.0 mp -98.07 -26.99 14.42 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.543 1.52 . . . . 0.0 110.848 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -53.88 -29.54 41.97 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.184 0.994 . . . . 0.0 111.233 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -74.49 -46.83 36.97 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 117.965 0.348 . . . . 0.0 110.709 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.2 mmt85 -157.03 151.46 25.33 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.201 -0.937 . . . . 0.0 111.819 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 51.5 m -76.43 160.55 29.44 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 32.8 pt -118.1 152.83 20.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 124.889 1.275 . . . . 0.0 108.592 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -146.16 168.87 19.94 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 122.853 0.461 . . . . 0.0 111.909 -178.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -154.51 127.69 8.37 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.572 1.549 . . . . 0.0 111.286 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -91.52 104.37 16.88 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.52 66.77 5.46 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.424 1.489 . . . . 0.0 107.034 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 66.84 -115.96 7.76 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -66.12 -34.03 77.13 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -107.32 152.76 23.71 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 119.165 0.893 . . . . 0.0 110.247 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.7 mt -121.16 151.97 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -126.93 136.72 52.68 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.714 1.605 . . . . 0.0 108.202 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -131.38 132.45 44.41 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.542 1.537 . . . . 0.0 108.955 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -126.04 117.27 22.87 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.607 1.163 . . . . 0.0 109.737 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 21.9 m -104.22 158.17 32.49 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 124.197 0.999 . . . . 0.0 111.502 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -63.67 84.91 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.621 1 C-N-CA 125.413 4.076 . . . . 0.0 116.101 -178.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.41 29.02 74.24 Favored Glycine 0 CA--C 1.529 0.938 0 O-C-N 121.394 -0.816 . . . . 0.0 111.542 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.1 mt -106.77 -67.25 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.414 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 7.8 pt-20 -172.56 165.31 5.58 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.713 1.205 . . . . 0.0 108.954 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.23 119.87 30.59 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 103.7 -2.704 . . . . 0.0 103.7 177.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.43 156.63 42.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 124.53 1.132 . . . . 0.0 112.02 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -123.81 133.67 53.76 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -146.11 158.25 43.87 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.71 1.204 . . . . 0.0 111.629 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 50.3 t60 -87.94 154.86 20.18 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 157.9 -162.19 31.98 Favored Glycine 0 C--N 1.333 0.409 0 O-C-N 121.21 -0.931 . . . . 0.0 111.28 -178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.61 145.9 49.07 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 54.2 t -128.95 153.82 39.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 124.971 1.308 . . . . 0.0 108.3 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -106.99 94.96 5.38 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.8 t -54.72 -12.68 0.82 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 120.154 1.343 . . . . 0.0 112.169 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -55.72 -30.5 61.27 Favored 'General case' 0 C--N 1.344 0.363 0 O-C-N 120.79 -1.194 . . . . 0.0 110.296 177.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.86 -43.31 0.23 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.308 1.443 . . . . 0.0 108.712 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 121.01 11.21 6.42 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 126.329 1.919 . . . . 0.0 110.985 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -64.99 127.56 32.09 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 118.924 1.362 . . . . 0.0 110.17 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 26.2 mt -73.92 128.31 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.17 -74.18 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.39 117.42 24.3 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 125.946 1.698 . . . . 0.0 107.646 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.26 37.09 4.2 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.839 1.256 . . . . 0.0 111.435 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -61.55 133.14 55.34 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.206 2.202 . . . . 0.0 111.4 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -75.19 6.14 4.67 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 t -85.15 -16.88 38.97 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.24 1.382 . . . . 0.0 113.332 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 84.5 mt -133.06 79.63 1.85 Allowed 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 119.7 1.137 . . . . 0.0 109.735 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.78 147.14 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -142.41 153.04 43.4 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.717 1.207 . . . . 0.0 110.538 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 37.5 mtm105 -101.1 126.32 47.78 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 22.7 mt -101.68 -62.4 1.26 Allowed 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -134.15 153.49 20.97 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -129.22 86.25 57.26 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 126.872 2.069 . . . . 0.0 109.239 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 41.5 Cg_endo -80.47 176.7 8.9 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 123.672 2.915 . . . . 0.0 110.788 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.2 mmmt -92.64 156.45 17.07 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.49 -25.03 41.92 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.015 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -107.29 126.89 53.01 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.58 1.152 . . . . 0.0 108.042 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.4 p -52.9 -34.23 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.834 1.254 . . . . 0.0 111.195 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -61.09 -18.26 56.98 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 129.722 3.209 . . . . 0.0 113.521 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -112.32 -4.08 14.39 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.024 1.73 . . . . 0.0 111.736 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 61.2 mtp180 -91.3 176.87 6.42 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.821 0.82 . . . . 0.0 109.777 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -142.68 134.76 27.27 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -144.0 150.07 37.7 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.782 1.633 . . . . 0.0 107.864 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -133.11 131.73 40.87 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.643 1.177 . . . . 0.0 108.5 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 28.1 tp -86.2 99.65 11.68 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 44.0 mt -101.19 175.04 5.72 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.166 0.986 . . . . 0.0 109.613 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.413 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 5.7 p90 -155.93 156.6 34.85 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.866 0.841 . . . . 0.0 109.648 177.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -135.16 -179.73 5.81 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -54.18 -32.09 54.6 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 125.598 1.559 . . . . 0.0 112.298 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 58.2 t -73.9 -59.06 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.222 1.009 . . . . 0.0 109.13 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -178.96 -168.7 38.5 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 124.552 1.072 . . . . 0.0 111.726 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.413 ' CD2' ' HB3' ' A' ' 176' ' ' TYR . 24.4 m-85 -83.35 161.25 21.45 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.681 1.193 . . . . 0.0 112.36 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -168.03 168.97 11.58 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.78 2.032 . . . . 0.0 109.026 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 15.9 mt -114.28 138.37 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.0 t -111.25 123.54 50.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.902 1.281 . . . . 0.0 108.102 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.4 109.94 11.49 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 177.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 2.3 tt -100.82 126.09 54.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.2 mt -116.44 112.37 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.144 0.978 . . . . 0.0 110.989 -177.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -108.57 -161.27 20.26 Favored Glycine 0 CA--C 1.522 0.492 0 C-N-CA 124.784 1.183 . . . . 0.0 111.126 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 74.44 31.86 0.99 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.411 1.485 . . . . 0.0 110.386 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -87.97 -102.18 0.91 Allowed Glycine 0 C--N 1.336 0.548 1 N-CA-C 102.788 -4.125 . . . . 0.0 102.788 177.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -145.88 160.54 41.66 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 24.2 mm -92.49 132.71 36.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 125.026 1.33 . . . . 0.0 109.141 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 59.3 m -88.4 93.86 9.67 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 100.329 -3.952 . . . . 0.0 100.329 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -53.42 -24.45 12.6 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -177.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -51.11 -34.32 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 125.99 1.716 . . . . 0.0 111.334 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.1 p -126.08 -25.63 3.53 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.879 0.872 . . . . 0.0 112.36 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 92.57 19.5 37.7 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.803 1.192 . . . . 0.0 111.722 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -95.79 165.18 12.42 Favored 'General case' 0 N--CA 1.454 -0.225 0 O-C-N 121.269 -1.136 . . . . 0.0 110.285 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.437 ' C ' ' H ' ' A' ' 201' ' ' MET . 4.1 mt-10 -96.25 147.22 24.0 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.812 0.845 . . . . 0.0 109.163 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -75.56 28.3 0.1 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.971 2.108 . . . . 0.0 110.286 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.437 ' H ' ' C ' ' A' ' 199' ' ' GLU . 4.9 ptm -72.62 146.19 46.8 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.507 1.146 . . . . 0.0 108.299 -176.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.3 p -120.1 140.03 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 113.901 -1.5 . . . . 0.0 112.549 -176.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -105.13 131.74 52.23 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.1 mp -115.91 113.98 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -97.31 109.08 21.91 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -85.53 118.05 24.81 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.54 0.736 . . . . 0.0 109.585 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.79 172.89 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 125.732 1.613 . . . . 0.0 112.184 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.6 t -86.38 136.58 33.07 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.108 1.763 . . . . 0.0 108.405 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.93 158.05 32.88 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -63.52 -68.29 1.72 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 108.266 -1.934 . . . . 0.0 108.266 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 17.0 p -81.6 91.5 6.4 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 104.084 -2.561 . . . . 0.0 104.084 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -72.51 37.44 0.07 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.753 2.421 . . . . 0.0 113.487 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.4 m -138.22 46.12 2.06 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 115.097 1.518 . . . . 0.0 115.097 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -156.9 175.08 34.51 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -71.66 165.65 31.86 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.071 1.847 . . . . 0.0 110.733 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 52.0 p -72.93 153.89 40.78 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.338 1.055 . . . . 0.0 110.519 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -169.27 160.71 9.71 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.261 1.424 . . . . 0.0 108.652 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.8 127.83 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -72.24 -60.95 1.97 Allowed 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.868 1.667 . . . . 0.0 109.8 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 40.7 p-90 -143.03 168.46 19.66 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.859 2.064 . . . . 0.0 109.091 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 55.9 t -144.2 145.3 21.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 126.283 1.833 . . . . 0.0 106.42 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.34 118.8 1.44 Allowed 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -75.64 92.2 2.93 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 102.285 -3.228 . . . . 0.0 102.285 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 4.8 p -56.09 -55.2 35.83 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.853 1.261 . . . . 0.0 112.408 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -111.59 -172.54 2.06 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.8 mp -62.23 -38.67 81.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 O-C-N 121.396 -0.815 . . . . 0.0 110.214 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.76 -41.05 3.26 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.877 0.871 . . . . 0.0 112.285 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 10.0 t -64.49 132.25 30.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -130.82 141.7 50.35 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.335 1.454 . . . . 0.0 107.288 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -127.01 141.83 51.69 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.75 161.8 38.34 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.445 1.498 . . . . 0.0 108.854 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -138.95 147.46 42.28 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 123.583 0.753 . . . . 0.0 109.99 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.4 m -132.76 151.65 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.127 0.571 . . . . 0.0 109.487 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.1 p -113.42 131.87 55.85 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 122.802 0.441 . . . . 0.0 109.814 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 85.3 mt -129.63 136.12 28.61 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.34 -40.34 0.85 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.207 1.938 . . . . 0.0 112.639 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -61.45 -26.22 67.74 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.38 0.672 . . . . 0.0 111.721 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 3.8 mp -66.29 -35.17 79.71 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.762 0.71 . . . . 0.0 109.309 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 44.0 m -59.51 -19.63 49.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.725 1.21 . . . . 0.0 113.234 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -62.85 -34.52 77.52 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.567 0.747 . . . . 0.0 110.581 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 47.9 mt -73.1 118.92 16.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.218 1.407 . . . . 0.0 107.654 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -49.91 -39.75 41.0 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.0 mp -59.98 -34.32 73.15 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.191 -0.943 . . . . 0.0 111.19 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.454 ' C ' ' H ' ' A' ' 246' ' ' LYS . 2.5 mm? -101.13 5.54 42.82 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 126.583 1.953 . . . . 0.0 112.495 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -75.58 38.51 0.15 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.946 0.898 . . . . 0.0 109.646 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.454 ' H ' ' C ' ' A' ' 244' ' ' LEU . 42.6 tptt -134.7 129.57 34.96 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 129.429 3.091 . . . . 0.0 105.74 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 39.5 p30 -150.91 167.32 27.92 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.484 1.914 . . . . 0.0 106.53 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -149.15 66.64 1.03 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 . . . . . 0 C--O 1.247 0.93 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.797 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 40.23 36.46 0.33 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 127.1 2.16 . . . . 0.0 114.446 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 73.5 m -94.82 164.57 12.87 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.974 0.91 . . . . 0.0 110.05 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -124.27 177.78 5.69 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.922 1.689 . . . . 0.0 107.291 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.3 m -44.81 -55.15 5.62 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -63.0 -46.56 87.07 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.017 0.437 . . . . 0.0 111.492 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -59.23 -48.87 79.99 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 124.797 1.239 . . . . 0.0 110.677 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.1 p -63.55 -35.87 81.91 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 122.008 -0.433 . . . . 0.0 110.697 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.83 -43.61 92.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 48.6 tp -60.65 -48.36 82.13 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 124.034 0.934 . . . . 0.0 108.607 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.9 mt -58.58 -52.05 67.32 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.209 1.004 . . . . 0.0 110.016 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 97.3 m -56.64 -50.28 72.52 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.292 1.037 . . . . 0.0 110.662 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -64.23 -50.94 66.04 Favored 'General case' 0 C--O 1.224 -0.244 0 O-C-N 121.455 -0.778 . . . . 0.0 110.118 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.4 m -51.97 -43.24 63.47 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.411 1.084 . . . . 0.0 111.026 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.6 tt -58.47 -57.08 14.54 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 119.368 0.986 . . . . 0.0 110.122 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -63.64 -38.02 89.52 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -59.9 -36.03 76.12 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -66.93 -51.4 40.2 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.1 t -56.07 -52.97 44.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 118.483 1.142 . . . . 0.0 112.4 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.16 -32.66 68.42 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.907 0.776 . . . . 0.0 111.213 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.1 m -75.63 -46.71 30.02 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 122.845 0.458 . . . . 0.0 110.917 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 24.8 mt -55.75 -52.42 48.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.07 -41.38 83.26 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 123.778 0.674 . . . . 0.0 110.88 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -62.1 -50.63 71.15 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 118.376 0.534 . . . . 0.0 110.929 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.1 -3.55 7.72 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.058 0.943 . . . . 0.0 113.444 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.9 mt -115.22 -28.89 6.78 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.676 1.59 . . . . 0.0 110.075 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -62.18 -26.14 68.17 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.238 0.615 . . . . 0.0 110.612 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.09 -46.89 60.93 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.706 0.802 . . . . 0.0 109.289 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -160.85 147.71 15.29 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 125.703 1.601 . . . . 0.0 108.495 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 67.7 m -75.71 173.21 11.38 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.7 pt -128.61 146.75 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 C-N-CA 123.639 0.775 . . . . 0.0 110.59 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -142.01 162.14 36.22 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.549 0.74 . . . . 0.0 111.057 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -146.9 125.03 12.11 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.441 1.096 . . . . 0.0 109.715 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -87.93 102.35 14.63 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.5 67.04 7.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 66.13 -115.09 7.11 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -63.61 -36.96 85.54 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.099 -0.953 . . . . 0.0 113.146 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -107.31 154.2 21.62 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 120.499 1.5 . . . . 0.0 111.613 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 30.2 mt -118.45 135.23 59.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -110.12 127.61 54.99 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 105.55 -2.018 . . . . 0.0 105.55 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -123.11 119.9 31.66 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.408 1.883 . . . . 0.0 111.718 -177.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -119.87 126.07 50.05 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.034 1.334 . . . . 0.0 110.947 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 3.3 m -111.13 160.84 27.52 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.685 1.594 . . . . 0.0 114.624 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -65.6 87.1 0.21 Allowed 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 124.794 3.663 . . . . 0.0 112.417 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 55.93 56.47 23.8 Favored Glycine 0 C--N 1.331 0.29 0 O-C-N 121.216 -0.927 . . . . 0.0 111.727 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.2 mt -128.05 -66.18 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.425 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 17.3 pt-20 -178.89 173.56 1.2 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.532 1.933 . . . . 0.0 110.982 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.72 118.74 28.77 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 176.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.43 154.97 41.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.984 0.913 . . . . 0.0 111.016 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -117.87 136.2 53.6 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -146.45 156.44 43.29 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.45 1.1 . . . . 0.0 112.413 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -92.19 147.44 22.93 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 162.9 -163.9 35.58 Favored Glycine 0 C--N 1.336 0.554 0 CA-C-N 120.126 1.33 . . . . 0.0 113.231 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -123.24 135.61 54.34 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.922 1.689 . . . . 0.0 110.095 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.2 p -152.33 151.16 12.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 124.502 1.121 . . . . 0.0 108.726 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -96.1 96.3 8.75 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 125.367 1.467 . . . . 0.0 107.182 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.9 t -55.71 -12.27 1.21 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -73.38 -24.93 60.38 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 120.293 1.406 . . . . 0.0 112.793 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.0 t -135.84 -20.84 1.5 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.104 1.361 . . . . 0.0 110.665 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 90.65 12.97 60.22 Favored Glycine 0 C--O 1.222 -0.6 0 C-N-CA 125.503 1.525 . . . . 0.0 110.461 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -69.69 113.19 6.73 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 118.209 1.004 . . . . 0.0 109.688 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 72.2 mt -74.43 111.29 9.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 58.9 t -65.46 -45.07 93.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 126.575 1.95 . . . . 0.0 110.659 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -145.21 160.9 40.76 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.658 1.183 . . . . 0.0 109.525 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -136.76 155.39 49.89 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.351 1.461 . . . . 0.0 107.287 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -150.31 142.0 23.63 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -95.79 -2.14 48.24 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.7 t -66.29 -43.13 87.21 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.976 1.31 . . . . 0.0 113.423 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 49.1 mt -119.23 89.08 3.06 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.085 0.954 . . . . 0.0 109.417 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.6 t -143.4 129.3 16.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -119.74 157.35 28.77 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 122.871 0.468 . . . . 0.0 112.013 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 26.6 mmm-85 -105.58 129.78 53.76 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.152 1.381 . . . . 0.0 107.907 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.9 mp -110.2 -65.66 1.14 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.516 0.726 . . . . 0.0 110.712 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -125.71 154.06 18.52 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -129.72 96.73 25.89 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.228 1.811 . . . . 0.0 108.913 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 44.6 Cg_endo -74.35 -170.41 0.73 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.638 2.892 . . . . 0.0 108.796 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -100.88 165.38 11.38 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -81.46 -34.09 31.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.668 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -98.95 133.7 42.85 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 118.589 0.631 . . . . 0.0 110.355 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.6 p -58.26 -28.3 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.277 1.031 . . . . 0.0 109.611 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -69.01 -19.11 64.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 128.192 2.597 . . . . 0.0 112.84 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -99.62 -9.8 22.75 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.878 0.871 . . . . 0.0 110.476 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -70.3 161.5 30.26 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -140.35 95.64 2.91 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -101.37 167.38 10.21 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.539 1.136 . . . . 0.0 109.934 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -137.05 132.48 34.25 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.311 1.044 . . . . 0.0 110.12 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.4 tp -90.87 98.56 11.85 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 16.4 mt -107.19 -178.92 3.78 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.629 1.172 . . . . 0.0 109.494 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -155.47 161.66 40.9 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -136.6 -178.3 5.11 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 124.567 1.147 . . . . 0.0 108.437 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -56.34 -23.04 34.68 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.876 1.27 . . . . 0.0 111.511 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 58.6 t -81.67 -66.81 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -174.71 -164.22 29.18 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -77.22 160.03 29.23 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.299 0.64 . . . . 0.0 111.205 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -168.2 161.39 12.31 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.653 1.581 . . . . 0.0 109.381 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 4.1 mt -106.6 133.47 51.03 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 178.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 4.1 t -108.55 131.68 54.6 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -134.59 124.85 26.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.0 tt -115.38 140.15 38.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.3 mt -135.2 115.7 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 O-C-N 121.699 -0.626 . . . . 0.0 110.971 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -105.33 -168.0 23.83 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.683 1.611 . . . . 0.0 110.015 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.5 t 78.16 58.05 0.03 OUTLIER 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.452 1.901 . . . . 0.0 110.713 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -110.53 -104.21 2.81 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 106.941 -2.464 . . . . 0.0 106.941 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -153.97 119.61 5.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 42.6 mm -60.66 133.95 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 123.963 0.905 . . . . 0.0 109.108 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 58.9 m -86.36 106.52 17.46 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.11 -15.68 5.96 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.307 0.958 . . . . 0.0 112.964 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 49.0 t -58.28 -46.4 88.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.983 1.313 . . . . 0.0 110.34 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.6 p -119.89 -20.88 7.38 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.553 1.141 . . . . 0.0 111.71 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 81.95 13.25 79.83 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 127.14 2.305 . . . . 0.0 112.139 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -85.77 170.59 12.3 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.549 1.54 . . . . 0.0 110.823 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.09 153.54 22.63 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 122.104 0.954 . . . . 0.0 111.536 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 29.9 ttm-85 -92.76 29.97 1.67 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 127.769 2.428 . . . . 0.0 109.463 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.0 ptt? -73.93 154.58 39.31 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.6 p -122.61 144.4 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.453 -177.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -111.57 131.91 54.92 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.7 mp -123.48 119.5 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 125.097 1.359 . . . . 0.0 108.835 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -100.84 120.64 40.43 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.68 0.792 . . . . 0.0 108.951 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -99.4 123.1 43.38 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.838 0.745 . . . . 0.0 110.137 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 14.8 m -135.12 170.08 20.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.9 1.28 . . . . 0.0 111.389 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.1 136.04 41.14 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -92.59 108.17 3.61 Favored Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 107.548 -2.221 . . . . 0.0 107.548 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -34.99 -54.3 0.87 Allowed Glycine 0 C--N 1.338 0.647 0 C-N-CA 126.728 2.109 . . . . 0.0 113.473 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 14.9 m -79.56 71.27 6.15 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -50.15 23.1 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.647 1 C-N-CA 133.767 4.827 . . . . 0.0 118.406 -178.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 7.9 t -145.96 47.39 1.24 Allowed 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.154 -1.591 . . . . 0.0 110.891 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -140.46 166.98 25.68 Favored Glycine 0 C--N 1.336 0.571 0 O-C-N 120.508 -1.37 . . . . 0.0 110.405 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.34 168.92 23.68 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 CA-C-N 119.623 1.711 . . . . 0.0 108.915 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 99.1 p -72.23 153.42 41.59 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.9 p -160.44 165.16 31.54 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.561 1.545 . . . . 0.0 108.18 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.2 mp -84.92 132.08 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -78.95 -55.33 5.22 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 124.804 1.242 . . . . 0.0 111.297 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 33.2 p-90 -146.24 165.45 29.17 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.408 HG12 ' CE1' ' A' ' 229' ' ' TYR . 52.6 t -144.38 139.19 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 126.259 1.824 . . . . 0.0 106.19 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.22 134.86 11.69 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.606 0.717 . . . . 0.0 110.621 178.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -90.54 90.35 7.96 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.3 p -75.32 -46.05 35.76 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.227 1.011 . . . . 0.0 111.584 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -103.52 -179.61 4.0 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.2 mp -78.16 -27.8 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.5 t -118.27 -56.81 2.13 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.288 1.435 . . . . 0.0 111.24 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 3.7 t -60.02 141.42 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . 0.408 ' CE1' HG12 ' A' ' 221' ' ' VAL . 1.2 t80 -125.85 150.5 47.82 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.905 2.082 . . . . 0.0 109.035 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -131.44 138.7 49.16 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.777 1.631 . . . . 0.0 108.837 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.71 162.22 40.19 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.091 1.757 . . . . 0.0 111.745 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -132.38 147.66 52.39 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 89.3 t -129.59 139.07 52.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 126.065 1.746 . . . . 0.0 108.377 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.92 140.77 46.3 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 124.134 0.974 . . . . 0.0 109.678 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 56.9 mt -137.83 140.4 29.42 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.53 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.85 -45.04 0.31 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.049 2.499 . . . . 0.0 112.284 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -61.08 -25.69 67.12 Favored 'General case' 0 N--CA 1.461 0.124 0 O-C-N 121.235 -0.916 . . . . 0.0 111.914 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.2 mp -60.1 -37.66 80.64 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 118.336 -0.84 . . . . 0.0 109.905 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 32.6 m -54.47 -26.7 32.71 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.819 1.648 . . . . 0.0 113.181 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -62.08 -30.15 70.8 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 41.7 mt -76.19 116.21 16.67 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.578 1.151 . . . . 0.0 112.151 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -48.19 -39.96 22.6 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.636 1.974 . . . . 0.0 114.853 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 13.4 mt -61.53 -34.08 74.91 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.183 -0.948 . . . . 0.0 112.968 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 1.9 mp -104.95 7.72 34.28 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -68.07 70.26 0.15 Allowed 'General case' 0 C--O 1.235 0.317 0 C-N-CA 129.084 2.954 . . . . 0.0 110.047 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -141.67 158.45 43.8 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 130.572 3.549 . . . . 0.0 107.819 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 29.0 m120 62.55 15.88 8.29 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.381 1.872 . . . . 0.0 115.67 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -80.3 72.51 7.15 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 2.9 p30 . . . . . 0 C--O 1.247 0.972 0 C-N-CA 126.955 2.102 . . . . 0.0 109.774 179.664 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.972 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.9 -33.82 76.43 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 117.992 0.896 . . . . 0.0 111.506 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.4 m -67.55 76.19 0.18 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.766 1.627 . . . . 0.0 112.53 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -60.13 -36.05 76.63 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.635 -1.291 . . . . 0.0 110.527 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 58.0 m -60.13 -41.8 93.43 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.08 0.952 . . . . 0.0 111.193 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -68.98 -29.73 68.0 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.768 -0.826 . . . . 0.0 108.768 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -50.88 65.97 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.2 p -61.59 -39.93 92.95 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.8 90.04 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 118.616 0.644 . . . . 0.0 110.683 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 47.6 tp -61.53 -45.75 92.86 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.0 mt -64.5 -52.16 59.31 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.543 0.737 . . . . 0.0 110.484 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 53.3 m -54.89 -51.75 65.02 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.654 -0.654 . . . . 0.0 110.188 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -60.21 -46.59 89.23 Favored 'General case' 0 C--N 1.339 0.116 0 O-C-N 121.656 -0.652 . . . . 0.0 110.64 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.1 m -53.34 -45.96 69.3 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.093 0.957 . . . . 0.0 110.2 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 27.4 tp -59.45 -56.64 19.43 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.611 0.641 . . . . 0.0 110.721 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -56.56 -51.47 68.46 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 118.436 0.562 . . . . 0.0 111.723 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -55.2 -38.92 69.01 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.415 0.686 . . . . 0.0 109.674 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -67.04 -52.79 30.27 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 87.8 t -55.03 -53.32 35.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.734 1.214 . . . . 0.0 111.276 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -31.52 72.68 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 118.64 0.654 . . . . 0.0 110.822 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.0 m -69.71 -46.7 65.41 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 25.0 mt -57.33 -52.21 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.35 -41.02 88.24 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 119.171 -0.442 . . . . 0.0 111.466 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -60.54 -50.77 72.22 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.19 0.45 . . . . 0.0 110.79 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -71.32 -19.92 62.25 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.2 mp -102.8 -25.72 13.41 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.125 1.329 . . . . 0.0 111.526 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -55.12 -39.21 69.14 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 121.551 -0.718 . . . . 0.0 110.802 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.96 -42.73 89.58 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.487 -0.768 . . . . 0.0 111.184 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 -153.63 147.21 25.07 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 120.224 1.375 . . . . 0.0 112.403 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 60.7 m -76.14 167.88 21.06 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 36.3 pt -128.15 148.42 32.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.74 167.92 20.94 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.222 0.609 . . . . 0.0 112.141 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -151.04 127.43 10.66 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.318 1.447 . . . . 0.0 109.758 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -91.07 102.73 15.49 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.704 0.802 . . . . 0.0 109.176 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.27 66.75 8.53 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.89 -114.96 7.04 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -63.84 -32.87 74.53 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.036 0.934 . . . . 0.0 112.594 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -107.68 159.43 16.48 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 119.663 1.119 . . . . 0.0 111.094 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.6 mt -127.92 147.05 32.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -123.05 128.62 50.4 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.295 1.838 . . . . 0.0 108.776 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -122.2 130.52 53.28 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.619 1.968 . . . . 0.0 110.01 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -124.21 119.41 29.28 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.398 1.479 . . . . 0.0 108.256 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 14.9 m -108.52 157.71 35.86 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 123.45 0.7 . . . . 0.0 111.274 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -65.69 87.41 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.552 1 C-N-CA 125.67 4.246 . . . . 0.0 115.55 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.58 34.42 89.85 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 119.479 -0.623 . . . . 0.0 111.851 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.5 mt -112.44 -67.22 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.446 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 11.7 pt-20 -173.26 168.21 4.7 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.73 1.612 . . . . 0.0 109.379 -178.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.63 120.38 29.37 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 177.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.2 m -138.33 156.56 30.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 124.832 1.253 . . . . 0.0 111.553 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -132.64 127.05 34.05 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.958 0.903 . . . . 0.0 108.835 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -136.93 159.25 42.44 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 126.909 2.084 . . . . 0.0 113.283 -178.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -87.36 153.3 21.56 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 159.75 -164.98 34.42 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.83 147.35 49.46 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 89.8 t -121.54 156.16 25.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 124.398 1.079 . . . . 0.0 110.604 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -101.69 89.42 3.69 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 103.541 -2.763 . . . . 0.0 103.541 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 8.8 t -49.98 -21.78 1.33 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.485 1.114 . . . . 0.0 112.399 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -56.69 -26.74 57.35 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.89 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.51 -30.05 0.38 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.209 0.913 . . . . 0.0 111.88 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 114.55 -0.0 23.36 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 126.48 1.991 . . . . 0.0 110.259 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -56.06 128.56 35.98 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 126.046 1.739 . . . . 0.0 111.479 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 48.7 mt -67.34 129.04 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 47.7 t -76.3 -51.47 19.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 O-C-N 120.641 -1.287 . . . . 0.0 110.197 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 -138.61 152.25 47.97 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.52 -2.029 . . . . 0.0 105.52 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -144.14 139.69 28.96 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.934 0.894 . . . . 0.0 110.544 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -151.33 153.71 35.32 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -95.48 24.97 4.75 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.125 0.57 . . . . 0.0 109.9 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.7 t -83.69 -30.22 26.96 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 120.287 -1.508 . . . . 0.0 111.311 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 19.2 tp -140.88 72.74 1.4 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.558 0.617 . . . . 0.0 110.607 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 3.9 p -134.95 154.97 37.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.666 1.586 . . . . 0.0 110.002 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -143.32 151.38 40.42 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.125 1.37 . . . . 0.0 109.846 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 13.9 ptt-85 -99.18 135.49 40.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 125.513 1.525 . . . . 0.0 109.315 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.25 -65.67 1.1 Allowed 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 123.377 0.671 . . . . 0.0 109.722 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -130.73 150.21 19.25 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.75 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 6.5 ttpp -123.25 90.36 50.48 Favored Pre-proline 0 N--CA 1.451 -0.386 0 C-N-CA 125.932 1.693 . . . . 0.0 108.388 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 93.1 Cg_endo -70.59 175.14 9.19 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.956 2.438 . . . . 0.0 109.275 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -91.28 166.06 13.12 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.334 0.653 . . . . 0.0 110.531 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -77.61 -27.79 51.33 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.987 0.915 . . . . 0.0 113.316 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -112.99 137.89 50.71 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.725 1.21 . . . . 0.0 109.094 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.5 p -60.4 -27.34 39.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.22 1.008 . . . . 0.0 111.823 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -71.93 -8.32 53.78 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 129.128 2.971 . . . . 0.0 112.287 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -112.97 -5.13 13.81 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.676 1.99 . . . . 0.0 110.425 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 45.2 mmm-85 -82.55 165.73 19.87 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -134.24 96.59 3.64 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -111.3 139.57 46.6 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.283 1.833 . . . . 0.0 107.459 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -131.03 137.11 49.03 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.272 1.029 . . . . 0.0 109.029 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 43.8 tp -88.52 103.3 15.76 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.468 1.107 . . . . 0.0 109.717 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 7.2 mt -119.63 177.64 4.87 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.845 1.258 . . . . 0.0 108.342 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -157.49 166.85 31.87 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.579 0.751 . . . . 0.0 110.019 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.505 ' CG ' ' H ' ' A' ' 178' ' ' ASP . 31.6 t70 -136.6 -178.46 5.18 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.505 ' H ' ' CG ' ' A' ' 177' ' ' ASP . 0.5 OUTLIER -54.51 -30.67 54.22 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 125.491 1.516 . . . . 0.0 111.36 179.647 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 20.2 t -77.52 -64.25 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.491 1.116 . . . . 0.0 110.012 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -169.67 -170.83 34.61 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 119.059 0.845 . . . . 0.0 112.491 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -87.67 154.77 20.32 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 123.637 0.775 . . . . 0.0 110.816 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -159.72 172.83 17.01 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.719 1.208 . . . . 0.0 107.977 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.1 mt -117.41 137.96 49.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.2 t -106.0 118.29 36.23 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 124.916 1.385 . . . . 0.0 107.437 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.82 107.78 11.77 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 2.1 tt -101.99 128.33 54.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.1 mt -120.4 111.1 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.955 1.302 . . . . 0.0 111.551 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -104.75 -159.01 23.65 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 125.7 1.619 . . . . 0.0 110.042 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 74.82 36.94 0.53 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.772 1.629 . . . . 0.0 109.735 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -89.89 -126.91 3.18 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 107.576 -2.21 . . . . 0.0 107.576 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -137.35 127.95 26.85 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.9 mm -61.45 129.36 24.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 123.499 0.719 . . . . 0.0 111.784 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 5.1 m -90.0 94.07 9.65 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 101.198 -3.63 . . . . 0.0 101.198 176.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -57.67 -17.72 16.52 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.4 m -53.05 -33.04 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.466 1.507 . . . . 0.0 109.854 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 1.4 p -122.35 -34.01 3.36 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 123.25 0.62 . . . . 0.0 111.33 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 95.46 22.79 20.85 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.284 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -111.1 165.59 11.76 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.299 1.84 . . . . 0.0 109.159 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -87.21 145.48 26.38 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.355 1.462 . . . . 0.0 111.954 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -79.05 29.81 0.21 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.638 2.775 . . . . 0.0 111.06 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.8 ptm -73.12 149.44 43.04 Favored 'General case' 0 C--O 1.239 0.512 0 O-C-N 121.124 -0.985 . . . . 0.0 109.504 -177.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -116.73 146.88 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.607 -177.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -115.05 127.98 55.96 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.7 mp -117.06 116.53 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.109 0.964 . . . . 0.0 108.412 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -100.32 113.69 26.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -92.2 116.78 29.24 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 28.3 m -125.31 169.84 16.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 125.789 1.636 . . . . 0.0 111.806 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -81.37 137.41 35.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -101.24 122.46 7.6 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 107.364 -2.294 . . . . 0.0 107.364 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -45.32 -46.13 11.13 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.37 1.462 . . . . 0.0 113.238 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 8.3 t -81.62 65.2 6.65 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -57.14 28.19 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 130.099 3.36 . . . . 0.0 117.538 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.1 t -138.78 47.1 1.95 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 120.637 1.562 . . . . 0.0 112.486 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -153.24 172.68 32.15 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -73.28 167.1 28.18 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.276 1.984 . . . . 0.0 109.799 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.19 155.71 34.28 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.66 159.77 12.21 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.241 1.416 . . . . 0.0 107.373 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.86 128.89 37.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -72.9 -61.01 1.96 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 124.08 0.952 . . . . 0.0 109.184 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . 0.435 ' CE3' ' HD2' ' A' ' 222' ' ' ARG . 28.6 p-90 -139.64 167.2 22.65 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.595 1.558 . . . . 0.0 109.443 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 24.9 t -144.01 129.15 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.435 ' HD2' ' CE3' ' A' ' 220' ' ' TRP . 0.1 OUTLIER -145.51 118.03 8.55 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.99 0.9 . . . . 0.0 109.417 178.053 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -76.36 94.58 3.64 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 102.714 -3.069 . . . . 0.0 102.714 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 17.4 p -61.45 -66.41 0.54 Allowed 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.274 0.629 . . . . 0.0 109.669 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -101.38 179.12 4.45 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 34.7 mm -62.07 -21.47 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 123.535 0.734 . . . . 0.0 111.871 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.01 -45.57 1.26 Allowed 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.243 0.617 . . . . 0.0 111.228 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 25.2 t -67.29 133.58 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -130.09 144.63 51.45 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.752 1.621 . . . . 0.0 108.661 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -123.74 138.38 54.53 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 126.363 1.865 . . . . 0.0 107.944 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.1 156.51 43.94 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.868 1.267 . . . . 0.0 109.91 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -130.9 143.3 50.63 Favored 'General case' 0 CA--C 1.52 -0.211 0 O-C-N 121.344 -0.847 . . . . 0.0 110.673 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 61.1 t -125.61 140.89 47.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.44 1.496 . . . . 0.0 107.419 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.72 136.81 52.44 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 96.6 mt -133.02 143.47 48.67 Favored Pre-proline 0 C--O 1.236 0.385 0 CA-C-O 118.192 -0.909 . . . . 0.0 109.112 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.39 -44.2 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.34 2.026 . . . . 0.0 111.445 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -62.36 -20.3 64.26 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.721 1.208 . . . . 0.0 113.291 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 14.9 mt -69.63 -38.11 77.07 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.047 0.839 . . . . 0.0 109.982 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 34.5 m -54.31 -21.58 9.71 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.433 1.493 . . . . 0.0 113.61 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -61.94 -30.66 71.06 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.391 1.076 . . . . 0.0 110.835 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 52.8 mt -79.09 124.08 27.96 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -48.02 -45.41 31.94 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 126.267 1.827 . . . . 0.0 112.824 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 6.1 mp -60.7 -28.91 68.99 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.271 -0.893 . . . . 0.0 111.512 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 246' ' ' LYS . 2.7 mm? -99.91 -0.68 39.05 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.596 1.558 . . . . 0.0 111.627 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -78.1 37.97 0.27 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.744 1.618 . . . . 0.0 109.493 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 244' ' ' LEU . 52.6 tptt -144.3 132.96 22.29 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 127.681 2.392 . . . . 0.0 107.113 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -163.14 153.85 16.54 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 126.82 2.048 . . . . 0.0 105.516 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -172.93 -22.98 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.535 1.534 . . . . 0.0 112.949 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 21.8 t0 . . . . . 0 C--O 1.25 1.114 0 C-N-CA 127.377 2.271 . . . . 0.0 110.885 179.699 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.741 0 N-CA-C 108.761 -1.735 . . . . 0.0 108.761 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.44 -26.61 68.81 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.485 1.143 . . . . 0.0 110.453 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.8 m -136.45 170.86 15.36 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.955 1.702 . . . . 0.0 108.481 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 61.7 21.96 12.59 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.313 1.445 . . . . 0.0 114.418 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.7 m -64.6 -34.47 78.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 122.923 1.344 . . . . 0.0 111.29 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -72.55 -35.26 67.98 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 125.02 1.328 . . . . 0.0 107.737 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -68.29 -49.62 59.24 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.549 1.54 . . . . 0.0 108.26 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.4 p -57.0 -45.58 82.93 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 120.247 1.385 . . . . 0.0 110.879 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.5 -45.59 93.24 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.415 0.686 . . . . 0.0 110.262 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.1 tp -62.74 -42.86 99.87 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 117.895 -1.05 . . . . 0.0 110.482 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.7 mt -58.99 -53.82 54.12 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.441 1.019 . . . . 0.0 109.123 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.6 m -56.1 -42.03 76.15 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.816 0.447 . . . . 0.0 110.129 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -65.72 -51.07 62.2 Favored 'General case' 0 CA--C 1.527 0.09 0 O-C-N 120.97 -1.082 . . . . 0.0 110.044 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.7 m -53.02 -43.19 66.34 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.182 1.393 . . . . 0.0 110.323 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 19.9 tp -60.08 -55.55 32.57 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.943 0.792 . . . . 0.0 111.489 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -65.46 -40.07 92.77 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 118.867 0.758 . . . . 0.0 112.124 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -61.59 -41.46 97.46 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 124.052 0.941 . . . . 0.0 109.851 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -66.26 -49.47 57.09 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 62.6 t -54.52 -53.05 34.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 126.036 1.734 . . . . 0.0 111.412 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -32.99 74.77 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 118.133 0.424 . . . . 0.0 110.463 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.09 -42.78 72.28 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 118.324 0.511 . . . . 0.0 110.492 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 16.6 mt -53.4 -53.5 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.97 -42.36 98.16 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 118.643 -0.694 . . . . 0.0 110.422 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -61.44 -30.04 70.33 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.948 0.794 . . . . 0.0 111.174 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -91.96 -3.81 55.42 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.67 1.188 . . . . 0.0 112.511 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.9 mt -119.75 -29.28 5.05 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.041 1.291 . . . . 0.0 112.586 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -62.07 -24.77 67.3 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.46 0.704 . . . . 0.0 111.313 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -73.45 -46.62 47.29 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.657 1.183 . . . . 0.0 108.565 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -161.33 145.16 13.01 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.034 1.733 . . . . 0.0 108.951 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 33.9 m -76.19 173.73 10.99 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.322 0.649 . . . . 0.0 109.778 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 42.1 pt -125.55 151.56 31.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 123.794 0.838 . . . . 0.0 109.209 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.89 160.89 41.76 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 122.849 0.46 . . . . 0.0 109.901 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -150.95 125.13 9.35 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.568 -0.708 . . . . 0.0 111.278 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -84.58 101.73 12.34 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 178.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.21 67.2 9.55 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.32 -115.68 6.94 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -66.85 -33.74 76.28 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -106.78 160.37 15.53 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.464 1.029 . . . . 0.0 110.363 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 21.3 mt -125.07 133.52 69.25 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 N-CA-C 104.894 -2.262 . . . . 0.0 104.894 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -110.63 131.64 54.88 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -121.49 128.36 52.0 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 125.245 1.418 . . . . 0.0 109.368 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -127.24 108.85 11.23 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 124.288 0.992 . . . . 0.0 112.096 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 1.7 m -98.23 159.28 31.07 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.038 0.935 . . . . 0.0 112.858 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.06 96.34 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.562 1 C-N-CA 125.925 4.417 . . . . 0.0 113.62 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 55.54 49.78 63.42 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-O 119.076 -0.847 . . . . 0.0 111.18 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 5.1 mt -125.95 -68.01 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.613 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -172.64 162.57 5.11 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -123.73 119.76 30.73 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 103.011 -2.959 . . . . 0.0 103.011 177.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.8 m -131.38 155.87 42.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 124.123 0.969 . . . . 0.0 111.166 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -122.51 131.63 53.94 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 177.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -146.11 157.41 43.84 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.972 0.909 . . . . 0.0 111.102 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -89.39 154.4 20.09 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 157.05 -163.62 32.41 Favored Glycine 0 C--N 1.33 0.231 0 O-C-N 120.175 -1.578 . . . . 0.0 110.768 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.09 144.3 51.06 Favored 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.4 p -154.87 147.52 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 126.106 1.762 . . . . 0.0 106.454 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -89.16 83.15 6.5 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 101.06 -3.682 . . . . 0.0 101.06 177.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.4 t -52.63 -14.82 0.57 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.117 1.367 . . . . 0.0 114.499 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.431 ' HA ' ' HE2' ' A' ' 145' ' ' LYS . 11.3 mmpt? -69.62 -35.78 75.56 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.636 1.975 . . . . 0.0 111.557 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.4 t -119.76 -21.52 7.21 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.61 1.564 . . . . 0.0 111.321 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 88.08 35.03 9.2 Favored Glycine 0 C--O 1.224 -0.487 0 O-C-N 121.4 -0.813 . . . . 0.0 111.224 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -101.67 119.97 39.61 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 34.5 mm -69.4 158.33 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 13.4 t -131.44 -16.92 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.884 1.274 . . . . 0.0 110.809 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -143.44 148.06 35.52 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.854 1.261 . . . . 0.0 108.281 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -134.3 35.39 3.24 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.168 0.987 . . . . 0.0 110.365 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -51.81 121.31 6.38 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -86.84 -0.14 55.91 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.611 1.165 . . . . 0.0 112.833 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.4 t -76.81 -42.34 40.89 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 125.097 1.359 . . . . 0.0 111.097 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 47.3 mt -110.72 73.45 0.83 Allowed 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.863 0.865 . . . . 0.0 110.713 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.9 p -142.8 141.69 27.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -132.5 157.83 43.65 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.605 1.562 . . . . 0.0 109.484 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -107.71 130.66 54.92 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.495 1.118 . . . . 0.0 109.746 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.4 -75.98 0.51 Allowed 'General case' 0 N--CA 1.458 -0.052 0 C-N-CA 124.434 1.093 . . . . 0.0 109.68 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -127.72 153.76 19.41 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -129.45 90.97 42.65 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -74.87 173.67 14.06 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.965 2.444 . . . . 0.0 110.984 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -83.16 164.52 20.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.825 0.821 . . . . 0.0 109.493 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -81.92 -24.02 35.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.307 -1.315 . . . . 0.0 113.592 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -102.03 144.1 31.04 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.8 p -72.95 -31.53 36.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 121.426 0.631 . . . . 0.0 110.199 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.55 -21.93 66.65 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.822 2.049 . . . . 0.0 110.571 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -83.48 -18.41 38.65 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.288 -0.883 . . . . 0.0 112.302 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.45 ' HD3' ' CE1' ' A' ' 172' ' ' PHE . 3.0 mtt180 -76.36 172.34 13.07 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.175 0.59 . . . . 0.0 112.304 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -136.75 95.03 3.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.254 1.422 . . . . 0.0 107.988 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.45 ' CE1' ' HD3' ' A' ' 170' ' ' ARG . 85.7 m-85 -99.09 161.61 13.53 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.64 1.176 . . . . 0.0 109.535 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -141.51 129.51 21.97 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 118.671 0.669 . . . . 0.0 110.155 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 21.5 tp -87.88 99.66 12.29 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 26.5 mt -106.84 -179.67 4.0 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.758 1.223 . . . . 0.0 109.556 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -159.72 159.88 33.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -140.81 -173.53 3.73 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -50.87 -34.03 26.4 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.953 1.701 . . . . 0.0 112.631 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.435 ' O ' ' HE3' ' A' ' 246' ' ' LYS . 41.3 t -79.16 -73.47 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -165.65 -169.05 28.75 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 119.366 0.984 . . . . 0.0 111.959 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -78.49 156.37 29.35 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.269 0.628 . . . . 0.0 110.789 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -159.55 167.53 28.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.431 1.492 . . . . 0.0 107.616 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.3 mt -114.88 125.13 72.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.3 t -99.18 130.08 45.47 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -137.99 107.06 6.01 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 103.72 -2.696 . . . . 0.0 103.72 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.0 tt -99.65 140.45 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 15.2 mt -129.59 112.28 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 123.291 0.636 . . . . 0.0 110.092 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.34 -159.07 26.07 Favored Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.1 m 72.05 57.99 0.15 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.557 1.543 . . . . 0.0 109.286 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -116.4 -118.78 3.08 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 125.589 1.566 . . . . 0.0 109.501 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -140.59 122.81 15.8 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.366 1.466 . . . . 0.0 109.79 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.6 mm -61.15 119.29 4.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 126.065 1.746 . . . . 0.0 110.497 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 35.2 m -77.58 100.9 6.29 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -48.56 -29.7 4.51 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.737 1.615 . . . . 0.0 113.476 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 27.1 t -53.36 -40.84 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.186 1.394 . . . . 0.0 111.585 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 37.9 p -124.07 -18.4 5.92 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.694 0.759 . . . . 0.0 111.554 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 77.56 15.84 80.92 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 128.68 3.038 . . . . 0.0 111.994 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -86.45 168.9 13.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.068 1.347 . . . . 0.0 110.801 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -85.32 148.15 26.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.252 1.025 . . . . 0.0 108.443 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.91 29.93 0.99 Allowed 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 127.933 2.493 . . . . 0.0 111.232 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 11.9 ptt? -73.18 156.26 38.78 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.18 143.53 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.978 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -106.78 133.23 51.76 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.73 111.81 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 C-N-CA 124.378 1.071 . . . . 0.0 108.373 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -97.12 114.56 26.24 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -91.28 122.92 34.32 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.488 0.715 . . . . 0.0 110.142 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.82 176.49 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 125.864 1.666 . . . . 0.0 110.728 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.9 t -88.09 143.15 27.24 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -107.07 151.84 16.88 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -51.66 -61.55 6.3 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.843 1.687 . . . . 0.0 113.952 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 11.7 m -78.03 92.57 4.36 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 118.568 1.184 . . . . 0.0 108.669 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -66.42 17.36 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.041 2.536 . . . . 0.0 114.166 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 3.8 m -132.78 47.04 2.55 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 -177.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -157.88 175.51 35.12 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 120.647 -1.283 . . . . 0.0 111.552 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.44 162.6 37.89 Favored 'Trans proline' 0 C--O 1.239 0.562 0 C-N-CA 122.661 2.241 . . . . 0.0 110.959 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 12.4 p -69.38 162.09 28.03 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.875 0.87 . . . . 0.0 109.366 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.21 157.25 9.22 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.16 1.384 . . . . 0.0 107.927 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.83 132.32 33.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -81.25 -53.17 6.58 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 125.59 1.556 . . . . 0.0 111.377 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 41.3 p-90 -148.94 165.85 30.35 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 124.135 0.974 . . . . 0.0 108.446 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 49.1 t -145.67 136.39 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 127.146 2.179 . . . . 0.0 105.504 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.02 130.57 10.65 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -78.69 87.93 4.59 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 2.6 p -60.45 -53.45 57.41 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.423 0.689 . . . . 0.0 110.989 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 17.5 mmtp -114.81 179.33 3.98 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.6 mp -66.22 -33.04 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -108.83 -65.05 1.17 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.871 0.868 . . . . 0.0 109.88 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 5.5 t -55.35 138.88 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 124.892 1.277 . . . . 0.0 109.749 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -133.49 151.03 51.71 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.698 1.999 . . . . 0.0 108.341 -178.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -132.22 141.06 48.91 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 126.109 1.764 . . . . 0.0 108.793 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.01 162.31 37.26 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.429 2.292 . . . . 0.0 111.177 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -134.48 147.64 50.41 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.746 0.818 . . . . 0.0 108.898 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 93.3 t -134.66 135.5 53.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 C-N-CA 124.687 1.195 . . . . 0.0 108.689 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.7 p -102.75 142.19 34.31 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.706 0.802 . . . . 0.0 108.979 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 34.0 mt -139.48 137.61 19.13 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 123.693 0.797 . . . . 0.0 109.9 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.34 -34.66 2.63 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.914 2.41 . . . . 0.0 113.029 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -67.81 -26.46 66.09 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.224 -0.922 . . . . 0.0 110.595 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 3.9 mp -65.9 -34.47 78.21 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 28.3 m -59.13 -11.16 3.35 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.252 1.421 . . . . 0.0 112.98 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -81.96 -30.34 31.76 Favored 'General case' 0 CA--C 1.528 0.098 0 O-C-N 120.16 -1.587 . . . . 0.0 111.142 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 23.8 mt -78.78 111.88 15.35 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.41 -27.87 1.86 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 116.404 2.001 . . . . 0.0 116.404 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 5.2 mp -63.68 -45.03 91.92 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.466 0.706 . . . . 0.0 110.445 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -82.21 3.59 26.76 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 127.002 2.121 . . . . 0.0 113.3 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -74.02 64.2 1.0 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 127.949 2.5 . . . . 0.0 110.584 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.435 ' HE3' ' O ' ' A' ' 179' ' ' VAL . 4.8 tptp -135.34 146.39 48.37 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 128.673 2.789 . . . . 0.0 108.404 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 18.4 m120 67.86 11.66 8.47 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.785 1.634 . . . . 0.0 112.614 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -85.82 73.58 10.34 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 178.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 39.0 t70 . . . . . 0 C--O 1.245 0.859 0 CA-C-O 118.49 -0.767 . . . . 0.0 109.891 179.655 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.171 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -144.71 171.87 13.8 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.852 1.661 . . . . 0.0 107.637 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.1 m -153.51 -172.34 4.2 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.121 0.969 . . . . 0.0 109.452 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 55.55 35.66 25.6 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.608 1.563 . . . . 0.0 113.622 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 63.9 m -55.41 -53.68 53.25 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 121.363 -0.836 . . . . 0.0 111.929 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -59.85 -39.55 85.54 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.143 0.577 . . . . 0.0 111.974 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -57.14 -52.37 65.58 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.9 m -65.31 -36.03 82.8 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 118.79 -0.624 . . . . 0.0 110.422 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.59 -46.06 84.48 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.662 1.119 . . . . 0.0 110.064 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.9 tp -66.39 -39.74 89.24 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.112 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.2 mt -60.95 -51.75 67.94 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.403 1.002 . . . . 0.0 110.392 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 90.1 m -55.12 -56.45 19.75 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.26 1.424 . . . . 0.0 109.906 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.04 -48.91 78.66 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-O 119.043 -0.503 . . . . 0.0 111.332 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 54.9 m -52.84 -50.39 63.82 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.439 0.695 . . . . 0.0 111.41 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.9 tp -58.59 -54.12 50.7 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.766 -0.635 . . . . 0.0 110.138 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -55.12 -51.54 66.1 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.555 0.742 . . . . 0.0 112.071 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -59.09 -40.08 84.19 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.24 -52.48 52.45 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-O 118.146 -1.363 . . . . 0.0 110.973 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 29.5 t -55.72 -53.19 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 119.255 1.528 . . . . 0.0 111.289 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -35.04 79.13 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.863 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.2 m -64.91 -45.24 86.7 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 41.0 mt -56.66 -54.36 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -56.7 -43.23 80.34 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 123.278 0.361 . . . . 0.0 110.466 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -67.56 -37.63 82.94 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.823 -0.548 . . . . 0.0 112.294 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.86 -1.97 41.45 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.935 0.894 . . . . 0.0 113.235 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.2 mt -119.39 -26.16 5.89 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 119.645 1.111 . . . . 0.0 111.744 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -58.7 -23.57 59.83 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -74.22 -43.17 58.19 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 117.946 -1.026 . . . . 0.0 111.383 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -156.23 150.21 25.19 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.523 1.129 . . . . 0.0 112.376 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 57.4 m -76.02 171.58 14.21 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 23.0 pt -129.38 156.12 41.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 123.955 0.902 . . . . 0.0 109.018 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -151.21 154.03 36.06 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 122.059 -0.401 . . . . 0.0 111.196 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -141.37 127.42 19.51 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 124.118 0.967 . . . . 0.0 110.699 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -87.22 118.13 26.43 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -109.84 67.41 0.65 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.045 2.138 . . . . 0.0 106.105 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.14 -120.8 8.03 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -66.46 -33.07 74.87 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.531 1.132 . . . . 0.0 112.508 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -106.92 145.31 32.37 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 118.737 0.699 . . . . 0.0 109.847 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 10.6 mt -116.06 151.16 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -118.7 135.92 54.22 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 126.057 1.743 . . . . 0.0 106.447 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.63 131.43 48.07 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 125.661 1.584 . . . . 0.0 108.516 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -128.2 109.35 11.41 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.183 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 2.5 m -89.45 160.04 42.97 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 117.832 -1.08 . . . . 0.0 108.709 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -61.49 70.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 125.15 3.9 . . . . 0.0 116.145 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.46 48.74 65.6 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 125.257 1.408 . . . . 0.0 111.772 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.2 mt -114.65 -66.29 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -160.14 160.95 33.57 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.462 1.905 . . . . 0.0 107.915 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -123.46 120.81 34.02 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 102.525 -3.139 . . . . 0.0 102.525 177.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.94 155.52 27.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 123.593 0.757 . . . . 0.0 111.751 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -121.24 135.74 55.08 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -145.97 157.69 43.88 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 125.206 1.402 . . . . 0.0 111.144 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -88.78 151.44 22.39 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 164.68 -163.33 36.21 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.4 139.24 50.63 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.706 2.002 . . . . 0.0 106.268 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 91.5 t -116.8 153.19 18.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 125.189 1.396 . . . . 0.0 109.594 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -105.98 93.44 4.63 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 127.427 2.291 . . . . 0.0 105.559 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.7 t -57.56 -13.84 4.36 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 119.271 0.942 . . . . 0.0 112.812 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -50.71 -40.32 53.88 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 125.125 1.37 . . . . 0.0 109.803 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.4 t -145.8 -11.46 0.51 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.265 0.626 . . . . 0.0 111.355 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 105.46 5.49 39.62 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.598 1.57 . . . . 0.0 114.097 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -61.14 160.53 10.07 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.568 1.947 . . . . 0.0 112.637 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 20.2 mt -106.98 124.74 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.7 t -72.22 -54.72 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 118.147 -0.93 . . . . 0.0 112.642 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -125.54 103.03 7.65 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.64 1.564 . . . . 0.0 109.636 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -76.0 129.05 36.29 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -142.21 142.8 32.69 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 118.554 0.616 . . . . 0.0 109.623 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -95.92 -6.16 39.76 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.87 1.268 . . . . 0.0 111.887 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 62.7 p -63.1 -36.59 84.09 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 93.3 mt -127.66 86.42 2.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.782 1.233 . . . . 0.0 109.455 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.8 t -140.99 141.48 31.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -132.78 144.86 50.53 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.222 1.409 . . . . 0.0 110.084 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.3 mmt85 -93.39 114.19 26.54 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.937 1.295 . . . . 0.0 110.215 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.0 mp -89.85 -79.82 0.33 Allowed 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -118.58 157.23 15.33 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -133.63 88.63 33.18 Favored Pre-proline 0 N--CA 1.454 -0.258 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -77.37 172.2 16.36 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.069 2.513 . . . . 0.0 112.18 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -89.63 165.25 14.35 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 125.1 1.36 . . . . 0.0 111.659 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.95 -43.55 21.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.712 0.768 . . . . 0.0 110.708 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -78.96 130.0 35.1 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.666 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.7 p -64.88 -32.97 60.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 O-C-N 123.286 0.366 . . . . 0.0 110.149 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -67.72 -28.44 67.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.54 1.136 . . . . 0.0 112.049 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -71.81 -33.3 68.41 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -75.06 174.47 9.33 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.835 1.254 . . . . 0.0 109.251 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -143.53 149.28 37.23 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -136.76 146.58 45.93 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.933 1.293 . . . . 0.0 107.966 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.99 123.35 40.18 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.816 1.246 . . . . 0.0 110.115 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 tt -86.6 106.31 17.47 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 45.2 mt -113.45 177.99 4.44 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.597 1.159 . . . . 0.0 110.689 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -152.66 159.28 43.19 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -140.65 -178.42 5.51 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.43 -28.47 68.3 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 41.0 t -71.63 -56.66 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.256 1.022 . . . . 0.0 109.754 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 178.24 -173.69 46.11 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -78.05 164.13 25.31 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.068 0.547 . . . . 0.0 109.726 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -164.19 170.55 16.19 Favored 'General case' 0 N--CA 1.461 0.095 0 C-N-CA 125.434 1.493 . . . . 0.0 109.076 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 5.9 mt -118.2 134.67 61.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 103.816 -2.661 . . . . 0.0 103.816 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 21.1 t -110.57 139.61 45.66 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -137.3 112.71 9.3 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 6.3 tt -101.52 140.3 20.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.8 mt -131.46 110.7 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.201 1.0 . . . . 0.0 109.853 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -101.32 -157.68 27.03 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 49.6 m 70.57 55.76 0.27 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.562 1.145 . . . . 0.0 112.205 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -114.42 -126.31 4.24 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -130.01 123.67 31.12 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.911 1.684 . . . . 0.0 107.508 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.0 mm -60.94 146.18 11.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 124.805 1.242 . . . . 0.0 111.371 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 64.4 m -105.92 91.31 3.68 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 103.776 -2.675 . . . . 0.0 103.776 177.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -49.8 -30.78 10.28 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.614 1.166 . . . . 0.0 113.11 -178.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 60.6 t -45.96 -40.2 3.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 127.168 2.187 . . . . 0.0 110.276 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 7.1 p -120.4 -27.36 5.21 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.002 0.521 . . . . 0.0 110.963 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 92.31 22.57 29.18 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.898 1.714 . . . . 0.0 110.724 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -101.6 164.49 11.73 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.666 1.233 . . . . 0.0 112.388 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -89.49 146.47 24.6 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.541 -1.209 . . . . 0.0 107.866 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -77.35 30.84 0.15 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 127.522 2.329 . . . . 0.0 111.203 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -73.61 145.01 45.74 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 1.4 p -112.4 142.3 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 C-N-CA 124.468 1.107 . . . . 0.0 110.058 -177.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -109.51 123.59 49.65 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.2 mp -115.34 121.55 67.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 124.444 1.098 . . . . 0.0 108.822 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -102.37 116.67 33.12 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.47 0.708 . . . . 0.0 109.683 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -96.02 117.94 31.65 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.918 1.287 . . . . 0.0 109.625 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 22.2 m -133.21 167.85 25.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 124.565 1.146 . . . . 0.0 112.035 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.6 t -81.19 128.49 33.83 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 177.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.6 137.11 13.07 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -51.43 -41.84 49.35 Favored Glycine 0 C--N 1.336 0.528 0 CA-C-O 119.014 -0.881 . . . . 0.0 112.385 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.402 ' C ' ' H ' ' A' ' 213' ' ' SER . 4.7 m -80.71 74.9 7.63 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 178.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -71.33 30.88 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.218 2.207 . . . . 0.0 112.939 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' SER . . . . . 0.402 ' H ' ' C ' ' A' ' 211' ' ' SER . 37.8 m -143.96 47.33 1.43 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.208 2.203 . . . . 0.0 108.242 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -155.11 164.2 31.77 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -78.25 172.76 14.88 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.874 2.382 . . . . 0.0 112.354 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 24.2 m -62.25 147.63 47.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.485 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -165.92 156.29 12.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.8 mt -87.6 127.81 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -72.43 -52.95 13.68 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.783 1.233 . . . . 0.0 110.996 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 39.9 p-90 -150.58 166.6 29.76 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.002 1.321 . . . . 0.0 109.395 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 40.4 t -146.46 128.42 7.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 C-N-CA 126.015 1.726 . . . . 0.0 106.795 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.26 124.8 12.43 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.361 0.6 . . . . 0.0 109.898 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -79.42 93.06 5.3 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 103.08 -2.933 . . . . 0.0 103.08 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.0 p -68.8 -53.59 20.81 Favored 'General case' 0 C--O 1.237 0.424 0 O-C-N 121.667 -0.646 . . . . 0.0 110.348 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -103.33 174.54 5.82 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 25.1 mm -62.94 -27.62 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 O-C-N 121.89 -0.506 . . . . 0.0 111.144 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.89 -52.68 1.99 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.778 0.831 . . . . 0.0 110.697 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 1.7 t -64.94 132.33 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.737 0.815 . . . . 0.0 109.187 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -124.49 154.77 40.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.327 1.851 . . . . 0.0 109.187 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -131.23 137.77 49.05 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 125.937 1.695 . . . . 0.0 108.784 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -143.61 161.62 38.04 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 126.274 1.83 . . . . 0.0 110.544 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -137.63 143.76 41.57 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.9 m -133.69 146.59 31.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 123.808 0.843 . . . . 0.0 108.97 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.87 143.78 33.54 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.454 0.701 . . . . 0.0 110.08 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 22.9 mt -140.33 134.49 15.46 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.876 0.871 . . . . 0.0 109.135 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.12 -45.63 0.64 Allowed 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.176 1.917 . . . . 0.0 110.9 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -61.73 -21.43 64.5 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.4 mp -64.57 -36.32 83.84 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.685 1.13 . . . . 0.0 109.993 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 50.8 m -56.75 -23.53 43.49 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.022 1.729 . . . . 0.0 113.208 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -64.24 -26.98 68.74 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 121.236 -0.915 . . . . 0.0 112.769 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 28.9 mt -83.19 122.79 28.86 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -48.26 -41.27 27.26 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.95 2.1 . . . . 0.0 113.84 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 49.6 mt -63.52 -37.17 86.26 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.76 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 24.0 mt -97.29 6.67 47.98 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 127.19 2.196 . . . . 0.0 112.788 -177.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -80.46 54.7 2.1 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.356 1.863 . . . . 0.0 108.644 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -150.47 133.57 16.15 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.977 0.911 . . . . 0.0 109.944 -178.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -160.44 163.35 33.11 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -141.9 70.86 1.34 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.404 1.082 . . . . 0.0 109.567 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 116.316 -1.802 . . . . 0.0 107.878 178.261 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.083 0 N-CA-C 107.975 -2.05 . . . . 0.0 107.975 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.51 123.96 23.6 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.7 m -137.08 136.62 38.51 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -139.69 87.15 2.15 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.2 m -47.26 -46.87 24.93 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 124.506 1.123 . . . . 0.0 112.212 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -58.97 -40.41 84.7 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.349 0.66 . . . . 0.0 112.464 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.58 -43.92 83.63 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 119.652 1.114 . . . . 0.0 108.192 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.9 p -63.41 -36.13 82.71 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.533 0.606 . . . . 0.0 110.121 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.49 -46.21 89.5 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 59.9 tp -59.65 -49.04 79.31 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.09 0.956 . . . . 0.0 109.098 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.9 mt -59.05 -50.49 73.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.363 1.065 . . . . 0.0 109.778 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 75.0 m -55.77 -52.48 63.83 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.225 1.41 . . . . 0.0 110.231 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -64.47 -41.9 96.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.214 1.006 . . . . 0.0 110.784 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 23.9 m -55.52 -51.69 66.19 Favored 'General case' 0 CA--C 1.523 -0.089 0 C-N-CA 125.284 1.434 . . . . 0.0 109.41 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.5 tp -56.98 -52.37 65.49 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 118.669 -0.682 . . . . 0.0 109.933 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -56.79 -50.86 71.06 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.478 0.581 . . . . 0.0 111.303 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -55.76 -38.89 70.46 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.546 1.138 . . . . 0.0 109.443 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.64 -53.26 36.17 Favored Glycine 0 N--CA 1.437 -1.25 0 CA-C-O 118.323 -1.265 . . . . 0.0 110.181 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.1 t -55.88 -53.13 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 119.297 1.548 . . . . 0.0 110.348 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -32.55 72.46 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 118.561 0.618 . . . . 0.0 112.007 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.3 m -68.2 -51.51 44.74 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 25.4 mt -55.1 -54.26 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.97 -39.14 80.84 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.648 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -61.89 -42.05 98.61 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 118.814 0.734 . . . . 0.0 111.257 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -82.0 -8.22 59.66 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 117.586 -1.197 . . . . 0.0 113.405 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.8 mp -111.65 -33.11 6.45 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 120.941 1.7 . . . . 0.0 110.87 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -53.67 -36.64 62.37 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 122.943 0.497 . . . . 0.0 110.876 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -61.94 -42.57 99.26 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 117.627 -1.178 . . . . 0.0 113.566 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -162.38 150.18 14.18 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 126.696 1.998 . . . . 0.0 111.261 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 31.5 m -75.96 167.27 22.17 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.713 0.805 . . . . 0.0 109.554 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.8 pt -125.55 157.27 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 125.256 1.423 . . . . 0.0 108.592 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.21 168.48 22.36 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.289 0.636 . . . . 0.0 111.667 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -151.68 119.94 6.35 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 124.883 1.273 . . . . 0.0 108.433 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -87.98 102.63 14.93 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.87 67.73 6.19 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.23 -116.2 9.02 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 107.815 -2.114 . . . . 0.0 107.815 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -65.51 -33.42 75.89 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -107.59 121.62 45.04 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 119.081 0.855 . . . . 0.0 111.128 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.5 mt -95.03 150.21 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -119.61 137.87 53.59 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 126.149 1.78 . . . . 0.0 106.354 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.19 132.19 41.26 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 125.288 1.435 . . . . 0.0 109.11 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -130.3 112.28 13.17 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 124.893 1.37 . . . . 0.0 109.859 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 6.8 m -96.04 159.38 32.36 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.006 0.922 . . . . 0.0 111.018 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -64.87 88.02 0.18 Allowed 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 123.714 2.942 . . . . 0.0 114.046 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 56.98 54.56 35.96 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.3 mt -126.49 -66.52 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.401 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 8.6 pt-20 -167.5 163.37 14.78 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.178 1.791 . . . . 0.0 108.193 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -124.62 115.75 21.3 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 101.473 -3.529 . . . . 0.0 101.473 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.4 m -130.23 155.55 41.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 123.456 0.702 . . . . 0.0 111.849 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -119.26 126.68 52.07 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 104.961 -2.236 . . . . 0.0 104.961 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -144.91 157.67 44.07 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.885 0.874 . . . . 0.0 112.339 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -89.29 154.59 19.97 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 177.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 166.25 -162.86 36.42 Favored Glycine 0 CA--C 1.521 0.426 0 O-C-N 120.282 -1.511 . . . . 0.0 111.723 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.1 131.72 45.84 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 177.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.4 p -142.43 159.45 19.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -106.26 96.27 6.35 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.711 1.605 . . . . 0.0 108.161 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.2 t -54.86 -11.56 0.64 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.647 1.579 . . . . 0.0 115.065 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.8 mmtp -71.45 -23.33 61.82 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.71 1.204 . . . . 0.0 111.982 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.5 t -146.22 -20.29 0.44 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.625 0.77 . . . . 0.0 111.191 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 97.49 11.7 50.43 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 125.177 1.37 . . . . 0.0 112.074 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -72.2 115.19 11.14 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 117.862 0.831 . . . . 0.0 110.333 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 47.6 mt -72.69 118.24 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 28.1 t -79.39 -54.03 12.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 124.636 1.175 . . . . 0.0 108.512 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -141.52 153.31 44.81 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.512 1.125 . . . . 0.0 108.603 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 29.2 ptt85 -148.93 170.48 18.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.897 2.079 . . . . 0.0 108.772 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -153.13 151.9 30.69 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -92.93 -8.15 44.06 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.309 0.643 . . . . 0.0 111.452 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.4 p -72.5 -21.5 61.19 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 83.9 mt -129.99 80.4 1.95 Allowed 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.8 t -142.63 132.76 23.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 124.983 1.313 . . . . 0.0 108.452 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -121.7 150.18 42.17 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.926 1.69 . . . . 0.0 109.872 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -101.42 117.07 34.2 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 35.0 mt -89.35 -72.92 0.53 Allowed 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -133.69 152.45 20.49 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -122.7 94.77 47.25 Favored Pre-proline 0 N--CA 1.447 -0.584 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.406 ' HB2' HH22 ' A' ' 170' ' ' ARG . 41.8 Cg_endo -79.13 179.53 6.37 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 122.559 2.173 . . . . 0.0 109.723 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -92.09 173.03 8.04 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -90.59 -41.44 11.35 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.769 0.668 . . . . 0.0 110.268 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -83.35 138.29 33.59 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 125.666 1.586 . . . . 0.0 108.504 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.44 -24.3 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -77.56 -20.73 53.63 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.834 0.853 . . . . 0.0 113.059 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -76.64 -37.28 56.59 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.787 0.804 . . . . 0.0 110.547 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.406 HH22 ' HB2' ' A' ' 163' ' ' PRO . 0.3 OUTLIER -84.72 174.4 9.94 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.531 0.732 . . . . 0.0 110.192 179.563 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -147.6 120.56 8.77 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -96.75 160.01 14.61 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -131.62 122.04 25.36 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.982 0.913 . . . . 0.0 110.966 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 22.0 tp -84.65 103.53 13.84 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 36.0 mt -109.75 -179.84 3.92 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.134 1.374 . . . . 0.0 108.854 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.415 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 5.0 p90 -159.03 164.56 35.37 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.19 -0.944 . . . . 0.0 109.918 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -140.71 -178.29 5.46 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.1 -20.63 64.24 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.675 1.19 . . . . 0.0 110.641 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 74.0 t -79.65 -65.74 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -173.29 -172.27 38.65 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.122 1.344 . . . . 0.0 110.01 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.415 ' CD2' ' HB3' ' A' ' 176' ' ' TYR . 29.3 m-85 -83.69 164.47 19.62 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.538 0.735 . . . . 0.0 111.433 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -168.08 165.92 13.22 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.638 1.575 . . . . 0.0 109.247 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 4.8 mt -112.46 128.97 68.83 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 40.3 t -97.11 130.78 44.34 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 126.155 1.782 . . . . 0.0 108.205 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -138.15 107.48 6.12 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 7.6 tt -100.53 140.53 19.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 5.6 mt -131.76 111.26 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 123.72 0.808 . . . . 0.0 110.532 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.72 -161.21 25.85 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 178.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 50.6 m 71.38 50.08 0.29 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.234 1.814 . . . . 0.0 112.206 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -105.5 -95.2 2.38 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 107.514 -2.234 . . . . 0.0 107.514 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -154.48 123.78 6.45 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.553 1.541 . . . . 0.0 110.854 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.4 mm -65.6 116.87 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 119.616 1.098 . . . . 0.0 108.886 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 19.8 p -69.83 119.84 14.66 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 122.524 0.33 . . . . 0.0 110.908 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -70.72 -8.47 52.36 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.581 -0.699 . . . . 0.0 110.145 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 23.1 t -65.23 -42.93 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 126.359 1.864 . . . . 0.0 109.042 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 6.7 p -125.88 -27.88 3.27 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.948 0.795 . . . . 0.0 112.814 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 97.74 19.28 25.16 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 126.801 2.143 . . . . 0.0 110.036 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -107.25 168.3 9.31 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 119.2 1.5 . . . . 0.0 112.45 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.45 163.0 27.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 122.289 1.042 . . . . 0.0 111.401 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -99.3 29.09 4.12 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 126.514 1.926 . . . . 0.0 108.059 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -73.08 148.08 44.36 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.781 0.8 . . . . 0.0 110.433 -175.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.2 p -116.02 141.53 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.542 -177.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -110.65 124.52 52.06 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.6 mp -113.3 128.03 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 125.649 1.58 . . . . 0.0 109.059 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -108.4 107.7 18.36 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.581 1.152 . . . . 0.0 108.578 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -84.0 122.47 28.81 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 107.886 -1.154 . . . . 0.0 107.886 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 23.0 m -131.45 169.86 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 125.767 1.627 . . . . 0.0 112.527 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -83.11 144.05 30.13 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.633 -1.292 . . . . 0.0 107.735 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -113.39 123.62 6.23 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -32.04 -62.2 0.29 Allowed Glycine 0 CA--C 1.523 0.55 0 C-N-CA 128.954 3.169 . . . . 0.0 114.765 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 2.0 p -78.02 89.79 4.18 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -67.33 35.09 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.107 2.163 . . . . 0.0 115.488 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.4 m -148.5 45.82 1.04 Allowed 'General case' 0 CA--C 1.54 0.559 0 O-C-N 119.837 -1.789 . . . . 0.0 111.161 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.54 162.59 28.48 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.02 169.86 20.34 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.849 2.366 . . . . 0.0 112.036 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 10.3 m -70.7 156.09 39.93 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -168.45 155.88 7.87 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.8 mt -77.73 134.17 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -74.14 -61.43 1.86 Allowed 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 41.7 p-90 -140.25 166.47 24.61 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 125.812 1.645 . . . . 0.0 109.121 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.446 HG13 ' CE1' ' A' ' 229' ' ' TYR . 53.3 t -147.5 134.6 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.19 131.35 11.08 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -85.69 86.37 7.37 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 101.629 -3.471 . . . . 0.0 101.629 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 8.6 p -61.2 -58.09 9.73 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.88 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 56.3 mmtt -91.61 -172.82 3.35 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.7 mp -74.54 -36.61 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 121.021 -1.049 . . . . 0.0 109.492 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 4.6 m -120.91 -43.08 2.47 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.468 0.707 . . . . 0.0 111.835 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 1.1 t -67.7 136.11 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . 0.446 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.7 OUTLIER -124.11 148.02 47.48 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.41 2.284 . . . . 0.0 110.011 -178.01 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -126.18 138.21 53.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.369 2.268 . . . . 0.0 106.655 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.95 161.98 38.84 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.943 1.697 . . . . 0.0 111.065 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -138.35 149.67 45.82 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.453 0.701 . . . . 0.0 109.962 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 72.2 t -133.18 135.96 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.593 1.157 . . . . 0.0 109.306 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.37 130.0 53.57 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.171 1.389 . . . . 0.0 111.26 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 33.4 mt -133.56 138.49 31.29 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-O 118.612 -0.708 . . . . 0.0 110.522 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.76 -43.9 1.63 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.213 2.609 . . . . 0.0 112.467 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -63.57 -20.44 65.64 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 37.1 mt -72.01 -35.28 69.38 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-O 118.828 -0.606 . . . . 0.0 110.037 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 48.2 m -56.3 -21.67 25.53 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.393 1.477 . . . . 0.0 113.149 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -65.98 -31.39 72.27 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.626 0.77 . . . . 0.0 112.115 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 64.4 mt -77.02 116.46 17.7 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -48.1 -37.12 14.56 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.5 mp -63.73 -36.76 84.94 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.01 -1.056 . . . . 0.0 110.028 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -91.87 3.21 55.69 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.746 2.019 . . . . 0.0 112.704 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -78.21 34.05 0.2 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.779 0.832 . . . . 0.0 111.002 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -153.04 128.04 9.66 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.796 1.638 . . . . 0.0 109.46 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -170.81 162.03 7.43 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.954 1.702 . . . . 0.0 107.751 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 53.36 33.63 16.18 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.608 1.163 . . . . 0.0 112.926 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.986 0 C-N-CA 127.523 2.329 . . . . 0.0 113.323 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.469 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.59 164.38 25.0 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 117.919 0.859 . . . . 0.0 110.537 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.6 p -156.19 171.27 20.46 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 125.877 1.671 . . . . 0.0 108.479 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -137.2 153.59 50.38 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.452 1.501 . . . . 0.0 108.109 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.9 m -45.09 -44.75 10.62 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 128.472 2.709 . . . . 0.0 114.45 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -60.56 -45.2 94.79 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 121.872 -0.517 . . . . 0.0 111.316 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -73.9 -44.75 54.2 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.167 0.587 . . . . 0.0 110.588 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 43.4 p -61.53 -35.91 79.07 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 118.52 0.6 . . . . 0.0 110.243 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.94 -48.81 75.05 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.908 0.883 . . . . 0.0 108.774 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 41.6 tp -57.71 -46.76 83.95 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.9 mt -59.1 -53.22 60.79 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.458 0.703 . . . . 0.0 109.704 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 38.6 m -55.1 -43.64 74.21 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.132 1.373 . . . . 0.0 110.803 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.75 -51.52 33.38 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 117.843 -1.075 . . . . 0.0 109.013 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 42.0 m -54.36 -44.26 72.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 119.701 1.137 . . . . 0.0 110.971 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.3 tp -60.12 -55.51 32.96 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 118.686 0.675 . . . . 0.0 109.612 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -56.72 -49.55 74.84 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.779 1.232 . . . . 0.0 110.598 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -57.35 -49.81 74.95 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.722 1.209 . . . . 0.0 108.543 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.78 -46.45 94.48 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 49.9 t -58.8 -52.23 62.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 C-N-CA 126.096 1.758 . . . . 0.0 111.133 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -32.66 74.45 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 119.552 1.069 . . . . 0.0 109.732 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.5 m -66.85 -43.27 84.11 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 34.7 mt -59.16 -51.89 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -35.68 72.27 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.98 -0.533 . . . . 0.0 111.297 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -66.89 -56.56 9.73 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.244 0.929 . . . . 0.0 109.953 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.89 -24.12 66.74 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -178.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 80.5 mt -94.31 -27.93 15.84 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 119.045 0.839 . . . . 0.0 109.955 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -64.1 -27.33 69.02 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 121.663 -0.648 . . . . 0.0 109.709 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -63.74 -46.89 83.3 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.346 1.058 . . . . 0.0 109.012 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -163.37 156.46 18.87 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 126.073 1.749 . . . . 0.0 110.487 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 76.8 m -75.84 176.2 8.03 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 34.1 pt -135.58 149.78 28.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.69 168.13 20.92 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.091 0.556 . . . . 0.0 111.337 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -154.96 128.54 8.55 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.339 1.056 . . . . 0.0 112.16 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -92.45 102.61 15.07 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.4 0.68 . . . . 0.0 109.35 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.92 67.63 8.23 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.461 1.904 . . . . 0.0 106.558 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 67.21 -115.36 7.08 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -68.25 -33.22 73.98 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 118.789 -0.624 . . . . 0.0 112.188 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -106.25 154.18 21.1 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 119.794 1.179 . . . . 0.0 111.603 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.7 mt -121.36 149.94 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -126.76 129.08 47.66 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 127.014 2.125 . . . . 0.0 107.993 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -125.3 125.21 43.16 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 127.104 2.162 . . . . 0.0 109.13 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -122.68 126.67 48.05 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.978 1.311 . . . . 0.0 109.637 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 17.8 m -113.72 157.24 42.19 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.641 0.776 . . . . 0.0 112.77 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -60.29 90.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.354 0.845 1 C-N-CA 126.163 4.575 . . . . 0.0 115.976 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 62.21 31.05 77.71 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.874 -0.491 . . . . 0.0 111.874 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.9 mt -110.64 -66.08 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.252 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.443 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 9.4 pt-20 179.67 164.74 1.08 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.753 1.621 . . . . 0.0 109.689 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.35 123.12 38.7 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.2 m -131.23 155.85 42.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 124.385 1.074 . . . . 0.0 111.747 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -123.29 122.72 39.04 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.908 1.683 . . . . 0.0 108.144 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -146.45 156.71 43.49 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.364 1.066 . . . . 0.0 111.404 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -93.15 153.53 18.59 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 168.18 -163.71 37.39 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -116.18 142.9 46.21 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.9 p -154.79 140.67 11.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 124.004 0.922 . . . . 0.0 108.886 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -82.78 95.85 8.02 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.0 t -56.54 -17.22 7.72 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.102 1.319 . . . . 0.0 112.479 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -62.78 -23.56 67.28 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.835 2.454 . . . . 0.0 112.654 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.408 HG21 ' H ' ' A' ' 148' ' ' GLU . 1.5 t -141.77 -33.09 0.51 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.215 1.406 . . . . 0.0 110.79 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 106.99 0.64 35.98 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.963 1.744 . . . . 0.0 110.371 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.408 ' H ' HG21 ' A' ' 146' ' ' THR . 77.3 mt-10 -63.89 113.07 3.21 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.434 1.617 . . . . 0.0 110.415 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.3 mt -71.57 139.31 20.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 103.66 -2.719 . . . . 0.0 103.66 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 15.0 t -103.3 -36.16 4.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 123.748 0.819 . . . . 0.0 110.71 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -147.43 126.94 13.22 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 119.199 0.908 . . . . 0.0 109.057 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -108.05 104.68 14.17 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.115 1.766 . . . . 0.0 108.424 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.33 150.76 46.98 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.193 0.997 . . . . 0.0 109.362 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -97.41 -22.81 16.39 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 118.271 2.693 . . . . 0.0 118.271 -178.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 10.5 t -96.67 -43.03 7.73 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 120.559 1.527 . . . . 0.0 112.091 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 76.9 mt -83.24 72.43 10.17 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 41.9 t -137.96 138.12 44.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -141.56 153.51 44.88 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.364 1.465 . . . . 0.0 108.33 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -109.88 127.92 55.02 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.508 1.523 . . . . 0.0 110.513 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -90.66 -71.16 0.64 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -133.59 160.66 24.08 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 124.137 0.875 . . . . 0.0 111.759 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -130.36 90.6 40.91 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 126.167 1.787 . . . . 0.0 107.879 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 54.6 Cg_endo -75.95 -175.55 2.56 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 124.471 3.447 . . . . 0.0 110.288 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -110.75 161.19 16.03 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.915 0.886 . . . . 0.0 110.314 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.15 -29.55 57.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.731 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -99.11 133.79 42.89 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.6 p -67.18 -26.43 36.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 122.917 0.487 . . . . 0.0 110.349 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -74.0 -16.19 61.07 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.145 1.778 . . . . 0.0 112.548 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -91.94 -13.69 30.74 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.63 1.572 . . . . 0.0 108.744 177.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -107.15 175.25 5.56 Favored 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 126.961 2.104 . . . . 0.0 107.786 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -148.07 152.34 37.2 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -138.6 165.52 26.68 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.784 1.234 . . . . 0.0 107.819 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -139.37 122.59 16.97 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.477 1.111 . . . . 0.0 109.296 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 25.7 tp -88.89 100.16 12.96 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 54.1 mt -106.29 -179.55 3.97 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.281 2.233 . . . . 0.0 110.504 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -156.54 151.8 26.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.137 0.975 . . . . 0.0 109.035 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -134.32 -174.54 3.59 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.066 1.746 . . . . 0.0 106.621 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -54.87 -31.4 59.7 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.997 2.119 . . . . 0.0 112.035 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 73.0 t -69.81 -67.53 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -177.61 -163.6 29.71 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -78.19 160.95 27.68 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.421 0.688 . . . . 0.0 109.397 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -165.84 168.4 15.97 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.27 1.428 . . . . 0.0 109.453 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.0 mt -117.45 124.85 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.3 t -102.16 133.44 47.01 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -137.04 111.57 8.63 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.6 tt -101.1 127.82 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 5.8 mt -120.39 114.13 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.29 1.036 . . . . 0.0 111.522 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.0 -172.81 27.64 Favored Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 125.17 1.367 . . . . 0.0 111.455 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.2 t 84.57 58.52 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 128.242 2.617 . . . . 0.0 110.808 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -110.23 -127.4 5.28 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 107.656 -2.178 . . . . 0.0 107.656 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -126.82 118.79 25.34 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 19.1 mm -59.82 134.53 25.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 18.9 p -89.25 106.73 18.63 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -63.66 -12.22 32.18 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 119.104 0.865 . . . . 0.0 110.385 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 29.0 t -60.73 -42.01 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 126.937 2.095 . . . . 0.0 109.767 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 3.5 p -125.23 -24.06 4.05 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.856 0.753 . . . . 0.0 112.504 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 87.51 29.31 22.08 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 108.499 -1.84 . . . . 0.0 108.499 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -108.15 164.55 12.2 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 122.545 1.165 . . . . 0.0 111.283 178.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -91.51 138.41 31.59 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 1.8 mtt85 -70.69 29.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 129.921 3.288 . . . . 0.0 112.784 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 16.0 ptt? -72.46 148.81 44.77 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.018 0.913 . . . . 0.0 110.552 -174.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -115.91 143.39 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.369 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -108.26 133.61 52.25 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.41 110.17 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -95.21 108.4 20.53 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.656 0.782 . . . . 0.0 109.814 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -84.68 126.85 33.73 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.054 0.542 . . . . 0.0 109.726 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 32.3 m -139.27 175.65 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 125.877 1.671 . . . . 0.0 112.315 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.9 t -93.0 126.16 37.94 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.533 1.533 . . . . 0.0 107.563 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.12 164.82 44.57 Favored Glycine 0 N--CA 1.467 0.756 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -54.12 -76.12 0.2 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 125.094 1.33 . . . . 0.0 110.394 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 47.8 m -70.85 145.73 50.08 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 34.0 p30 -117.26 33.26 5.71 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 29.6 m -134.78 47.33 2.38 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.733 1.213 . . . . 0.0 113.433 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -153.54 165.71 31.53 Favored Glycine 0 CA--C 1.524 0.615 0 O-C-N 120.451 -1.405 . . . . 0.0 110.333 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -70.82 163.99 37.18 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.038 1.825 . . . . 0.0 110.327 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 14.1 p -67.24 155.83 37.86 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.236 1.014 . . . . 0.0 109.137 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -169.02 159.42 9.25 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.67 1.188 . . . . 0.0 108.711 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.6 mp -76.74 134.03 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -78.11 -55.34 5.36 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 125.973 1.709 . . . . 0.0 109.934 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . 0.402 ' CE3' ' CD ' ' A' ' 222' ' ' ARG . 27.9 p-90 -145.69 165.05 29.9 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 124.755 1.222 . . . . 0.0 108.686 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 39.0 t -144.47 127.39 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.402 ' CD ' ' CE3' ' A' ' 220' ' ' TRP . 0.3 OUTLIER -153.82 118.69 5.01 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 124.107 0.879 . . . . 0.0 109.189 179.355 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -74.64 95.2 2.79 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 102.626 -3.102 . . . . 0.0 102.626 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.7 p -63.73 -57.77 8.95 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.81 0.844 . . . . 0.0 111.69 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -100.87 -178.51 3.79 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.4 mp -58.2 -41.55 81.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 O-C-N 121.79 -0.569 . . . . 0.0 110.022 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -123.52 -10.1 7.93 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -177.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 59.0 t -91.74 130.5 40.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -123.38 143.51 50.07 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.218 1.007 . . . . 0.0 108.354 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -127.3 140.92 51.87 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 125.609 1.564 . . . . 0.0 107.451 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -139.7 159.04 43.09 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.272 1.829 . . . . 0.0 108.042 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -131.48 144.62 51.28 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 99.6 t -132.55 133.44 59.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.2 p -104.66 141.0 37.22 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 43.6 mt -137.36 137.12 21.55 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -72.99 -39.28 2.35 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.065 1.843 . . . . 0.0 112.127 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -60.52 -34.61 74.35 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.587 0.63 . . . . 0.0 111.338 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 5.1 mp -59.45 -29.95 68.15 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-O 118.745 -0.645 . . . . 0.0 111.428 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 57.2 m -63.57 -19.35 64.75 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.935 0.894 . . . . 0.0 112.618 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -67.46 -38.58 84.66 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.169 0.588 . . . . 0.0 111.086 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 49.6 mt -67.0 117.45 9.08 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.352 1.061 . . . . 0.0 108.539 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -48.36 -37.87 17.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.347 1.459 . . . . 0.0 114.874 -178.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 17.9 mt -62.72 -33.55 75.35 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.578 -0.702 . . . . 0.0 110.015 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -98.21 2.42 48.35 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.986 2.115 . . . . 0.0 113.064 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -81.48 49.41 1.3 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.534 1.134 . . . . 0.0 107.998 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -155.17 140.11 17.29 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 131.383 3.873 . . . . 0.0 106.478 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -167.77 167.96 12.76 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 127.859 2.463 . . . . 0.0 106.209 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -142.75 55.92 1.41 Allowed 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 27.1 t70 . . . . . 0 C--O 1.252 1.209 0 O-C-N 120.872 -1.143 . . . . 0.0 109.882 179.264 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.768 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -111.19 165.9 11.53 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.728 1.611 . . . . 0.0 110.496 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.0 p -98.52 -29.56 13.02 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.664 0.786 . . . . 0.0 110.699 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -145.7 119.52 9.27 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 72.0 m -53.67 -52.88 58.57 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.462 0.705 . . . . 0.0 111.361 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -53.24 -46.25 69.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.802 1.241 . . . . 0.0 111.409 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -58.79 -51.04 71.68 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 122.797 0.439 . . . . 0.0 110.246 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.9 p -62.82 -39.82 95.51 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 117.652 0.206 . . . . 0.0 111.221 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.68 -45.21 91.13 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.479 -0.763 . . . . 0.0 108.971 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 45.8 tp -58.42 -44.79 89.22 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.707 1.203 . . . . 0.0 108.434 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 11.5 mt -64.05 -54.92 26.59 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.238 1.015 . . . . 0.0 110.184 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.3 m -57.14 -44.24 83.19 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.03 -1.044 . . . . 0.0 110.784 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -62.31 -50.46 71.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 120.977 -1.077 . . . . 0.0 108.441 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.0 m -56.0 -40.77 73.85 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.144 0.977 . . . . 0.0 110.477 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 13.6 tp -62.29 -53.33 56.64 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.726 0.694 . . . . 0.0 109.136 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.34 -48.33 80.9 Favored 'General case' 0 C--N 1.335 -0.064 0 C-N-CA 123.43 0.692 . . . . 0.0 110.616 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -60.86 -42.88 98.73 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.374 1.47 . . . . 0.0 110.269 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.11 -47.11 85.13 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 94.5 t -57.87 -53.07 50.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 118.566 1.183 . . . . 0.0 110.125 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -31.4 72.55 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 119.177 0.899 . . . . 0.0 110.488 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.6 m -65.75 -48.11 72.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 40.8 mt -58.78 -53.02 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 C-N-CA 123.886 0.875 . . . . 0.0 108.805 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.47 -36.57 73.92 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.326 0.512 . . . . 0.0 111.31 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -63.58 -54.5 35.0 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.536 1.062 . . . . 0.0 108.318 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.21 10.59 0.55 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 128.399 2.68 . . . . 0.0 114.825 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.6 mt -132.68 -32.85 1.25 Allowed 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 124.636 1.174 . . . . 0.0 108.278 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -61.39 -34.43 75.33 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -59.14 -45.05 91.95 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.92 1.688 . . . . 0.0 111.922 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -166.72 153.04 8.52 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.593 1.957 . . . . 0.0 109.683 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.0 m -76.48 174.76 9.9 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 27.5 pt -131.66 152.16 36.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -146.75 165.05 30.82 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 122.91 0.484 . . . . 0.0 110.786 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -150.34 128.48 11.95 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.539 1.536 . . . . 0.0 110.595 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -94.27 102.8 14.82 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.463 1.105 . . . . 0.0 109.707 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.77 66.87 6.16 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.52 -115.47 7.67 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -63.6 -35.26 79.92 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.325 1.05 . . . . 0.0 112.213 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -107.14 153.45 22.63 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 119.211 0.914 . . . . 0.0 110.502 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.2 mt -119.92 152.68 22.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -124.97 132.47 53.27 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 127.182 2.193 . . . . 0.0 107.31 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -126.96 132.93 50.71 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 125.87 1.668 . . . . 0.0 107.376 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -129.49 111.52 12.84 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 6.6 m -100.37 159.0 30.92 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 123.814 0.846 . . . . 0.0 111.236 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -61.46 92.97 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 124.442 3.428 . . . . 0.0 114.121 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 54.95 39.28 67.97 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.062 -0.854 . . . . 0.0 112.217 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.4 mt -109.9 -66.94 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -171.32 161.34 6.47 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.982 1.713 . . . . 0.0 106.917 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -119.91 121.7 39.6 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 101.625 -3.472 . . . . 0.0 101.625 177.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.1 m -137.39 155.06 31.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 123.506 0.722 . . . . 0.0 111.725 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -119.91 132.6 55.59 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 177.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -146.34 158.19 43.86 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.235 1.014 . . . . 0.0 113.032 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -88.8 148.46 23.9 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 165.64 -162.93 36.3 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.95 147.04 50.81 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 124.497 1.119 . . . . 0.0 108.186 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.2 p -152.81 162.74 2.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 124.988 1.315 . . . . 0.0 107.813 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -105.82 107.41 18.39 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.923 1.689 . . . . 0.0 107.122 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.1 t -62.49 -22.47 66.29 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 121.051 1.751 . . . . 0.0 110.827 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -58.1 -25.18 61.04 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.515 1.526 . . . . 0.0 114.154 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.9 t -146.68 -23.6 0.42 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.33 0.968 . . . . 0.0 111.558 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 101.52 6.91 49.71 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.863 1.697 . . . . 0.0 110.052 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -67.26 114.85 6.31 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 118.897 1.349 . . . . 0.0 110.927 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 56.3 mt -71.74 158.34 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 19.4 t -135.58 -34.67 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 O-C-N 120.955 -1.091 . . . . 0.0 110.998 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -131.4 122.96 27.21 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 104.262 -2.496 . . . . 0.0 104.262 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -141.33 54.51 1.54 Allowed 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.163 1.385 . . . . 0.0 111.27 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -59.46 120.62 9.71 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.225 1.41 . . . . 0.0 110.196 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -69.87 1.86 4.01 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.22 -10.24 59.64 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.357 -1.465 . . . . 0.0 112.699 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 43.3 mt -136.45 77.97 1.68 Allowed 'General case' 0 C--O 1.231 0.096 0 C-N-CA 124.053 0.941 . . . . 0.0 108.733 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 12.2 t -140.91 135.44 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.924 1.29 . . . . 0.0 109.351 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -119.64 176.27 5.46 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.735 1.214 . . . . 0.0 110.972 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -128.31 120.31 26.82 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 26.2 mt -96.77 -67.37 0.85 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.738 1.215 . . . . 0.0 109.807 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -127.25 149.2 17.73 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.406 ' HB3' ' HB3' ' A' ' 189' ' ' SER . 26.7 tttp -124.89 83.54 59.59 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 125.969 1.708 . . . . 0.0 108.261 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -75.58 173.61 14.2 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.403 2.069 . . . . 0.0 109.928 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -92.89 161.57 14.43 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.554 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -80.68 -22.98 39.91 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.742 0.817 . . . . 0.0 112.929 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -112.35 147.51 36.22 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.157 0.983 . . . . 0.0 108.456 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.2 p -71.25 -32.14 46.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -74.14 -12.87 60.72 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -177.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -84.68 -18.67 34.56 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.474 0.309 . . . . 0.0 110.289 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -111.84 171.84 7.25 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.662 1.185 . . . . 0.0 111.983 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -138.69 117.14 12.03 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.445 1.098 . . . . 0.0 109.471 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -96.76 158.29 15.5 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -130.55 126.6 37.18 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.081 0.553 . . . . 0.0 112.159 -177.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.2 tt -90.28 101.8 14.52 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.332 0.653 . . . . 0.0 110.504 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 5.2 mt -115.03 174.81 5.79 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.87 1.668 . . . . 0.0 108.333 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -143.02 163.96 31.37 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 120.345 -1.472 . . . . 0.0 109.069 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -137.94 -176.38 4.41 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.902 1.681 . . . . 0.0 110.388 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -69.39 5.28 1.37 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.401 1.88 . . . . 0.0 115.076 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 41.5 t -118.9 -63.98 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -162.51 -160.86 11.47 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 119.812 1.187 . . . . 0.0 111.888 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -91.13 160.85 15.36 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -164.84 171.88 13.61 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 7.4 mt -121.07 133.57 67.28 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 4.4 t -111.13 132.11 54.55 Favored 'General case' 0 N--CA 1.439 -1.002 0 O-C-N 124.579 1.175 . . . . 0.0 108.752 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -133.64 111.57 10.72 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.8 tt -96.79 132.78 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.5 mt -124.32 111.4 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 124.501 1.121 . . . . 0.0 111.03 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -103.34 -158.54 25.01 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 162' ' ' LYS . 1.6 t 70.69 28.29 3.5 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 127.062 2.145 . . . . 0.0 112.286 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -81.28 -90.45 0.56 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 103.611 -3.796 . . . . 0.0 103.611 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -157.14 165.97 34.54 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 29.2 mm -94.36 145.5 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 126.235 1.814 . . . . 0.0 108.448 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.8 p -107.71 98.41 8.01 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 106.114 -1.809 . . . . 0.0 106.114 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -63.22 -7.62 6.42 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 120.28 1.4 . . . . 0.0 112.444 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 86.0 t -63.65 -38.43 82.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 126.499 1.92 . . . . 0.0 108.147 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 21.0 p -119.45 -32.5 4.32 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.213 1.005 . . . . 0.0 110.539 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 88.72 32.95 10.47 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -118.01 -176.93 3.15 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.643 1.577 . . . . 0.0 109.116 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -102.89 148.34 25.77 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.878 0.871 . . . . 0.0 110.228 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.04 29.62 0.08 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 129.317 3.047 . . . . 0.0 111.312 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -72.74 151.48 42.12 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 120.819 -1.176 . . . . 0.0 110.967 -174.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.3 p -121.95 149.12 25.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.771 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -114.95 130.35 56.9 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.6 mp -117.63 111.91 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -96.04 108.39 20.8 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.651 1.18 . . . . 0.0 108.835 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -87.83 121.15 29.9 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.115 0.966 . . . . 0.0 111.677 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.71 163.86 36.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 126.085 1.754 . . . . 0.0 111.002 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.17 139.8 40.01 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -94.85 178.23 36.11 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -89.77 -39.14 6.29 Favored Glycine 0 CA--C 1.525 0.699 0 O-C-N 121.909 -0.759 . . . . 0.0 111.513 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.8 t -82.62 94.8 7.61 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -77.64 39.8 0.28 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.066 0.546 . . . . 0.0 111.246 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 41.0 p -156.7 26.26 0.33 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -138.18 176.99 20.39 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 118.676 0.671 . . . . 0.0 112.562 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.47 164.33 28.7 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.298 2.666 . . . . 0.0 112.098 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 8.6 t -70.91 159.58 34.41 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.89 161.85 7.22 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 126.079 1.752 . . . . 0.0 107.452 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.8 mp -82.2 130.08 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -71.15 -59.22 2.89 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.539 1.135 . . . . 0.0 110.351 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 29.6 p-90 -143.55 166.04 25.92 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 125.244 1.418 . . . . 0.0 108.552 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 42.7 t -145.55 127.74 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.82 118.23 8.48 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 177.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -77.81 91.27 4.1 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 101.002 -3.703 . . . . 0.0 101.002 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.7 p -56.75 -53.13 61.37 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.871 1.669 . . . . 0.0 113.513 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.453 ' HB2' ' H ' ' A' ' 228' ' ' VAL . 71.6 mmtt -116.14 176.63 5.01 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 16.9 mm -61.72 -30.52 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -122.69 -24.28 4.92 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.453 ' H ' ' HB2' ' A' ' 225' ' ' LYS . 21.8 t -90.28 135.67 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -131.81 142.13 49.64 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -127.17 140.04 52.53 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 125.111 1.364 . . . . 0.0 108.615 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -140.72 159.12 42.88 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.462 1.505 . . . . 0.0 109.042 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -130.56 139.63 50.46 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 79.7 t -122.06 146.74 26.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 124.503 1.121 . . . . 0.0 108.313 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.52 130.4 54.23 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 123.122 0.569 . . . . 0.0 109.98 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 63.4 mt -132.19 137.94 31.18 Favored Pre-proline 0 C--O 1.236 0.383 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.193 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -74.89 -44.88 0.32 Allowed 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.188 1.926 . . . . 0.0 112.478 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.84 -25.76 21.15 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.681 1.192 . . . . 0.0 113.261 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 88.6 mt -67.49 -34.38 77.02 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-N 118.651 0.659 . . . . 0.0 112.762 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 19.0 m -57.66 -17.75 16.6 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.879 1.272 . . . . 0.0 114.312 -178.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -64.12 -29.02 70.17 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.941 -0.475 . . . . 0.0 110.363 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 30.0 mt -80.29 113.44 18.47 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -49.61 -30.74 9.31 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 17.5 mt -62.74 -36.18 82.18 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.756 -0.59 . . . . 0.0 109.535 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -95.28 2.96 54.96 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 126.888 2.075 . . . . 0.0 114.586 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -73.09 59.68 0.53 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.58 1.952 . . . . 0.0 109.101 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -134.1 153.23 51.94 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 128.757 2.823 . . . . 0.0 109.804 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 39.9 m-20 53.0 36.05 21.03 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.135 2.174 . . . . 0.0 111.557 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -112.79 -3.39 14.2 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 129.363 3.065 . . . . 0.0 111.797 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 . . . . . 0 C--O 1.245 0.853 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.16 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.185 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.35 164.32 30.16 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.3 p -141.14 104.83 4.71 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 58.77 10.58 1.52 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.6 m -49.77 -49.05 49.9 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 125.146 1.378 . . . . 0.0 111.945 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -62.69 -15.07 50.85 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -91.18 -53.7 4.25 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.4 p -59.34 -36.46 75.74 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.858 -0.591 . . . . 0.0 110.774 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.48 -45.56 92.48 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.001 0.819 . . . . 0.0 110.03 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.7 tp -60.95 -40.66 94.16 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 118.947 0.794 . . . . 0.0 109.449 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.4 mt -60.65 -54.38 46.02 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 55.9 m -54.2 -44.88 72.0 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.499 1.12 . . . . 0.0 111.534 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.2 ttmt -62.78 -50.99 68.85 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 m -56.88 -42.91 80.68 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 117.815 -1.088 . . . . 0.0 111.156 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 20.9 tp -62.66 -53.48 53.93 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 119.881 1.219 . . . . 0.0 109.504 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -55.38 -52.41 63.62 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 123.91 0.884 . . . . 0.0 111.198 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -55.22 -50.48 69.31 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 125.008 1.323 . . . . 0.0 108.496 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.05 -50.27 67.57 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 123.91 0.767 . . . . 0.0 112.081 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 89.9 t -59.18 -53.23 50.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 124.215 1.006 . . . . 0.0 110.136 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -30.86 71.9 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 118.983 0.811 . . . . 0.0 110.6 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.4 m -66.49 -45.15 80.6 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 31.0 mt -58.28 -53.84 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.21 -37.59 83.53 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.183 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -60.74 -44.46 96.63 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.215 1.006 . . . . 0.0 109.472 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.86 -19.29 44.81 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 71.0 mt -100.74 -25.06 14.26 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 121.132 1.787 . . . . 0.0 112.793 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -59.36 -21.12 59.37 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -71.2 -46.09 61.98 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.77 2.428 . . . . 0.0 110.542 179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -162.28 153.29 17.68 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 125.558 1.543 . . . . 0.0 112.456 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.6 m -76.36 159.92 30.06 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 175.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 24.7 pt -117.63 154.64 19.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -147.09 165.86 28.66 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.294 0.569 . . . . 0.0 111.217 -178.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -151.1 134.56 16.23 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.094 1.357 . . . . 0.0 109.555 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -97.45 105.39 17.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 123.52 0.728 . . . . 0.0 109.813 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.84 67.33 9.79 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.104 1.361 . . . . 0.0 107.609 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 69.76 -115.18 6.07 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -66.83 -32.4 73.66 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.028 1.331 . . . . 0.0 112.679 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -106.09 162.84 13.26 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 119.036 0.835 . . . . 0.0 111.89 -177.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 45.3 mt -130.66 149.43 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -125.49 129.81 50.53 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.182 2.193 . . . . 0.0 108.255 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -125.98 129.6 49.54 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.333 1.853 . . . . 0.0 109.392 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -124.03 117.16 24.08 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.941 1.696 . . . . 0.0 109.666 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 19.8 m -99.35 159.7 29.43 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.574 1.15 . . . . 0.0 111.056 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -62.78 87.24 0.11 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 124.797 3.665 . . . . 0.0 113.687 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 57.61 45.77 92.85 Favored Glycine 0 CA--C 1.527 0.814 0 O-C-N 121.201 -0.937 . . . . 0.0 112.0 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.5 mt -118.26 -66.74 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 118.607 1.203 . . . . 0.0 108.435 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -166.02 159.81 15.93 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 126.954 2.102 . . . . 0.0 107.885 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -123.92 117.65 25.27 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 102.072 -3.307 . . . . 0.0 102.072 177.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.0 m -128.9 156.24 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.43 1.092 . . . . 0.0 111.979 -178.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -127.26 127.51 44.5 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 178.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -146.4 159.4 43.43 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.201 1.4 . . . . 0.0 113.04 -178.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -88.7 153.58 20.98 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 177.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 163.2 -163.81 35.7 Favored Glycine 0 C--O 1.241 0.579 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.53 139.28 53.33 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 126.102 1.761 . . . . 0.0 106.607 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.5 p -146.12 147.56 18.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.56 96.44 10.08 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 104.274 -2.491 . . . . 0.0 104.274 178.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.5 t -54.12 -24.75 18.92 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 120.436 1.471 . . . . 0.0 111.126 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -59.91 -22.74 62.81 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 129.59 3.156 . . . . 0.0 114.7 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.4 t -142.96 -24.14 0.62 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.488 1.115 . . . . 0.0 111.036 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 100.4 -3.9 56.68 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 127.105 2.288 . . . . 0.0 111.737 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -70.41 115.68 9.87 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 124.12 0.968 . . . . 0.0 112.998 -178.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.66 140.11 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 39.7 t -99.71 -43.18 11.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 124.751 1.22 . . . . 0.0 108.095 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -167.32 161.13 14.04 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 126.025 1.73 . . . . 0.0 108.009 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -150.47 168.25 24.75 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.64 1.976 . . . . 0.0 106.756 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -121.54 154.09 37.13 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -93.38 -10.68 34.41 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.432 0.693 . . . . 0.0 110.911 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.29 -24.78 32.05 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.968 -1.082 . . . . 0.0 113.097 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.5 mt -117.88 80.93 1.58 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.146 1.378 . . . . 0.0 109.252 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.3 t -142.73 142.41 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 123.508 0.723 . . . . 0.0 109.88 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -139.95 159.26 42.59 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.367 1.467 . . . . 0.0 109.197 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.2 124.99 51.64 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.99 -62.54 1.54 Allowed 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 124.631 1.172 . . . . 0.0 109.557 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -139.92 158.29 25.66 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.9 ttpp -126.03 89.7 51.79 Favored Pre-proline 0 N--CA 1.452 -0.334 0 C-N-CA 124.875 1.27 . . . . 0.0 108.467 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -75.4 177.36 8.75 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.982 2.455 . . . . 0.0 109.502 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -91.63 155.57 18.24 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 121.788 -0.57 . . . . 0.0 111.588 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.42 -24.15 61.19 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 125.036 1.334 . . . . 0.0 113.277 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -109.61 148.49 31.21 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.753 1.621 . . . . 0.0 108.777 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.1 p -73.32 -32.87 39.16 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 C-N-CA 121.987 0.115 . . . . 0.0 111.267 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -72.95 -21.98 60.78 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 120.454 -1.404 . . . . 0.0 113.465 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -79.68 -17.72 53.01 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.295 0.638 . . . . 0.0 111.626 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.96 176.56 5.23 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.245 1.018 . . . . 0.0 111.15 178.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -146.76 137.1 23.67 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.712 1.205 . . . . 0.0 108.612 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -127.05 159.67 33.44 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.706 2.803 . . . . 0.0 106.777 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -136.08 131.65 35.12 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.276 0.63 . . . . 0.0 112.165 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 35.2 tp -85.23 101.65 12.68 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.613 1.565 . . . . 0.0 108.413 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 27.8 mt -113.55 -179.15 3.56 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.605 1.562 . . . . 0.0 109.603 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -153.46 158.07 40.82 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 52.4 p30 -134.8 -173.37 3.28 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 127.596 2.358 . . . . 0.0 107.094 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.55 -22.76 66.15 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.107 -1.621 . . . . 0.0 113.469 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 74.6 t -78.31 -53.48 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 178.3 -163.09 30.9 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-O 122.023 0.791 . . . . 0.0 112.368 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -82.7 159.9 22.49 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -167.43 165.83 14.68 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.939 0.896 . . . . 0.0 109.684 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 5.8 mt -109.92 136.47 45.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 177.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -110.96 116.74 31.73 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 125.106 1.362 . . . . 0.0 107.818 -179.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -116.3 108.67 16.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.2 tt -99.65 140.19 19.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.5 mt -135.66 107.43 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 124.335 1.054 . . . . 0.0 111.153 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -101.45 -157.19 26.87 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 18.1 m 68.23 34.26 3.98 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.759 0.424 . . . . 0.0 112.075 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -89.84 -96.34 1.12 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 103.812 -3.715 . . . . 0.0 103.812 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -150.54 170.58 18.79 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.99 1.716 . . . . 0.0 107.575 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 23.5 mm -100.64 123.06 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 126.365 1.866 . . . . 0.0 107.946 178.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 8.1 m -88.1 94.39 9.79 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 101.505 -3.517 . . . . 0.0 101.505 177.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -57.89 -15.63 9.26 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 3.1 m -55.91 -35.62 41.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.003 0.921 . . . . 0.0 108.87 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 75.0 p -114.87 -24.45 8.65 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.569 1.148 . . . . 0.0 110.275 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 81.91 34.44 24.39 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -129.85 169.68 14.87 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.052 1.341 . . . . 0.0 110.939 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -83.02 145.76 29.12 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 12.2 ttt85 -76.82 29.17 0.13 Allowed 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 129.913 3.285 . . . . 0.0 112.384 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -72.19 144.1 48.64 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 122.351 1.072 . . . . 0.0 111.959 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -110.8 155.67 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 113.489 -1.687 . . . . 0.0 111.493 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -123.87 128.46 49.52 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.021 1.728 . . . . 0.0 106.972 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.5 mp -118.09 119.79 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 124.968 1.307 . . . . 0.0 107.723 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -102.5 113.81 27.48 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -94.1 116.75 29.21 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 33.6 m -126.4 169.35 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 125.298 1.439 . . . . 0.0 112.096 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -85.48 135.78 33.7 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 177.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -101.56 156.08 18.91 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 118.936 0.789 . . . . 0.0 111.608 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -51.01 -68.21 1.6 Allowed Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.902 1.715 . . . . 0.0 112.145 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 13.3 p -75.66 80.24 2.64 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 117.913 0.856 . . . . 0.0 108.776 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -67.46 36.23 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.132 2.573 . . . . 0.0 115.777 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 14.3 m -148.05 46.65 1.08 Allowed 'General case' 0 CA--C 1.536 0.408 0 O-C-N 119.932 -1.73 . . . . 0.0 113.093 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -148.28 -178.58 23.54 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.63 164.9 32.79 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.862 2.375 . . . . 0.0 110.417 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 60.6 p -81.42 151.95 27.65 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.934 0.894 . . . . 0.0 108.706 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.32 163.6 17.57 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.274 1.429 . . . . 0.0 107.454 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.3 mp -77.36 130.07 36.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -72.38 -61.07 1.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.968 1.707 . . . . 0.0 110.222 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -142.26 167.85 21.14 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 125.689 1.596 . . . . 0.0 108.804 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.404 HG12 ' CE1' ' A' ' 229' ' ' TYR . 28.7 t -145.69 137.63 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.97 117.8 3.3 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -77.16 92.7 3.83 Favored 'General case' 0 C--N 1.328 -0.357 1 N-CA-C 99.715 -4.18 . . . . 0.0 99.715 177.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 2.0 p -58.42 -61.38 2.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.875 1.27 . . . . 0.0 112.348 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -98.78 -172.72 2.36 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 28.2 mm -63.25 -46.1 96.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 O-C-N 121.256 -0.902 . . . . 0.0 111.089 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 9.1 t -109.72 -16.89 13.81 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 16.2 t -87.32 140.56 15.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 123.928 0.891 . . . . 0.0 108.874 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . 0.404 ' CE1' HG12 ' A' ' 221' ' ' VAL . 2.3 t80 -133.78 140.64 47.07 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.126 0.971 . . . . 0.0 109.038 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -127.98 138.48 52.63 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.02 161.44 39.39 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.524 1.529 . . . . 0.0 109.71 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -133.46 149.85 51.75 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 123.334 0.654 . . . . 0.0 110.355 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 60.5 t -128.29 144.98 36.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 125.511 1.524 . . . . 0.0 107.554 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.66 133.03 56.43 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 83.0 mt -134.75 137.58 27.76 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.056 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.34 -43.19 1.1 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.169 2.579 . . . . 0.0 112.708 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -57.76 -33.78 68.85 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.072 0.549 . . . . 0.0 111.081 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 55.6 mt -61.81 -33.79 74.76 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.891 0.769 . . . . 0.0 111.898 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 53.1 m -61.84 -17.16 55.32 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.017 0.927 . . . . 0.0 113.133 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -69.31 -17.98 63.77 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 123.923 0.889 . . . . 0.0 112.896 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 45.1 mt -90.74 120.73 32.02 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 126.235 1.814 . . . . 0.0 107.017 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.14 -41.79 49.53 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.898 1.279 . . . . 0.0 113.055 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 31.7 mt -56.39 -34.8 67.04 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.416 0.687 . . . . 0.0 110.193 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -100.88 4.53 42.8 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 126.791 2.036 . . . . 0.0 113.84 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -77.69 45.22 0.49 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -158.39 144.76 17.27 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 128.694 2.797 . . . . 0.0 107.593 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -167.91 178.38 5.2 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 127.079 2.152 . . . . 0.0 107.043 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 58.34 -19.96 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 118.842 2.904 . . . . 0.0 118.842 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 38.1 t70 . . . . . 0 N--CA 1.482 1.16 0 C-N-CA 131.267 3.827 . . . . 0.0 110.142 179.544 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.797 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.01 157.64 45.94 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 126.293 1.837 . . . . 0.0 107.975 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.9 m -60.7 -32.17 71.41 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.185 0.594 . . . . 0.0 112.101 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -82.51 24.83 0.67 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 117.385 -1.293 . . . . 0.0 113.537 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.0 m -47.5 -43.21 24.36 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 121.522 1.964 . . . . 0.0 111.956 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -56.83 -38.47 72.67 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.282 1.033 . . . . 0.0 112.75 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -63.26 -44.75 94.25 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.6 m -63.14 -42.8 99.54 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.7 -39.11 87.33 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-N 118.622 0.646 . . . . 0.0 109.841 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.9 tp -64.6 -44.89 89.16 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mt -59.11 -51.07 71.62 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.0 m -55.17 -44.75 75.52 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.34 1.056 . . . . 0.0 111.083 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -67.23 -51.17 56.48 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 121.548 -0.72 . . . . 0.0 110.232 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 21.8 m -54.82 -42.07 71.43 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 118.153 -0.927 . . . . 0.0 110.506 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.8 tp -61.01 -56.15 24.43 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 120.051 1.296 . . . . 0.0 110.034 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -57.23 -49.49 75.85 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.987 0.812 . . . . 0.0 111.602 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -56.85 -44.48 82.2 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.334 0.654 . . . . 0.0 109.269 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.52 -47.2 89.25 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 79.7 t -58.18 -52.99 51.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.671 1.189 . . . . 0.0 109.838 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -31.1 72.05 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.14 0.882 . . . . 0.0 110.315 178.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -68.53 -47.96 65.56 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 24.3 mt -57.06 -54.72 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 123.075 0.55 . . . . 0.0 109.583 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.52 -41.24 80.45 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 124.188 0.93 . . . . 0.0 110.23 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -64.64 -43.98 91.96 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.079 0.466 . . . . 0.0 111.894 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.31 -13.08 61.05 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 73.9 mt -106.75 -26.85 11.12 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 119.488 1.04 . . . . 0.0 111.945 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -57.15 -28.19 62.52 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.178 0.591 . . . . 0.0 111.625 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -68.52 -45.88 71.07 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.342 1.457 . . . . 0.0 111.096 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -161.07 149.55 16.08 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.978 1.311 . . . . 0.0 109.896 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 60.3 m -75.38 163.16 27.72 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 177.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 28.2 pt -118.24 148.7 20.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.8 154.58 44.34 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 122.673 0.389 . . . . 0.0 110.689 -177.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -143.13 124.96 15.07 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 124.439 1.096 . . . . 0.0 110.143 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -87.63 102.86 15.03 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.6 67.32 6.41 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.52 -115.95 6.26 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -66.4 -33.15 75.08 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.479 0.712 . . . . 0.0 112.59 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -106.64 160.29 15.56 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 122.153 0.977 . . . . 0.0 110.947 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.0 mt -124.57 147.99 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 178.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -121.64 134.53 54.99 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -130.49 125.25 33.88 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 126.629 1.972 . . . . 0.0 108.221 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -126.39 119.07 26.35 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 125.043 1.337 . . . . 0.0 109.799 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 12.5 m -102.88 160.52 25.97 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 124.76 1.224 . . . . 0.0 113.229 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.88 80.64 0.64 Allowed 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 124.47 3.447 . . . . 0.0 113.506 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.76 52.19 35.66 Favored Glycine 0 C--O 1.237 0.324 0 O-C-N 121.546 -0.721 . . . . 0.0 111.505 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.3 mt -129.17 -67.09 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -174.41 160.19 3.17 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.17 1.388 . . . . 0.0 108.987 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.91 120.23 38.51 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 176.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.18 154.86 40.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 118.758 0.708 . . . . 0.0 111.083 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -123.04 130.32 52.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 127.897 2.479 . . . . 0.0 106.579 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -146.37 156.92 43.67 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.357 1.063 . . . . 0.0 110.198 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 56.3 t60 -89.2 153.83 20.62 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 156.21 -164.14 32.26 Favored Glycine 0 CA--C 1.523 0.537 0 O-C-N 120.829 -1.169 . . . . 0.0 111.59 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.16 150.05 45.61 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 124.388 1.075 . . . . 0.0 110.517 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.96 156.81 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.091 1.357 . . . . 0.0 108.205 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -101.39 99.2 9.51 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.138 1.775 . . . . 0.0 107.869 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.6 t -52.79 -23.32 6.63 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.158 1.383 . . . . 0.0 112.714 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -64.44 -27.25 68.86 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.7 t -146.55 -10.32 0.47 Allowed 'General case' 0 CA--C 1.539 0.536 0 O-C-N 124.401 1.063 . . . . 0.0 111.557 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.69 36.41 16.34 Favored Glycine 0 C--N 1.339 0.739 0 O-C-N 121.076 -1.015 . . . . 0.0 110.993 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -107.24 133.18 52.19 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.886 1.275 . . . . 0.0 107.786 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.5 mt -70.73 149.2 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 67.3 t -100.95 -35.14 4.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 123.935 0.894 . . . . 0.0 112.048 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -141.74 139.01 32.75 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -118.37 73.98 0.93 Allowed 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 124.953 1.301 . . . . 0.0 107.89 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -71.87 136.9 47.12 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.995 1.318 . . . . 0.0 109.832 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -96.62 -4.24 41.42 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.788 1.235 . . . . 0.0 111.993 178.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 2.5 t -72.51 -42.57 64.68 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.701 1.137 . . . . 0.0 111.653 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 84.3 mt -115.03 87.48 2.66 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 123.873 0.869 . . . . 0.0 111.14 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 9.8 t -136.69 152.8 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.802 1.241 . . . . 0.0 108.585 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -145.44 171.8 14.12 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 126.286 1.835 . . . . 0.0 110.112 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -125.9 125.59 43.04 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.118 1.767 . . . . 0.0 109.55 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 22.1 mt -102.89 -72.83 0.68 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.227 1.011 . . . . 0.0 109.395 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -124.0 149.18 16.88 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -132.37 89.14 37.6 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.01 0.924 . . . . 0.0 110.443 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -77.5 -179.15 5.16 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 125.049 3.833 . . . . 0.0 113.293 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -90.05 161.67 15.71 Favored 'General case' 0 C--O 1.231 0.084 0 C-N-CA 124.069 0.948 . . . . 0.0 110.211 178.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.19 -24.81 57.87 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -118.99 157.91 26.82 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 123.629 0.771 . . . . 0.0 109.331 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 5.2 p -73.97 -33.02 35.21 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 C-N-CA 124.633 1.173 . . . . 0.0 112.095 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -75.13 -7.05 52.69 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.22 1.808 . . . . 0.0 112.93 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -94.2 -14.99 25.0 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.115 1.366 . . . . 0.0 109.708 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -124.35 179.32 4.96 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 128.665 2.786 . . . . 0.0 112.811 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -138.17 166.76 23.35 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.414 2.286 . . . . 0.0 107.817 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -141.06 159.34 42.42 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.864 2.066 . . . . 0.0 107.612 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -124.38 124.54 42.58 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.755 1.222 . . . . 0.0 111.309 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 21.6 tp -90.02 100.77 13.53 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 22.6 mt -107.21 -178.72 3.72 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.308 1.843 . . . . 0.0 108.754 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -158.81 159.89 35.62 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.61 -175.67 4.03 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -48.2 -35.78 12.48 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.979 1.711 . . . . 0.0 111.307 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 60.0 t -77.77 -67.63 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 126.193 1.797 . . . . 0.0 111.27 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -167.46 -170.22 32.0 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -178.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -78.81 152.79 31.15 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.469 1.108 . . . . 0.0 112.037 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -162.49 156.56 21.15 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.005 1.322 . . . . 0.0 109.971 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 7.4 mt -102.04 140.08 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 4.3 t -121.98 136.35 54.92 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -142.62 119.18 11.01 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 176.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.8 tt -97.28 140.39 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.7 mt -130.51 112.59 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 O-C-N 120.742 -1.224 . . . . 0.0 110.161 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.18 -155.57 25.83 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 107.89 -2.084 . . . . 0.0 107.89 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 49.1 m 73.16 44.43 0.33 Allowed 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.095 1.358 . . . . 0.0 108.586 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -99.91 -121.9 4.74 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 125.158 1.361 . . . . 0.0 110.026 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -136.29 122.61 20.58 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.368 1.867 . . . . 0.0 108.774 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 14.1 mm -60.95 136.57 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 119.736 1.153 . . . . 0.0 110.155 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 28.5 p -90.58 111.58 22.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -68.13 -10.69 56.02 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 120.475 1.489 . . . . 0.0 110.391 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 40.6 t -60.33 -45.33 96.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 126.709 2.004 . . . . 0.0 108.808 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 1.3 p -125.41 -20.57 4.75 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 92.49 10.31 60.69 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.75 2.119 . . . . 0.0 112.255 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -94.32 169.66 10.06 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.544 1.138 . . . . 0.0 112.157 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -88.28 156.08 19.38 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 122.159 0.981 . . . . 0.0 109.707 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -79.52 30.21 0.24 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 128.97 2.908 . . . . 0.0 111.286 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 1.9 ptm -72.39 150.46 43.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.958 0.885 . . . . 0.0 110.428 -175.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.1 p -120.23 149.01 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 114.341 -1.3 . . . . 0.0 111.699 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -112.77 127.92 56.28 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.945 1.698 . . . . 0.0 106.853 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.1 mp -119.93 115.97 49.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.248 1.019 . . . . 0.0 108.454 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -101.19 116.43 32.79 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.338 0.655 . . . . 0.0 110.64 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -92.4 114.41 26.95 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.047 1.339 . . . . 0.0 110.104 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 27.4 m -127.38 172.28 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 126.197 1.799 . . . . 0.0 111.801 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -85.7 142.65 28.87 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -113.55 144.88 18.27 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-O 118.583 -1.12 . . . . 0.0 110.878 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -32.94 -73.98 0.07 OUTLIER Glycine 0 C--N 1.337 0.631 0 C-N-CA 128.724 3.059 . . . . 0.0 113.233 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 39.6 t -70.72 94.09 0.99 Allowed 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -74.39 21.12 0.11 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.312 1.845 . . . . 0.0 111.667 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 37.5 m -135.82 40.48 2.74 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.909 1.684 . . . . 0.0 112.578 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -150.94 166.95 30.5 Favored Glycine 0 CA--C 1.526 0.748 0 O-C-N 120.682 -1.261 . . . . 0.0 111.505 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.46 167.03 25.21 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.492 2.128 . . . . 0.0 112.128 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 51.0 m -76.87 155.19 33.1 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.979 178.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.0 p -162.05 163.63 28.63 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 126.55 1.94 . . . . 0.0 107.216 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.3 mp -81.45 129.23 37.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -79.23 -47.08 16.59 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.493 0.717 . . . . 0.0 112.635 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 40.0 p-90 -151.99 166.98 29.87 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 46.8 t -144.77 138.92 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 C-N-CA 125.719 1.608 . . . . 0.0 106.808 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.96 134.34 4.27 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.621 0.724 . . . . 0.0 112.104 177.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -86.96 93.11 9.25 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 78.2 p -67.53 -56.42 9.57 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.576 0.703 . . . . 0.0 110.693 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -95.03 -175.04 3.41 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.983 1.713 . . . . 0.0 107.591 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.6 mp -74.71 -39.17 46.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 O-C-N 121.713 -0.617 . . . . 0.0 109.706 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 5.4 m -115.69 -18.91 10.73 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 3.5 t -85.13 152.82 3.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -135.41 139.85 44.48 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.604 1.162 . . . . 0.0 108.585 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -120.84 135.43 55.17 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.035 1.334 . . . . 0.0 108.57 -178.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -138.46 161.13 37.8 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.93 1.692 . . . . 0.0 109.751 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -138.53 144.13 39.8 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 66.6 t -131.72 133.55 61.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 125.624 1.57 . . . . 0.0 109.449 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.9 p -99.49 146.6 26.19 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 13.4 mt -142.99 136.18 13.96 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.277 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -72.55 -44.69 0.68 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.433 2.089 . . . . 0.0 111.492 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -58.93 -20.82 55.61 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.13 0.972 . . . . 0.0 112.289 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 2.2 mp -71.69 -39.16 70.39 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.783 0.833 . . . . 0.0 108.987 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 29.2 m -58.3 -30.5 66.7 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.453 1.501 . . . . 0.0 111.979 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -60.2 -38.17 82.5 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.577 0.351 . . . . 0.0 110.788 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 23.8 mt -72.64 117.04 13.83 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -47.92 -34.34 8.91 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -177.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 20.1 mt -64.13 -40.86 97.08 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.941 0.792 . . . . 0.0 110.661 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 4.8 mp -99.58 9.38 43.28 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 125.295 1.438 . . . . 0.0 113.798 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -72.05 48.3 0.17 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.533 1.933 . . . . 0.0 111.231 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -130.69 142.82 50.44 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 127.707 2.403 . . . . 0.0 108.029 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 81.51 4.99 1.34 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.635 2.774 . . . . 0.0 114.054 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.7 7.63 4.44 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.933 2.093 . . . . 0.0 109.965 177.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 38.5 t70 . . . . . 0 C--O 1.245 0.849 0 C-N-CA 126.688 1.995 . . . . 0.0 111.978 -179.458 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.965 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.11 2.09 16.22 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.327 1.451 . . . . 0.0 113.228 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.6 m -126.94 144.71 50.92 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.366 1.866 . . . . 0.0 107.211 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -144.57 145.25 31.71 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.649 1.98 . . . . 0.0 108.562 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.7 m -65.17 -44.54 88.17 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.483 1.513 . . . . 0.0 113.357 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.57 -32.69 74.22 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.394 -0.816 . . . . 0.0 111.139 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -64.46 -39.14 93.25 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.81 -41.74 91.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 118.702 0.683 . . . . 0.0 109.681 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.57 -40.57 95.8 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.2 tp -62.22 -45.69 92.2 Favored 'General case' 0 C--O 1.221 -0.396 0 C-N-CA 124.31 1.044 . . . . 0.0 109.148 178.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 mt -59.66 -51.3 70.37 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.173 0.989 . . . . 0.0 109.457 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.1 m -55.0 -55.48 30.43 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.553 1.141 . . . . 0.0 109.626 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -61.23 -46.33 90.87 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.12 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.1 m -52.23 -51.71 56.69 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 119.608 1.095 . . . . 0.0 110.196 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.2 tp -56.56 -55.31 35.5 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 119.229 0.922 . . . . 0.0 108.826 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.61 -49.6 67.48 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.803 1.241 . . . . 0.0 113.507 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -42.2 93.36 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.914 1.686 . . . . 0.0 108.525 179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.39 -50.23 69.91 Favored Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.84 -53.14 49.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 118.793 1.297 . . . . 0.0 111.109 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -31.78 72.0 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.206 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 m -66.08 -48.23 71.65 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 27.1 mt -58.36 -54.64 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.733 0.813 . . . . 0.0 110.318 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.77 -31.8 71.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 123.036 0.21 . . . . 0.0 111.525 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -73.64 -46.62 45.6 Favored 'General case' 0 C--O 1.225 -0.211 0 O-C-N 121.526 -0.734 . . . . 0.0 109.059 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.18 5.18 5.74 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.692 1.997 . . . . 0.0 113.887 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.3 mt -123.42 -30.43 3.66 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 125.516 1.526 . . . . 0.0 109.199 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -62.01 -28.5 69.62 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.158 0.435 . . . . 0.0 109.961 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -62.89 -47.16 84.51 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.706 0.802 . . . . 0.0 109.262 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -164.35 150.29 10.7 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.275 1.83 . . . . 0.0 109.883 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 64.2 m -75.27 171.75 13.65 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.3 pt -128.39 147.66 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 O-C-N 121.395 -0.815 . . . . 0.0 110.318 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.84 167.91 20.96 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.565 0.746 . . . . 0.0 110.894 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -153.71 124.88 7.41 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.65 1.58 . . . . 0.0 110.594 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -87.04 102.31 14.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.14 67.36 6.91 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.149 1.78 . . . . 0.0 109.608 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.8 -115.26 4.66 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -73.29 -27.77 61.73 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.245 1.818 . . . . 0.0 112.883 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -107.66 161.85 14.5 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 118.945 0.793 . . . . 0.0 110.293 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 24.1 mt -128.23 141.01 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 104.154 -2.535 . . . . 0.0 104.154 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -116.73 135.18 53.98 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 124.786 1.234 . . . . 0.0 107.776 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.38 130.44 46.03 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.625 1.57 . . . . 0.0 108.488 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -128.24 121.73 30.05 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.615 1.166 . . . . 0.0 110.622 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 4.2 m -108.73 159.19 31.85 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 123.956 0.902 . . . . 0.0 112.231 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -65.7 95.13 0.28 Allowed 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 125.259 3.973 . . . . 0.0 114.562 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 57.94 39.69 92.15 Favored Glycine 0 CA--C 1.525 0.67 0 O-C-N 121.554 -0.716 . . . . 0.0 111.636 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.8 mt -115.16 -65.17 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.43 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 5.7 pt-20 179.4 169.51 1.05 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.894 2.078 . . . . 0.0 108.695 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.45 124.6 40.5 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.9 m -135.01 156.95 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 125.479 1.511 . . . . 0.0 111.189 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -124.03 133.63 53.61 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 103.327 -2.842 . . . . 0.0 103.327 176.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -146.25 156.62 43.51 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.902 0.881 . . . . 0.0 110.575 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -89.47 153.82 20.51 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 155.68 -162.82 31.4 Favored Glycine 0 CA--C 1.519 0.292 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.95 152.59 50.1 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.251 1.02 . . . . 0.0 108.355 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 93.3 t -120.34 145.88 26.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 124.408 1.083 . . . . 0.0 109.559 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -93.61 94.92 8.89 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 178.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 8.9 t -47.2 -26.53 1.2 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.837 1.655 . . . . 0.0 113.801 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -52.03 -38.17 56.04 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 119.066 0.848 . . . . 0.0 111.632 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.2 t -147.02 -10.67 0.44 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 99.67 7.72 53.09 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.316 1.436 . . . . 0.0 112.344 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -62.46 135.86 57.63 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 119.494 1.647 . . . . 0.0 110.307 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 38.0 mm -73.6 134.35 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.5 t -93.32 -23.74 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.074 0.95 . . . . 0.0 112.065 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -145.72 109.09 4.66 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? -89.11 17.06 6.23 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.677 1.591 . . . . 0.0 114.147 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -44.31 133.36 5.5 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.047 1.339 . . . . 0.0 111.578 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -95.0 6.01 50.31 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 74.6 m -81.74 -3.39 53.63 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.7 mt -144.83 77.23 1.52 Allowed 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.2 143.26 28.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 124.74 1.216 . . . . 0.0 108.186 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -134.88 155.65 50.32 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.785 1.234 . . . . 0.0 109.256 178.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 28.9 ttp180 -97.06 130.23 44.39 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 128.021 2.528 . . . . 0.0 108.331 -178.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 27.5 mt -112.54 -69.88 0.84 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.415 1.007 . . . . 0.0 108.666 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -139.58 141.8 12.08 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-O 121.446 0.47 . . . . 0.0 112.979 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -110.88 92.9 15.71 Favored Pre-proline 0 N--CA 1.447 -0.582 0 C-N-CA 127.366 2.266 . . . . 0.0 110.637 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 75.5 Cg_endo -75.53 -177.16 3.36 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.646 2.897 . . . . 0.0 109.358 178.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -96.81 157.96 15.65 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.14 -26.51 56.39 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 124.901 1.376 . . . . 0.0 114.15 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -108.97 139.63 43.57 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 124.164 0.986 . . . . 0.0 108.466 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.4 p -62.97 -31.04 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -61.88 -26.7 68.31 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.727 1.611 . . . . 0.0 112.542 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -94.6 -2.33 51.62 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -79.62 163.56 24.5 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.434 -0.791 . . . . 0.0 110.297 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -137.58 95.1 3.0 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -102.35 160.2 14.75 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -135.63 143.86 45.77 Favored 'General case' 0 C--O 1.227 -0.11 0 C-N-CA 124.304 1.042 . . . . 0.0 110.221 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 36.3 tp -110.07 97.85 7.26 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.48 174.23 5.96 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.411 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 6.1 p90 -150.67 162.63 40.31 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 121.401 -0.812 . . . . 0.0 110.486 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -140.71 -175.3 4.24 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.4 1.062 . . . . 0.0 109.185 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -57.04 -20.3 23.84 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.155 1.382 . . . . 0.0 113.991 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 97.4 t -81.09 -65.66 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 178.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 175.57 -170.16 43.09 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.411 ' CD2' ' HB3' ' A' ' 176' ' ' TYR . 15.6 m-85 -78.52 159.13 28.35 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.721 0.772 . . . . 0.0 109.911 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -156.21 176.2 12.98 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.53 1.932 . . . . 0.0 106.805 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 18.8 mt -121.1 114.46 43.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 4.7 t -90.46 141.58 28.6 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.423 ' HG2' ' HH ' ' A' ' 206' ' ' TYR . 1.8 tp10 -146.29 107.01 4.09 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.6 tt -98.68 140.44 18.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.9 mt -133.97 113.71 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 123.869 0.868 . . . . 0.0 110.847 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -107.85 -156.73 19.5 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 124.754 1.169 . . . . 0.0 110.275 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 68.5 m 73.09 37.55 0.76 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.775 1.23 . . . . 0.0 109.983 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -94.16 -108.35 2.04 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 126.858 2.17 . . . . 0.0 108.336 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -140.07 120.99 14.54 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.638 1.175 . . . . 0.0 107.921 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 17.7 mm -60.58 121.59 8.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 124.336 1.054 . . . . 0.0 109.272 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 77.6 m -82.22 96.42 7.85 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 125.735 1.614 . . . . 0.0 109.923 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.09 -18.47 58.09 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -59.3 -31.48 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.674 1.189 . . . . 0.0 110.76 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 44.8 p -125.07 -35.0 2.7 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.777 0.831 . . . . 0.0 111.799 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.92 32.93 5.7 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 126.43 1.966 . . . . 0.0 110.779 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -124.13 171.12 10.05 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.372 1.869 . . . . 0.0 112.174 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -83.33 148.7 27.19 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 122.322 1.058 . . . . 0.0 110.439 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -82.98 30.77 0.44 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 130.8 3.64 . . . . 0.0 109.251 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.5 ptt? -74.28 150.83 40.03 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.688 1.195 . . . . 0.0 110.334 -175.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -113.32 146.79 17.49 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.355 -177.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -114.42 116.39 28.81 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.8 mp -106.26 130.66 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -117.85 103.76 10.28 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.719 0.807 . . . . 0.0 110.108 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . 0.423 ' HH ' ' HG2' ' A' ' 185' ' ' GLU . 43.4 m-85 -83.02 125.31 31.3 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 15.5 m -135.96 171.09 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.44 1.496 . . . . 0.0 110.974 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 2.1 t -81.61 140.5 34.39 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -118.43 109.21 1.73 Allowed Glycine 0 C--N 1.34 0.752 0 CA-C-O 117.836 -1.536 . . . . 0.0 113.217 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 4.71 -92.15 0.0 OUTLIER Glycine 0 C--N 1.34 0.803 0 C-N-CA 129.626 3.489 . . . . 0.0 114.07 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.0 100.0 0.39 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -72.11 29.13 0.05 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.486 1.914 . . . . 0.0 113.169 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 14.8 t -119.29 47.2 1.73 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.685 1.994 . . . . 0.0 114.19 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -166.08 162.99 36.5 Favored Glycine 0 C--N 1.339 0.717 0 C-N-CA 118.014 -2.041 . . . . 0.0 117.523 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -66.64 164.81 27.59 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.355 2.704 . . . . 0.0 110.321 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 28.8 m -64.47 155.46 32.66 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.473 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -168.88 157.16 7.94 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 126.025 1.73 . . . . 0.0 108.111 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.9 mt -83.38 133.81 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -74.95 -55.27 5.94 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 125.061 1.345 . . . . 0.0 111.772 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 52.1 p-90 -149.94 165.93 31.15 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.218 1.407 . . . . 0.0 108.347 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.401 ' CG2' ' HH ' ' A' ' 229' ' ' TYR . 39.6 t -148.34 130.42 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 125.198 1.399 . . . . 0.0 107.62 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.37 140.65 16.59 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -92.16 90.23 7.24 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 102.365 -3.198 . . . . 0.0 102.365 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 2.0 p -61.31 -65.15 0.74 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.767 1.627 . . . . 0.0 110.747 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -86.88 -172.59 4.06 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.6 mp -58.97 -41.53 83.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 118.322 -0.846 . . . . 0.0 110.163 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 7.3 m -129.86 -8.91 4.45 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 25.1 t -71.87 121.72 22.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 103.927 -2.62 . . . . 0.0 103.927 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . 0.401 ' HH ' ' CG2' ' A' ' 221' ' ' VAL . 1.0 OUTLIER -110.17 124.63 51.9 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 179.323 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -114.33 135.16 54.38 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -139.79 158.29 44.33 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.04 1.736 . . . . 0.0 109.621 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -130.69 146.21 52.12 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 85.1 t -131.95 135.48 58.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.77 138.25 40.65 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.726 0.81 . . . . 0.0 110.376 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 48.4 mt -139.81 137.05 17.91 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 124.052 0.941 . . . . 0.0 109.594 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.59 -32.77 2.67 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.722 2.948 . . . . 0.0 113.11 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -69.19 -23.81 63.96 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.717 1.207 . . . . 0.0 112.146 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 37.4 mt -66.28 -36.54 83.24 Favored 'General case' 0 C--O 1.226 -0.139 0 O-C-N 121.238 -0.914 . . . . 0.0 110.292 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 3.7 m -56.39 -19.23 13.85 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.893 1.277 . . . . 0.0 113.553 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -62.85 -31.98 73.12 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.23 1.412 . . . . 0.0 110.358 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 26.8 mt -84.11 120.14 25.82 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.44 -37.8 57.74 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.715 0.689 . . . . 0.0 112.072 -178.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 6.0 mp -57.6 -38.84 75.59 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.485 -0.76 . . . . 0.0 111.248 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -97.35 6.08 48.85 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.071 1.748 . . . . 0.0 111.675 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -79.21 64.96 4.25 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -139.81 153.39 47.08 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 126.783 2.033 . . . . 0.0 108.302 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 62.04 7.44 2.13 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.42 1.488 . . . . 0.0 114.61 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -73.48 -4.56 34.54 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 128.91 2.884 . . . . 0.0 112.303 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 C--O 1.251 1.161 0 C-N-CA 127.973 2.509 . . . . 0.0 113.315 -178.601 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.895 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.64 170.34 5.25 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.843 0.857 . . . . 0.0 112.103 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.3 m 61.84 70.42 0.59 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.871 2.069 . . . . 0.0 111.908 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -145.25 146.85 31.85 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.594 -0.691 . . . . 0.0 111.121 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 68.1 m -54.95 -39.86 69.37 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 126.755 2.022 . . . . 0.0 113.409 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -64.03 -20.25 65.78 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 121.853 -0.529 . . . . 0.0 112.316 -178.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -70.57 -43.11 70.13 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.7 m -66.43 -41.51 89.09 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.036 0.934 . . . . 0.0 108.896 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.93 -45.81 89.48 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 66.7 tp -62.62 -41.34 98.95 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.413 0.685 . . . . 0.0 110.272 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.8 mt -60.08 -54.28 47.8 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.983 0.913 . . . . 0.0 109.762 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 45.2 m -56.21 -51.79 66.78 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.228 1.011 . . . . 0.0 110.748 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -58.03 -49.55 76.47 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.7 m -53.94 -49.55 68.45 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 118.425 -0.798 . . . . 0.0 110.598 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.2 tp -56.77 -54.91 40.83 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.967 0.803 . . . . 0.0 109.579 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -55.29 -53.64 53.62 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.684 0.793 . . . . 0.0 111.492 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -57.37 -33.51 67.88 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.315 1.446 . . . . 0.0 110.363 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -69.43 -53.38 17.41 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.4 t -56.55 -52.1 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 118.799 1.3 . . . . 0.0 111.706 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -37.24 79.76 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 118.89 -0.576 . . . . 0.0 110.779 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.4 m -67.43 -48.11 68.23 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 43.8 mt -53.5 -52.97 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 123.978 0.911 . . . . 0.0 109.575 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.54 -39.45 83.99 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 122.187 0.195 . . . . 0.0 111.234 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -69.73 -33.93 73.17 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.294 -0.879 . . . . 0.0 111.461 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.24 10.25 15.25 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.569 1.548 . . . . 0.0 112.239 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.3 mt -133.35 -33.35 1.12 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.841 1.256 . . . . 0.0 110.557 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -56.26 -31.23 63.39 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 123.693 0.797 . . . . 0.0 111.57 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -69.47 -45.96 67.79 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 118.668 -0.682 . . . . 0.0 112.465 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -157.26 143.65 18.0 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 125.336 1.454 . . . . 0.0 108.244 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 30.5 m -75.87 172.08 13.31 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 122.906 0.482 . . . . 0.0 110.959 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 25.6 pt -125.9 154.91 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.591 1.156 . . . . 0.0 111.418 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.62 167.69 21.64 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.738 0.815 . . . . 0.0 109.956 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -150.53 117.75 6.0 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.772 1.629 . . . . 0.0 109.935 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -82.54 102.14 11.19 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.0 66.8 3.62 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.474 -0.766 . . . . 0.0 110.472 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.19 -113.06 3.74 Favored Glycine 0 C--N 1.339 0.697 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -77.39 -38.33 50.11 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -106.65 126.44 52.28 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.874 1.215 . . . . 0.0 113.503 -178.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.0 mt -90.6 147.8 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -115.11 135.8 53.81 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 178.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.72 123.91 27.14 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.789 1.236 . . . . 0.0 109.337 -177.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -126.8 119.51 27.05 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.824 1.249 . . . . 0.0 111.743 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 1.4 m -100.62 160.81 25.85 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 125.391 1.477 . . . . 0.0 112.477 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -64.13 88.86 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 124.249 3.299 . . . . 0.0 112.288 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 53.48 57.46 15.49 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 123.934 0.778 . . . . 0.0 111.274 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 15.6 mt -124.94 -65.67 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.445 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 15.6 pt-20 -176.15 168.92 2.86 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 127.621 2.368 . . . . 0.0 109.677 177.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -123.52 124.15 42.2 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.5 155.76 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.301 1.041 . . . . 0.0 112.256 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -119.82 126.24 50.51 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -146.48 157.67 43.78 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.093 0.861 . . . . 0.0 112.065 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -88.68 148.63 23.91 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 160.32 -162.17 33.09 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 108.871 -1.691 . . . . 0.0 108.871 -177.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.4 ttm-85 -125.63 164.15 21.22 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.34 1.456 . . . . 0.0 111.104 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 84.5 t -137.27 135.17 47.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -81.13 89.82 6.01 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 127.925 2.49 . . . . 0.0 107.737 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.9 t -54.3 -17.2 2.7 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.697 1.199 . . . . 0.0 113.714 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -64.11 -24.28 67.64 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 120.902 -1.124 . . . . 0.0 112.681 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 t -142.9 -31.1 0.51 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.673 0.789 . . . . 0.0 110.455 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 106.34 19.61 9.82 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 125.503 1.525 . . . . 0.0 111.3 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -85.27 155.75 21.24 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 119.289 1.544 . . . . 0.0 111.461 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.6 mp -71.79 154.54 7.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 123.853 0.861 . . . . 0.0 108.801 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.3 p -162.91 157.94 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.507 1.523 . . . . 0.0 108.733 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 12.7 t30 24.94 83.34 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 129.753 3.221 . . . . 0.0 113.213 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.97 177.77 5.17 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.934 1.294 . . . . 0.0 112.886 -178.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.23 142.58 39.93 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 125.531 1.532 . . . . 0.0 107.157 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -95.58 0.7 53.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 111.344 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 t -86.28 -10.67 54.1 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.666 1.586 . . . . 0.0 111.789 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 76.6 mt -128.82 79.21 1.9 Allowed 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.8 t -135.84 142.54 38.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.534 1.134 . . . . 0.0 108.054 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -137.61 158.62 43.99 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 126.348 1.859 . . . . 0.0 109.049 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -113.01 130.43 56.14 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.437 1.095 . . . . 0.0 110.196 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.96 -75.19 0.53 Allowed 'General case' 0 C--O 1.226 -0.153 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -134.68 152.39 20.68 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 116.255 -0.43 . . . . 0.0 112.73 -178.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -116.49 94.39 42.93 Favored Pre-proline 0 N--CA 1.453 -0.32 0 C-N-CA 125.271 1.428 . . . . 0.0 108.601 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 88.1 Cg_endo -73.48 -175.82 2.21 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.343 2.695 . . . . 0.0 109.555 178.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.442 ' HE2' ' OE2' ' A' ' 169' ' ' GLU . 25.3 mmmt -97.53 161.1 13.94 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.16 0.584 . . . . 0.0 112.238 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -78.26 -24.21 46.96 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.87 1.668 . . . . 0.0 113.362 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -116.37 147.75 41.3 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.5 p -73.06 -27.23 24.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -79.68 -12.73 59.8 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.296 0.639 . . . . 0.0 112.445 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.442 ' OE2' ' HE2' ' A' ' 164' ' ' LYS . 4.3 mm-40 -79.62 -21.5 44.84 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.865 0.466 . . . . 0.0 110.864 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -107.3 172.1 7.01 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.744 1.618 . . . . 0.0 110.652 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -134.29 131.31 38.26 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 124.186 0.994 . . . . 0.0 109.434 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -107.86 162.29 14.14 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -130.11 120.86 25.28 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.056 -1.028 . . . . 0.0 109.738 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 48.4 tp -87.24 100.6 12.81 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 39.5 mt -105.32 -179.21 3.88 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 126.207 1.803 . . . . 0.0 109.972 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -157.09 157.07 33.87 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 124.458 1.103 . . . . 0.0 109.596 177.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -137.51 -179.36 5.69 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.143 2.177 . . . . 0.0 108.604 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -58.53 -26.41 63.49 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.445 1.098 . . . . 0.0 113.533 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 59.8 t -79.62 -62.81 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -172.99 -164.41 28.34 Favored Glycine 0 C--N 1.339 0.725 0 CA-C-N 119.031 0.832 . . . . 0.0 111.366 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -78.21 166.38 22.8 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.193 -0.593 . . . . 0.0 109.982 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -167.62 162.09 13.97 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.508 1.523 . . . . 0.0 108.145 178.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 3.6 mt -113.97 121.43 66.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.154 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.2 t -95.96 135.03 38.25 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -138.57 133.63 32.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 178.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.9 tt -121.45 141.37 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 124.679 1.191 . . . . 0.0 109.072 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.4 mt -137.14 115.14 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 122.596 0.358 . . . . 0.0 111.705 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -103.74 -166.96 25.28 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 126.497 1.999 . . . . 0.0 110.125 178.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 69.3 m 73.23 60.41 0.1 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.624 1.569 . . . . 0.0 109.056 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -108.13 -95.58 2.4 Favored Glycine 0 CA--C 1.519 0.286 0 N-CA-C 104.513 -3.435 . . . . 0.0 104.513 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -155.59 125.23 6.41 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 18.0 mm -60.25 121.29 7.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.2 99.94 10.27 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 125.839 1.656 . . . . 0.0 110.153 -178.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -60.94 -20.49 62.28 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.364 0.602 . . . . 0.0 111.51 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.5 m -57.18 -32.64 41.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.642 1.577 . . . . 0.0 112.235 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 67.0 p -125.17 -29.22 3.32 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.078 1.351 . . . . 0.0 112.017 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 88.22 32.37 12.34 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -178.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -126.82 -179.72 4.96 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.915 1.686 . . . . 0.0 111.322 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -91.86 148.15 22.44 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.298 0.639 . . . . 0.0 109.496 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 45.2 ttm-85 -79.32 30.12 0.23 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.287 2.635 . . . . 0.0 109.729 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.7 ptm -72.87 153.96 40.8 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 122.064 0.935 . . . . 0.0 110.075 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 6.0 p -122.97 148.93 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 113.876 -1.511 . . . . 0.0 113.696 -176.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -114.09 137.46 51.7 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.5 mp -126.03 118.41 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 127.516 2.326 . . . . 0.0 107.921 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -106.88 104.28 13.92 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.554 1.141 . . . . 0.0 110.42 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -80.95 129.53 34.58 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 120.523 -1.361 . . . . 0.0 111.8 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 33.9 m -137.8 172.15 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.643 1.177 . . . . 0.0 112.634 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.4 137.64 37.35 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.176 0.991 . . . . 0.0 108.352 178.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -105.38 117.95 5.69 Favored Glycine 0 C--N 1.332 0.352 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -42.34 -46.8 5.56 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 126.239 1.876 . . . . 0.0 113.283 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.463 ' C ' ' H ' ' A' ' 213' ' ' SER . 1.8 p -76.45 80.73 3.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -65.02 21.46 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 130.317 3.447 . . . . 0.0 113.329 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 211' ' ' SER . 23.4 t -142.49 47.24 1.58 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 129.567 3.147 . . . . 0.0 107.642 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -149.61 159.3 28.02 Favored Glycine 0 C--N 1.34 0.771 0 O-C-N 119.668 -1.895 . . . . 0.0 114.6 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.93 173.47 13.51 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.851 3.034 . . . . 0.0 111.015 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 49.0 m -75.28 152.13 38.26 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -168.39 152.59 5.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 178.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.1 mt -78.66 134.68 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -77.63 -51.81 10.03 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.007 0.923 . . . . 0.0 111.794 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 55.9 p-90 -149.66 165.55 31.99 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.244 1.418 . . . . 0.0 108.439 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 24.5 t -147.42 134.16 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 126.228 1.811 . . . . 0.0 106.883 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.68 124.75 6.15 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 177.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -78.96 86.99 4.79 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 103.517 -2.771 . . . . 0.0 103.517 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 8.6 p -53.14 -52.55 58.34 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.904 1.682 . . . . 0.0 112.606 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -107.05 -177.36 3.34 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . 0.253 2.6 mp -68.24 -18.95 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 118.882 -1.127 . . . . 0.0 110.603 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -132.31 -39.6 1.03 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.519 1.054 . . . . 0.0 112.614 178.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 11.8 t -63.47 135.3 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.34 139.65 46.96 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.43 1.092 . . . . 0.0 109.9 -178.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -121.03 140.57 51.74 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.478 1.511 . . . . 0.0 111.755 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -142.94 161.31 38.46 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 128.183 2.593 . . . . 0.0 109.723 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -137.22 146.67 45.12 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.034 1.334 . . . . 0.0 107.496 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 98.5 t -131.92 134.68 59.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 125.294 1.438 . . . . 0.0 107.862 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.64 134.56 45.8 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.234 1.014 . . . . 0.0 110.577 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 69.6 mt -131.74 138.47 32.64 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.71 -46.2 0.89 Allowed 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.542 2.828 . . . . 0.0 111.553 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.98 -27.48 66.88 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.947 1.299 . . . . 0.0 111.79 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 3.5 mp -61.68 -31.62 71.77 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 117.871 -1.061 . . . . 0.0 110.477 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 8.3 m -65.64 -19.16 65.8 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.978 1.263 . . . . 0.0 113.158 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -63.54 -29.82 71.02 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.051 0.941 . . . . 0.0 111.419 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 50.7 mt -82.34 113.78 20.36 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -48.2 -31.2 5.47 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 21.2 mt -67.58 -36.5 81.02 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.162 -0.961 . . . . 0.0 110.338 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 17.9 mt -100.06 8.89 43.63 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 127.341 2.256 . . . . 0.0 111.204 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -80.69 68.75 7.04 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 20.6 tptp -144.63 137.88 26.98 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 126.204 1.802 . . . . 0.0 107.858 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . 0.416 ' C ' ' H ' ' A' ' 249' ' ' ASP . 21.0 m120 72.05 29.34 2.37 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 126.12 1.768 . . . . 0.0 112.17 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -73.83 37.48 0.1 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 128.218 2.607 . . . . 0.0 108.971 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . 0.416 ' H ' ' C ' ' A' ' 247' ' ' ASN . 54.2 m-20 . . . . . 0 C--O 1.247 0.922 0 C-N-CA 127.072 2.149 . . . . 0.0 110.046 -177.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.713 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.94 20.92 3.81 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.993 0.917 . . . . 0.0 112.815 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.0 p -156.6 -59.91 0.09 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.245 0.929 . . . . 0.0 112.408 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -75.48 59.06 1.06 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.566 1.146 . . . . 0.0 110.834 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.6 m -47.18 -58.54 3.95 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 126.52 1.928 . . . . 0.0 112.782 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -52.59 -53.04 52.06 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.815 0.734 . . . . 0.0 111.921 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -58.75 -40.46 83.91 Favored 'General case' 0 C--O 1.225 -0.207 0 O-C-N 121.872 -0.517 . . . . 0.0 110.314 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.9 m -65.67 -43.61 88.8 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.15 -45.04 96.3 Favored 'General case' 0 C--N 1.337 0.06 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 67.7 tp -58.3 -44.01 88.37 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.081 -0.961 . . . . 0.0 108.87 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.2 mt -61.24 -53.92 50.66 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.243 0.929 . . . . 0.0 109.388 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 51.6 m -55.13 -48.58 73.48 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.806 0.842 . . . . 0.0 111.198 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -62.87 -46.3 88.51 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 120.403 -1.436 . . . . 0.0 110.214 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 52.9 m -54.18 -46.04 72.28 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.576 1.15 . . . . 0.0 109.915 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 22.0 tp -58.6 -54.08 51.14 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.761 0.709 . . . . 0.0 110.452 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 25.4 t30 -57.47 -46.93 83.12 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.263 0.483 . . . . 0.0 111.526 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -55.52 -46.64 77.01 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.974 0.91 . . . . 0.0 109.169 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.04 -46.47 91.21 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 93.2 t -59.01 -53.22 51.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.047 1.339 . . . . 0.0 110.393 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -32.52 73.49 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.775 1.17 . . . . 0.0 110.16 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.2 m -67.22 -46.46 73.77 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 33.8 mt -59.64 -51.6 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.99 -35.72 77.56 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 118.659 -0.686 . . . . 0.0 110.217 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.27 -48.42 75.79 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 119.708 1.14 . . . . 0.0 110.357 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.14 -27.65 60.95 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 -178.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.8 mp -85.72 -28.37 24.67 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 120.19 1.359 . . . . 0.0 109.336 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -60.53 -19.47 57.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.127 0.571 . . . . 0.0 111.452 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.36 -46.64 54.53 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.19 0.596 . . . . 0.0 110.868 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -165.54 155.63 13.0 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.586 1.554 . . . . 0.0 108.258 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 33.5 m -75.77 162.85 27.83 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.3 pt -117.68 156.23 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.22 163.23 38.23 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 120.712 0.292 . . . . 0.0 111.191 -177.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -152.31 127.63 9.9 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.739 1.616 . . . . 0.0 109.816 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -89.14 104.43 16.98 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.17 67.66 5.9 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.43 -115.03 4.92 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.491 -1.043 . . . . 0.0 110.491 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -73.82 -34.26 64.5 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -106.38 138.2 42.98 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 119.355 0.98 . . . . 0.0 110.976 -178.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.2 mt -102.89 149.69 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -122.24 133.79 54.7 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 126.406 1.882 . . . . 0.0 106.223 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.47 132.72 44.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.101 1.761 . . . . 0.0 107.945 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -126.46 117.84 23.72 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.424 1.089 . . . . 0.0 110.959 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 8.7 m -102.64 155.99 35.84 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.008 0.923 . . . . 0.0 112.924 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.34 92.21 0.28 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 125.069 3.846 . . . . 0.0 116.164 -178.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 62.64 36.27 93.01 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.3 mt -116.68 -66.99 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.418 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 7.2 pt-20 176.96 166.62 0.53 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.075 1.75 . . . . 0.0 109.58 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -117.62 129.63 55.87 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 104.278 -2.49 . . . . 0.0 104.278 177.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.1 m -138.32 155.46 28.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.922 0.889 . . . . 0.0 110.725 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -121.12 131.44 54.25 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -145.96 157.84 43.88 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.418 1.087 . . . . 0.0 111.479 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -88.61 154.27 20.46 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 165.34 -163.66 36.7 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.64 142.04 50.81 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.7 p -152.88 159.19 3.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 118.777 0.717 . . . . 0.0 109.709 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -102.59 112.77 25.67 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.654 1.182 . . . . 0.0 109.466 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.1 t -57.72 -19.09 24.95 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.742 1.155 . . . . 0.0 113.575 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -59.26 -35.43 73.7 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.469 1.108 . . . . 0.0 113.533 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.2 t -143.82 -20.35 0.58 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.489 0.716 . . . . 0.0 111.629 -178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 97.16 17.62 31.46 Favored Glycine 0 C--O 1.223 -0.588 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -71.0 114.55 9.17 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 118.4 1.1 . . . . 0.0 108.281 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 14.1 mt -81.73 120.14 32.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 127.504 2.322 . . . . 0.0 106.672 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 42.2 t -79.47 -81.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 126.038 1.735 . . . . 0.0 108.918 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -78.47 123.99 27.64 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 46.8 mtm105 -117.62 101.68 8.55 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 101.852 -3.388 . . . . 0.0 101.852 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -120.44 112.68 19.27 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.18 1.392 . . . . 0.0 109.995 -177.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -73.08 10.51 0.91 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.138 1.375 . . . . 0.0 113.27 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 3.5 t -89.49 -42.49 11.44 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 120.48 -1.388 . . . . 0.0 111.775 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 23.5 mt -105.94 81.24 1.62 Allowed 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 119.131 0.878 . . . . 0.0 109.491 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.5 p -143.18 152.52 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.848 0.859 . . . . 0.0 109.872 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -142.38 145.56 33.99 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.913 1.685 . . . . 0.0 108.124 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -95.58 135.15 37.62 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.522 1.129 . . . . 0.0 108.676 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.4 mp -102.15 -69.69 0.78 Allowed 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 123.122 0.569 . . . . 0.0 110.486 -178.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -127.96 165.83 20.82 Favored Glycine 0 C--O 1.243 0.681 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -132.32 89.12 37.87 Favored Pre-proline 0 N--CA 1.448 -0.569 0 C-N-CA 125.428 1.491 . . . . 0.0 109.52 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 90.9 Cg_endo -74.93 176.63 9.63 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 123.201 2.601 . . . . 0.0 108.02 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -94.8 155.37 16.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.916 0.865 . . . . 0.0 111.443 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.28 -20.25 61.55 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 126.074 1.75 . . . . 0.0 113.317 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -122.97 136.83 55.01 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.466 1.506 . . . . 0.0 109.91 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.9 p -61.37 -27.76 42.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.536 0.684 . . . . 0.0 110.691 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -71.06 -6.44 39.09 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 127.755 2.422 . . . . 0.0 113.013 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -112.35 -20.11 11.94 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.561 1.144 . . . . 0.0 112.721 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.27 165.78 13.26 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -145.79 112.71 6.04 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -101.56 170.14 8.38 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.999 1.32 . . . . 0.0 110.522 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -131.81 125.82 32.8 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.481 1.512 . . . . 0.0 110.836 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 24.4 tp -86.51 104.46 15.99 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 61.2 mt -107.47 177.0 4.96 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.21 1.404 . . . . 0.0 110.78 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.445 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 12.0 p90 -162.37 166.53 25.03 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 122.813 1.292 . . . . 0.0 110.766 178.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.483 ' CG ' ' H ' ' A' ' 178' ' ' ASP . 27.4 t70 -140.85 177.42 8.05 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 126.125 1.77 . . . . 0.0 106.759 178.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.483 ' H ' ' CG ' ' A' ' 177' ' ' ASP . 6.7 m-20 -59.28 -31.67 69.33 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 125.379 1.471 . . . . 0.0 107.948 177.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 38.7 t -66.1 -62.11 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 125.756 1.623 . . . . 0.0 107.791 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 178.9 -171.97 44.15 Favored Glycine 0 C--N 1.339 0.745 0 C-N-CA 124.392 0.996 . . . . 0.0 113.158 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.445 ' CD2' ' HB3' ' A' ' 176' ' ' TYR . 32.9 m-85 -90.27 155.05 19.27 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.692 1.197 . . . . 0.0 111.789 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -164.87 162.05 20.61 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.416 1.887 . . . . 0.0 109.171 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 8.6 mt -106.3 141.68 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 5.3 t -122.77 132.75 54.36 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -132.9 120.55 21.63 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 177.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.9 tt -105.91 128.0 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 5.5 mt -120.71 107.28 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 124.312 1.045 . . . . 0.0 110.653 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -99.7 -156.62 28.48 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 107.146 -2.382 . . . . 0.0 107.146 177.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 46.8 m 70.22 51.72 0.38 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.547 0.689 . . . . 0.0 110.757 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -115.71 -119.93 3.26 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 107.244 -2.342 . . . . 0.0 107.244 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -129.39 141.75 50.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.544 1.138 . . . . 0.0 108.793 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 24.5 mm -79.55 128.89 38.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 16.7 m -90.53 104.42 17.0 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 101.908 -3.367 . . . . 0.0 101.908 176.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -55.45 -16.04 3.31 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -177.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 3.0 m -59.05 -39.7 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.207 1.003 . . . . 0.0 110.246 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 1.2 p -125.21 -17.95 5.54 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.627 1.103 . . . . 0.0 111.551 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 85.94 5.48 83.52 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.685 0.659 . . . . 0.0 113.549 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -83.93 160.83 21.0 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.271 1.429 . . . . 0.0 108.351 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.415 ' C ' ' H ' ' A' ' 201' ' ' MET . 36.6 mt-10 -86.61 152.11 22.87 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -74.96 29.84 0.09 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 127.415 2.286 . . . . 0.0 109.962 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.415 ' H ' ' C ' ' A' ' 199' ' ' GLU . 6.3 ptt? -72.1 149.3 44.91 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 122.025 0.917 . . . . 0.0 109.838 -175.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.6 p -123.08 144.12 33.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.252 -176.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -108.35 130.18 55.21 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 178.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.1 mp -118.38 112.42 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 124.744 1.217 . . . . 0.0 108.225 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -95.33 116.79 29.25 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -94.53 116.38 28.7 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.326 0.65 . . . . 0.0 110.305 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 32.2 m -126.57 171.61 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 125.518 1.527 . . . . 0.0 111.955 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -85.86 135.8 33.56 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.783 1.633 . . . . 0.0 106.991 177.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -91.57 154.66 22.84 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 119.195 0.907 . . . . 0.0 111.406 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -62.61 -60.79 7.26 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 27.5 p -78.58 74.1 5.12 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -70.23 57.95 0.17 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.94 2.496 . . . . 0.0 112.011 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.36 47.51 0.35 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.984 1.714 . . . . 0.0 110.761 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -165.19 174.25 41.05 Favored Glycine 0 CA--C 1.527 0.788 0 O-C-N 119.736 -1.852 . . . . 0.0 112.159 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -71.73 162.06 43.22 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.438 2.092 . . . . 0.0 110.57 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 7.8 m -73.95 151.04 40.46 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 126.414 1.886 . . . . 0.0 111.034 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -164.85 165.15 20.72 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.735 1.614 . . . . 0.0 108.267 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.4 mp -79.15 128.02 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 177.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . 0.492 ' NE2' ' HG1' ' A' ' 234' ' ' THR . 18.9 mm-40 -72.09 -60.56 2.17 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.847 1.659 . . . . 0.0 109.867 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 28.7 p-90 -140.24 166.56 24.35 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.242 1.417 . . . . 0.0 109.807 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 49.9 t -145.85 133.03 15.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 125.585 1.554 . . . . 0.0 107.012 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.7 127.48 12.56 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.63 0.729 . . . . 0.0 109.362 178.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -79.99 87.88 5.38 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.9 p -57.42 -53.94 52.47 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.227 1.011 . . . . 0.0 112.622 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -119.31 -179.23 3.79 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.7 mp -61.27 -27.18 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.244 1.018 . . . . 0.0 110.838 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.8 t -131.64 -30.89 1.61 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.364 0.666 . . . . 0.0 111.765 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 16.7 t -76.31 135.42 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -129.02 148.35 50.97 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.72 1.608 . . . . 0.0 108.681 -179.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -132.2 136.76 47.26 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 126.524 1.93 . . . . 0.0 107.564 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.72 161.61 38.78 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.751 1.62 . . . . 0.0 110.191 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -134.87 145.19 48.03 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.521 0.729 . . . . 0.0 109.998 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.1 t -124.2 146.12 30.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 125.657 1.583 . . . . 0.0 108.263 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' THR . . . . . 0.492 ' HG1' ' NE2' ' A' ' 219' ' ' GLN . 0.7 OUTLIER -115.87 133.14 56.34 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.924 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 87.9 mt -134.74 135.99 24.47 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 123.828 0.851 . . . . 0.0 108.911 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.29 -42.38 2.0 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.662 2.241 . . . . 0.0 112.554 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -60.64 -24.9 65.91 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.308 0.643 . . . . 0.0 112.113 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 54.6 mt -68.19 -28.14 67.01 Favored 'General case' 0 C--O 1.225 -0.194 0 O-C-N 121.099 -1.0 . . . . 0.0 110.844 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 39.3 m -63.74 -15.76 59.4 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.763 1.225 . . . . 0.0 113.39 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -68.54 -24.08 64.59 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 41.0 mt -85.38 121.99 28.9 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.693 1.597 . . . . 0.0 107.882 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -50.5 -37.21 37.63 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.6 mp -61.02 -38.59 86.62 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.415 -0.803 . . . . 0.0 109.994 178.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.503 ' C ' ' H ' ' A' ' 246' ' ' LYS . 2.6 mm? -91.89 3.04 56.07 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 127.567 2.347 . . . . 0.0 113.226 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -79.89 36.44 0.33 Allowed 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.503 ' H ' ' C ' ' A' ' 244' ' ' LEU . 57.0 tptt -145.83 136.51 24.28 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 129.347 3.059 . . . . 0.0 108.649 -178.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -174.69 158.98 2.78 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 128.887 2.875 . . . . 0.0 106.329 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -156.57 46.92 0.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.113 0.965 . . . . 0.0 109.178 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.171 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.523 0 N-CA-C 107.297 -2.321 . . . . 0.0 107.297 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.58 -31.73 71.8 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.739 1.769 . . . . 0.0 107.702 177.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 59.7 m 43.53 19.06 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 130.037 3.335 . . . . 0.0 118.038 176.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -57.28 -35.63 70.04 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 120.342 1.428 . . . . 0.0 109.775 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.4 m -63.67 -45.39 90.32 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 119.301 0.955 . . . . 0.0 110.349 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -65.79 -35.31 80.34 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.57 1.148 . . . . 0.0 110.594 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -69.53 -55.06 11.25 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.376 1.07 . . . . 0.0 108.311 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.4 p -60.52 -35.83 76.93 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 123.834 0.854 . . . . 0.0 111.307 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.69 -44.61 81.65 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 119.346 0.975 . . . . 0.0 109.71 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 52.0 tp -62.49 -44.89 95.28 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 118.52 -0.752 . . . . 0.0 109.036 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.7 mt -60.78 -48.27 82.57 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.272 0.942 . . . . 0.0 110.539 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 33.0 m -56.46 -56.5 20.39 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.676 1.19 . . . . 0.0 109.335 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.9 ttpp -58.69 -48.22 81.84 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-O 118.948 -0.548 . . . . 0.0 110.4 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.1 m -52.88 -52.95 55.57 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.231 1.012 . . . . 0.0 110.933 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 17.1 tp -57.81 -53.59 56.47 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 118.882 0.765 . . . . 0.0 110.099 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -58.69 -46.72 86.63 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -59.17 -43.44 92.12 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 125.049 1.339 . . . . 0.0 107.832 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.27 -50.53 65.64 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 15.7 t -57.32 -53.49 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 118.69 1.245 . . . . 0.0 110.684 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -32.8 74.22 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.044 0.838 . . . . 0.0 110.979 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.3 m -66.21 -45.71 79.81 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 34.1 mt -60.56 -51.43 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 123.848 0.859 . . . . 0.0 108.79 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.19 -38.97 69.06 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 123.521 0.513 . . . . 0.0 109.978 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -67.58 -54.51 19.22 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 118.808 0.731 . . . . 0.0 110.669 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.11 -17.5 7.32 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 125.874 1.67 . . . . 0.0 114.537 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.6 mp -111.59 -27.86 8.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 119.388 0.995 . . . . 0.0 109.509 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -59.71 -31.07 69.26 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.447 0.567 . . . . 0.0 110.919 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -64.38 -46.04 85.1 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 122.901 0.48 . . . . 0.0 111.348 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -162.95 152.6 15.56 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.996 1.719 . . . . 0.0 110.094 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 55.9 m -75.68 166.79 23.01 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 23.6 pt -125.12 153.29 32.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 124.426 1.091 . . . . 0.0 109.108 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -146.3 168.27 21.5 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.996 -0.44 . . . . 0.0 112.149 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -154.11 121.38 5.74 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.072 0.949 . . . . 0.0 109.665 178.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -81.71 103.96 11.77 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.5 0.72 . . . . 0.0 109.634 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.94 70.83 2.92 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 178.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 67.66 -121.15 14.1 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -69.11 -28.13 66.2 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -107.13 137.5 45.07 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 119.482 1.037 . . . . 0.0 110.056 -178.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.8 mt -112.74 134.13 56.33 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -100.68 129.01 46.53 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 125.124 1.37 . . . . 0.0 107.977 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -123.57 132.5 53.9 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.897 1.279 . . . . 0.0 108.712 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -129.62 112.91 14.17 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.447 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 19.8 m -97.42 159.74 30.44 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-O 118.402 -0.809 . . . . 0.0 111.214 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.2 90.34 0.1 OUTLIER 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 123.989 3.126 . . . . 0.0 113.622 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 56.07 44.69 88.3 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 123.827 0.727 . . . . 0.0 112.751 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 6.5 mt -113.58 -66.89 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.413 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 13.6 pt-20 -171.41 167.56 6.76 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.894 1.278 . . . . 0.0 109.354 178.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.61 122.22 38.32 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 178.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.8 m -137.84 156.5 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -122.09 125.99 47.41 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 177.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -146.91 157.95 43.78 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.442 1.497 . . . . 0.0 110.13 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -88.56 153.25 21.29 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 178.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 174.08 -163.53 34.46 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.241 -1.943 . . . . 0.0 108.241 -178.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.12 137.84 46.45 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.8 146.89 20.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -90.79 98.57 11.85 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.266 1.426 . . . . 0.0 107.425 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.6 t -51.99 -23.87 5.75 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -52.03 -33.59 39.3 Favored 'General case' 0 C--N 1.341 0.198 0 O-C-N 121.268 -0.895 . . . . 0.0 112.762 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.0 t -146.43 -9.6 0.49 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.52 9.75 58.64 Favored Glycine 0 CA--C 1.523 0.572 0 O-C-N 120.591 -1.318 . . . . 0.0 112.714 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -68.65 121.71 17.02 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.401 1.1 . . . . 0.0 110.966 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 65.2 mt -75.67 126.16 36.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 40.8 t -89.69 -55.62 6.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -133.47 152.21 51.88 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.604 0.762 . . . . 0.0 110.241 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -147.04 173.67 12.24 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.604 2.362 . . . . 0.0 108.251 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -162.42 141.31 9.09 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -95.03 -5.49 44.36 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -178.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 21.5 m -83.0 -12.49 57.23 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.752 -1.218 . . . . 0.0 111.343 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.7 tp -131.89 72.94 1.51 Allowed 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.646 1.178 . . . . 0.0 109.322 -178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 22.1 t -137.06 140.5 42.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.377 1.071 . . . . 0.0 108.23 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -126.14 134.46 51.31 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -85.91 120.88 27.79 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 126.531 1.932 . . . . 0.0 108.576 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 50.7 mt -94.08 -89.03 0.23 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -114.63 145.7 18.64 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -114.9 92.57 30.91 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 83.5 Cg_endo -71.9 179.67 4.62 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.682 2.922 . . . . 0.0 111.387 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -104.08 160.45 14.83 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 124.656 1.182 . . . . 0.0 111.676 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -77.37 -26.53 52.0 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -110.75 136.71 49.41 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.0 p -63.39 -24.11 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 124.147 0.979 . . . . 0.0 112.237 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -81.45 -18.5 45.05 Favored 'General case' 0 C--N 1.335 -0.038 0 C-N-CA 123.314 0.645 . . . . 0.0 112.258 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -71.55 -23.63 61.8 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 122.818 0.447 . . . . 0.0 110.3 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -113.62 168.6 9.63 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.01 1.724 . . . . 0.0 108.352 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -142.12 134.77 28.3 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 8.7 m-30 -101.03 170.86 7.99 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.07 0.948 . . . . 0.0 109.1 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -137.61 129.66 28.98 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 24.8 tp -100.79 98.35 8.88 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.12 -179.73 3.98 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 126.561 1.944 . . . . 0.0 108.775 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -149.64 162.74 39.61 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 122.23 1.014 . . . . 0.0 110.254 178.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -133.14 -179.67 5.64 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.997 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -58.66 -35.7 72.97 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 125.103 1.361 . . . . 0.0 109.092 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 44.7 t -72.05 -62.11 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -177.64 -169.14 38.3 Favored Glycine 0 C--N 1.338 0.679 0 CA-C-N 119.178 0.899 . . . . 0.0 111.234 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -78.4 158.4 28.75 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.997 0.427 . . . . 0.0 111.149 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -158.1 166.36 32.67 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.056 1.343 . . . . 0.0 107.894 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 3.5 mt -114.63 136.09 52.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 7.1 t -110.98 145.34 38.59 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -140.27 120.32 13.69 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 178.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 2.6 tt -114.85 134.55 57.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 178.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.5 mt -129.32 112.42 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 124.063 0.945 . . . . 0.0 110.289 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -104.29 -160.39 24.27 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 126.343 1.925 . . . . 0.0 111.292 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 40.0 m 67.55 60.12 0.48 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.465 1.506 . . . . 0.0 112.633 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -112.24 -119.47 3.73 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -126.28 115.57 19.9 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.496 1.518 . . . . 0.0 107.893 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 46.1 mm -60.26 114.59 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 54.3 m -72.8 100.07 2.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.73 -15.55 20.72 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.833 0.742 . . . . 0.0 112.7 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.46 -36.71 42.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.514 1.526 . . . . 0.0 107.513 177.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 5.0 p -126.49 -30.76 2.81 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 96.57 17.13 34.47 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 127.317 2.389 . . . . 0.0 111.116 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -92.46 166.18 12.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.35 1.075 . . . . 0.0 111.98 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -87.49 146.74 25.68 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.603 178.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -76.8 30.22 0.13 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.367 2.267 . . . . 0.0 110.744 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -74.6 140.93 44.69 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.964 0.888 . . . . 0.0 110.719 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.3 p -109.47 150.04 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.252 -1.34 . . . . 0.0 109.377 -178.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -120.62 130.44 54.15 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.9 mp -120.19 110.01 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 124.929 1.291 . . . . 0.0 108.2 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -96.46 107.07 19.42 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -84.19 124.45 31.18 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.099 0.96 . . . . 0.0 109.426 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 27.9 m -134.9 173.22 14.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 125.1 1.36 . . . . 0.0 110.645 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 2.4 t -86.86 127.55 35.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 177.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -85.44 171.85 46.2 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 118.61 0.641 . . . . 0.0 112.991 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -68.02 -16.13 68.14 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.831 1.205 . . . . 0.0 112.418 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 40.0 t -118.17 119.33 34.4 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -97.22 18.21 15.53 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.796 0.438 . . . . 0.0 111.253 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 91.2 p -138.41 48.33 1.95 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.045 1.738 . . . . 0.0 110.927 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.83 168.08 28.15 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 120.762 -1.211 . . . . 0.0 111.617 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.68 169.96 21.38 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.865 2.377 . . . . 0.0 111.041 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 78.9 p -68.54 155.05 40.71 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -169.64 154.05 5.32 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 121.66 -0.65 . . . . 0.0 109.611 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.9 mt -82.06 130.23 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -75.98 -59.42 2.77 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.364 1.065 . . . . 0.0 111.441 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 45.1 p-90 -142.23 165.32 27.76 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.775 1.63 . . . . 0.0 108.222 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 46.3 t -145.24 127.01 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.75 133.76 17.07 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 122.051 0.929 . . . . 0.0 110.801 178.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -82.39 86.52 6.71 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 6.7 p -57.59 -64.76 0.79 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.587 1.155 . . . . 0.0 108.915 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -98.76 -174.49 2.8 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 178.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 34.3 mm -69.71 -43.93 79.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 O-C-N 121.347 -0.846 . . . . 0.0 110.486 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -103.81 -39.72 6.53 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.006 0.522 . . . . 0.0 112.308 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 15.5 t -72.56 130.82 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.5 148.88 50.32 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.915 1.686 . . . . 0.0 108.693 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -129.02 144.23 51.12 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.804 1.242 . . . . 0.0 109.258 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.67 161.48 40.48 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.269 1.828 . . . . 0.0 108.698 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -131.05 144.88 51.78 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 86.8 t -130.94 135.23 60.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 4.6 p -102.64 142.58 33.56 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 72.9 mt -141.87 131.75 12.6 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-O 118.748 -0.644 . . . . 0.0 109.714 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -71.54 -32.97 11.38 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.514 2.143 . . . . 0.0 112.128 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -69.38 -22.02 63.74 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.029 0.932 . . . . 0.0 111.246 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.6 mp -68.91 -41.2 78.52 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 22.4 m -57.63 -19.76 28.52 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.137 1.375 . . . . 0.0 112.469 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -64.98 -26.38 68.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.247 0.619 . . . . 0.0 110.643 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 25.1 mt -88.03 133.8 33.88 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.704 2.401 . . . . 0.0 108.477 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -54.9 -47.37 74.43 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.935 2.094 . . . . 0.0 113.937 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 8.1 mp -58.91 -34.63 71.92 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.225 -0.922 . . . . 0.0 111.925 -178.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -92.66 3.88 54.75 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.046 1.338 . . . . 0.0 111.476 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -76.78 52.75 0.86 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.259 1.823 . . . . 0.0 110.491 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -153.43 134.77 14.21 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.188 1.395 . . . . 0.0 107.321 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -164.41 178.74 7.23 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.962 1.705 . . . . 0.0 107.921 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 59.56 21.3 9.84 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.079 1.351 . . . . 0.0 113.026 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 36.9 t70 . . . . . 0 C--O 1.252 1.232 0 C-N-CA 124.672 1.189 . . . . 0.0 110.787 -179.455 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.761 0 N-CA-C 108.436 -1.866 . . . . 0.0 108.436 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.37 -5.25 1.82 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.593 1.157 . . . . 0.0 113.499 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.7 t -68.57 155.66 39.55 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -150.08 107.11 3.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.3 m -57.81 -26.39 61.91 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -84.02 -25.72 29.69 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.786 -0.571 . . . . 0.0 110.245 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.6 tptm -67.87 -44.86 76.09 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.1 p -63.54 -40.23 96.46 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.89 95.69 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 40.7 tp -65.61 -44.83 85.32 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.981 0.912 . . . . 0.0 110.041 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 21.4 mt -62.24 -49.02 77.37 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 79.0 m -54.46 -54.22 43.75 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.638 0.775 . . . . 0.0 109.092 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -58.0 -51.36 69.97 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 122.835 0.454 . . . . 0.0 109.989 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 28.3 m -56.52 -42.61 78.7 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.819 0.847 . . . . 0.0 112.548 -178.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.6 tp -66.98 -55.66 13.52 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 119.328 0.967 . . . . 0.0 110.136 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -60.21 -47.15 87.19 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 118.749 0.704 . . . . 0.0 111.971 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -57.79 -49.79 75.43 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.31 -47.18 91.1 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 42.5 t -59.74 -53.55 46.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 126.238 1.815 . . . . 0.0 110.783 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -32.56 74.17 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 119.776 -0.769 . . . . 0.0 109.68 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.6 m -65.36 -44.92 86.14 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.284 0.947 . . . . 0.0 108.63 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.9 mt -53.02 -53.16 23.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.33 -46.87 79.73 Favored 'General case' 0 N--CA 1.436 -1.15 0 O-C-N 124.688 1.243 . . . . 0.0 111.99 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.21 -50.83 71.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.809 0.814 . . . . 0.0 110.023 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -68.46 -8.96 45.52 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.721 1.208 . . . . 0.0 114.059 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.4 mt -115.27 -25.15 8.14 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.416 1.007 . . . . 0.0 111.861 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -61.87 -29.27 70.08 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.125 0.42 . . . . 0.0 110.347 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -69.62 -46.35 66.43 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.883 1.273 . . . . 0.0 109.546 178.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 -160.15 147.45 16.28 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.641 1.576 . . . . 0.0 110.218 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 65.9 m -75.58 177.57 6.66 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 34.0 pt -131.86 150.32 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 O-C-N 121.432 -0.793 . . . . 0.0 109.556 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.59 164.91 28.94 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.961 0.504 . . . . 0.0 110.604 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -147.08 129.13 15.5 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.057 1.743 . . . . 0.0 109.237 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -91.33 102.76 15.46 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.97 66.64 3.62 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.959 1.303 . . . . 0.0 107.791 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.16 -120.28 11.77 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -63.34 -34.9 78.7 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.809 0.844 . . . . 0.0 112.558 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -107.44 148.85 28.61 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 118.743 0.701 . . . . 0.0 110.637 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.0 mt -112.06 151.03 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -125.22 128.4 48.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.246 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -126.33 130.69 51.31 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.846 1.658 . . . . 0.0 108.544 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -125.76 120.97 32.02 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.35 1.46 . . . . 0.0 109.33 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 6.5 m -105.53 160.02 27.51 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.755 1.222 . . . . 0.0 113.89 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.02 86.12 0.49 Allowed 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 124.585 3.524 . . . . 0.0 113.208 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 61.93 54.95 31.11 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.0 mt -130.02 -67.46 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.408 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 20.9 pt-20 -170.29 166.57 8.72 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 126.337 1.855 . . . . 0.0 108.05 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.58 119.07 27.12 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 102.472 -3.159 . . . . 0.0 102.472 177.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.6 m -139.24 148.39 23.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -178.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -113.69 138.02 50.8 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -145.76 158.5 43.85 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.753 1.221 . . . . 0.0 111.158 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -87.81 154.48 20.51 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 152.34 -164.14 30.48 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -132.13 161.29 33.68 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.173 1.389 . . . . 0.0 108.01 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 53.7 t -131.69 136.63 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.579 1.152 . . . . 0.0 109.928 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.89 93.33 5.64 Favored 'General case' 0 N--CA 1.461 0.09 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.2 t -48.13 -27.95 2.65 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -54.42 -30.16 51.46 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.258 1.423 . . . . 0.0 112.498 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.1 t -145.18 -16.69 0.5 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.533 0.606 . . . . 0.0 112.196 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 96.26 4.91 59.55 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 125.191 1.377 . . . . 0.0 113.173 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -68.85 142.46 54.82 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.557 1.178 . . . . 0.0 110.34 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.7 mt -74.76 158.29 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 57.6 t -99.87 -41.97 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 117.798 -1.096 . . . . 0.0 112.127 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -128.56 174.71 9.15 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 120.635 1.562 . . . . 0.0 112.246 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -141.11 58.14 1.54 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.455 1.102 . . . . 0.0 110.468 -178.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.79 106.28 11.69 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 120.536 -1.352 . . . . 0.0 109.343 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -63.91 -12.95 41.55 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.525 1.057 . . . . 0.0 110.963 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.1 t -66.26 -25.84 67.07 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 128.071 2.548 . . . . 0.0 114.366 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 46.8 mt -129.78 76.7 1.74 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.172 0.897 . . . . 0.0 108.696 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.2 t -142.67 138.95 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 126.145 1.778 . . . . 0.0 108.933 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -132.04 153.48 50.36 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 125.215 1.406 . . . . 0.0 110.673 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -95.39 135.96 36.35 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.658 1.583 . . . . 0.0 108.2 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 63.7 mt -115.89 -78.85 0.58 Allowed 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -121.38 154.05 16.6 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt -132.84 90.57 31.74 Favored Pre-proline 0 N--CA 1.456 -0.148 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 48.6 Cg_endo -76.27 -178.99 4.83 Favored 'Trans proline' 0 C--O 1.239 0.529 0 C-N-CA 123.194 2.596 . . . . 0.0 111.951 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -85.59 166.97 15.8 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.24 -37.03 39.03 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -105.33 152.0 23.47 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.375 -0.828 . . . . 0.0 111.67 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.1 p -68.25 -24.68 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.575 0.75 . . . . 0.0 112.393 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -82.82 -8.24 59.6 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.909 1.284 . . . . 0.0 112.372 -178.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -96.79 -11.72 24.58 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.466 1.107 . . . . 0.0 110.258 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -120.53 177.91 4.87 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.83 2.452 . . . . 0.0 111.552 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -142.85 165.78 26.44 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.02 1.728 . . . . 0.0 109.786 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -140.94 168.42 19.84 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.885 1.674 . . . . 0.0 109.28 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -129.97 122.0 27.65 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.638 0.775 . . . . 0.0 109.488 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.0 tt -81.28 105.0 12.12 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 45.7 mt -115.78 -179.89 3.78 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.944 0.897 . . . . 0.0 110.995 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -161.91 156.15 22.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -138.42 -172.83 3.38 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -54.16 -24.2 17.18 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.487 1.915 . . . . 0.0 113.626 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 45.7 t -80.85 -75.5 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -166.68 -168.97 29.67 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -78.16 154.78 30.88 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.249 1.02 . . . . 0.0 111.177 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -160.85 175.38 12.61 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.149 1.78 . . . . 0.0 108.74 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 15.8 mt -120.01 137.85 52.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 103.063 -2.94 . . . . 0.0 103.063 177.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.4 t -124.88 125.85 44.61 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -128.55 146.02 50.95 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 5.8 tt -121.53 138.2 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 13.8 mt -126.06 109.54 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 125.65 1.58 . . . . 0.0 109.512 -178.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.34 -153.26 24.9 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 41.7 m 75.95 31.67 0.68 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.866 1.267 . . . . 0.0 111.357 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -91.62 -138.22 7.92 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 108.266 -1.934 . . . . 0.0 108.266 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -117.47 121.71 41.77 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 127.229 2.212 . . . . 0.0 110.04 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 10.6 mm -60.79 125.63 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 123.378 0.671 . . . . 0.0 109.839 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 56.6 m -84.64 101.96 12.56 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 103.922 -2.621 . . . . 0.0 103.922 177.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -58.61 -17.79 24.91 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.579 0.627 . . . . 0.0 110.762 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 24.9 t -50.69 -41.56 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 125.526 1.53 . . . . 0.0 109.098 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 7.5 p -125.45 -24.23 3.96 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 96.1 6.21 59.13 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 126.713 2.101 . . . . 0.0 112.441 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -86.23 166.82 15.4 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.038 0.935 . . . . 0.0 110.965 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -90.39 150.87 21.68 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 2.6 tpt85 -76.88 30.69 0.13 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 128.216 2.606 . . . . 0.0 110.789 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.1 ptt? -72.44 149.13 44.5 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -176.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.3 p -121.74 140.78 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 114.616 -1.174 . . . . 0.0 112.218 -176.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -112.57 123.09 49.51 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.365 1.066 . . . . 0.0 110.394 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 2.3 mp -109.04 128.67 64.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 126.115 1.766 . . . . 0.0 111.098 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -106.23 118.69 37.29 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.36 1.064 . . . . 0.0 108.724 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -97.27 115.33 27.43 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.91 0.884 . . . . 0.0 109.61 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 32.8 m -125.54 165.42 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.647 1.579 . . . . 0.0 112.106 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.13 137.33 37.43 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -107.06 128.03 9.08 Favored Glycine 0 C--N 1.334 0.471 0 N-CA-C 108.265 -1.934 . . . . 0.0 108.265 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -42.91 -41.63 4.63 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.592 1.568 . . . . 0.0 113.656 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.4 t -79.49 85.37 5.27 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -72.66 9.15 1.17 Allowed 'General case' 0 CA--C 1.549 0.908 0 O-C-N 121.276 -0.89 . . . . 0.0 113.115 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.95 46.51 1.65 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.43 1.892 . . . . 0.0 112.906 -178.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -166.83 159.89 33.38 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 120.299 -1.5 . . . . 0.0 111.993 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.25 166.59 22.82 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.135 2.557 . . . . 0.0 111.825 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 5.2 p -66.22 158.62 28.38 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.827 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.0 p -161.6 165.31 28.58 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.125 1.77 . . . . 0.0 107.376 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.8 mt -85.61 132.1 32.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -78.2 -53.03 7.79 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.787 1.635 . . . . 0.0 110.542 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . 0.434 ' CE3' ' HD2' ' A' ' 222' ' ' ARG . 37.9 p-90 -152.16 167.4 28.66 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.38 1.472 . . . . 0.0 108.685 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 47.0 t -146.29 133.88 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 126.253 1.821 . . . . 0.0 106.923 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.434 ' HD2' ' CE3' ' A' ' 220' ' ' TRP . 0.1 OUTLIER -153.75 130.47 10.81 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.912 0.778 . . . . 0.0 111.12 178.082 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -81.73 86.88 6.36 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' THR . . . . . 0.597 ' HG1' ' CD ' ' A' ' 230' ' ' GLU . 6.6 p -65.32 -55.02 20.61 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 127.022 2.129 . . . . 0.0 110.599 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -98.38 -176.51 3.42 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.5 mp -78.79 -29.98 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.8 t -111.61 -54.34 2.62 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.511 0.725 . . . . 0.0 110.898 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.94 149.4 10.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 123.639 0.776 . . . . 0.0 109.283 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.24 139.56 39.29 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.213 1.805 . . . . 0.0 109.453 -178.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.597 ' CD ' ' HG1' ' A' ' 224' ' ' THR . 0.6 OUTLIER -117.3 140.34 49.68 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.03 1.332 . . . . 0.0 108.553 179.703 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.39 162.32 38.46 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.394 1.877 . . . . 0.0 109.12 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -131.79 149.4 52.48 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 94.3 t -132.55 132.77 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 125.836 1.654 . . . . 0.0 108.887 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.25 144.29 27.2 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 32.7 mt -141.28 136.97 16.21 Favored Pre-proline 0 N--CA 1.454 -0.262 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.75 -40.88 0.46 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.627 1.551 . . . . 0.0 112.338 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -68.27 -17.67 64.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 120.768 -1.208 . . . . 0.0 111.944 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 17.0 mt -66.04 -30.77 71.36 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 176.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 28.9 m -61.11 -13.78 19.71 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.024 1.33 . . . . 0.0 111.167 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -75.37 -32.37 60.81 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 120.142 -1.599 . . . . 0.0 111.534 178.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 40.5 mt -81.31 111.47 17.72 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 126.5 1.92 . . . . 0.0 109.0 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -47.08 -34.11 5.58 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 128.847 2.859 . . . . 0.0 114.878 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 12.5 mt -62.82 -39.62 94.88 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.355 -0.841 . . . . 0.0 111.531 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 4.8 mp -91.51 10.33 28.27 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 127.058 2.143 . . . . 0.0 113.5 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -72.09 65.62 0.58 Allowed 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 126.462 1.905 . . . . 0.0 110.694 -178.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -140.7 146.39 37.73 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 130.206 3.403 . . . . 0.0 107.754 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 27.0 m120 67.43 20.25 9.92 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -82.48 85.54 6.92 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 100.414 -3.921 . . . . 0.0 100.414 176.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 18.6 t70 . . . . . 0 C--O 1.247 0.943 0 C-N-CA 126.857 2.063 . . . . 0.0 109.808 -178.935 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.715 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -144.26 -78.7 0.2 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.736 1.214 . . . . 0.0 110.127 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.1 p -72.61 81.29 1.1 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.357 1.063 . . . . 0.0 109.528 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -82.45 -38.76 23.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 118.623 -0.703 . . . . 0.0 112.57 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 63.4 m -57.92 -54.54 45.72 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.955 0.902 . . . . 0.0 111.918 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -62.83 -27.93 69.66 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.554 0.342 . . . . 0.0 111.57 -178.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? -66.67 -57.22 7.6 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.9 p -61.81 -36.17 80.34 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 118.17 0.441 . . . . 0.0 110.415 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.49 -48.17 82.94 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 118.293 0.497 . . . . 0.0 110.096 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 47.1 tp -67.53 -40.2 85.06 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 118.218 -0.896 . . . . 0.0 109.445 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.7 mt -59.35 -52.49 65.43 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.864 1.211 . . . . 0.0 109.266 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.4 m -57.3 -49.57 75.68 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 121.648 -0.657 . . . . 0.0 109.47 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -57.89 -49.1 77.86 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 118.238 0.472 . . . . 0.0 109.776 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 59.6 m -53.05 -52.57 58.09 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.71 1.604 . . . . 0.0 110.422 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 19.0 tp -59.83 -54.3 47.88 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 118.802 -0.618 . . . . 0.0 110.603 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.86 -47.67 79.88 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 118.262 0.483 . . . . 0.0 111.708 -178.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -60.06 -39.74 87.05 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.285 1.034 . . . . 0.0 108.512 178.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.89 -52.83 50.53 Favored Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 40.3 t -56.39 -52.99 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 118.661 1.231 . . . . 0.0 111.165 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -29.67 70.87 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.405 1.002 . . . . 0.0 111.54 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.1 m -75.41 -42.69 53.09 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 118.79 -0.624 . . . . 0.0 110.459 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 22.6 mt -56.12 -50.87 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.03 -43.19 91.57 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -65.77 -20.51 66.29 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.72 1.208 . . . . 0.0 112.81 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.16 10.36 33.84 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.003 1.321 . . . . 0.0 112.583 178.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.7 mt -135.59 -29.15 1.07 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.497 1.119 . . . . 0.0 113.555 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -51.7 -37.16 49.61 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -178.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -65.45 -40.07 92.79 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 116.069 1.878 . . . . 0.0 116.069 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.9 mmt180 -159.12 147.87 18.25 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.395 1.478 . . . . 0.0 109.243 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 32.2 m -75.72 172.3 12.87 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 32.9 pt -126.31 146.24 32.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -144.96 152.65 40.51 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 122.84 0.456 . . . . 0.0 110.889 -178.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -137.08 127.71 26.98 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 124.046 0.938 . . . . 0.0 110.455 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -89.15 102.86 15.52 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.57 70.75 4.24 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.08 -115.51 5.5 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -77.27 -28.03 53.37 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.322 1.049 . . . . 0.0 111.794 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -106.65 135.56 47.96 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 119.327 0.967 . . . . 0.0 111.215 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.4 mt -106.82 145.82 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -121.27 128.33 52.26 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.409 1.484 . . . . 0.0 107.627 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -122.94 128.24 50.0 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.676 1.59 . . . . 0.0 110.255 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -121.06 109.97 15.68 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.074 0.95 . . . . 0.0 108.612 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 11.6 m -95.23 158.8 34.15 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 123.226 0.61 . . . . 0.0 110.972 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.5 83.55 0.39 Allowed 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 123.903 3.069 . . . . 0.0 115.658 -178.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.32 51.68 50.47 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 124.205 0.907 . . . . 0.0 111.085 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.8 mt -126.8 -67.17 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -170.64 163.35 8.11 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 126.414 1.885 . . . . 0.0 108.362 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.67 121.12 36.64 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 102.154 -3.276 . . . . 0.0 102.154 177.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.4 m -131.5 156.95 43.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 124.548 1.139 . . . . 0.0 111.13 -178.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -125.83 126.39 44.41 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 178.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -143.99 157.53 44.28 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.489 1.115 . . . . 0.0 111.926 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -89.29 153.24 21.05 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 178.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 161.84 -163.03 34.51 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.38 140.86 50.58 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.6 t -123.37 144.54 32.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -94.64 100.41 12.35 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.3 t -57.01 -20.31 23.43 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.676 1.126 . . . . 0.0 112.191 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -46.97 -38.84 11.32 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 126.857 2.063 . . . . 0.0 112.317 178.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.7 t -144.61 -10.65 0.61 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.833 0.853 . . . . 0.0 112.034 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.13 3.81 63.35 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.581 1.563 . . . . 0.0 113.182 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -64.88 143.62 57.82 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.561 1.544 . . . . 0.0 111.149 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 39.7 mt -91.91 139.57 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 60.3 t -85.3 -82.35 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 123.553 0.741 . . . . 0.0 109.351 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -82.26 155.56 24.8 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.877 1.217 . . . . 0.0 109.103 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 62.2 mtp85 -122.33 34.22 5.22 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.301 1.44 . . . . 0.0 110.51 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -49.95 128.93 19.68 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.581 1.552 . . . . 0.0 110.524 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -95.99 -6.01 39.89 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.049 1.739 . . . . 0.0 114.959 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 41.7 p -75.75 -21.52 57.38 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 80.6 mt -128.92 81.81 2.05 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.3 t -142.5 135.12 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.071 1.348 . . . . 0.0 107.838 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -124.31 151.38 44.35 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.087 1.355 . . . . 0.0 111.051 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -96.99 112.64 24.3 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 127.068 2.147 . . . . 0.0 107.449 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.3 mp -93.82 -78.53 0.43 Allowed 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -120.49 144.23 16.95 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -121.52 89.35 47.19 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -77.58 173.35 14.32 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.793 2.995 . . . . 0.0 111.608 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -87.88 161.88 17.25 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.184 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -82.97 -37.84 23.51 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.066 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -93.34 132.59 37.42 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 15.0 p -60.65 -31.74 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 123.85 0.86 . . . . 0.0 112.086 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -68.03 -21.36 65.02 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.704 0.684 . . . . 0.0 112.01 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -84.31 -20.31 32.3 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.838 0.455 . . . . 0.0 110.614 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 32.9 mmm-85 -70.72 165.93 21.95 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.748 0.819 . . . . 0.0 109.904 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -134.86 95.98 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.086 0.955 . . . . 0.0 109.241 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -106.68 156.65 18.4 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.946 1.298 . . . . 0.0 108.932 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -140.92 147.49 38.92 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.759 1.224 . . . . 0.0 107.888 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 25.1 tp -107.94 102.64 11.81 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 125.705 1.602 . . . . 0.0 106.875 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.81 179.0 4.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.28 1.432 . . . . 0.0 107.837 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -154.07 163.66 39.74 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -133.81 173.9 11.04 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -63.78 -11.43 26.69 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.403 -0.81 . . . . 0.0 110.61 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 83.7 t -83.76 -66.16 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -176.32 -174.54 42.91 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -81.41 156.57 25.33 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 124.798 1.239 . . . . 0.0 111.842 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -162.79 169.96 19.08 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.228 1.011 . . . . 0.0 111.258 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 7.9 mt -116.57 121.78 68.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 11.8 t -97.69 131.61 44.08 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.704 1.202 . . . . 0.0 110.321 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -137.93 110.14 7.34 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.114 1.766 . . . . 0.0 109.075 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 2.7 tt -103.22 140.23 22.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.2 mt -132.83 113.79 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 123.647 0.779 . . . . 0.0 110.289 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -106.55 -156.87 21.33 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 125.293 1.425 . . . . 0.0 110.897 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 65.69 60.79 0.7 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.109 1.763 . . . . 0.0 111.554 -178.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -116.84 -124.01 3.52 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 104.633 -3.387 . . . . 0.0 104.633 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -127.95 123.58 35.22 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.759 1.224 . . . . 0.0 110.754 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 31.0 mm -64.25 116.96 4.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 71.8 m -73.71 102.09 3.86 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -53.18 -28.8 28.24 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.5 m -52.41 -33.28 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 C-N-CA 125.025 1.33 . . . . 0.0 111.384 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 73.1 p -123.0 -45.79 2.12 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.74 12.43 20.88 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.994 2.235 . . . . 0.0 111.32 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -92.56 169.97 10.11 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.942 1.297 . . . . 0.0 111.488 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -85.17 148.51 26.07 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.589 0.709 . . . . 0.0 111.792 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 18.3 tpt85 -84.05 28.56 0.6 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.676 2.39 . . . . 0.0 109.157 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 3.5 ptt? -73.47 158.77 34.3 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -177.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 1.9 p -125.93 140.1 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.155 -178.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -105.96 115.54 30.4 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 125.84 1.656 . . . . 0.0 107.083 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.6 mp -107.12 131.65 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -118.1 120.15 36.88 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 125.435 1.494 . . . . 0.0 108.511 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -101.05 119.4 38.69 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.42 1.488 . . . . 0.0 112.368 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 17.2 m -127.05 176.34 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.808 1.243 . . . . 0.0 111.8 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.6 t -91.0 124.32 35.15 Favored 'General case' 0 C--N 1.337 0.053 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 178.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.34 155.24 34.03 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.258 -0.496 . . . . 0.0 113.043 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -57.44 -27.22 57.98 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.305 0.955 . . . . 0.0 111.594 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 6.0 m -114.68 93.69 4.44 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -77.55 25.03 0.19 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.967 1.707 . . . . 0.0 112.552 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 27.2 t -131.98 45.48 2.77 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.343 1.857 . . . . 0.0 110.005 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -161.35 166.03 35.69 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-O 118.619 -1.101 . . . . 0.0 111.27 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -71.09 166.75 28.16 Favored 'Trans proline' 0 C--O 1.24 0.589 0 C-N-CA 122.821 2.347 . . . . 0.0 112.413 -178.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 96.7 p -70.38 155.58 40.49 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -166.01 156.11 12.5 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.0 mt -78.87 127.03 39.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -72.01 -51.25 22.71 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.743 1.617 . . . . 0.0 112.139 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 20.7 p-90 -152.76 164.92 36.86 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.183 1.393 . . . . 0.0 109.334 -178.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 51.3 t -147.36 120.75 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.15 127.42 21.19 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -80.68 92.26 5.97 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 104.101 -2.555 . . . . 0.0 104.101 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 5.7 p -65.69 -65.65 0.65 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.35 1.46 . . . . 0.0 109.786 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -88.71 -172.83 3.88 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.052 0.941 . . . . 0.0 108.489 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.4 mp -78.71 -40.99 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -106.07 -49.41 3.38 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.106 1.363 . . . . 0.0 112.539 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 2.4 t -68.26 145.54 13.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.2 136.1 37.86 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.716 1.606 . . . . 0.0 109.177 -178.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.42 139.93 43.78 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 125.047 1.339 . . . . 0.0 108.577 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -142.06 155.1 45.38 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 126.088 1.755 . . . . 0.0 110.136 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -136.25 146.42 46.7 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 1.6 m -137.34 154.56 30.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.1 p -109.08 148.67 30.46 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 123.469 0.708 . . . . 0.0 110.33 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 41.6 mt -142.27 133.35 12.94 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.27 -46.56 0.65 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.772 2.315 . . . . 0.0 112.324 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -62.03 -22.73 65.96 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.953 0.901 . . . . 0.0 113.375 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.8 mp -63.26 -40.06 96.35 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.223 0.92 . . . . 0.0 108.974 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 30.2 m -54.59 -22.53 13.58 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.84 1.656 . . . . 0.0 113.152 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -62.7 -31.47 72.38 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 121.1 -1.0 . . . . 0.0 110.841 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 26.4 mt -79.4 118.88 21.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.7 -35.52 31.52 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.9 mp -58.93 -45.19 90.99 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.336 -0.852 . . . . 0.0 109.599 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.76 5.45 36.31 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.125 1.77 . . . . 0.0 112.62 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -78.18 52.18 1.08 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 119.68 1.127 . . . . 0.0 111.261 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -152.48 155.6 37.79 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.548 1.539 . . . . 0.0 109.069 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -160.91 157.58 26.76 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 125.886 1.675 . . . . 0.0 109.583 177.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.25 -1.46 5.71 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 125.384 1.473 . . . . 0.0 109.826 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 26.3 t0 . . . . . 0 C--O 1.243 0.737 0 CA-C-O 117.385 -1.293 . . . . 0.0 109.192 -179.875 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.284 0 N-CA-C 107.843 -2.103 . . . . 0.0 107.843 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.38 168.95 11.57 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.78 1.29 . . . . 0.0 108.41 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.8 t 57.23 29.67 17.11 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.334 1.054 . . . . 0.0 111.681 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -61.19 161.4 8.87 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.4 m -53.8 -61.08 2.53 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.071 1.349 . . . . 0.0 112.941 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -58.25 -36.64 73.52 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.818 1.19 . . . . 0.0 110.484 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.42 -38.75 74.84 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.6 m -72.69 -47.53 46.46 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.102 1.361 . . . . 0.0 109.28 178.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.05 -38.31 70.44 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.373 0.669 . . . . 0.0 110.659 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.3 tp -60.57 -38.11 83.5 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 119.003 -0.523 . . . . 0.0 110.457 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.4 mt -67.23 -49.51 64.2 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 58.7 m -54.6 -44.57 73.16 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.919 0.888 . . . . 0.0 109.904 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -66.31 -50.78 62.45 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 121.104 -0.998 . . . . 0.0 110.246 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 58.4 m -53.99 -47.43 71.44 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.287 1.435 . . . . 0.0 111.145 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 28.5 tp -63.31 -54.79 31.51 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 119.051 0.841 . . . . 0.0 110.911 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -54.01 -48.99 69.86 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.414 0.686 . . . . 0.0 110.52 -178.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -57.37 -50.79 71.85 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 124.07 0.948 . . . . 0.0 109.051 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -57.04 -49.38 72.13 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-O 119.178 -0.79 . . . . 0.0 111.687 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 72.6 t -58.88 -53.2 50.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 125.343 1.457 . . . . 0.0 110.867 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -31.23 72.34 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 118.573 0.624 . . . . 0.0 110.531 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.8 m -70.44 -46.13 64.47 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.9 mt -53.56 -54.31 19.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.37 -44.04 84.09 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 124.035 0.834 . . . . 0.0 110.81 -178.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -60.41 -52.53 64.82 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.163 0.506 . . . . 0.0 111.6 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -22.19 66.8 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.8 mt -96.04 -27.37 15.14 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 118.823 0.738 . . . . 0.0 110.311 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -61.79 -28.44 69.46 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.186 0.594 . . . . 0.0 110.178 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -66.53 -46.93 74.52 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -165.44 152.75 10.64 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.908 2.083 . . . . 0.0 109.431 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 57.5 m -75.44 171.82 13.58 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 41.6 pt -125.78 147.55 30.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 123.801 0.84 . . . . 0.0 108.981 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.73 156.42 45.01 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 122.78 0.432 . . . . 0.0 110.375 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -142.91 128.02 18.58 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 124.167 0.987 . . . . 0.0 110.195 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -88.71 106.12 18.14 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.29 67.23 0.92 Allowed 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.35 -120.53 7.11 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.173 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -66.73 -32.06 73.12 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.64 1.176 . . . . 0.0 111.345 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -107.64 135.84 48.41 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.463 0.649 . . . . 0.0 111.626 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.409 HD11 ' H ' ' A' ' 140' ' ' GLY . 33.1 mt -105.8 149.72 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 177.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -119.08 134.8 54.98 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.334 -1.757 . . . . 0.0 108.205 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -128.91 130.74 47.19 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.751 1.22 . . . . 0.0 108.495 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -129.4 118.82 22.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.585 1.154 . . . . 0.0 109.219 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 10.6 m -105.41 160.32 26.46 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.668 1.187 . . . . 0.0 113.57 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -63.79 92.82 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 124.858 3.706 . . . . 0.0 113.157 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 52.17 53.06 32.7 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-O 119.579 -0.567 . . . . 0.0 111.846 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.1 mt -124.92 -67.36 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.434 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 22.2 pt-20 -177.38 174.73 1.55 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.98 1.712 . . . . 0.0 109.203 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.82 124.55 39.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 177.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.9 m -134.42 156.94 41.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 124.379 1.072 . . . . 0.0 110.879 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -124.09 124.12 41.82 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -146.17 156.37 43.37 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.323 1.049 . . . . 0.0 111.615 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -102.21 119.59 39.06 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.409 ' H ' HD11 ' A' ' 126' ' ' ILE . . . -154.44 -165.14 13.54 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.921 1.724 . . . . 0.0 108.962 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.66 136.89 50.28 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.6 p -149.62 153.44 10.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 123.902 0.881 . . . . 0.0 112.319 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -95.18 113.76 25.48 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.7 t -65.03 -16.3 63.29 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 120.721 1.6 . . . . 0.0 111.818 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -71.3 -23.06 61.88 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.934 1.694 . . . . 0.0 114.046 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.2 t -145.07 -23.0 0.49 Allowed 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.559 -0.713 . . . . 0.0 110.679 -178.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.37 15.29 44.62 Favored Glycine 0 C--O 1.223 -0.578 0 C-N-CA 126.011 1.767 . . . . 0.0 110.959 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -71.36 112.08 7.2 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 118.226 1.013 . . . . 0.0 110.267 -178.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 88.1 mt -80.35 107.95 13.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 102.744 -3.058 . . . . 0.0 102.744 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 35.0 t -70.89 -41.56 77.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 126.702 2.001 . . . . 0.0 111.379 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -138.03 139.12 39.43 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 119.121 0.873 . . . . 0.0 110.744 -178.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 56.9 mtm180 -112.78 85.68 2.22 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 125.451 1.5 . . . . 0.0 112.677 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -71.95 134.17 45.81 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -95.56 -6.76 39.64 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.011 1.324 . . . . 0.0 111.593 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.08 -28.42 61.37 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -177.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 93.5 mt -123.27 81.6 1.9 Allowed 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.108 0.963 . . . . 0.0 108.553 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.8 t -134.95 133.95 53.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.044 0.838 . . . . 0.0 108.965 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -130.3 163.4 26.88 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.492 1.517 . . . . 0.0 110.792 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -112.9 143.38 44.28 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 18.5 mt -116.32 -72.92 0.67 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -128.67 148.88 18.19 Favored Glycine 0 C--O 1.241 0.564 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -130.78 91.83 36.0 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.718 1.207 . . . . 0.0 109.286 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 43.5 Cg_endo -74.46 -166.09 0.31 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 125.06 3.84 . . . . 0.0 111.051 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -95.98 168.1 10.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.114 1.366 . . . . 0.0 109.395 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -81.79 -28.45 33.2 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -113.98 162.56 16.27 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 123.328 0.651 . . . . 0.0 110.324 -179.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.8 p -73.63 -34.58 41.96 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 C-N-CA 123.364 0.665 . . . . 0.0 110.379 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -74.37 -16.03 60.91 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.404 -0.81 . . . . 0.0 112.182 -177.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -81.57 -19.66 41.53 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.183 0.993 . . . . 0.0 110.603 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -117.33 177.91 4.56 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.608 1.563 . . . . 0.0 110.985 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -140.51 156.86 46.2 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -133.83 166.99 21.37 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.308 1.843 . . . . 0.0 107.977 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -133.74 123.7 25.38 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 120.498 1.499 . . . . 0.0 112.614 -179.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.77 99.08 9.45 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.005 1.322 . . . . 0.0 109.442 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 24.7 mt -108.21 174.02 6.06 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 122.394 1.092 . . . . 0.0 109.516 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -154.52 163.11 40.7 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -141.25 -178.44 5.59 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -52.55 -34.25 49.3 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 125.335 1.454 . . . . 0.0 110.523 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 56.1 t -70.79 -67.78 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 127.005 2.122 . . . . 0.0 109.191 178.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -175.77 -174.69 42.54 Favored Glycine 0 N--CA 1.446 -0.66 0 O-C-N 121.817 -0.552 . . . . 0.0 111.931 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -80.06 158.32 26.49 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.515 1.126 . . . . 0.0 111.973 -178.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -165.69 177.0 7.58 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.457 1.503 . . . . 0.0 108.531 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 8.9 mt -121.92 126.28 74.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 101.609 -3.478 . . . . 0.0 101.609 177.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.2 t -106.4 107.8 19.0 Favored 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 124.325 1.016 . . . . 0.0 109.248 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -111.22 118.78 36.85 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 118.5 -0.762 . . . . 0.0 110.699 -179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.8 tt -108.95 140.27 28.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.5 mt -133.87 113.47 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 C-N-CA 123.997 0.919 . . . . 0.0 110.637 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.68 -162.41 26.01 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 177.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.0 m 84.45 29.19 0.07 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.251 2.221 . . . . 0.0 112.959 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -87.4 -109.15 0.92 Allowed Glycine 0 C--N 1.338 0.649 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -139.11 126.6 21.7 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.337 1.455 . . . . 0.0 109.053 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.5 mm -68.19 122.54 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 120.503 1.501 . . . . 0.0 109.453 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 30.5 p -82.01 117.76 22.46 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 123.156 0.583 . . . . 0.0 111.622 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -71.89 -3.52 22.95 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.115 -0.991 . . . . 0.0 110.718 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 39.6 t -66.98 -42.06 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 125.127 1.371 . . . . 0.0 108.278 178.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.9 p -124.34 -28.57 3.64 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 122.898 0.479 . . . . 0.0 111.613 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.77 30.62 10.22 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -116.55 169.28 9.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.74 1.216 . . . . 0.0 112.289 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -83.83 139.91 32.36 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.351 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 2.9 tpp85 -77.13 30.75 0.14 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 130.013 3.325 . . . . 0.0 109.371 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 12.2 ptt? -73.11 157.11 37.9 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 122.008 0.909 . . . . 0.0 109.329 -176.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.5 p -125.19 146.05 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 114.37 -1.287 . . . . 0.0 111.317 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -112.7 138.6 49.27 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 1.8 mp -125.94 114.38 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 126.455 1.902 . . . . 0.0 107.579 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -99.69 116.28 31.43 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -93.54 118.17 31.01 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 125.242 1.417 . . . . 0.0 111.506 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 32.5 m -129.49 172.21 15.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 124.266 1.026 . . . . 0.0 111.312 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.2 t -78.59 134.96 37.16 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -93.21 122.01 6.79 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -37.68 -61.73 1.06 Allowed Glycine 0 C--N 1.336 0.538 0 C-N-CA 126.74 2.114 . . . . 0.0 111.343 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.8 p -77.66 83.09 4.05 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 37.2 p-10 -76.64 66.78 2.66 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.9 p -149.47 19.45 0.94 Allowed 'General case' 0 C--O 1.238 0.458 0 N-CA-C 116.539 2.052 . . . . 0.0 116.539 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -163.95 173.65 40.01 Favored Glycine 0 N--CA 1.47 0.941 0 O-C-N 121.189 -0.945 . . . . 0.0 115.197 -178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -64.77 164.24 24.97 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.036 2.49 . . . . 0.0 112.535 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 15.8 p -67.31 157.59 33.59 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.368 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 1.7 p -161.27 163.72 30.75 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.417 2.287 . . . . 0.0 106.923 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.5 mt -82.75 134.57 26.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 178.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -81.57 -55.22 4.81 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.052 1.341 . . . . 0.0 111.097 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 26.2 p-90 -147.92 166.54 27.36 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.259 1.424 . . . . 0.0 108.541 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 49.6 t -146.1 131.76 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.43 133.65 15.25 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.73 0.776 . . . . 0.0 111.223 177.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -81.72 89.3 6.27 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.2 p -66.01 -51.91 54.03 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.082 0.953 . . . . 0.0 111.734 -178.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -103.18 -173.83 2.4 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.0 mp -72.17 -43.54 66.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 3.4 m -111.94 -28.55 7.99 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -177.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 2.1 t -81.78 143.1 12.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -129.04 145.5 51.24 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.31 1.444 . . . . 0.0 110.09 -177.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -129.33 142.02 50.93 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 125.442 1.497 . . . . 0.0 108.39 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.28 163.2 37.16 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.296 1.839 . . . . 0.0 110.786 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -126.89 149.15 49.91 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 88.7 t -132.77 134.37 58.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 125.525 1.53 . . . . 0.0 107.803 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.41 143.48 32.63 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.922 0.889 . . . . 0.0 108.877 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 33.8 mt -139.85 138.13 19.36 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 118.251 -0.88 . . . . 0.0 109.215 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.22 -46.16 0.31 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.647 2.231 . . . . 0.0 110.838 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.71 -25.41 62.88 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.996 1.318 . . . . 0.0 110.816 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 15.3 mt -65.52 -41.33 93.26 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 24.7 m -58.01 -16.1 11.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.604 1.562 . . . . 0.0 113.061 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -63.19 -43.84 97.07 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.006 0.923 . . . . 0.0 109.143 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.8 mt -71.87 120.04 16.9 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 128.809 2.844 . . . . 0.0 107.049 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -52.67 -35.21 54.75 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.4 mp -58.73 -36.7 74.72 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.602 -0.686 . . . . 0.0 110.897 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -94.41 3.88 54.6 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 125.046 1.338 . . . . 0.0 111.949 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -75.95 40.91 0.21 Allowed 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.506 -0.746 . . . . 0.0 112.384 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 20.6 tptt -153.62 154.28 33.91 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 127.025 2.13 . . . . 0.0 107.36 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -166.19 138.2 3.8 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 125.362 1.465 . . . . 0.0 107.806 177.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -138.7 69.81 1.38 Allowed 'General case' 0 C--O 1.235 0.316 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.9 p30 . . . . . 0 C--O 1.249 1.063 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.537 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.117 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -146.5 -172.91 4.06 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.699 2.0 . . . . 0.0 106.32 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.7 t -138.04 149.34 45.95 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -130.32 14.37 5.59 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 127.977 2.511 . . . . 0.0 110.127 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 26.2 m -49.17 -41.72 37.57 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.265 1.026 . . . . 0.0 113.707 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -67.8 -37.39 81.93 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.706 -0.621 . . . . 0.0 110.187 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -64.83 -48.06 75.71 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.8 p -63.68 -36.08 82.65 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 118.375 -0.821 . . . . 0.0 110.22 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.53 -35.97 77.27 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.715 1.143 . . . . 0.0 110.34 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.22 -45.34 88.69 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.6 mt -63.46 -53.93 44.47 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.494 1.118 . . . . 0.0 109.538 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 55.2 m -54.87 -44.51 74.1 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.637 1.175 . . . . 0.0 110.648 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.1 ttmm -65.97 -49.79 66.6 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.813 -0.613 . . . . 0.0 109.945 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 79.9 m -51.92 -43.28 63.35 Favored 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 124.523 1.129 . . . . 0.0 111.157 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tt -61.79 -56.88 14.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.299 0.5 . . . . 0.0 111.898 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -60.69 -45.71 93.16 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.744 0.817 . . . . 0.0 111.42 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -57.72 -44.28 85.87 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.861 0.864 . . . . 0.0 108.851 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.98 -52.03 54.87 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 94.8 t -55.1 -53.2 36.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 124.977 1.311 . . . . 0.0 111.711 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.04 -33.36 75.58 Favored 'General case' 0 C--N 1.335 -0.052 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.741 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.2 m -67.63 -46.22 73.13 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 27.9 mt -55.64 -54.31 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 124.606 1.163 . . . . 0.0 108.855 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.02 -43.73 82.13 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.468 -178.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -60.99 -52.96 62.81 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-N 118.78 0.718 . . . . 0.0 110.637 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.68 -15.65 53.48 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.2 mt -101.54 -28.11 12.73 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 119.358 0.981 . . . . 0.0 109.174 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -65.5 -26.22 67.82 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -66.6 -46.23 76.61 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 -161.77 148.56 14.1 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.307 1.843 . . . . 0.0 109.297 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 71.0 m -74.99 164.42 26.57 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 178.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 33.3 pt -119.36 154.98 21.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -145.21 165.39 28.48 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.031 -178.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -151.25 125.34 9.26 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.194 1.397 . . . . 0.0 109.369 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -88.76 117.38 27.7 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -108.41 67.49 0.67 Allowed 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.722 1.209 . . . . 0.0 109.0 178.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.0 -114.09 3.88 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 107.917 -2.073 . . . . 0.0 107.917 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -83.99 -26.5 29.14 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.162 1.385 . . . . 0.0 112.463 179.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -106.38 115.44 30.22 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.409 1.484 . . . . 0.0 112.638 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 51.2 mt -92.57 146.74 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 C-N-CA 125.559 1.543 . . . . 0.0 108.219 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -118.04 135.23 54.3 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.499 -1.228 . . . . 0.0 107.74 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -133.14 126.43 31.69 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.311 1.044 . . . . 0.0 108.772 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.599 ' HH ' HD13 ' A' ' 187' ' ' ILE . 18.5 t80 -122.85 127.07 48.53 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.595 1.158 . . . . 0.0 111.677 -179.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 17.6 m -114.21 158.66 39.06 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 123.428 0.691 . . . . 0.0 112.351 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.28 92.78 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.625 1 C-N-CA 125.614 4.21 . . . . 0.0 113.858 -178.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 58.91 47.49 90.37 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.1 mt -125.37 -66.86 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.215 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.449 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 20.8 pt-20 -178.13 167.11 1.99 Allowed 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.415 1.486 . . . . 0.0 109.117 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.32 119.28 29.65 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 178.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.6 m -127.2 156.67 38.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 125.252 1.421 . . . . 0.0 110.765 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.36 124.07 41.57 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 103.638 -2.726 . . . . 0.0 103.638 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -146.29 158.79 43.91 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -178.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -89.37 153.64 20.7 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 169.48 -168.46 41.3 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -125.62 138.22 53.91 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.563 1.545 . . . . 0.0 107.075 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.9 p -148.8 152.43 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 119.244 0.929 . . . . 0.0 110.907 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -93.74 105.16 17.22 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.243 1.017 . . . . 0.0 108.353 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.9 t -50.05 -35.5 25.36 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.909 1.231 . . . . 0.0 112.142 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -46.73 -31.45 2.96 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.21 1.804 . . . . 0.0 114.0 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.1 t -146.4 -24.03 0.43 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 101.26 13.73 32.52 Favored Glycine 0 CA--C 1.527 0.842 0 O-C-N 120.984 -1.073 . . . . 0.0 111.237 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -70.08 115.28 9.11 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 23.0 mt -84.96 119.22 33.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 89.0 t -73.55 -72.3 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.34 1.456 . . . . 0.0 107.896 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -127.5 152.92 46.96 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.207 1.803 . . . . 0.0 108.04 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.3 87.88 1.48 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -61.13 118.62 7.04 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.738 1.215 . . . . 0.0 107.775 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -69.96 6.01 1.38 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 -178.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.43 -1.51 58.08 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 120.418 1.463 . . . . 0.0 111.357 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 15.9 mt -138.08 78.08 1.66 Allowed 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -136.2 135.18 50.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -134.49 154.82 51.23 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.96 1.704 . . . . 0.0 108.689 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -107.68 143.19 36.52 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.874 0.87 . . . . 0.0 109.236 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 35.5 mt -113.6 -69.96 0.83 Allowed 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 124.255 0.972 . . . . 0.0 109.432 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -133.57 156.51 22.3 Favored Glycine 0 C--O 1.239 0.422 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -126.78 93.7 41.67 Favored Pre-proline 0 C--O 1.231 0.102 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 57.3 Cg_endo -76.73 174.69 12.43 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 122.421 2.08 . . . . 0.0 110.068 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -81.32 162.03 23.62 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.47 -28.96 24.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.937 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -103.44 135.48 44.96 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.39 -22.54 28.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -83.28 -14.44 53.08 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 124.865 1.266 . . . . 0.0 111.448 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -84.55 -13.74 50.93 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.404 0.682 . . . . 0.0 110.864 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -117.51 174.56 6.08 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.345 1.858 . . . . 0.0 111.524 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -142.68 154.4 44.29 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.104 1.361 . . . . 0.0 109.511 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -128.96 169.41 14.69 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.874 2.469 . . . . 0.0 108.759 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -131.78 135.84 47.08 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.663 1.185 . . . . 0.0 109.514 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 17.4 tp -89.15 98.76 11.95 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.444 1.097 . . . . 0.0 108.343 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 20.6 mt -105.32 178.37 4.58 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.95 0.881 . . . . 0.0 111.341 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -158.58 162.66 37.38 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -138.62 -178.39 5.28 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 125.346 1.459 . . . . 0.0 109.827 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -58.92 -15.59 13.56 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 45.4 t -98.58 -56.32 5.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 C-N-CA 125.569 1.548 . . . . 0.0 108.768 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -169.21 -167.42 29.77 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 119.324 0.966 . . . . 0.0 113.172 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -88.64 156.09 19.23 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 122.192 -0.593 . . . . 0.0 110.848 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -157.64 173.98 16.04 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.162 1.385 . . . . 0.0 107.934 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 18.9 mt -118.27 140.22 42.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 102.908 -2.997 . . . . 0.0 102.908 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 36.1 t -117.94 131.26 56.52 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.6 127.05 18.81 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 178.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.6 tt -115.19 134.74 57.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.599 HD13 ' HH ' ' A' ' 129' ' ' TYR . 4.5 mt -125.04 111.08 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.681 1.192 . . . . 0.0 111.823 -177.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -100.42 -158.32 27.95 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 108.328 -1.909 . . . . 0.0 108.328 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 9.1 m 69.53 56.95 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 123.93 0.892 . . . . 0.0 109.467 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -114.79 -116.06 3.11 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 105.678 -2.969 . . . . 0.0 105.678 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -135.24 129.05 33.05 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.902 1.681 . . . . 0.0 107.375 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 25.8 mm -67.28 132.73 32.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 29.3 p -80.31 113.48 18.52 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.22 -24.46 66.37 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.863 1.211 . . . . 0.0 111.86 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 3.6 m -57.34 -41.5 78.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 117.251 -1.357 . . . . 0.0 112.634 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 1.3 p -125.41 -21.43 4.54 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 120.612 1.551 . . . . 0.0 112.591 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 89.31 13.45 61.72 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.875 1.702 . . . . 0.0 110.923 -178.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -90.2 169.6 11.0 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.61 1.205 . . . . 0.0 108.98 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.47 ' C ' ' H ' ' A' ' 201' ' ' MET . 17.6 mt-10 -86.31 149.66 24.89 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -78.44 31.08 0.18 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.112 2.165 . . . . 0.0 107.775 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.47 ' H ' ' C ' ' A' ' 199' ' ' GLU . 11.5 ptt? -71.37 152.14 43.44 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -175.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.7 p -119.47 146.38 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 114.207 -1.361 . . . . 0.0 111.57 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -111.76 132.24 54.79 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 125.145 1.378 . . . . 0.0 107.391 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 2.4 mp -118.13 139.77 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 178.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -122.74 100.21 6.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -81.06 126.53 31.54 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 118.817 0.735 . . . . 0.0 110.198 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 33.0 m -134.79 172.24 16.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 126.014 1.726 . . . . 0.0 111.144 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.7 t -78.75 139.47 38.43 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -107.33 146.87 16.21 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -40.96 -66.14 0.94 Allowed Glycine 0 CA--C 1.522 0.514 0 C-N-CA 126.49 1.995 . . . . 0.0 112.469 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.7 t -70.75 103.72 2.66 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 117.845 0.822 . . . . 0.0 110.557 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -71.59 6.8 1.7 Allowed 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.68 -0.637 . . . . 0.0 111.018 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 73.9 p -126.95 30.72 5.41 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.335 1.854 . . . . 0.0 110.283 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -120.64 170.32 14.38 Favored Glycine 0 N--CA 1.47 0.925 0 CA-C-N 119.675 1.125 . . . . 0.0 115.159 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -79.91 165.75 21.75 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.583 2.188 . . . . 0.0 110.477 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 90.5 p -78.74 152.31 31.58 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.38 164.18 7.01 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.558 1.543 . . . . 0.0 108.215 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.1 mt -84.82 134.53 26.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -79.59 -54.27 6.05 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 125.224 1.409 . . . . 0.0 111.443 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 41.1 p-90 -146.94 162.65 38.28 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.71 1.204 . . . . 0.0 108.7 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 44.0 t -148.41 135.34 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 125.943 1.697 . . . . 0.0 107.062 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.07 138.4 10.26 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 177.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -82.51 87.3 6.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 102.564 -3.125 . . . . 0.0 102.564 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.1 p -63.13 -49.65 73.56 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.692 1.597 . . . . 0.0 111.913 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -95.2 -172.37 2.65 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.6 mp -71.51 -46.4 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 4.9 m -113.37 -36.55 4.95 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 2.7 t -70.17 144.63 13.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.56 139.76 52.55 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.079 1.752 . . . . 0.0 108.141 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -121.94 142.99 49.73 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.895 1.278 . . . . 0.0 109.425 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.69 162.71 36.92 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.624 1.57 . . . . 0.0 110.019 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -129.11 142.93 50.73 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 93.5 t -129.25 137.88 55.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 124.891 1.277 . . . . 0.0 108.192 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.97 139.85 41.99 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 123.849 0.859 . . . . 0.0 111.153 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 26.6 mt -140.33 139.07 19.91 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.259 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.05 -43.98 0.29 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.683 2.256 . . . . 0.0 111.983 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -59.22 -21.21 59.16 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.807 0.843 . . . . 0.0 111.373 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 14.1 mt -69.85 -39.92 76.12 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 117.383 -1.294 . . . . 0.0 109.032 177.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 9.1 m -58.44 -22.13 53.38 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 119.657 1.117 . . . . 0.0 113.386 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -60.78 -32.03 71.37 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.362 0.665 . . . . 0.0 110.301 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 23.7 mt -79.86 118.84 21.99 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -48.33 -35.15 11.82 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 3.6 mp -57.61 -41.4 81.21 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 121.093 -1.004 . . . . 0.0 111.148 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -89.42 1.83 55.31 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.87 1.668 . . . . 0.0 112.905 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -76.01 59.86 1.34 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.418 1.487 . . . . 0.0 108.6 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -147.43 127.16 13.41 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.857 2.063 . . . . 0.0 108.823 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . 0.251 17.3 m120 85.32 9.37 0.35 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 130.408 3.483 . . . . 0.0 112.246 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -73.4 -19.9 60.87 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.657 1.983 . . . . 0.0 108.844 177.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 4.7 t70 . . . . . 0 C--O 1.251 1.164 0 C-N-CA 128.253 2.621 . . . . 0.0 110.647 179.488 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 CA--C 1.534 0.346 0 CA-C-O 119.013 -0.518 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.18 -45.26 77.5 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.03 -39.41 81.89 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.1 mt -63.72 -52.83 58.76 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 19.6 m -54.71 -44.96 73.91 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.876 -0.515 . . . . 0.0 109.618 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -63.77 -51.67 63.79 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.195 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.0 m -58.47 -39.96 81.4 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 120.325 1.42 . . . . 0.0 111.317 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.577 ' O ' HG23 ' A' ' 106' ' ' VAL . 10.3 tp -64.67 -55.48 19.87 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 119.016 0.825 . . . . 0.0 110.072 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -59.65 -46.98 87.38 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -57.58 -44.23 85.21 Favored 'General case' 0 C--O 1.225 -0.204 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.73 -53.39 46.62 Favored Glycine 0 N--CA 1.438 -1.228 0 CA-C-O 118.473 -1.181 . . . . 0.0 111.11 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 102' ' ' LEU . 5.0 t -55.19 -52.96 39.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 119.132 1.466 . . . . 0.0 111.142 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -33.76 76.19 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 118.816 -0.612 . . . . 0.0 111.274 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.0 m -70.04 -45.83 66.33 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.463 HD11 HD12 ' A' ' 183' ' ' ILE . 32.9 mt -56.27 -54.67 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 123.94 0.896 . . . . 0.0 109.814 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.76 -39.64 92.34 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 123.614 0.571 . . . . 0.0 110.266 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -62.86 -44.48 95.99 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.166 0.894 . . . . 0.0 110.526 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -20.32 62.29 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 118.266 -0.873 . . . . 0.0 112.765 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.8 mt -98.77 -28.85 13.31 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 120.34 1.427 . . . . 0.0 111.651 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -59.35 -37.43 77.83 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.91 0.484 . . . . 0.0 110.618 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -64.03 -46.76 83.02 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -156.94 148.32 22.22 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.013 0.925 . . . . 0.0 110.245 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 85.7 m -75.26 174.48 9.45 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 41.4 pt -130.71 148.6 33.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 123.476 0.71 . . . . 0.0 110.074 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.54 168.23 20.26 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.218 0.607 . . . . 0.0 110.038 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -151.43 129.59 11.91 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.906 1.682 . . . . 0.0 109.67 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -95.0 102.33 14.13 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.53 67.41 2.86 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 126.573 1.949 . . . . 0.0 109.384 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.15 -116.85 5.69 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 124.5 1.048 . . . . 0.0 110.803 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -70.2 -30.62 67.77 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.144 0.978 . . . . 0.0 111.443 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -107.33 160.39 15.65 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.865 0.841 . . . . 0.0 110.051 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.6 mt -125.86 151.66 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.432 ' CD1' HG11 ' A' ' 221' ' ' VAL . 40.4 m-85 -123.18 131.56 53.73 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 126.456 1.902 . . . . 0.0 106.749 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -126.35 131.54 51.78 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.849 1.659 . . . . 0.0 108.325 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -128.52 123.65 34.06 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.952 1.301 . . . . 0.0 109.869 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 4.6 m -109.91 160.35 28.43 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.236 1.414 . . . . 0.0 113.718 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.96 90.41 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.13 3.22 . . . . 0.0 113.324 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 59.19 52.07 55.45 Favored Glycine 0 CA--C 1.519 0.34 0 O-C-N 120.957 -1.089 . . . . 0.0 111.743 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.6 mt -127.31 -67.17 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.09 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.411 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 8.7 pt-20 -173.09 167.31 4.94 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 126.13 1.772 . . . . 0.0 109.281 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.22 117.24 24.13 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.0 m -130.57 156.19 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 124.386 1.074 . . . . 0.0 112.706 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -124.79 135.46 52.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 177.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -146.45 157.41 43.75 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.079 0.952 . . . . 0.0 113.35 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 33.5 t60 -88.79 119.72 29.54 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 103.581 -2.748 . . . . 0.0 103.581 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -165.25 -163.14 17.9 Favored Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 111.666 -0.573 . . . . 0.0 111.666 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.3 154.31 51.58 Favored 'General case' 0 CA--C 1.526 0.039 0 C-N-CA 123.505 0.722 . . . . 0.0 109.486 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.4 t . . . . . 0 C--O 1.24 0.603 0 C-N-CA 124.087 0.955 . . . . 0.0 110.716 -179.047 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 . . . . . 0 C--O 1.235 0.299 0 CA-C-O 120.69 0.281 . . . . 0.0 110.363 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 23.4 mt . . . . . 0 CA--C 1.54 0.59 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -179.888 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 89.9 mt . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.3 t -137.17 143.83 33.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 125.745 1.618 . . . . 0.0 106.788 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -140.44 162.63 34.88 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.907 0.883 . . . . 0.0 111.56 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.3 ptp85 -108.34 143.21 37.54 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.926 1.291 . . . . 0.0 110.076 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.3 mp -120.03 -70.2 0.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.375 1.47 . . . . 0.0 107.788 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -132.6 152.98 20.43 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 123.547 0.594 . . . . 0.0 112.589 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -124.43 91.07 50.05 Favored Pre-proline 0 N--CA 1.452 -0.352 0 C-N-CA 126.028 1.731 . . . . 0.0 109.434 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 97.2 Cg_endo -73.55 177.22 8.27 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.014 2.476 . . . . 0.0 111.37 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -91.09 169.13 11.11 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -82.48 -42.67 18.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.948 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -93.27 149.76 20.99 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 122.969 0.508 . . . . 0.0 110.065 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.2 p -69.79 -20.05 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 123.33 0.652 . . . . 0.0 112.45 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -88.96 -20.0 25.03 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.661 1.184 . . . . 0.0 111.656 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -77.34 -19.31 56.51 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.094 0.558 . . . . 0.0 109.793 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -103.56 171.11 7.55 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.15 1.38 . . . . 0.0 109.788 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -137.81 134.6 35.38 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.89 1.276 . . . . 0.0 107.788 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.497 ' CD2' HG22 ' A' ' 106' ' ' VAL . 4.4 m-30 -115.5 164.59 14.08 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.959 1.304 . . . . 0.0 110.672 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -131.67 122.03 25.28 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 124.621 1.168 . . . . 0.0 112.0 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 15.7 tp -85.76 104.34 15.36 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.426 HD12 ' HB2' ' A' ' 184' ' ' SER . 38.8 mt -114.49 177.03 4.79 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 122.139 0.971 . . . . 0.0 110.939 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -156.76 155.67 32.0 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.037 1.335 . . . . 0.0 107.463 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -138.59 -177.15 4.73 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -49.25 -31.33 8.59 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.079 1.352 . . . . 0.0 113.218 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 89.8 t -74.28 -74.37 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -166.53 -162.34 17.81 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.585 ' CZ ' HD22 ' A' ' 243' ' ' LEU . 3.7 m-85 -78.31 161.87 26.91 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.293 0.637 . . . . 0.0 112.06 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -163.15 175.25 11.2 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.854 2.062 . . . . 0.0 108.302 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.463 HD12 HD11 ' A' ' 109' ' ' ILE . 7.2 mt -127.01 121.51 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.426 ' HB2' HD12 ' A' ' 175' ' ' LEU . 39.9 t -91.35 137.81 32.07 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -139.18 120.51 14.87 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.8 tt -114.72 139.81 38.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.3 mt -133.51 112.53 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 123.4 0.68 . . . . 0.0 112.284 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -105.78 -167.69 23.42 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 124.604 1.097 . . . . 0.0 110.956 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.5 t 80.69 47.27 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.307 1.843 . . . . 0.0 110.39 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -97.76 -112.02 3.02 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 105.645 -2.982 . . . . 0.0 105.645 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -141.36 122.61 14.81 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 104.265 -2.494 . . . . 0.0 104.265 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.5 mm -60.17 134.38 25.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 98.8 m -81.58 100.81 9.59 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.98 -19.27 51.35 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.33 0.652 . . . . 0.0 111.325 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.32 -30.24 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 126.141 1.776 . . . . 0.0 110.767 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.3 p -125.01 -36.2 2.57 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 119.601 1.091 . . . . 0.0 112.416 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 96.54 33.81 6.03 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.084 1.326 . . . . 0.0 110.581 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -124.95 171.05 10.51 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.376 1.47 . . . . 0.0 112.058 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -89.1 141.85 28.15 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.558 0.743 . . . . 0.0 112.006 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.17 29.14 0.22 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 128.455 2.702 . . . . 0.0 110.764 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -73.52 142.38 46.73 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 122.282 1.039 . . . . 0.0 109.489 -176.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -104.81 149.58 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 CA-C-N 113.399 -1.728 . . . . 0.0 111.417 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -118.2 124.96 49.2 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.2 mp -115.86 129.86 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 125.806 1.642 . . . . 0.0 106.638 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -114.57 108.97 17.55 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -85.27 119.49 25.7 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.593 0.757 . . . . 0.0 110.602 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 32.0 m -131.43 171.57 17.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 C-N-CA 125.026 1.33 . . . . 0.0 111.796 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.37 133.55 39.91 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -89.7 149.13 20.31 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 123.557 0.599 . . . . 0.0 111.811 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -60.67 -45.02 97.18 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 47.1 t -87.21 98.58 11.4 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -72.21 8.04 1.48 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.385 0.674 . . . . 0.0 109.381 177.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 60.2 m -130.84 38.44 3.69 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.241 1.817 . . . . 0.0 113.267 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.2 165.7 28.16 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 121.475 -0.766 . . . . 0.0 112.161 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.66 168.24 20.57 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.969 2.446 . . . . 0.0 112.492 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 81.0 p -77.26 150.0 35.37 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.78 162.73 23.98 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.174 1.39 . . . . 0.0 107.446 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.1 mp -76.68 141.77 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -84.63 -59.65 2.3 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 -141.58 166.56 24.42 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.171 1.388 . . . . 0.0 108.484 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.729 HG13 ' CE1' ' A' ' 229' ' ' TYR . 47.7 t -145.84 136.39 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 C-N-CA 126.142 1.777 . . . . 0.0 106.391 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.46 121.09 3.71 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.375 0.607 . . . . 0.0 109.862 177.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -81.05 88.14 5.98 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 14.7 p -58.02 -56.8 17.36 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.587 1.555 . . . . 0.0 112.095 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt -99.76 -172.55 2.26 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.239 -1.764 . . . . 0.0 106.239 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 31.2 mm -75.5 -35.22 31.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 O-C-N 121.081 -1.012 . . . . 0.0 109.392 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.98 -54.05 2.54 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.912 0.885 . . . . 0.0 110.861 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 29.2 t -62.56 137.44 24.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 121.41 0.624 . . . . 0.0 109.391 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' TYR . . . . . 0.729 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.4 OUTLIER -133.08 139.92 47.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.147 1.779 . . . . 0.0 107.048 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -120.6 140.52 51.41 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 125.409 1.484 . . . . 0.0 108.945 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.84 161.41 39.36 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 126.132 1.773 . . . . 0.0 109.745 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -133.02 146.11 51.44 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 99.0 t -131.65 134.14 60.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 124.68 1.192 . . . . 0.0 108.376 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.08 142.06 35.13 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.624 0.77 . . . . 0.0 109.812 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 61.7 mt -139.72 135.68 16.92 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.73 -41.84 0.68 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.881 1.721 . . . . 0.0 112.367 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -62.99 -20.46 65.31 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 16.2 mt -68.52 -33.04 73.42 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 118.174 -0.917 . . . . 0.0 109.882 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 21.0 m -62.88 -13.4 33.64 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -70.37 -36.71 74.32 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.827 0.822 . . . . 0.0 109.152 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 24.0 mt -70.52 114.02 8.21 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -48.16 -33.77 8.91 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.585 HD22 ' CZ ' ' A' ' 181' ' ' TYR . 16.6 mt -61.49 -37.05 82.25 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.257 -0.902 . . . . 0.0 109.817 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 13.0 mt -95.74 9.69 39.55 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 127.505 2.322 . . . . 0.0 113.491 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.761 0 O-C-N 121.564 -0.71 . . . . 0.0 110.457 179.315 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 118.799 -0.619 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.88 -49.55 75.77 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.584 0.707 . . . . 0.0 109.516 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 62.3 tp -55.15 -43.63 74.38 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 125.3 1.44 . . . . 0.0 109.666 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.2 mt -62.52 -53.67 51.23 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.553 1.07 . . . . 0.0 109.506 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 85.2 m -54.36 -52.7 60.8 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.013 0.525 . . . . 0.0 109.826 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -61.9 -42.14 98.72 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 118.488 -0.768 . . . . 0.0 110.801 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.1 m -55.8 -47.8 76.5 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 119.318 0.963 . . . . 0.0 109.771 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 26.6 tp -59.28 -55.8 30.28 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 118.373 0.533 . . . . 0.0 109.765 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -51.21 -52.42 44.65 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 124.778 1.231 . . . . 0.0 110.997 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -55.83 -44.59 78.08 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 125.088 1.355 . . . . 0.0 109.711 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.62 -53.24 39.86 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 125.117 1.341 . . . . 0.0 111.785 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 59.1 t -55.25 -52.92 40.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 119.018 1.409 . . . . 0.0 110.998 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -31.07 72.01 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 118.51 0.596 . . . . 0.0 110.703 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.2 m -69.05 -42.62 76.05 Favored 'General case' 0 CA--C 1.523 -0.093 0 CA-C-N 118.682 0.674 . . . . 0.0 109.403 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.473 HD11 HD12 ' A' ' 183' ' ' ILE . 34.1 mt -58.09 -51.16 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 107.103 -1.444 . . . . 0.0 107.103 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.88 -40.03 94.0 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 118.762 -0.637 . . . . 0.0 111.095 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -59.32 -47.48 85.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.875 0.762 . . . . 0.0 109.375 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -73.51 -19.3 60.96 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.6 mt -102.67 -28.29 12.21 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 119.901 1.228 . . . . 0.0 112.124 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -58.03 -32.46 67.99 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -65.84 -45.58 81.69 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 119.036 -0.507 . . . . 0.0 110.504 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -158.4 156.38 30.34 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.662 1.119 . . . . 0.0 111.203 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 59.9 m -76.09 176.04 8.36 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 34.0 pt -135.7 155.49 36.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.49 163.3 38.18 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.126 0.488 . . . . 0.0 112.137 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -150.92 129.01 11.83 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.22 1.408 . . . . 0.0 110.638 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -92.23 107.6 19.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.57 73.09 3.73 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.627 1.571 . . . . 0.0 107.545 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.59 -115.43 5.93 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -74.15 -27.22 60.74 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.322 1.049 . . . . 0.0 112.638 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -107.13 157.6 17.73 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 118.718 0.69 . . . . 0.0 110.299 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 58.7 mt -123.99 149.41 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.467 ' CD1' HG11 ' A' ' 221' ' ' VAL . 55.5 m-85 -126.15 129.3 48.77 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.219 2.208 . . . . 0.0 107.424 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -127.03 130.96 50.99 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.722 1.609 . . . . 0.0 107.644 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -122.3 115.44 22.34 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.814 1.246 . . . . 0.0 108.594 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 15.6 m -105.02 154.86 38.41 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 123.48 0.712 . . . . 0.0 110.588 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -61.05 90.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.589 1 C-N-CA 125.887 4.391 . . . . 0.0 116.091 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 60.05 33.96 81.58 Favored Glycine 0 CA--C 1.528 0.853 0 O-C-N 121.682 -0.636 . . . . 0.0 112.323 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.0 mt -111.23 -66.36 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.448 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 5.3 pt-20 -180.0 162.52 1.01 Allowed 'General case' 0 C--O 1.24 0.586 0 C-N-CA 126.468 1.907 . . . . 0.0 108.901 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -115.52 122.29 45.26 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 102.544 -3.132 . . . . 0.0 102.544 178.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.4 m -130.32 156.17 42.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 123.358 0.663 . . . . 0.0 111.228 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -125.62 126.43 44.73 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -146.33 158.95 43.94 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.435 1.094 . . . . 0.0 112.435 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -88.39 154.64 20.22 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 177.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 166.0 -163.97 37.15 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -127.82 144.32 51.09 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.624 1.97 . . . . 0.0 106.7 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 C--O 1.236 0.348 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.98 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 . . . . . 0 N--CA 1.447 -0.623 0 CA-C-O 121.199 0.524 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 74.6 mt . . . . . 0 N--CA 1.447 -0.618 0 N-CA-C 103.167 -2.901 . . . . 0.0 103.167 177.65 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 83.7 mt . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 39.6 t -136.78 143.14 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.384 1.074 . . . . 0.0 108.568 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -143.59 147.36 34.28 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.191 1.397 . . . . 0.0 111.714 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.92 123.63 40.68 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 124.809 1.244 . . . . 0.0 108.073 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.5 mp -95.28 -72.47 0.62 Allowed 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -125.76 148.14 16.87 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -128.44 91.97 42.33 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 42.5 Cg_endo -77.01 176.57 9.97 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.615 2.877 . . . . 0.0 110.698 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -83.76 167.73 16.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.177 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.43 -33.62 23.65 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.488 1.115 . . . . 0.0 112.001 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -90.9 142.2 28.02 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 126.402 1.881 . . . . 0.0 106.258 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.3 p -72.96 -28.35 26.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 118.224 0.465 . . . . 0.0 110.078 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -73.1 0.51 11.34 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 127.479 2.311 . . . . 0.0 113.059 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -114.76 -13.12 12.06 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.329 1.852 . . . . 0.0 110.227 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 36.1 mmm-85 -77.25 163.68 26.29 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.824 1.25 . . . . 0.0 108.358 177.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -131.03 95.89 3.92 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.301 0.572 . . . . 0.0 110.134 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -108.53 148.94 29.53 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 125.774 1.629 . . . . 0.0 108.279 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -138.37 134.92 34.79 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.358 1.063 . . . . 0.0 109.791 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.95 98.51 10.41 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.29 1.036 . . . . 0.0 109.515 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.433 HD12 ' HB2' ' A' ' 184' ' ' SER . 35.4 mt -103.77 172.01 7.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.761 0.791 . . . . 0.0 110.195 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -157.37 157.09 33.43 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.246 -0.909 . . . . 0.0 109.503 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -138.83 -179.23 5.71 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -56.79 -11.75 1.56 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.788 2.035 . . . . 0.0 113.026 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 54.8 t -94.07 -67.07 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 126.484 1.914 . . . . 0.0 107.873 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -169.63 -174.11 37.69 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -81.05 158.76 24.98 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 114.606 -0.797 . . . . 0.0 109.044 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -162.61 176.55 10.26 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.546 1.538 . . . . 0.0 108.469 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.473 HD12 HD11 ' A' ' 109' ' ' ILE . 14.3 mt -123.93 133.75 68.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.433 ' HB2' HD12 ' A' ' 175' ' ' LEU . 32.3 t -109.19 122.49 47.42 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -125.58 112.93 16.76 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.9 tt -100.86 130.93 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 11.0 mt -123.36 109.7 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.088 1.355 . . . . 0.0 109.053 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -104.36 -153.04 22.59 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 107.559 -2.217 . . . . 0.0 107.559 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.3 m 74.43 46.07 0.17 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.34 1.456 . . . . 0.0 109.444 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -111.95 -126.95 4.84 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -130.42 124.91 33.18 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.441 1.096 . . . . 0.0 110.986 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 46.1 mm -61.08 137.28 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.82 0.848 . . . . 0.0 112.296 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 74.1 m -94.66 95.36 8.7 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 102.866 -3.013 . . . . 0.0 102.866 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -55.07 -17.79 4.47 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.888 1.275 . . . . 0.0 113.537 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 73.4 t -59.73 -38.18 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 124.878 1.271 . . . . 0.0 109.567 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 20.9 p -125.32 -15.9 6.07 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 78.52 32.94 40.36 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -103.48 159.9 15.19 Favored 'General case' 0 CA--C 1.52 -0.189 0 O-C-N 121.435 -1.038 . . . . 0.0 110.651 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -91.71 142.4 27.64 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.903 1.281 . . . . 0.0 107.725 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -73.46 28.96 0.07 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 127.854 2.461 . . . . 0.0 111.82 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.3 ptt? -73.2 141.0 47.35 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 122.58 1.181 . . . . 0.0 110.04 -175.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 1.5 p -113.06 144.35 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.33 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -112.26 125.25 53.96 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.6 mp -109.67 119.11 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -102.38 106.39 17.14 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -85.36 115.17 22.95 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.37 1.068 . . . . 0.0 110.46 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.8 m -127.93 172.83 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 126.14 1.776 . . . . 0.0 112.277 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.3 t -85.5 133.09 34.1 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.445 1.498 . . . . 0.0 107.313 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -89.67 161.86 29.94 Favored Glycine 0 N--CA 1.47 0.95 0 CA-C-N 119.555 1.071 . . . . 0.0 112.032 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -47.22 -79.61 0.07 OUTLIER Glycine 0 C--N 1.341 0.824 0 C-N-CA 126.315 1.912 . . . . 0.0 110.997 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 25.3 m -70.42 126.3 29.24 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -98.28 35.98 1.68 Allowed 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 8.6 m -143.24 33.19 1.34 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -129.52 179.15 16.95 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 120.361 1.437 . . . . 0.0 113.122 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -75.09 170.06 21.22 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.949 2.432 . . . . 0.0 109.273 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 98.3 p -81.72 156.36 25.04 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.853 -0.529 . . . . 0.0 109.692 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.85 164.69 7.85 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 126.143 1.777 . . . . 0.0 109.276 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.9 mt -79.75 136.09 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.164 1.386 . . . . 0.0 107.37 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -81.21 -54.84 5.16 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 124.574 1.15 . . . . 0.0 109.753 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 19.0 p-90 -148.59 166.54 27.96 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 124.794 1.237 . . . . 0.0 108.761 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.76 HG13 ' CE1' ' A' ' 229' ' ' TYR . 45.3 t -145.28 126.58 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.01 122.05 10.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -75.02 97.92 3.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 2.1 p -66.14 -51.79 54.52 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 118.311 -0.852 . . . . 0.0 111.715 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -120.72 179.11 4.45 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.437 0.695 . . . . 0.0 109.781 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.548 ' H ' HD12 ' A' ' 226' ' ' ILE . 3.8 mp -55.19 -37.82 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 C-N-CA 125.908 1.683 . . . . 0.0 110.666 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.75 -21.04 5.29 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 56.4 t -85.21 124.51 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' TYR . . . . . 0.76 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.6 OUTLIER -123.68 142.9 50.63 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 179.398 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -129.79 139.95 51.15 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -138.83 160.85 38.69 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.086 1.354 . . . . 0.0 109.505 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -127.28 143.71 51.18 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.0 t -128.53 143.75 40.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 125.084 1.354 . . . . 0.0 107.683 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.45 134.13 55.32 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 124.29 1.036 . . . . 0.0 110.408 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 93.9 mt -136.72 138.36 26.08 Favored Pre-proline 0 C--O 1.236 0.355 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.638 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.08 -43.29 0.25 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.312 2.008 . . . . 0.0 111.944 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -57.32 -26.82 61.52 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.794 0.837 . . . . 0.0 111.278 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 16.9 mt -66.17 -38.72 88.74 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 120.947 -1.096 . . . . 0.0 110.189 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 42.8 m -55.21 -21.85 15.53 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.6 1.56 . . . . 0.0 113.921 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -64.98 -34.44 78.43 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 123.393 0.677 . . . . 0.0 111.192 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 29.9 mt -71.95 117.27 13.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -48.67 -36.11 15.34 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.82 -36.17 78.37 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.527 -0.733 . . . . 0.0 110.254 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -97.84 3.58 49.83 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.389 1.875 . . . . 0.0 113.271 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 178.902 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.9 m . . . . . 0 CA--C 1.537 0.445 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.34 -48.31 82.12 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 119.633 1.106 . . . . 0.0 108.409 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 58.9 tp -56.97 -44.83 83.04 Favored 'General case' 0 C--N 1.343 0.322 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.1 mt -61.4 -50.52 72.52 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.955 0.798 . . . . 0.0 110.577 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 54.9 m -54.97 -52.44 63.06 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.815 1.246 . . . . 0.0 110.669 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -63.96 -42.78 97.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.575 0.75 . . . . 0.0 110.62 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.2 m -54.1 -49.14 69.78 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.155 0.982 . . . . 0.0 109.007 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 41.1 tp -57.38 -54.24 49.09 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.929 0.331 . . . . 0.0 110.72 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -52.65 -50.99 62.08 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 124.428 1.091 . . . . 0.0 111.654 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -56.11 -52.2 65.18 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.393 1.077 . . . . 0.0 108.604 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -55.29 -51.04 56.97 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 96.4 t -57.2 -52.79 51.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 C-N-CA 125.206 1.402 . . . . 0.0 111.809 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -32.3 73.57 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 119.289 0.95 . . . . 0.0 110.313 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.1 m -66.3 -42.02 88.89 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 34.0 mt -61.49 -50.72 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.51 -40.92 72.4 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 117.9 -1.048 . . . . 0.0 110.809 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -62.61 -55.01 31.01 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.305 1.042 . . . . 0.0 110.436 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -62.7 -25.92 68.4 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 11.0 mp -98.07 -26.99 14.42 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.543 1.52 . . . . 0.0 110.848 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -53.88 -29.54 41.97 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.184 0.994 . . . . 0.0 111.233 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -74.49 -46.83 36.97 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 117.965 0.348 . . . . 0.0 110.709 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.2 mmt85 -157.03 151.46 25.33 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.201 -0.937 . . . . 0.0 111.819 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 51.5 m -76.43 160.55 29.44 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 32.8 pt -118.1 152.83 20.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 124.889 1.275 . . . . 0.0 108.592 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -146.16 168.87 19.94 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 122.853 0.461 . . . . 0.0 111.909 -178.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -154.51 127.69 8.37 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.572 1.549 . . . . 0.0 111.286 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -91.52 104.37 16.88 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.52 66.77 5.46 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.424 1.489 . . . . 0.0 107.034 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 66.84 -115.96 7.76 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -66.12 -34.03 77.13 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -107.32 152.76 23.71 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 119.165 0.893 . . . . 0.0 110.247 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.7 mt -121.16 151.97 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -126.93 136.72 52.68 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.714 1.605 . . . . 0.0 108.202 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -131.38 132.45 44.41 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.542 1.537 . . . . 0.0 108.955 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -126.04 117.27 22.87 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.607 1.163 . . . . 0.0 109.737 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 21.9 m -104.22 158.17 32.49 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 124.197 0.999 . . . . 0.0 111.502 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -63.67 84.91 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.621 1 C-N-CA 125.413 4.076 . . . . 0.0 116.101 -178.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.41 29.02 74.24 Favored Glycine 0 CA--C 1.529 0.938 0 O-C-N 121.394 -0.816 . . . . 0.0 111.542 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.1 mt -106.77 -67.25 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.415 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 7.8 pt-20 -172.56 165.31 5.58 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.713 1.205 . . . . 0.0 108.954 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.23 119.87 30.59 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 103.7 -2.704 . . . . 0.0 103.7 177.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.43 156.63 42.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 124.53 1.132 . . . . 0.0 112.02 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -123.81 133.67 53.76 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -146.11 158.25 43.87 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.71 1.204 . . . . 0.0 111.629 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 50.3 t60 -87.94 154.86 20.18 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 157.9 -162.19 31.98 Favored Glycine 0 C--N 1.333 0.409 0 O-C-N 121.21 -0.931 . . . . 0.0 111.28 -178.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.61 145.9 49.07 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 54.2 t . . . . . 0 C--O 1.237 0.413 0 C-N-CA 124.971 1.308 . . . . 0.0 108.3 179.825 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 . . . . . 0 C--O 1.242 0.676 0 CA-C-O 121.009 0.433 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 26.2 mt . . . . . 0 N--CA 1.449 -0.507 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 178.913 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 84.5 mt . . . . . 0 N--CA 1.463 0.175 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.78 147.14 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -142.41 153.04 43.4 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.717 1.207 . . . . 0.0 110.538 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 37.5 mtm105 -101.1 126.32 47.78 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 22.7 mt -101.68 -62.4 1.26 Allowed 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -134.15 153.49 20.97 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.441 ' HB3' ' HB3' ' A' ' 189' ' ' SER . 0.9 OUTLIER -129.22 86.25 57.26 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 126.872 2.069 . . . . 0.0 109.239 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.437 ' HD3' HG21 ' A' ' 187' ' ' ILE . 41.5 Cg_endo -80.47 176.7 8.9 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 123.672 2.915 . . . . 0.0 110.788 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.2 mmmt -92.64 156.45 17.07 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.49 -25.03 41.92 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.015 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -107.29 126.89 53.01 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.58 1.152 . . . . 0.0 108.042 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.4 p -52.9 -34.23 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.834 1.254 . . . . 0.0 111.195 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.428 ' HG3' ' H ' ' A' ' 168' ' ' GLU . 14.1 mt-10 -61.09 -18.26 56.98 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 129.722 3.209 . . . . 0.0 113.521 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -112.32 -4.08 14.39 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.024 1.73 . . . . 0.0 111.736 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 61.2 mtp180 -91.3 176.87 6.42 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.821 0.82 . . . . 0.0 109.777 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -142.68 134.76 27.27 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -144.0 150.07 37.7 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.782 1.633 . . . . 0.0 107.864 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -133.11 131.73 40.87 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.643 1.177 . . . . 0.0 108.5 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 28.1 tp -86.2 99.65 11.68 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 44.0 mt -101.19 175.04 5.72 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.166 0.986 . . . . 0.0 109.613 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.425 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 5.7 p90 -155.93 156.6 34.85 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.866 0.841 . . . . 0.0 109.648 177.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -135.16 -179.73 5.81 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -54.18 -32.09 54.6 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 125.598 1.559 . . . . 0.0 112.298 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 58.2 t -73.9 -59.06 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.222 1.009 . . . . 0.0 109.13 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -178.96 -168.7 38.5 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 124.552 1.072 . . . . 0.0 111.726 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.425 ' CD2' ' HB3' ' A' ' 176' ' ' TYR . 24.4 m-85 -83.35 161.25 21.45 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.681 1.193 . . . . 0.0 112.36 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -168.03 168.97 11.58 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.78 2.032 . . . . 0.0 109.026 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 15.9 mt -114.28 138.37 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.0 t -111.25 123.54 50.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.902 1.281 . . . . 0.0 108.102 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.4 109.94 11.49 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 177.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 2.3 tt -100.82 126.09 54.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.437 HG21 ' HD3' ' A' ' 163' ' ' PRO . 7.2 mt -116.44 112.37 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.144 0.978 . . . . 0.0 110.989 -177.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -108.57 -161.27 20.26 Favored Glycine 0 CA--C 1.522 0.492 0 C-N-CA 124.784 1.183 . . . . 0.0 111.126 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.441 ' HB3' ' HB3' ' A' ' 162' ' ' LYS . 0.4 OUTLIER 74.44 31.86 0.99 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.411 1.485 . . . . 0.0 110.386 -179.265 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -87.97 -102.18 0.91 Allowed Glycine 0 C--N 1.336 0.548 1 N-CA-C 102.788 -4.125 . . . . 0.0 102.788 177.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -145.88 160.54 41.66 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 24.2 mm -92.49 132.71 36.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 125.026 1.33 . . . . 0.0 109.141 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 59.3 m -88.4 93.86 9.67 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 100.329 -3.952 . . . . 0.0 100.329 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -53.42 -24.45 12.6 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -177.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -51.11 -34.32 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 125.99 1.716 . . . . 0.0 111.334 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.1 p -126.08 -25.63 3.53 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.879 0.872 . . . . 0.0 112.36 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 92.57 19.5 37.7 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.803 1.192 . . . . 0.0 111.722 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -95.79 165.18 12.42 Favored 'General case' 0 N--CA 1.454 -0.225 0 O-C-N 121.269 -1.136 . . . . 0.0 110.285 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -96.25 147.22 24.0 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.812 0.845 . . . . 0.0 109.163 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -75.56 28.3 0.1 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.971 2.108 . . . . 0.0 110.286 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.9 ptm -72.62 146.19 46.8 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.507 1.146 . . . . 0.0 108.299 -176.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.3 p -120.1 140.03 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 113.901 -1.5 . . . . 0.0 112.549 -176.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -105.13 131.74 52.23 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.1 mp -115.91 113.98 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -97.31 109.08 21.91 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -85.53 118.05 24.81 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.54 0.736 . . . . 0.0 109.585 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.79 172.89 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 125.732 1.613 . . . . 0.0 112.184 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.6 t -86.38 136.58 33.07 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.108 1.763 . . . . 0.0 108.405 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.93 158.05 32.88 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -63.52 -68.29 1.72 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 108.266 -1.934 . . . . 0.0 108.266 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 17.0 p -81.6 91.5 6.4 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 104.084 -2.561 . . . . 0.0 104.084 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -72.51 37.44 0.07 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.753 2.421 . . . . 0.0 113.487 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.4 m -138.22 46.12 2.06 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 115.097 1.518 . . . . 0.0 115.097 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -156.9 175.08 34.51 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -71.66 165.65 31.86 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.071 1.847 . . . . 0.0 110.733 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 52.0 p -72.93 153.89 40.78 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.338 1.055 . . . . 0.0 110.519 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -169.27 160.71 9.71 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.261 1.424 . . . . 0.0 108.652 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.8 127.83 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -72.24 -60.95 1.97 Allowed 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.868 1.667 . . . . 0.0 109.8 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' TRP . . . . . 0.412 ' CE3' ' HD2' ' A' ' 222' ' ' ARG . 40.7 p-90 -143.03 168.46 19.66 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.859 2.064 . . . . 0.0 109.091 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.603 HG13 ' CE1' ' A' ' 229' ' ' TYR . 55.9 t -144.2 145.3 21.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 126.283 1.833 . . . . 0.0 106.42 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.412 ' HD2' ' CE3' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -164.34 118.8 1.44 Allowed 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.143 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -75.64 92.2 2.93 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 102.285 -3.228 . . . . 0.0 102.285 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 4.8 p -56.09 -55.2 35.83 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.853 1.261 . . . . 0.0 112.408 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -111.59 -172.54 2.06 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.595 ' H ' HD12 ' A' ' 226' ' ' ILE . 3.8 mp -62.23 -38.67 81.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 O-C-N 121.396 -0.815 . . . . 0.0 110.214 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.76 -41.05 3.26 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.877 0.871 . . . . 0.0 112.285 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 10.0 t -64.49 132.25 30.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' TYR . . . . . 0.603 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.5 OUTLIER -130.82 141.7 50.35 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.335 1.454 . . . . 0.0 107.288 -179.297 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -127.01 141.83 51.69 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.75 161.8 38.34 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.445 1.498 . . . . 0.0 108.854 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -138.95 147.46 42.28 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 123.583 0.753 . . . . 0.0 109.99 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.4 m -132.76 151.65 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.127 0.571 . . . . 0.0 109.487 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.1 p -113.42 131.87 55.85 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 122.802 0.441 . . . . 0.0 109.814 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 85.3 mt -129.63 136.12 28.61 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.34 -40.34 0.85 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.207 1.938 . . . . 0.0 112.639 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -61.45 -26.22 67.74 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.38 0.672 . . . . 0.0 111.721 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 3.8 mp -66.29 -35.17 79.71 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.762 0.71 . . . . 0.0 109.309 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 44.0 m -59.51 -19.63 49.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.725 1.21 . . . . 0.0 113.234 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -62.85 -34.52 77.52 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.567 0.747 . . . . 0.0 110.581 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 47.9 mt -73.1 118.92 16.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.218 1.407 . . . . 0.0 107.654 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -49.91 -39.75 41.0 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.0 mp -59.98 -34.32 73.15 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.191 -0.943 . . . . 0.0 111.19 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.407 HD22 ' N ' ' A' ' 244' ' ' LEU . 2.5 mm? -101.13 5.54 42.82 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 126.583 1.953 . . . . 0.0 112.495 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.461 0 C-N-CA 123.946 0.898 . . . . 0.0 109.646 179.441 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.1 p . . . . . 0 C--O 1.235 0.31 0 CA-C-O 119.676 -0.202 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.83 -43.61 92.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 48.6 tp -60.65 -48.36 82.13 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 124.034 0.934 . . . . 0.0 108.607 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.9 mt -58.58 -52.05 67.32 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.209 1.004 . . . . 0.0 110.016 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 97.3 m -56.64 -50.28 72.52 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.292 1.037 . . . . 0.0 110.662 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -64.23 -50.94 66.04 Favored 'General case' 0 C--O 1.224 -0.244 0 O-C-N 121.455 -0.778 . . . . 0.0 110.118 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.4 m -51.97 -43.24 63.47 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.411 1.084 . . . . 0.0 111.026 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.6 tt -58.47 -57.08 14.54 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 119.368 0.986 . . . . 0.0 110.122 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -63.64 -38.02 89.52 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -59.9 -36.03 76.12 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.493 ' HA3' HD11 ' A' ' 183' ' ' ILE . . . -66.93 -51.4 40.2 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.1 t -56.07 -52.97 44.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 118.483 1.142 . . . . 0.0 112.4 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.16 -32.66 68.42 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.907 0.776 . . . . 0.0 111.213 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.1 m -75.63 -46.71 30.02 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 122.845 0.458 . . . . 0.0 110.917 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.589 HD11 HD12 ' A' ' 183' ' ' ILE . 24.8 mt -55.75 -52.42 48.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.07 -41.38 83.26 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 123.778 0.674 . . . . 0.0 110.88 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -62.1 -50.63 71.15 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 118.376 0.534 . . . . 0.0 110.929 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.404 ' HE2' ' OE2' ' A' ' 237' ' ' GLU . 0.7 OUTLIER -67.1 -3.55 7.72 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.058 0.943 . . . . 0.0 113.444 -179.303 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.9 mt -115.22 -28.89 6.78 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.676 1.59 . . . . 0.0 110.075 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -62.18 -26.14 68.17 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.238 0.615 . . . . 0.0 110.612 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.09 -46.89 60.93 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.706 0.802 . . . . 0.0 109.289 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -160.85 147.71 15.29 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 125.703 1.601 . . . . 0.0 108.495 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 67.7 m -75.71 173.21 11.38 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.7 pt -128.61 146.75 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 C-N-CA 123.639 0.775 . . . . 0.0 110.59 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -142.01 162.14 36.22 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.549 0.74 . . . . 0.0 111.057 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -146.9 125.03 12.11 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.441 1.096 . . . . 0.0 109.715 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -87.93 102.35 14.63 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.5 67.04 7.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 66.13 -115.09 7.11 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -63.61 -36.96 85.54 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.099 -0.953 . . . . 0.0 113.146 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -107.31 154.2 21.62 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 120.499 1.5 . . . . 0.0 111.613 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 30.2 mt -118.45 135.23 59.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -110.12 127.61 54.99 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 105.55 -2.018 . . . . 0.0 105.55 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -123.11 119.9 31.66 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.408 1.883 . . . . 0.0 111.718 -177.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -119.87 126.07 50.05 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.034 1.334 . . . . 0.0 110.947 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 3.3 m -111.13 160.84 27.52 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.685 1.594 . . . . 0.0 114.624 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -65.6 87.1 0.21 Allowed 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 124.794 3.663 . . . . 0.0 112.417 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 55.93 56.47 23.8 Favored Glycine 0 C--N 1.331 0.29 0 O-C-N 121.216 -0.927 . . . . 0.0 111.727 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.2 mt -128.05 -66.18 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -178.89 173.56 1.2 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.532 1.933 . . . . 0.0 110.982 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.72 118.74 28.77 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 176.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.43 154.97 41.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.984 0.913 . . . . 0.0 111.016 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -117.87 136.2 53.6 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -146.45 156.44 43.29 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.45 1.1 . . . . 0.0 112.413 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -92.19 147.44 22.93 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 162.9 -163.9 35.58 Favored Glycine 0 C--N 1.336 0.554 0 CA-C-N 120.126 1.33 . . . . 0.0 113.231 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -123.24 135.61 54.34 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.922 1.689 . . . . 0.0 110.095 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 CA--C 1.53 0.184 0 C-N-CA 124.502 1.121 . . . . 0.0 108.726 -179.824 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 . . . . . 0 N--CA 1.443 -0.798 0 CA-C-O 121.95 0.881 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 72.2 mt . . . . . 0 C--N 1.326 -0.443 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 179.684 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 49.1 mt . . . . . 0 CA--C 1.515 -0.37 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.6 t -143.4 129.3 16.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -119.74 157.35 28.77 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 122.871 0.468 . . . . 0.0 112.013 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 26.6 mmm-85 -105.58 129.78 53.76 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.152 1.381 . . . . 0.0 107.907 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.9 mp -110.2 -65.66 1.14 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.516 0.726 . . . . 0.0 110.712 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -125.71 154.06 18.52 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -129.72 96.73 25.89 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.228 1.811 . . . . 0.0 108.913 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -74.35 -170.41 0.73 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.638 2.892 . . . . 0.0 108.796 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -100.88 165.38 11.38 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -81.46 -34.09 31.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.668 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -98.95 133.7 42.85 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 118.589 0.631 . . . . 0.0 110.355 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.6 p -58.26 -28.3 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.277 1.031 . . . . 0.0 109.611 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -69.01 -19.11 64.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 128.192 2.597 . . . . 0.0 112.84 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -99.62 -9.8 22.75 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.878 0.871 . . . . 0.0 110.476 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -70.3 161.5 30.26 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -140.35 95.64 2.91 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -101.37 167.38 10.21 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.539 1.136 . . . . 0.0 109.934 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -137.05 132.48 34.25 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.311 1.044 . . . . 0.0 110.12 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.4 tp -90.87 98.56 11.85 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 16.4 mt -107.19 -178.92 3.78 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.629 1.172 . . . . 0.0 109.494 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -155.47 161.66 40.9 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -136.6 -178.3 5.11 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 124.567 1.147 . . . . 0.0 108.437 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -56.34 -23.04 34.68 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.876 1.27 . . . . 0.0 111.511 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 58.6 t -81.67 -66.81 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -174.71 -164.22 29.18 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -77.22 160.03 29.23 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.299 0.64 . . . . 0.0 111.205 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -168.2 161.39 12.31 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.653 1.581 . . . . 0.0 109.381 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.589 HD12 HD11 ' A' ' 109' ' ' ILE . 4.1 mt -106.6 133.47 51.03 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 178.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 4.1 t -108.55 131.68 54.6 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -134.59 124.85 26.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.0 tt -115.38 140.15 38.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.3 mt -135.2 115.7 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 O-C-N 121.699 -0.626 . . . . 0.0 110.971 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -105.33 -168.0 23.83 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.683 1.611 . . . . 0.0 110.015 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.5 t 78.16 58.05 0.03 OUTLIER 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.452 1.901 . . . . 0.0 110.713 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -110.53 -104.21 2.81 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 106.941 -2.464 . . . . 0.0 106.941 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -153.97 119.61 5.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 42.6 mm -60.66 133.95 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 123.963 0.905 . . . . 0.0 109.108 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 58.9 m -86.36 106.52 17.46 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.11 -15.68 5.96 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.307 0.958 . . . . 0.0 112.964 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 49.0 t -58.28 -46.4 88.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.983 1.313 . . . . 0.0 110.34 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.6 p -119.89 -20.88 7.38 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.553 1.141 . . . . 0.0 111.71 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 81.95 13.25 79.83 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 127.14 2.305 . . . . 0.0 112.139 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -85.77 170.59 12.3 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.549 1.54 . . . . 0.0 110.823 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.09 153.54 22.63 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 122.104 0.954 . . . . 0.0 111.536 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 29.9 ttm-85 -92.76 29.97 1.67 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 127.769 2.428 . . . . 0.0 109.463 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.0 ptt? -73.93 154.58 39.31 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.6 p -122.61 144.4 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.453 -177.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -111.57 131.91 54.92 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.7 mp -123.48 119.5 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 125.097 1.359 . . . . 0.0 108.835 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -100.84 120.64 40.43 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.68 0.792 . . . . 0.0 108.951 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -99.4 123.1 43.38 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.838 0.745 . . . . 0.0 110.137 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 14.8 m -135.12 170.08 20.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.9 1.28 . . . . 0.0 111.389 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.1 136.04 41.14 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -92.59 108.17 3.61 Favored Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 107.548 -2.221 . . . . 0.0 107.548 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -34.99 -54.3 0.87 Allowed Glycine 0 C--N 1.338 0.647 0 C-N-CA 126.728 2.109 . . . . 0.0 113.473 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 14.9 m -79.56 71.27 6.15 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -50.15 23.1 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.647 1 C-N-CA 133.767 4.827 . . . . 0.0 118.406 -178.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 7.9 t -145.96 47.39 1.24 Allowed 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.154 -1.591 . . . . 0.0 110.891 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -140.46 166.98 25.68 Favored Glycine 0 C--N 1.336 0.571 0 O-C-N 120.508 -1.37 . . . . 0.0 110.405 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.34 168.92 23.68 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 CA-C-N 119.623 1.711 . . . . 0.0 108.915 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 99.1 p -72.23 153.42 41.59 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.9 p -160.44 165.16 31.54 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.561 1.545 . . . . 0.0 108.18 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.2 mp -84.92 132.08 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -78.95 -55.33 5.22 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 124.804 1.242 . . . . 0.0 111.297 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 33.2 p-90 -146.24 165.45 29.17 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.652 HG13 ' CE1' ' A' ' 229' ' ' TYR . 52.6 t -144.38 139.19 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 126.259 1.824 . . . . 0.0 106.19 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.22 134.86 11.69 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.606 0.717 . . . . 0.0 110.621 178.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -90.54 90.35 7.96 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.3 p -75.32 -46.05 35.76 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.227 1.011 . . . . 0.0 111.584 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -103.52 -179.61 4.0 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.2 mp -78.16 -27.8 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.5 t -118.27 -56.81 2.13 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.288 1.435 . . . . 0.0 111.24 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 3.7 t -60.02 141.42 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' TYR . . . . . 0.652 ' CE1' HG13 ' A' ' 221' ' ' VAL . 1.2 t80 -125.85 150.5 47.82 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.905 2.082 . . . . 0.0 109.035 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -131.44 138.7 49.16 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.777 1.631 . . . . 0.0 108.837 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.71 162.22 40.19 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.091 1.757 . . . . 0.0 111.745 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -132.38 147.66 52.39 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 89.3 t -129.59 139.07 52.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 126.065 1.746 . . . . 0.0 108.377 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.92 140.77 46.3 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 124.134 0.974 . . . . 0.0 109.678 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 56.9 mt -137.83 140.4 29.42 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.53 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.85 -45.04 0.31 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.049 2.499 . . . . 0.0 112.284 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.404 ' OE2' ' HE2' ' A' ' 112' ' ' LYS . 10.5 mt-10 -61.08 -25.69 67.12 Favored 'General case' 0 N--CA 1.461 0.124 0 O-C-N 121.235 -0.916 . . . . 0.0 111.914 -178.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.2 mp -60.1 -37.66 80.64 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 118.336 -0.84 . . . . 0.0 109.905 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 32.6 m -54.47 -26.7 32.71 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.819 1.648 . . . . 0.0 113.181 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -62.08 -30.15 70.8 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 41.7 mt -76.19 116.21 16.67 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.578 1.151 . . . . 0.0 112.151 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -48.19 -39.96 22.6 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.636 1.974 . . . . 0.0 114.853 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 13.4 mt -61.53 -34.08 74.91 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.183 -0.948 . . . . 0.0 112.968 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 1.9 mp -104.95 7.72 34.28 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.317 0 C-N-CA 129.084 2.954 . . . . 0.0 110.047 -178.523 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.534 0.331 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.8 90.04 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 118.616 0.644 . . . . 0.0 110.683 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 47.6 tp -61.53 -45.75 92.86 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.0 mt -64.5 -52.16 59.31 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.543 0.737 . . . . 0.0 110.484 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 53.3 m -54.89 -51.75 65.02 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.654 -0.654 . . . . 0.0 110.188 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -60.21 -46.59 89.23 Favored 'General case' 0 C--N 1.339 0.116 0 O-C-N 121.656 -0.652 . . . . 0.0 110.64 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.1 m -53.34 -45.96 69.3 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.093 0.957 . . . . 0.0 110.2 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 27.4 tp -59.45 -56.64 19.43 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.611 0.641 . . . . 0.0 110.721 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -56.56 -51.47 68.46 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 118.436 0.562 . . . . 0.0 111.723 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -55.2 -38.92 69.01 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.415 0.686 . . . . 0.0 109.674 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -67.04 -52.79 30.27 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 87.8 t -55.03 -53.32 35.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.734 1.214 . . . . 0.0 111.276 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -31.52 72.68 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 118.64 0.654 . . . . 0.0 110.822 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.0 m -69.71 -46.7 65.41 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.576 HD11 HD12 ' A' ' 183' ' ' ILE . 25.0 mt -57.33 -52.21 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.35 -41.02 88.24 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 119.171 -0.442 . . . . 0.0 111.466 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -60.54 -50.77 72.22 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.19 0.45 . . . . 0.0 110.79 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -71.32 -19.92 62.25 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.2 mp -102.8 -25.72 13.41 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.125 1.329 . . . . 0.0 111.526 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -55.12 -39.21 69.14 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 121.551 -0.718 . . . . 0.0 110.802 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.96 -42.73 89.58 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.487 -0.768 . . . . 0.0 111.184 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 -153.63 147.21 25.07 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 120.224 1.375 . . . . 0.0 112.403 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 60.7 m -76.14 167.88 21.06 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 36.3 pt -128.15 148.42 32.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.74 167.92 20.94 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.222 0.609 . . . . 0.0 112.141 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -151.04 127.43 10.66 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.318 1.447 . . . . 0.0 109.758 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -91.07 102.73 15.49 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.704 0.802 . . . . 0.0 109.176 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.27 66.75 8.53 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.89 -114.96 7.04 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -63.84 -32.87 74.53 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.036 0.934 . . . . 0.0 112.594 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -107.68 159.43 16.48 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 119.663 1.119 . . . . 0.0 111.094 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.6 mt -127.92 147.05 32.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.419 ' CD1' HG11 ' A' ' 221' ' ' VAL . 47.9 m-85 -123.05 128.62 50.4 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.295 1.838 . . . . 0.0 108.776 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -122.2 130.52 53.28 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.619 1.968 . . . . 0.0 110.01 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -124.21 119.41 29.28 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.398 1.479 . . . . 0.0 108.256 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 14.9 m -108.52 157.71 35.86 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 123.45 0.7 . . . . 0.0 111.274 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -65.69 87.41 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.552 1 C-N-CA 125.67 4.246 . . . . 0.0 115.55 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.58 34.42 89.85 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 119.479 -0.623 . . . . 0.0 111.851 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.5 mt -112.44 -67.22 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.487 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 11.7 pt-20 -173.26 168.21 4.7 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.73 1.612 . . . . 0.0 109.379 -178.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.63 120.38 29.37 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 177.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.2 m -138.33 156.56 30.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 124.832 1.253 . . . . 0.0 111.553 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -132.64 127.05 34.05 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.958 0.903 . . . . 0.0 108.835 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.407 ' HB3' ' HB ' ' A' ' 157' ' ' VAL . 7.4 p90 -136.93 159.25 42.44 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 126.909 2.084 . . . . 0.0 113.283 -178.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -87.36 153.3 21.56 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 159.75 -164.98 34.42 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.83 147.35 49.46 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 89.8 t . . . . . 0 C--O 1.235 0.311 0 C-N-CA 124.398 1.079 . . . . 0.0 110.604 -178.895 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 . . . . . 0 N--CA 1.442 -0.832 0 CA-C-O 121.366 0.603 . . . . 0.0 111.479 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 48.7 mt . . . . . 0 N--CA 1.442 -0.84 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 179.41 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 19.2 tp . . . . . 0 CA--C 1.531 0.242 0 CA-C-O 120.681 0.277 . . . . 0.0 110.607 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 138' ' ' PHE . 3.9 p -134.95 154.97 37.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.666 1.586 . . . . 0.0 110.002 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -143.32 151.38 40.42 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.125 1.37 . . . . 0.0 109.846 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 13.9 ptt-85 -99.18 135.49 40.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 125.513 1.525 . . . . 0.0 109.315 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.25 -65.67 1.1 Allowed 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 123.377 0.671 . . . . 0.0 109.722 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -130.73 150.21 19.25 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.75 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 6.5 ttpp -123.25 90.36 50.48 Favored Pre-proline 0 N--CA 1.451 -0.386 0 C-N-CA 125.932 1.693 . . . . 0.0 108.388 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.487 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 93.1 Cg_endo -70.59 175.14 9.19 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.956 2.438 . . . . 0.0 109.275 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -91.28 166.06 13.12 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.334 0.653 . . . . 0.0 110.531 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -77.61 -27.79 51.33 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.987 0.915 . . . . 0.0 113.316 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -112.99 137.89 50.71 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.725 1.21 . . . . 0.0 109.094 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.5 p -60.4 -27.34 39.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.22 1.008 . . . . 0.0 111.823 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -71.93 -8.32 53.78 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 129.128 2.971 . . . . 0.0 112.287 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -112.97 -5.13 13.81 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.676 1.99 . . . . 0.0 110.425 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 45.2 mmm-85 -82.55 165.73 19.87 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -134.24 96.59 3.64 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.421 ' CE2' ' HG3' ' A' ' 185' ' ' GLU . 77.5 m-85 -111.3 139.57 46.6 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.283 1.833 . . . . 0.0 107.459 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -131.03 137.11 49.03 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.272 1.029 . . . . 0.0 109.029 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 43.8 tp -88.52 103.3 15.76 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.468 1.107 . . . . 0.0 109.717 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 7.2 mt -119.63 177.64 4.87 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.845 1.258 . . . . 0.0 108.342 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.4 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 19.8 p90 -157.49 166.85 31.87 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.579 0.751 . . . . 0.0 110.019 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 178' ' ' ASP . 31.6 t70 -136.6 -178.46 5.18 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.427 ' H ' ' CG ' ' A' ' 177' ' ' ASP . 0.5 OUTLIER -54.51 -30.67 54.22 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 125.491 1.516 . . . . 0.0 111.36 179.647 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 20.2 t -77.52 -64.25 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.491 1.116 . . . . 0.0 110.012 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -169.67 -170.83 34.61 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 119.059 0.845 . . . . 0.0 112.491 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.4 ' CD2' ' HB3' ' A' ' 176' ' ' TYR . 8.1 m-85 -87.67 154.77 20.32 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 123.637 0.775 . . . . 0.0 110.816 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -159.72 172.83 17.01 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.719 1.208 . . . . 0.0 107.977 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.576 HD12 HD11 ' A' ' 109' ' ' ILE . 9.1 mt -117.41 137.96 49.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 177.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.2 t -106.0 118.29 36.23 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 124.916 1.385 . . . . 0.0 107.437 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.421 ' HG3' ' CE2' ' A' ' 172' ' ' PHE . 0.6 OUTLIER -123.82 107.78 11.77 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 178.031 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 2.1 tt -101.99 128.33 54.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.1 mt -120.4 111.1 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.955 1.302 . . . . 0.0 111.551 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -104.75 -159.01 23.65 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 125.7 1.619 . . . . 0.0 110.042 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 74.82 36.94 0.53 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.772 1.629 . . . . 0.0 109.735 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -89.89 -126.91 3.18 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 107.576 -2.21 . . . . 0.0 107.576 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -137.35 127.95 26.85 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.9 mm -61.45 129.36 24.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 123.499 0.719 . . . . 0.0 111.784 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 5.1 m -90.0 94.07 9.65 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 101.198 -3.63 . . . . 0.0 101.198 176.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -57.67 -17.72 16.52 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.4 m -53.05 -33.04 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.466 1.507 . . . . 0.0 109.854 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 1.4 p -122.35 -34.01 3.36 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 123.25 0.62 . . . . 0.0 111.33 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 95.46 22.79 20.85 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.284 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -111.1 165.59 11.76 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.299 1.84 . . . . 0.0 109.159 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -87.21 145.48 26.38 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.355 1.462 . . . . 0.0 111.954 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -79.05 29.81 0.21 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.638 2.775 . . . . 0.0 111.06 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.8 ptm -73.12 149.44 43.04 Favored 'General case' 0 C--O 1.239 0.512 0 O-C-N 121.124 -0.985 . . . . 0.0 109.504 -177.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -116.73 146.88 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.607 -177.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -115.05 127.98 55.96 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.7 mp -117.06 116.53 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.109 0.964 . . . . 0.0 108.412 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -100.32 113.69 26.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -92.2 116.78 29.24 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 28.3 m -125.31 169.84 16.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 125.789 1.636 . . . . 0.0 111.806 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -81.37 137.41 35.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -101.24 122.46 7.6 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 107.364 -2.294 . . . . 0.0 107.364 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -45.32 -46.13 11.13 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.37 1.462 . . . . 0.0 113.238 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 8.3 t -81.62 65.2 6.65 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -57.14 28.19 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 130.099 3.36 . . . . 0.0 117.538 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.1 t -138.78 47.1 1.95 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 120.637 1.562 . . . . 0.0 112.486 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -153.24 172.68 32.15 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -73.28 167.1 28.18 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.276 1.984 . . . . 0.0 109.799 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.19 155.71 34.28 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.66 159.77 12.21 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.241 1.416 . . . . 0.0 107.373 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.86 128.89 37.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -72.9 -61.01 1.96 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 124.08 0.952 . . . . 0.0 109.184 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' TRP . . . . . 0.459 ' CE3' ' HD2' ' A' ' 222' ' ' ARG . 28.6 p-90 -139.64 167.2 22.65 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.595 1.558 . . . . 0.0 109.443 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.742 HG13 ' CE1' ' A' ' 229' ' ' TYR . 24.9 t -144.01 129.15 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.459 ' HD2' ' CE3' ' A' ' 220' ' ' TRP . 0.1 OUTLIER -145.51 118.03 8.55 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.99 0.9 . . . . 0.0 109.417 178.053 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -76.36 94.58 3.64 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 102.714 -3.069 . . . . 0.0 102.714 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 17.4 p -61.45 -66.41 0.54 Allowed 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.274 0.629 . . . . 0.0 109.669 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -101.38 179.12 4.45 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 34.7 mm -62.07 -21.47 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 123.535 0.734 . . . . 0.0 111.871 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.01 -45.57 1.26 Allowed 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.243 0.617 . . . . 0.0 111.228 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 25.2 t -67.29 133.58 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' TYR . . . . . 0.742 ' CE1' HG13 ' A' ' 221' ' ' VAL . 1.2 t80 -130.09 144.63 51.45 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.752 1.621 . . . . 0.0 108.661 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -123.74 138.38 54.53 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 126.363 1.865 . . . . 0.0 107.944 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.1 156.51 43.94 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.868 1.267 . . . . 0.0 109.91 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -130.9 143.3 50.63 Favored 'General case' 0 CA--C 1.52 -0.211 0 O-C-N 121.344 -0.847 . . . . 0.0 110.673 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 61.1 t -125.61 140.89 47.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.44 1.496 . . . . 0.0 107.419 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.72 136.81 52.44 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 96.6 mt -133.02 143.47 48.67 Favored Pre-proline 0 C--O 1.236 0.385 0 CA-C-O 118.192 -0.909 . . . . 0.0 109.112 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.39 -44.2 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.34 2.026 . . . . 0.0 111.445 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -62.36 -20.3 64.26 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.721 1.208 . . . . 0.0 113.291 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 14.9 mt -69.63 -38.11 77.07 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.047 0.839 . . . . 0.0 109.982 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 34.5 m -54.31 -21.58 9.71 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.433 1.493 . . . . 0.0 113.61 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -61.94 -30.66 71.06 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.391 1.076 . . . . 0.0 110.835 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 52.8 mt -79.09 124.08 27.96 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -48.02 -45.41 31.94 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 126.267 1.827 . . . . 0.0 112.824 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 6.1 mp -60.7 -28.91 68.99 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.271 -0.893 . . . . 0.0 111.512 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -99.91 -0.68 39.05 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.596 1.558 . . . . 0.0 111.627 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.457 0 C-N-CA 125.744 1.618 . . . . 0.0 109.493 -179.808 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.4 p . . . . . 0 C--O 1.237 0.408 0 CA-C-O 119.545 -0.264 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.5 -45.59 93.24 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.415 0.686 . . . . 0.0 110.262 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.1 tp -62.74 -42.86 99.87 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 117.895 -1.05 . . . . 0.0 110.482 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.7 mt -58.99 -53.82 54.12 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.441 1.019 . . . . 0.0 109.123 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.6 m -56.1 -42.03 76.15 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.816 0.447 . . . . 0.0 110.129 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -65.72 -51.07 62.2 Favored 'General case' 0 CA--C 1.527 0.09 0 O-C-N 120.97 -1.082 . . . . 0.0 110.044 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.7 m -53.02 -43.19 66.34 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.182 1.393 . . . . 0.0 110.323 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.405 ' O ' HG23 ' A' ' 106' ' ' VAL . 19.9 tp -60.08 -55.55 32.57 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.943 0.792 . . . . 0.0 111.489 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -65.46 -40.07 92.77 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 118.867 0.758 . . . . 0.0 112.124 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -61.59 -41.46 97.46 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 124.052 0.941 . . . . 0.0 109.851 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.406 ' HA3' HD11 ' A' ' 183' ' ' ILE . . . -66.26 -49.47 57.09 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.412 HG13 ' CE1' ' A' ' 172' ' ' PHE . 62.6 t -54.52 -53.05 34.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 126.036 1.734 . . . . 0.0 111.412 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -32.99 74.77 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 118.133 0.424 . . . . 0.0 110.463 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.09 -42.78 72.28 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 118.324 0.511 . . . . 0.0 110.492 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.418 HD11 HD12 ' A' ' 183' ' ' ILE . 16.6 mt -53.4 -53.5 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.97 -42.36 98.16 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 118.643 -0.694 . . . . 0.0 110.422 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -61.44 -30.04 70.33 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.948 0.794 . . . . 0.0 111.174 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -91.96 -3.81 55.42 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.67 1.188 . . . . 0.0 112.511 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.9 mt -119.75 -29.28 5.05 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.041 1.291 . . . . 0.0 112.586 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -62.07 -24.77 67.3 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.46 0.704 . . . . 0.0 111.313 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -73.45 -46.62 47.29 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.657 1.183 . . . . 0.0 108.565 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -161.33 145.16 13.01 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.034 1.733 . . . . 0.0 108.951 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 33.9 m -76.19 173.73 10.99 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.322 0.649 . . . . 0.0 109.778 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 42.1 pt -125.55 151.56 31.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 123.794 0.838 . . . . 0.0 109.209 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.89 160.89 41.76 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 122.849 0.46 . . . . 0.0 109.901 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -150.95 125.13 9.35 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.568 -0.708 . . . . 0.0 111.278 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -84.58 101.73 12.34 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 178.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.21 67.2 9.55 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.32 -115.68 6.94 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -66.85 -33.74 76.28 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -106.78 160.37 15.53 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.464 1.029 . . . . 0.0 110.363 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 21.3 mt -125.07 133.52 69.25 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 N-CA-C 104.894 -2.262 . . . . 0.0 104.894 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.528 ' CD1' HG11 ' A' ' 221' ' ' VAL . 67.7 m-85 -110.63 131.64 54.88 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -121.49 128.36 52.0 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 125.245 1.418 . . . . 0.0 109.368 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -127.24 108.85 11.23 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 124.288 0.992 . . . . 0.0 112.096 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 1.7 m -98.23 159.28 31.07 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.038 0.935 . . . . 0.0 112.858 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.06 96.34 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.562 1 C-N-CA 125.925 4.417 . . . . 0.0 113.62 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 55.54 49.78 63.42 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-O 119.076 -0.847 . . . . 0.0 111.18 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 5.1 mt -125.95 -68.01 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.613 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -172.64 162.57 5.11 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -123.73 119.76 30.73 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 103.011 -2.959 . . . . 0.0 103.011 177.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.8 m -131.38 155.87 42.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 124.123 0.969 . . . . 0.0 111.166 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -122.51 131.63 53.94 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 177.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -146.11 157.41 43.84 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.972 0.909 . . . . 0.0 111.102 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -89.39 154.4 20.09 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 157.05 -163.62 32.41 Favored Glycine 0 C--N 1.33 0.231 0 O-C-N 120.175 -1.578 . . . . 0.0 110.768 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.09 144.3 51.06 Favored 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.4 p . . . . . 0 C--N 1.328 -0.368 0 C-N-CA 126.106 1.762 . . . . 0.0 106.454 -179.693 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 34.5 mm . . . . . 0 CA--C 1.547 0.832 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.414 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 47.3 mt . . . . . 0 C--O 1.233 0.206 0 N-CA-C 110.713 -0.106 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.9 p -142.8 141.69 27.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -132.5 157.83 43.65 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.605 1.562 . . . . 0.0 109.484 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -107.71 130.66 54.92 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.495 1.118 . . . . 0.0 109.746 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.4 -75.98 0.51 Allowed 'General case' 0 N--CA 1.458 -0.052 0 C-N-CA 124.434 1.093 . . . . 0.0 109.68 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -127.72 153.76 19.41 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -129.45 90.97 42.65 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.441 ' HD3' HG21 ' A' ' 187' ' ' ILE . 54.7 Cg_endo -74.87 173.67 14.06 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.965 2.444 . . . . 0.0 110.984 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -83.16 164.52 20.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.825 0.821 . . . . 0.0 109.493 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -81.92 -24.02 35.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.307 -1.315 . . . . 0.0 113.592 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -102.03 144.1 31.04 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.8 p -72.95 -31.53 36.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 121.426 0.631 . . . . 0.0 110.199 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.55 -21.93 66.65 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.822 2.049 . . . . 0.0 110.571 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -83.48 -18.41 38.65 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.288 -0.883 . . . . 0.0 112.302 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.502 ' HD3' ' CE1' ' A' ' 172' ' ' PHE . 3.0 mtt180 -76.36 172.34 13.07 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.175 0.59 . . . . 0.0 112.304 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -136.75 95.03 3.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.254 1.422 . . . . 0.0 107.988 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.502 ' CE1' ' HD3' ' A' ' 170' ' ' ARG . 85.7 m-85 -99.09 161.61 13.53 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.64 1.176 . . . . 0.0 109.535 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -141.51 129.51 21.97 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 118.671 0.669 . . . . 0.0 110.155 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 21.5 tp -87.88 99.66 12.29 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 26.5 mt -106.84 -179.67 4.0 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.758 1.223 . . . . 0.0 109.556 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 181' ' ' TYR . 4.1 p90 -159.72 159.88 33.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -140.81 -173.53 3.73 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -50.87 -34.03 26.4 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.953 1.701 . . . . 0.0 112.631 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 41.3 t -79.16 -73.47 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -165.65 -169.05 28.75 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 119.366 0.984 . . . . 0.0 111.959 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 176' ' ' TYR . 5.6 m-85 -78.49 156.37 29.35 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.269 0.628 . . . . 0.0 110.789 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -159.55 167.53 28.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.431 1.492 . . . . 0.0 107.616 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.418 HD12 HD11 ' A' ' 109' ' ' ILE . 9.3 mt -114.88 125.13 72.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.3 t -99.18 130.08 45.47 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -137.99 107.06 6.01 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 103.72 -2.696 . . . . 0.0 103.72 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.0 tt -99.65 140.45 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.441 HG21 ' HD3' ' A' ' 163' ' ' PRO . 15.2 mt -129.59 112.28 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 123.291 0.636 . . . . 0.0 110.092 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.34 -159.07 26.07 Favored Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.1 m 72.05 57.99 0.15 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.557 1.543 . . . . 0.0 109.286 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -116.4 -118.78 3.08 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 125.589 1.566 . . . . 0.0 109.501 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -140.59 122.81 15.8 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.366 1.466 . . . . 0.0 109.79 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.6 mm -61.15 119.29 4.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 126.065 1.746 . . . . 0.0 110.497 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 35.2 m -77.58 100.9 6.29 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -48.56 -29.7 4.51 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.737 1.615 . . . . 0.0 113.476 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 27.1 t -53.36 -40.84 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.186 1.394 . . . . 0.0 111.585 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 37.9 p -124.07 -18.4 5.92 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.694 0.759 . . . . 0.0 111.554 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 77.56 15.84 80.92 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 128.68 3.038 . . . . 0.0 111.994 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -86.45 168.9 13.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.068 1.347 . . . . 0.0 110.801 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -85.32 148.15 26.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.252 1.025 . . . . 0.0 108.443 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.91 29.93 0.99 Allowed 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 127.933 2.493 . . . . 0.0 111.232 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 11.9 ptt? -73.18 156.26 38.78 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.18 143.53 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.978 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -106.78 133.23 51.76 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.73 111.81 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 C-N-CA 124.378 1.071 . . . . 0.0 108.373 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -97.12 114.56 26.24 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -91.28 122.92 34.32 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.488 0.715 . . . . 0.0 110.142 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.82 176.49 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 125.864 1.666 . . . . 0.0 110.728 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.9 t -88.09 143.15 27.24 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -107.07 151.84 16.88 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -51.66 -61.55 6.3 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.843 1.687 . . . . 0.0 113.952 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 11.7 m -78.03 92.57 4.36 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 118.568 1.184 . . . . 0.0 108.669 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -66.42 17.36 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.041 2.536 . . . . 0.0 114.166 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 3.8 m -132.78 47.04 2.55 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 -177.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -157.88 175.51 35.12 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 120.647 -1.283 . . . . 0.0 111.552 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.44 162.6 37.89 Favored 'Trans proline' 0 C--O 1.239 0.562 0 C-N-CA 122.661 2.241 . . . . 0.0 110.959 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 12.4 p -69.38 162.09 28.03 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.875 0.87 . . . . 0.0 109.366 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.21 157.25 9.22 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.16 1.384 . . . . 0.0 107.927 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.83 132.32 33.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -81.25 -53.17 6.58 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 125.59 1.556 . . . . 0.0 111.377 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 41.3 p-90 -148.94 165.85 30.35 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 124.135 0.974 . . . . 0.0 108.446 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.749 HG13 ' CE1' ' A' ' 229' ' ' TYR . 49.1 t -145.67 136.39 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 127.146 2.179 . . . . 0.0 105.504 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.02 130.57 10.65 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -78.69 87.93 4.59 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' THR . . . . . 0.405 ' HB ' ' HE3' ' A' ' 225' ' ' LYS . 2.6 p -60.45 -53.45 57.41 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.423 0.689 . . . . 0.0 110.989 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.405 ' HE3' ' HB ' ' A' ' 224' ' ' THR . 17.5 mmtp -114.81 179.33 3.98 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.6 mp -66.22 -33.04 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -108.83 -65.05 1.17 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.871 0.868 . . . . 0.0 109.88 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 5.5 t -55.35 138.88 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 124.892 1.277 . . . . 0.0 109.749 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' TYR . . . . . 0.749 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.3 OUTLIER -133.49 151.03 51.71 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.698 1.999 . . . . 0.0 108.341 -178.845 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -132.22 141.06 48.91 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 126.109 1.764 . . . . 0.0 108.793 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.01 162.31 37.26 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.429 2.292 . . . . 0.0 111.177 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -134.48 147.64 50.41 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.746 0.818 . . . . 0.0 108.898 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 93.3 t -134.66 135.5 53.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 C-N-CA 124.687 1.195 . . . . 0.0 108.689 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.7 p -102.75 142.19 34.31 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.706 0.802 . . . . 0.0 108.979 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 34.0 mt -139.48 137.61 19.13 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 123.693 0.797 . . . . 0.0 109.9 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.34 -34.66 2.63 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.914 2.41 . . . . 0.0 113.029 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -67.81 -26.46 66.09 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.224 -0.922 . . . . 0.0 110.595 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 3.9 mp -65.9 -34.47 78.21 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 28.3 m -59.13 -11.16 3.35 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.252 1.421 . . . . 0.0 112.98 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -81.96 -30.34 31.76 Favored 'General case' 0 CA--C 1.528 0.098 0 O-C-N 120.16 -1.587 . . . . 0.0 111.142 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 23.8 mt -78.78 111.88 15.35 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.41 -27.87 1.86 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 116.404 2.001 . . . . 0.0 116.404 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 5.2 mp -63.68 -45.03 91.92 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.466 0.706 . . . . 0.0 110.445 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -82.21 3.59 26.76 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 127.002 2.121 . . . . 0.0 113.3 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.32 0 C-N-CA 127.949 2.5 . . . . 0.0 110.584 -177.546 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.9 m . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 118.79 -0.624 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.59 -46.06 84.48 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.662 1.119 . . . . 0.0 110.064 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.9 tp -66.39 -39.74 89.24 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.112 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.2 mt -60.95 -51.75 67.94 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.403 1.002 . . . . 0.0 110.392 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 90.1 m -55.12 -56.45 19.75 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.26 1.424 . . . . 0.0 109.906 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.04 -48.91 78.66 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-O 119.043 -0.503 . . . . 0.0 111.332 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 54.9 m -52.84 -50.39 63.82 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.439 0.695 . . . . 0.0 111.41 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.9 tp -58.59 -54.12 50.7 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.766 -0.635 . . . . 0.0 110.138 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -55.12 -51.54 66.1 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.555 0.742 . . . . 0.0 112.071 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -59.09 -40.08 84.19 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.24 -52.48 52.45 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-O 118.146 -1.363 . . . . 0.0 110.973 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.422 HG22 ' CG ' ' A' ' 172' ' ' PHE . 29.5 t -55.72 -53.19 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 119.255 1.528 . . . . 0.0 111.289 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -35.04 79.13 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.863 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.2 m -64.91 -45.24 86.7 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 41.0 mt -56.66 -54.36 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -56.7 -43.23 80.34 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 123.278 0.361 . . . . 0.0 110.466 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -67.56 -37.63 82.94 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.823 -0.548 . . . . 0.0 112.294 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.86 -1.97 41.45 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.935 0.894 . . . . 0.0 113.235 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.2 mt -119.39 -26.16 5.89 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 119.645 1.111 . . . . 0.0 111.744 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -58.7 -23.57 59.83 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -74.22 -43.17 58.19 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 117.946 -1.026 . . . . 0.0 111.383 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -156.23 150.21 25.19 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.523 1.129 . . . . 0.0 112.376 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 57.4 m -76.02 171.58 14.21 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 23.0 pt -129.38 156.12 41.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 123.955 0.902 . . . . 0.0 109.018 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -151.21 154.03 36.06 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 122.059 -0.401 . . . . 0.0 111.196 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -141.37 127.42 19.51 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 124.118 0.967 . . . . 0.0 110.699 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -87.22 118.13 26.43 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -109.84 67.41 0.65 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.045 2.138 . . . . 0.0 106.105 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.14 -120.8 8.03 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -66.46 -33.07 74.87 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.531 1.132 . . . . 0.0 112.508 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -106.92 145.31 32.37 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 118.737 0.699 . . . . 0.0 109.847 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 10.6 mt -116.06 151.16 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.494 ' CD1' HG11 ' A' ' 221' ' ' VAL . 42.3 m-85 -118.7 135.92 54.22 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 126.057 1.743 . . . . 0.0 106.447 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.63 131.43 48.07 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 125.661 1.584 . . . . 0.0 108.516 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -128.2 109.35 11.41 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.183 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 2.5 m -89.45 160.04 42.97 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 117.832 -1.08 . . . . 0.0 108.709 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -61.49 70.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 125.15 3.9 . . . . 0.0 116.145 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.46 48.74 65.6 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 125.257 1.408 . . . . 0.0 111.772 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.2 mt -114.65 -66.29 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -160.14 160.95 33.57 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.462 1.905 . . . . 0.0 107.915 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -123.46 120.81 34.02 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 102.525 -3.139 . . . . 0.0 102.525 177.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.94 155.52 27.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 123.593 0.757 . . . . 0.0 111.751 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -121.24 135.74 55.08 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -145.97 157.69 43.88 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 125.206 1.402 . . . . 0.0 111.144 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -88.78 151.44 22.39 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 164.68 -163.33 36.21 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.4 139.24 50.63 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.706 2.002 . . . . 0.0 106.268 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 91.5 t . . . . . 0 C--N 1.328 -0.335 0 C-N-CA 125.189 1.396 . . . . 0.0 109.594 -178.81 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 . . . . . 0 N--CA 1.454 -0.257 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 20.2 mt . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 179.784 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 93.3 mt . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.8 t -140.99 141.48 31.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -132.78 144.86 50.53 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.222 1.409 . . . . 0.0 110.084 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.3 mmt85 -93.39 114.19 26.54 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.937 1.295 . . . . 0.0 110.215 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.0 mp -89.85 -79.82 0.33 Allowed 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -118.58 157.23 15.33 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -133.63 88.63 33.18 Favored Pre-proline 0 N--CA 1.454 -0.258 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -77.37 172.2 16.36 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.069 2.513 . . . . 0.0 112.18 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -89.63 165.25 14.35 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 125.1 1.36 . . . . 0.0 111.659 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.95 -43.55 21.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.712 0.768 . . . . 0.0 110.708 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -78.96 130.0 35.1 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.666 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.7 p -64.88 -32.97 60.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 O-C-N 123.286 0.366 . . . . 0.0 110.149 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -67.72 -28.44 67.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.54 1.136 . . . . 0.0 112.049 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -71.81 -33.3 68.41 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -75.06 174.47 9.33 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.835 1.254 . . . . 0.0 109.251 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -143.53 149.28 37.23 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.422 ' CG ' HG22 ' A' ' 106' ' ' VAL . 41.5 m-85 -136.76 146.58 45.93 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.933 1.293 . . . . 0.0 107.966 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.99 123.35 40.18 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.816 1.246 . . . . 0.0 110.115 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 tt -86.6 106.31 17.47 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 45.2 mt -113.45 177.99 4.44 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.597 1.159 . . . . 0.0 110.689 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 181' ' ' TYR . 5.2 p90 -152.66 159.28 43.19 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 177.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -140.65 -178.42 5.51 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.43 -28.47 68.3 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 41.0 t -71.63 -56.66 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.256 1.022 . . . . 0.0 109.754 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 178.24 -173.69 46.11 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.713 ' CE2' HD22 ' A' ' 243' ' ' LEU . 2.5 m-85 -78.05 164.13 25.31 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.068 0.547 . . . . 0.0 109.726 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -164.19 170.55 16.19 Favored 'General case' 0 N--CA 1.461 0.095 0 C-N-CA 125.434 1.493 . . . . 0.0 109.076 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 5.9 mt -118.2 134.67 61.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 103.816 -2.661 . . . . 0.0 103.816 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 21.1 t -110.57 139.61 45.66 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -137.3 112.71 9.3 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 6.3 tt -101.52 140.3 20.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.8 mt -131.46 110.7 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.201 1.0 . . . . 0.0 109.853 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -101.32 -157.68 27.03 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 49.6 m 70.57 55.76 0.27 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.562 1.145 . . . . 0.0 112.205 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -114.42 -126.31 4.24 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -130.01 123.67 31.12 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.911 1.684 . . . . 0.0 107.508 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.0 mm -60.94 146.18 11.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 124.805 1.242 . . . . 0.0 111.371 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 64.4 m -105.92 91.31 3.68 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 103.776 -2.675 . . . . 0.0 103.776 177.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -49.8 -30.78 10.28 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.614 1.166 . . . . 0.0 113.11 -178.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 60.6 t -45.96 -40.2 3.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 127.168 2.187 . . . . 0.0 110.276 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 7.1 p -120.4 -27.36 5.21 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.002 0.521 . . . . 0.0 110.963 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 92.31 22.57 29.18 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.898 1.714 . . . . 0.0 110.724 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -101.6 164.49 11.73 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.666 1.233 . . . . 0.0 112.388 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -89.49 146.47 24.6 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.541 -1.209 . . . . 0.0 107.866 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -77.35 30.84 0.15 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 127.522 2.329 . . . . 0.0 111.203 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -73.61 145.01 45.74 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 1.4 p -112.4 142.3 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 C-N-CA 124.468 1.107 . . . . 0.0 110.058 -177.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -109.51 123.59 49.65 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.2 mp -115.34 121.55 67.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 124.444 1.098 . . . . 0.0 108.822 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -102.37 116.67 33.12 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.47 0.708 . . . . 0.0 109.683 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -96.02 117.94 31.65 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.918 1.287 . . . . 0.0 109.625 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 22.2 m -133.21 167.85 25.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 124.565 1.146 . . . . 0.0 112.035 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.6 t -81.19 128.49 33.83 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 177.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.6 137.11 13.07 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -51.43 -41.84 49.35 Favored Glycine 0 C--N 1.336 0.528 0 CA-C-O 119.014 -0.881 . . . . 0.0 112.385 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 4.7 m -80.71 74.9 7.63 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -71.33 30.88 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.218 2.207 . . . . 0.0 112.939 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 37.8 m -143.96 47.33 1.43 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.208 2.203 . . . . 0.0 108.242 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -155.11 164.2 31.77 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -78.25 172.76 14.88 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.874 2.382 . . . . 0.0 112.354 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 24.2 m -62.25 147.63 47.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.485 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -165.92 156.29 12.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.8 mt -87.6 127.81 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -72.43 -52.95 13.68 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.783 1.233 . . . . 0.0 110.996 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' TRP . . . . . 0.42 ' CZ2' ' HB2' ' A' ' 232' ' ' GLN . 39.9 p-90 -150.58 166.6 29.76 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.002 1.321 . . . . 0.0 109.395 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.817 HG13 ' CE1' ' A' ' 229' ' ' TYR . 40.4 t -146.46 128.42 7.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 C-N-CA 126.015 1.726 . . . . 0.0 106.795 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.414 ' HD2' ' CE3' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -146.26 124.8 12.43 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.361 0.6 . . . . 0.0 109.898 178.67 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -79.42 93.06 5.3 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 103.08 -2.933 . . . . 0.0 103.08 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.0 p -68.8 -53.59 20.81 Favored 'General case' 0 C--O 1.237 0.424 0 O-C-N 121.667 -0.646 . . . . 0.0 110.348 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -103.33 174.54 5.82 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 25.1 mm -62.94 -27.62 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 O-C-N 121.89 -0.506 . . . . 0.0 111.144 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.89 -52.68 1.99 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.778 0.831 . . . . 0.0 110.697 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 1.7 t -64.94 132.33 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.737 0.815 . . . . 0.0 109.187 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' TYR . . . . . 0.817 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.3 OUTLIER -124.49 154.77 40.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.327 1.851 . . . . 0.0 109.187 -178.985 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -131.23 137.77 49.05 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 125.937 1.695 . . . . 0.0 108.784 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -143.61 161.62 38.04 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 126.274 1.83 . . . . 0.0 110.544 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.42 ' HB2' ' CZ2' ' A' ' 220' ' ' TRP . 22.6 tt0 -137.63 143.76 41.57 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.9 m -133.69 146.59 31.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 123.808 0.843 . . . . 0.0 108.97 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.87 143.78 33.54 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.454 0.701 . . . . 0.0 110.08 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 22.9 mt -140.33 134.49 15.46 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.876 0.871 . . . . 0.0 109.135 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.12 -45.63 0.64 Allowed 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.176 1.917 . . . . 0.0 110.9 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -61.73 -21.43 64.5 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.4 mp -64.57 -36.32 83.84 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.685 1.13 . . . . 0.0 109.993 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 50.8 m -56.75 -23.53 43.49 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.022 1.729 . . . . 0.0 113.208 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -64.24 -26.98 68.74 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 121.236 -0.915 . . . . 0.0 112.769 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 28.9 mt -83.19 122.79 28.86 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -48.26 -41.27 27.26 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.95 2.1 . . . . 0.0 113.84 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.713 HD22 ' CE2' ' A' ' 181' ' ' TYR . 49.6 mt -63.52 -37.17 86.26 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.76 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 24.0 mt -97.29 6.67 47.98 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 127.19 2.196 . . . . 0.0 112.788 -177.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.311 0 C-N-CA 126.356 1.863 . . . . 0.0 108.644 179.777 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.9 p . . . . . 0 CA--C 1.532 0.27 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.49 -46.21 89.5 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 59.9 tp -59.65 -49.04 79.31 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.09 0.956 . . . . 0.0 109.098 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.9 mt -59.05 -50.49 73.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.363 1.065 . . . . 0.0 109.778 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 75.0 m -55.77 -52.48 63.83 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.225 1.41 . . . . 0.0 110.231 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -64.47 -41.9 96.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.214 1.006 . . . . 0.0 110.784 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 23.9 m -55.52 -51.69 66.19 Favored 'General case' 0 CA--C 1.523 -0.089 0 C-N-CA 125.284 1.434 . . . . 0.0 109.41 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 106' ' ' VAL . 12.5 tp -56.98 -52.37 65.49 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 118.669 -0.682 . . . . 0.0 109.933 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -56.79 -50.86 71.06 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.478 0.581 . . . . 0.0 111.303 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -55.76 -38.89 70.46 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.546 1.138 . . . . 0.0 109.443 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.64 -53.26 36.17 Favored Glycine 0 N--CA 1.437 -1.25 0 CA-C-O 118.323 -1.265 . . . . 0.0 110.181 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 102' ' ' LEU . 4.1 t -55.88 -53.13 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 119.297 1.548 . . . . 0.0 110.348 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -32.55 72.46 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 118.561 0.618 . . . . 0.0 112.007 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.3 m -68.2 -51.51 44.74 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.45 HD11 HD12 ' A' ' 183' ' ' ILE . 25.4 mt -55.1 -54.26 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.97 -39.14 80.84 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.648 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -61.89 -42.05 98.61 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 118.814 0.734 . . . . 0.0 111.257 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -82.0 -8.22 59.66 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 117.586 -1.197 . . . . 0.0 113.405 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.8 mp -111.65 -33.11 6.45 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 120.941 1.7 . . . . 0.0 110.87 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -53.67 -36.64 62.37 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 122.943 0.497 . . . . 0.0 110.876 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -61.94 -42.57 99.26 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 117.627 -1.178 . . . . 0.0 113.566 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -162.38 150.18 14.18 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 126.696 1.998 . . . . 0.0 111.261 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 31.5 m -75.96 167.27 22.17 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.713 0.805 . . . . 0.0 109.554 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.8 pt -125.55 157.27 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 125.256 1.423 . . . . 0.0 108.592 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.21 168.48 22.36 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.289 0.636 . . . . 0.0 111.667 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -151.68 119.94 6.35 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 124.883 1.273 . . . . 0.0 108.433 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -87.98 102.63 14.93 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.87 67.73 6.19 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.23 -116.2 9.02 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 107.815 -2.114 . . . . 0.0 107.815 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -65.51 -33.42 75.89 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -107.59 121.62 45.04 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 119.081 0.855 . . . . 0.0 111.128 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.5 mt -95.03 150.21 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.403 ' CD1' HG11 ' A' ' 221' ' ' VAL . 45.1 m-85 -119.61 137.87 53.59 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 126.149 1.78 . . . . 0.0 106.354 178.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.19 132.19 41.26 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 125.288 1.435 . . . . 0.0 109.11 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -130.3 112.28 13.17 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 124.893 1.37 . . . . 0.0 109.859 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 6.8 m -96.04 159.38 32.36 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.006 0.922 . . . . 0.0 111.018 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -64.87 88.02 0.18 Allowed 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 123.714 2.942 . . . . 0.0 114.046 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 56.98 54.56 35.96 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.3 mt -126.49 -66.52 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.418 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 8.6 pt-20 -167.5 163.37 14.78 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.178 1.791 . . . . 0.0 108.193 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -124.62 115.75 21.3 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 101.473 -3.529 . . . . 0.0 101.473 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.4 m -130.23 155.55 41.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 123.456 0.702 . . . . 0.0 111.849 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -119.26 126.68 52.07 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 104.961 -2.236 . . . . 0.0 104.961 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -144.91 157.67 44.07 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.885 0.874 . . . . 0.0 112.339 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -89.29 154.59 19.97 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 177.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 166.25 -162.86 36.42 Favored Glycine 0 CA--C 1.521 0.426 0 O-C-N 120.282 -1.511 . . . . 0.0 111.723 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.1 131.72 45.84 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 177.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.4 p . . . . . 0 C--O 1.239 0.529 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 179.952 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 . . . . . 0 N--CA 1.45 -0.459 0 CA-C-O 121.281 0.563 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 47.6 mt . . . . . 0 C--N 1.329 -0.286 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 179.607 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 C--O 1.232 0.174 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.8 t -142.63 132.76 23.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 124.983 1.313 . . . . 0.0 108.452 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -121.7 150.18 42.17 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.926 1.69 . . . . 0.0 109.872 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -101.42 117.07 34.2 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 35.0 mt -89.35 -72.92 0.53 Allowed 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -133.69 152.45 20.49 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -122.7 94.77 47.25 Favored Pre-proline 0 N--CA 1.447 -0.584 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.53 ' HB2' HH22 ' A' ' 170' ' ' ARG . 41.8 Cg_endo -79.13 179.53 6.37 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 122.559 2.173 . . . . 0.0 109.723 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -92.09 173.03 8.04 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -90.59 -41.44 11.35 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.769 0.668 . . . . 0.0 110.268 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -83.35 138.29 33.59 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 125.666 1.586 . . . . 0.0 108.504 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.44 -24.3 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -77.56 -20.73 53.63 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.834 0.853 . . . . 0.0 113.059 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -76.64 -37.28 56.59 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.787 0.804 . . . . 0.0 110.547 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.53 HH22 ' HB2' ' A' ' 163' ' ' PRO . 0.3 OUTLIER -84.72 174.4 9.94 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.531 0.732 . . . . 0.0 110.192 179.563 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -147.6 120.56 8.77 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -96.75 160.01 14.61 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -131.62 122.04 25.36 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.982 0.913 . . . . 0.0 110.966 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 22.0 tp -84.65 103.53 13.84 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.403 HD12 ' HB2' ' A' ' 184' ' ' SER . 36.0 mt -109.75 -179.84 3.92 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.134 1.374 . . . . 0.0 108.854 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.427 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 5.0 p90 -159.03 164.56 35.37 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.19 -0.944 . . . . 0.0 109.918 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -140.71 -178.29 5.46 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.1 -20.63 64.24 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.675 1.19 . . . . 0.0 110.641 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 74.0 t -79.65 -65.74 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -173.29 -172.27 38.65 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.122 1.344 . . . . 0.0 110.01 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.427 ' CD2' ' HB3' ' A' ' 176' ' ' TYR . 29.3 m-85 -83.69 164.47 19.62 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.538 0.735 . . . . 0.0 111.433 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -168.08 165.92 13.22 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.638 1.575 . . . . 0.0 109.247 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.45 HD12 HD11 ' A' ' 109' ' ' ILE . 4.8 mt -112.46 128.97 68.83 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.403 ' HB2' HD12 ' A' ' 175' ' ' LEU . 40.3 t -97.11 130.78 44.34 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 126.155 1.782 . . . . 0.0 108.205 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -138.15 107.48 6.12 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 7.6 tt -100.53 140.53 19.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 5.6 mt -131.76 111.26 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 123.72 0.808 . . . . 0.0 110.532 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.72 -161.21 25.85 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 178.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 50.6 m 71.38 50.08 0.29 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.234 1.814 . . . . 0.0 112.206 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -105.5 -95.2 2.38 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 107.514 -2.234 . . . . 0.0 107.514 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -154.48 123.78 6.45 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.553 1.541 . . . . 0.0 110.854 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.4 mm -65.6 116.87 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 119.616 1.098 . . . . 0.0 108.886 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 19.8 p -69.83 119.84 14.66 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 122.524 0.33 . . . . 0.0 110.908 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -70.72 -8.47 52.36 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.581 -0.699 . . . . 0.0 110.145 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 23.1 t -65.23 -42.93 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 126.359 1.864 . . . . 0.0 109.042 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 6.7 p -125.88 -27.88 3.27 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.948 0.795 . . . . 0.0 112.814 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 97.74 19.28 25.16 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 126.801 2.143 . . . . 0.0 110.036 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -107.25 168.3 9.31 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 119.2 1.5 . . . . 0.0 112.45 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.45 163.0 27.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 122.289 1.042 . . . . 0.0 111.401 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -99.3 29.09 4.12 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 126.514 1.926 . . . . 0.0 108.059 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -73.08 148.08 44.36 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.781 0.8 . . . . 0.0 110.433 -175.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.2 p -116.02 141.53 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.542 -177.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -110.65 124.52 52.06 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.6 mp -113.3 128.03 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 125.649 1.58 . . . . 0.0 109.059 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -108.4 107.7 18.36 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.581 1.152 . . . . 0.0 108.578 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -84.0 122.47 28.81 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 107.886 -1.154 . . . . 0.0 107.886 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 23.0 m -131.45 169.86 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 125.767 1.627 . . . . 0.0 112.527 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -83.11 144.05 30.13 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.633 -1.292 . . . . 0.0 107.735 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -113.39 123.62 6.23 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -32.04 -62.2 0.29 Allowed Glycine 0 CA--C 1.523 0.55 0 C-N-CA 128.954 3.169 . . . . 0.0 114.765 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 2.0 p -78.02 89.79 4.18 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -67.33 35.09 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.107 2.163 . . . . 0.0 115.488 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.4 m -148.5 45.82 1.04 Allowed 'General case' 0 CA--C 1.54 0.559 0 O-C-N 119.837 -1.789 . . . . 0.0 111.161 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.54 162.59 28.48 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.02 169.86 20.34 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.849 2.366 . . . . 0.0 112.036 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 10.3 m -70.7 156.09 39.93 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -168.45 155.88 7.87 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.8 mt -77.73 134.17 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -74.14 -61.43 1.86 Allowed 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 41.7 p-90 -140.25 166.47 24.61 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 125.812 1.645 . . . . 0.0 109.121 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.586 HG13 ' CE1' ' A' ' 229' ' ' TYR . 53.3 t -147.5 134.6 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.19 131.35 11.08 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -85.69 86.37 7.37 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 101.629 -3.471 . . . . 0.0 101.629 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 8.6 p -61.2 -58.09 9.73 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.88 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 56.3 mmtt -91.61 -172.82 3.35 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.7 mp -74.54 -36.61 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 121.021 -1.049 . . . . 0.0 109.492 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 4.6 m -120.91 -43.08 2.47 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.468 0.707 . . . . 0.0 111.835 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 1.1 t -67.7 136.11 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' TYR . . . . . 0.586 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.7 OUTLIER -124.11 148.02 47.48 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.41 2.284 . . . . 0.0 110.011 -178.01 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -126.18 138.21 53.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.369 2.268 . . . . 0.0 106.655 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.95 161.98 38.84 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.943 1.697 . . . . 0.0 111.065 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -138.35 149.67 45.82 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.453 0.701 . . . . 0.0 109.962 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 72.2 t -133.18 135.96 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.593 1.157 . . . . 0.0 109.306 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.37 130.0 53.57 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.171 1.389 . . . . 0.0 111.26 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 33.4 mt -133.56 138.49 31.29 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-O 118.612 -0.708 . . . . 0.0 110.522 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.76 -43.9 1.63 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.213 2.609 . . . . 0.0 112.467 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -63.57 -20.44 65.64 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 37.1 mt -72.01 -35.28 69.38 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-O 118.828 -0.606 . . . . 0.0 110.037 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 48.2 m -56.3 -21.67 25.53 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.393 1.477 . . . . 0.0 113.149 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -65.98 -31.39 72.27 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.626 0.77 . . . . 0.0 112.115 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 64.4 mt -77.02 116.46 17.7 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -48.1 -37.12 14.56 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.5 mp -63.73 -36.76 84.94 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.01 -1.056 . . . . 0.0 110.028 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -91.87 3.21 55.69 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.746 2.019 . . . . 0.0 112.704 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.714 0 C-N-CA 123.779 0.832 . . . . 0.0 111.002 179.688 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 43.4 p . . . . . 0 CA--C 1.528 0.114 0 CA-C-O 119.395 -0.336 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.94 -48.81 75.05 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.908 0.883 . . . . 0.0 108.774 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 41.6 tp -57.71 -46.76 83.95 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.9 mt -59.1 -53.22 60.79 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.458 0.703 . . . . 0.0 109.704 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 38.6 m -55.1 -43.64 74.21 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.132 1.373 . . . . 0.0 110.803 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.75 -51.52 33.38 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 117.843 -1.075 . . . . 0.0 109.013 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 42.0 m -54.36 -44.26 72.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 119.701 1.137 . . . . 0.0 110.971 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.3 tp -60.12 -55.51 32.96 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 118.686 0.675 . . . . 0.0 109.612 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -56.72 -49.55 74.84 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.779 1.232 . . . . 0.0 110.598 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -57.35 -49.81 74.95 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.722 1.209 . . . . 0.0 108.543 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.78 -46.45 94.48 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 49.9 t -58.8 -52.23 62.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 C-N-CA 126.096 1.758 . . . . 0.0 111.133 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -32.66 74.45 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 119.552 1.069 . . . . 0.0 109.732 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.5 m -66.85 -43.27 84.11 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 34.7 mt -59.16 -51.89 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -35.68 72.27 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.98 -0.533 . . . . 0.0 111.297 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -66.89 -56.56 9.73 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.244 0.929 . . . . 0.0 109.953 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.89 -24.12 66.74 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -178.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 80.5 mt -94.31 -27.93 15.84 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 119.045 0.839 . . . . 0.0 109.955 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -64.1 -27.33 69.02 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 121.663 -0.648 . . . . 0.0 109.709 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -63.74 -46.89 83.3 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.346 1.058 . . . . 0.0 109.012 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -163.37 156.46 18.87 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 126.073 1.749 . . . . 0.0 110.487 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 76.8 m -75.84 176.2 8.03 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 34.1 pt -135.58 149.78 28.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.69 168.13 20.92 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.091 0.556 . . . . 0.0 111.337 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -154.96 128.54 8.55 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.339 1.056 . . . . 0.0 112.16 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -92.45 102.61 15.07 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.4 0.68 . . . . 0.0 109.35 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.92 67.63 8.23 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.461 1.904 . . . . 0.0 106.558 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 67.21 -115.36 7.08 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -68.25 -33.22 73.98 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 118.789 -0.624 . . . . 0.0 112.188 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -106.25 154.18 21.1 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 119.794 1.179 . . . . 0.0 111.603 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.7 mt -121.36 149.94 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.529 ' CD1' HG11 ' A' ' 221' ' ' VAL . 53.1 m-85 -126.76 129.08 47.66 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 127.014 2.125 . . . . 0.0 107.993 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -125.3 125.21 43.16 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 127.104 2.162 . . . . 0.0 109.13 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -122.68 126.67 48.05 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.978 1.311 . . . . 0.0 109.637 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.445 ' HB3' HD12 ' A' ' 133' ' ' ILE . 17.8 m -113.72 157.24 42.19 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.641 0.776 . . . . 0.0 112.77 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -60.29 90.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.354 0.845 1 C-N-CA 126.163 4.575 . . . . 0.0 115.976 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 62.21 31.05 77.71 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.874 -0.491 . . . . 0.0 111.874 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.445 HD12 ' HB3' ' A' ' 130' ' ' CYS . 4.9 mt -110.64 -66.08 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.252 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.52 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 9.4 pt-20 179.67 164.74 1.08 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.753 1.621 . . . . 0.0 109.689 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.35 123.12 38.7 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.2 m -131.23 155.85 42.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 124.385 1.074 . . . . 0.0 111.747 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -123.29 122.72 39.04 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.908 1.683 . . . . 0.0 108.144 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -146.45 156.71 43.49 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.364 1.066 . . . . 0.0 111.404 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -93.15 153.53 18.59 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 168.18 -163.71 37.39 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -116.18 142.9 46.21 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.234 0.25 0 C-N-CA 124.004 0.922 . . . . 0.0 108.886 -179.141 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 . . . . . 0 C--O 1.237 0.397 0 CA-C-O 120.641 0.257 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.3 mt . . . . . 0 C--N 1.328 -0.349 0 N-CA-C 103.66 -2.719 . . . . 0.0 103.66 178.339 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 76.9 mt . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 41.9 t -137.96 138.12 44.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -141.56 153.51 44.88 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.364 1.465 . . . . 0.0 108.33 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -109.88 127.92 55.02 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.508 1.523 . . . . 0.0 110.513 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -90.66 -71.16 0.64 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -133.59 160.66 24.08 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 124.137 0.875 . . . . 0.0 111.759 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -130.36 90.6 40.91 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 126.167 1.787 . . . . 0.0 107.879 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.52 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 54.6 Cg_endo -75.95 -175.55 2.56 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 124.471 3.447 . . . . 0.0 110.288 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -110.75 161.19 16.03 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.915 0.886 . . . . 0.0 110.314 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.15 -29.55 57.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.731 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -99.11 133.79 42.89 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.6 p -67.18 -26.43 36.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 122.917 0.487 . . . . 0.0 110.349 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -74.0 -16.19 61.07 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.145 1.778 . . . . 0.0 112.548 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -91.94 -13.69 30.74 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.63 1.572 . . . . 0.0 108.744 177.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -107.15 175.25 5.56 Favored 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 126.961 2.104 . . . . 0.0 107.786 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -148.07 152.34 37.2 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -138.6 165.52 26.68 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.784 1.234 . . . . 0.0 107.819 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -139.37 122.59 16.97 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.477 1.111 . . . . 0.0 109.296 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 25.7 tp -88.89 100.16 12.96 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 54.1 mt -106.29 -179.55 3.97 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.281 2.233 . . . . 0.0 110.504 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -156.54 151.8 26.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.137 0.975 . . . . 0.0 109.035 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -134.32 -174.54 3.59 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.066 1.746 . . . . 0.0 106.621 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -54.87 -31.4 59.7 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.997 2.119 . . . . 0.0 112.035 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 73.0 t -69.81 -67.53 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -177.61 -163.6 29.71 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.534 ' CE2' HD22 ' A' ' 243' ' ' LEU . 3.3 m-85 -78.19 160.95 27.68 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.421 0.688 . . . . 0.0 109.397 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -165.84 168.4 15.97 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.27 1.428 . . . . 0.0 109.453 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.0 mt -117.45 124.85 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.3 t -102.16 133.44 47.01 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -137.04 111.57 8.63 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.6 tt -101.1 127.82 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 5.8 mt -120.39 114.13 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.29 1.036 . . . . 0.0 111.522 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.0 -172.81 27.64 Favored Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 125.17 1.367 . . . . 0.0 111.455 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.2 t 84.57 58.52 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 128.242 2.617 . . . . 0.0 110.808 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -110.23 -127.4 5.28 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 107.656 -2.178 . . . . 0.0 107.656 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -126.82 118.79 25.34 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 19.1 mm -59.82 134.53 25.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 18.9 p -89.25 106.73 18.63 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -63.66 -12.22 32.18 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 119.104 0.865 . . . . 0.0 110.385 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 29.0 t -60.73 -42.01 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 126.937 2.095 . . . . 0.0 109.767 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 3.5 p -125.23 -24.06 4.05 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.856 0.753 . . . . 0.0 112.504 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 87.51 29.31 22.08 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 108.499 -1.84 . . . . 0.0 108.499 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -108.15 164.55 12.2 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 122.545 1.165 . . . . 0.0 111.283 178.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -91.51 138.41 31.59 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 1.8 mtt85 -70.69 29.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 129.921 3.288 . . . . 0.0 112.784 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 16.0 ptt? -72.46 148.81 44.77 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.018 0.913 . . . . 0.0 110.552 -174.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -115.91 143.39 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.369 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -108.26 133.61 52.25 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.41 110.17 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -95.21 108.4 20.53 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.656 0.782 . . . . 0.0 109.814 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -84.68 126.85 33.73 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.054 0.542 . . . . 0.0 109.726 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 32.3 m -139.27 175.65 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 125.877 1.671 . . . . 0.0 112.315 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.9 t -93.0 126.16 37.94 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.533 1.533 . . . . 0.0 107.563 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.12 164.82 44.57 Favored Glycine 0 N--CA 1.467 0.756 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -54.12 -76.12 0.2 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 125.094 1.33 . . . . 0.0 110.394 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 47.8 m -70.85 145.73 50.08 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 34.0 p30 -117.26 33.26 5.71 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 29.6 m -134.78 47.33 2.38 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.733 1.213 . . . . 0.0 113.433 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -153.54 165.71 31.53 Favored Glycine 0 CA--C 1.524 0.615 0 O-C-N 120.451 -1.405 . . . . 0.0 110.333 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -70.82 163.99 37.18 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.038 1.825 . . . . 0.0 110.327 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 14.1 p -67.24 155.83 37.86 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.236 1.014 . . . . 0.0 109.137 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -169.02 159.42 9.25 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.67 1.188 . . . . 0.0 108.711 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.6 mp -76.74 134.03 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -78.11 -55.34 5.36 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 125.973 1.709 . . . . 0.0 109.934 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' TRP . . . . . 0.402 ' CE3' ' CD ' ' A' ' 222' ' ' ARG . 27.9 p-90 -145.69 165.05 29.9 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 124.755 1.222 . . . . 0.0 108.686 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.766 HG13 ' CE1' ' A' ' 229' ' ' TYR . 39.0 t -144.47 127.39 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.402 ' CD ' ' CE3' ' A' ' 220' ' ' TRP . 0.3 OUTLIER -153.82 118.69 5.01 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 124.107 0.879 . . . . 0.0 109.189 179.355 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -74.64 95.2 2.79 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 102.626 -3.102 . . . . 0.0 102.626 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.7 p -63.73 -57.77 8.95 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.81 0.844 . . . . 0.0 111.69 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -100.87 -178.51 3.79 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.435 ' H ' HD12 ' A' ' 226' ' ' ILE . 4.4 mp -58.2 -41.55 81.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 O-C-N 121.79 -0.569 . . . . 0.0 110.022 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -123.52 -10.1 7.93 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -177.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 59.0 t -91.74 130.5 40.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' TYR . . . . . 0.766 ' CE1' HG13 ' A' ' 221' ' ' VAL . 1.1 t80 -123.38 143.51 50.07 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.218 1.007 . . . . 0.0 108.354 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -127.3 140.92 51.87 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 125.609 1.564 . . . . 0.0 107.451 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -139.7 159.04 43.09 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.272 1.829 . . . . 0.0 108.042 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -131.48 144.62 51.28 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 99.6 t -132.55 133.44 59.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.2 p -104.66 141.0 37.22 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 43.6 mt -137.36 137.12 21.55 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -72.99 -39.28 2.35 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.065 1.843 . . . . 0.0 112.127 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -60.52 -34.61 74.35 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.587 0.63 . . . . 0.0 111.338 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 5.1 mp -59.45 -29.95 68.15 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-O 118.745 -0.645 . . . . 0.0 111.428 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 57.2 m -63.57 -19.35 64.75 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.935 0.894 . . . . 0.0 112.618 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -67.46 -38.58 84.66 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.169 0.588 . . . . 0.0 111.086 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 49.6 mt -67.0 117.45 9.08 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.352 1.061 . . . . 0.0 108.539 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -48.36 -37.87 17.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.347 1.459 . . . . 0.0 114.874 -178.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.534 HD22 ' CE2' ' A' ' 181' ' ' TYR . 17.9 mt -62.72 -33.55 75.35 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.578 -0.702 . . . . 0.0 110.015 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -98.21 2.42 48.35 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.986 2.115 . . . . 0.0 113.064 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.517 0 C-N-CA 124.534 1.134 . . . . 0.0 107.998 179.036 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.9 p . . . . . 0 CA--C 1.535 0.376 0 CA-C-O 119.726 -0.178 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.68 -45.21 91.13 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.479 -0.763 . . . . 0.0 108.971 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 45.8 tp -58.42 -44.79 89.22 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.707 1.203 . . . . 0.0 108.434 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 11.5 mt -64.05 -54.92 26.59 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.238 1.015 . . . . 0.0 110.184 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.3 m -57.14 -44.24 83.19 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.03 -1.044 . . . . 0.0 110.784 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -62.31 -50.46 71.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 120.977 -1.077 . . . . 0.0 108.441 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.0 m -56.0 -40.77 73.85 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.144 0.977 . . . . 0.0 110.477 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.503 ' O ' HG23 ' A' ' 106' ' ' VAL . 13.6 tp -62.29 -53.33 56.64 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.726 0.694 . . . . 0.0 109.136 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -58.34 -48.33 80.9 Favored 'General case' 0 C--N 1.335 -0.064 0 C-N-CA 123.43 0.692 . . . . 0.0 110.616 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -60.86 -42.88 98.73 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.374 1.47 . . . . 0.0 110.269 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.11 -47.11 85.13 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 102' ' ' LEU . 94.5 t -57.87 -53.07 50.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 118.566 1.183 . . . . 0.0 110.125 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -31.4 72.55 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 119.177 0.899 . . . . 0.0 110.488 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.6 m -65.75 -48.11 72.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 40.8 mt -58.78 -53.02 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 C-N-CA 123.886 0.875 . . . . 0.0 108.805 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.47 -36.57 73.92 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.326 0.512 . . . . 0.0 111.31 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -63.58 -54.5 35.0 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.536 1.062 . . . . 0.0 108.318 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.21 10.59 0.55 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 128.399 2.68 . . . . 0.0 114.825 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.6 mt -132.68 -32.85 1.25 Allowed 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 124.636 1.174 . . . . 0.0 108.278 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -61.39 -34.43 75.33 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -59.14 -45.05 91.95 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.92 1.688 . . . . 0.0 111.922 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -166.72 153.04 8.52 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.593 1.957 . . . . 0.0 109.683 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.0 m -76.48 174.76 9.9 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 27.5 pt -131.66 152.16 36.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -146.75 165.05 30.82 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 122.91 0.484 . . . . 0.0 110.786 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -150.34 128.48 11.95 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.539 1.536 . . . . 0.0 110.595 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -94.27 102.8 14.82 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.463 1.105 . . . . 0.0 109.707 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.77 66.87 6.16 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.52 -115.47 7.67 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -63.6 -35.26 79.92 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.325 1.05 . . . . 0.0 112.213 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -107.14 153.45 22.63 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 119.211 0.914 . . . . 0.0 110.502 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.2 mt -119.92 152.68 22.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -124.97 132.47 53.27 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 127.182 2.193 . . . . 0.0 107.31 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -126.96 132.93 50.71 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 125.87 1.668 . . . . 0.0 107.376 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -129.49 111.52 12.84 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 6.6 m -100.37 159.0 30.92 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 123.814 0.846 . . . . 0.0 111.236 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -61.46 92.97 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 124.442 3.428 . . . . 0.0 114.121 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 54.95 39.28 67.97 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.062 -0.854 . . . . 0.0 112.217 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.4 mt -109.9 -66.94 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.412 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 9.7 pt-20 -171.32 161.34 6.47 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.982 1.713 . . . . 0.0 106.917 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -119.91 121.7 39.6 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 101.625 -3.472 . . . . 0.0 101.625 177.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.1 m -137.39 155.06 31.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 123.506 0.722 . . . . 0.0 111.725 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -119.91 132.6 55.59 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 177.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -146.34 158.19 43.86 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.235 1.014 . . . . 0.0 113.032 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -88.8 148.46 23.9 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 165.64 -162.93 36.3 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -178.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.95 147.04 50.81 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 124.497 1.119 . . . . 0.0 108.186 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 C--N 1.325 -0.478 0 C-N-CA 124.988 1.315 . . . . 0.0 107.813 179.78 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 . . . . . 0 N--CA 1.448 -0.551 0 CA-C-O 120.471 0.177 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 56.3 mt . . . . . 0 CA--C 1.549 0.928 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 177.414 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 43.3 mt . . . . . 0 C--O 1.231 0.096 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 12.2 t -140.91 135.44 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.924 1.29 . . . . 0.0 109.351 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -119.64 176.27 5.46 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.735 1.214 . . . . 0.0 110.972 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -128.31 120.31 26.82 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 26.2 mt -96.77 -67.37 0.85 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.738 1.215 . . . . 0.0 109.807 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -127.25 149.2 17.73 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 189' ' ' SER . 26.7 tttp -124.89 83.54 59.59 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 125.969 1.708 . . . . 0.0 108.261 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 63.8 Cg_endo -75.58 173.61 14.2 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.403 2.069 . . . . 0.0 109.928 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -92.89 161.57 14.43 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.554 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -80.68 -22.98 39.91 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.742 0.817 . . . . 0.0 112.929 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -112.35 147.51 36.22 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.157 0.983 . . . . 0.0 108.456 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.2 p -71.25 -32.14 46.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -74.14 -12.87 60.72 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -177.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -84.68 -18.67 34.56 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.474 0.309 . . . . 0.0 110.289 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -111.84 171.84 7.25 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.662 1.185 . . . . 0.0 111.983 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -138.69 117.14 12.03 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.445 1.098 . . . . 0.0 109.471 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.408 ' CD2' HG22 ' A' ' 106' ' ' VAL . 3.3 m-30 -96.76 158.29 15.5 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -130.55 126.6 37.18 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.081 0.553 . . . . 0.0 112.159 -177.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.2 tt -90.28 101.8 14.52 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.332 0.653 . . . . 0.0 110.504 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 5.2 mt -115.03 174.81 5.79 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.87 1.668 . . . . 0.0 108.333 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -143.02 163.96 31.37 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 120.345 -1.472 . . . . 0.0 109.069 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -137.94 -176.38 4.41 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.902 1.681 . . . . 0.0 110.388 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -69.39 5.28 1.37 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.401 1.88 . . . . 0.0 115.076 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 41.5 t -118.9 -63.98 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -162.51 -160.86 11.47 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 119.812 1.187 . . . . 0.0 111.888 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.547 ' CE2' HD22 ' A' ' 243' ' ' LEU . 3.1 m-85 -91.13 160.85 15.36 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -164.84 171.88 13.61 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 7.4 mt -121.07 133.57 67.28 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 4.4 t -111.13 132.11 54.55 Favored 'General case' 0 N--CA 1.439 -1.002 0 O-C-N 124.579 1.175 . . . . 0.0 108.752 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -133.64 111.57 10.72 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.8 tt -96.79 132.78 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.5 mt -124.32 111.4 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 124.501 1.121 . . . . 0.0 111.03 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -103.34 -158.54 25.01 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.468 ' HB3' ' HB3' ' A' ' 162' ' ' LYS . 1.6 t 70.69 28.29 3.5 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 127.062 2.145 . . . . 0.0 112.286 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -81.28 -90.45 0.56 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 103.611 -3.796 . . . . 0.0 103.611 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -157.14 165.97 34.54 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 29.2 mm -94.36 145.5 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 126.235 1.814 . . . . 0.0 108.448 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.8 p -107.71 98.41 8.01 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 106.114 -1.809 . . . . 0.0 106.114 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -63.22 -7.62 6.42 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 120.28 1.4 . . . . 0.0 112.444 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 86.0 t -63.65 -38.43 82.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 126.499 1.92 . . . . 0.0 108.147 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 21.0 p -119.45 -32.5 4.32 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.213 1.005 . . . . 0.0 110.539 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 88.72 32.95 10.47 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -118.01 -176.93 3.15 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.643 1.577 . . . . 0.0 109.116 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -102.89 148.34 25.77 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.878 0.871 . . . . 0.0 110.228 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.04 29.62 0.08 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 129.317 3.047 . . . . 0.0 111.312 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -72.74 151.48 42.12 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 120.819 -1.176 . . . . 0.0 110.967 -174.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.3 p -121.95 149.12 25.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.771 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -114.95 130.35 56.9 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.6 mp -117.63 111.91 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -96.04 108.39 20.8 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.651 1.18 . . . . 0.0 108.835 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -87.83 121.15 29.9 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.115 0.966 . . . . 0.0 111.677 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.71 163.86 36.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 126.085 1.754 . . . . 0.0 111.002 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.17 139.8 40.01 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -94.85 178.23 36.11 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -89.77 -39.14 6.29 Favored Glycine 0 CA--C 1.525 0.699 0 O-C-N 121.909 -0.759 . . . . 0.0 111.513 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.8 t -82.62 94.8 7.61 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.48 ' HA ' ' HB3' ' A' ' 236' ' ' PRO . 5.6 p30 -77.64 39.8 0.28 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.066 0.546 . . . . 0.0 111.246 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 41.0 p -156.7 26.26 0.33 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -138.18 176.99 20.39 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 118.676 0.671 . . . . 0.0 112.562 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.47 164.33 28.7 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.298 2.666 . . . . 0.0 112.098 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 8.6 t -70.91 159.58 34.41 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.89 161.85 7.22 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 126.079 1.752 . . . . 0.0 107.452 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.8 mp -82.2 130.08 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -71.15 -59.22 2.89 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.539 1.135 . . . . 0.0 110.351 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 29.6 p-90 -143.55 166.04 25.92 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 125.244 1.418 . . . . 0.0 108.552 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.653 HG13 ' CE1' ' A' ' 229' ' ' TYR . 42.7 t -145.55 127.74 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.82 118.23 8.48 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 177.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -77.81 91.27 4.1 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 101.002 -3.703 . . . . 0.0 101.002 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.7 p -56.75 -53.13 61.37 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.871 1.669 . . . . 0.0 113.513 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.495 ' HB2' ' H ' ' A' ' 228' ' ' VAL . 71.6 mmtt -116.14 176.63 5.01 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 16.9 mm -61.72 -30.52 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -122.69 -24.28 4.92 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.495 ' H ' ' HB2' ' A' ' 225' ' ' LYS . 21.8 t -90.28 135.67 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' TYR . . . . . 0.653 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.8 OUTLIER -131.81 142.13 49.64 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -179.517 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -127.17 140.04 52.53 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 125.111 1.364 . . . . 0.0 108.615 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -140.72 159.12 42.88 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.462 1.505 . . . . 0.0 109.042 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -130.56 139.63 50.46 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 79.7 t -122.06 146.74 26.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 124.503 1.121 . . . . 0.0 108.313 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.52 130.4 54.23 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 123.122 0.569 . . . . 0.0 109.98 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 63.4 mt -132.19 137.94 31.18 Favored Pre-proline 0 C--O 1.236 0.383 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.193 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.48 ' HB3' ' HA ' ' A' ' 212' ' ' ASN . 81.3 Cg_endo -74.89 -44.88 0.32 Allowed 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.188 1.926 . . . . 0.0 112.478 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.84 -25.76 21.15 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.681 1.192 . . . . 0.0 113.261 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 88.6 mt -67.49 -34.38 77.02 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-N 118.651 0.659 . . . . 0.0 112.762 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 19.0 m -57.66 -17.75 16.6 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.879 1.272 . . . . 0.0 114.312 -178.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -64.12 -29.02 70.17 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.941 -0.475 . . . . 0.0 110.363 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 30.0 mt -80.29 113.44 18.47 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -49.61 -30.74 9.31 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.547 HD22 ' CE2' ' A' ' 181' ' ' TYR . 17.5 mt -62.74 -36.18 82.18 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.756 -0.59 . . . . 0.0 109.535 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -95.28 2.96 54.96 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 126.888 2.075 . . . . 0.0 114.586 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.597 0 C-N-CA 126.58 1.952 . . . . 0.0 109.101 179.551 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.4 p . . . . . 0 CA--C 1.531 0.237 0 CA-C-O 118.858 -0.591 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.48 -45.56 92.48 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.001 0.819 . . . . 0.0 110.03 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.7 tp -60.95 -40.66 94.16 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 118.947 0.794 . . . . 0.0 109.449 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.4 mt -60.65 -54.38 46.02 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 55.9 m -54.2 -44.88 72.0 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.499 1.12 . . . . 0.0 111.534 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.2 ttmt -62.78 -50.99 68.85 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 m -56.88 -42.91 80.68 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 117.815 -1.088 . . . . 0.0 111.156 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.438 ' O ' HG23 ' A' ' 106' ' ' VAL . 20.9 tp -62.66 -53.48 53.93 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 119.881 1.219 . . . . 0.0 109.504 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -55.38 -52.41 63.62 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 123.91 0.884 . . . . 0.0 111.198 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -55.22 -50.48 69.31 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 125.008 1.323 . . . . 0.0 108.496 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.421 ' HA3' HD11 ' A' ' 183' ' ' ILE . . . -58.05 -50.27 67.57 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 123.91 0.767 . . . . 0.0 112.081 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 102' ' ' LEU . 89.9 t -59.18 -53.23 50.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 124.215 1.006 . . . . 0.0 110.136 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -30.86 71.9 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 118.983 0.811 . . . . 0.0 110.6 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.4 m -66.49 -45.15 80.6 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.426 HD11 HD12 ' A' ' 183' ' ' ILE . 31.0 mt -58.28 -53.84 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.21 -37.59 83.53 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.183 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -60.74 -44.46 96.63 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.215 1.006 . . . . 0.0 109.472 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.86 -19.29 44.81 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 71.0 mt -100.74 -25.06 14.26 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 121.132 1.787 . . . . 0.0 112.793 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -59.36 -21.12 59.37 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -71.2 -46.09 61.98 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.77 2.428 . . . . 0.0 110.542 179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -162.28 153.29 17.68 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 125.558 1.543 . . . . 0.0 112.456 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.6 m -76.36 159.92 30.06 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 175.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 24.7 pt -117.63 154.64 19.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -147.09 165.86 28.66 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.294 0.569 . . . . 0.0 111.217 -178.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -151.1 134.56 16.23 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.094 1.357 . . . . 0.0 109.555 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -97.45 105.39 17.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 123.52 0.728 . . . . 0.0 109.813 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.84 67.33 9.79 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.104 1.361 . . . . 0.0 107.609 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 69.76 -115.18 6.07 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -66.83 -32.4 73.66 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.028 1.331 . . . . 0.0 112.679 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -106.09 162.84 13.26 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 119.036 0.835 . . . . 0.0 111.89 -177.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 45.3 mt -130.66 149.43 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -125.49 129.81 50.53 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.182 2.193 . . . . 0.0 108.255 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -125.98 129.6 49.54 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.333 1.853 . . . . 0.0 109.392 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -124.03 117.16 24.08 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.941 1.696 . . . . 0.0 109.666 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 19.8 m -99.35 159.7 29.43 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.574 1.15 . . . . 0.0 111.056 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -62.78 87.24 0.11 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 124.797 3.665 . . . . 0.0 113.687 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 57.61 45.77 92.85 Favored Glycine 0 CA--C 1.527 0.814 0 O-C-N 121.201 -0.937 . . . . 0.0 112.0 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.5 mt -118.26 -66.74 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 118.607 1.203 . . . . 0.0 108.435 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -166.02 159.81 15.93 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 126.954 2.102 . . . . 0.0 107.885 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -123.92 117.65 25.27 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 102.072 -3.307 . . . . 0.0 102.072 177.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.0 m -128.9 156.24 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.43 1.092 . . . . 0.0 111.979 -178.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -127.26 127.51 44.5 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 178.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -146.4 159.4 43.43 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.201 1.4 . . . . 0.0 113.04 -178.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -88.7 153.58 20.98 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 177.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 163.2 -163.81 35.7 Favored Glycine 0 C--O 1.241 0.579 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -178.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.53 139.28 53.33 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 126.102 1.761 . . . . 0.0 106.607 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 C--N 1.323 -0.569 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 179.358 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 N--CA 1.445 -0.675 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.8 mt . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 178.493 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.5 mt . . . . . 0 N--CA 1.464 0.26 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.3 t -142.73 142.41 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 123.508 0.723 . . . . 0.0 109.88 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -139.95 159.26 42.59 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.367 1.467 . . . . 0.0 109.197 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.2 124.99 51.64 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.99 -62.54 1.54 Allowed 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 124.631 1.172 . . . . 0.0 109.557 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -139.92 158.29 25.66 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.9 ttpp -126.03 89.7 51.79 Favored Pre-proline 0 N--CA 1.452 -0.334 0 C-N-CA 124.875 1.27 . . . . 0.0 108.467 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -75.4 177.36 8.75 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.982 2.455 . . . . 0.0 109.502 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -91.63 155.57 18.24 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 121.788 -0.57 . . . . 0.0 111.588 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.42 -24.15 61.19 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 125.036 1.334 . . . . 0.0 113.277 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -109.61 148.49 31.21 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.753 1.621 . . . . 0.0 108.777 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.1 p -73.32 -32.87 39.16 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 C-N-CA 121.987 0.115 . . . . 0.0 111.267 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -72.95 -21.98 60.78 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 120.454 -1.404 . . . . 0.0 113.465 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -79.68 -17.72 53.01 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.295 0.638 . . . . 0.0 111.626 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.96 176.56 5.23 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.245 1.018 . . . . 0.0 111.15 178.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -146.76 137.1 23.67 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.712 1.205 . . . . 0.0 108.612 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.401 ' CD2' HG22 ' A' ' 106' ' ' VAL . 3.5 m-30 -127.05 159.67 33.44 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.706 2.803 . . . . 0.0 106.777 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -136.08 131.65 35.12 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.276 0.63 . . . . 0.0 112.165 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 35.2 tp -85.23 101.65 12.68 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.613 1.565 . . . . 0.0 108.413 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.43 HD12 ' HB2' ' A' ' 184' ' ' SER . 27.8 mt -113.55 -179.15 3.56 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.605 1.562 . . . . 0.0 109.603 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -153.46 158.07 40.82 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 52.4 p30 -134.8 -173.37 3.28 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 127.596 2.358 . . . . 0.0 107.094 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.55 -22.76 66.15 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.107 -1.621 . . . . 0.0 113.469 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 74.6 t -78.31 -53.48 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 178.3 -163.09 30.9 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-O 122.023 0.791 . . . . 0.0 112.368 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.475 ' CE2' HD22 ' A' ' 243' ' ' LEU . 3.0 m-85 -82.7 159.9 22.49 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -167.43 165.83 14.68 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.939 0.896 . . . . 0.0 109.684 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.426 HD12 HD11 ' A' ' 109' ' ' ILE . 5.8 mt -109.92 136.47 45.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 177.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.43 ' HB2' HD12 ' A' ' 175' ' ' LEU . 0.6 OUTLIER -110.96 116.74 31.73 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 125.106 1.362 . . . . 0.0 107.818 -179.153 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -116.3 108.67 16.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.2 tt -99.65 140.19 19.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.5 mt -135.66 107.43 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 124.335 1.054 . . . . 0.0 111.153 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -101.45 -157.19 26.87 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 18.1 m 68.23 34.26 3.98 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.759 0.424 . . . . 0.0 112.075 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -89.84 -96.34 1.12 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 103.812 -3.715 . . . . 0.0 103.812 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -150.54 170.58 18.79 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.99 1.716 . . . . 0.0 107.575 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 23.5 mm -100.64 123.06 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 126.365 1.866 . . . . 0.0 107.946 178.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 8.1 m -88.1 94.39 9.79 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 101.505 -3.517 . . . . 0.0 101.505 177.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -57.89 -15.63 9.26 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 3.1 m -55.91 -35.62 41.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.003 0.921 . . . . 0.0 108.87 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 75.0 p -114.87 -24.45 8.65 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.569 1.148 . . . . 0.0 110.275 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 81.91 34.44 24.39 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -129.85 169.68 14.87 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.052 1.341 . . . . 0.0 110.939 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -83.02 145.76 29.12 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 12.2 ttt85 -76.82 29.17 0.13 Allowed 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 129.913 3.285 . . . . 0.0 112.384 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -72.19 144.1 48.64 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 122.351 1.072 . . . . 0.0 111.959 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -110.8 155.67 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 113.489 -1.687 . . . . 0.0 111.493 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -123.87 128.46 49.52 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.021 1.728 . . . . 0.0 106.972 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.5 mp -118.09 119.79 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 124.968 1.307 . . . . 0.0 107.723 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -102.5 113.81 27.48 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -94.1 116.75 29.21 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 33.6 m -126.4 169.35 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 125.298 1.439 . . . . 0.0 112.096 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -85.48 135.78 33.7 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 177.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -101.56 156.08 18.91 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 118.936 0.789 . . . . 0.0 111.608 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -51.01 -68.21 1.6 Allowed Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.902 1.715 . . . . 0.0 112.145 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 13.3 p -75.66 80.24 2.64 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 117.913 0.856 . . . . 0.0 108.776 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -67.46 36.23 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.132 2.573 . . . . 0.0 115.777 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 14.3 m -148.05 46.65 1.08 Allowed 'General case' 0 CA--C 1.536 0.408 0 O-C-N 119.932 -1.73 . . . . 0.0 113.093 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -148.28 -178.58 23.54 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.63 164.9 32.79 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.862 2.375 . . . . 0.0 110.417 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 60.6 p -81.42 151.95 27.65 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.934 0.894 . . . . 0.0 108.706 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.32 163.6 17.57 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.274 1.429 . . . . 0.0 107.454 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.3 mp -77.36 130.07 36.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -72.38 -61.07 1.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.968 1.707 . . . . 0.0 110.222 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -142.26 167.85 21.14 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 125.689 1.596 . . . . 0.0 108.804 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.609 HG13 ' CE1' ' A' ' 229' ' ' TYR . 28.7 t -145.69 137.63 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.97 117.8 3.3 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.005 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -77.16 92.7 3.83 Favored 'General case' 0 C--N 1.328 -0.357 1 N-CA-C 99.715 -4.18 . . . . 0.0 99.715 177.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 2.0 p -58.42 -61.38 2.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.875 1.27 . . . . 0.0 112.348 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -98.78 -172.72 2.36 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 28.2 mm -63.25 -46.1 96.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 O-C-N 121.256 -0.902 . . . . 0.0 111.089 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 9.1 t -109.72 -16.89 13.81 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 16.2 t -87.32 140.56 15.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 123.928 0.891 . . . . 0.0 108.874 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' TYR . . . . . 0.609 ' CE1' HG13 ' A' ' 221' ' ' VAL . 2.3 t80 -133.78 140.64 47.07 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.126 0.971 . . . . 0.0 109.038 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -127.98 138.48 52.63 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.02 161.44 39.39 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.524 1.529 . . . . 0.0 109.71 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -133.46 149.85 51.75 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 123.334 0.654 . . . . 0.0 110.355 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 60.5 t -128.29 144.98 36.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 125.511 1.524 . . . . 0.0 107.554 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.66 133.03 56.43 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 83.0 mt -134.75 137.58 27.76 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.056 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.34 -43.19 1.1 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.169 2.579 . . . . 0.0 112.708 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -57.76 -33.78 68.85 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.072 0.549 . . . . 0.0 111.081 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 55.6 mt -61.81 -33.79 74.76 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.891 0.769 . . . . 0.0 111.898 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 53.1 m -61.84 -17.16 55.32 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.017 0.927 . . . . 0.0 113.133 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -69.31 -17.98 63.77 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 123.923 0.889 . . . . 0.0 112.896 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 45.1 mt -90.74 120.73 32.02 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 126.235 1.814 . . . . 0.0 107.017 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.14 -41.79 49.53 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.898 1.279 . . . . 0.0 113.055 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.475 HD22 ' CE2' ' A' ' 181' ' ' TYR . 31.7 mt -56.39 -34.8 67.04 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.416 0.687 . . . . 0.0 110.193 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -100.88 4.53 42.8 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 126.791 2.036 . . . . 0.0 113.84 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.463 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.787 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.6 m . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.7 -39.11 87.33 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-N 118.622 0.646 . . . . 0.0 109.841 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.9 tp -64.6 -44.89 89.16 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mt -59.11 -51.07 71.62 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.0 m -55.17 -44.75 75.52 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.34 1.056 . . . . 0.0 111.083 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -67.23 -51.17 56.48 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 121.548 -0.72 . . . . 0.0 110.232 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 21.8 m -54.82 -42.07 71.43 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 118.153 -0.927 . . . . 0.0 110.506 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.8 tp -61.01 -56.15 24.43 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 120.051 1.296 . . . . 0.0 110.034 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -57.23 -49.49 75.85 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.987 0.812 . . . . 0.0 111.602 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -56.85 -44.48 82.2 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.334 0.654 . . . . 0.0 109.269 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.542 ' HA3' HD11 ' A' ' 183' ' ' ILE . . . -63.52 -47.2 89.25 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 79.7 t -58.18 -52.99 51.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.671 1.189 . . . . 0.0 109.838 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -31.1 72.05 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.14 0.882 . . . . 0.0 110.315 178.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -68.53 -47.96 65.56 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.637 HD11 HD12 ' A' ' 183' ' ' ILE . 24.3 mt -57.06 -54.72 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 123.075 0.55 . . . . 0.0 109.583 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.52 -41.24 80.45 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 124.188 0.93 . . . . 0.0 110.23 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -64.64 -43.98 91.96 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.079 0.466 . . . . 0.0 111.894 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.31 -13.08 61.05 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 73.9 mt -106.75 -26.85 11.12 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 119.488 1.04 . . . . 0.0 111.945 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -57.15 -28.19 62.52 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.178 0.591 . . . . 0.0 111.625 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -68.52 -45.88 71.07 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.342 1.457 . . . . 0.0 111.096 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -161.07 149.55 16.08 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.978 1.311 . . . . 0.0 109.896 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 60.3 m -75.38 163.16 27.72 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 177.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 28.2 pt -118.24 148.7 20.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.8 154.58 44.34 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 122.673 0.389 . . . . 0.0 110.689 -177.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -143.13 124.96 15.07 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 124.439 1.096 . . . . 0.0 110.143 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -87.63 102.86 15.03 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.6 67.32 6.41 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.52 -115.95 6.26 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -66.4 -33.15 75.08 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.479 0.712 . . . . 0.0 112.59 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -106.64 160.29 15.56 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 122.153 0.977 . . . . 0.0 110.947 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.0 mt -124.57 147.99 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 178.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -121.64 134.53 54.99 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -130.49 125.25 33.88 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 126.629 1.972 . . . . 0.0 108.221 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -126.39 119.07 26.35 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 125.043 1.337 . . . . 0.0 109.799 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 12.5 m -102.88 160.52 25.97 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 124.76 1.224 . . . . 0.0 113.229 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.88 80.64 0.64 Allowed 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 124.47 3.447 . . . . 0.0 113.506 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.76 52.19 35.66 Favored Glycine 0 C--O 1.237 0.324 0 O-C-N 121.546 -0.721 . . . . 0.0 111.505 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.3 mt -129.17 -67.09 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -174.41 160.19 3.17 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.17 1.388 . . . . 0.0 108.987 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.91 120.23 38.51 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 176.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.18 154.86 40.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 118.758 0.708 . . . . 0.0 111.083 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -123.04 130.32 52.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 127.897 2.479 . . . . 0.0 106.579 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -146.37 156.92 43.67 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.357 1.063 . . . . 0.0 110.198 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 56.3 t60 -89.2 153.83 20.62 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 156.21 -164.14 32.26 Favored Glycine 0 CA--C 1.523 0.537 0 O-C-N 120.829 -1.169 . . . . 0.0 111.59 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.16 150.05 45.61 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 124.388 1.075 . . . . 0.0 110.517 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 CA--C 1.535 0.392 0 C-N-CA 125.091 1.357 . . . . 0.0 108.205 179.285 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.5 mt . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 179.172 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 84.3 mt . . . . . 0 C--O 1.23 0.061 0 CA-C-O 119.399 -0.334 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 9.8 t -136.69 152.8 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.802 1.241 . . . . 0.0 108.585 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -145.44 171.8 14.12 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 126.286 1.835 . . . . 0.0 110.112 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -125.9 125.59 43.04 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.118 1.767 . . . . 0.0 109.55 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 22.1 mt -102.89 -72.83 0.68 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.227 1.011 . . . . 0.0 109.395 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -124.0 149.18 16.88 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -132.37 89.14 37.6 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.01 0.924 . . . . 0.0 110.443 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -77.5 -179.15 5.16 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 125.049 3.833 . . . . 0.0 113.293 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -90.05 161.67 15.71 Favored 'General case' 0 C--O 1.231 0.084 0 C-N-CA 124.069 0.948 . . . . 0.0 110.211 178.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.19 -24.81 57.87 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -118.99 157.91 26.82 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 123.629 0.771 . . . . 0.0 109.331 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 5.2 p -73.97 -33.02 35.21 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 C-N-CA 124.633 1.173 . . . . 0.0 112.095 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -75.13 -7.05 52.69 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.22 1.808 . . . . 0.0 112.93 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -94.2 -14.99 25.0 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.115 1.366 . . . . 0.0 109.708 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -124.35 179.32 4.96 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 128.665 2.786 . . . . 0.0 112.811 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -138.17 166.76 23.35 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.414 2.286 . . . . 0.0 107.817 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -141.06 159.34 42.42 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.864 2.066 . . . . 0.0 107.612 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -124.38 124.54 42.58 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.755 1.222 . . . . 0.0 111.309 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 21.6 tp -90.02 100.77 13.53 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 22.6 mt -107.21 -178.72 3.72 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.308 1.843 . . . . 0.0 108.754 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -158.81 159.89 35.62 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.61 -175.67 4.03 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -48.2 -35.78 12.48 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.979 1.711 . . . . 0.0 111.307 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 60.0 t -77.77 -67.63 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 126.193 1.797 . . . . 0.0 111.27 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -167.46 -170.22 32.0 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -178.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.478 ' CE2' HD22 ' A' ' 243' ' ' LEU . 3.6 m-85 -78.81 152.79 31.15 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.469 1.108 . . . . 0.0 112.037 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -162.49 156.56 21.15 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.005 1.322 . . . . 0.0 109.971 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.637 HD12 HD11 ' A' ' 109' ' ' ILE . 7.4 mt -102.04 140.08 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 177.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 4.3 t -121.98 136.35 54.92 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -142.62 119.18 11.01 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 176.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.8 tt -97.28 140.39 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.7 mt -130.51 112.59 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 O-C-N 120.742 -1.224 . . . . 0.0 110.161 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.18 -155.57 25.83 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 107.89 -2.084 . . . . 0.0 107.89 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 49.1 m 73.16 44.43 0.33 Allowed 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.095 1.358 . . . . 0.0 108.586 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -99.91 -121.9 4.74 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 125.158 1.361 . . . . 0.0 110.026 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -136.29 122.61 20.58 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.368 1.867 . . . . 0.0 108.774 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 14.1 mm -60.95 136.57 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 119.736 1.153 . . . . 0.0 110.155 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 28.5 p -90.58 111.58 22.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -68.13 -10.69 56.02 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 120.475 1.489 . . . . 0.0 110.391 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 40.6 t -60.33 -45.33 96.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 126.709 2.004 . . . . 0.0 108.808 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 1.3 p -125.41 -20.57 4.75 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 92.49 10.31 60.69 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.75 2.119 . . . . 0.0 112.255 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -94.32 169.66 10.06 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.544 1.138 . . . . 0.0 112.157 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -88.28 156.08 19.38 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 122.159 0.981 . . . . 0.0 109.707 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -79.52 30.21 0.24 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 128.97 2.908 . . . . 0.0 111.286 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 1.9 ptm -72.39 150.46 43.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.958 0.885 . . . . 0.0 110.428 -175.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.1 p -120.23 149.01 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 114.341 -1.3 . . . . 0.0 111.699 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -112.77 127.92 56.28 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.945 1.698 . . . . 0.0 106.853 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.1 mp -119.93 115.97 49.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.248 1.019 . . . . 0.0 108.454 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -101.19 116.43 32.79 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.338 0.655 . . . . 0.0 110.64 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -92.4 114.41 26.95 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.047 1.339 . . . . 0.0 110.104 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 27.4 m -127.38 172.28 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 126.197 1.799 . . . . 0.0 111.801 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -85.7 142.65 28.87 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -113.55 144.88 18.27 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-O 118.583 -1.12 . . . . 0.0 110.878 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -32.94 -73.98 0.07 OUTLIER Glycine 0 C--N 1.337 0.631 0 C-N-CA 128.724 3.059 . . . . 0.0 113.233 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 39.6 t -70.72 94.09 0.99 Allowed 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -74.39 21.12 0.11 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.312 1.845 . . . . 0.0 111.667 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 37.5 m -135.82 40.48 2.74 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.909 1.684 . . . . 0.0 112.578 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -150.94 166.95 30.5 Favored Glycine 0 CA--C 1.526 0.748 0 O-C-N 120.682 -1.261 . . . . 0.0 111.505 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.46 167.03 25.21 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.492 2.128 . . . . 0.0 112.128 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 51.0 m -76.87 155.19 33.1 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.979 178.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.0 p -162.05 163.63 28.63 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 126.55 1.94 . . . . 0.0 107.216 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.3 mp -81.45 129.23 37.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' GLN . . . . . 0.459 ' HG3' HG23 ' A' ' 234' ' ' THR . 64.9 mm-40 -79.23 -47.08 16.59 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.493 0.717 . . . . 0.0 112.635 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 40.0 p-90 -151.99 166.98 29.87 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.696 HG13 ' CE1' ' A' ' 229' ' ' TYR . 46.8 t -144.77 138.92 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 C-N-CA 125.719 1.608 . . . . 0.0 106.808 -178.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.96 134.34 4.27 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.621 0.724 . . . . 0.0 112.104 177.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -86.96 93.11 9.25 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 78.2 p -67.53 -56.42 9.57 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.576 0.703 . . . . 0.0 110.693 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -95.03 -175.04 3.41 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.983 1.713 . . . . 0.0 107.591 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.6 mp -74.71 -39.17 46.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 O-C-N 121.713 -0.617 . . . . 0.0 109.706 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 5.4 m -115.69 -18.91 10.73 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 3.5 t -85.13 152.82 3.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' TYR . . . . . 0.696 ' CE1' HG13 ' A' ' 221' ' ' VAL . 3.3 t80 -135.41 139.85 44.48 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.604 1.162 . . . . 0.0 108.585 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -120.84 135.43 55.17 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.035 1.334 . . . . 0.0 108.57 -178.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -138.46 161.13 37.8 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.93 1.692 . . . . 0.0 109.751 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -138.53 144.13 39.8 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 66.6 t -131.72 133.55 61.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 125.624 1.57 . . . . 0.0 109.449 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' THR . . . . . 0.459 HG23 ' HG3' ' A' ' 219' ' ' GLN . 1.9 p -99.49 146.6 26.19 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 13.4 mt -142.99 136.18 13.96 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.277 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -72.55 -44.69 0.68 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.433 2.089 . . . . 0.0 111.492 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -58.93 -20.82 55.61 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.13 0.972 . . . . 0.0 112.289 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 2.2 mp -71.69 -39.16 70.39 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.783 0.833 . . . . 0.0 108.987 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 29.2 m -58.3 -30.5 66.7 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.453 1.501 . . . . 0.0 111.979 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -60.2 -38.17 82.5 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.577 0.351 . . . . 0.0 110.788 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 23.8 mt -72.64 117.04 13.83 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -47.92 -34.34 8.91 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -177.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.478 HD22 ' CE2' ' A' ' 181' ' ' TYR . 20.1 mt -64.13 -40.86 97.08 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.941 0.792 . . . . 0.0 110.661 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 4.8 mp -99.58 9.38 43.28 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 125.295 1.438 . . . . 0.0 113.798 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.723 0 C-N-CA 126.533 1.933 . . . . 0.0 111.231 179.623 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.534 0.345 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.57 -40.57 95.8 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.2 tp -62.22 -45.69 92.2 Favored 'General case' 0 C--O 1.221 -0.396 0 C-N-CA 124.31 1.044 . . . . 0.0 109.148 178.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 mt -59.66 -51.3 70.37 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.173 0.989 . . . . 0.0 109.457 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.1 m -55.0 -55.48 30.43 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.553 1.141 . . . . 0.0 109.626 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -61.23 -46.33 90.87 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.12 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.1 m -52.23 -51.71 56.69 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 119.608 1.095 . . . . 0.0 110.196 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.2 tp -56.56 -55.31 35.5 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 119.229 0.922 . . . . 0.0 108.826 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.61 -49.6 67.48 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.803 1.241 . . . . 0.0 113.507 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -42.2 93.36 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.914 1.686 . . . . 0.0 108.525 179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.39 -50.23 69.91 Favored Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.84 -53.14 49.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 118.793 1.297 . . . . 0.0 111.109 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -31.78 72.0 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.206 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 m -66.08 -48.23 71.65 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.435 HD11 HD12 ' A' ' 183' ' ' ILE . 27.1 mt -58.36 -54.64 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.733 0.813 . . . . 0.0 110.318 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.77 -31.8 71.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 123.036 0.21 . . . . 0.0 111.525 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -73.64 -46.62 45.6 Favored 'General case' 0 C--O 1.225 -0.211 0 O-C-N 121.526 -0.734 . . . . 0.0 109.059 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.18 5.18 5.74 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.692 1.997 . . . . 0.0 113.887 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.3 mt -123.42 -30.43 3.66 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 125.516 1.526 . . . . 0.0 109.199 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -62.01 -28.5 69.62 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.158 0.435 . . . . 0.0 109.961 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -62.89 -47.16 84.51 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.706 0.802 . . . . 0.0 109.262 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -164.35 150.29 10.7 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.275 1.83 . . . . 0.0 109.883 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 64.2 m -75.27 171.75 13.65 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.3 pt -128.39 147.66 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 O-C-N 121.395 -0.815 . . . . 0.0 110.318 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.84 167.91 20.96 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.565 0.746 . . . . 0.0 110.894 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -153.71 124.88 7.41 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.65 1.58 . . . . 0.0 110.594 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -87.04 102.31 14.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.14 67.36 6.91 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.149 1.78 . . . . 0.0 109.608 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.8 -115.26 4.66 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -73.29 -27.77 61.73 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.245 1.818 . . . . 0.0 112.883 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -107.66 161.85 14.5 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 118.945 0.793 . . . . 0.0 110.293 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 24.1 mt -128.23 141.01 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 104.154 -2.535 . . . . 0.0 104.154 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.423 ' CD1' HG11 ' A' ' 221' ' ' VAL . 53.3 m-85 -116.73 135.18 53.98 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 124.786 1.234 . . . . 0.0 107.776 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.38 130.44 46.03 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.625 1.57 . . . . 0.0 108.488 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -128.24 121.73 30.05 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.615 1.166 . . . . 0.0 110.622 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 4.2 m -108.73 159.19 31.85 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 123.956 0.902 . . . . 0.0 112.231 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -65.7 95.13 0.28 Allowed 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 125.259 3.973 . . . . 0.0 114.562 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 57.94 39.69 92.15 Favored Glycine 0 CA--C 1.525 0.67 0 O-C-N 121.554 -0.716 . . . . 0.0 111.636 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.8 mt -115.16 -65.17 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.462 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 5.7 pt-20 179.4 169.51 1.05 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.894 2.078 . . . . 0.0 108.695 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.45 124.6 40.5 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.9 m -135.01 156.95 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 125.479 1.511 . . . . 0.0 111.189 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -124.03 133.63 53.61 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 103.327 -2.842 . . . . 0.0 103.327 176.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -146.25 156.62 43.51 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.902 0.881 . . . . 0.0 110.575 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -89.47 153.82 20.51 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 155.68 -162.82 31.4 Favored Glycine 0 CA--C 1.519 0.292 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.95 152.59 50.1 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.251 1.02 . . . . 0.0 108.355 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 93.3 t . . . . . 0 C--O 1.237 0.411 0 C-N-CA 124.408 1.083 . . . . 0.0 109.559 179.556 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 . . . . . 0 C--O 1.234 0.255 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 38.0 mm . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 179.124 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.7 mt . . . . . 0 CA--C 1.521 -0.14 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.2 143.26 28.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 124.74 1.216 . . . . 0.0 108.186 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -134.88 155.65 50.32 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.785 1.234 . . . . 0.0 109.256 178.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 28.9 ttp180 -97.06 130.23 44.39 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 128.021 2.528 . . . . 0.0 108.331 -178.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 27.5 mt -112.54 -69.88 0.84 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.415 1.007 . . . . 0.0 108.666 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -139.58 141.8 12.08 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-O 121.446 0.47 . . . . 0.0 112.979 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -110.88 92.9 15.71 Favored Pre-proline 0 N--CA 1.447 -0.582 0 C-N-CA 127.366 2.266 . . . . 0.0 110.637 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.462 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 75.5 Cg_endo -75.53 -177.16 3.36 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.646 2.897 . . . . 0.0 109.358 178.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -96.81 157.96 15.65 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.14 -26.51 56.39 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 124.901 1.376 . . . . 0.0 114.15 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -108.97 139.63 43.57 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 124.164 0.986 . . . . 0.0 108.466 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.4 p -62.97 -31.04 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -61.88 -26.7 68.31 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.727 1.611 . . . . 0.0 112.542 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -94.6 -2.33 51.62 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -79.62 163.56 24.5 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.434 -0.791 . . . . 0.0 110.297 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -137.58 95.1 3.0 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -102.35 160.2 14.75 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -135.63 143.86 45.77 Favored 'General case' 0 C--O 1.227 -0.11 0 C-N-CA 124.304 1.042 . . . . 0.0 110.221 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 36.3 tp -110.07 97.85 7.26 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.443 HD23 ' HB2' ' A' ' 184' ' ' SER . 0.5 OUTLIER -109.48 174.23 5.96 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.852 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.417 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 6.1 p90 -150.67 162.63 40.31 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 121.401 -0.812 . . . . 0.0 110.486 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -140.71 -175.3 4.24 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.4 1.062 . . . . 0.0 109.185 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -57.04 -20.3 23.84 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.155 1.382 . . . . 0.0 113.991 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 97.4 t -81.09 -65.66 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 178.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 175.57 -170.16 43.09 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.417 ' CD2' ' HB3' ' A' ' 176' ' ' TYR . 15.6 m-85 -78.52 159.13 28.35 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.721 0.772 . . . . 0.0 109.911 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -156.21 176.2 12.98 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.53 1.932 . . . . 0.0 106.805 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.435 HD12 HD11 ' A' ' 109' ' ' ILE . 18.8 mt -121.1 114.46 43.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 178.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.443 ' HB2' HD23 ' A' ' 175' ' ' LEU . 4.7 t -90.46 141.58 28.6 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -146.29 107.01 4.09 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.6 tt -98.68 140.44 18.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.9 mt -133.97 113.71 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 123.869 0.868 . . . . 0.0 110.847 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -107.85 -156.73 19.5 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 124.754 1.169 . . . . 0.0 110.275 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 68.5 m 73.09 37.55 0.76 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.775 1.23 . . . . 0.0 109.983 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -94.16 -108.35 2.04 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 126.858 2.17 . . . . 0.0 108.336 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -140.07 120.99 14.54 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.638 1.175 . . . . 0.0 107.921 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 17.7 mm -60.58 121.59 8.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 124.336 1.054 . . . . 0.0 109.272 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 77.6 m -82.22 96.42 7.85 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 125.735 1.614 . . . . 0.0 109.923 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.09 -18.47 58.09 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -59.3 -31.48 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.674 1.189 . . . . 0.0 110.76 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 44.8 p -125.07 -35.0 2.7 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.777 0.831 . . . . 0.0 111.799 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.92 32.93 5.7 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 126.43 1.966 . . . . 0.0 110.779 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -124.13 171.12 10.05 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.372 1.869 . . . . 0.0 112.174 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -83.33 148.7 27.19 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 122.322 1.058 . . . . 0.0 110.439 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -82.98 30.77 0.44 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 130.8 3.64 . . . . 0.0 109.251 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.5 ptt? -74.28 150.83 40.03 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.688 1.195 . . . . 0.0 110.334 -175.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -113.32 146.79 17.49 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.355 -177.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -114.42 116.39 28.81 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.8 mp -106.26 130.66 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -117.85 103.76 10.28 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.719 0.807 . . . . 0.0 110.108 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -83.02 125.31 31.3 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 15.5 m -135.96 171.09 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.44 1.496 . . . . 0.0 110.974 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 2.1 t -81.61 140.5 34.39 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -118.43 109.21 1.73 Allowed Glycine 0 C--N 1.34 0.752 0 CA-C-O 117.836 -1.536 . . . . 0.0 113.217 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 4.71 -92.15 0.0 OUTLIER Glycine 0 C--N 1.34 0.803 0 C-N-CA 129.626 3.489 . . . . 0.0 114.07 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.0 100.0 0.39 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -72.11 29.13 0.05 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.486 1.914 . . . . 0.0 113.169 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 14.8 t -119.29 47.2 1.73 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.685 1.994 . . . . 0.0 114.19 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -166.08 162.99 36.5 Favored Glycine 0 C--N 1.339 0.717 0 C-N-CA 118.014 -2.041 . . . . 0.0 117.523 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -66.64 164.81 27.59 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.355 2.704 . . . . 0.0 110.321 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 28.8 m -64.47 155.46 32.66 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.473 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -168.88 157.16 7.94 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 126.025 1.73 . . . . 0.0 108.111 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.9 mt -83.38 133.81 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -74.95 -55.27 5.94 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 125.061 1.345 . . . . 0.0 111.772 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 52.1 p-90 -149.94 165.93 31.15 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.218 1.407 . . . . 0.0 108.347 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.8 HG13 ' CE1' ' A' ' 229' ' ' TYR . 39.6 t -148.34 130.42 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 125.198 1.399 . . . . 0.0 107.62 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.37 140.65 16.59 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -92.16 90.23 7.24 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 102.365 -3.198 . . . . 0.0 102.365 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 2.0 p -61.31 -65.15 0.74 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.767 1.627 . . . . 0.0 110.747 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -86.88 -172.59 4.06 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.501 ' H ' HD12 ' A' ' 226' ' ' ILE . 3.6 mp -58.97 -41.53 83.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 118.322 -0.846 . . . . 0.0 110.163 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 7.3 m -129.86 -8.91 4.45 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 25.1 t -71.87 121.72 22.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 103.927 -2.62 . . . . 0.0 103.927 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' TYR . . . . . 0.8 ' CE1' HG13 ' A' ' 221' ' ' VAL . 1.0 OUTLIER -110.17 124.63 51.9 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 179.323 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -114.33 135.16 54.38 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -139.79 158.29 44.33 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.04 1.736 . . . . 0.0 109.621 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -130.69 146.21 52.12 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 85.1 t -131.95 135.48 58.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.77 138.25 40.65 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.726 0.81 . . . . 0.0 110.376 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 48.4 mt -139.81 137.05 17.91 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 124.052 0.941 . . . . 0.0 109.594 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.59 -32.77 2.67 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.722 2.948 . . . . 0.0 113.11 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -69.19 -23.81 63.96 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.717 1.207 . . . . 0.0 112.146 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 37.4 mt -66.28 -36.54 83.24 Favored 'General case' 0 C--O 1.226 -0.139 0 O-C-N 121.238 -0.914 . . . . 0.0 110.292 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 3.7 m -56.39 -19.23 13.85 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.893 1.277 . . . . 0.0 113.553 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -62.85 -31.98 73.12 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.23 1.412 . . . . 0.0 110.358 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 26.8 mt -84.11 120.14 25.82 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.44 -37.8 57.74 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.715 0.689 . . . . 0.0 112.072 -178.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 6.0 mp -57.6 -38.84 75.59 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.485 -0.76 . . . . 0.0 111.248 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -97.35 6.08 48.85 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.071 1.748 . . . . 0.0 111.675 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.259 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 179.27 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 CA--C 1.535 0.383 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.93 -45.81 89.48 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 66.7 tp -62.62 -41.34 98.95 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.413 0.685 . . . . 0.0 110.272 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.8 mt -60.08 -54.28 47.8 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.983 0.913 . . . . 0.0 109.762 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 45.2 m -56.21 -51.79 66.78 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.228 1.011 . . . . 0.0 110.748 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -58.03 -49.55 76.47 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.7 m -53.94 -49.55 68.45 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 118.425 -0.798 . . . . 0.0 110.598 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.521 ' O ' HG23 ' A' ' 106' ' ' VAL . 9.2 tp -56.77 -54.91 40.83 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.967 0.803 . . . . 0.0 109.579 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -55.29 -53.64 53.62 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.684 0.793 . . . . 0.0 111.492 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -57.37 -33.51 67.88 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.315 1.446 . . . . 0.0 110.363 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -69.43 -53.38 17.41 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 102' ' ' LEU . 3.4 t -56.55 -52.1 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 118.799 1.3 . . . . 0.0 111.706 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -37.24 79.76 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 118.89 -0.576 . . . . 0.0 110.779 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.4 m -67.43 -48.11 68.23 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.497 HD11 HD12 ' A' ' 183' ' ' ILE . 43.8 mt -53.5 -52.97 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 123.978 0.911 . . . . 0.0 109.575 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.54 -39.45 83.99 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 122.187 0.195 . . . . 0.0 111.234 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -69.73 -33.93 73.17 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.294 -0.879 . . . . 0.0 111.461 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.24 10.25 15.25 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.569 1.548 . . . . 0.0 112.239 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.3 mt -133.35 -33.35 1.12 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.841 1.256 . . . . 0.0 110.557 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -56.26 -31.23 63.39 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 123.693 0.797 . . . . 0.0 111.57 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -69.47 -45.96 67.79 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 118.668 -0.682 . . . . 0.0 112.465 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -157.26 143.65 18.0 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 125.336 1.454 . . . . 0.0 108.244 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 30.5 m -75.87 172.08 13.31 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 122.906 0.482 . . . . 0.0 110.959 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 25.6 pt -125.9 154.91 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.591 1.156 . . . . 0.0 111.418 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.62 167.69 21.64 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.738 0.815 . . . . 0.0 109.956 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -150.53 117.75 6.0 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.772 1.629 . . . . 0.0 109.935 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -82.54 102.14 11.19 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.0 66.8 3.62 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.474 -0.766 . . . . 0.0 110.472 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.19 -113.06 3.74 Favored Glycine 0 C--N 1.339 0.697 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -77.39 -38.33 50.11 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -106.65 126.44 52.28 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.874 1.215 . . . . 0.0 113.503 -178.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.0 mt -90.6 147.8 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.484 ' CD1' HG11 ' A' ' 221' ' ' VAL . 66.2 m-85 -115.11 135.8 53.81 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 178.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.72 123.91 27.14 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.789 1.236 . . . . 0.0 109.337 -177.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -126.8 119.51 27.05 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.824 1.249 . . . . 0.0 111.743 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 1.4 m -100.62 160.81 25.85 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 125.391 1.477 . . . . 0.0 112.477 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -64.13 88.86 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 124.249 3.299 . . . . 0.0 112.288 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 53.48 57.46 15.49 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 123.934 0.778 . . . . 0.0 111.274 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 15.6 mt -124.94 -65.67 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.509 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 15.6 pt-20 -176.15 168.92 2.86 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 127.621 2.368 . . . . 0.0 109.677 177.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -123.52 124.15 42.2 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.5 155.76 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.301 1.041 . . . . 0.0 112.256 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -119.82 126.24 50.51 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -146.48 157.67 43.78 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.093 0.861 . . . . 0.0 112.065 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -88.68 148.63 23.91 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 160.32 -162.17 33.09 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 108.871 -1.691 . . . . 0.0 108.871 -177.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.4 ttm-85 -125.63 164.15 21.22 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.34 1.456 . . . . 0.0 111.104 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 84.5 t . . . . . 0 C--O 1.24 0.571 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.749 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 . . . . . 0 N--CA 1.46 0.04 0 CA-C-O 121.202 0.525 . . . . 0.0 111.461 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.6 mp . . . . . 0 C--O 1.236 0.382 0 C-N-CA 123.853 0.861 . . . . 0.0 108.801 178.654 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 76.6 mt . . . . . 0 N--CA 1.456 -0.172 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.8 t -135.84 142.54 38.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.534 1.134 . . . . 0.0 108.054 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -137.61 158.62 43.99 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 126.348 1.859 . . . . 0.0 109.049 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -113.01 130.43 56.14 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.437 1.095 . . . . 0.0 110.196 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.96 -75.19 0.53 Allowed 'General case' 0 C--O 1.226 -0.153 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -134.68 152.39 20.68 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 116.255 -0.43 . . . . 0.0 112.73 -178.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -116.49 94.39 42.93 Favored Pre-proline 0 N--CA 1.453 -0.32 0 C-N-CA 125.271 1.428 . . . . 0.0 108.601 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.509 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 88.1 Cg_endo -73.48 -175.82 2.21 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.343 2.695 . . . . 0.0 109.555 178.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.457 ' HE2' ' OE2' ' A' ' 169' ' ' GLU . 25.3 mmmt -97.53 161.1 13.94 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.16 0.584 . . . . 0.0 112.238 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -78.26 -24.21 46.96 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.87 1.668 . . . . 0.0 113.362 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -116.37 147.75 41.3 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.5 p -73.06 -27.23 24.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -79.68 -12.73 59.8 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.296 0.639 . . . . 0.0 112.445 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.457 ' OE2' ' HE2' ' A' ' 164' ' ' LYS . 4.3 mm-40 -79.62 -21.5 44.84 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.865 0.466 . . . . 0.0 110.864 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -107.3 172.1 7.01 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.744 1.618 . . . . 0.0 110.652 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -134.29 131.31 38.26 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 124.186 0.994 . . . . 0.0 109.434 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -107.86 162.29 14.14 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -130.11 120.86 25.28 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.056 -1.028 . . . . 0.0 109.738 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 48.4 tp -87.24 100.6 12.81 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 39.5 mt -105.32 -179.21 3.88 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 126.207 1.803 . . . . 0.0 109.972 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 181' ' ' TYR . 4.6 p90 -157.09 157.07 33.87 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 124.458 1.103 . . . . 0.0 109.596 177.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -137.51 -179.36 5.69 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.143 2.177 . . . . 0.0 108.604 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -58.53 -26.41 63.49 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.445 1.098 . . . . 0.0 113.533 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 59.8 t -79.62 -62.81 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -172.99 -164.41 28.34 Favored Glycine 0 C--N 1.339 0.725 0 CA-C-N 119.031 0.832 . . . . 0.0 111.366 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.508 ' CE2' HD13 ' A' ' 243' ' ' LEU . 2.9 m-85 -78.21 166.38 22.8 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.193 -0.593 . . . . 0.0 109.982 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -167.62 162.09 13.97 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.508 1.523 . . . . 0.0 108.145 178.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.497 HD12 HD11 ' A' ' 109' ' ' ILE . 3.6 mt -113.97 121.43 66.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.154 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.2 t -95.96 135.03 38.25 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -138.57 133.63 32.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 178.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.9 tt -121.45 141.37 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 124.679 1.191 . . . . 0.0 109.072 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.4 mt -137.14 115.14 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 122.596 0.358 . . . . 0.0 111.705 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -103.74 -166.96 25.28 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 126.497 1.999 . . . . 0.0 110.125 178.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 69.3 m 73.23 60.41 0.1 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.624 1.569 . . . . 0.0 109.056 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -108.13 -95.58 2.4 Favored Glycine 0 CA--C 1.519 0.286 0 N-CA-C 104.513 -3.435 . . . . 0.0 104.513 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -155.59 125.23 6.41 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 18.0 mm -60.25 121.29 7.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.2 99.94 10.27 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 125.839 1.656 . . . . 0.0 110.153 -178.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -60.94 -20.49 62.28 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.364 0.602 . . . . 0.0 111.51 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.5 m -57.18 -32.64 41.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.642 1.577 . . . . 0.0 112.235 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 67.0 p -125.17 -29.22 3.32 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.078 1.351 . . . . 0.0 112.017 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 88.22 32.37 12.34 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -178.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -126.82 -179.72 4.96 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.915 1.686 . . . . 0.0 111.322 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -91.86 148.15 22.44 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.298 0.639 . . . . 0.0 109.496 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 45.2 ttm-85 -79.32 30.12 0.23 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.287 2.635 . . . . 0.0 109.729 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.7 ptm -72.87 153.96 40.8 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 122.064 0.935 . . . . 0.0 110.075 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 6.0 p -122.97 148.93 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 113.876 -1.511 . . . . 0.0 113.696 -176.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -114.09 137.46 51.7 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.5 mp -126.03 118.41 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 127.516 2.326 . . . . 0.0 107.921 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -106.88 104.28 13.92 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.554 1.141 . . . . 0.0 110.42 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -80.95 129.53 34.58 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 120.523 -1.361 . . . . 0.0 111.8 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 33.9 m -137.8 172.15 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.643 1.177 . . . . 0.0 112.634 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.4 137.64 37.35 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.176 0.991 . . . . 0.0 108.352 178.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -105.38 117.95 5.69 Favored Glycine 0 C--N 1.332 0.352 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -42.34 -46.8 5.56 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 126.239 1.876 . . . . 0.0 113.283 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.42 ' C ' ' H ' ' A' ' 213' ' ' SER . 1.8 p -76.45 80.73 3.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -65.02 21.46 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 130.317 3.447 . . . . 0.0 113.329 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' SER . . . . . 0.42 ' H ' ' C ' ' A' ' 211' ' ' SER . 23.4 t -142.49 47.24 1.58 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 129.567 3.147 . . . . 0.0 107.642 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -149.61 159.3 28.02 Favored Glycine 0 C--N 1.34 0.771 0 O-C-N 119.668 -1.895 . . . . 0.0 114.6 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.93 173.47 13.51 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.851 3.034 . . . . 0.0 111.015 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 49.0 m -75.28 152.13 38.26 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -168.39 152.59 5.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 178.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.1 mt -78.66 134.68 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' GLN . . . . . 0.462 ' HG3' HE21 ' A' ' 232' ' ' GLN . 14.7 mm100 -77.63 -51.81 10.03 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.007 0.923 . . . . 0.0 111.794 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 55.9 p-90 -149.66 165.55 31.99 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.244 1.418 . . . . 0.0 108.439 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.812 HG13 ' CE1' ' A' ' 229' ' ' TYR . 24.5 t -147.42 134.16 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 126.228 1.811 . . . . 0.0 106.883 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.68 124.75 6.15 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 177.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -78.96 86.99 4.79 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 103.517 -2.771 . . . . 0.0 103.517 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 8.6 p -53.14 -52.55 58.34 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.904 1.682 . . . . 0.0 112.606 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -107.05 -177.36 3.34 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . 0.253 2.6 mp -68.24 -18.95 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 118.882 -1.127 . . . . 0.0 110.603 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -132.31 -39.6 1.03 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.519 1.054 . . . . 0.0 112.614 178.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 11.8 t -63.47 135.3 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' TYR . . . . . 0.812 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.2 OUTLIER -133.34 139.65 46.96 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.43 1.092 . . . . 0.0 109.9 -178.07 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -121.03 140.57 51.74 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.478 1.511 . . . . 0.0 111.755 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -142.94 161.31 38.46 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 128.183 2.593 . . . . 0.0 109.723 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.462 HE21 ' HG3' ' A' ' 219' ' ' GLN . 38.7 tt0 -137.22 146.67 45.12 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.034 1.334 . . . . 0.0 107.496 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 98.5 t -131.92 134.68 59.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 125.294 1.438 . . . . 0.0 107.862 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.64 134.56 45.8 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.234 1.014 . . . . 0.0 110.577 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 69.6 mt -131.74 138.47 32.64 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.71 -46.2 0.89 Allowed 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.542 2.828 . . . . 0.0 111.553 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.98 -27.48 66.88 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.947 1.299 . . . . 0.0 111.79 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 3.5 mp -61.68 -31.62 71.77 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 117.871 -1.061 . . . . 0.0 110.477 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 8.3 m -65.64 -19.16 65.8 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.978 1.263 . . . . 0.0 113.158 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -63.54 -29.82 71.02 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.051 0.941 . . . . 0.0 111.419 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 50.7 mt -82.34 113.78 20.36 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -48.2 -31.2 5.47 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.508 HD13 ' CE2' ' A' ' 181' ' ' TYR . 21.2 mt -67.58 -36.5 81.02 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.162 -0.961 . . . . 0.0 110.338 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 17.9 mt -100.06 8.89 43.63 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 127.341 2.256 . . . . 0.0 111.204 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 178.574 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 CA--C 1.536 0.418 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.15 -45.04 96.3 Favored 'General case' 0 C--N 1.337 0.06 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 67.7 tp -58.3 -44.01 88.37 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.081 -0.961 . . . . 0.0 108.87 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.2 mt -61.24 -53.92 50.66 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.243 0.929 . . . . 0.0 109.388 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 51.6 m -55.13 -48.58 73.48 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.806 0.842 . . . . 0.0 111.198 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -62.87 -46.3 88.51 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 120.403 -1.436 . . . . 0.0 110.214 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 52.9 m -54.18 -46.04 72.28 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.576 1.15 . . . . 0.0 109.915 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.479 ' O ' HG23 ' A' ' 106' ' ' VAL . 22.0 tp -58.6 -54.08 51.14 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.761 0.709 . . . . 0.0 110.452 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 25.4 t30 -57.47 -46.93 83.12 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.263 0.483 . . . . 0.0 111.526 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -55.52 -46.64 77.01 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.974 0.91 . . . . 0.0 109.169 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.449 ' HA3' HD11 ' A' ' 183' ' ' ILE . . . -64.04 -46.47 91.21 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 102' ' ' LEU . 93.2 t -59.01 -53.22 51.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.047 1.339 . . . . 0.0 110.393 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -32.52 73.49 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.775 1.17 . . . . 0.0 110.16 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.2 m -67.22 -46.46 73.77 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.437 HD11 HD12 ' A' ' 183' ' ' ILE . 33.8 mt -59.64 -51.6 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.99 -35.72 77.56 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 118.659 -0.686 . . . . 0.0 110.217 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.27 -48.42 75.79 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 119.708 1.14 . . . . 0.0 110.357 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.14 -27.65 60.95 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 -178.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.8 mp -85.72 -28.37 24.67 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 120.19 1.359 . . . . 0.0 109.336 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -60.53 -19.47 57.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.127 0.571 . . . . 0.0 111.452 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.36 -46.64 54.53 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.19 0.596 . . . . 0.0 110.868 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -165.54 155.63 13.0 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.586 1.554 . . . . 0.0 108.258 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 33.5 m -75.77 162.85 27.83 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.3 pt -117.68 156.23 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.22 163.23 38.23 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 120.712 0.292 . . . . 0.0 111.191 -177.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -152.31 127.63 9.9 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.739 1.616 . . . . 0.0 109.816 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -89.14 104.43 16.98 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.17 67.66 5.9 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.43 -115.03 4.92 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.491 -1.043 . . . . 0.0 110.491 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -73.82 -34.26 64.5 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -106.38 138.2 42.98 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 119.355 0.98 . . . . 0.0 110.976 -178.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.2 mt -102.89 149.69 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -122.24 133.79 54.7 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 126.406 1.882 . . . . 0.0 106.223 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.47 132.72 44.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.101 1.761 . . . . 0.0 107.945 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -126.46 117.84 23.72 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.424 1.089 . . . . 0.0 110.959 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 8.7 m -102.64 155.99 35.84 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.008 0.923 . . . . 0.0 112.924 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.34 92.21 0.28 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 125.069 3.846 . . . . 0.0 116.164 -178.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 62.64 36.27 93.01 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.3 mt -116.68 -66.99 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.461 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 7.2 pt-20 176.96 166.62 0.53 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.075 1.75 . . . . 0.0 109.58 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -117.62 129.63 55.87 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 104.278 -2.49 . . . . 0.0 104.278 177.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.1 m -138.32 155.46 28.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.922 0.889 . . . . 0.0 110.725 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -121.12 131.44 54.25 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -145.96 157.84 43.88 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.418 1.087 . . . . 0.0 111.479 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -88.61 154.27 20.46 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 165.34 -163.66 36.7 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.64 142.04 50.81 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.235 0.341 0 CA-C-N 118.777 0.717 . . . . 0.0 109.709 -178.803 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 14.1 mt . . . . . 0 C--N 1.326 -0.433 0 C-N-CA 127.504 2.322 . . . . 0.0 106.672 -179.323 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 23.5 mt . . . . . 0 CA--C 1.515 -0.377 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.5 p -143.18 152.52 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.848 0.859 . . . . 0.0 109.872 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -142.38 145.56 33.99 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.913 1.685 . . . . 0.0 108.124 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -95.58 135.15 37.62 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.522 1.129 . . . . 0.0 108.676 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.4 mp -102.15 -69.69 0.78 Allowed 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 123.122 0.569 . . . . 0.0 110.486 -178.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -127.96 165.83 20.82 Favored Glycine 0 C--O 1.243 0.681 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -132.32 89.12 37.87 Favored Pre-proline 0 N--CA 1.448 -0.569 0 C-N-CA 125.428 1.491 . . . . 0.0 109.52 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 90.9 Cg_endo -74.93 176.63 9.63 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 123.201 2.601 . . . . 0.0 108.02 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -94.8 155.37 16.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.916 0.865 . . . . 0.0 111.443 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.28 -20.25 61.55 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 126.074 1.75 . . . . 0.0 113.317 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -122.97 136.83 55.01 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.466 1.506 . . . . 0.0 109.91 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.9 p -61.37 -27.76 42.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.536 0.684 . . . . 0.0 110.691 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -71.06 -6.44 39.09 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 127.755 2.422 . . . . 0.0 113.013 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -112.35 -20.11 11.94 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.561 1.144 . . . . 0.0 112.721 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.27 165.78 13.26 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -145.79 112.71 6.04 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -101.56 170.14 8.38 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.999 1.32 . . . . 0.0 110.522 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -131.81 125.82 32.8 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.481 1.512 . . . . 0.0 110.836 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 24.4 tp -86.51 104.46 15.99 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 61.2 mt -107.47 177.0 4.96 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.21 1.404 . . . . 0.0 110.78 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.464 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 12.0 p90 -162.37 166.53 25.03 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 122.813 1.292 . . . . 0.0 110.766 178.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -140.85 177.42 8.05 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 126.125 1.77 . . . . 0.0 106.759 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.28 -31.67 69.33 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 125.379 1.471 . . . . 0.0 107.948 177.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 38.7 t -66.1 -62.11 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 125.756 1.623 . . . . 0.0 107.791 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 178.9 -171.97 44.15 Favored Glycine 0 C--N 1.339 0.745 0 C-N-CA 124.392 0.996 . . . . 0.0 113.158 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.464 ' CD2' ' HB3' ' A' ' 176' ' ' TYR . 32.9 m-85 -90.27 155.05 19.27 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.692 1.197 . . . . 0.0 111.789 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -164.87 162.05 20.61 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.416 1.887 . . . . 0.0 109.171 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.449 HD11 ' HA3' ' A' ' 105' ' ' GLY . 8.6 mt -106.3 141.68 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 177.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 5.3 t -122.77 132.75 54.36 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -132.9 120.55 21.63 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 177.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.9 tt -105.91 128.0 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 5.5 mt -120.71 107.28 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 124.312 1.045 . . . . 0.0 110.653 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -99.7 -156.62 28.48 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 107.146 -2.382 . . . . 0.0 107.146 177.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 46.8 m 70.22 51.72 0.38 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.547 0.689 . . . . 0.0 110.757 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -115.71 -119.93 3.26 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 107.244 -2.342 . . . . 0.0 107.244 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -129.39 141.75 50.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.544 1.138 . . . . 0.0 108.793 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 24.5 mm -79.55 128.89 38.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 16.7 m -90.53 104.42 17.0 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 101.908 -3.367 . . . . 0.0 101.908 176.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -55.45 -16.04 3.31 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -177.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 3.0 m -59.05 -39.7 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.207 1.003 . . . . 0.0 110.246 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 1.2 p -125.21 -17.95 5.54 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.627 1.103 . . . . 0.0 111.551 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 85.94 5.48 83.52 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.685 0.659 . . . . 0.0 113.549 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -83.93 160.83 21.0 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.271 1.429 . . . . 0.0 108.351 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -86.61 152.11 22.87 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -74.96 29.84 0.09 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 127.415 2.286 . . . . 0.0 109.962 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.3 ptt? -72.1 149.3 44.91 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 122.025 0.917 . . . . 0.0 109.838 -175.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.6 p -123.08 144.12 33.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.252 -176.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -108.35 130.18 55.21 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 178.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.1 mp -118.38 112.42 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 124.744 1.217 . . . . 0.0 108.225 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -95.33 116.79 29.25 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -94.53 116.38 28.7 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.326 0.65 . . . . 0.0 110.305 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 32.2 m -126.57 171.61 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 125.518 1.527 . . . . 0.0 111.955 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -85.86 135.8 33.56 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.783 1.633 . . . . 0.0 106.991 177.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -91.57 154.66 22.84 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 119.195 0.907 . . . . 0.0 111.406 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -62.61 -60.79 7.26 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 27.5 p -78.58 74.1 5.12 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -70.23 57.95 0.17 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.94 2.496 . . . . 0.0 112.011 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.36 47.51 0.35 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.984 1.714 . . . . 0.0 110.761 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -165.19 174.25 41.05 Favored Glycine 0 CA--C 1.527 0.788 0 O-C-N 119.736 -1.852 . . . . 0.0 112.159 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -71.73 162.06 43.22 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.438 2.092 . . . . 0.0 110.57 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 7.8 m -73.95 151.04 40.46 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 126.414 1.886 . . . . 0.0 111.034 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -164.85 165.15 20.72 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.735 1.614 . . . . 0.0 108.267 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.4 mp -79.15 128.02 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 177.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -72.09 -60.56 2.17 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.847 1.659 . . . . 0.0 109.867 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' TRP . . . . . 0.41 ' CE3' ' HD2' ' A' ' 222' ' ' ARG . 28.7 p-90 -140.24 166.56 24.35 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.242 1.417 . . . . 0.0 109.807 -178.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.596 HG13 ' CE1' ' A' ' 229' ' ' TYR . 49.9 t -145.85 133.03 15.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 125.585 1.554 . . . . 0.0 107.012 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.41 ' HD2' ' CE3' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -148.7 127.48 12.56 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.63 0.729 . . . . 0.0 109.362 178.255 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -79.99 87.88 5.38 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.9 p -57.42 -53.94 52.47 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.227 1.011 . . . . 0.0 112.622 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -119.31 -179.23 3.79 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.7 mp -61.27 -27.18 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.244 1.018 . . . . 0.0 110.838 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.8 t -131.64 -30.89 1.61 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.364 0.666 . . . . 0.0 111.765 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 16.7 t -76.31 135.42 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' TYR . . . . . 0.596 ' CE1' HG13 ' A' ' 221' ' ' VAL . 1.6 t80 -129.02 148.35 50.97 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.72 1.608 . . . . 0.0 108.681 -179.037 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -132.2 136.76 47.26 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 126.524 1.93 . . . . 0.0 107.564 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.72 161.61 38.78 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.751 1.62 . . . . 0.0 110.191 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -134.87 145.19 48.03 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.521 0.729 . . . . 0.0 109.998 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.1 t -124.2 146.12 30.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 125.657 1.583 . . . . 0.0 108.263 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.87 133.14 56.34 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 87.9 mt -134.74 135.99 24.47 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 123.828 0.851 . . . . 0.0 108.911 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.29 -42.38 2.0 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.662 2.241 . . . . 0.0 112.554 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -60.64 -24.9 65.91 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.308 0.643 . . . . 0.0 112.113 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 54.6 mt -68.19 -28.14 67.01 Favored 'General case' 0 C--O 1.225 -0.194 0 O-C-N 121.099 -1.0 . . . . 0.0 110.844 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 39.3 m -63.74 -15.76 59.4 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.763 1.225 . . . . 0.0 113.39 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -68.54 -24.08 64.59 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.41 ' HB2' HD23 ' A' ' 244' ' ' LEU . 41.0 mt -85.38 121.99 28.9 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.693 1.597 . . . . 0.0 107.882 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -50.5 -37.21 37.63 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.6 mp -61.02 -38.59 86.62 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.415 -0.803 . . . . 0.0 109.994 178.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.41 HD23 ' HB2' ' A' ' 241' ' ' LEU . 2.6 mm? -91.89 3.04 56.07 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 127.567 2.347 . . . . 0.0 113.226 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.673 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.569 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.4 p . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.307 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.69 -44.61 81.65 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 119.346 0.975 . . . . 0.0 109.71 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 52.0 tp -62.49 -44.89 95.28 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 118.52 -0.752 . . . . 0.0 109.036 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.7 mt -60.78 -48.27 82.57 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.272 0.942 . . . . 0.0 110.539 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 33.0 m -56.46 -56.5 20.39 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.676 1.19 . . . . 0.0 109.335 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.9 ttpp -58.69 -48.22 81.84 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-O 118.948 -0.548 . . . . 0.0 110.4 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.1 m -52.88 -52.95 55.57 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.231 1.012 . . . . 0.0 110.933 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.546 ' O ' HG23 ' A' ' 106' ' ' VAL . 17.1 tp -57.81 -53.59 56.47 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 118.882 0.765 . . . . 0.0 110.099 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -58.69 -46.72 86.63 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -59.17 -43.44 92.12 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 125.049 1.339 . . . . 0.0 107.832 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.27 -50.53 65.64 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.552 HG22 ' CD2' ' A' ' 172' ' ' PHE . 15.7 t -57.32 -53.49 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 118.69 1.245 . . . . 0.0 110.684 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -32.8 74.22 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.044 0.838 . . . . 0.0 110.979 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.3 m -66.21 -45.71 79.81 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 34.1 mt -60.56 -51.43 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 123.848 0.859 . . . . 0.0 108.79 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.19 -38.97 69.06 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 123.521 0.513 . . . . 0.0 109.978 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -67.58 -54.51 19.22 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 118.808 0.731 . . . . 0.0 110.669 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.11 -17.5 7.32 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 125.874 1.67 . . . . 0.0 114.537 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.6 mp -111.59 -27.86 8.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 119.388 0.995 . . . . 0.0 109.509 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -59.71 -31.07 69.26 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.447 0.567 . . . . 0.0 110.919 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -64.38 -46.04 85.1 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 122.901 0.48 . . . . 0.0 111.348 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -162.95 152.6 15.56 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.996 1.719 . . . . 0.0 110.094 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 55.9 m -75.68 166.79 23.01 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 23.6 pt -125.12 153.29 32.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 124.426 1.091 . . . . 0.0 109.108 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -146.3 168.27 21.5 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.996 -0.44 . . . . 0.0 112.149 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -154.11 121.38 5.74 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.072 0.949 . . . . 0.0 109.665 178.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -81.71 103.96 11.77 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.5 0.72 . . . . 0.0 109.634 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.94 70.83 2.92 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 178.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 67.66 -121.15 14.1 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -69.11 -28.13 66.2 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -107.13 137.5 45.07 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 119.482 1.037 . . . . 0.0 110.056 -178.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.8 mt -112.74 134.13 56.33 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.42 ' CD1' HG11 ' A' ' 221' ' ' VAL . 43.7 m-85 -100.68 129.01 46.53 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 125.124 1.37 . . . . 0.0 107.977 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -123.57 132.5 53.9 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.897 1.279 . . . . 0.0 108.712 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -129.62 112.91 14.17 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.447 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 19.8 m -97.42 159.74 30.44 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-O 118.402 -0.809 . . . . 0.0 111.214 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.2 90.34 0.1 OUTLIER 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 123.989 3.126 . . . . 0.0 113.622 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 56.07 44.69 88.3 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 123.827 0.727 . . . . 0.0 112.751 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 6.5 mt -113.58 -66.89 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.449 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 13.6 pt-20 -171.41 167.56 6.76 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.894 1.278 . . . . 0.0 109.354 178.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.61 122.22 38.32 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 178.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.8 m -137.84 156.5 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -122.09 125.99 47.41 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 177.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -146.91 157.95 43.78 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.442 1.497 . . . . 0.0 110.13 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -88.56 153.25 21.29 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 178.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 174.08 -163.53 34.46 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.241 -1.943 . . . . 0.0 108.241 -178.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.12 137.84 46.45 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.325 -0.488 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 . . . . . 0 C--O 1.235 0.292 0 CA-C-O 120.818 0.342 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 65.2 mt . . . . . 0 C--N 1.328 -0.365 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 179.376 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.7 tp . . . . . 0 C--O 1.233 0.187 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 22.1 t -137.06 140.5 42.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.377 1.071 . . . . 0.0 108.23 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -126.14 134.46 51.31 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -85.91 120.88 27.79 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 126.531 1.932 . . . . 0.0 108.576 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 50.7 mt -94.08 -89.03 0.23 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -114.63 145.7 18.64 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -114.9 92.57 30.91 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 83.5 Cg_endo -71.9 179.67 4.62 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.682 2.922 . . . . 0.0 111.387 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -104.08 160.45 14.83 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 124.656 1.182 . . . . 0.0 111.676 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -77.37 -26.53 52.0 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -110.75 136.71 49.41 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.0 p -63.39 -24.11 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 124.147 0.979 . . . . 0.0 112.237 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -81.45 -18.5 45.05 Favored 'General case' 0 C--N 1.335 -0.038 0 C-N-CA 123.314 0.645 . . . . 0.0 112.258 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -71.55 -23.63 61.8 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 122.818 0.447 . . . . 0.0 110.3 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -113.62 168.6 9.63 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.01 1.724 . . . . 0.0 108.352 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -142.12 134.77 28.3 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.552 ' CD2' HG22 ' A' ' 106' ' ' VAL . 8.7 m-30 -101.03 170.86 7.99 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.07 0.948 . . . . 0.0 109.1 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -137.61 129.66 28.98 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 24.8 tp -100.79 98.35 8.88 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.12 -179.73 3.98 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 126.561 1.944 . . . . 0.0 108.775 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -149.64 162.74 39.61 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 122.23 1.014 . . . . 0.0 110.254 178.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -133.14 -179.67 5.64 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.997 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -58.66 -35.7 72.97 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 125.103 1.361 . . . . 0.0 109.092 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 44.7 t -72.05 -62.11 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -177.64 -169.14 38.3 Favored Glycine 0 C--N 1.338 0.679 0 CA-C-N 119.178 0.899 . . . . 0.0 111.234 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -78.4 158.4 28.75 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.997 0.427 . . . . 0.0 111.149 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -158.1 166.36 32.67 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.056 1.343 . . . . 0.0 107.894 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 3.5 mt -114.63 136.09 52.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 7.1 t -110.98 145.34 38.59 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -140.27 120.32 13.69 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 178.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 2.6 tt -114.85 134.55 57.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 178.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.5 mt -129.32 112.42 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 124.063 0.945 . . . . 0.0 110.289 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -104.29 -160.39 24.27 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 126.343 1.925 . . . . 0.0 111.292 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 40.0 m 67.55 60.12 0.48 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.465 1.506 . . . . 0.0 112.633 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -112.24 -119.47 3.73 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -126.28 115.57 19.9 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.496 1.518 . . . . 0.0 107.893 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 46.1 mm -60.26 114.59 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 54.3 m -72.8 100.07 2.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.73 -15.55 20.72 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.833 0.742 . . . . 0.0 112.7 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.46 -36.71 42.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.514 1.526 . . . . 0.0 107.513 177.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 5.0 p -126.49 -30.76 2.81 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 96.57 17.13 34.47 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 127.317 2.389 . . . . 0.0 111.116 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -92.46 166.18 12.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.35 1.075 . . . . 0.0 111.98 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -87.49 146.74 25.68 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.603 178.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -76.8 30.22 0.13 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.367 2.267 . . . . 0.0 110.744 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -74.6 140.93 44.69 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.964 0.888 . . . . 0.0 110.719 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.3 p -109.47 150.04 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.252 -1.34 . . . . 0.0 109.377 -178.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -120.62 130.44 54.15 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.9 mp -120.19 110.01 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 124.929 1.291 . . . . 0.0 108.2 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -96.46 107.07 19.42 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -84.19 124.45 31.18 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.099 0.96 . . . . 0.0 109.426 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 27.9 m -134.9 173.22 14.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 125.1 1.36 . . . . 0.0 110.645 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 2.4 t -86.86 127.55 35.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 177.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -85.44 171.85 46.2 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 118.61 0.641 . . . . 0.0 112.991 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -68.02 -16.13 68.14 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.831 1.205 . . . . 0.0 112.418 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 40.0 t -118.17 119.33 34.4 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -97.22 18.21 15.53 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.796 0.438 . . . . 0.0 111.253 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 91.2 p -138.41 48.33 1.95 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.045 1.738 . . . . 0.0 110.927 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.83 168.08 28.15 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 120.762 -1.211 . . . . 0.0 111.617 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.68 169.96 21.38 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.865 2.377 . . . . 0.0 111.041 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.5 ' O ' HG23 ' A' ' 217' ' ' THR . 78.9 p -68.54 155.05 40.71 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 216' ' ' SER . 0.8 OUTLIER -169.64 154.05 5.32 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 121.66 -0.65 . . . . 0.0 109.611 179.247 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.9 mt -82.06 130.23 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -75.98 -59.42 2.77 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.364 1.065 . . . . 0.0 111.441 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 45.1 p-90 -142.23 165.32 27.76 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.775 1.63 . . . . 0.0 108.222 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.807 HG13 ' CE1' ' A' ' 229' ' ' TYR . 46.3 t -145.24 127.01 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.75 133.76 17.07 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 122.051 0.929 . . . . 0.0 110.801 178.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -82.39 86.52 6.71 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 6.7 p -57.59 -64.76 0.79 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.587 1.155 . . . . 0.0 108.915 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -98.76 -174.49 2.8 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 178.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 34.3 mm -69.71 -43.93 79.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 O-C-N 121.347 -0.846 . . . . 0.0 110.486 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -103.81 -39.72 6.53 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.006 0.522 . . . . 0.0 112.308 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 15.5 t -72.56 130.82 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' TYR . . . . . 0.807 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.2 OUTLIER -127.5 148.88 50.32 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.915 1.686 . . . . 0.0 108.693 -179.207 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -129.02 144.23 51.12 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.804 1.242 . . . . 0.0 109.258 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.67 161.48 40.48 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.269 1.828 . . . . 0.0 108.698 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -131.05 144.88 51.78 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 86.8 t -130.94 135.23 60.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 4.6 p -102.64 142.58 33.56 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 72.9 mt -141.87 131.75 12.6 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-O 118.748 -0.644 . . . . 0.0 109.714 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -71.54 -32.97 11.38 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.514 2.143 . . . . 0.0 112.128 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -69.38 -22.02 63.74 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.029 0.932 . . . . 0.0 111.246 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.6 mp -68.91 -41.2 78.52 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 22.4 m -57.63 -19.76 28.52 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.137 1.375 . . . . 0.0 112.469 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -64.98 -26.38 68.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.247 0.619 . . . . 0.0 110.643 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 25.1 mt -88.03 133.8 33.88 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.704 2.401 . . . . 0.0 108.477 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -54.9 -47.37 74.43 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.935 2.094 . . . . 0.0 113.937 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 8.1 mp -58.91 -34.63 71.92 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.225 -0.922 . . . . 0.0 111.925 -178.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -92.66 3.88 54.75 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.046 1.338 . . . . 0.0 111.476 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.37 0 C-N-CA 126.259 1.823 . . . . 0.0 110.491 -179.479 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.89 95.69 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 40.7 tp -65.61 -44.83 85.32 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.981 0.912 . . . . 0.0 110.041 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 21.4 mt -62.24 -49.02 77.37 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 79.0 m -54.46 -54.22 43.75 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.638 0.775 . . . . 0.0 109.092 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -58.0 -51.36 69.97 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 122.835 0.454 . . . . 0.0 109.989 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 28.3 m -56.52 -42.61 78.7 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.819 0.847 . . . . 0.0 112.548 -178.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.6 tp -66.98 -55.66 13.52 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 119.328 0.967 . . . . 0.0 110.136 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -60.21 -47.15 87.19 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 118.749 0.704 . . . . 0.0 111.971 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -57.79 -49.79 75.43 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.31 -47.18 91.1 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.478 HG13 ' CE1' ' A' ' 172' ' ' PHE . 42.5 t -59.74 -53.55 46.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 126.238 1.815 . . . . 0.0 110.783 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -32.56 74.17 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 119.776 -0.769 . . . . 0.0 109.68 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.6 m -65.36 -44.92 86.14 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.284 0.947 . . . . 0.0 108.63 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.518 HD11 HD12 ' A' ' 183' ' ' ILE . 7.9 mt -53.02 -53.16 23.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.33 -46.87 79.73 Favored 'General case' 0 N--CA 1.436 -1.15 0 O-C-N 124.688 1.243 . . . . 0.0 111.99 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.21 -50.83 71.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.809 0.814 . . . . 0.0 110.023 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -68.46 -8.96 45.52 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.721 1.208 . . . . 0.0 114.059 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.4 mt -115.27 -25.15 8.14 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.416 1.007 . . . . 0.0 111.861 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -61.87 -29.27 70.08 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.125 0.42 . . . . 0.0 110.347 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -69.62 -46.35 66.43 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.883 1.273 . . . . 0.0 109.546 178.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 -160.15 147.45 16.28 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.641 1.576 . . . . 0.0 110.218 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 65.9 m -75.58 177.57 6.66 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 34.0 pt -131.86 150.32 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 O-C-N 121.432 -0.793 . . . . 0.0 109.556 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.59 164.91 28.94 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.961 0.504 . . . . 0.0 110.604 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -147.08 129.13 15.5 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.057 1.743 . . . . 0.0 109.237 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -91.33 102.76 15.46 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.97 66.64 3.62 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.959 1.303 . . . . 0.0 107.791 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.16 -120.28 11.77 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -63.34 -34.9 78.7 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.809 0.844 . . . . 0.0 112.558 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -107.44 148.85 28.61 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 118.743 0.701 . . . . 0.0 110.637 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.0 mt -112.06 151.03 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -125.22 128.4 48.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.246 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -126.33 130.69 51.31 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.846 1.658 . . . . 0.0 108.544 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -125.76 120.97 32.02 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.35 1.46 . . . . 0.0 109.33 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 6.5 m -105.53 160.02 27.51 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.755 1.222 . . . . 0.0 113.89 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.02 86.12 0.49 Allowed 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 124.585 3.524 . . . . 0.0 113.208 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 61.93 54.95 31.11 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.0 mt -130.02 -67.46 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.414 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 20.9 pt-20 -170.29 166.57 8.72 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 126.337 1.855 . . . . 0.0 108.05 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.58 119.07 27.12 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 102.472 -3.159 . . . . 0.0 102.472 177.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.6 m -139.24 148.39 23.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -178.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -113.69 138.02 50.8 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -145.76 158.5 43.85 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.753 1.221 . . . . 0.0 111.158 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -87.81 154.48 20.51 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 152.34 -164.14 30.48 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -132.13 161.29 33.68 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.173 1.389 . . . . 0.0 108.01 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 53.7 t . . . . . 0 N--CA 1.467 0.397 0 C-N-CA 124.579 1.152 . . . . 0.0 109.928 -179.309 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 . . . . . 0 C--O 1.235 0.303 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.7 mt . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 179.516 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 46.8 mt . . . . . 0 C--O 1.234 0.258 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.2 t -142.67 138.95 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 126.145 1.778 . . . . 0.0 108.933 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -132.04 153.48 50.36 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 125.215 1.406 . . . . 0.0 110.673 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -95.39 135.96 36.35 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.658 1.583 . . . . 0.0 108.2 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 63.7 mt -115.89 -78.85 0.58 Allowed 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -121.38 154.05 16.6 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt -132.84 90.57 31.74 Favored Pre-proline 0 N--CA 1.456 -0.148 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 48.6 Cg_endo -76.27 -178.99 4.83 Favored 'Trans proline' 0 C--O 1.239 0.529 0 C-N-CA 123.194 2.596 . . . . 0.0 111.951 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -85.59 166.97 15.8 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.24 -37.03 39.03 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -105.33 152.0 23.47 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.375 -0.828 . . . . 0.0 111.67 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.1 p -68.25 -24.68 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.575 0.75 . . . . 0.0 112.393 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -82.82 -8.24 59.6 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.909 1.284 . . . . 0.0 112.372 -178.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -96.79 -11.72 24.58 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.466 1.107 . . . . 0.0 110.258 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -120.53 177.91 4.87 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.83 2.452 . . . . 0.0 111.552 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -142.85 165.78 26.44 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.02 1.728 . . . . 0.0 109.786 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.478 ' CE1' HG13 ' A' ' 106' ' ' VAL . 77.7 m-85 -140.94 168.42 19.84 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.885 1.674 . . . . 0.0 109.28 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -129.97 122.0 27.65 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.638 0.775 . . . . 0.0 109.488 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.0 tt -81.28 105.0 12.12 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 45.7 mt -115.78 -179.89 3.78 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.944 0.897 . . . . 0.0 110.995 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -161.91 156.15 22.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -138.42 -172.83 3.38 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -54.16 -24.2 17.18 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.487 1.915 . . . . 0.0 113.626 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 45.7 t -80.85 -75.5 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -166.68 -168.97 29.67 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.571 ' CE2' HD22 ' A' ' 243' ' ' LEU . 6.3 m-85 -78.16 154.78 30.88 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.249 1.02 . . . . 0.0 111.177 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -160.85 175.38 12.61 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.149 1.78 . . . . 0.0 108.74 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.518 HD12 HD11 ' A' ' 109' ' ' ILE . 15.8 mt -120.01 137.85 52.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 103.063 -2.94 . . . . 0.0 103.063 177.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.4 t -124.88 125.85 44.61 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -128.55 146.02 50.95 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 5.8 tt -121.53 138.2 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.409 HG21 ' HD3' ' A' ' 163' ' ' PRO . 13.8 mt -126.06 109.54 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 125.65 1.58 . . . . 0.0 109.512 -178.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.34 -153.26 24.9 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 41.7 m 75.95 31.67 0.68 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.866 1.267 . . . . 0.0 111.357 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -91.62 -138.22 7.92 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 108.266 -1.934 . . . . 0.0 108.266 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -117.47 121.71 41.77 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 127.229 2.212 . . . . 0.0 110.04 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 10.6 mm -60.79 125.63 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 123.378 0.671 . . . . 0.0 109.839 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 56.6 m -84.64 101.96 12.56 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 103.922 -2.621 . . . . 0.0 103.922 177.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -58.61 -17.79 24.91 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.579 0.627 . . . . 0.0 110.762 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 24.9 t -50.69 -41.56 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 125.526 1.53 . . . . 0.0 109.098 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 7.5 p -125.45 -24.23 3.96 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 96.1 6.21 59.13 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 126.713 2.101 . . . . 0.0 112.441 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -86.23 166.82 15.4 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.038 0.935 . . . . 0.0 110.965 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -90.39 150.87 21.68 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 2.6 tpt85 -76.88 30.69 0.13 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 128.216 2.606 . . . . 0.0 110.789 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.1 ptt? -72.44 149.13 44.5 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -176.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.3 p -121.74 140.78 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 114.616 -1.174 . . . . 0.0 112.218 -176.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -112.57 123.09 49.51 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.365 1.066 . . . . 0.0 110.394 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 2.3 mp -109.04 128.67 64.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 126.115 1.766 . . . . 0.0 111.098 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -106.23 118.69 37.29 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.36 1.064 . . . . 0.0 108.724 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -97.27 115.33 27.43 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.91 0.884 . . . . 0.0 109.61 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 32.8 m -125.54 165.42 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.647 1.579 . . . . 0.0 112.106 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.13 137.33 37.43 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -107.06 128.03 9.08 Favored Glycine 0 C--N 1.334 0.471 0 N-CA-C 108.265 -1.934 . . . . 0.0 108.265 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -42.91 -41.63 4.63 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.592 1.568 . . . . 0.0 113.656 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.4 t -79.49 85.37 5.27 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.414 ' HA ' ' HB3' ' A' ' 236' ' ' PRO . 18.1 p-10 -72.66 9.15 1.17 Allowed 'General case' 0 CA--C 1.549 0.908 0 O-C-N 121.276 -0.89 . . . . 0.0 113.115 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.95 46.51 1.65 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.43 1.892 . . . . 0.0 112.906 -178.271 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -166.83 159.89 33.38 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 120.299 -1.5 . . . . 0.0 111.993 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.25 166.59 22.82 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.135 2.557 . . . . 0.0 111.825 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 5.2 p -66.22 158.62 28.38 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.827 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.0 p -161.6 165.31 28.58 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.125 1.77 . . . . 0.0 107.376 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.8 mt -85.61 132.1 32.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -78.2 -53.03 7.79 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.787 1.635 . . . . 0.0 110.542 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' TRP . . . . . 0.489 ' CE3' ' HD2' ' A' ' 222' ' ' ARG . 37.9 p-90 -152.16 167.4 28.66 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.38 1.472 . . . . 0.0 108.685 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.717 HG13 ' CE1' ' A' ' 229' ' ' TYR . 47.0 t -146.29 133.88 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 126.253 1.821 . . . . 0.0 106.923 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.489 ' HD2' ' CE3' ' A' ' 220' ' ' TRP . 0.1 OUTLIER -153.75 130.47 10.81 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.912 0.778 . . . . 0.0 111.12 178.082 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -81.73 86.88 6.36 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 6.6 p -65.32 -55.02 20.61 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 127.022 2.129 . . . . 0.0 110.599 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -98.38 -176.51 3.42 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.5 mp -78.79 -29.98 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.8 t -111.61 -54.34 2.62 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.511 0.725 . . . . 0.0 110.898 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.94 149.4 10.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 123.639 0.776 . . . . 0.0 109.283 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' TYR . . . . . 0.717 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.2 OUTLIER -138.24 139.56 39.29 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.213 1.805 . . . . 0.0 109.453 -178.168 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.3 140.34 49.68 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.03 1.332 . . . . 0.0 108.553 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.39 162.32 38.46 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.394 1.877 . . . . 0.0 109.12 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -131.79 149.4 52.48 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 94.3 t -132.55 132.77 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 125.836 1.654 . . . . 0.0 108.887 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.25 144.29 27.2 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 32.7 mt -141.28 136.97 16.21 Favored Pre-proline 0 N--CA 1.454 -0.262 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.414 ' HB3' ' HA ' ' A' ' 212' ' ' ASN . 89.9 Cg_endo -76.75 -40.88 0.46 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.627 1.551 . . . . 0.0 112.338 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -68.27 -17.67 64.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 120.768 -1.208 . . . . 0.0 111.944 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 17.0 mt -66.04 -30.77 71.36 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 176.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 28.9 m -61.11 -13.78 19.71 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.024 1.33 . . . . 0.0 111.167 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -75.37 -32.37 60.81 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 120.142 -1.599 . . . . 0.0 111.534 178.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 40.5 mt -81.31 111.47 17.72 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 126.5 1.92 . . . . 0.0 109.0 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -47.08 -34.11 5.58 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 128.847 2.859 . . . . 0.0 114.878 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.571 HD22 ' CE2' ' A' ' 181' ' ' TYR . 12.5 mt -62.82 -39.62 94.88 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.355 -0.841 . . . . 0.0 111.531 178.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 4.8 mp -91.51 10.33 28.27 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 127.058 2.143 . . . . 0.0 113.5 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.164 0 C-N-CA 126.462 1.905 . . . . 0.0 110.694 -178.289 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.9 p . . . . . 0 CA--C 1.528 0.115 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.49 -48.17 82.94 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 118.293 0.497 . . . . 0.0 110.096 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 47.1 tp -67.53 -40.2 85.06 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 118.218 -0.896 . . . . 0.0 109.445 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.7 mt -59.35 -52.49 65.43 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.864 1.211 . . . . 0.0 109.266 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.4 m -57.3 -49.57 75.68 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 121.648 -0.657 . . . . 0.0 109.47 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -57.89 -49.1 77.86 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 118.238 0.472 . . . . 0.0 109.776 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 59.6 m -53.05 -52.57 58.09 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.71 1.604 . . . . 0.0 110.422 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 19.0 tp -59.83 -54.3 47.88 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 118.802 -0.618 . . . . 0.0 110.603 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.86 -47.67 79.88 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 118.262 0.483 . . . . 0.0 111.708 -178.044 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -60.06 -39.74 87.05 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.285 1.034 . . . . 0.0 108.512 178.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.89 -52.83 50.53 Favored Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 40.3 t -56.39 -52.99 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 118.661 1.231 . . . . 0.0 111.165 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -29.67 70.87 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.405 1.002 . . . . 0.0 111.54 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.1 m -75.41 -42.69 53.09 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 118.79 -0.624 . . . . 0.0 110.459 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.427 HD11 HD12 ' A' ' 183' ' ' ILE . 22.6 mt -56.12 -50.87 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.03 -43.19 91.57 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -65.77 -20.51 66.29 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.72 1.208 . . . . 0.0 112.81 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.16 10.36 33.84 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.003 1.321 . . . . 0.0 112.583 178.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.7 mt -135.59 -29.15 1.07 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.497 1.119 . . . . 0.0 113.555 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -51.7 -37.16 49.61 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -178.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -65.45 -40.07 92.79 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 116.069 1.878 . . . . 0.0 116.069 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.9 mmt180 -159.12 147.87 18.25 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.395 1.478 . . . . 0.0 109.243 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 32.2 m -75.72 172.3 12.87 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 32.9 pt -126.31 146.24 32.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.422 ' CD1' HD11 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -144.96 152.65 40.51 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 122.84 0.456 . . . . 0.0 110.889 -178.562 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -137.08 127.71 26.98 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 124.046 0.938 . . . . 0.0 110.455 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -89.15 102.86 15.52 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.57 70.75 4.24 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.08 -115.51 5.5 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -77.27 -28.03 53.37 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.322 1.049 . . . . 0.0 111.794 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -106.65 135.56 47.96 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 119.327 0.967 . . . . 0.0 111.215 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.4 mt -106.82 145.82 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.515 ' CD1' HG11 ' A' ' 221' ' ' VAL . 67.1 m-85 -121.27 128.33 52.26 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.409 1.484 . . . . 0.0 107.627 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -122.94 128.24 50.0 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.676 1.59 . . . . 0.0 110.255 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -121.06 109.97 15.68 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.074 0.95 . . . . 0.0 108.612 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 11.6 m -95.23 158.8 34.15 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 123.226 0.61 . . . . 0.0 110.972 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.5 83.55 0.39 Allowed 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 123.903 3.069 . . . . 0.0 115.658 -178.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.32 51.68 50.47 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 124.205 0.907 . . . . 0.0 111.085 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.8 mt -126.8 -67.17 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.4 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 10.5 pt-20 -170.64 163.35 8.11 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 126.414 1.885 . . . . 0.0 108.362 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.67 121.12 36.64 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 102.154 -3.276 . . . . 0.0 102.154 177.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.4 m -131.5 156.95 43.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 124.548 1.139 . . . . 0.0 111.13 -178.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -125.83 126.39 44.41 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 178.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -143.99 157.53 44.28 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.489 1.115 . . . . 0.0 111.926 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -89.29 153.24 21.05 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 178.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 161.84 -163.03 34.51 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.38 140.86 50.58 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.6 t . . . . . 0 C--N 1.332 -0.186 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.829 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 . . . . . 0 C--O 1.234 0.258 0 CA-C-O 121.408 0.623 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.422 HD11 ' CD1' ' A' ' 119' ' ' PHE . 39.7 mt . . . . . 0 N--CA 1.45 -0.438 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 80.6 mt . . . . . 0 C--O 1.233 0.235 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.3 t -142.5 135.12 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.071 1.348 . . . . 0.0 107.838 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -124.31 151.38 44.35 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.087 1.355 . . . . 0.0 111.051 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -96.99 112.64 24.3 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 127.068 2.147 . . . . 0.0 107.449 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.3 mp -93.82 -78.53 0.43 Allowed 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -120.49 144.23 16.95 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -121.52 89.35 47.19 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 52.5 Cg_endo -77.58 173.35 14.32 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.793 2.995 . . . . 0.0 111.608 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -87.88 161.88 17.25 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.184 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -82.97 -37.84 23.51 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.066 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -93.34 132.59 37.42 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 15.0 p -60.65 -31.74 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 123.85 0.86 . . . . 0.0 112.086 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -68.03 -21.36 65.02 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.704 0.684 . . . . 0.0 112.01 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -84.31 -20.31 32.3 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.838 0.455 . . . . 0.0 110.614 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 32.9 mmm-85 -70.72 165.93 21.95 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.748 0.819 . . . . 0.0 109.904 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -134.86 95.98 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.086 0.955 . . . . 0.0 109.241 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -106.68 156.65 18.4 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.946 1.298 . . . . 0.0 108.932 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -140.92 147.49 38.92 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.759 1.224 . . . . 0.0 107.888 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 25.1 tp -107.94 102.64 11.81 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 125.705 1.602 . . . . 0.0 106.875 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.81 179.0 4.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.28 1.432 . . . . 0.0 107.837 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.415 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 20.5 p90 -154.07 163.66 39.74 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -133.81 173.9 11.04 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -63.78 -11.43 26.69 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.403 -0.81 . . . . 0.0 110.61 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 83.7 t -83.76 -66.16 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -176.32 -174.54 42.91 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.415 ' CD2' ' HB3' ' A' ' 176' ' ' TYR . 26.2 m-85 -81.41 156.57 25.33 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 124.798 1.239 . . . . 0.0 111.842 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -162.79 169.96 19.08 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.228 1.011 . . . . 0.0 111.258 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.427 HD12 HD11 ' A' ' 109' ' ' ILE . 7.9 mt -116.57 121.78 68.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 11.8 t -97.69 131.61 44.08 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.704 1.202 . . . . 0.0 110.321 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -137.93 110.14 7.34 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.114 1.766 . . . . 0.0 109.075 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 2.7 tt -103.22 140.23 22.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.2 mt -132.83 113.79 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 123.647 0.779 . . . . 0.0 110.289 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -106.55 -156.87 21.33 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 125.293 1.425 . . . . 0.0 110.897 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 65.69 60.79 0.7 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.109 1.763 . . . . 0.0 111.554 -178.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -116.84 -124.01 3.52 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 104.633 -3.387 . . . . 0.0 104.633 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -127.95 123.58 35.22 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.759 1.224 . . . . 0.0 110.754 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 31.0 mm -64.25 116.96 4.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 71.8 m -73.71 102.09 3.86 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -53.18 -28.8 28.24 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.5 m -52.41 -33.28 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 C-N-CA 125.025 1.33 . . . . 0.0 111.384 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 73.1 p -123.0 -45.79 2.12 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.74 12.43 20.88 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.994 2.235 . . . . 0.0 111.32 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -92.56 169.97 10.11 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.942 1.297 . . . . 0.0 111.488 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -85.17 148.51 26.07 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.589 0.709 . . . . 0.0 111.792 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 18.3 tpt85 -84.05 28.56 0.6 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.676 2.39 . . . . 0.0 109.157 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 3.5 ptt? -73.47 158.77 34.3 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -177.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 1.9 p -125.93 140.1 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.155 -178.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -105.96 115.54 30.4 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 125.84 1.656 . . . . 0.0 107.083 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.6 mp -107.12 131.65 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -118.1 120.15 36.88 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 125.435 1.494 . . . . 0.0 108.511 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -101.05 119.4 38.69 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.42 1.488 . . . . 0.0 112.368 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 17.2 m -127.05 176.34 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.808 1.243 . . . . 0.0 111.8 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.6 t -91.0 124.32 35.15 Favored 'General case' 0 C--N 1.337 0.053 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 178.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.34 155.24 34.03 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.258 -0.496 . . . . 0.0 113.043 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -57.44 -27.22 57.98 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.305 0.955 . . . . 0.0 111.594 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 6.0 m -114.68 93.69 4.44 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -77.55 25.03 0.19 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.967 1.707 . . . . 0.0 112.552 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 27.2 t -131.98 45.48 2.77 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.343 1.857 . . . . 0.0 110.005 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -161.35 166.03 35.69 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-O 118.619 -1.101 . . . . 0.0 111.27 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -71.09 166.75 28.16 Favored 'Trans proline' 0 C--O 1.24 0.589 0 C-N-CA 122.821 2.347 . . . . 0.0 112.413 -178.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 96.7 p -70.38 155.58 40.49 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -166.01 156.11 12.5 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.0 mt -78.87 127.03 39.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -72.01 -51.25 22.71 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.743 1.617 . . . . 0.0 112.139 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' TRP . . . . . 0.441 ' CZ2' ' HB2' ' A' ' 232' ' ' GLN . 20.7 p-90 -152.76 164.92 36.86 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.183 1.393 . . . . 0.0 109.334 -178.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.798 HG13 ' CE1' ' A' ' 229' ' ' TYR . 51.3 t -147.36 120.75 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.42 ' HD3' ' CE3' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -140.15 127.42 21.19 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 178.674 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -80.68 92.26 5.97 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 104.101 -2.555 . . . . 0.0 104.101 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 5.7 p -65.69 -65.65 0.65 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.35 1.46 . . . . 0.0 109.786 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -88.71 -172.83 3.88 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.052 0.941 . . . . 0.0 108.489 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.4 mp -78.71 -40.99 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -106.07 -49.41 3.38 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.106 1.363 . . . . 0.0 112.539 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 2.4 t -68.26 145.54 13.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' TYR . . . . . 0.798 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.2 OUTLIER -137.2 136.1 37.86 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.716 1.606 . . . . 0.0 109.177 -178.413 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.42 139.93 43.78 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 125.047 1.339 . . . . 0.0 108.577 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -142.06 155.1 45.38 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 126.088 1.755 . . . . 0.0 110.136 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.441 ' HB2' ' CZ2' ' A' ' 220' ' ' TRP . 5.0 tt0 -136.25 146.42 46.7 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 1.6 m -137.34 154.56 30.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.1 p -109.08 148.67 30.46 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 123.469 0.708 . . . . 0.0 110.33 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 41.6 mt -142.27 133.35 12.94 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.27 -46.56 0.65 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.772 2.315 . . . . 0.0 112.324 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -62.03 -22.73 65.96 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.953 0.901 . . . . 0.0 113.375 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.8 mp -63.26 -40.06 96.35 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.223 0.92 . . . . 0.0 108.974 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 30.2 m -54.59 -22.53 13.58 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.84 1.656 . . . . 0.0 113.152 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -62.7 -31.47 72.38 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 121.1 -1.0 . . . . 0.0 110.841 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 26.4 mt -79.4 118.88 21.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.7 -35.52 31.52 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.9 mp -58.93 -45.19 90.99 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.336 -0.852 . . . . 0.0 109.599 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.76 5.45 36.31 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.125 1.77 . . . . 0.0 112.62 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.526 0 CA-C-N 119.68 1.127 . . . . 0.0 111.261 -179.549 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.6 m . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.05 -38.31 70.44 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.373 0.669 . . . . 0.0 110.659 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.3 tp -60.57 -38.11 83.5 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 119.003 -0.523 . . . . 0.0 110.457 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.497 HD23 HD13 ' A' ' 174' ' ' LEU . 3.4 mt -67.23 -49.51 64.2 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 58.7 m -54.6 -44.57 73.16 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.919 0.888 . . . . 0.0 109.904 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -66.31 -50.78 62.45 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 121.104 -0.998 . . . . 0.0 110.246 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 58.4 m -53.99 -47.43 71.44 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.287 1.435 . . . . 0.0 111.145 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 28.5 tp -63.31 -54.79 31.51 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 119.051 0.841 . . . . 0.0 110.911 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -54.01 -48.99 69.86 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.414 0.686 . . . . 0.0 110.52 -178.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -57.37 -50.79 71.85 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 124.07 0.948 . . . . 0.0 109.051 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -57.04 -49.38 72.13 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-O 119.178 -0.79 . . . . 0.0 111.687 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 72.6 t -58.88 -53.2 50.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 125.343 1.457 . . . . 0.0 110.867 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -31.23 72.34 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 118.573 0.624 . . . . 0.0 110.531 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.8 m -70.44 -46.13 64.47 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.537 HD11 HD12 ' A' ' 183' ' ' ILE . 10.9 mt -53.56 -54.31 19.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.37 -44.04 84.09 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 124.035 0.834 . . . . 0.0 110.81 -178.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -60.41 -52.53 64.82 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.163 0.506 . . . . 0.0 111.6 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -22.19 66.8 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.8 mt -96.04 -27.37 15.14 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 118.823 0.738 . . . . 0.0 110.311 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -61.79 -28.44 69.46 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.186 0.594 . . . . 0.0 110.178 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -66.53 -46.93 74.52 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -165.44 152.75 10.64 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.908 2.083 . . . . 0.0 109.431 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 57.5 m -75.44 171.82 13.58 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 41.6 pt -125.78 147.55 30.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 123.801 0.84 . . . . 0.0 108.981 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.73 156.42 45.01 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 122.78 0.432 . . . . 0.0 110.375 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -142.91 128.02 18.58 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 124.167 0.987 . . . . 0.0 110.195 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -88.71 106.12 18.14 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.29 67.23 0.92 Allowed 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.35 -120.53 7.11 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.173 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -66.73 -32.06 73.12 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.64 1.176 . . . . 0.0 111.345 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -107.64 135.84 48.41 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.463 0.649 . . . . 0.0 111.626 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.459 HD12 ' H ' ' A' ' 140' ' ' GLY . 33.1 mt -105.8 149.72 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 177.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -119.08 134.8 54.98 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.334 -1.757 . . . . 0.0 108.205 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -128.91 130.74 47.19 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.751 1.22 . . . . 0.0 108.495 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -129.4 118.82 22.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.585 1.154 . . . . 0.0 109.219 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 10.6 m -105.41 160.32 26.46 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.668 1.187 . . . . 0.0 113.57 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -63.79 92.82 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 124.858 3.706 . . . . 0.0 113.157 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 52.17 53.06 32.7 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-O 119.579 -0.567 . . . . 0.0 111.846 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.1 mt -124.92 -67.36 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -177.38 174.73 1.55 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.98 1.712 . . . . 0.0 109.203 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.82 124.55 39.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 177.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.9 m -134.42 156.94 41.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 124.379 1.072 . . . . 0.0 110.879 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -124.09 124.12 41.82 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -146.17 156.37 43.37 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.323 1.049 . . . . 0.0 111.615 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -102.21 119.59 39.06 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.459 ' H ' HD12 ' A' ' 126' ' ' ILE . . . -154.44 -165.14 13.54 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.921 1.724 . . . . 0.0 108.962 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.66 136.89 50.28 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 C--O 1.237 0.417 0 C-N-CA 123.902 0.881 . . . . 0.0 112.319 -179.193 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 . . . . . 0 N--CA 1.445 -0.715 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 88.1 mt . . . . . 0 C--N 1.326 -0.442 0 N-CA-C 102.744 -3.058 . . . . 0.0 102.744 178.863 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 N--CA 1.456 -0.144 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.8 t -134.95 133.95 53.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.044 0.838 . . . . 0.0 108.965 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -130.3 163.4 26.88 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.492 1.517 . . . . 0.0 110.792 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -112.9 143.38 44.28 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 18.5 mt -116.32 -72.92 0.67 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -128.67 148.88 18.19 Favored Glycine 0 C--O 1.241 0.564 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -130.78 91.83 36.0 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.718 1.207 . . . . 0.0 109.286 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.441 ' HD3' HG21 ' A' ' 187' ' ' ILE . 43.5 Cg_endo -74.46 -166.09 0.31 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 125.06 3.84 . . . . 0.0 111.051 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -95.98 168.1 10.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.114 1.366 . . . . 0.0 109.395 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -81.79 -28.45 33.2 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -113.98 162.56 16.27 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 123.328 0.651 . . . . 0.0 110.324 -179.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.8 p -73.63 -34.58 41.96 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 C-N-CA 123.364 0.665 . . . . 0.0 110.379 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -74.37 -16.03 60.91 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.404 -0.81 . . . . 0.0 112.182 -177.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -81.57 -19.66 41.53 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.183 0.993 . . . . 0.0 110.603 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -117.33 177.91 4.56 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.608 1.563 . . . . 0.0 110.985 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -140.51 156.86 46.2 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -133.83 166.99 21.37 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.308 1.843 . . . . 0.0 107.977 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -133.74 123.7 25.38 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 120.498 1.499 . . . . 0.0 112.614 -179.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.497 HD13 HD23 ' A' ' 98' ' ' LEU . 0.7 OUTLIER -82.77 99.08 9.45 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.005 1.322 . . . . 0.0 109.442 179.581 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.43 HD12 ' HB2' ' A' ' 184' ' ' SER . 24.7 mt -108.21 174.02 6.06 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 122.394 1.092 . . . . 0.0 109.516 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -154.52 163.11 40.7 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -141.25 -178.44 5.59 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -52.55 -34.25 49.3 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 125.335 1.454 . . . . 0.0 110.523 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 56.1 t -70.79 -67.78 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 127.005 2.122 . . . . 0.0 109.191 178.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -175.77 -174.69 42.54 Favored Glycine 0 N--CA 1.446 -0.66 0 O-C-N 121.817 -0.552 . . . . 0.0 111.931 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -80.06 158.32 26.49 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.515 1.126 . . . . 0.0 111.973 -178.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -165.69 177.0 7.58 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.457 1.503 . . . . 0.0 108.531 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.537 HD12 HD11 ' A' ' 109' ' ' ILE . 8.9 mt -121.92 126.28 74.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 101.609 -3.478 . . . . 0.0 101.609 177.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.43 ' HB2' HD12 ' A' ' 175' ' ' LEU . 3.2 t -106.4 107.8 19.0 Favored 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 124.325 1.016 . . . . 0.0 109.248 -178.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -111.22 118.78 36.85 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 118.5 -0.762 . . . . 0.0 110.699 -179.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.8 tt -108.95 140.27 28.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.441 HG21 ' HD3' ' A' ' 163' ' ' PRO . 7.5 mt -133.87 113.47 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 C-N-CA 123.997 0.919 . . . . 0.0 110.637 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.68 -162.41 26.01 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 177.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.0 m 84.45 29.19 0.07 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.251 2.221 . . . . 0.0 112.959 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -87.4 -109.15 0.92 Allowed Glycine 0 C--N 1.338 0.649 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -139.11 126.6 21.7 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.337 1.455 . . . . 0.0 109.053 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.5 mm -68.19 122.54 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 120.503 1.501 . . . . 0.0 109.453 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 30.5 p -82.01 117.76 22.46 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 123.156 0.583 . . . . 0.0 111.622 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -71.89 -3.52 22.95 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.115 -0.991 . . . . 0.0 110.718 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 39.6 t -66.98 -42.06 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 125.127 1.371 . . . . 0.0 108.278 178.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.9 p -124.34 -28.57 3.64 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 122.898 0.479 . . . . 0.0 111.613 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.77 30.62 10.22 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -116.55 169.28 9.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.74 1.216 . . . . 0.0 112.289 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -83.83 139.91 32.36 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.351 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 2.9 tpp85 -77.13 30.75 0.14 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 130.013 3.325 . . . . 0.0 109.371 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 12.2 ptt? -73.11 157.11 37.9 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 122.008 0.909 . . . . 0.0 109.329 -176.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.5 p -125.19 146.05 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 114.37 -1.287 . . . . 0.0 111.317 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -112.7 138.6 49.27 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 1.8 mp -125.94 114.38 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 126.455 1.902 . . . . 0.0 107.579 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -99.69 116.28 31.43 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -93.54 118.17 31.01 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 125.242 1.417 . . . . 0.0 111.506 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 32.5 m -129.49 172.21 15.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 124.266 1.026 . . . . 0.0 111.312 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.2 t -78.59 134.96 37.16 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -93.21 122.01 6.79 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -37.68 -61.73 1.06 Allowed Glycine 0 C--N 1.336 0.538 0 C-N-CA 126.74 2.114 . . . . 0.0 111.343 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.8 p -77.66 83.09 4.05 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.483 ' HA ' ' HB3' ' A' ' 236' ' ' PRO . 37.2 p-10 -76.64 66.78 2.66 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.9 p -149.47 19.45 0.94 Allowed 'General case' 0 C--O 1.238 0.458 0 N-CA-C 116.539 2.052 . . . . 0.0 116.539 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -163.95 173.65 40.01 Favored Glycine 0 N--CA 1.47 0.941 0 O-C-N 121.189 -0.945 . . . . 0.0 115.197 -178.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -64.77 164.24 24.97 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.036 2.49 . . . . 0.0 112.535 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 15.8 p -67.31 157.59 33.59 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.368 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 1.7 p -161.27 163.72 30.75 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.417 2.287 . . . . 0.0 106.923 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.5 mt -82.75 134.57 26.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 178.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -81.57 -55.22 4.81 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.052 1.341 . . . . 0.0 111.097 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 26.2 p-90 -147.92 166.54 27.36 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.259 1.424 . . . . 0.0 108.541 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.679 HG13 ' CE1' ' A' ' 229' ' ' TYR . 49.6 t -146.1 131.76 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -179.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.43 133.65 15.25 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.73 0.776 . . . . 0.0 111.223 177.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -81.72 89.3 6.27 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.2 p -66.01 -51.91 54.03 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.082 0.953 . . . . 0.0 111.734 -178.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -103.18 -173.83 2.4 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.0 mp -72.17 -43.54 66.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 3.4 m -111.94 -28.55 7.99 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -177.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 2.1 t -81.78 143.1 12.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' TYR . . . . . 0.679 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.9 OUTLIER -129.04 145.5 51.24 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.31 1.444 . . . . 0.0 110.09 -177.964 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -129.33 142.02 50.93 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 125.442 1.497 . . . . 0.0 108.39 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.28 163.2 37.16 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.296 1.839 . . . . 0.0 110.786 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -126.89 149.15 49.91 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 88.7 t -132.77 134.37 58.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 125.525 1.53 . . . . 0.0 107.803 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.41 143.48 32.63 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.922 0.889 . . . . 0.0 108.877 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 33.8 mt -139.85 138.13 19.36 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 118.251 -0.88 . . . . 0.0 109.215 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.483 ' HB3' ' HA ' ' A' ' 212' ' ' ASN . 72.4 Cg_endo -74.22 -46.16 0.31 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.647 2.231 . . . . 0.0 110.838 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.71 -25.41 62.88 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.996 1.318 . . . . 0.0 110.816 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 238' ' ' LEU . 15.3 mt -65.52 -41.33 93.26 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 24.7 m -58.01 -16.1 11.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.604 1.562 . . . . 0.0 113.061 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -63.19 -43.84 97.07 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.006 0.923 . . . . 0.0 109.143 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.8 mt -71.87 120.04 16.9 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 128.809 2.844 . . . . 0.0 107.049 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -52.67 -35.21 54.75 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.4 mp -58.73 -36.7 74.72 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.602 -0.686 . . . . 0.0 110.897 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -94.41 3.88 54.6 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 125.046 1.338 . . . . 0.0 111.949 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.718 0 O-C-N 121.506 -0.746 . . . . 0.0 112.384 -179.346 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.446 -0.672 0 CA-C-O 118.375 -0.821 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.53 -35.97 77.27 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.715 1.143 . . . . 0.0 110.34 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.22 -45.34 88.69 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.6 mt -63.46 -53.93 44.47 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.494 1.118 . . . . 0.0 109.538 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 55.2 m -54.87 -44.51 74.1 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.637 1.175 . . . . 0.0 110.648 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.1 ttmm -65.97 -49.79 66.6 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.813 -0.613 . . . . 0.0 109.945 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 79.9 m -51.92 -43.28 63.35 Favored 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 124.523 1.129 . . . . 0.0 111.157 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tt -61.79 -56.88 14.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.299 0.5 . . . . 0.0 111.898 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -60.69 -45.71 93.16 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.744 0.817 . . . . 0.0 111.42 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -57.72 -44.28 85.87 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.861 0.864 . . . . 0.0 108.851 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.98 -52.03 54.87 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 94.8 t -55.1 -53.2 36.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 124.977 1.311 . . . . 0.0 111.711 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.04 -33.36 75.58 Favored 'General case' 0 C--N 1.335 -0.052 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.741 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.2 m -67.63 -46.22 73.13 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.453 HD11 HD12 ' A' ' 183' ' ' ILE . 27.9 mt -55.64 -54.31 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 124.606 1.163 . . . . 0.0 108.855 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.02 -43.73 82.13 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.468 -178.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -60.99 -52.96 62.81 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-N 118.78 0.718 . . . . 0.0 110.637 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.68 -15.65 53.48 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.2 mt -101.54 -28.11 12.73 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 119.358 0.981 . . . . 0.0 109.174 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -65.5 -26.22 67.82 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -66.6 -46.23 76.61 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 -161.77 148.56 14.1 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.307 1.843 . . . . 0.0 109.297 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 71.0 m -74.99 164.42 26.57 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 178.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 33.3 pt -119.36 154.98 21.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -145.21 165.39 28.48 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.031 -178.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -151.25 125.34 9.26 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.194 1.397 . . . . 0.0 109.369 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -88.76 117.38 27.7 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -108.41 67.49 0.67 Allowed 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.722 1.209 . . . . 0.0 109.0 178.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.0 -114.09 3.88 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 107.917 -2.073 . . . . 0.0 107.917 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -83.99 -26.5 29.14 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.162 1.385 . . . . 0.0 112.463 179.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -106.38 115.44 30.22 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.409 1.484 . . . . 0.0 112.638 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 51.2 mt -92.57 146.74 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 C-N-CA 125.559 1.543 . . . . 0.0 108.219 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.475 ' CD1' HG11 ' A' ' 221' ' ' VAL . 64.1 m-85 -118.04 135.23 54.3 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.499 -1.228 . . . . 0.0 107.74 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -133.14 126.43 31.69 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.311 1.044 . . . . 0.0 108.772 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -122.85 127.07 48.53 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.595 1.158 . . . . 0.0 111.677 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 17.6 m -114.21 158.66 39.06 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 123.428 0.691 . . . . 0.0 112.351 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.28 92.78 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.625 1 C-N-CA 125.614 4.21 . . . . 0.0 113.858 -178.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 58.91 47.49 90.37 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.1 mt -125.37 -66.86 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.215 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.523 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 20.8 pt-20 -178.13 167.11 1.99 Allowed 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.415 1.486 . . . . 0.0 109.117 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.32 119.28 29.65 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 178.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.6 m -127.2 156.67 38.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 125.252 1.421 . . . . 0.0 110.765 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.36 124.07 41.57 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 103.638 -2.726 . . . . 0.0 103.638 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -146.29 158.79 43.91 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -178.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -89.37 153.64 20.7 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 169.48 -168.46 41.3 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -125.62 138.22 53.91 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.563 1.545 . . . . 0.0 107.075 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.467 0.402 0 CA-C-N 119.244 0.929 . . . . 0.0 110.907 -178.857 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 . . . . . 0 C--O 1.236 0.365 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 23.0 mt . . . . . 0 C--O 1.237 0.434 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 179.111 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 15.9 mt . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -136.2 135.18 50.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -134.49 154.82 51.23 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.96 1.704 . . . . 0.0 108.689 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -107.68 143.19 36.52 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.874 0.87 . . . . 0.0 109.236 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 35.5 mt -113.6 -69.96 0.83 Allowed 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 124.255 0.972 . . . . 0.0 109.432 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -133.57 156.51 22.3 Favored Glycine 0 C--O 1.239 0.422 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -126.78 93.7 41.67 Favored Pre-proline 0 C--O 1.231 0.102 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.523 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 57.3 Cg_endo -76.73 174.69 12.43 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 122.421 2.08 . . . . 0.0 110.068 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -81.32 162.03 23.62 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.47 -28.96 24.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.937 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -103.44 135.48 44.96 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.39 -22.54 28.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -83.28 -14.44 53.08 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 124.865 1.266 . . . . 0.0 111.448 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -84.55 -13.74 50.93 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.404 0.682 . . . . 0.0 110.864 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -117.51 174.56 6.08 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.345 1.858 . . . . 0.0 111.524 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -142.68 154.4 44.29 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.104 1.361 . . . . 0.0 109.511 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -128.96 169.41 14.69 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.874 2.469 . . . . 0.0 108.759 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -131.78 135.84 47.08 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.663 1.185 . . . . 0.0 109.514 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 17.4 tp -89.15 98.76 11.95 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.444 1.097 . . . . 0.0 108.343 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.408 HD12 ' HB2' ' A' ' 184' ' ' SER . 20.6 mt -105.32 178.37 4.58 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.95 0.881 . . . . 0.0 111.341 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -158.58 162.66 37.38 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -138.62 -178.39 5.28 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 125.346 1.459 . . . . 0.0 109.827 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -58.92 -15.59 13.56 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 45.4 t -98.58 -56.32 5.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 C-N-CA 125.569 1.548 . . . . 0.0 108.768 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -169.21 -167.42 29.77 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 119.324 0.966 . . . . 0.0 113.172 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -88.64 156.09 19.23 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 122.192 -0.593 . . . . 0.0 110.848 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -157.64 173.98 16.04 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.162 1.385 . . . . 0.0 107.934 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.453 HD12 HD11 ' A' ' 109' ' ' ILE . 18.9 mt -118.27 140.22 42.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 102.908 -2.997 . . . . 0.0 102.908 178.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.408 ' HB2' HD12 ' A' ' 175' ' ' LEU . 36.1 t -117.94 131.26 56.52 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.6 127.05 18.81 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 178.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.6 tt -115.19 134.74 57.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.5 mt -125.04 111.08 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.681 1.192 . . . . 0.0 111.823 -177.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -100.42 -158.32 27.95 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 108.328 -1.909 . . . . 0.0 108.328 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 9.1 m 69.53 56.95 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 123.93 0.892 . . . . 0.0 109.467 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -114.79 -116.06 3.11 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 105.678 -2.969 . . . . 0.0 105.678 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -135.24 129.05 33.05 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.902 1.681 . . . . 0.0 107.375 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 25.8 mm -67.28 132.73 32.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 29.3 p -80.31 113.48 18.52 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.22 -24.46 66.37 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.863 1.211 . . . . 0.0 111.86 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 3.6 m -57.34 -41.5 78.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 117.251 -1.357 . . . . 0.0 112.634 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 1.3 p -125.41 -21.43 4.54 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 120.612 1.551 . . . . 0.0 112.591 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 89.31 13.45 61.72 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.875 1.702 . . . . 0.0 110.923 -178.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -90.2 169.6 11.0 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.61 1.205 . . . . 0.0 108.98 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.412 ' C ' ' H ' ' A' ' 201' ' ' MET . 17.6 mt-10 -86.31 149.66 24.89 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.049 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -78.44 31.08 0.18 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.112 2.165 . . . . 0.0 107.775 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.412 ' H ' ' C ' ' A' ' 199' ' ' GLU . 11.5 ptt? -71.37 152.14 43.44 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -175.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.7 p -119.47 146.38 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 114.207 -1.361 . . . . 0.0 111.57 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -111.76 132.24 54.79 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 125.145 1.378 . . . . 0.0 107.391 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 2.4 mp -118.13 139.77 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 178.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -122.74 100.21 6.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -81.06 126.53 31.54 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 118.817 0.735 . . . . 0.0 110.198 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 33.0 m -134.79 172.24 16.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 126.014 1.726 . . . . 0.0 111.144 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.7 t -78.75 139.47 38.43 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -107.33 146.87 16.21 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -40.96 -66.14 0.94 Allowed Glycine 0 CA--C 1.522 0.514 0 C-N-CA 126.49 1.995 . . . . 0.0 112.469 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.7 t -70.75 103.72 2.66 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 117.845 0.822 . . . . 0.0 110.557 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -71.59 6.8 1.7 Allowed 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.68 -0.637 . . . . 0.0 111.018 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 73.9 p -126.95 30.72 5.41 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.335 1.854 . . . . 0.0 110.283 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -120.64 170.32 14.38 Favored Glycine 0 N--CA 1.47 0.925 0 CA-C-N 119.675 1.125 . . . . 0.0 115.159 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -79.91 165.75 21.75 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.583 2.188 . . . . 0.0 110.477 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 90.5 p -78.74 152.31 31.58 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.38 164.18 7.01 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.558 1.543 . . . . 0.0 108.215 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.1 mt -84.82 134.53 26.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -79.59 -54.27 6.05 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 125.224 1.409 . . . . 0.0 111.443 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' TRP . . . . . 0.406 ' CZ2' ' HB2' ' A' ' 232' ' ' GLN . 41.1 p-90 -146.94 162.65 38.28 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.71 1.204 . . . . 0.0 108.7 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.87 HG13 ' CE1' ' A' ' 229' ' ' TYR . 44.0 t -148.41 135.34 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 125.943 1.697 . . . . 0.0 107.062 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.07 138.4 10.26 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 177.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -82.51 87.3 6.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 102.564 -3.125 . . . . 0.0 102.564 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.1 p -63.13 -49.65 73.56 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.692 1.597 . . . . 0.0 111.913 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -95.2 -172.37 2.65 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.6 mp -71.51 -46.4 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 4.9 m -113.37 -36.55 4.95 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 2.7 t -70.17 144.63 13.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' TYR . . . . . 0.87 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.1 OUTLIER -127.56 139.76 52.55 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.079 1.752 . . . . 0.0 108.141 -179.028 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -121.94 142.99 49.73 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.895 1.278 . . . . 0.0 109.425 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.69 162.71 36.92 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.624 1.57 . . . . 0.0 110.019 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.406 ' HB2' ' CZ2' ' A' ' 220' ' ' TRP . 15.8 tt0 -129.11 142.93 50.73 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 93.5 t -129.25 137.88 55.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 124.891 1.277 . . . . 0.0 108.192 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.97 139.85 41.99 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 123.849 0.859 . . . . 0.0 111.153 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 26.6 mt -140.33 139.07 19.91 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.259 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.05 -43.98 0.29 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.683 2.256 . . . . 0.0 111.983 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -59.22 -21.21 59.16 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.807 0.843 . . . . 0.0 111.373 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 14.1 mt -69.85 -39.92 76.12 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 117.383 -1.294 . . . . 0.0 109.032 177.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 9.1 m -58.44 -22.13 53.38 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 119.657 1.117 . . . . 0.0 113.386 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -60.78 -32.03 71.37 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.362 0.665 . . . . 0.0 110.301 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 23.7 mt -79.86 118.84 21.99 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -48.33 -35.15 11.82 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 3.6 mp -57.61 -41.4 81.21 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 121.093 -1.004 . . . . 0.0 111.148 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -89.42 1.83 55.31 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.87 1.668 . . . . 0.0 112.905 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.418 0 C-N-CA 125.418 1.487 . . . . 0.0 108.6 -179.876 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.221 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -150.94 177.54 10.04 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.172 1.789 . . . . 0.0 106.867 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 m -117.3 165.32 13.6 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.997 1.319 . . . . 0.0 108.457 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -126.26 36.6 4.47 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.645 0.778 . . . . 0.0 109.267 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.1 m -52.5 -50.63 62.39 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.671 1.188 . . . . 0.0 111.872 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -55.97 -31.8 63.32 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.317 1.047 . . . . 0.0 113.079 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.45 -44.13 89.1 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 123.478 0.711 . . . . 0.0 109.765 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.7 m -66.54 -36.21 82.11 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.781 -0.575 . . . . 0.0 110.248 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.18 -45.26 77.5 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.03 -39.41 81.89 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.1 mt -63.72 -52.83 58.76 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 19.6 m -54.71 -44.96 73.91 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.876 -0.515 . . . . 0.0 109.618 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -63.77 -51.67 63.79 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.195 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.0 m -58.47 -39.96 81.4 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 120.325 1.42 . . . . 0.0 111.317 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.577 ' O ' HG23 ' A' ' 106' ' ' VAL . 10.3 tp -64.67 -55.48 19.87 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 119.016 0.825 . . . . 0.0 110.072 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -59.65 -46.98 87.38 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -57.58 -44.23 85.21 Favored 'General case' 0 C--O 1.225 -0.204 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.73 -53.39 46.62 Favored Glycine 0 N--CA 1.438 -1.228 0 CA-C-O 118.473 -1.181 . . . . 0.0 111.11 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 102' ' ' LEU . 5.0 t -55.19 -52.96 39.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 119.132 1.466 . . . . 0.0 111.142 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -33.76 76.19 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 118.816 -0.612 . . . . 0.0 111.274 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.0 m -70.04 -45.83 66.33 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.463 HD11 HD12 ' A' ' 183' ' ' ILE . 32.9 mt -56.27 -54.67 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 123.94 0.896 . . . . 0.0 109.814 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.76 -39.64 92.34 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 123.614 0.571 . . . . 0.0 110.266 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -62.86 -44.48 95.99 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.166 0.894 . . . . 0.0 110.526 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -20.32 62.29 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 118.266 -0.873 . . . . 0.0 112.765 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.8 mt -98.77 -28.85 13.31 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 120.34 1.427 . . . . 0.0 111.651 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -59.35 -37.43 77.83 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.91 0.484 . . . . 0.0 110.618 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -64.03 -46.76 83.02 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -156.94 148.32 22.22 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.013 0.925 . . . . 0.0 110.245 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 85.7 m -75.26 174.48 9.45 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 41.4 pt -130.71 148.6 33.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 123.476 0.71 . . . . 0.0 110.074 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.54 168.23 20.26 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.218 0.607 . . . . 0.0 110.038 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -151.43 129.59 11.91 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.906 1.682 . . . . 0.0 109.67 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -95.0 102.33 14.13 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.53 67.41 2.86 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 126.573 1.949 . . . . 0.0 109.384 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.15 -116.85 5.69 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 124.5 1.048 . . . . 0.0 110.803 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -70.2 -30.62 67.77 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.144 0.978 . . . . 0.0 111.443 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -107.33 160.39 15.65 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.865 0.841 . . . . 0.0 110.051 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.6 mt -125.86 151.66 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.432 ' CD1' HG11 ' A' ' 221' ' ' VAL . 40.4 m-85 -123.18 131.56 53.73 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 126.456 1.902 . . . . 0.0 106.749 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -126.35 131.54 51.78 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.849 1.659 . . . . 0.0 108.325 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -128.52 123.65 34.06 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.952 1.301 . . . . 0.0 109.869 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 4.6 m -109.91 160.35 28.43 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.236 1.414 . . . . 0.0 113.718 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.96 90.41 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.13 3.22 . . . . 0.0 113.324 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 59.19 52.07 55.45 Favored Glycine 0 CA--C 1.519 0.34 0 O-C-N 120.957 -1.089 . . . . 0.0 111.743 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.6 mt -127.31 -67.17 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.09 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.411 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 8.7 pt-20 -173.09 167.31 4.94 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 126.13 1.772 . . . . 0.0 109.281 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.22 117.24 24.13 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.0 m -130.57 156.19 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 124.386 1.074 . . . . 0.0 112.706 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -124.79 135.46 52.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 177.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -146.45 157.41 43.75 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.079 0.952 . . . . 0.0 113.35 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 33.5 t60 -88.79 119.72 29.54 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 103.581 -2.748 . . . . 0.0 103.581 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -165.25 -163.14 17.9 Favored Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 111.666 -0.573 . . . . 0.0 111.666 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.3 154.31 51.58 Favored 'General case' 0 CA--C 1.526 0.039 0 C-N-CA 123.505 0.722 . . . . 0.0 109.486 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.4 t -128.59 154.36 39.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 124.087 0.955 . . . . 0.0 110.716 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -102.41 93.83 5.37 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 127.6 2.36 . . . . 0.0 105.851 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.2 t -48.75 -27.38 2.91 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.953 1.301 . . . . 0.0 113.875 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -55.89 -26.57 47.93 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.4 t -146.47 -18.21 0.43 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.682 0.674 . . . . 0.0 111.621 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 97.87 3.72 58.04 Favored Glycine 0 C--O 1.22 -0.729 0 C-N-CA 124.998 1.285 . . . . 0.0 111.738 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -64.21 147.81 51.52 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.018 1.409 . . . . 0.0 110.363 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 23.4 mt -87.45 158.75 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 84.5 t -103.44 143.24 15.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 124.565 1.146 . . . . 0.0 107.939 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -58.0 110.35 0.91 Allowed 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -137.06 164.63 27.95 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.42 1.088 . . . . 0.0 110.272 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.65 137.54 58.17 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.038 1.735 . . . . 0.0 109.866 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -95.59 15.06 20.88 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.881 2.073 . . . . 0.0 113.196 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.22 -10.17 58.73 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 120.224 -1.547 . . . . 0.0 112.553 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 89.9 mt -120.62 72.7 0.97 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.767 1.627 . . . . 0.0 106.636 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.3 t -137.17 143.83 33.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 125.745 1.618 . . . . 0.0 106.788 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -140.44 162.63 34.88 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.907 0.883 . . . . 0.0 111.56 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.3 ptp85 -108.34 143.21 37.54 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.926 1.291 . . . . 0.0 110.076 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.3 mp -120.03 -70.2 0.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.375 1.47 . . . . 0.0 107.788 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -132.6 152.98 20.43 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 123.547 0.594 . . . . 0.0 112.589 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -124.43 91.07 50.05 Favored Pre-proline 0 N--CA 1.452 -0.352 0 C-N-CA 126.028 1.731 . . . . 0.0 109.434 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 97.2 Cg_endo -73.55 177.22 8.27 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.014 2.476 . . . . 0.0 111.37 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -91.09 169.13 11.11 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -82.48 -42.67 18.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.948 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -93.27 149.76 20.99 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 122.969 0.508 . . . . 0.0 110.065 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.2 p -69.79 -20.05 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 123.33 0.652 . . . . 0.0 112.45 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -88.96 -20.0 25.03 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.661 1.184 . . . . 0.0 111.656 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -77.34 -19.31 56.51 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.094 0.558 . . . . 0.0 109.793 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -103.56 171.11 7.55 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.15 1.38 . . . . 0.0 109.788 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -137.81 134.6 35.38 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.89 1.276 . . . . 0.0 107.788 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.497 ' CD2' HG22 ' A' ' 106' ' ' VAL . 4.4 m-30 -115.5 164.59 14.08 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.959 1.304 . . . . 0.0 110.672 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -131.67 122.03 25.28 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 124.621 1.168 . . . . 0.0 112.0 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 15.7 tp -85.76 104.34 15.36 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.426 HD12 ' HB2' ' A' ' 184' ' ' SER . 38.8 mt -114.49 177.03 4.79 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 122.139 0.971 . . . . 0.0 110.939 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -156.76 155.67 32.0 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.037 1.335 . . . . 0.0 107.463 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -138.59 -177.15 4.73 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -49.25 -31.33 8.59 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.079 1.352 . . . . 0.0 113.218 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 89.8 t -74.28 -74.37 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -166.53 -162.34 17.81 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.585 ' CZ ' HD22 ' A' ' 243' ' ' LEU . 3.7 m-85 -78.31 161.87 26.91 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.293 0.637 . . . . 0.0 112.06 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -163.15 175.25 11.2 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.854 2.062 . . . . 0.0 108.302 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.463 HD12 HD11 ' A' ' 109' ' ' ILE . 7.2 mt -127.01 121.51 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.426 ' HB2' HD12 ' A' ' 175' ' ' LEU . 39.9 t -91.35 137.81 32.07 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -139.18 120.51 14.87 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.8 tt -114.72 139.81 38.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.3 mt -133.51 112.53 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 123.4 0.68 . . . . 0.0 112.284 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -105.78 -167.69 23.42 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 124.604 1.097 . . . . 0.0 110.956 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.5 t 80.69 47.27 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.307 1.843 . . . . 0.0 110.39 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -97.76 -112.02 3.02 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 105.645 -2.982 . . . . 0.0 105.645 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -141.36 122.61 14.81 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 104.265 -2.494 . . . . 0.0 104.265 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.5 mm -60.17 134.38 25.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 98.8 m -81.58 100.81 9.59 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.98 -19.27 51.35 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.33 0.652 . . . . 0.0 111.325 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.32 -30.24 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 126.141 1.776 . . . . 0.0 110.767 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.3 p -125.01 -36.2 2.57 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 119.601 1.091 . . . . 0.0 112.416 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 96.54 33.81 6.03 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.084 1.326 . . . . 0.0 110.581 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -124.95 171.05 10.51 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.376 1.47 . . . . 0.0 112.058 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -89.1 141.85 28.15 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.558 0.743 . . . . 0.0 112.006 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.17 29.14 0.22 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 128.455 2.702 . . . . 0.0 110.764 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -73.52 142.38 46.73 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 122.282 1.039 . . . . 0.0 109.489 -176.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -104.81 149.58 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 CA-C-N 113.399 -1.728 . . . . 0.0 111.417 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -118.2 124.96 49.2 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.2 mp -115.86 129.86 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 125.806 1.642 . . . . 0.0 106.638 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -114.57 108.97 17.55 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -85.27 119.49 25.7 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.593 0.757 . . . . 0.0 110.602 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 32.0 m -131.43 171.57 17.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 C-N-CA 125.026 1.33 . . . . 0.0 111.796 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.37 133.55 39.91 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -89.7 149.13 20.31 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 123.557 0.599 . . . . 0.0 111.811 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -60.67 -45.02 97.18 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 47.1 t -87.21 98.58 11.4 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -72.21 8.04 1.48 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.385 0.674 . . . . 0.0 109.381 177.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 60.2 m -130.84 38.44 3.69 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.241 1.817 . . . . 0.0 113.267 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.2 165.7 28.16 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 121.475 -0.766 . . . . 0.0 112.161 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.66 168.24 20.57 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.969 2.446 . . . . 0.0 112.492 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 81.0 p -77.26 150.0 35.37 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.78 162.73 23.98 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.174 1.39 . . . . 0.0 107.446 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.1 mp -76.68 141.77 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -84.63 -59.65 2.3 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 -141.58 166.56 24.42 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.171 1.388 . . . . 0.0 108.484 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.729 HG13 ' CE1' ' A' ' 229' ' ' TYR . 47.7 t -145.84 136.39 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 C-N-CA 126.142 1.777 . . . . 0.0 106.391 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.46 121.09 3.71 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.375 0.607 . . . . 0.0 109.862 177.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -81.05 88.14 5.98 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 14.7 p -58.02 -56.8 17.36 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.587 1.555 . . . . 0.0 112.095 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt -99.76 -172.55 2.26 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.239 -1.764 . . . . 0.0 106.239 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 31.2 mm -75.5 -35.22 31.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 O-C-N 121.081 -1.012 . . . . 0.0 109.392 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.98 -54.05 2.54 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.912 0.885 . . . . 0.0 110.861 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 29.2 t -62.56 137.44 24.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 121.41 0.624 . . . . 0.0 109.391 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' TYR . . . . . 0.729 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.4 OUTLIER -133.08 139.92 47.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.147 1.779 . . . . 0.0 107.048 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -120.6 140.52 51.41 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 125.409 1.484 . . . . 0.0 108.945 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.84 161.41 39.36 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 126.132 1.773 . . . . 0.0 109.745 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -133.02 146.11 51.44 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 99.0 t -131.65 134.14 60.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 124.68 1.192 . . . . 0.0 108.376 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.08 142.06 35.13 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.624 0.77 . . . . 0.0 109.812 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 61.7 mt -139.72 135.68 16.92 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.73 -41.84 0.68 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.881 1.721 . . . . 0.0 112.367 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -62.99 -20.46 65.31 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 16.2 mt -68.52 -33.04 73.42 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 118.174 -0.917 . . . . 0.0 109.882 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 21.0 m -62.88 -13.4 33.64 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -70.37 -36.71 74.32 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.827 0.822 . . . . 0.0 109.152 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 24.0 mt -70.52 114.02 8.21 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -48.16 -33.77 8.91 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.585 HD22 ' CZ ' ' A' ' 181' ' ' TYR . 16.6 mt -61.49 -37.05 82.25 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.257 -0.902 . . . . 0.0 109.817 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 13.0 mt -95.74 9.69 39.55 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 127.505 2.322 . . . . 0.0 113.491 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -77.21 41.4 0.3 Allowed 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.564 -0.71 . . . . 0.0 110.457 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -150.38 130.53 13.57 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.158 1.383 . . . . 0.0 110.206 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -172.54 -179.41 2.18 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.944 2.898 . . . . 0.0 106.716 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 62.24 7.68 2.35 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.029 2.131 . . . . 0.0 114.105 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 7.9 t70 . . . . . 0 C--O 1.25 1.12 0 C-N-CA 124.645 1.178 . . . . 0.0 112.613 -179.255 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.588 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -130.04 -169.09 2.06 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.603 1.161 . . . . 0.0 110.384 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.5 t -153.81 -160.11 1.06 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.853 1.261 . . . . 0.0 108.512 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -62.54 118.95 8.28 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.962 1.305 . . . . 0.0 108.619 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.8 m -46.02 -51.67 13.21 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.041 1.737 . . . . 0.0 114.039 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -58.56 -50.31 74.27 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 122.334 0.254 . . . . 0.0 110.393 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -58.78 -47.72 83.72 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 118.092 -0.956 . . . . 0.0 110.387 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p -60.12 -43.78 95.39 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 119.944 1.247 . . . . 0.0 111.875 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.88 -49.55 75.77 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.584 0.707 . . . . 0.0 109.516 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 62.3 tp -55.15 -43.63 74.38 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 125.3 1.44 . . . . 0.0 109.666 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.2 mt -62.52 -53.67 51.23 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.553 1.07 . . . . 0.0 109.506 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 85.2 m -54.36 -52.7 60.8 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.013 0.525 . . . . 0.0 109.826 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -61.9 -42.14 98.72 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 118.488 -0.768 . . . . 0.0 110.801 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.1 m -55.8 -47.8 76.5 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 119.318 0.963 . . . . 0.0 109.771 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 26.6 tp -59.28 -55.8 30.28 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 118.373 0.533 . . . . 0.0 109.765 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -51.21 -52.42 44.65 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 124.778 1.231 . . . . 0.0 110.997 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -55.83 -44.59 78.08 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 125.088 1.355 . . . . 0.0 109.711 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.62 -53.24 39.86 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 125.117 1.341 . . . . 0.0 111.785 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 59.1 t -55.25 -52.92 40.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 119.018 1.409 . . . . 0.0 110.998 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -31.07 72.01 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 118.51 0.596 . . . . 0.0 110.703 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.2 m -69.05 -42.62 76.05 Favored 'General case' 0 CA--C 1.523 -0.093 0 CA-C-N 118.682 0.674 . . . . 0.0 109.403 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.473 HD11 HD12 ' A' ' 183' ' ' ILE . 34.1 mt -58.09 -51.16 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 107.103 -1.444 . . . . 0.0 107.103 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.88 -40.03 94.0 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 118.762 -0.637 . . . . 0.0 111.095 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -59.32 -47.48 85.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.875 0.762 . . . . 0.0 109.375 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -73.51 -19.3 60.96 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.6 mt -102.67 -28.29 12.21 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 119.901 1.228 . . . . 0.0 112.124 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -58.03 -32.46 67.99 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -65.84 -45.58 81.69 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 119.036 -0.507 . . . . 0.0 110.504 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -158.4 156.38 30.34 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.662 1.119 . . . . 0.0 111.203 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 59.9 m -76.09 176.04 8.36 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 34.0 pt -135.7 155.49 36.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.49 163.3 38.18 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.126 0.488 . . . . 0.0 112.137 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -150.92 129.01 11.83 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.22 1.408 . . . . 0.0 110.638 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -92.23 107.6 19.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.57 73.09 3.73 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.627 1.571 . . . . 0.0 107.545 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.59 -115.43 5.93 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -74.15 -27.22 60.74 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.322 1.049 . . . . 0.0 112.638 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -107.13 157.6 17.73 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 118.718 0.69 . . . . 0.0 110.299 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 58.7 mt -123.99 149.41 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.467 ' CD1' HG11 ' A' ' 221' ' ' VAL . 55.5 m-85 -126.15 129.3 48.77 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.219 2.208 . . . . 0.0 107.424 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -127.03 130.96 50.99 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.722 1.609 . . . . 0.0 107.644 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -122.3 115.44 22.34 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.814 1.246 . . . . 0.0 108.594 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 15.6 m -105.02 154.86 38.41 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 123.48 0.712 . . . . 0.0 110.588 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -61.05 90.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.589 1 C-N-CA 125.887 4.391 . . . . 0.0 116.091 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 60.05 33.96 81.58 Favored Glycine 0 CA--C 1.528 0.853 0 O-C-N 121.682 -0.636 . . . . 0.0 112.323 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.0 mt -111.23 -66.36 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.448 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 5.3 pt-20 -180.0 162.52 1.01 Allowed 'General case' 0 C--O 1.24 0.586 0 C-N-CA 126.468 1.907 . . . . 0.0 108.901 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -115.52 122.29 45.26 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 102.544 -3.132 . . . . 0.0 102.544 178.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.4 m -130.32 156.17 42.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 123.358 0.663 . . . . 0.0 111.228 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -125.62 126.43 44.73 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -146.33 158.95 43.94 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.435 1.094 . . . . 0.0 112.435 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -88.39 154.64 20.22 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 177.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 166.0 -163.97 37.15 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -127.82 144.32 51.09 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.624 1.97 . . . . 0.0 106.7 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.9 p -155.16 148.2 12.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -97.13 91.05 5.37 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 103.564 -2.754 . . . . 0.0 103.564 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.9 t -51.2 -27.37 8.73 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -52.17 -28.45 18.18 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.553 1.541 . . . . 0.0 113.138 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.403 HG23 ' H ' ' A' ' 148' ' ' GLU . 1.8 t -131.49 -28.02 1.9 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.265 1.426 . . . . 0.0 109.499 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 98.56 7.55 55.6 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 126.095 1.807 . . . . 0.0 109.427 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.403 ' H ' HG23 ' A' ' 146' ' ' THR . 18.4 mt-10 -65.54 113.57 4.28 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 119.067 1.433 . . . . 0.0 110.849 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 74.6 mt -73.53 138.06 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 103.167 -2.901 . . . . 0.0 103.167 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 78.2 t -93.82 162.87 2.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 125.008 1.323 . . . . 0.0 107.644 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -52.63 122.19 8.53 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.73 -175.47 3.97 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.248 0.619 . . . . 0.0 112.083 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -106.31 129.87 54.25 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -88.72 24.16 2.09 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.696 1.198 . . . . 0.0 111.093 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -81.54 -14.34 56.99 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 121.304 -0.873 . . . . 0.0 111.271 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 83.7 mt -124.2 82.27 2.01 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.776 1.631 . . . . 0.0 107.619 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 39.6 t -136.78 143.14 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.384 1.074 . . . . 0.0 108.568 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -143.59 147.36 34.28 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.191 1.397 . . . . 0.0 111.714 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.92 123.63 40.68 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 124.809 1.244 . . . . 0.0 108.073 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.5 mp -95.28 -72.47 0.62 Allowed 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -125.76 148.14 16.87 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -128.44 91.97 42.33 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 42.5 Cg_endo -77.01 176.57 9.97 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.615 2.877 . . . . 0.0 110.698 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -83.76 167.73 16.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.177 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.43 -33.62 23.65 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.488 1.115 . . . . 0.0 112.001 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -90.9 142.2 28.02 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 126.402 1.881 . . . . 0.0 106.258 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.3 p -72.96 -28.35 26.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 118.224 0.465 . . . . 0.0 110.078 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -73.1 0.51 11.34 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 127.479 2.311 . . . . 0.0 113.059 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -114.76 -13.12 12.06 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.329 1.852 . . . . 0.0 110.227 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 36.1 mmm-85 -77.25 163.68 26.29 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.824 1.25 . . . . 0.0 108.358 177.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -131.03 95.89 3.92 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.301 0.572 . . . . 0.0 110.134 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -108.53 148.94 29.53 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 125.774 1.629 . . . . 0.0 108.279 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -138.37 134.92 34.79 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.358 1.063 . . . . 0.0 109.791 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.95 98.51 10.41 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.29 1.036 . . . . 0.0 109.515 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.433 HD12 ' HB2' ' A' ' 184' ' ' SER . 35.4 mt -103.77 172.01 7.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.761 0.791 . . . . 0.0 110.195 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -157.37 157.09 33.43 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.246 -0.909 . . . . 0.0 109.503 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -138.83 -179.23 5.71 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -56.79 -11.75 1.56 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.788 2.035 . . . . 0.0 113.026 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 54.8 t -94.07 -67.07 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 126.484 1.914 . . . . 0.0 107.873 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -169.63 -174.11 37.69 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -81.05 158.76 24.98 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 114.606 -0.797 . . . . 0.0 109.044 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -162.61 176.55 10.26 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.546 1.538 . . . . 0.0 108.469 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.473 HD12 HD11 ' A' ' 109' ' ' ILE . 14.3 mt -123.93 133.75 68.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.433 ' HB2' HD12 ' A' ' 175' ' ' LEU . 32.3 t -109.19 122.49 47.42 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -125.58 112.93 16.76 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.9 tt -100.86 130.93 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 11.0 mt -123.36 109.7 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.088 1.355 . . . . 0.0 109.053 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -104.36 -153.04 22.59 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 107.559 -2.217 . . . . 0.0 107.559 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.3 m 74.43 46.07 0.17 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.34 1.456 . . . . 0.0 109.444 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -111.95 -126.95 4.84 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -130.42 124.91 33.18 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.441 1.096 . . . . 0.0 110.986 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 46.1 mm -61.08 137.28 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.82 0.848 . . . . 0.0 112.296 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 74.1 m -94.66 95.36 8.7 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 102.866 -3.013 . . . . 0.0 102.866 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -55.07 -17.79 4.47 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.888 1.275 . . . . 0.0 113.537 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 73.4 t -59.73 -38.18 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 124.878 1.271 . . . . 0.0 109.567 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 20.9 p -125.32 -15.9 6.07 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 78.52 32.94 40.36 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -103.48 159.9 15.19 Favored 'General case' 0 CA--C 1.52 -0.189 0 O-C-N 121.435 -1.038 . . . . 0.0 110.651 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -91.71 142.4 27.64 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.903 1.281 . . . . 0.0 107.725 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -73.46 28.96 0.07 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 127.854 2.461 . . . . 0.0 111.82 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.3 ptt? -73.2 141.0 47.35 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 122.58 1.181 . . . . 0.0 110.04 -175.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 1.5 p -113.06 144.35 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.33 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -112.26 125.25 53.96 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.6 mp -109.67 119.11 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -102.38 106.39 17.14 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -85.36 115.17 22.95 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.37 1.068 . . . . 0.0 110.46 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.8 m -127.93 172.83 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 126.14 1.776 . . . . 0.0 112.277 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.3 t -85.5 133.09 34.1 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.445 1.498 . . . . 0.0 107.313 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -89.67 161.86 29.94 Favored Glycine 0 N--CA 1.47 0.95 0 CA-C-N 119.555 1.071 . . . . 0.0 112.032 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -47.22 -79.61 0.07 OUTLIER Glycine 0 C--N 1.341 0.824 0 C-N-CA 126.315 1.912 . . . . 0.0 110.997 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 25.3 m -70.42 126.3 29.24 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -98.28 35.98 1.68 Allowed 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 8.6 m -143.24 33.19 1.34 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -129.52 179.15 16.95 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 120.361 1.437 . . . . 0.0 113.122 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -75.09 170.06 21.22 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.949 2.432 . . . . 0.0 109.273 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 98.3 p -81.72 156.36 25.04 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.853 -0.529 . . . . 0.0 109.692 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.85 164.69 7.85 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 126.143 1.777 . . . . 0.0 109.276 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.9 mt -79.75 136.09 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.164 1.386 . . . . 0.0 107.37 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -81.21 -54.84 5.16 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 124.574 1.15 . . . . 0.0 109.753 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 19.0 p-90 -148.59 166.54 27.96 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 124.794 1.237 . . . . 0.0 108.761 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.76 HG13 ' CE1' ' A' ' 229' ' ' TYR . 45.3 t -145.28 126.58 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.01 122.05 10.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -75.02 97.92 3.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 2.1 p -66.14 -51.79 54.52 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 118.311 -0.852 . . . . 0.0 111.715 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -120.72 179.11 4.45 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.437 0.695 . . . . 0.0 109.781 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.548 ' H ' HD12 ' A' ' 226' ' ' ILE . 3.8 mp -55.19 -37.82 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 C-N-CA 125.908 1.683 . . . . 0.0 110.666 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.75 -21.04 5.29 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 56.4 t -85.21 124.51 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' TYR . . . . . 0.76 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.6 OUTLIER -123.68 142.9 50.63 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 179.398 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -129.79 139.95 51.15 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -138.83 160.85 38.69 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.086 1.354 . . . . 0.0 109.505 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -127.28 143.71 51.18 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.0 t -128.53 143.75 40.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 125.084 1.354 . . . . 0.0 107.683 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.45 134.13 55.32 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 124.29 1.036 . . . . 0.0 110.408 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 93.9 mt -136.72 138.36 26.08 Favored Pre-proline 0 C--O 1.236 0.355 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.638 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.08 -43.29 0.25 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.312 2.008 . . . . 0.0 111.944 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -57.32 -26.82 61.52 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.794 0.837 . . . . 0.0 111.278 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 16.9 mt -66.17 -38.72 88.74 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 120.947 -1.096 . . . . 0.0 110.189 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 42.8 m -55.21 -21.85 15.53 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.6 1.56 . . . . 0.0 113.921 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -64.98 -34.44 78.43 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 123.393 0.677 . . . . 0.0 111.192 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 29.9 mt -71.95 117.27 13.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -48.67 -36.11 15.34 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.82 -36.17 78.37 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.527 -0.733 . . . . 0.0 110.254 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -97.84 3.58 49.83 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.389 1.875 . . . . 0.0 113.271 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -79.02 47.64 0.79 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -157.78 144.34 17.8 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 127.811 2.444 . . . . 0.0 107.35 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -171.35 159.45 5.72 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 128.768 2.827 . . . . 0.0 105.88 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.6 68.55 1.28 Allowed 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.4 t70 . . . . . 0 C--O 1.25 1.13 0 CA-C-N 113.856 -1.52 . . . . 0.0 108.806 179.38 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.919 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -151.97 150.21 29.76 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.6 p -165.96 166.78 17.17 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.429 1.092 . . . . 0.0 108.947 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -111.63 175.85 5.26 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.219 1.408 . . . . 0.0 110.702 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.5 m -72.88 -45.85 56.03 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.875 1.27 . . . . 0.0 114.109 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -57.83 -34.59 69.85 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.816 0.735 . . . . 0.0 110.784 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -59.13 -47.43 85.31 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.9 m -65.92 -35.68 81.29 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.34 -48.31 82.12 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 119.633 1.106 . . . . 0.0 108.409 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 58.9 tp -56.97 -44.83 83.04 Favored 'General case' 0 C--N 1.343 0.322 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.1 mt -61.4 -50.52 72.52 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.955 0.798 . . . . 0.0 110.577 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 54.9 m -54.97 -52.44 63.06 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.815 1.246 . . . . 0.0 110.669 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -63.96 -42.78 97.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.575 0.75 . . . . 0.0 110.62 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.2 m -54.1 -49.14 69.78 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.155 0.982 . . . . 0.0 109.007 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 41.1 tp -57.38 -54.24 49.09 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.929 0.331 . . . . 0.0 110.72 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -52.65 -50.99 62.08 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 124.428 1.091 . . . . 0.0 111.654 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -56.11 -52.2 65.18 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.393 1.077 . . . . 0.0 108.604 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -55.29 -51.04 56.97 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 96.4 t -57.2 -52.79 51.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 C-N-CA 125.206 1.402 . . . . 0.0 111.809 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -32.3 73.57 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 119.289 0.95 . . . . 0.0 110.313 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.1 m -66.3 -42.02 88.89 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 34.0 mt -61.49 -50.72 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.51 -40.92 72.4 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 117.9 -1.048 . . . . 0.0 110.809 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -62.61 -55.01 31.01 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.305 1.042 . . . . 0.0 110.436 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -62.7 -25.92 68.4 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 11.0 mp -98.07 -26.99 14.42 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.543 1.52 . . . . 0.0 110.848 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -53.88 -29.54 41.97 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.184 0.994 . . . . 0.0 111.233 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -74.49 -46.83 36.97 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 117.965 0.348 . . . . 0.0 110.709 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.2 mmt85 -157.03 151.46 25.33 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.201 -0.937 . . . . 0.0 111.819 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 51.5 m -76.43 160.55 29.44 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 32.8 pt -118.1 152.83 20.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 124.889 1.275 . . . . 0.0 108.592 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -146.16 168.87 19.94 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 122.853 0.461 . . . . 0.0 111.909 -178.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -154.51 127.69 8.37 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.572 1.549 . . . . 0.0 111.286 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -91.52 104.37 16.88 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.52 66.77 5.46 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.424 1.489 . . . . 0.0 107.034 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 66.84 -115.96 7.76 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -66.12 -34.03 77.13 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -107.32 152.76 23.71 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 119.165 0.893 . . . . 0.0 110.247 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.7 mt -121.16 151.97 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -126.93 136.72 52.68 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.714 1.605 . . . . 0.0 108.202 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -131.38 132.45 44.41 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.542 1.537 . . . . 0.0 108.955 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -126.04 117.27 22.87 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.607 1.163 . . . . 0.0 109.737 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 21.9 m -104.22 158.17 32.49 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 124.197 0.999 . . . . 0.0 111.502 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -63.67 84.91 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.621 1 C-N-CA 125.413 4.076 . . . . 0.0 116.101 -178.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.41 29.02 74.24 Favored Glycine 0 CA--C 1.529 0.938 0 O-C-N 121.394 -0.816 . . . . 0.0 111.542 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.1 mt -106.77 -67.25 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.415 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 7.8 pt-20 -172.56 165.31 5.58 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.713 1.205 . . . . 0.0 108.954 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.23 119.87 30.59 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 103.7 -2.704 . . . . 0.0 103.7 177.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.43 156.63 42.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 124.53 1.132 . . . . 0.0 112.02 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -123.81 133.67 53.76 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -146.11 158.25 43.87 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.71 1.204 . . . . 0.0 111.629 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 50.3 t60 -87.94 154.86 20.18 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 157.9 -162.19 31.98 Favored Glycine 0 C--N 1.333 0.409 0 O-C-N 121.21 -0.931 . . . . 0.0 111.28 -178.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.61 145.9 49.07 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 54.2 t -128.95 153.82 39.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 124.971 1.308 . . . . 0.0 108.3 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -106.99 94.96 5.38 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.8 t -54.72 -12.68 0.82 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 120.154 1.343 . . . . 0.0 112.169 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -55.72 -30.5 61.27 Favored 'General case' 0 C--N 1.344 0.363 0 O-C-N 120.79 -1.194 . . . . 0.0 110.296 177.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.86 -43.31 0.23 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.308 1.443 . . . . 0.0 108.712 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 121.01 11.21 6.42 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 126.329 1.919 . . . . 0.0 110.985 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -64.99 127.56 32.09 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 118.924 1.362 . . . . 0.0 110.17 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 26.2 mt -73.92 128.31 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.17 -74.18 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -85.39 117.42 24.3 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 125.946 1.698 . . . . 0.0 107.646 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.26 37.09 4.2 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.839 1.256 . . . . 0.0 111.435 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -61.55 133.14 55.34 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.206 2.202 . . . . 0.0 111.4 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -75.19 6.14 4.67 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 t -85.15 -16.88 38.97 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.24 1.382 . . . . 0.0 113.332 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 84.5 mt -133.06 79.63 1.85 Allowed 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 119.7 1.137 . . . . 0.0 109.735 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.78 147.14 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -142.41 153.04 43.4 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.717 1.207 . . . . 0.0 110.538 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 37.5 mtm105 -101.1 126.32 47.78 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 22.7 mt -101.68 -62.4 1.26 Allowed 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -134.15 153.49 20.97 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.441 ' HB3' ' HB3' ' A' ' 189' ' ' SER . 0.9 OUTLIER -129.22 86.25 57.26 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 126.872 2.069 . . . . 0.0 109.239 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.437 ' HD3' HG21 ' A' ' 187' ' ' ILE . 41.5 Cg_endo -80.47 176.7 8.9 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 123.672 2.915 . . . . 0.0 110.788 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.2 mmmt -92.64 156.45 17.07 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.49 -25.03 41.92 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.015 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -107.29 126.89 53.01 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.58 1.152 . . . . 0.0 108.042 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.4 p -52.9 -34.23 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.834 1.254 . . . . 0.0 111.195 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.428 ' HG3' ' H ' ' A' ' 168' ' ' GLU . 14.1 mt-10 -61.09 -18.26 56.98 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 129.722 3.209 . . . . 0.0 113.521 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -112.32 -4.08 14.39 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.024 1.73 . . . . 0.0 111.736 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 61.2 mtp180 -91.3 176.87 6.42 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.821 0.82 . . . . 0.0 109.777 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -142.68 134.76 27.27 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -144.0 150.07 37.7 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.782 1.633 . . . . 0.0 107.864 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -133.11 131.73 40.87 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.643 1.177 . . . . 0.0 108.5 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 28.1 tp -86.2 99.65 11.68 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 44.0 mt -101.19 175.04 5.72 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.166 0.986 . . . . 0.0 109.613 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.425 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 5.7 p90 -155.93 156.6 34.85 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.866 0.841 . . . . 0.0 109.648 177.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -135.16 -179.73 5.81 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -54.18 -32.09 54.6 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 125.598 1.559 . . . . 0.0 112.298 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 58.2 t -73.9 -59.06 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.222 1.009 . . . . 0.0 109.13 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -178.96 -168.7 38.5 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 124.552 1.072 . . . . 0.0 111.726 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.425 ' CD2' ' HB3' ' A' ' 176' ' ' TYR . 24.4 m-85 -83.35 161.25 21.45 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.681 1.193 . . . . 0.0 112.36 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -168.03 168.97 11.58 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.78 2.032 . . . . 0.0 109.026 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 15.9 mt -114.28 138.37 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.0 t -111.25 123.54 50.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.902 1.281 . . . . 0.0 108.102 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.4 109.94 11.49 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 177.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 2.3 tt -100.82 126.09 54.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.437 HG21 ' HD3' ' A' ' 163' ' ' PRO . 7.2 mt -116.44 112.37 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.144 0.978 . . . . 0.0 110.989 -177.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -108.57 -161.27 20.26 Favored Glycine 0 CA--C 1.522 0.492 0 C-N-CA 124.784 1.183 . . . . 0.0 111.126 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.441 ' HB3' ' HB3' ' A' ' 162' ' ' LYS . 0.4 OUTLIER 74.44 31.86 0.99 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.411 1.485 . . . . 0.0 110.386 -179.265 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -87.97 -102.18 0.91 Allowed Glycine 0 C--N 1.336 0.548 1 N-CA-C 102.788 -4.125 . . . . 0.0 102.788 177.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -145.88 160.54 41.66 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 24.2 mm -92.49 132.71 36.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 125.026 1.33 . . . . 0.0 109.141 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 59.3 m -88.4 93.86 9.67 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 100.329 -3.952 . . . . 0.0 100.329 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -53.42 -24.45 12.6 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -177.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -51.11 -34.32 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 125.99 1.716 . . . . 0.0 111.334 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.1 p -126.08 -25.63 3.53 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.879 0.872 . . . . 0.0 112.36 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 92.57 19.5 37.7 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.803 1.192 . . . . 0.0 111.722 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -95.79 165.18 12.42 Favored 'General case' 0 N--CA 1.454 -0.225 0 O-C-N 121.269 -1.136 . . . . 0.0 110.285 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -96.25 147.22 24.0 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.812 0.845 . . . . 0.0 109.163 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -75.56 28.3 0.1 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.971 2.108 . . . . 0.0 110.286 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.9 ptm -72.62 146.19 46.8 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.507 1.146 . . . . 0.0 108.299 -176.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.3 p -120.1 140.03 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 113.901 -1.5 . . . . 0.0 112.549 -176.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -105.13 131.74 52.23 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.1 mp -115.91 113.98 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -97.31 109.08 21.91 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -85.53 118.05 24.81 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.54 0.736 . . . . 0.0 109.585 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.79 172.89 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 125.732 1.613 . . . . 0.0 112.184 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.6 t -86.38 136.58 33.07 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.108 1.763 . . . . 0.0 108.405 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.93 158.05 32.88 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -63.52 -68.29 1.72 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 108.266 -1.934 . . . . 0.0 108.266 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 17.0 p -81.6 91.5 6.4 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 104.084 -2.561 . . . . 0.0 104.084 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -72.51 37.44 0.07 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.753 2.421 . . . . 0.0 113.487 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.4 m -138.22 46.12 2.06 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 115.097 1.518 . . . . 0.0 115.097 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -156.9 175.08 34.51 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -71.66 165.65 31.86 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.071 1.847 . . . . 0.0 110.733 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 52.0 p -72.93 153.89 40.78 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.338 1.055 . . . . 0.0 110.519 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -169.27 160.71 9.71 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.261 1.424 . . . . 0.0 108.652 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.8 127.83 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -72.24 -60.95 1.97 Allowed 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.868 1.667 . . . . 0.0 109.8 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' TRP . . . . . 0.412 ' CE3' ' HD2' ' A' ' 222' ' ' ARG . 40.7 p-90 -143.03 168.46 19.66 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.859 2.064 . . . . 0.0 109.091 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.603 HG13 ' CE1' ' A' ' 229' ' ' TYR . 55.9 t -144.2 145.3 21.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 126.283 1.833 . . . . 0.0 106.42 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.412 ' HD2' ' CE3' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -164.34 118.8 1.44 Allowed 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.143 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -75.64 92.2 2.93 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 102.285 -3.228 . . . . 0.0 102.285 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 4.8 p -56.09 -55.2 35.83 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.853 1.261 . . . . 0.0 112.408 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -111.59 -172.54 2.06 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.595 ' H ' HD12 ' A' ' 226' ' ' ILE . 3.8 mp -62.23 -38.67 81.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 O-C-N 121.396 -0.815 . . . . 0.0 110.214 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.76 -41.05 3.26 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.877 0.871 . . . . 0.0 112.285 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 10.0 t -64.49 132.25 30.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' TYR . . . . . 0.603 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.5 OUTLIER -130.82 141.7 50.35 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.335 1.454 . . . . 0.0 107.288 -179.297 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -127.01 141.83 51.69 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.75 161.8 38.34 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.445 1.498 . . . . 0.0 108.854 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -138.95 147.46 42.28 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 123.583 0.753 . . . . 0.0 109.99 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.4 m -132.76 151.65 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.127 0.571 . . . . 0.0 109.487 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.1 p -113.42 131.87 55.85 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 122.802 0.441 . . . . 0.0 109.814 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 85.3 mt -129.63 136.12 28.61 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.34 -40.34 0.85 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.207 1.938 . . . . 0.0 112.639 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -61.45 -26.22 67.74 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.38 0.672 . . . . 0.0 111.721 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 3.8 mp -66.29 -35.17 79.71 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.762 0.71 . . . . 0.0 109.309 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 44.0 m -59.51 -19.63 49.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.725 1.21 . . . . 0.0 113.234 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -62.85 -34.52 77.52 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.567 0.747 . . . . 0.0 110.581 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 47.9 mt -73.1 118.92 16.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.218 1.407 . . . . 0.0 107.654 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -49.91 -39.75 41.0 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.0 mp -59.98 -34.32 73.15 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.191 -0.943 . . . . 0.0 111.19 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.434 ' C ' ' H ' ' A' ' 246' ' ' LYS . 2.5 mm? -101.13 5.54 42.82 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 126.583 1.953 . . . . 0.0 112.495 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -75.58 38.51 0.15 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.946 0.898 . . . . 0.0 109.646 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.434 ' H ' ' C ' ' A' ' 244' ' ' LEU . 42.6 tptt -134.7 129.57 34.96 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 129.429 3.091 . . . . 0.0 105.74 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 39.5 p30 -150.91 167.32 27.92 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.484 1.914 . . . . 0.0 106.53 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -149.15 66.64 1.03 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 . . . . . 0 C--O 1.247 0.93 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.797 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 40.23 36.46 0.33 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 127.1 2.16 . . . . 0.0 114.446 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 73.5 m -94.82 164.57 12.87 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.974 0.91 . . . . 0.0 110.05 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -124.27 177.78 5.69 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.922 1.689 . . . . 0.0 107.291 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.3 m -44.81 -55.15 5.62 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -63.0 -46.56 87.07 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.017 0.437 . . . . 0.0 111.492 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -59.23 -48.87 79.99 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 124.797 1.239 . . . . 0.0 110.677 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.1 p -63.55 -35.87 81.91 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 122.008 -0.433 . . . . 0.0 110.697 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.83 -43.61 92.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 48.6 tp -60.65 -48.36 82.13 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 124.034 0.934 . . . . 0.0 108.607 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.9 mt -58.58 -52.05 67.32 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.209 1.004 . . . . 0.0 110.016 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 97.3 m -56.64 -50.28 72.52 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.292 1.037 . . . . 0.0 110.662 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -64.23 -50.94 66.04 Favored 'General case' 0 C--O 1.224 -0.244 0 O-C-N 121.455 -0.778 . . . . 0.0 110.118 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.4 m -51.97 -43.24 63.47 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.411 1.084 . . . . 0.0 111.026 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.6 tt -58.47 -57.08 14.54 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 119.368 0.986 . . . . 0.0 110.122 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -63.64 -38.02 89.52 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -59.9 -36.03 76.12 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.493 ' HA3' HD11 ' A' ' 183' ' ' ILE . . . -66.93 -51.4 40.2 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.1 t -56.07 -52.97 44.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 118.483 1.142 . . . . 0.0 112.4 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.16 -32.66 68.42 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.907 0.776 . . . . 0.0 111.213 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.1 m -75.63 -46.71 30.02 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 122.845 0.458 . . . . 0.0 110.917 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.589 HD11 HD12 ' A' ' 183' ' ' ILE . 24.8 mt -55.75 -52.42 48.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.07 -41.38 83.26 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 123.778 0.674 . . . . 0.0 110.88 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -62.1 -50.63 71.15 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 118.376 0.534 . . . . 0.0 110.929 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.404 ' HE2' ' OE2' ' A' ' 237' ' ' GLU . 0.7 OUTLIER -67.1 -3.55 7.72 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.058 0.943 . . . . 0.0 113.444 -179.303 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.9 mt -115.22 -28.89 6.78 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.676 1.59 . . . . 0.0 110.075 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -62.18 -26.14 68.17 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.238 0.615 . . . . 0.0 110.612 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.09 -46.89 60.93 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.706 0.802 . . . . 0.0 109.289 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -160.85 147.71 15.29 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 125.703 1.601 . . . . 0.0 108.495 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 67.7 m -75.71 173.21 11.38 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.7 pt -128.61 146.75 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 C-N-CA 123.639 0.775 . . . . 0.0 110.59 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -142.01 162.14 36.22 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.549 0.74 . . . . 0.0 111.057 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -146.9 125.03 12.11 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.441 1.096 . . . . 0.0 109.715 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -87.93 102.35 14.63 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.5 67.04 7.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 66.13 -115.09 7.11 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -63.61 -36.96 85.54 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.099 -0.953 . . . . 0.0 113.146 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -107.31 154.2 21.62 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 120.499 1.5 . . . . 0.0 111.613 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 30.2 mt -118.45 135.23 59.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -110.12 127.61 54.99 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 105.55 -2.018 . . . . 0.0 105.55 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -123.11 119.9 31.66 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.408 1.883 . . . . 0.0 111.718 -177.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -119.87 126.07 50.05 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.034 1.334 . . . . 0.0 110.947 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 3.3 m -111.13 160.84 27.52 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.685 1.594 . . . . 0.0 114.624 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -65.6 87.1 0.21 Allowed 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 124.794 3.663 . . . . 0.0 112.417 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 55.93 56.47 23.8 Favored Glycine 0 C--N 1.331 0.29 0 O-C-N 121.216 -0.927 . . . . 0.0 111.727 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.2 mt -128.05 -66.18 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -178.89 173.56 1.2 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.532 1.933 . . . . 0.0 110.982 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.72 118.74 28.77 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 176.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.43 154.97 41.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.984 0.913 . . . . 0.0 111.016 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -117.87 136.2 53.6 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -146.45 156.44 43.29 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.45 1.1 . . . . 0.0 112.413 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -92.19 147.44 22.93 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 162.9 -163.9 35.58 Favored Glycine 0 C--N 1.336 0.554 0 CA-C-N 120.126 1.33 . . . . 0.0 113.231 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -123.24 135.61 54.34 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.922 1.689 . . . . 0.0 110.095 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.2 p -152.33 151.16 12.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 124.502 1.121 . . . . 0.0 108.726 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -96.1 96.3 8.75 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 125.367 1.467 . . . . 0.0 107.182 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.9 t -55.71 -12.27 1.21 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -73.38 -24.93 60.38 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 120.293 1.406 . . . . 0.0 112.793 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.0 t -135.84 -20.84 1.5 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.104 1.361 . . . . 0.0 110.665 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 90.65 12.97 60.22 Favored Glycine 0 C--O 1.222 -0.6 0 C-N-CA 125.503 1.525 . . . . 0.0 110.461 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -69.69 113.19 6.73 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 118.209 1.004 . . . . 0.0 109.688 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 72.2 mt -74.43 111.29 9.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 58.9 t -65.46 -45.07 93.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 126.575 1.95 . . . . 0.0 110.659 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -145.21 160.9 40.76 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.658 1.183 . . . . 0.0 109.525 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -136.76 155.39 49.89 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.351 1.461 . . . . 0.0 107.287 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -150.31 142.0 23.63 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -95.79 -2.14 48.24 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.7 t -66.29 -43.13 87.21 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.976 1.31 . . . . 0.0 113.423 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 49.1 mt -119.23 89.08 3.06 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.085 0.954 . . . . 0.0 109.417 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.6 t -143.4 129.3 16.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -119.74 157.35 28.77 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 122.871 0.468 . . . . 0.0 112.013 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 26.6 mmm-85 -105.58 129.78 53.76 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.152 1.381 . . . . 0.0 107.907 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.9 mp -110.2 -65.66 1.14 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.516 0.726 . . . . 0.0 110.712 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -125.71 154.06 18.52 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -129.72 96.73 25.89 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.228 1.811 . . . . 0.0 108.913 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -74.35 -170.41 0.73 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.638 2.892 . . . . 0.0 108.796 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -100.88 165.38 11.38 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -81.46 -34.09 31.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.668 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -98.95 133.7 42.85 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 118.589 0.631 . . . . 0.0 110.355 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.6 p -58.26 -28.3 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.277 1.031 . . . . 0.0 109.611 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -69.01 -19.11 64.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 128.192 2.597 . . . . 0.0 112.84 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -99.62 -9.8 22.75 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.878 0.871 . . . . 0.0 110.476 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -70.3 161.5 30.26 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -140.35 95.64 2.91 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -101.37 167.38 10.21 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.539 1.136 . . . . 0.0 109.934 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -137.05 132.48 34.25 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.311 1.044 . . . . 0.0 110.12 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.4 tp -90.87 98.56 11.85 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 16.4 mt -107.19 -178.92 3.78 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.629 1.172 . . . . 0.0 109.494 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -155.47 161.66 40.9 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -136.6 -178.3 5.11 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 124.567 1.147 . . . . 0.0 108.437 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -56.34 -23.04 34.68 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.876 1.27 . . . . 0.0 111.511 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 58.6 t -81.67 -66.81 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -174.71 -164.22 29.18 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -77.22 160.03 29.23 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.299 0.64 . . . . 0.0 111.205 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -168.2 161.39 12.31 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.653 1.581 . . . . 0.0 109.381 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.589 HD12 HD11 ' A' ' 109' ' ' ILE . 4.1 mt -106.6 133.47 51.03 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 178.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 4.1 t -108.55 131.68 54.6 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -134.59 124.85 26.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.0 tt -115.38 140.15 38.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.3 mt -135.2 115.7 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 O-C-N 121.699 -0.626 . . . . 0.0 110.971 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -105.33 -168.0 23.83 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.683 1.611 . . . . 0.0 110.015 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.5 t 78.16 58.05 0.03 OUTLIER 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.452 1.901 . . . . 0.0 110.713 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -110.53 -104.21 2.81 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 106.941 -2.464 . . . . 0.0 106.941 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -153.97 119.61 5.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 42.6 mm -60.66 133.95 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 123.963 0.905 . . . . 0.0 109.108 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 58.9 m -86.36 106.52 17.46 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.11 -15.68 5.96 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.307 0.958 . . . . 0.0 112.964 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 49.0 t -58.28 -46.4 88.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.983 1.313 . . . . 0.0 110.34 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.6 p -119.89 -20.88 7.38 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.553 1.141 . . . . 0.0 111.71 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 81.95 13.25 79.83 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 127.14 2.305 . . . . 0.0 112.139 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -85.77 170.59 12.3 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.549 1.54 . . . . 0.0 110.823 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.09 153.54 22.63 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 122.104 0.954 . . . . 0.0 111.536 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 29.9 ttm-85 -92.76 29.97 1.67 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 127.769 2.428 . . . . 0.0 109.463 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.0 ptt? -73.93 154.58 39.31 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.6 p -122.61 144.4 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.453 -177.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -111.57 131.91 54.92 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.7 mp -123.48 119.5 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 125.097 1.359 . . . . 0.0 108.835 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -100.84 120.64 40.43 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.68 0.792 . . . . 0.0 108.951 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -99.4 123.1 43.38 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.838 0.745 . . . . 0.0 110.137 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 14.8 m -135.12 170.08 20.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.9 1.28 . . . . 0.0 111.389 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.1 136.04 41.14 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -92.59 108.17 3.61 Favored Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 107.548 -2.221 . . . . 0.0 107.548 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -34.99 -54.3 0.87 Allowed Glycine 0 C--N 1.338 0.647 0 C-N-CA 126.728 2.109 . . . . 0.0 113.473 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 14.9 m -79.56 71.27 6.15 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -50.15 23.1 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.647 1 C-N-CA 133.767 4.827 . . . . 0.0 118.406 -178.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 7.9 t -145.96 47.39 1.24 Allowed 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.154 -1.591 . . . . 0.0 110.891 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -140.46 166.98 25.68 Favored Glycine 0 C--N 1.336 0.571 0 O-C-N 120.508 -1.37 . . . . 0.0 110.405 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.34 168.92 23.68 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 CA-C-N 119.623 1.711 . . . . 0.0 108.915 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 99.1 p -72.23 153.42 41.59 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.9 p -160.44 165.16 31.54 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.561 1.545 . . . . 0.0 108.18 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.2 mp -84.92 132.08 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -78.95 -55.33 5.22 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 124.804 1.242 . . . . 0.0 111.297 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 33.2 p-90 -146.24 165.45 29.17 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.652 HG13 ' CE1' ' A' ' 229' ' ' TYR . 52.6 t -144.38 139.19 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 126.259 1.824 . . . . 0.0 106.19 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.22 134.86 11.69 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.606 0.717 . . . . 0.0 110.621 178.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -90.54 90.35 7.96 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.3 p -75.32 -46.05 35.76 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.227 1.011 . . . . 0.0 111.584 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -103.52 -179.61 4.0 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.2 mp -78.16 -27.8 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.5 t -118.27 -56.81 2.13 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.288 1.435 . . . . 0.0 111.24 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 3.7 t -60.02 141.42 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' TYR . . . . . 0.652 ' CE1' HG13 ' A' ' 221' ' ' VAL . 1.2 t80 -125.85 150.5 47.82 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.905 2.082 . . . . 0.0 109.035 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -131.44 138.7 49.16 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.777 1.631 . . . . 0.0 108.837 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.71 162.22 40.19 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.091 1.757 . . . . 0.0 111.745 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -132.38 147.66 52.39 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 89.3 t -129.59 139.07 52.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 126.065 1.746 . . . . 0.0 108.377 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.92 140.77 46.3 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 124.134 0.974 . . . . 0.0 109.678 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 56.9 mt -137.83 140.4 29.42 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.53 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.85 -45.04 0.31 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.049 2.499 . . . . 0.0 112.284 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.404 ' OE2' ' HE2' ' A' ' 112' ' ' LYS . 10.5 mt-10 -61.08 -25.69 67.12 Favored 'General case' 0 N--CA 1.461 0.124 0 O-C-N 121.235 -0.916 . . . . 0.0 111.914 -178.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.2 mp -60.1 -37.66 80.64 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 118.336 -0.84 . . . . 0.0 109.905 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 32.6 m -54.47 -26.7 32.71 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.819 1.648 . . . . 0.0 113.181 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -62.08 -30.15 70.8 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 41.7 mt -76.19 116.21 16.67 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.578 1.151 . . . . 0.0 112.151 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -48.19 -39.96 22.6 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.636 1.974 . . . . 0.0 114.853 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 13.4 mt -61.53 -34.08 74.91 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.183 -0.948 . . . . 0.0 112.968 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 1.9 mp -104.95 7.72 34.28 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -68.07 70.26 0.15 Allowed 'General case' 0 C--O 1.235 0.317 0 C-N-CA 129.084 2.954 . . . . 0.0 110.047 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -141.67 158.45 43.8 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 130.572 3.549 . . . . 0.0 107.819 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 29.0 m120 62.55 15.88 8.29 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.381 1.872 . . . . 0.0 115.67 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -80.3 72.51 7.15 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 2.9 p30 . . . . . 0 C--O 1.247 0.972 0 C-N-CA 126.955 2.102 . . . . 0.0 109.774 179.664 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.972 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.9 -33.82 76.43 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 117.992 0.896 . . . . 0.0 111.506 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.4 m -67.55 76.19 0.18 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.766 1.627 . . . . 0.0 112.53 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -60.13 -36.05 76.63 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.635 -1.291 . . . . 0.0 110.527 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 58.0 m -60.13 -41.8 93.43 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.08 0.952 . . . . 0.0 111.193 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -68.98 -29.73 68.0 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.768 -0.826 . . . . 0.0 108.768 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -50.88 65.97 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.2 p -61.59 -39.93 92.95 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.8 90.04 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 118.616 0.644 . . . . 0.0 110.683 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 47.6 tp -61.53 -45.75 92.86 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.0 mt -64.5 -52.16 59.31 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.543 0.737 . . . . 0.0 110.484 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 53.3 m -54.89 -51.75 65.02 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.654 -0.654 . . . . 0.0 110.188 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -60.21 -46.59 89.23 Favored 'General case' 0 C--N 1.339 0.116 0 O-C-N 121.656 -0.652 . . . . 0.0 110.64 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.1 m -53.34 -45.96 69.3 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.093 0.957 . . . . 0.0 110.2 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 27.4 tp -59.45 -56.64 19.43 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.611 0.641 . . . . 0.0 110.721 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -56.56 -51.47 68.46 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 118.436 0.562 . . . . 0.0 111.723 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -55.2 -38.92 69.01 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.415 0.686 . . . . 0.0 109.674 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -67.04 -52.79 30.27 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 87.8 t -55.03 -53.32 35.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.734 1.214 . . . . 0.0 111.276 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -31.52 72.68 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 118.64 0.654 . . . . 0.0 110.822 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.0 m -69.71 -46.7 65.41 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.576 HD11 HD12 ' A' ' 183' ' ' ILE . 25.0 mt -57.33 -52.21 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.35 -41.02 88.24 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 119.171 -0.442 . . . . 0.0 111.466 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -60.54 -50.77 72.22 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.19 0.45 . . . . 0.0 110.79 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -71.32 -19.92 62.25 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.2 mp -102.8 -25.72 13.41 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.125 1.329 . . . . 0.0 111.526 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -55.12 -39.21 69.14 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 121.551 -0.718 . . . . 0.0 110.802 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.96 -42.73 89.58 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.487 -0.768 . . . . 0.0 111.184 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 -153.63 147.21 25.07 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 120.224 1.375 . . . . 0.0 112.403 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 60.7 m -76.14 167.88 21.06 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 36.3 pt -128.15 148.42 32.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.74 167.92 20.94 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.222 0.609 . . . . 0.0 112.141 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -151.04 127.43 10.66 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.318 1.447 . . . . 0.0 109.758 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -91.07 102.73 15.49 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.704 0.802 . . . . 0.0 109.176 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.27 66.75 8.53 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.89 -114.96 7.04 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -63.84 -32.87 74.53 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.036 0.934 . . . . 0.0 112.594 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -107.68 159.43 16.48 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 119.663 1.119 . . . . 0.0 111.094 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.6 mt -127.92 147.05 32.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.419 ' CD1' HG11 ' A' ' 221' ' ' VAL . 47.9 m-85 -123.05 128.62 50.4 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.295 1.838 . . . . 0.0 108.776 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -122.2 130.52 53.28 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.619 1.968 . . . . 0.0 110.01 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -124.21 119.41 29.28 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.398 1.479 . . . . 0.0 108.256 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 14.9 m -108.52 157.71 35.86 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 123.45 0.7 . . . . 0.0 111.274 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -65.69 87.41 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.552 1 C-N-CA 125.67 4.246 . . . . 0.0 115.55 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.58 34.42 89.85 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 119.479 -0.623 . . . . 0.0 111.851 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.5 mt -112.44 -67.22 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.487 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 11.7 pt-20 -173.26 168.21 4.7 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.73 1.612 . . . . 0.0 109.379 -178.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.63 120.38 29.37 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 177.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.2 m -138.33 156.56 30.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 124.832 1.253 . . . . 0.0 111.553 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -132.64 127.05 34.05 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.958 0.903 . . . . 0.0 108.835 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.407 ' HB3' ' HB ' ' A' ' 157' ' ' VAL . 7.4 p90 -136.93 159.25 42.44 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 126.909 2.084 . . . . 0.0 113.283 -178.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -87.36 153.3 21.56 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 159.75 -164.98 34.42 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.83 147.35 49.46 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 89.8 t -121.54 156.16 25.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 124.398 1.079 . . . . 0.0 110.604 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -101.69 89.42 3.69 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 103.541 -2.763 . . . . 0.0 103.541 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 8.8 t -49.98 -21.78 1.33 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.485 1.114 . . . . 0.0 112.399 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -56.69 -26.74 57.35 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.89 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.51 -30.05 0.38 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.209 0.913 . . . . 0.0 111.88 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 114.55 -0.0 23.36 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 126.48 1.991 . . . . 0.0 110.259 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -56.06 128.56 35.98 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 126.046 1.739 . . . . 0.0 111.479 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 48.7 mt -67.34 129.04 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 47.7 t -76.3 -51.47 19.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 O-C-N 120.641 -1.287 . . . . 0.0 110.197 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 -138.61 152.25 47.97 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.52 -2.029 . . . . 0.0 105.52 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -144.14 139.69 28.96 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.934 0.894 . . . . 0.0 110.544 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -151.33 153.71 35.32 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -95.48 24.97 4.75 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.125 0.57 . . . . 0.0 109.9 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.7 t -83.69 -30.22 26.96 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 120.287 -1.508 . . . . 0.0 111.311 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 19.2 tp -140.88 72.74 1.4 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.558 0.617 . . . . 0.0 110.607 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 138' ' ' PHE . 3.9 p -134.95 154.97 37.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.666 1.586 . . . . 0.0 110.002 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -143.32 151.38 40.42 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.125 1.37 . . . . 0.0 109.846 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 13.9 ptt-85 -99.18 135.49 40.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 125.513 1.525 . . . . 0.0 109.315 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.25 -65.67 1.1 Allowed 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 123.377 0.671 . . . . 0.0 109.722 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -130.73 150.21 19.25 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.75 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 6.5 ttpp -123.25 90.36 50.48 Favored Pre-proline 0 N--CA 1.451 -0.386 0 C-N-CA 125.932 1.693 . . . . 0.0 108.388 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.487 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 93.1 Cg_endo -70.59 175.14 9.19 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.956 2.438 . . . . 0.0 109.275 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -91.28 166.06 13.12 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.334 0.653 . . . . 0.0 110.531 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -77.61 -27.79 51.33 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.987 0.915 . . . . 0.0 113.316 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -112.99 137.89 50.71 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.725 1.21 . . . . 0.0 109.094 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.5 p -60.4 -27.34 39.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.22 1.008 . . . . 0.0 111.823 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -71.93 -8.32 53.78 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 129.128 2.971 . . . . 0.0 112.287 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -112.97 -5.13 13.81 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.676 1.99 . . . . 0.0 110.425 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 45.2 mmm-85 -82.55 165.73 19.87 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -134.24 96.59 3.64 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.421 ' CE2' ' HG3' ' A' ' 185' ' ' GLU . 77.5 m-85 -111.3 139.57 46.6 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.283 1.833 . . . . 0.0 107.459 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -131.03 137.11 49.03 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.272 1.029 . . . . 0.0 109.029 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 43.8 tp -88.52 103.3 15.76 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.468 1.107 . . . . 0.0 109.717 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 7.2 mt -119.63 177.64 4.87 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.845 1.258 . . . . 0.0 108.342 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.4 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 19.8 p90 -157.49 166.85 31.87 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.579 0.751 . . . . 0.0 110.019 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 178' ' ' ASP . 31.6 t70 -136.6 -178.46 5.18 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.427 ' H ' ' CG ' ' A' ' 177' ' ' ASP . 0.5 OUTLIER -54.51 -30.67 54.22 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 125.491 1.516 . . . . 0.0 111.36 179.647 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 20.2 t -77.52 -64.25 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.491 1.116 . . . . 0.0 110.012 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -169.67 -170.83 34.61 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 119.059 0.845 . . . . 0.0 112.491 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.4 ' CD2' ' HB3' ' A' ' 176' ' ' TYR . 8.1 m-85 -87.67 154.77 20.32 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 123.637 0.775 . . . . 0.0 110.816 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -159.72 172.83 17.01 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.719 1.208 . . . . 0.0 107.977 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.576 HD12 HD11 ' A' ' 109' ' ' ILE . 9.1 mt -117.41 137.96 49.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 177.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.2 t -106.0 118.29 36.23 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 124.916 1.385 . . . . 0.0 107.437 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.421 ' HG3' ' CE2' ' A' ' 172' ' ' PHE . 0.6 OUTLIER -123.82 107.78 11.77 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 178.031 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 2.1 tt -101.99 128.33 54.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.1 mt -120.4 111.1 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.955 1.302 . . . . 0.0 111.551 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -104.75 -159.01 23.65 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 125.7 1.619 . . . . 0.0 110.042 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 74.82 36.94 0.53 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.772 1.629 . . . . 0.0 109.735 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -89.89 -126.91 3.18 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 107.576 -2.21 . . . . 0.0 107.576 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -137.35 127.95 26.85 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.9 mm -61.45 129.36 24.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 123.499 0.719 . . . . 0.0 111.784 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 5.1 m -90.0 94.07 9.65 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 101.198 -3.63 . . . . 0.0 101.198 176.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -57.67 -17.72 16.52 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.4 m -53.05 -33.04 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.466 1.507 . . . . 0.0 109.854 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 1.4 p -122.35 -34.01 3.36 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 123.25 0.62 . . . . 0.0 111.33 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 95.46 22.79 20.85 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.284 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -111.1 165.59 11.76 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.299 1.84 . . . . 0.0 109.159 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -87.21 145.48 26.38 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.355 1.462 . . . . 0.0 111.954 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -79.05 29.81 0.21 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.638 2.775 . . . . 0.0 111.06 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.8 ptm -73.12 149.44 43.04 Favored 'General case' 0 C--O 1.239 0.512 0 O-C-N 121.124 -0.985 . . . . 0.0 109.504 -177.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -116.73 146.88 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.607 -177.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -115.05 127.98 55.96 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.7 mp -117.06 116.53 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.109 0.964 . . . . 0.0 108.412 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -100.32 113.69 26.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -92.2 116.78 29.24 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 28.3 m -125.31 169.84 16.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 125.789 1.636 . . . . 0.0 111.806 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -81.37 137.41 35.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -101.24 122.46 7.6 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 107.364 -2.294 . . . . 0.0 107.364 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -45.32 -46.13 11.13 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.37 1.462 . . . . 0.0 113.238 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 8.3 t -81.62 65.2 6.65 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -57.14 28.19 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 130.099 3.36 . . . . 0.0 117.538 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.1 t -138.78 47.1 1.95 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 120.637 1.562 . . . . 0.0 112.486 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -153.24 172.68 32.15 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -73.28 167.1 28.18 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.276 1.984 . . . . 0.0 109.799 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.19 155.71 34.28 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.66 159.77 12.21 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.241 1.416 . . . . 0.0 107.373 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.86 128.89 37.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -72.9 -61.01 1.96 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 124.08 0.952 . . . . 0.0 109.184 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' TRP . . . . . 0.459 ' CE3' ' HD2' ' A' ' 222' ' ' ARG . 28.6 p-90 -139.64 167.2 22.65 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.595 1.558 . . . . 0.0 109.443 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.742 HG13 ' CE1' ' A' ' 229' ' ' TYR . 24.9 t -144.01 129.15 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.459 ' HD2' ' CE3' ' A' ' 220' ' ' TRP . 0.1 OUTLIER -145.51 118.03 8.55 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.99 0.9 . . . . 0.0 109.417 178.053 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -76.36 94.58 3.64 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 102.714 -3.069 . . . . 0.0 102.714 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 17.4 p -61.45 -66.41 0.54 Allowed 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.274 0.629 . . . . 0.0 109.669 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -101.38 179.12 4.45 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 34.7 mm -62.07 -21.47 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 123.535 0.734 . . . . 0.0 111.871 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.01 -45.57 1.26 Allowed 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.243 0.617 . . . . 0.0 111.228 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 25.2 t -67.29 133.58 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' TYR . . . . . 0.742 ' CE1' HG13 ' A' ' 221' ' ' VAL . 1.2 t80 -130.09 144.63 51.45 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.752 1.621 . . . . 0.0 108.661 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -123.74 138.38 54.53 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 126.363 1.865 . . . . 0.0 107.944 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.1 156.51 43.94 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.868 1.267 . . . . 0.0 109.91 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -130.9 143.3 50.63 Favored 'General case' 0 CA--C 1.52 -0.211 0 O-C-N 121.344 -0.847 . . . . 0.0 110.673 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 61.1 t -125.61 140.89 47.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.44 1.496 . . . . 0.0 107.419 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.72 136.81 52.44 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 96.6 mt -133.02 143.47 48.67 Favored Pre-proline 0 C--O 1.236 0.385 0 CA-C-O 118.192 -0.909 . . . . 0.0 109.112 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.39 -44.2 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.34 2.026 . . . . 0.0 111.445 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -62.36 -20.3 64.26 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.721 1.208 . . . . 0.0 113.291 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 14.9 mt -69.63 -38.11 77.07 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.047 0.839 . . . . 0.0 109.982 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 34.5 m -54.31 -21.58 9.71 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.433 1.493 . . . . 0.0 113.61 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -61.94 -30.66 71.06 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.391 1.076 . . . . 0.0 110.835 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 52.8 mt -79.09 124.08 27.96 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -48.02 -45.41 31.94 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 126.267 1.827 . . . . 0.0 112.824 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 6.1 mp -60.7 -28.91 68.99 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.271 -0.893 . . . . 0.0 111.512 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -99.91 -0.68 39.05 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.596 1.558 . . . . 0.0 111.627 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -78.1 37.97 0.27 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.744 1.618 . . . . 0.0 109.493 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -144.3 132.96 22.29 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 127.681 2.392 . . . . 0.0 107.113 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -163.14 153.85 16.54 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 126.82 2.048 . . . . 0.0 105.516 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -172.93 -22.98 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.535 1.534 . . . . 0.0 112.949 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 21.8 t0 . . . . . 0 C--O 1.25 1.114 0 C-N-CA 127.377 2.271 . . . . 0.0 110.885 179.699 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.741 0 N-CA-C 108.761 -1.735 . . . . 0.0 108.761 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.44 -26.61 68.81 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.485 1.143 . . . . 0.0 110.453 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.8 m -136.45 170.86 15.36 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.955 1.702 . . . . 0.0 108.481 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 61.7 21.96 12.59 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.313 1.445 . . . . 0.0 114.418 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.7 m -64.6 -34.47 78.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 122.923 1.344 . . . . 0.0 111.29 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -72.55 -35.26 67.98 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 125.02 1.328 . . . . 0.0 107.737 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -68.29 -49.62 59.24 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.549 1.54 . . . . 0.0 108.26 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.4 p -57.0 -45.58 82.93 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 120.247 1.385 . . . . 0.0 110.879 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.5 -45.59 93.24 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.415 0.686 . . . . 0.0 110.262 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.1 tp -62.74 -42.86 99.87 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 117.895 -1.05 . . . . 0.0 110.482 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.7 mt -58.99 -53.82 54.12 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.441 1.019 . . . . 0.0 109.123 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.6 m -56.1 -42.03 76.15 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.816 0.447 . . . . 0.0 110.129 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -65.72 -51.07 62.2 Favored 'General case' 0 CA--C 1.527 0.09 0 O-C-N 120.97 -1.082 . . . . 0.0 110.044 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.7 m -53.02 -43.19 66.34 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.182 1.393 . . . . 0.0 110.323 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.405 ' O ' HG23 ' A' ' 106' ' ' VAL . 19.9 tp -60.08 -55.55 32.57 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.943 0.792 . . . . 0.0 111.489 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -65.46 -40.07 92.77 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 118.867 0.758 . . . . 0.0 112.124 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -61.59 -41.46 97.46 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 124.052 0.941 . . . . 0.0 109.851 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.406 ' HA3' HD11 ' A' ' 183' ' ' ILE . . . -66.26 -49.47 57.09 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.412 HG13 ' CE1' ' A' ' 172' ' ' PHE . 62.6 t -54.52 -53.05 34.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 126.036 1.734 . . . . 0.0 111.412 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -32.99 74.77 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 118.133 0.424 . . . . 0.0 110.463 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.09 -42.78 72.28 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 118.324 0.511 . . . . 0.0 110.492 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.418 HD11 HD12 ' A' ' 183' ' ' ILE . 16.6 mt -53.4 -53.5 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.97 -42.36 98.16 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 118.643 -0.694 . . . . 0.0 110.422 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -61.44 -30.04 70.33 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.948 0.794 . . . . 0.0 111.174 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -91.96 -3.81 55.42 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.67 1.188 . . . . 0.0 112.511 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.9 mt -119.75 -29.28 5.05 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.041 1.291 . . . . 0.0 112.586 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -62.07 -24.77 67.3 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.46 0.704 . . . . 0.0 111.313 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -73.45 -46.62 47.29 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.657 1.183 . . . . 0.0 108.565 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -161.33 145.16 13.01 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.034 1.733 . . . . 0.0 108.951 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 33.9 m -76.19 173.73 10.99 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.322 0.649 . . . . 0.0 109.778 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 42.1 pt -125.55 151.56 31.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 123.794 0.838 . . . . 0.0 109.209 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.89 160.89 41.76 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 122.849 0.46 . . . . 0.0 109.901 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -150.95 125.13 9.35 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.568 -0.708 . . . . 0.0 111.278 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -84.58 101.73 12.34 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 178.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.21 67.2 9.55 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.32 -115.68 6.94 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -66.85 -33.74 76.28 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -106.78 160.37 15.53 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.464 1.029 . . . . 0.0 110.363 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 21.3 mt -125.07 133.52 69.25 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 N-CA-C 104.894 -2.262 . . . . 0.0 104.894 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.528 ' CD1' HG11 ' A' ' 221' ' ' VAL . 67.7 m-85 -110.63 131.64 54.88 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -121.49 128.36 52.0 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 125.245 1.418 . . . . 0.0 109.368 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -127.24 108.85 11.23 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 124.288 0.992 . . . . 0.0 112.096 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 1.7 m -98.23 159.28 31.07 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.038 0.935 . . . . 0.0 112.858 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.06 96.34 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.562 1 C-N-CA 125.925 4.417 . . . . 0.0 113.62 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 55.54 49.78 63.42 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-O 119.076 -0.847 . . . . 0.0 111.18 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 5.1 mt -125.95 -68.01 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.613 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -172.64 162.57 5.11 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -123.73 119.76 30.73 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 103.011 -2.959 . . . . 0.0 103.011 177.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.8 m -131.38 155.87 42.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 124.123 0.969 . . . . 0.0 111.166 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -122.51 131.63 53.94 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 177.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -146.11 157.41 43.84 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.972 0.909 . . . . 0.0 111.102 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -89.39 154.4 20.09 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 157.05 -163.62 32.41 Favored Glycine 0 C--N 1.33 0.231 0 O-C-N 120.175 -1.578 . . . . 0.0 110.768 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.09 144.3 51.06 Favored 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.4 p -154.87 147.52 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 126.106 1.762 . . . . 0.0 106.454 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -89.16 83.15 6.5 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 101.06 -3.682 . . . . 0.0 101.06 177.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.4 t -52.63 -14.82 0.57 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.117 1.367 . . . . 0.0 114.499 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.464 ' HA ' ' HE2' ' A' ' 145' ' ' LYS . 11.3 mmpt? -69.62 -35.78 75.56 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.636 1.975 . . . . 0.0 111.557 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.4 t -119.76 -21.52 7.21 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.61 1.564 . . . . 0.0 111.321 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 88.08 35.03 9.2 Favored Glycine 0 C--O 1.224 -0.487 0 O-C-N 121.4 -0.813 . . . . 0.0 111.224 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -101.67 119.97 39.61 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 34.5 mm -69.4 158.33 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 13.4 t -131.44 -16.92 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.884 1.274 . . . . 0.0 110.809 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -143.44 148.06 35.52 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.854 1.261 . . . . 0.0 108.281 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -134.3 35.39 3.24 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.168 0.987 . . . . 0.0 110.365 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -51.81 121.31 6.38 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -86.84 -0.14 55.91 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.611 1.165 . . . . 0.0 112.833 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.4 t -76.81 -42.34 40.89 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 125.097 1.359 . . . . 0.0 111.097 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 47.3 mt -110.72 73.45 0.83 Allowed 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.863 0.865 . . . . 0.0 110.713 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.9 p -142.8 141.69 27.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -132.5 157.83 43.65 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.605 1.562 . . . . 0.0 109.484 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -107.71 130.66 54.92 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.495 1.118 . . . . 0.0 109.746 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.4 -75.98 0.51 Allowed 'General case' 0 N--CA 1.458 -0.052 0 C-N-CA 124.434 1.093 . . . . 0.0 109.68 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -127.72 153.76 19.41 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -129.45 90.97 42.65 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.441 ' HD3' HG21 ' A' ' 187' ' ' ILE . 54.7 Cg_endo -74.87 173.67 14.06 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.965 2.444 . . . . 0.0 110.984 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -83.16 164.52 20.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.825 0.821 . . . . 0.0 109.493 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -81.92 -24.02 35.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.307 -1.315 . . . . 0.0 113.592 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -102.03 144.1 31.04 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.8 p -72.95 -31.53 36.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 121.426 0.631 . . . . 0.0 110.199 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.55 -21.93 66.65 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.822 2.049 . . . . 0.0 110.571 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -83.48 -18.41 38.65 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.288 -0.883 . . . . 0.0 112.302 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.502 ' HD3' ' CE1' ' A' ' 172' ' ' PHE . 3.0 mtt180 -76.36 172.34 13.07 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.175 0.59 . . . . 0.0 112.304 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -136.75 95.03 3.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.254 1.422 . . . . 0.0 107.988 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.502 ' CE1' ' HD3' ' A' ' 170' ' ' ARG . 85.7 m-85 -99.09 161.61 13.53 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.64 1.176 . . . . 0.0 109.535 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -141.51 129.51 21.97 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 118.671 0.669 . . . . 0.0 110.155 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 21.5 tp -87.88 99.66 12.29 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 26.5 mt -106.84 -179.67 4.0 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.758 1.223 . . . . 0.0 109.556 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 181' ' ' TYR . 4.1 p90 -159.72 159.88 33.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -140.81 -173.53 3.73 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -50.87 -34.03 26.4 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.953 1.701 . . . . 0.0 112.631 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.432 ' O ' ' HE3' ' A' ' 246' ' ' LYS . 41.3 t -79.16 -73.47 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -165.65 -169.05 28.75 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 119.366 0.984 . . . . 0.0 111.959 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 176' ' ' TYR . 5.6 m-85 -78.49 156.37 29.35 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.269 0.628 . . . . 0.0 110.789 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -159.55 167.53 28.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.431 1.492 . . . . 0.0 107.616 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.418 HD12 HD11 ' A' ' 109' ' ' ILE . 9.3 mt -114.88 125.13 72.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.3 t -99.18 130.08 45.47 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -137.99 107.06 6.01 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 103.72 -2.696 . . . . 0.0 103.72 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.0 tt -99.65 140.45 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.441 HG21 ' HD3' ' A' ' 163' ' ' PRO . 15.2 mt -129.59 112.28 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 123.291 0.636 . . . . 0.0 110.092 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.34 -159.07 26.07 Favored Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.1 m 72.05 57.99 0.15 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.557 1.543 . . . . 0.0 109.286 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -116.4 -118.78 3.08 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 125.589 1.566 . . . . 0.0 109.501 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -140.59 122.81 15.8 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.366 1.466 . . . . 0.0 109.79 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.6 mm -61.15 119.29 4.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 126.065 1.746 . . . . 0.0 110.497 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 35.2 m -77.58 100.9 6.29 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -48.56 -29.7 4.51 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.737 1.615 . . . . 0.0 113.476 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 27.1 t -53.36 -40.84 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.186 1.394 . . . . 0.0 111.585 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 37.9 p -124.07 -18.4 5.92 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.694 0.759 . . . . 0.0 111.554 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 77.56 15.84 80.92 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 128.68 3.038 . . . . 0.0 111.994 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -86.45 168.9 13.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.068 1.347 . . . . 0.0 110.801 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -85.32 148.15 26.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.252 1.025 . . . . 0.0 108.443 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.91 29.93 0.99 Allowed 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 127.933 2.493 . . . . 0.0 111.232 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 11.9 ptt? -73.18 156.26 38.78 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.18 143.53 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.978 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -106.78 133.23 51.76 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.73 111.81 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 C-N-CA 124.378 1.071 . . . . 0.0 108.373 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -97.12 114.56 26.24 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -91.28 122.92 34.32 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.488 0.715 . . . . 0.0 110.142 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.82 176.49 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 125.864 1.666 . . . . 0.0 110.728 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.9 t -88.09 143.15 27.24 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -107.07 151.84 16.88 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -51.66 -61.55 6.3 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.843 1.687 . . . . 0.0 113.952 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 11.7 m -78.03 92.57 4.36 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 118.568 1.184 . . . . 0.0 108.669 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -66.42 17.36 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.041 2.536 . . . . 0.0 114.166 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 3.8 m -132.78 47.04 2.55 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 -177.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -157.88 175.51 35.12 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 120.647 -1.283 . . . . 0.0 111.552 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.44 162.6 37.89 Favored 'Trans proline' 0 C--O 1.239 0.562 0 C-N-CA 122.661 2.241 . . . . 0.0 110.959 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 12.4 p -69.38 162.09 28.03 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.875 0.87 . . . . 0.0 109.366 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.21 157.25 9.22 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.16 1.384 . . . . 0.0 107.927 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.83 132.32 33.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -81.25 -53.17 6.58 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 125.59 1.556 . . . . 0.0 111.377 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 41.3 p-90 -148.94 165.85 30.35 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 124.135 0.974 . . . . 0.0 108.446 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.749 HG13 ' CE1' ' A' ' 229' ' ' TYR . 49.1 t -145.67 136.39 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 127.146 2.179 . . . . 0.0 105.504 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.02 130.57 10.65 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -78.69 87.93 4.59 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.405 ' HB ' ' HE3' ' A' ' 225' ' ' LYS . 2.6 p -60.45 -53.45 57.41 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.423 0.689 . . . . 0.0 110.989 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.405 ' HE3' ' HB ' ' A' ' 224' ' ' THR . 17.5 mmtp -114.81 179.33 3.98 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.6 mp -66.22 -33.04 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -108.83 -65.05 1.17 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.871 0.868 . . . . 0.0 109.88 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 5.5 t -55.35 138.88 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 124.892 1.277 . . . . 0.0 109.749 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' TYR . . . . . 0.749 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.3 OUTLIER -133.49 151.03 51.71 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.698 1.999 . . . . 0.0 108.341 -178.845 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -132.22 141.06 48.91 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 126.109 1.764 . . . . 0.0 108.793 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.01 162.31 37.26 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.429 2.292 . . . . 0.0 111.177 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -134.48 147.64 50.41 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.746 0.818 . . . . 0.0 108.898 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 93.3 t -134.66 135.5 53.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 C-N-CA 124.687 1.195 . . . . 0.0 108.689 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.7 p -102.75 142.19 34.31 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.706 0.802 . . . . 0.0 108.979 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 34.0 mt -139.48 137.61 19.13 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 123.693 0.797 . . . . 0.0 109.9 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.34 -34.66 2.63 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.914 2.41 . . . . 0.0 113.029 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -67.81 -26.46 66.09 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.224 -0.922 . . . . 0.0 110.595 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 3.9 mp -65.9 -34.47 78.21 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 28.3 m -59.13 -11.16 3.35 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.252 1.421 . . . . 0.0 112.98 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -81.96 -30.34 31.76 Favored 'General case' 0 CA--C 1.528 0.098 0 O-C-N 120.16 -1.587 . . . . 0.0 111.142 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 23.8 mt -78.78 111.88 15.35 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.41 -27.87 1.86 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 116.404 2.001 . . . . 0.0 116.404 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 5.2 mp -63.68 -45.03 91.92 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.466 0.706 . . . . 0.0 110.445 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -82.21 3.59 26.76 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 127.002 2.121 . . . . 0.0 113.3 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -74.02 64.2 1.0 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 127.949 2.5 . . . . 0.0 110.584 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.432 ' HE3' ' O ' ' A' ' 179' ' ' VAL . 4.8 tptp -135.34 146.39 48.37 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 128.673 2.789 . . . . 0.0 108.404 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 18.4 m120 67.86 11.66 8.47 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.785 1.634 . . . . 0.0 112.614 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -85.82 73.58 10.34 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 178.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 39.0 t70 . . . . . 0 C--O 1.245 0.859 0 CA-C-O 118.49 -0.767 . . . . 0.0 109.891 179.655 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.171 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -144.71 171.87 13.8 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.852 1.661 . . . . 0.0 107.637 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.1 m -153.51 -172.34 4.2 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.121 0.969 . . . . 0.0 109.452 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 55.55 35.66 25.6 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.608 1.563 . . . . 0.0 113.622 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 63.9 m -55.41 -53.68 53.25 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 121.363 -0.836 . . . . 0.0 111.929 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -59.85 -39.55 85.54 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.143 0.577 . . . . 0.0 111.974 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -57.14 -52.37 65.58 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.9 m -65.31 -36.03 82.8 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 118.79 -0.624 . . . . 0.0 110.422 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.59 -46.06 84.48 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.662 1.119 . . . . 0.0 110.064 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.9 tp -66.39 -39.74 89.24 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.112 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.2 mt -60.95 -51.75 67.94 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.403 1.002 . . . . 0.0 110.392 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 90.1 m -55.12 -56.45 19.75 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.26 1.424 . . . . 0.0 109.906 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.04 -48.91 78.66 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-O 119.043 -0.503 . . . . 0.0 111.332 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 54.9 m -52.84 -50.39 63.82 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.439 0.695 . . . . 0.0 111.41 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.9 tp -58.59 -54.12 50.7 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.766 -0.635 . . . . 0.0 110.138 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -55.12 -51.54 66.1 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.555 0.742 . . . . 0.0 112.071 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -59.09 -40.08 84.19 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.24 -52.48 52.45 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-O 118.146 -1.363 . . . . 0.0 110.973 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.422 HG22 ' CG ' ' A' ' 172' ' ' PHE . 29.5 t -55.72 -53.19 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 119.255 1.528 . . . . 0.0 111.289 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -35.04 79.13 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.863 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.2 m -64.91 -45.24 86.7 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 41.0 mt -56.66 -54.36 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -56.7 -43.23 80.34 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 123.278 0.361 . . . . 0.0 110.466 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -67.56 -37.63 82.94 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.823 -0.548 . . . . 0.0 112.294 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.86 -1.97 41.45 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.935 0.894 . . . . 0.0 113.235 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.2 mt -119.39 -26.16 5.89 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 119.645 1.111 . . . . 0.0 111.744 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -58.7 -23.57 59.83 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -74.22 -43.17 58.19 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 117.946 -1.026 . . . . 0.0 111.383 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -156.23 150.21 25.19 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.523 1.129 . . . . 0.0 112.376 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 57.4 m -76.02 171.58 14.21 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 23.0 pt -129.38 156.12 41.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 123.955 0.902 . . . . 0.0 109.018 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -151.21 154.03 36.06 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 122.059 -0.401 . . . . 0.0 111.196 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -141.37 127.42 19.51 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 124.118 0.967 . . . . 0.0 110.699 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -87.22 118.13 26.43 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -109.84 67.41 0.65 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.045 2.138 . . . . 0.0 106.105 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.14 -120.8 8.03 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -66.46 -33.07 74.87 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.531 1.132 . . . . 0.0 112.508 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -106.92 145.31 32.37 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 118.737 0.699 . . . . 0.0 109.847 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 10.6 mt -116.06 151.16 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.494 ' CD1' HG11 ' A' ' 221' ' ' VAL . 42.3 m-85 -118.7 135.92 54.22 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 126.057 1.743 . . . . 0.0 106.447 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.63 131.43 48.07 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 125.661 1.584 . . . . 0.0 108.516 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -128.2 109.35 11.41 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.183 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 2.5 m -89.45 160.04 42.97 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 117.832 -1.08 . . . . 0.0 108.709 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -61.49 70.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 125.15 3.9 . . . . 0.0 116.145 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.46 48.74 65.6 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 125.257 1.408 . . . . 0.0 111.772 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.2 mt -114.65 -66.29 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -160.14 160.95 33.57 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.462 1.905 . . . . 0.0 107.915 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -123.46 120.81 34.02 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 102.525 -3.139 . . . . 0.0 102.525 177.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.94 155.52 27.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 123.593 0.757 . . . . 0.0 111.751 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -121.24 135.74 55.08 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -145.97 157.69 43.88 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 125.206 1.402 . . . . 0.0 111.144 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -88.78 151.44 22.39 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 164.68 -163.33 36.21 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.4 139.24 50.63 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.706 2.002 . . . . 0.0 106.268 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 91.5 t -116.8 153.19 18.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 125.189 1.396 . . . . 0.0 109.594 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -105.98 93.44 4.63 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 127.427 2.291 . . . . 0.0 105.559 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.7 t -57.56 -13.84 4.36 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 119.271 0.942 . . . . 0.0 112.812 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -50.71 -40.32 53.88 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 125.125 1.37 . . . . 0.0 109.803 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.4 t -145.8 -11.46 0.51 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.265 0.626 . . . . 0.0 111.355 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 105.46 5.49 39.62 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.598 1.57 . . . . 0.0 114.097 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -61.14 160.53 10.07 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.568 1.947 . . . . 0.0 112.637 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 20.2 mt -106.98 124.74 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.7 t -72.22 -54.72 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 118.147 -0.93 . . . . 0.0 112.642 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -125.54 103.03 7.65 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.64 1.564 . . . . 0.0 109.636 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -76.0 129.05 36.29 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -142.21 142.8 32.69 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 118.554 0.616 . . . . 0.0 109.623 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -95.92 -6.16 39.76 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.87 1.268 . . . . 0.0 111.887 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 62.7 p -63.1 -36.59 84.09 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 93.3 mt -127.66 86.42 2.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.782 1.233 . . . . 0.0 109.455 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.8 t -140.99 141.48 31.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -132.78 144.86 50.53 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.222 1.409 . . . . 0.0 110.084 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.3 mmt85 -93.39 114.19 26.54 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.937 1.295 . . . . 0.0 110.215 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.0 mp -89.85 -79.82 0.33 Allowed 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -118.58 157.23 15.33 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -133.63 88.63 33.18 Favored Pre-proline 0 N--CA 1.454 -0.258 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -77.37 172.2 16.36 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.069 2.513 . . . . 0.0 112.18 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -89.63 165.25 14.35 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 125.1 1.36 . . . . 0.0 111.659 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.95 -43.55 21.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.712 0.768 . . . . 0.0 110.708 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -78.96 130.0 35.1 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.666 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.7 p -64.88 -32.97 60.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 O-C-N 123.286 0.366 . . . . 0.0 110.149 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -67.72 -28.44 67.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.54 1.136 . . . . 0.0 112.049 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -71.81 -33.3 68.41 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -75.06 174.47 9.33 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.835 1.254 . . . . 0.0 109.251 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -143.53 149.28 37.23 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.422 ' CG ' HG22 ' A' ' 106' ' ' VAL . 41.5 m-85 -136.76 146.58 45.93 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.933 1.293 . . . . 0.0 107.966 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.99 123.35 40.18 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.816 1.246 . . . . 0.0 110.115 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 tt -86.6 106.31 17.47 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 45.2 mt -113.45 177.99 4.44 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.597 1.159 . . . . 0.0 110.689 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 181' ' ' TYR . 5.2 p90 -152.66 159.28 43.19 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 177.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -140.65 -178.42 5.51 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.43 -28.47 68.3 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 41.0 t -71.63 -56.66 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.256 1.022 . . . . 0.0 109.754 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 178.24 -173.69 46.11 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.713 ' CE2' HD22 ' A' ' 243' ' ' LEU . 2.5 m-85 -78.05 164.13 25.31 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.068 0.547 . . . . 0.0 109.726 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -164.19 170.55 16.19 Favored 'General case' 0 N--CA 1.461 0.095 0 C-N-CA 125.434 1.493 . . . . 0.0 109.076 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 5.9 mt -118.2 134.67 61.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 103.816 -2.661 . . . . 0.0 103.816 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 21.1 t -110.57 139.61 45.66 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -137.3 112.71 9.3 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 6.3 tt -101.52 140.3 20.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.8 mt -131.46 110.7 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.201 1.0 . . . . 0.0 109.853 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -101.32 -157.68 27.03 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 49.6 m 70.57 55.76 0.27 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.562 1.145 . . . . 0.0 112.205 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -114.42 -126.31 4.24 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -130.01 123.67 31.12 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.911 1.684 . . . . 0.0 107.508 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.0 mm -60.94 146.18 11.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 124.805 1.242 . . . . 0.0 111.371 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 64.4 m -105.92 91.31 3.68 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 103.776 -2.675 . . . . 0.0 103.776 177.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -49.8 -30.78 10.28 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.614 1.166 . . . . 0.0 113.11 -178.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 60.6 t -45.96 -40.2 3.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 127.168 2.187 . . . . 0.0 110.276 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 7.1 p -120.4 -27.36 5.21 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.002 0.521 . . . . 0.0 110.963 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 92.31 22.57 29.18 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.898 1.714 . . . . 0.0 110.724 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -101.6 164.49 11.73 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.666 1.233 . . . . 0.0 112.388 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -89.49 146.47 24.6 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.541 -1.209 . . . . 0.0 107.866 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -77.35 30.84 0.15 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 127.522 2.329 . . . . 0.0 111.203 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -73.61 145.01 45.74 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 1.4 p -112.4 142.3 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 C-N-CA 124.468 1.107 . . . . 0.0 110.058 -177.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -109.51 123.59 49.65 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.2 mp -115.34 121.55 67.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 124.444 1.098 . . . . 0.0 108.822 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -102.37 116.67 33.12 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.47 0.708 . . . . 0.0 109.683 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -96.02 117.94 31.65 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.918 1.287 . . . . 0.0 109.625 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 22.2 m -133.21 167.85 25.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 124.565 1.146 . . . . 0.0 112.035 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.6 t -81.19 128.49 33.83 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 177.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.6 137.11 13.07 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -51.43 -41.84 49.35 Favored Glycine 0 C--N 1.336 0.528 0 CA-C-O 119.014 -0.881 . . . . 0.0 112.385 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 4.7 m -80.71 74.9 7.63 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -71.33 30.88 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.218 2.207 . . . . 0.0 112.939 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 37.8 m -143.96 47.33 1.43 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.208 2.203 . . . . 0.0 108.242 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -155.11 164.2 31.77 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -78.25 172.76 14.88 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.874 2.382 . . . . 0.0 112.354 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 24.2 m -62.25 147.63 47.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.485 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -165.92 156.29 12.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.8 mt -87.6 127.81 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -72.43 -52.95 13.68 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.783 1.233 . . . . 0.0 110.996 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' TRP . . . . . 0.42 ' CZ2' ' HB2' ' A' ' 232' ' ' GLN . 39.9 p-90 -150.58 166.6 29.76 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.002 1.321 . . . . 0.0 109.395 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.817 HG13 ' CE1' ' A' ' 229' ' ' TYR . 40.4 t -146.46 128.42 7.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 C-N-CA 126.015 1.726 . . . . 0.0 106.795 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.414 ' HD2' ' CE3' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -146.26 124.8 12.43 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.361 0.6 . . . . 0.0 109.898 178.67 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -79.42 93.06 5.3 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 103.08 -2.933 . . . . 0.0 103.08 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.0 p -68.8 -53.59 20.81 Favored 'General case' 0 C--O 1.237 0.424 0 O-C-N 121.667 -0.646 . . . . 0.0 110.348 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -103.33 174.54 5.82 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 25.1 mm -62.94 -27.62 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 O-C-N 121.89 -0.506 . . . . 0.0 111.144 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.89 -52.68 1.99 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.778 0.831 . . . . 0.0 110.697 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 1.7 t -64.94 132.33 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.737 0.815 . . . . 0.0 109.187 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' TYR . . . . . 0.817 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.3 OUTLIER -124.49 154.77 40.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.327 1.851 . . . . 0.0 109.187 -178.985 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -131.23 137.77 49.05 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 125.937 1.695 . . . . 0.0 108.784 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -143.61 161.62 38.04 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 126.274 1.83 . . . . 0.0 110.544 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.42 ' HB2' ' CZ2' ' A' ' 220' ' ' TRP . 22.6 tt0 -137.63 143.76 41.57 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.9 m -133.69 146.59 31.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 123.808 0.843 . . . . 0.0 108.97 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.87 143.78 33.54 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.454 0.701 . . . . 0.0 110.08 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 22.9 mt -140.33 134.49 15.46 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.876 0.871 . . . . 0.0 109.135 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.12 -45.63 0.64 Allowed 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.176 1.917 . . . . 0.0 110.9 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -61.73 -21.43 64.5 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.4 mp -64.57 -36.32 83.84 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.685 1.13 . . . . 0.0 109.993 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 50.8 m -56.75 -23.53 43.49 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.022 1.729 . . . . 0.0 113.208 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -64.24 -26.98 68.74 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 121.236 -0.915 . . . . 0.0 112.769 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 28.9 mt -83.19 122.79 28.86 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -48.26 -41.27 27.26 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.95 2.1 . . . . 0.0 113.84 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.713 HD22 ' CE2' ' A' ' 181' ' ' TYR . 49.6 mt -63.52 -37.17 86.26 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.76 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 24.0 mt -97.29 6.67 47.98 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 127.19 2.196 . . . . 0.0 112.788 -177.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -80.46 54.7 2.1 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.356 1.863 . . . . 0.0 108.644 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -150.47 133.57 16.15 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.977 0.911 . . . . 0.0 109.944 -178.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -160.44 163.35 33.11 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -141.9 70.86 1.34 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.404 1.082 . . . . 0.0 109.567 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 116.316 -1.802 . . . . 0.0 107.878 178.261 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.083 0 N-CA-C 107.975 -2.05 . . . . 0.0 107.975 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.51 123.96 23.6 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.7 m -137.08 136.62 38.51 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -139.69 87.15 2.15 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.2 m -47.26 -46.87 24.93 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 124.506 1.123 . . . . 0.0 112.212 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -58.97 -40.41 84.7 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.349 0.66 . . . . 0.0 112.464 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.58 -43.92 83.63 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 119.652 1.114 . . . . 0.0 108.192 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.9 p -63.41 -36.13 82.71 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.533 0.606 . . . . 0.0 110.121 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.49 -46.21 89.5 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 59.9 tp -59.65 -49.04 79.31 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.09 0.956 . . . . 0.0 109.098 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.9 mt -59.05 -50.49 73.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.363 1.065 . . . . 0.0 109.778 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 75.0 m -55.77 -52.48 63.83 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.225 1.41 . . . . 0.0 110.231 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -64.47 -41.9 96.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.214 1.006 . . . . 0.0 110.784 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 23.9 m -55.52 -51.69 66.19 Favored 'General case' 0 CA--C 1.523 -0.089 0 C-N-CA 125.284 1.434 . . . . 0.0 109.41 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 106' ' ' VAL . 12.5 tp -56.98 -52.37 65.49 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 118.669 -0.682 . . . . 0.0 109.933 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -56.79 -50.86 71.06 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.478 0.581 . . . . 0.0 111.303 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -55.76 -38.89 70.46 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.546 1.138 . . . . 0.0 109.443 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.64 -53.26 36.17 Favored Glycine 0 N--CA 1.437 -1.25 0 CA-C-O 118.323 -1.265 . . . . 0.0 110.181 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 102' ' ' LEU . 4.1 t -55.88 -53.13 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 119.297 1.548 . . . . 0.0 110.348 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -32.55 72.46 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 118.561 0.618 . . . . 0.0 112.007 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.3 m -68.2 -51.51 44.74 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.45 HD11 HD12 ' A' ' 183' ' ' ILE . 25.4 mt -55.1 -54.26 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.97 -39.14 80.84 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.648 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -61.89 -42.05 98.61 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 118.814 0.734 . . . . 0.0 111.257 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -82.0 -8.22 59.66 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 117.586 -1.197 . . . . 0.0 113.405 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.8 mp -111.65 -33.11 6.45 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 120.941 1.7 . . . . 0.0 110.87 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -53.67 -36.64 62.37 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 122.943 0.497 . . . . 0.0 110.876 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -61.94 -42.57 99.26 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 117.627 -1.178 . . . . 0.0 113.566 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -162.38 150.18 14.18 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 126.696 1.998 . . . . 0.0 111.261 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 31.5 m -75.96 167.27 22.17 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.713 0.805 . . . . 0.0 109.554 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.8 pt -125.55 157.27 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 125.256 1.423 . . . . 0.0 108.592 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.21 168.48 22.36 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.289 0.636 . . . . 0.0 111.667 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -151.68 119.94 6.35 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 124.883 1.273 . . . . 0.0 108.433 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -87.98 102.63 14.93 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.87 67.73 6.19 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.23 -116.2 9.02 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 107.815 -2.114 . . . . 0.0 107.815 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -65.51 -33.42 75.89 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -107.59 121.62 45.04 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 119.081 0.855 . . . . 0.0 111.128 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.5 mt -95.03 150.21 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.403 ' CD1' HG11 ' A' ' 221' ' ' VAL . 45.1 m-85 -119.61 137.87 53.59 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 126.149 1.78 . . . . 0.0 106.354 178.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.19 132.19 41.26 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 125.288 1.435 . . . . 0.0 109.11 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -130.3 112.28 13.17 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 124.893 1.37 . . . . 0.0 109.859 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 6.8 m -96.04 159.38 32.36 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.006 0.922 . . . . 0.0 111.018 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -64.87 88.02 0.18 Allowed 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 123.714 2.942 . . . . 0.0 114.046 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 56.98 54.56 35.96 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.3 mt -126.49 -66.52 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.418 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 8.6 pt-20 -167.5 163.37 14.78 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.178 1.791 . . . . 0.0 108.193 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -124.62 115.75 21.3 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 101.473 -3.529 . . . . 0.0 101.473 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.4 m -130.23 155.55 41.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 123.456 0.702 . . . . 0.0 111.849 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -119.26 126.68 52.07 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 104.961 -2.236 . . . . 0.0 104.961 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -144.91 157.67 44.07 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.885 0.874 . . . . 0.0 112.339 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -89.29 154.59 19.97 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 177.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 166.25 -162.86 36.42 Favored Glycine 0 CA--C 1.521 0.426 0 O-C-N 120.282 -1.511 . . . . 0.0 111.723 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.1 131.72 45.84 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 177.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.4 p -142.43 159.45 19.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -106.26 96.27 6.35 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.711 1.605 . . . . 0.0 108.161 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.2 t -54.86 -11.56 0.64 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.647 1.579 . . . . 0.0 115.065 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.8 mmtp -71.45 -23.33 61.82 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.71 1.204 . . . . 0.0 111.982 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.5 t -146.22 -20.29 0.44 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.625 0.77 . . . . 0.0 111.191 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 97.49 11.7 50.43 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 125.177 1.37 . . . . 0.0 112.074 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -72.2 115.19 11.14 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 117.862 0.831 . . . . 0.0 110.333 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 47.6 mt -72.69 118.24 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 28.1 t -79.39 -54.03 12.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 124.636 1.175 . . . . 0.0 108.512 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -141.52 153.31 44.81 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.512 1.125 . . . . 0.0 108.603 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 29.2 ptt85 -148.93 170.48 18.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.897 2.079 . . . . 0.0 108.772 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -153.13 151.9 30.69 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -92.93 -8.15 44.06 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.309 0.643 . . . . 0.0 111.452 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.4 p -72.5 -21.5 61.19 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 83.9 mt -129.99 80.4 1.95 Allowed 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.8 t -142.63 132.76 23.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 124.983 1.313 . . . . 0.0 108.452 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -121.7 150.18 42.17 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.926 1.69 . . . . 0.0 109.872 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -101.42 117.07 34.2 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 35.0 mt -89.35 -72.92 0.53 Allowed 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -133.69 152.45 20.49 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -122.7 94.77 47.25 Favored Pre-proline 0 N--CA 1.447 -0.584 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.53 ' HB2' HH22 ' A' ' 170' ' ' ARG . 41.8 Cg_endo -79.13 179.53 6.37 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 122.559 2.173 . . . . 0.0 109.723 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -92.09 173.03 8.04 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -90.59 -41.44 11.35 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.769 0.668 . . . . 0.0 110.268 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -83.35 138.29 33.59 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 125.666 1.586 . . . . 0.0 108.504 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.44 -24.3 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -77.56 -20.73 53.63 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.834 0.853 . . . . 0.0 113.059 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -76.64 -37.28 56.59 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.787 0.804 . . . . 0.0 110.547 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.53 HH22 ' HB2' ' A' ' 163' ' ' PRO . 0.3 OUTLIER -84.72 174.4 9.94 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.531 0.732 . . . . 0.0 110.192 179.563 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -147.6 120.56 8.77 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -96.75 160.01 14.61 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -131.62 122.04 25.36 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.982 0.913 . . . . 0.0 110.966 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 22.0 tp -84.65 103.53 13.84 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.403 HD12 ' HB2' ' A' ' 184' ' ' SER . 36.0 mt -109.75 -179.84 3.92 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.134 1.374 . . . . 0.0 108.854 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.427 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 5.0 p90 -159.03 164.56 35.37 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.19 -0.944 . . . . 0.0 109.918 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -140.71 -178.29 5.46 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.1 -20.63 64.24 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.675 1.19 . . . . 0.0 110.641 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 74.0 t -79.65 -65.74 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -173.29 -172.27 38.65 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.122 1.344 . . . . 0.0 110.01 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.427 ' CD2' ' HB3' ' A' ' 176' ' ' TYR . 29.3 m-85 -83.69 164.47 19.62 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.538 0.735 . . . . 0.0 111.433 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -168.08 165.92 13.22 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.638 1.575 . . . . 0.0 109.247 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.45 HD12 HD11 ' A' ' 109' ' ' ILE . 4.8 mt -112.46 128.97 68.83 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.403 ' HB2' HD12 ' A' ' 175' ' ' LEU . 40.3 t -97.11 130.78 44.34 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 126.155 1.782 . . . . 0.0 108.205 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -138.15 107.48 6.12 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 7.6 tt -100.53 140.53 19.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 5.6 mt -131.76 111.26 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 123.72 0.808 . . . . 0.0 110.532 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.72 -161.21 25.85 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 178.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 50.6 m 71.38 50.08 0.29 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.234 1.814 . . . . 0.0 112.206 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -105.5 -95.2 2.38 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 107.514 -2.234 . . . . 0.0 107.514 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -154.48 123.78 6.45 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.553 1.541 . . . . 0.0 110.854 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.4 mm -65.6 116.87 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 119.616 1.098 . . . . 0.0 108.886 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 19.8 p -69.83 119.84 14.66 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 122.524 0.33 . . . . 0.0 110.908 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -70.72 -8.47 52.36 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.581 -0.699 . . . . 0.0 110.145 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 23.1 t -65.23 -42.93 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 126.359 1.864 . . . . 0.0 109.042 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 6.7 p -125.88 -27.88 3.27 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.948 0.795 . . . . 0.0 112.814 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 97.74 19.28 25.16 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 126.801 2.143 . . . . 0.0 110.036 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -107.25 168.3 9.31 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 119.2 1.5 . . . . 0.0 112.45 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.45 163.0 27.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 122.289 1.042 . . . . 0.0 111.401 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -99.3 29.09 4.12 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 126.514 1.926 . . . . 0.0 108.059 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -73.08 148.08 44.36 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.781 0.8 . . . . 0.0 110.433 -175.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.2 p -116.02 141.53 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.542 -177.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -110.65 124.52 52.06 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.6 mp -113.3 128.03 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 125.649 1.58 . . . . 0.0 109.059 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -108.4 107.7 18.36 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.581 1.152 . . . . 0.0 108.578 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -84.0 122.47 28.81 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 107.886 -1.154 . . . . 0.0 107.886 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 23.0 m -131.45 169.86 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 125.767 1.627 . . . . 0.0 112.527 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -83.11 144.05 30.13 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.633 -1.292 . . . . 0.0 107.735 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -113.39 123.62 6.23 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -32.04 -62.2 0.29 Allowed Glycine 0 CA--C 1.523 0.55 0 C-N-CA 128.954 3.169 . . . . 0.0 114.765 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 2.0 p -78.02 89.79 4.18 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -67.33 35.09 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.107 2.163 . . . . 0.0 115.488 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.4 m -148.5 45.82 1.04 Allowed 'General case' 0 CA--C 1.54 0.559 0 O-C-N 119.837 -1.789 . . . . 0.0 111.161 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.54 162.59 28.48 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.02 169.86 20.34 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.849 2.366 . . . . 0.0 112.036 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 10.3 m -70.7 156.09 39.93 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -168.45 155.88 7.87 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.8 mt -77.73 134.17 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -74.14 -61.43 1.86 Allowed 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 41.7 p-90 -140.25 166.47 24.61 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 125.812 1.645 . . . . 0.0 109.121 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.586 HG13 ' CE1' ' A' ' 229' ' ' TYR . 53.3 t -147.5 134.6 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.19 131.35 11.08 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -85.69 86.37 7.37 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 101.629 -3.471 . . . . 0.0 101.629 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 8.6 p -61.2 -58.09 9.73 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.88 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 56.3 mmtt -91.61 -172.82 3.35 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.7 mp -74.54 -36.61 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 121.021 -1.049 . . . . 0.0 109.492 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 4.6 m -120.91 -43.08 2.47 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.468 0.707 . . . . 0.0 111.835 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 1.1 t -67.7 136.11 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' TYR . . . . . 0.586 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.7 OUTLIER -124.11 148.02 47.48 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.41 2.284 . . . . 0.0 110.011 -178.01 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -126.18 138.21 53.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.369 2.268 . . . . 0.0 106.655 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.95 161.98 38.84 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.943 1.697 . . . . 0.0 111.065 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -138.35 149.67 45.82 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.453 0.701 . . . . 0.0 109.962 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 72.2 t -133.18 135.96 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.593 1.157 . . . . 0.0 109.306 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.37 130.0 53.57 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.171 1.389 . . . . 0.0 111.26 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 33.4 mt -133.56 138.49 31.29 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-O 118.612 -0.708 . . . . 0.0 110.522 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.76 -43.9 1.63 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.213 2.609 . . . . 0.0 112.467 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -63.57 -20.44 65.64 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 37.1 mt -72.01 -35.28 69.38 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-O 118.828 -0.606 . . . . 0.0 110.037 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 48.2 m -56.3 -21.67 25.53 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.393 1.477 . . . . 0.0 113.149 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -65.98 -31.39 72.27 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.626 0.77 . . . . 0.0 112.115 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 64.4 mt -77.02 116.46 17.7 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -48.1 -37.12 14.56 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.5 mp -63.73 -36.76 84.94 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.01 -1.056 . . . . 0.0 110.028 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -91.87 3.21 55.69 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.746 2.019 . . . . 0.0 112.704 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -78.21 34.05 0.2 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.779 0.832 . . . . 0.0 111.002 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -153.04 128.04 9.66 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.796 1.638 . . . . 0.0 109.46 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -170.81 162.03 7.43 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.954 1.702 . . . . 0.0 107.751 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 53.36 33.63 16.18 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.608 1.163 . . . . 0.0 112.926 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.986 0 C-N-CA 127.523 2.329 . . . . 0.0 113.323 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.469 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.59 164.38 25.0 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 117.919 0.859 . . . . 0.0 110.537 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.6 p -156.19 171.27 20.46 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 125.877 1.671 . . . . 0.0 108.479 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -137.2 153.59 50.38 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.452 1.501 . . . . 0.0 108.109 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.9 m -45.09 -44.75 10.62 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 128.472 2.709 . . . . 0.0 114.45 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -60.56 -45.2 94.79 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 121.872 -0.517 . . . . 0.0 111.316 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -73.9 -44.75 54.2 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.167 0.587 . . . . 0.0 110.588 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 43.4 p -61.53 -35.91 79.07 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 118.52 0.6 . . . . 0.0 110.243 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.94 -48.81 75.05 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.908 0.883 . . . . 0.0 108.774 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 41.6 tp -57.71 -46.76 83.95 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.9 mt -59.1 -53.22 60.79 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.458 0.703 . . . . 0.0 109.704 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 38.6 m -55.1 -43.64 74.21 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.132 1.373 . . . . 0.0 110.803 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.75 -51.52 33.38 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 117.843 -1.075 . . . . 0.0 109.013 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 42.0 m -54.36 -44.26 72.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 119.701 1.137 . . . . 0.0 110.971 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.3 tp -60.12 -55.51 32.96 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 118.686 0.675 . . . . 0.0 109.612 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -56.72 -49.55 74.84 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.779 1.232 . . . . 0.0 110.598 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -57.35 -49.81 74.95 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.722 1.209 . . . . 0.0 108.543 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.78 -46.45 94.48 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 49.9 t -58.8 -52.23 62.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 C-N-CA 126.096 1.758 . . . . 0.0 111.133 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -32.66 74.45 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 119.552 1.069 . . . . 0.0 109.732 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.5 m -66.85 -43.27 84.11 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 34.7 mt -59.16 -51.89 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -35.68 72.27 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.98 -0.533 . . . . 0.0 111.297 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -66.89 -56.56 9.73 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.244 0.929 . . . . 0.0 109.953 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.89 -24.12 66.74 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -178.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 80.5 mt -94.31 -27.93 15.84 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 119.045 0.839 . . . . 0.0 109.955 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -64.1 -27.33 69.02 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 121.663 -0.648 . . . . 0.0 109.709 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -63.74 -46.89 83.3 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.346 1.058 . . . . 0.0 109.012 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -163.37 156.46 18.87 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 126.073 1.749 . . . . 0.0 110.487 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 76.8 m -75.84 176.2 8.03 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 34.1 pt -135.58 149.78 28.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.69 168.13 20.92 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.091 0.556 . . . . 0.0 111.337 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -154.96 128.54 8.55 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.339 1.056 . . . . 0.0 112.16 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -92.45 102.61 15.07 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.4 0.68 . . . . 0.0 109.35 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.92 67.63 8.23 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.461 1.904 . . . . 0.0 106.558 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 67.21 -115.36 7.08 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -68.25 -33.22 73.98 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 118.789 -0.624 . . . . 0.0 112.188 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -106.25 154.18 21.1 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 119.794 1.179 . . . . 0.0 111.603 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.7 mt -121.36 149.94 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.529 ' CD1' HG11 ' A' ' 221' ' ' VAL . 53.1 m-85 -126.76 129.08 47.66 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 127.014 2.125 . . . . 0.0 107.993 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -125.3 125.21 43.16 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 127.104 2.162 . . . . 0.0 109.13 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -122.68 126.67 48.05 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.978 1.311 . . . . 0.0 109.637 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.445 ' HB3' HD12 ' A' ' 133' ' ' ILE . 17.8 m -113.72 157.24 42.19 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.641 0.776 . . . . 0.0 112.77 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -60.29 90.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.354 0.845 1 C-N-CA 126.163 4.575 . . . . 0.0 115.976 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 62.21 31.05 77.71 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.874 -0.491 . . . . 0.0 111.874 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.445 HD12 ' HB3' ' A' ' 130' ' ' CYS . 4.9 mt -110.64 -66.08 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.252 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.52 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 9.4 pt-20 179.67 164.74 1.08 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.753 1.621 . . . . 0.0 109.689 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.35 123.12 38.7 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.2 m -131.23 155.85 42.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 124.385 1.074 . . . . 0.0 111.747 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -123.29 122.72 39.04 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.908 1.683 . . . . 0.0 108.144 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -146.45 156.71 43.49 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.364 1.066 . . . . 0.0 111.404 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -93.15 153.53 18.59 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 168.18 -163.71 37.39 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -116.18 142.9 46.21 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.9 p -154.79 140.67 11.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 124.004 0.922 . . . . 0.0 108.886 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -82.78 95.85 8.02 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.0 t -56.54 -17.22 7.72 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.102 1.319 . . . . 0.0 112.479 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -62.78 -23.56 67.28 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.835 2.454 . . . . 0.0 112.654 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.439 HG23 ' H ' ' A' ' 148' ' ' GLU . 1.5 t -141.77 -33.09 0.51 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.215 1.406 . . . . 0.0 110.79 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 106.99 0.64 35.98 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.963 1.744 . . . . 0.0 110.371 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.439 ' H ' HG23 ' A' ' 146' ' ' THR . 77.3 mt-10 -63.89 113.07 3.21 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.434 1.617 . . . . 0.0 110.415 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.3 mt -71.57 139.31 20.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 103.66 -2.719 . . . . 0.0 103.66 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 15.0 t -103.3 -36.16 4.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 123.748 0.819 . . . . 0.0 110.71 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -147.43 126.94 13.22 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 119.199 0.908 . . . . 0.0 109.057 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -108.05 104.68 14.17 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.115 1.766 . . . . 0.0 108.424 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.33 150.76 46.98 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.193 0.997 . . . . 0.0 109.362 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -97.41 -22.81 16.39 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 118.271 2.693 . . . . 0.0 118.271 -178.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 10.5 t -96.67 -43.03 7.73 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 120.559 1.527 . . . . 0.0 112.091 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 76.9 mt -83.24 72.43 10.17 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 41.9 t -137.96 138.12 44.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -141.56 153.51 44.88 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.364 1.465 . . . . 0.0 108.33 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -109.88 127.92 55.02 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.508 1.523 . . . . 0.0 110.513 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -90.66 -71.16 0.64 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -133.59 160.66 24.08 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 124.137 0.875 . . . . 0.0 111.759 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -130.36 90.6 40.91 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 126.167 1.787 . . . . 0.0 107.879 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.52 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 54.6 Cg_endo -75.95 -175.55 2.56 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 124.471 3.447 . . . . 0.0 110.288 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -110.75 161.19 16.03 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.915 0.886 . . . . 0.0 110.314 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.15 -29.55 57.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.731 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -99.11 133.79 42.89 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.6 p -67.18 -26.43 36.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 122.917 0.487 . . . . 0.0 110.349 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -74.0 -16.19 61.07 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.145 1.778 . . . . 0.0 112.548 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -91.94 -13.69 30.74 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.63 1.572 . . . . 0.0 108.744 177.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -107.15 175.25 5.56 Favored 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 126.961 2.104 . . . . 0.0 107.786 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -148.07 152.34 37.2 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -138.6 165.52 26.68 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.784 1.234 . . . . 0.0 107.819 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -139.37 122.59 16.97 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.477 1.111 . . . . 0.0 109.296 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 25.7 tp -88.89 100.16 12.96 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 54.1 mt -106.29 -179.55 3.97 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.281 2.233 . . . . 0.0 110.504 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -156.54 151.8 26.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.137 0.975 . . . . 0.0 109.035 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -134.32 -174.54 3.59 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.066 1.746 . . . . 0.0 106.621 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -54.87 -31.4 59.7 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.997 2.119 . . . . 0.0 112.035 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 73.0 t -69.81 -67.53 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -177.61 -163.6 29.71 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.534 ' CE2' HD22 ' A' ' 243' ' ' LEU . 3.3 m-85 -78.19 160.95 27.68 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.421 0.688 . . . . 0.0 109.397 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -165.84 168.4 15.97 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.27 1.428 . . . . 0.0 109.453 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.0 mt -117.45 124.85 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.3 t -102.16 133.44 47.01 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -137.04 111.57 8.63 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.6 tt -101.1 127.82 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 5.8 mt -120.39 114.13 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.29 1.036 . . . . 0.0 111.522 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.0 -172.81 27.64 Favored Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 125.17 1.367 . . . . 0.0 111.455 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.2 t 84.57 58.52 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 128.242 2.617 . . . . 0.0 110.808 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -110.23 -127.4 5.28 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 107.656 -2.178 . . . . 0.0 107.656 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -126.82 118.79 25.34 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 19.1 mm -59.82 134.53 25.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 18.9 p -89.25 106.73 18.63 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -63.66 -12.22 32.18 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 119.104 0.865 . . . . 0.0 110.385 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 29.0 t -60.73 -42.01 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 126.937 2.095 . . . . 0.0 109.767 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 3.5 p -125.23 -24.06 4.05 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.856 0.753 . . . . 0.0 112.504 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 87.51 29.31 22.08 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 108.499 -1.84 . . . . 0.0 108.499 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -108.15 164.55 12.2 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 122.545 1.165 . . . . 0.0 111.283 178.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -91.51 138.41 31.59 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 1.8 mtt85 -70.69 29.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 129.921 3.288 . . . . 0.0 112.784 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 16.0 ptt? -72.46 148.81 44.77 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.018 0.913 . . . . 0.0 110.552 -174.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -115.91 143.39 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.369 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -108.26 133.61 52.25 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.41 110.17 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -95.21 108.4 20.53 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.656 0.782 . . . . 0.0 109.814 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -84.68 126.85 33.73 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.054 0.542 . . . . 0.0 109.726 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 32.3 m -139.27 175.65 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 125.877 1.671 . . . . 0.0 112.315 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.9 t -93.0 126.16 37.94 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.533 1.533 . . . . 0.0 107.563 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.12 164.82 44.57 Favored Glycine 0 N--CA 1.467 0.756 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -54.12 -76.12 0.2 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 125.094 1.33 . . . . 0.0 110.394 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 47.8 m -70.85 145.73 50.08 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 34.0 p30 -117.26 33.26 5.71 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 29.6 m -134.78 47.33 2.38 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.733 1.213 . . . . 0.0 113.433 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -153.54 165.71 31.53 Favored Glycine 0 CA--C 1.524 0.615 0 O-C-N 120.451 -1.405 . . . . 0.0 110.333 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -70.82 163.99 37.18 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.038 1.825 . . . . 0.0 110.327 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 14.1 p -67.24 155.83 37.86 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.236 1.014 . . . . 0.0 109.137 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -169.02 159.42 9.25 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.67 1.188 . . . . 0.0 108.711 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.6 mp -76.74 134.03 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -78.11 -55.34 5.36 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 125.973 1.709 . . . . 0.0 109.934 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' TRP . . . . . 0.402 ' CE3' ' CD ' ' A' ' 222' ' ' ARG . 27.9 p-90 -145.69 165.05 29.9 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 124.755 1.222 . . . . 0.0 108.686 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.766 HG13 ' CE1' ' A' ' 229' ' ' TYR . 39.0 t -144.47 127.39 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.402 ' CD ' ' CE3' ' A' ' 220' ' ' TRP . 0.3 OUTLIER -153.82 118.69 5.01 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 124.107 0.879 . . . . 0.0 109.189 179.355 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -74.64 95.2 2.79 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 102.626 -3.102 . . . . 0.0 102.626 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.7 p -63.73 -57.77 8.95 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.81 0.844 . . . . 0.0 111.69 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -100.87 -178.51 3.79 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.435 ' H ' HD12 ' A' ' 226' ' ' ILE . 4.4 mp -58.2 -41.55 81.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 O-C-N 121.79 -0.569 . . . . 0.0 110.022 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -123.52 -10.1 7.93 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -177.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 59.0 t -91.74 130.5 40.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' TYR . . . . . 0.766 ' CE1' HG13 ' A' ' 221' ' ' VAL . 1.1 t80 -123.38 143.51 50.07 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.218 1.007 . . . . 0.0 108.354 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -127.3 140.92 51.87 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 125.609 1.564 . . . . 0.0 107.451 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -139.7 159.04 43.09 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.272 1.829 . . . . 0.0 108.042 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -131.48 144.62 51.28 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 99.6 t -132.55 133.44 59.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.2 p -104.66 141.0 37.22 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 43.6 mt -137.36 137.12 21.55 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -72.99 -39.28 2.35 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.065 1.843 . . . . 0.0 112.127 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -60.52 -34.61 74.35 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.587 0.63 . . . . 0.0 111.338 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 5.1 mp -59.45 -29.95 68.15 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-O 118.745 -0.645 . . . . 0.0 111.428 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 57.2 m -63.57 -19.35 64.75 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.935 0.894 . . . . 0.0 112.618 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -67.46 -38.58 84.66 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.169 0.588 . . . . 0.0 111.086 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 49.6 mt -67.0 117.45 9.08 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.352 1.061 . . . . 0.0 108.539 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -48.36 -37.87 17.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.347 1.459 . . . . 0.0 114.874 -178.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.534 HD22 ' CE2' ' A' ' 181' ' ' TYR . 17.9 mt -62.72 -33.55 75.35 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.578 -0.702 . . . . 0.0 110.015 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -98.21 2.42 48.35 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.986 2.115 . . . . 0.0 113.064 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -81.48 49.41 1.3 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.534 1.134 . . . . 0.0 107.998 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -155.17 140.11 17.29 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 131.383 3.873 . . . . 0.0 106.478 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -167.77 167.96 12.76 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 127.859 2.463 . . . . 0.0 106.209 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -142.75 55.92 1.41 Allowed 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 27.1 t70 . . . . . 0 C--O 1.252 1.209 0 O-C-N 120.872 -1.143 . . . . 0.0 109.882 179.264 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.768 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -111.19 165.9 11.53 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.728 1.611 . . . . 0.0 110.496 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.0 p -98.52 -29.56 13.02 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.664 0.786 . . . . 0.0 110.699 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -145.7 119.52 9.27 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 72.0 m -53.67 -52.88 58.57 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.462 0.705 . . . . 0.0 111.361 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -53.24 -46.25 69.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.802 1.241 . . . . 0.0 111.409 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -58.79 -51.04 71.68 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 122.797 0.439 . . . . 0.0 110.246 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.9 p -62.82 -39.82 95.51 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 117.652 0.206 . . . . 0.0 111.221 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.68 -45.21 91.13 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.479 -0.763 . . . . 0.0 108.971 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 45.8 tp -58.42 -44.79 89.22 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.707 1.203 . . . . 0.0 108.434 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 11.5 mt -64.05 -54.92 26.59 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.238 1.015 . . . . 0.0 110.184 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.3 m -57.14 -44.24 83.19 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.03 -1.044 . . . . 0.0 110.784 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -62.31 -50.46 71.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 120.977 -1.077 . . . . 0.0 108.441 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.0 m -56.0 -40.77 73.85 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.144 0.977 . . . . 0.0 110.477 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.503 ' O ' HG23 ' A' ' 106' ' ' VAL . 13.6 tp -62.29 -53.33 56.64 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.726 0.694 . . . . 0.0 109.136 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -58.34 -48.33 80.9 Favored 'General case' 0 C--N 1.335 -0.064 0 C-N-CA 123.43 0.692 . . . . 0.0 110.616 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -60.86 -42.88 98.73 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.374 1.47 . . . . 0.0 110.269 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.11 -47.11 85.13 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 102' ' ' LEU . 94.5 t -57.87 -53.07 50.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 118.566 1.183 . . . . 0.0 110.125 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -31.4 72.55 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 119.177 0.899 . . . . 0.0 110.488 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.6 m -65.75 -48.11 72.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 40.8 mt -58.78 -53.02 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 C-N-CA 123.886 0.875 . . . . 0.0 108.805 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.47 -36.57 73.92 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.326 0.512 . . . . 0.0 111.31 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -63.58 -54.5 35.0 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.536 1.062 . . . . 0.0 108.318 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.21 10.59 0.55 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 128.399 2.68 . . . . 0.0 114.825 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.6 mt -132.68 -32.85 1.25 Allowed 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 124.636 1.174 . . . . 0.0 108.278 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -61.39 -34.43 75.33 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -59.14 -45.05 91.95 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.92 1.688 . . . . 0.0 111.922 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -166.72 153.04 8.52 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.593 1.957 . . . . 0.0 109.683 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.0 m -76.48 174.76 9.9 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 27.5 pt -131.66 152.16 36.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -146.75 165.05 30.82 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 122.91 0.484 . . . . 0.0 110.786 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -150.34 128.48 11.95 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.539 1.536 . . . . 0.0 110.595 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -94.27 102.8 14.82 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.463 1.105 . . . . 0.0 109.707 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.77 66.87 6.16 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.52 -115.47 7.67 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -63.6 -35.26 79.92 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.325 1.05 . . . . 0.0 112.213 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -107.14 153.45 22.63 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 119.211 0.914 . . . . 0.0 110.502 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.2 mt -119.92 152.68 22.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -124.97 132.47 53.27 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 127.182 2.193 . . . . 0.0 107.31 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -126.96 132.93 50.71 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 125.87 1.668 . . . . 0.0 107.376 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -129.49 111.52 12.84 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 6.6 m -100.37 159.0 30.92 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 123.814 0.846 . . . . 0.0 111.236 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -61.46 92.97 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 124.442 3.428 . . . . 0.0 114.121 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 54.95 39.28 67.97 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.062 -0.854 . . . . 0.0 112.217 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.4 mt -109.9 -66.94 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.412 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 9.7 pt-20 -171.32 161.34 6.47 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.982 1.713 . . . . 0.0 106.917 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -119.91 121.7 39.6 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 101.625 -3.472 . . . . 0.0 101.625 177.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.1 m -137.39 155.06 31.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 123.506 0.722 . . . . 0.0 111.725 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -119.91 132.6 55.59 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 177.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -146.34 158.19 43.86 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.235 1.014 . . . . 0.0 113.032 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -88.8 148.46 23.9 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 165.64 -162.93 36.3 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -178.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.95 147.04 50.81 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 124.497 1.119 . . . . 0.0 108.186 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.2 p -152.81 162.74 2.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 124.988 1.315 . . . . 0.0 107.813 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -105.82 107.41 18.39 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.923 1.689 . . . . 0.0 107.122 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.1 t -62.49 -22.47 66.29 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 121.051 1.751 . . . . 0.0 110.827 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -58.1 -25.18 61.04 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.515 1.526 . . . . 0.0 114.154 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.9 t -146.68 -23.6 0.42 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.33 0.968 . . . . 0.0 111.558 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 101.52 6.91 49.71 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.863 1.697 . . . . 0.0 110.052 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -67.26 114.85 6.31 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 118.897 1.349 . . . . 0.0 110.927 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 56.3 mt -71.74 158.34 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 19.4 t -135.58 -34.67 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 O-C-N 120.955 -1.091 . . . . 0.0 110.998 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -131.4 122.96 27.21 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 104.262 -2.496 . . . . 0.0 104.262 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -141.33 54.51 1.54 Allowed 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.163 1.385 . . . . 0.0 111.27 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -59.46 120.62 9.71 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.225 1.41 . . . . 0.0 110.196 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -69.87 1.86 4.01 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.22 -10.24 59.64 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.357 -1.465 . . . . 0.0 112.699 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 43.3 mt -136.45 77.97 1.68 Allowed 'General case' 0 C--O 1.231 0.096 0 C-N-CA 124.053 0.941 . . . . 0.0 108.733 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 12.2 t -140.91 135.44 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.924 1.29 . . . . 0.0 109.351 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -119.64 176.27 5.46 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.735 1.214 . . . . 0.0 110.972 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -128.31 120.31 26.82 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 26.2 mt -96.77 -67.37 0.85 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.738 1.215 . . . . 0.0 109.807 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -127.25 149.2 17.73 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 189' ' ' SER . 26.7 tttp -124.89 83.54 59.59 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 125.969 1.708 . . . . 0.0 108.261 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 63.8 Cg_endo -75.58 173.61 14.2 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.403 2.069 . . . . 0.0 109.928 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -92.89 161.57 14.43 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.554 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -80.68 -22.98 39.91 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.742 0.817 . . . . 0.0 112.929 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -112.35 147.51 36.22 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.157 0.983 . . . . 0.0 108.456 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.2 p -71.25 -32.14 46.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -74.14 -12.87 60.72 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -177.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -84.68 -18.67 34.56 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.474 0.309 . . . . 0.0 110.289 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -111.84 171.84 7.25 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.662 1.185 . . . . 0.0 111.983 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -138.69 117.14 12.03 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.445 1.098 . . . . 0.0 109.471 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.408 ' CD2' HG22 ' A' ' 106' ' ' VAL . 3.3 m-30 -96.76 158.29 15.5 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -130.55 126.6 37.18 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.081 0.553 . . . . 0.0 112.159 -177.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.2 tt -90.28 101.8 14.52 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.332 0.653 . . . . 0.0 110.504 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 5.2 mt -115.03 174.81 5.79 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.87 1.668 . . . . 0.0 108.333 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -143.02 163.96 31.37 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 120.345 -1.472 . . . . 0.0 109.069 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -137.94 -176.38 4.41 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.902 1.681 . . . . 0.0 110.388 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -69.39 5.28 1.37 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.401 1.88 . . . . 0.0 115.076 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 41.5 t -118.9 -63.98 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -162.51 -160.86 11.47 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 119.812 1.187 . . . . 0.0 111.888 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.547 ' CE2' HD22 ' A' ' 243' ' ' LEU . 3.1 m-85 -91.13 160.85 15.36 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -164.84 171.88 13.61 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 7.4 mt -121.07 133.57 67.28 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 4.4 t -111.13 132.11 54.55 Favored 'General case' 0 N--CA 1.439 -1.002 0 O-C-N 124.579 1.175 . . . . 0.0 108.752 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -133.64 111.57 10.72 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.8 tt -96.79 132.78 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.5 mt -124.32 111.4 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 124.501 1.121 . . . . 0.0 111.03 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -103.34 -158.54 25.01 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.468 ' HB3' ' HB3' ' A' ' 162' ' ' LYS . 1.6 t 70.69 28.29 3.5 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 127.062 2.145 . . . . 0.0 112.286 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -81.28 -90.45 0.56 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 103.611 -3.796 . . . . 0.0 103.611 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -157.14 165.97 34.54 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 29.2 mm -94.36 145.5 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 126.235 1.814 . . . . 0.0 108.448 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.8 p -107.71 98.41 8.01 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 106.114 -1.809 . . . . 0.0 106.114 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -63.22 -7.62 6.42 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 120.28 1.4 . . . . 0.0 112.444 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 86.0 t -63.65 -38.43 82.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 126.499 1.92 . . . . 0.0 108.147 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 21.0 p -119.45 -32.5 4.32 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.213 1.005 . . . . 0.0 110.539 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 88.72 32.95 10.47 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -118.01 -176.93 3.15 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.643 1.577 . . . . 0.0 109.116 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -102.89 148.34 25.77 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.878 0.871 . . . . 0.0 110.228 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.04 29.62 0.08 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 129.317 3.047 . . . . 0.0 111.312 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -72.74 151.48 42.12 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 120.819 -1.176 . . . . 0.0 110.967 -174.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.3 p -121.95 149.12 25.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.771 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -114.95 130.35 56.9 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.6 mp -117.63 111.91 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -96.04 108.39 20.8 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.651 1.18 . . . . 0.0 108.835 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -87.83 121.15 29.9 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.115 0.966 . . . . 0.0 111.677 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.71 163.86 36.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 126.085 1.754 . . . . 0.0 111.002 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.17 139.8 40.01 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -94.85 178.23 36.11 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -89.77 -39.14 6.29 Favored Glycine 0 CA--C 1.525 0.699 0 O-C-N 121.909 -0.759 . . . . 0.0 111.513 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.8 t -82.62 94.8 7.61 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.48 ' HA ' ' HB3' ' A' ' 236' ' ' PRO . 5.6 p30 -77.64 39.8 0.28 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.066 0.546 . . . . 0.0 111.246 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 41.0 p -156.7 26.26 0.33 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -138.18 176.99 20.39 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 118.676 0.671 . . . . 0.0 112.562 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.47 164.33 28.7 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.298 2.666 . . . . 0.0 112.098 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 8.6 t -70.91 159.58 34.41 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.89 161.85 7.22 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 126.079 1.752 . . . . 0.0 107.452 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.8 mp -82.2 130.08 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -71.15 -59.22 2.89 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.539 1.135 . . . . 0.0 110.351 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 29.6 p-90 -143.55 166.04 25.92 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 125.244 1.418 . . . . 0.0 108.552 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.653 HG13 ' CE1' ' A' ' 229' ' ' TYR . 42.7 t -145.55 127.74 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.82 118.23 8.48 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 177.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -77.81 91.27 4.1 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 101.002 -3.703 . . . . 0.0 101.002 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.7 p -56.75 -53.13 61.37 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.871 1.669 . . . . 0.0 113.513 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.495 ' HB2' ' H ' ' A' ' 228' ' ' VAL . 71.6 mmtt -116.14 176.63 5.01 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 16.9 mm -61.72 -30.52 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -122.69 -24.28 4.92 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.495 ' H ' ' HB2' ' A' ' 225' ' ' LYS . 21.8 t -90.28 135.67 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' TYR . . . . . 0.653 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.8 OUTLIER -131.81 142.13 49.64 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -179.517 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -127.17 140.04 52.53 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 125.111 1.364 . . . . 0.0 108.615 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -140.72 159.12 42.88 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.462 1.505 . . . . 0.0 109.042 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -130.56 139.63 50.46 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 79.7 t -122.06 146.74 26.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 124.503 1.121 . . . . 0.0 108.313 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.52 130.4 54.23 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 123.122 0.569 . . . . 0.0 109.98 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 63.4 mt -132.19 137.94 31.18 Favored Pre-proline 0 C--O 1.236 0.383 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.193 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.48 ' HB3' ' HA ' ' A' ' 212' ' ' ASN . 81.3 Cg_endo -74.89 -44.88 0.32 Allowed 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.188 1.926 . . . . 0.0 112.478 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.84 -25.76 21.15 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.681 1.192 . . . . 0.0 113.261 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 88.6 mt -67.49 -34.38 77.02 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-N 118.651 0.659 . . . . 0.0 112.762 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 19.0 m -57.66 -17.75 16.6 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.879 1.272 . . . . 0.0 114.312 -178.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -64.12 -29.02 70.17 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.941 -0.475 . . . . 0.0 110.363 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 30.0 mt -80.29 113.44 18.47 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -49.61 -30.74 9.31 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.547 HD22 ' CE2' ' A' ' 181' ' ' TYR . 17.5 mt -62.74 -36.18 82.18 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.756 -0.59 . . . . 0.0 109.535 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -95.28 2.96 54.96 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 126.888 2.075 . . . . 0.0 114.586 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -73.09 59.68 0.53 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.58 1.952 . . . . 0.0 109.101 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -134.1 153.23 51.94 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 128.757 2.823 . . . . 0.0 109.804 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 39.9 m-20 53.0 36.05 21.03 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.135 2.174 . . . . 0.0 111.557 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -112.79 -3.39 14.2 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 129.363 3.065 . . . . 0.0 111.797 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 . . . . . 0 C--O 1.245 0.853 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.16 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.185 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.35 164.32 30.16 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.3 p -141.14 104.83 4.71 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 58.77 10.58 1.52 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.6 m -49.77 -49.05 49.9 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 125.146 1.378 . . . . 0.0 111.945 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -62.69 -15.07 50.85 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -91.18 -53.7 4.25 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.4 p -59.34 -36.46 75.74 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.858 -0.591 . . . . 0.0 110.774 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.48 -45.56 92.48 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.001 0.819 . . . . 0.0 110.03 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.7 tp -60.95 -40.66 94.16 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 118.947 0.794 . . . . 0.0 109.449 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.4 mt -60.65 -54.38 46.02 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 55.9 m -54.2 -44.88 72.0 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.499 1.12 . . . . 0.0 111.534 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.2 ttmt -62.78 -50.99 68.85 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 m -56.88 -42.91 80.68 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 117.815 -1.088 . . . . 0.0 111.156 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.438 ' O ' HG23 ' A' ' 106' ' ' VAL . 20.9 tp -62.66 -53.48 53.93 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 119.881 1.219 . . . . 0.0 109.504 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -55.38 -52.41 63.62 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 123.91 0.884 . . . . 0.0 111.198 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -55.22 -50.48 69.31 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 125.008 1.323 . . . . 0.0 108.496 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.421 ' HA3' HD11 ' A' ' 183' ' ' ILE . . . -58.05 -50.27 67.57 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 123.91 0.767 . . . . 0.0 112.081 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 102' ' ' LEU . 89.9 t -59.18 -53.23 50.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 124.215 1.006 . . . . 0.0 110.136 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -30.86 71.9 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 118.983 0.811 . . . . 0.0 110.6 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.4 m -66.49 -45.15 80.6 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.426 HD11 HD12 ' A' ' 183' ' ' ILE . 31.0 mt -58.28 -53.84 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.21 -37.59 83.53 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.183 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -60.74 -44.46 96.63 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.215 1.006 . . . . 0.0 109.472 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.86 -19.29 44.81 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 71.0 mt -100.74 -25.06 14.26 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 121.132 1.787 . . . . 0.0 112.793 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -59.36 -21.12 59.37 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -71.2 -46.09 61.98 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.77 2.428 . . . . 0.0 110.542 179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -162.28 153.29 17.68 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 125.558 1.543 . . . . 0.0 112.456 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.6 m -76.36 159.92 30.06 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 175.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 24.7 pt -117.63 154.64 19.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -147.09 165.86 28.66 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.294 0.569 . . . . 0.0 111.217 -178.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -151.1 134.56 16.23 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.094 1.357 . . . . 0.0 109.555 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -97.45 105.39 17.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 123.52 0.728 . . . . 0.0 109.813 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.84 67.33 9.79 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.104 1.361 . . . . 0.0 107.609 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 69.76 -115.18 6.07 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -66.83 -32.4 73.66 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.028 1.331 . . . . 0.0 112.679 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -106.09 162.84 13.26 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 119.036 0.835 . . . . 0.0 111.89 -177.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 45.3 mt -130.66 149.43 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -125.49 129.81 50.53 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.182 2.193 . . . . 0.0 108.255 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -125.98 129.6 49.54 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.333 1.853 . . . . 0.0 109.392 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -124.03 117.16 24.08 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.941 1.696 . . . . 0.0 109.666 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 19.8 m -99.35 159.7 29.43 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.574 1.15 . . . . 0.0 111.056 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -62.78 87.24 0.11 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 124.797 3.665 . . . . 0.0 113.687 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 57.61 45.77 92.85 Favored Glycine 0 CA--C 1.527 0.814 0 O-C-N 121.201 -0.937 . . . . 0.0 112.0 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.5 mt -118.26 -66.74 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 118.607 1.203 . . . . 0.0 108.435 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -166.02 159.81 15.93 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 126.954 2.102 . . . . 0.0 107.885 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -123.92 117.65 25.27 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 102.072 -3.307 . . . . 0.0 102.072 177.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.0 m -128.9 156.24 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.43 1.092 . . . . 0.0 111.979 -178.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -127.26 127.51 44.5 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 178.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -146.4 159.4 43.43 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.201 1.4 . . . . 0.0 113.04 -178.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -88.7 153.58 20.98 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 177.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 163.2 -163.81 35.7 Favored Glycine 0 C--O 1.241 0.579 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -178.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.53 139.28 53.33 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 126.102 1.761 . . . . 0.0 106.607 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.5 p -146.12 147.56 18.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.56 96.44 10.08 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 104.274 -2.491 . . . . 0.0 104.274 178.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.5 t -54.12 -24.75 18.92 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 120.436 1.471 . . . . 0.0 111.126 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -59.91 -22.74 62.81 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 129.59 3.156 . . . . 0.0 114.7 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.418 HG23 ' H ' ' A' ' 148' ' ' GLU . 6.4 t -142.96 -24.14 0.62 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.488 1.115 . . . . 0.0 111.036 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 100.4 -3.9 56.68 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 127.105 2.288 . . . . 0.0 111.737 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.418 ' H ' HG23 ' A' ' 146' ' ' THR . 39.2 mt-10 -70.41 115.68 9.87 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 124.12 0.968 . . . . 0.0 112.998 -178.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.66 140.11 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 39.7 t -99.71 -43.18 11.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 124.751 1.22 . . . . 0.0 108.095 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -167.32 161.13 14.04 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 126.025 1.73 . . . . 0.0 108.009 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -150.47 168.25 24.75 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.64 1.976 . . . . 0.0 106.756 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -121.54 154.09 37.13 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -93.38 -10.68 34.41 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.432 0.693 . . . . 0.0 110.911 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.29 -24.78 32.05 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.968 -1.082 . . . . 0.0 113.097 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.5 mt -117.88 80.93 1.58 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.146 1.378 . . . . 0.0 109.252 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.3 t -142.73 142.41 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 123.508 0.723 . . . . 0.0 109.88 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -139.95 159.26 42.59 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.367 1.467 . . . . 0.0 109.197 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.2 124.99 51.64 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.99 -62.54 1.54 Allowed 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 124.631 1.172 . . . . 0.0 109.557 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -139.92 158.29 25.66 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.9 ttpp -126.03 89.7 51.79 Favored Pre-proline 0 N--CA 1.452 -0.334 0 C-N-CA 124.875 1.27 . . . . 0.0 108.467 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -75.4 177.36 8.75 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.982 2.455 . . . . 0.0 109.502 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -91.63 155.57 18.24 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 121.788 -0.57 . . . . 0.0 111.588 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.42 -24.15 61.19 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 125.036 1.334 . . . . 0.0 113.277 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -109.61 148.49 31.21 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.753 1.621 . . . . 0.0 108.777 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.1 p -73.32 -32.87 39.16 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 C-N-CA 121.987 0.115 . . . . 0.0 111.267 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -72.95 -21.98 60.78 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 120.454 -1.404 . . . . 0.0 113.465 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -79.68 -17.72 53.01 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.295 0.638 . . . . 0.0 111.626 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.96 176.56 5.23 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.245 1.018 . . . . 0.0 111.15 178.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -146.76 137.1 23.67 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.712 1.205 . . . . 0.0 108.612 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.401 ' CD2' HG22 ' A' ' 106' ' ' VAL . 3.5 m-30 -127.05 159.67 33.44 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.706 2.803 . . . . 0.0 106.777 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -136.08 131.65 35.12 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.276 0.63 . . . . 0.0 112.165 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 35.2 tp -85.23 101.65 12.68 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.613 1.565 . . . . 0.0 108.413 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.43 HD12 ' HB2' ' A' ' 184' ' ' SER . 27.8 mt -113.55 -179.15 3.56 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.605 1.562 . . . . 0.0 109.603 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -153.46 158.07 40.82 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 52.4 p30 -134.8 -173.37 3.28 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 127.596 2.358 . . . . 0.0 107.094 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.55 -22.76 66.15 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.107 -1.621 . . . . 0.0 113.469 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 74.6 t -78.31 -53.48 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 178.3 -163.09 30.9 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-O 122.023 0.791 . . . . 0.0 112.368 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.475 ' CE2' HD22 ' A' ' 243' ' ' LEU . 3.0 m-85 -82.7 159.9 22.49 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -167.43 165.83 14.68 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.939 0.896 . . . . 0.0 109.684 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.426 HD12 HD11 ' A' ' 109' ' ' ILE . 5.8 mt -109.92 136.47 45.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 177.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.43 ' HB2' HD12 ' A' ' 175' ' ' LEU . 0.6 OUTLIER -110.96 116.74 31.73 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 125.106 1.362 . . . . 0.0 107.818 -179.153 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -116.3 108.67 16.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.2 tt -99.65 140.19 19.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.5 mt -135.66 107.43 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 124.335 1.054 . . . . 0.0 111.153 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -101.45 -157.19 26.87 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 18.1 m 68.23 34.26 3.98 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.759 0.424 . . . . 0.0 112.075 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -89.84 -96.34 1.12 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 103.812 -3.715 . . . . 0.0 103.812 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -150.54 170.58 18.79 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.99 1.716 . . . . 0.0 107.575 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 23.5 mm -100.64 123.06 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 126.365 1.866 . . . . 0.0 107.946 178.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 8.1 m -88.1 94.39 9.79 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 101.505 -3.517 . . . . 0.0 101.505 177.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -57.89 -15.63 9.26 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 3.1 m -55.91 -35.62 41.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.003 0.921 . . . . 0.0 108.87 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 75.0 p -114.87 -24.45 8.65 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.569 1.148 . . . . 0.0 110.275 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 81.91 34.44 24.39 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -129.85 169.68 14.87 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.052 1.341 . . . . 0.0 110.939 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -83.02 145.76 29.12 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 12.2 ttt85 -76.82 29.17 0.13 Allowed 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 129.913 3.285 . . . . 0.0 112.384 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -72.19 144.1 48.64 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 122.351 1.072 . . . . 0.0 111.959 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -110.8 155.67 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 113.489 -1.687 . . . . 0.0 111.493 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -123.87 128.46 49.52 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.021 1.728 . . . . 0.0 106.972 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.5 mp -118.09 119.79 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 124.968 1.307 . . . . 0.0 107.723 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -102.5 113.81 27.48 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -94.1 116.75 29.21 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 33.6 m -126.4 169.35 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 125.298 1.439 . . . . 0.0 112.096 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -85.48 135.78 33.7 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 177.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -101.56 156.08 18.91 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 118.936 0.789 . . . . 0.0 111.608 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -51.01 -68.21 1.6 Allowed Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.902 1.715 . . . . 0.0 112.145 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 13.3 p -75.66 80.24 2.64 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 117.913 0.856 . . . . 0.0 108.776 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -67.46 36.23 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.132 2.573 . . . . 0.0 115.777 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 14.3 m -148.05 46.65 1.08 Allowed 'General case' 0 CA--C 1.536 0.408 0 O-C-N 119.932 -1.73 . . . . 0.0 113.093 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -148.28 -178.58 23.54 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.63 164.9 32.79 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.862 2.375 . . . . 0.0 110.417 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 60.6 p -81.42 151.95 27.65 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.934 0.894 . . . . 0.0 108.706 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.32 163.6 17.57 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.274 1.429 . . . . 0.0 107.454 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.3 mp -77.36 130.07 36.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -72.38 -61.07 1.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.968 1.707 . . . . 0.0 110.222 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -142.26 167.85 21.14 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 125.689 1.596 . . . . 0.0 108.804 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.609 HG13 ' CE1' ' A' ' 229' ' ' TYR . 28.7 t -145.69 137.63 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.97 117.8 3.3 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -77.16 92.7 3.83 Favored 'General case' 0 C--N 1.328 -0.357 1 N-CA-C 99.715 -4.18 . . . . 0.0 99.715 177.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 2.0 p -58.42 -61.38 2.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.875 1.27 . . . . 0.0 112.348 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -98.78 -172.72 2.36 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 28.2 mm -63.25 -46.1 96.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 O-C-N 121.256 -0.902 . . . . 0.0 111.089 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 9.1 t -109.72 -16.89 13.81 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 16.2 t -87.32 140.56 15.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 123.928 0.891 . . . . 0.0 108.874 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' TYR . . . . . 0.609 ' CE1' HG13 ' A' ' 221' ' ' VAL . 2.3 t80 -133.78 140.64 47.07 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.126 0.971 . . . . 0.0 109.038 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -127.98 138.48 52.63 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.02 161.44 39.39 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.524 1.529 . . . . 0.0 109.71 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -133.46 149.85 51.75 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 123.334 0.654 . . . . 0.0 110.355 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 60.5 t -128.29 144.98 36.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 125.511 1.524 . . . . 0.0 107.554 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.66 133.03 56.43 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 83.0 mt -134.75 137.58 27.76 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.056 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.34 -43.19 1.1 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.169 2.579 . . . . 0.0 112.708 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -57.76 -33.78 68.85 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.072 0.549 . . . . 0.0 111.081 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 55.6 mt -61.81 -33.79 74.76 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.891 0.769 . . . . 0.0 111.898 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 53.1 m -61.84 -17.16 55.32 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.017 0.927 . . . . 0.0 113.133 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -69.31 -17.98 63.77 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 123.923 0.889 . . . . 0.0 112.896 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 45.1 mt -90.74 120.73 32.02 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 126.235 1.814 . . . . 0.0 107.017 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.14 -41.79 49.53 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.898 1.279 . . . . 0.0 113.055 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.475 HD22 ' CE2' ' A' ' 181' ' ' TYR . 31.7 mt -56.39 -34.8 67.04 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.416 0.687 . . . . 0.0 110.193 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -100.88 4.53 42.8 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 126.791 2.036 . . . . 0.0 113.84 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -77.69 45.22 0.49 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -158.39 144.76 17.27 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 128.694 2.797 . . . . 0.0 107.593 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -167.91 178.38 5.2 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 127.079 2.152 . . . . 0.0 107.043 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 58.34 -19.96 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 118.842 2.904 . . . . 0.0 118.842 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 38.1 t70 . . . . . 0 N--CA 1.482 1.16 0 C-N-CA 131.267 3.827 . . . . 0.0 110.142 179.544 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.797 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.01 157.64 45.94 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 126.293 1.837 . . . . 0.0 107.975 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.9 m -60.7 -32.17 71.41 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.185 0.594 . . . . 0.0 112.101 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -82.51 24.83 0.67 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 117.385 -1.293 . . . . 0.0 113.537 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.0 m -47.5 -43.21 24.36 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 121.522 1.964 . . . . 0.0 111.956 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -56.83 -38.47 72.67 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.282 1.033 . . . . 0.0 112.75 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -63.26 -44.75 94.25 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.6 m -63.14 -42.8 99.54 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.7 -39.11 87.33 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-N 118.622 0.646 . . . . 0.0 109.841 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.9 tp -64.6 -44.89 89.16 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mt -59.11 -51.07 71.62 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.0 m -55.17 -44.75 75.52 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.34 1.056 . . . . 0.0 111.083 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -67.23 -51.17 56.48 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 121.548 -0.72 . . . . 0.0 110.232 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 21.8 m -54.82 -42.07 71.43 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 118.153 -0.927 . . . . 0.0 110.506 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.8 tp -61.01 -56.15 24.43 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 120.051 1.296 . . . . 0.0 110.034 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -57.23 -49.49 75.85 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.987 0.812 . . . . 0.0 111.602 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -56.85 -44.48 82.2 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.334 0.654 . . . . 0.0 109.269 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.542 ' HA3' HD11 ' A' ' 183' ' ' ILE . . . -63.52 -47.2 89.25 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 79.7 t -58.18 -52.99 51.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.671 1.189 . . . . 0.0 109.838 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -31.1 72.05 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.14 0.882 . . . . 0.0 110.315 178.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -68.53 -47.96 65.56 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.637 HD11 HD12 ' A' ' 183' ' ' ILE . 24.3 mt -57.06 -54.72 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 123.075 0.55 . . . . 0.0 109.583 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.52 -41.24 80.45 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 124.188 0.93 . . . . 0.0 110.23 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -64.64 -43.98 91.96 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.079 0.466 . . . . 0.0 111.894 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.31 -13.08 61.05 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 73.9 mt -106.75 -26.85 11.12 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 119.488 1.04 . . . . 0.0 111.945 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -57.15 -28.19 62.52 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.178 0.591 . . . . 0.0 111.625 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -68.52 -45.88 71.07 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.342 1.457 . . . . 0.0 111.096 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -161.07 149.55 16.08 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.978 1.311 . . . . 0.0 109.896 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 60.3 m -75.38 163.16 27.72 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 177.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 28.2 pt -118.24 148.7 20.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.8 154.58 44.34 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 122.673 0.389 . . . . 0.0 110.689 -177.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -143.13 124.96 15.07 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 124.439 1.096 . . . . 0.0 110.143 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -87.63 102.86 15.03 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.6 67.32 6.41 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.52 -115.95 6.26 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -66.4 -33.15 75.08 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.479 0.712 . . . . 0.0 112.59 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -106.64 160.29 15.56 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 122.153 0.977 . . . . 0.0 110.947 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.0 mt -124.57 147.99 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 178.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -121.64 134.53 54.99 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -130.49 125.25 33.88 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 126.629 1.972 . . . . 0.0 108.221 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -126.39 119.07 26.35 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 125.043 1.337 . . . . 0.0 109.799 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 12.5 m -102.88 160.52 25.97 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 124.76 1.224 . . . . 0.0 113.229 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.88 80.64 0.64 Allowed 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 124.47 3.447 . . . . 0.0 113.506 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.76 52.19 35.66 Favored Glycine 0 C--O 1.237 0.324 0 O-C-N 121.546 -0.721 . . . . 0.0 111.505 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.3 mt -129.17 -67.09 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -174.41 160.19 3.17 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.17 1.388 . . . . 0.0 108.987 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.91 120.23 38.51 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 176.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.18 154.86 40.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 118.758 0.708 . . . . 0.0 111.083 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -123.04 130.32 52.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 127.897 2.479 . . . . 0.0 106.579 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -146.37 156.92 43.67 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.357 1.063 . . . . 0.0 110.198 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 56.3 t60 -89.2 153.83 20.62 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 156.21 -164.14 32.26 Favored Glycine 0 CA--C 1.523 0.537 0 O-C-N 120.829 -1.169 . . . . 0.0 111.59 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.41 ' CD ' HG21 ' A' ' 150' ' ' VAL . 0.0 OUTLIER -124.16 150.05 45.61 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 124.388 1.075 . . . . 0.0 110.517 179.753 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.96 156.81 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.091 1.357 . . . . 0.0 108.205 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -101.39 99.2 9.51 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.138 1.775 . . . . 0.0 107.869 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.6 t -52.79 -23.32 6.63 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.158 1.383 . . . . 0.0 112.714 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -64.44 -27.25 68.86 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.7 t -146.55 -10.32 0.47 Allowed 'General case' 0 CA--C 1.539 0.536 0 O-C-N 124.401 1.063 . . . . 0.0 111.557 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.69 36.41 16.34 Favored Glycine 0 C--N 1.339 0.739 0 O-C-N 121.076 -1.015 . . . . 0.0 110.993 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -107.24 133.18 52.19 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.886 1.275 . . . . 0.0 107.786 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.5 mt -70.73 149.2 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.41 HG21 ' CD ' ' A' ' 141' ' ' ARG . 67.3 t -100.95 -35.14 4.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 123.935 0.894 . . . . 0.0 112.048 -178.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -141.74 139.01 32.75 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -118.37 73.98 0.93 Allowed 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 124.953 1.301 . . . . 0.0 107.89 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -71.87 136.9 47.12 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.995 1.318 . . . . 0.0 109.832 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -96.62 -4.24 41.42 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.788 1.235 . . . . 0.0 111.993 178.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 2.5 t -72.51 -42.57 64.68 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.701 1.137 . . . . 0.0 111.653 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 84.3 mt -115.03 87.48 2.66 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 123.873 0.869 . . . . 0.0 111.14 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 9.8 t -136.69 152.8 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.802 1.241 . . . . 0.0 108.585 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -145.44 171.8 14.12 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 126.286 1.835 . . . . 0.0 110.112 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -125.9 125.59 43.04 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.118 1.767 . . . . 0.0 109.55 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 22.1 mt -102.89 -72.83 0.68 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.227 1.011 . . . . 0.0 109.395 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -124.0 149.18 16.88 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -132.37 89.14 37.6 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.01 0.924 . . . . 0.0 110.443 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -77.5 -179.15 5.16 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 125.049 3.833 . . . . 0.0 113.293 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -90.05 161.67 15.71 Favored 'General case' 0 C--O 1.231 0.084 0 C-N-CA 124.069 0.948 . . . . 0.0 110.211 178.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.19 -24.81 57.87 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -118.99 157.91 26.82 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 123.629 0.771 . . . . 0.0 109.331 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 5.2 p -73.97 -33.02 35.21 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 C-N-CA 124.633 1.173 . . . . 0.0 112.095 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -75.13 -7.05 52.69 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.22 1.808 . . . . 0.0 112.93 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -94.2 -14.99 25.0 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.115 1.366 . . . . 0.0 109.708 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -124.35 179.32 4.96 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 128.665 2.786 . . . . 0.0 112.811 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -138.17 166.76 23.35 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.414 2.286 . . . . 0.0 107.817 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -141.06 159.34 42.42 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.864 2.066 . . . . 0.0 107.612 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -124.38 124.54 42.58 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.755 1.222 . . . . 0.0 111.309 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 21.6 tp -90.02 100.77 13.53 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 22.6 mt -107.21 -178.72 3.72 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.308 1.843 . . . . 0.0 108.754 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -158.81 159.89 35.62 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.61 -175.67 4.03 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -48.2 -35.78 12.48 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.979 1.711 . . . . 0.0 111.307 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 60.0 t -77.77 -67.63 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 126.193 1.797 . . . . 0.0 111.27 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -167.46 -170.22 32.0 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -178.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.478 ' CE2' HD22 ' A' ' 243' ' ' LEU . 3.6 m-85 -78.81 152.79 31.15 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.469 1.108 . . . . 0.0 112.037 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -162.49 156.56 21.15 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.005 1.322 . . . . 0.0 109.971 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.637 HD12 HD11 ' A' ' 109' ' ' ILE . 7.4 mt -102.04 140.08 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 177.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 4.3 t -121.98 136.35 54.92 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -142.62 119.18 11.01 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 176.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.8 tt -97.28 140.39 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.7 mt -130.51 112.59 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 O-C-N 120.742 -1.224 . . . . 0.0 110.161 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.18 -155.57 25.83 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 107.89 -2.084 . . . . 0.0 107.89 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 49.1 m 73.16 44.43 0.33 Allowed 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.095 1.358 . . . . 0.0 108.586 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -99.91 -121.9 4.74 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 125.158 1.361 . . . . 0.0 110.026 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -136.29 122.61 20.58 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.368 1.867 . . . . 0.0 108.774 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 14.1 mm -60.95 136.57 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 119.736 1.153 . . . . 0.0 110.155 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 28.5 p -90.58 111.58 22.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -68.13 -10.69 56.02 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 120.475 1.489 . . . . 0.0 110.391 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 40.6 t -60.33 -45.33 96.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 126.709 2.004 . . . . 0.0 108.808 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 1.3 p -125.41 -20.57 4.75 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 92.49 10.31 60.69 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.75 2.119 . . . . 0.0 112.255 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -94.32 169.66 10.06 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.544 1.138 . . . . 0.0 112.157 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -88.28 156.08 19.38 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 122.159 0.981 . . . . 0.0 109.707 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -79.52 30.21 0.24 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 128.97 2.908 . . . . 0.0 111.286 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 1.9 ptm -72.39 150.46 43.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.958 0.885 . . . . 0.0 110.428 -175.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.1 p -120.23 149.01 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 114.341 -1.3 . . . . 0.0 111.699 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -112.77 127.92 56.28 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.945 1.698 . . . . 0.0 106.853 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.1 mp -119.93 115.97 49.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.248 1.019 . . . . 0.0 108.454 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -101.19 116.43 32.79 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.338 0.655 . . . . 0.0 110.64 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -92.4 114.41 26.95 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.047 1.339 . . . . 0.0 110.104 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 27.4 m -127.38 172.28 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 126.197 1.799 . . . . 0.0 111.801 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -85.7 142.65 28.87 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -113.55 144.88 18.27 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-O 118.583 -1.12 . . . . 0.0 110.878 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -32.94 -73.98 0.07 OUTLIER Glycine 0 C--N 1.337 0.631 0 C-N-CA 128.724 3.059 . . . . 0.0 113.233 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 39.6 t -70.72 94.09 0.99 Allowed 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -74.39 21.12 0.11 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.312 1.845 . . . . 0.0 111.667 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 37.5 m -135.82 40.48 2.74 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.909 1.684 . . . . 0.0 112.578 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -150.94 166.95 30.5 Favored Glycine 0 CA--C 1.526 0.748 0 O-C-N 120.682 -1.261 . . . . 0.0 111.505 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.46 167.03 25.21 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.492 2.128 . . . . 0.0 112.128 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 51.0 m -76.87 155.19 33.1 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.979 178.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.0 p -162.05 163.63 28.63 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 126.55 1.94 . . . . 0.0 107.216 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.3 mp -81.45 129.23 37.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' GLN . . . . . 0.459 ' HG3' HG23 ' A' ' 234' ' ' THR . 64.9 mm-40 -79.23 -47.08 16.59 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.493 0.717 . . . . 0.0 112.635 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 40.0 p-90 -151.99 166.98 29.87 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.696 HG13 ' CE1' ' A' ' 229' ' ' TYR . 46.8 t -144.77 138.92 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 C-N-CA 125.719 1.608 . . . . 0.0 106.808 -178.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.96 134.34 4.27 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.621 0.724 . . . . 0.0 112.104 177.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -86.96 93.11 9.25 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 78.2 p -67.53 -56.42 9.57 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.576 0.703 . . . . 0.0 110.693 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -95.03 -175.04 3.41 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.983 1.713 . . . . 0.0 107.591 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.6 mp -74.71 -39.17 46.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 O-C-N 121.713 -0.617 . . . . 0.0 109.706 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 5.4 m -115.69 -18.91 10.73 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 3.5 t -85.13 152.82 3.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' TYR . . . . . 0.696 ' CE1' HG13 ' A' ' 221' ' ' VAL . 3.3 t80 -135.41 139.85 44.48 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.604 1.162 . . . . 0.0 108.585 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -120.84 135.43 55.17 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.035 1.334 . . . . 0.0 108.57 -178.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -138.46 161.13 37.8 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.93 1.692 . . . . 0.0 109.751 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -138.53 144.13 39.8 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 66.6 t -131.72 133.55 61.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 125.624 1.57 . . . . 0.0 109.449 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' THR . . . . . 0.459 HG23 ' HG3' ' A' ' 219' ' ' GLN . 1.9 p -99.49 146.6 26.19 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 13.4 mt -142.99 136.18 13.96 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.277 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -72.55 -44.69 0.68 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.433 2.089 . . . . 0.0 111.492 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -58.93 -20.82 55.61 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.13 0.972 . . . . 0.0 112.289 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 2.2 mp -71.69 -39.16 70.39 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.783 0.833 . . . . 0.0 108.987 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 29.2 m -58.3 -30.5 66.7 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.453 1.501 . . . . 0.0 111.979 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -60.2 -38.17 82.5 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.577 0.351 . . . . 0.0 110.788 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 23.8 mt -72.64 117.04 13.83 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -47.92 -34.34 8.91 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -177.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.478 HD22 ' CE2' ' A' ' 181' ' ' TYR . 20.1 mt -64.13 -40.86 97.08 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.941 0.792 . . . . 0.0 110.661 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 4.8 mp -99.58 9.38 43.28 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 125.295 1.438 . . . . 0.0 113.798 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -72.05 48.3 0.17 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.533 1.933 . . . . 0.0 111.231 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -130.69 142.82 50.44 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 127.707 2.403 . . . . 0.0 108.029 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 43.9 t30 81.51 4.99 1.34 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.635 2.774 . . . . 0.0 114.054 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.7 7.63 4.44 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.933 2.093 . . . . 0.0 109.965 177.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 38.5 t70 . . . . . 0 C--O 1.245 0.849 0 C-N-CA 126.688 1.995 . . . . 0.0 111.978 -179.458 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.965 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.11 2.09 16.22 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.327 1.451 . . . . 0.0 113.228 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.6 m -126.94 144.71 50.92 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.366 1.866 . . . . 0.0 107.211 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -144.57 145.25 31.71 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.649 1.98 . . . . 0.0 108.562 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.7 m -65.17 -44.54 88.17 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.483 1.513 . . . . 0.0 113.357 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.57 -32.69 74.22 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.394 -0.816 . . . . 0.0 111.139 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.472 ' HE3' HD11 ' A' ' 243' ' ' LEU . 21.2 tptm -64.46 -39.14 93.25 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.81 -41.74 91.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 118.702 0.683 . . . . 0.0 109.681 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.57 -40.57 95.8 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.2 tp -62.22 -45.69 92.2 Favored 'General case' 0 C--O 1.221 -0.396 0 C-N-CA 124.31 1.044 . . . . 0.0 109.148 178.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 mt -59.66 -51.3 70.37 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.173 0.989 . . . . 0.0 109.457 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.1 m -55.0 -55.48 30.43 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.553 1.141 . . . . 0.0 109.626 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -61.23 -46.33 90.87 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.12 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.1 m -52.23 -51.71 56.69 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 119.608 1.095 . . . . 0.0 110.196 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.2 tp -56.56 -55.31 35.5 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 119.229 0.922 . . . . 0.0 108.826 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.61 -49.6 67.48 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.803 1.241 . . . . 0.0 113.507 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -42.2 93.36 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.914 1.686 . . . . 0.0 108.525 179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.39 -50.23 69.91 Favored Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.84 -53.14 49.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 118.793 1.297 . . . . 0.0 111.109 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -31.78 72.0 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.206 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 m -66.08 -48.23 71.65 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.435 HD11 HD12 ' A' ' 183' ' ' ILE . 27.1 mt -58.36 -54.64 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.733 0.813 . . . . 0.0 110.318 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.77 -31.8 71.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 123.036 0.21 . . . . 0.0 111.525 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -73.64 -46.62 45.6 Favored 'General case' 0 C--O 1.225 -0.211 0 O-C-N 121.526 -0.734 . . . . 0.0 109.059 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.18 5.18 5.74 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.692 1.997 . . . . 0.0 113.887 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.3 mt -123.42 -30.43 3.66 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 125.516 1.526 . . . . 0.0 109.199 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -62.01 -28.5 69.62 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.158 0.435 . . . . 0.0 109.961 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -62.89 -47.16 84.51 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.706 0.802 . . . . 0.0 109.262 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -164.35 150.29 10.7 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.275 1.83 . . . . 0.0 109.883 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 64.2 m -75.27 171.75 13.65 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.3 pt -128.39 147.66 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 O-C-N 121.395 -0.815 . . . . 0.0 110.318 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.84 167.91 20.96 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.565 0.746 . . . . 0.0 110.894 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -153.71 124.88 7.41 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.65 1.58 . . . . 0.0 110.594 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -87.04 102.31 14.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.14 67.36 6.91 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.149 1.78 . . . . 0.0 109.608 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.8 -115.26 4.66 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -73.29 -27.77 61.73 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.245 1.818 . . . . 0.0 112.883 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -107.66 161.85 14.5 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 118.945 0.793 . . . . 0.0 110.293 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 24.1 mt -128.23 141.01 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 104.154 -2.535 . . . . 0.0 104.154 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.423 ' CD1' HG11 ' A' ' 221' ' ' VAL . 53.3 m-85 -116.73 135.18 53.98 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 124.786 1.234 . . . . 0.0 107.776 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.38 130.44 46.03 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.625 1.57 . . . . 0.0 108.488 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -128.24 121.73 30.05 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.615 1.166 . . . . 0.0 110.622 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 4.2 m -108.73 159.19 31.85 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 123.956 0.902 . . . . 0.0 112.231 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -65.7 95.13 0.28 Allowed 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 125.259 3.973 . . . . 0.0 114.562 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 57.94 39.69 92.15 Favored Glycine 0 CA--C 1.525 0.67 0 O-C-N 121.554 -0.716 . . . . 0.0 111.636 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.8 mt -115.16 -65.17 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.462 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 5.7 pt-20 179.4 169.51 1.05 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.894 2.078 . . . . 0.0 108.695 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.45 124.6 40.5 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.9 m -135.01 156.95 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 125.479 1.511 . . . . 0.0 111.189 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -124.03 133.63 53.61 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 103.327 -2.842 . . . . 0.0 103.327 176.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -146.25 156.62 43.51 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.902 0.881 . . . . 0.0 110.575 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -89.47 153.82 20.51 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 155.68 -162.82 31.4 Favored Glycine 0 CA--C 1.519 0.292 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.405 ' HD3' HG21 ' A' ' 150' ' ' VAL . 0.0 OUTLIER -130.95 152.59 50.1 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.251 1.02 . . . . 0.0 108.355 179.103 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 93.3 t -120.34 145.88 26.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 124.408 1.083 . . . . 0.0 109.559 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -93.61 94.92 8.89 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 178.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 8.9 t -47.2 -26.53 1.2 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.837 1.655 . . . . 0.0 113.801 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -52.03 -38.17 56.04 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 119.066 0.848 . . . . 0.0 111.632 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.2 t -147.02 -10.67 0.44 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 99.67 7.72 53.09 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.316 1.436 . . . . 0.0 112.344 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -62.46 135.86 57.63 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 119.494 1.647 . . . . 0.0 110.307 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 38.0 mm -73.6 134.35 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.405 HG21 ' HD3' ' A' ' 141' ' ' ARG . 7.5 t -93.32 -23.74 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.074 0.95 . . . . 0.0 112.065 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -145.72 109.09 4.66 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? -89.11 17.06 6.23 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.677 1.591 . . . . 0.0 114.147 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -44.31 133.36 5.5 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.047 1.339 . . . . 0.0 111.578 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -95.0 6.01 50.31 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 74.6 m -81.74 -3.39 53.63 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.7 mt -144.83 77.23 1.52 Allowed 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.2 143.26 28.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 124.74 1.216 . . . . 0.0 108.186 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -134.88 155.65 50.32 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.785 1.234 . . . . 0.0 109.256 178.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 28.9 ttp180 -97.06 130.23 44.39 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 128.021 2.528 . . . . 0.0 108.331 -178.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 27.5 mt -112.54 -69.88 0.84 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.415 1.007 . . . . 0.0 108.666 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -139.58 141.8 12.08 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-O 121.446 0.47 . . . . 0.0 112.979 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -110.88 92.9 15.71 Favored Pre-proline 0 N--CA 1.447 -0.582 0 C-N-CA 127.366 2.266 . . . . 0.0 110.637 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.462 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 75.5 Cg_endo -75.53 -177.16 3.36 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.646 2.897 . . . . 0.0 109.358 178.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -96.81 157.96 15.65 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.14 -26.51 56.39 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 124.901 1.376 . . . . 0.0 114.15 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -108.97 139.63 43.57 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 124.164 0.986 . . . . 0.0 108.466 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.4 p -62.97 -31.04 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -61.88 -26.7 68.31 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.727 1.611 . . . . 0.0 112.542 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -94.6 -2.33 51.62 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -79.62 163.56 24.5 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.434 -0.791 . . . . 0.0 110.297 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -137.58 95.1 3.0 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -102.35 160.2 14.75 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -135.63 143.86 45.77 Favored 'General case' 0 C--O 1.227 -0.11 0 C-N-CA 124.304 1.042 . . . . 0.0 110.221 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 36.3 tp -110.07 97.85 7.26 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.443 HD23 ' HB2' ' A' ' 184' ' ' SER . 0.5 OUTLIER -109.48 174.23 5.96 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.852 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.417 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 6.1 p90 -150.67 162.63 40.31 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 121.401 -0.812 . . . . 0.0 110.486 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -140.71 -175.3 4.24 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.4 1.062 . . . . 0.0 109.185 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -57.04 -20.3 23.84 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.155 1.382 . . . . 0.0 113.991 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 97.4 t -81.09 -65.66 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 178.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 175.57 -170.16 43.09 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.417 ' CD2' ' HB3' ' A' ' 176' ' ' TYR . 15.6 m-85 -78.52 159.13 28.35 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.721 0.772 . . . . 0.0 109.911 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -156.21 176.2 12.98 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.53 1.932 . . . . 0.0 106.805 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.435 HD12 HD11 ' A' ' 109' ' ' ILE . 18.8 mt -121.1 114.46 43.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 178.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.443 ' HB2' HD23 ' A' ' 175' ' ' LEU . 4.7 t -90.46 141.58 28.6 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -146.29 107.01 4.09 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.6 tt -98.68 140.44 18.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.9 mt -133.97 113.71 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 123.869 0.868 . . . . 0.0 110.847 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -107.85 -156.73 19.5 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 124.754 1.169 . . . . 0.0 110.275 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 68.5 m 73.09 37.55 0.76 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.775 1.23 . . . . 0.0 109.983 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -94.16 -108.35 2.04 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 126.858 2.17 . . . . 0.0 108.336 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -140.07 120.99 14.54 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.638 1.175 . . . . 0.0 107.921 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 17.7 mm -60.58 121.59 8.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 124.336 1.054 . . . . 0.0 109.272 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 77.6 m -82.22 96.42 7.85 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 125.735 1.614 . . . . 0.0 109.923 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.09 -18.47 58.09 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -59.3 -31.48 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.674 1.189 . . . . 0.0 110.76 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 44.8 p -125.07 -35.0 2.7 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.777 0.831 . . . . 0.0 111.799 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.92 32.93 5.7 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 126.43 1.966 . . . . 0.0 110.779 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -124.13 171.12 10.05 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.372 1.869 . . . . 0.0 112.174 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -83.33 148.7 27.19 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 122.322 1.058 . . . . 0.0 110.439 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -82.98 30.77 0.44 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 130.8 3.64 . . . . 0.0 109.251 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.5 ptt? -74.28 150.83 40.03 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.688 1.195 . . . . 0.0 110.334 -175.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -113.32 146.79 17.49 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.355 -177.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -114.42 116.39 28.81 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.8 mp -106.26 130.66 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -117.85 103.76 10.28 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.719 0.807 . . . . 0.0 110.108 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -83.02 125.31 31.3 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 15.5 m -135.96 171.09 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.44 1.496 . . . . 0.0 110.974 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 2.1 t -81.61 140.5 34.39 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -118.43 109.21 1.73 Allowed Glycine 0 C--N 1.34 0.752 0 CA-C-O 117.836 -1.536 . . . . 0.0 113.217 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 4.71 -92.15 0.0 OUTLIER Glycine 0 C--N 1.34 0.803 0 C-N-CA 129.626 3.489 . . . . 0.0 114.07 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.0 100.0 0.39 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -72.11 29.13 0.05 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.486 1.914 . . . . 0.0 113.169 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 14.8 t -119.29 47.2 1.73 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.685 1.994 . . . . 0.0 114.19 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -166.08 162.99 36.5 Favored Glycine 0 C--N 1.339 0.717 0 C-N-CA 118.014 -2.041 . . . . 0.0 117.523 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -66.64 164.81 27.59 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.355 2.704 . . . . 0.0 110.321 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 28.8 m -64.47 155.46 32.66 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.473 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -168.88 157.16 7.94 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 126.025 1.73 . . . . 0.0 108.111 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.9 mt -83.38 133.81 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -74.95 -55.27 5.94 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 125.061 1.345 . . . . 0.0 111.772 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 52.1 p-90 -149.94 165.93 31.15 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.218 1.407 . . . . 0.0 108.347 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.8 HG13 ' CE1' ' A' ' 229' ' ' TYR . 39.6 t -148.34 130.42 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 125.198 1.399 . . . . 0.0 107.62 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.37 140.65 16.59 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -92.16 90.23 7.24 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 102.365 -3.198 . . . . 0.0 102.365 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 2.0 p -61.31 -65.15 0.74 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.767 1.627 . . . . 0.0 110.747 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -86.88 -172.59 4.06 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.501 ' H ' HD12 ' A' ' 226' ' ' ILE . 3.6 mp -58.97 -41.53 83.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 118.322 -0.846 . . . . 0.0 110.163 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 7.3 m -129.86 -8.91 4.45 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 25.1 t -71.87 121.72 22.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 103.927 -2.62 . . . . 0.0 103.927 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' TYR . . . . . 0.8 ' CE1' HG13 ' A' ' 221' ' ' VAL . 1.0 OUTLIER -110.17 124.63 51.9 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 179.323 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -114.33 135.16 54.38 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -139.79 158.29 44.33 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.04 1.736 . . . . 0.0 109.621 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -130.69 146.21 52.12 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 85.1 t -131.95 135.48 58.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.77 138.25 40.65 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.726 0.81 . . . . 0.0 110.376 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 48.4 mt -139.81 137.05 17.91 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 124.052 0.941 . . . . 0.0 109.594 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.59 -32.77 2.67 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.722 2.948 . . . . 0.0 113.11 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -69.19 -23.81 63.96 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.717 1.207 . . . . 0.0 112.146 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 37.4 mt -66.28 -36.54 83.24 Favored 'General case' 0 C--O 1.226 -0.139 0 O-C-N 121.238 -0.914 . . . . 0.0 110.292 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 3.7 m -56.39 -19.23 13.85 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.893 1.277 . . . . 0.0 113.553 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -62.85 -31.98 73.12 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.23 1.412 . . . . 0.0 110.358 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 26.8 mt -84.11 120.14 25.82 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.44 -37.8 57.74 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.715 0.689 . . . . 0.0 112.072 -178.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.472 HD11 ' HE3' ' A' ' 94' ' ' LYS . 6.0 mp -57.6 -38.84 75.59 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.485 -0.76 . . . . 0.0 111.248 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -97.35 6.08 48.85 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.071 1.748 . . . . 0.0 111.675 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -79.21 64.96 4.25 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -139.81 153.39 47.08 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 126.783 2.033 . . . . 0.0 108.302 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 62.04 7.44 2.13 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.42 1.488 . . . . 0.0 114.61 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -73.48 -4.56 34.54 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 128.91 2.884 . . . . 0.0 112.303 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 C--O 1.251 1.161 0 C-N-CA 127.973 2.509 . . . . 0.0 113.315 -178.601 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.895 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.64 170.34 5.25 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.843 0.857 . . . . 0.0 112.103 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.3 m 61.84 70.42 0.59 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.871 2.069 . . . . 0.0 111.908 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -145.25 146.85 31.85 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.594 -0.691 . . . . 0.0 111.121 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 68.1 m -54.95 -39.86 69.37 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 126.755 2.022 . . . . 0.0 113.409 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -64.03 -20.25 65.78 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 121.853 -0.529 . . . . 0.0 112.316 -178.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -70.57 -43.11 70.13 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.7 m -66.43 -41.51 89.09 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.036 0.934 . . . . 0.0 108.896 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.93 -45.81 89.48 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 66.7 tp -62.62 -41.34 98.95 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.413 0.685 . . . . 0.0 110.272 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.8 mt -60.08 -54.28 47.8 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.983 0.913 . . . . 0.0 109.762 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 45.2 m -56.21 -51.79 66.78 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.228 1.011 . . . . 0.0 110.748 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -58.03 -49.55 76.47 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.7 m -53.94 -49.55 68.45 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 118.425 -0.798 . . . . 0.0 110.598 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.521 ' O ' HG23 ' A' ' 106' ' ' VAL . 9.2 tp -56.77 -54.91 40.83 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.967 0.803 . . . . 0.0 109.579 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -55.29 -53.64 53.62 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.684 0.793 . . . . 0.0 111.492 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -57.37 -33.51 67.88 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.315 1.446 . . . . 0.0 110.363 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -69.43 -53.38 17.41 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 102' ' ' LEU . 3.4 t -56.55 -52.1 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 118.799 1.3 . . . . 0.0 111.706 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -37.24 79.76 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 118.89 -0.576 . . . . 0.0 110.779 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.4 m -67.43 -48.11 68.23 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.497 HD11 HD12 ' A' ' 183' ' ' ILE . 43.8 mt -53.5 -52.97 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 123.978 0.911 . . . . 0.0 109.575 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.54 -39.45 83.99 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 122.187 0.195 . . . . 0.0 111.234 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -69.73 -33.93 73.17 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.294 -0.879 . . . . 0.0 111.461 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.24 10.25 15.25 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.569 1.548 . . . . 0.0 112.239 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.3 mt -133.35 -33.35 1.12 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.841 1.256 . . . . 0.0 110.557 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -56.26 -31.23 63.39 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 123.693 0.797 . . . . 0.0 111.57 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -69.47 -45.96 67.79 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 118.668 -0.682 . . . . 0.0 112.465 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -157.26 143.65 18.0 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 125.336 1.454 . . . . 0.0 108.244 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 30.5 m -75.87 172.08 13.31 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 122.906 0.482 . . . . 0.0 110.959 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 25.6 pt -125.9 154.91 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.591 1.156 . . . . 0.0 111.418 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.62 167.69 21.64 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.738 0.815 . . . . 0.0 109.956 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -150.53 117.75 6.0 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.772 1.629 . . . . 0.0 109.935 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -82.54 102.14 11.19 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.0 66.8 3.62 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.474 -0.766 . . . . 0.0 110.472 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.19 -113.06 3.74 Favored Glycine 0 C--N 1.339 0.697 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -77.39 -38.33 50.11 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -106.65 126.44 52.28 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.874 1.215 . . . . 0.0 113.503 -178.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.0 mt -90.6 147.8 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.484 ' CD1' HG11 ' A' ' 221' ' ' VAL . 66.2 m-85 -115.11 135.8 53.81 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 178.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.72 123.91 27.14 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.789 1.236 . . . . 0.0 109.337 -177.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -126.8 119.51 27.05 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.824 1.249 . . . . 0.0 111.743 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 1.4 m -100.62 160.81 25.85 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 125.391 1.477 . . . . 0.0 112.477 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -64.13 88.86 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 124.249 3.299 . . . . 0.0 112.288 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 53.48 57.46 15.49 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 123.934 0.778 . . . . 0.0 111.274 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 15.6 mt -124.94 -65.67 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.509 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 15.6 pt-20 -176.15 168.92 2.86 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 127.621 2.368 . . . . 0.0 109.677 177.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -123.52 124.15 42.2 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.5 155.76 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.301 1.041 . . . . 0.0 112.256 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -119.82 126.24 50.51 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -146.48 157.67 43.78 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.093 0.861 . . . . 0.0 112.065 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -88.68 148.63 23.91 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 160.32 -162.17 33.09 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 108.871 -1.691 . . . . 0.0 108.871 -177.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.4 ttm-85 -125.63 164.15 21.22 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.34 1.456 . . . . 0.0 111.104 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 84.5 t -137.27 135.17 47.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -81.13 89.82 6.01 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 127.925 2.49 . . . . 0.0 107.737 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.9 t -54.3 -17.2 2.7 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.697 1.199 . . . . 0.0 113.714 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -64.11 -24.28 67.64 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 120.902 -1.124 . . . . 0.0 112.681 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 t -142.9 -31.1 0.51 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.673 0.789 . . . . 0.0 110.455 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 106.34 19.61 9.82 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 125.503 1.525 . . . . 0.0 111.3 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -85.27 155.75 21.24 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 119.289 1.544 . . . . 0.0 111.461 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.6 mp -71.79 154.54 7.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 123.853 0.861 . . . . 0.0 108.801 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.3 p -162.91 157.94 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.507 1.523 . . . . 0.0 108.733 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 12.7 t30 24.94 83.34 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 129.753 3.221 . . . . 0.0 113.213 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.97 177.77 5.17 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.934 1.294 . . . . 0.0 112.886 -178.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.23 142.58 39.93 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 125.531 1.532 . . . . 0.0 107.157 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -95.58 0.7 53.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 111.344 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 t -86.28 -10.67 54.1 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.666 1.586 . . . . 0.0 111.789 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 76.6 mt -128.82 79.21 1.9 Allowed 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.8 t -135.84 142.54 38.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.534 1.134 . . . . 0.0 108.054 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -137.61 158.62 43.99 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 126.348 1.859 . . . . 0.0 109.049 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -113.01 130.43 56.14 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.437 1.095 . . . . 0.0 110.196 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.96 -75.19 0.53 Allowed 'General case' 0 C--O 1.226 -0.153 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -134.68 152.39 20.68 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 116.255 -0.43 . . . . 0.0 112.73 -178.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -116.49 94.39 42.93 Favored Pre-proline 0 N--CA 1.453 -0.32 0 C-N-CA 125.271 1.428 . . . . 0.0 108.601 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.509 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 88.1 Cg_endo -73.48 -175.82 2.21 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.343 2.695 . . . . 0.0 109.555 178.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.457 ' HE2' ' OE2' ' A' ' 169' ' ' GLU . 25.3 mmmt -97.53 161.1 13.94 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.16 0.584 . . . . 0.0 112.238 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -78.26 -24.21 46.96 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.87 1.668 . . . . 0.0 113.362 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -116.37 147.75 41.3 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.5 p -73.06 -27.23 24.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -79.68 -12.73 59.8 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.296 0.639 . . . . 0.0 112.445 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.457 ' OE2' ' HE2' ' A' ' 164' ' ' LYS . 4.3 mm-40 -79.62 -21.5 44.84 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.865 0.466 . . . . 0.0 110.864 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -107.3 172.1 7.01 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.744 1.618 . . . . 0.0 110.652 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -134.29 131.31 38.26 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 124.186 0.994 . . . . 0.0 109.434 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -107.86 162.29 14.14 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -130.11 120.86 25.28 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.056 -1.028 . . . . 0.0 109.738 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 48.4 tp -87.24 100.6 12.81 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 39.5 mt -105.32 -179.21 3.88 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 126.207 1.803 . . . . 0.0 109.972 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 181' ' ' TYR . 4.6 p90 -157.09 157.07 33.87 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 124.458 1.103 . . . . 0.0 109.596 177.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -137.51 -179.36 5.69 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.143 2.177 . . . . 0.0 108.604 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -58.53 -26.41 63.49 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.445 1.098 . . . . 0.0 113.533 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 59.8 t -79.62 -62.81 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -172.99 -164.41 28.34 Favored Glycine 0 C--N 1.339 0.725 0 CA-C-N 119.031 0.832 . . . . 0.0 111.366 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.508 ' CE2' HD13 ' A' ' 243' ' ' LEU . 2.9 m-85 -78.21 166.38 22.8 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.193 -0.593 . . . . 0.0 109.982 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -167.62 162.09 13.97 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.508 1.523 . . . . 0.0 108.145 178.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.497 HD12 HD11 ' A' ' 109' ' ' ILE . 3.6 mt -113.97 121.43 66.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.154 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.2 t -95.96 135.03 38.25 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -138.57 133.63 32.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 178.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.9 tt -121.45 141.37 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 124.679 1.191 . . . . 0.0 109.072 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.4 mt -137.14 115.14 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 122.596 0.358 . . . . 0.0 111.705 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -103.74 -166.96 25.28 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 126.497 1.999 . . . . 0.0 110.125 178.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 69.3 m 73.23 60.41 0.1 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.624 1.569 . . . . 0.0 109.056 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -108.13 -95.58 2.4 Favored Glycine 0 CA--C 1.519 0.286 0 N-CA-C 104.513 -3.435 . . . . 0.0 104.513 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -155.59 125.23 6.41 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 18.0 mm -60.25 121.29 7.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.2 99.94 10.27 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 125.839 1.656 . . . . 0.0 110.153 -178.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -60.94 -20.49 62.28 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.364 0.602 . . . . 0.0 111.51 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.5 m -57.18 -32.64 41.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.642 1.577 . . . . 0.0 112.235 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 67.0 p -125.17 -29.22 3.32 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.078 1.351 . . . . 0.0 112.017 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 88.22 32.37 12.34 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -178.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -126.82 -179.72 4.96 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.915 1.686 . . . . 0.0 111.322 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -91.86 148.15 22.44 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.298 0.639 . . . . 0.0 109.496 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 45.2 ttm-85 -79.32 30.12 0.23 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.287 2.635 . . . . 0.0 109.729 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.7 ptm -72.87 153.96 40.8 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 122.064 0.935 . . . . 0.0 110.075 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 6.0 p -122.97 148.93 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 113.876 -1.511 . . . . 0.0 113.696 -176.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -114.09 137.46 51.7 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.5 mp -126.03 118.41 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 127.516 2.326 . . . . 0.0 107.921 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -106.88 104.28 13.92 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.554 1.141 . . . . 0.0 110.42 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -80.95 129.53 34.58 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 120.523 -1.361 . . . . 0.0 111.8 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 33.9 m -137.8 172.15 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.643 1.177 . . . . 0.0 112.634 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.4 137.64 37.35 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.176 0.991 . . . . 0.0 108.352 178.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -105.38 117.95 5.69 Favored Glycine 0 C--N 1.332 0.352 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -42.34 -46.8 5.56 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 126.239 1.876 . . . . 0.0 113.283 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.42 ' C ' ' H ' ' A' ' 213' ' ' SER . 1.8 p -76.45 80.73 3.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -65.02 21.46 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 130.317 3.447 . . . . 0.0 113.329 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.42 ' H ' ' C ' ' A' ' 211' ' ' SER . 23.4 t -142.49 47.24 1.58 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 129.567 3.147 . . . . 0.0 107.642 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -149.61 159.3 28.02 Favored Glycine 0 C--N 1.34 0.771 0 O-C-N 119.668 -1.895 . . . . 0.0 114.6 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.93 173.47 13.51 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.851 3.034 . . . . 0.0 111.015 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 49.0 m -75.28 152.13 38.26 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -168.39 152.59 5.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 178.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.1 mt -78.66 134.68 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' GLN . . . . . 0.462 ' HG3' HE21 ' A' ' 232' ' ' GLN . 14.7 mm100 -77.63 -51.81 10.03 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.007 0.923 . . . . 0.0 111.794 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 55.9 p-90 -149.66 165.55 31.99 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.244 1.418 . . . . 0.0 108.439 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.812 HG13 ' CE1' ' A' ' 229' ' ' TYR . 24.5 t -147.42 134.16 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 126.228 1.811 . . . . 0.0 106.883 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.68 124.75 6.15 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 177.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -78.96 86.99 4.79 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 103.517 -2.771 . . . . 0.0 103.517 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 8.6 p -53.14 -52.55 58.34 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.904 1.682 . . . . 0.0 112.606 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -107.05 -177.36 3.34 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . 0.253 2.6 mp -68.24 -18.95 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 118.882 -1.127 . . . . 0.0 110.603 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -132.31 -39.6 1.03 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.519 1.054 . . . . 0.0 112.614 178.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 11.8 t -63.47 135.3 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' TYR . . . . . 0.812 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.2 OUTLIER -133.34 139.65 46.96 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.43 1.092 . . . . 0.0 109.9 -178.07 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -121.03 140.57 51.74 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.478 1.511 . . . . 0.0 111.755 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -142.94 161.31 38.46 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 128.183 2.593 . . . . 0.0 109.723 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.462 HE21 ' HG3' ' A' ' 219' ' ' GLN . 38.7 tt0 -137.22 146.67 45.12 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.034 1.334 . . . . 0.0 107.496 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 98.5 t -131.92 134.68 59.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 125.294 1.438 . . . . 0.0 107.862 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.64 134.56 45.8 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.234 1.014 . . . . 0.0 110.577 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 69.6 mt -131.74 138.47 32.64 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.71 -46.2 0.89 Allowed 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.542 2.828 . . . . 0.0 111.553 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.98 -27.48 66.88 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.947 1.299 . . . . 0.0 111.79 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 3.5 mp -61.68 -31.62 71.77 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 117.871 -1.061 . . . . 0.0 110.477 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 8.3 m -65.64 -19.16 65.8 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.978 1.263 . . . . 0.0 113.158 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -63.54 -29.82 71.02 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.051 0.941 . . . . 0.0 111.419 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 50.7 mt -82.34 113.78 20.36 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -48.2 -31.2 5.47 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.508 HD13 ' CE2' ' A' ' 181' ' ' TYR . 21.2 mt -67.58 -36.5 81.02 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.162 -0.961 . . . . 0.0 110.338 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 17.9 mt -100.06 8.89 43.63 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 127.341 2.256 . . . . 0.0 111.204 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -80.69 68.75 7.04 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 20.6 tptp -144.63 137.88 26.98 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 126.204 1.802 . . . . 0.0 107.858 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 21.0 m120 72.05 29.34 2.37 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 126.12 1.768 . . . . 0.0 112.17 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -73.83 37.48 0.1 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 128.218 2.607 . . . . 0.0 108.971 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 . . . . . 0 C--O 1.247 0.922 0 C-N-CA 127.072 2.149 . . . . 0.0 110.046 -177.75 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.713 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.94 20.92 3.81 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.993 0.917 . . . . 0.0 112.815 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.0 p -156.6 -59.91 0.09 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.245 0.929 . . . . 0.0 112.408 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -75.48 59.06 1.06 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.566 1.146 . . . . 0.0 110.834 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.6 m -47.18 -58.54 3.95 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 126.52 1.928 . . . . 0.0 112.782 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -52.59 -53.04 52.06 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.815 0.734 . . . . 0.0 111.921 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -58.75 -40.46 83.91 Favored 'General case' 0 C--O 1.225 -0.207 0 O-C-N 121.872 -0.517 . . . . 0.0 110.314 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.9 m -65.67 -43.61 88.8 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.15 -45.04 96.3 Favored 'General case' 0 C--N 1.337 0.06 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 67.7 tp -58.3 -44.01 88.37 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.081 -0.961 . . . . 0.0 108.87 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.2 mt -61.24 -53.92 50.66 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.243 0.929 . . . . 0.0 109.388 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 51.6 m -55.13 -48.58 73.48 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.806 0.842 . . . . 0.0 111.198 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -62.87 -46.3 88.51 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 120.403 -1.436 . . . . 0.0 110.214 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 52.9 m -54.18 -46.04 72.28 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.576 1.15 . . . . 0.0 109.915 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.479 ' O ' HG23 ' A' ' 106' ' ' VAL . 22.0 tp -58.6 -54.08 51.14 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.761 0.709 . . . . 0.0 110.452 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 25.4 t30 -57.47 -46.93 83.12 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.263 0.483 . . . . 0.0 111.526 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -55.52 -46.64 77.01 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.974 0.91 . . . . 0.0 109.169 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.449 ' HA3' HD11 ' A' ' 183' ' ' ILE . . . -64.04 -46.47 91.21 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 102' ' ' LEU . 93.2 t -59.01 -53.22 51.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.047 1.339 . . . . 0.0 110.393 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -32.52 73.49 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.775 1.17 . . . . 0.0 110.16 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.2 m -67.22 -46.46 73.77 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.437 HD11 HD12 ' A' ' 183' ' ' ILE . 33.8 mt -59.64 -51.6 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.99 -35.72 77.56 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 118.659 -0.686 . . . . 0.0 110.217 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.27 -48.42 75.79 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 119.708 1.14 . . . . 0.0 110.357 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.14 -27.65 60.95 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 -178.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.8 mp -85.72 -28.37 24.67 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 120.19 1.359 . . . . 0.0 109.336 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -60.53 -19.47 57.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.127 0.571 . . . . 0.0 111.452 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.36 -46.64 54.53 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.19 0.596 . . . . 0.0 110.868 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -165.54 155.63 13.0 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.586 1.554 . . . . 0.0 108.258 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 33.5 m -75.77 162.85 27.83 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.3 pt -117.68 156.23 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.22 163.23 38.23 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 120.712 0.292 . . . . 0.0 111.191 -177.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -152.31 127.63 9.9 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.739 1.616 . . . . 0.0 109.816 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -89.14 104.43 16.98 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.17 67.66 5.9 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.43 -115.03 4.92 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.491 -1.043 . . . . 0.0 110.491 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -73.82 -34.26 64.5 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -106.38 138.2 42.98 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 119.355 0.98 . . . . 0.0 110.976 -178.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.2 mt -102.89 149.69 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -122.24 133.79 54.7 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 126.406 1.882 . . . . 0.0 106.223 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.47 132.72 44.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.101 1.761 . . . . 0.0 107.945 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -126.46 117.84 23.72 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.424 1.089 . . . . 0.0 110.959 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 8.7 m -102.64 155.99 35.84 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.008 0.923 . . . . 0.0 112.924 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.34 92.21 0.28 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 125.069 3.846 . . . . 0.0 116.164 -178.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 62.64 36.27 93.01 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.3 mt -116.68 -66.99 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.461 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 7.2 pt-20 176.96 166.62 0.53 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.075 1.75 . . . . 0.0 109.58 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -117.62 129.63 55.87 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 104.278 -2.49 . . . . 0.0 104.278 177.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.1 m -138.32 155.46 28.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.922 0.889 . . . . 0.0 110.725 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -121.12 131.44 54.25 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -145.96 157.84 43.88 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.418 1.087 . . . . 0.0 111.479 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -88.61 154.27 20.46 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 165.34 -163.66 36.7 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.429 ' HD2' HG21 ' A' ' 150' ' ' VAL . 0.0 OUTLIER -129.64 142.04 50.81 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 179.457 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.7 p -152.88 159.19 3.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 118.777 0.717 . . . . 0.0 109.709 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -102.59 112.77 25.67 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.654 1.182 . . . . 0.0 109.466 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.1 t -57.72 -19.09 24.95 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.742 1.155 . . . . 0.0 113.575 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -59.26 -35.43 73.7 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.469 1.108 . . . . 0.0 113.533 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.2 t -143.82 -20.35 0.58 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.489 0.716 . . . . 0.0 111.629 -178.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 97.16 17.62 31.46 Favored Glycine 0 C--O 1.223 -0.588 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -71.0 114.55 9.17 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 118.4 1.1 . . . . 0.0 108.281 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 14.1 mt -81.73 120.14 32.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 127.504 2.322 . . . . 0.0 106.672 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.429 HG21 ' HD2' ' A' ' 141' ' ' ARG . 42.2 t -79.47 -81.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 126.038 1.735 . . . . 0.0 108.918 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -78.47 123.99 27.64 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 46.8 mtm105 -117.62 101.68 8.55 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 101.852 -3.388 . . . . 0.0 101.852 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -120.44 112.68 19.27 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.18 1.392 . . . . 0.0 109.995 -177.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -73.08 10.51 0.91 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.138 1.375 . . . . 0.0 113.27 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 3.5 t -89.49 -42.49 11.44 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 120.48 -1.388 . . . . 0.0 111.775 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 23.5 mt -105.94 81.24 1.62 Allowed 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 119.131 0.878 . . . . 0.0 109.491 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.5 p -143.18 152.52 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.848 0.859 . . . . 0.0 109.872 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -142.38 145.56 33.99 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.913 1.685 . . . . 0.0 108.124 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -95.58 135.15 37.62 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.522 1.129 . . . . 0.0 108.676 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.4 mp -102.15 -69.69 0.78 Allowed 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 123.122 0.569 . . . . 0.0 110.486 -178.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -127.96 165.83 20.82 Favored Glycine 0 C--O 1.243 0.681 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -132.32 89.12 37.87 Favored Pre-proline 0 N--CA 1.448 -0.569 0 C-N-CA 125.428 1.491 . . . . 0.0 109.52 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 90.9 Cg_endo -74.93 176.63 9.63 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 123.201 2.601 . . . . 0.0 108.02 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -94.8 155.37 16.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.916 0.865 . . . . 0.0 111.443 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.28 -20.25 61.55 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 126.074 1.75 . . . . 0.0 113.317 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -122.97 136.83 55.01 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.466 1.506 . . . . 0.0 109.91 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.9 p -61.37 -27.76 42.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.536 0.684 . . . . 0.0 110.691 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -71.06 -6.44 39.09 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 127.755 2.422 . . . . 0.0 113.013 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -112.35 -20.11 11.94 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.561 1.144 . . . . 0.0 112.721 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.27 165.78 13.26 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -145.79 112.71 6.04 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -101.56 170.14 8.38 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.999 1.32 . . . . 0.0 110.522 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -131.81 125.82 32.8 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.481 1.512 . . . . 0.0 110.836 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 24.4 tp -86.51 104.46 15.99 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 61.2 mt -107.47 177.0 4.96 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.21 1.404 . . . . 0.0 110.78 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.464 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 12.0 p90 -162.37 166.53 25.03 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 122.813 1.292 . . . . 0.0 110.766 178.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -140.85 177.42 8.05 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 126.125 1.77 . . . . 0.0 106.759 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.28 -31.67 69.33 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 125.379 1.471 . . . . 0.0 107.948 177.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 38.7 t -66.1 -62.11 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 125.756 1.623 . . . . 0.0 107.791 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 178.9 -171.97 44.15 Favored Glycine 0 C--N 1.339 0.745 0 C-N-CA 124.392 0.996 . . . . 0.0 113.158 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.464 ' CD2' ' HB3' ' A' ' 176' ' ' TYR . 32.9 m-85 -90.27 155.05 19.27 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.692 1.197 . . . . 0.0 111.789 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -164.87 162.05 20.61 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.416 1.887 . . . . 0.0 109.171 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.449 HD11 ' HA3' ' A' ' 105' ' ' GLY . 8.6 mt -106.3 141.68 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 177.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 5.3 t -122.77 132.75 54.36 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -132.9 120.55 21.63 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 177.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.9 tt -105.91 128.0 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 5.5 mt -120.71 107.28 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 124.312 1.045 . . . . 0.0 110.653 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -99.7 -156.62 28.48 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 107.146 -2.382 . . . . 0.0 107.146 177.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 46.8 m 70.22 51.72 0.38 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.547 0.689 . . . . 0.0 110.757 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -115.71 -119.93 3.26 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 107.244 -2.342 . . . . 0.0 107.244 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -129.39 141.75 50.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.544 1.138 . . . . 0.0 108.793 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 24.5 mm -79.55 128.89 38.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 16.7 m -90.53 104.42 17.0 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 101.908 -3.367 . . . . 0.0 101.908 176.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -55.45 -16.04 3.31 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -177.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 3.0 m -59.05 -39.7 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.207 1.003 . . . . 0.0 110.246 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 1.2 p -125.21 -17.95 5.54 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.627 1.103 . . . . 0.0 111.551 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 85.94 5.48 83.52 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.685 0.659 . . . . 0.0 113.549 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -83.93 160.83 21.0 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.271 1.429 . . . . 0.0 108.351 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -86.61 152.11 22.87 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -74.96 29.84 0.09 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 127.415 2.286 . . . . 0.0 109.962 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.3 ptt? -72.1 149.3 44.91 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 122.025 0.917 . . . . 0.0 109.838 -175.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.6 p -123.08 144.12 33.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.252 -176.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -108.35 130.18 55.21 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 178.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.1 mp -118.38 112.42 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 124.744 1.217 . . . . 0.0 108.225 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -95.33 116.79 29.25 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -94.53 116.38 28.7 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.326 0.65 . . . . 0.0 110.305 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 32.2 m -126.57 171.61 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 125.518 1.527 . . . . 0.0 111.955 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -85.86 135.8 33.56 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.783 1.633 . . . . 0.0 106.991 177.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -91.57 154.66 22.84 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 119.195 0.907 . . . . 0.0 111.406 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -62.61 -60.79 7.26 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 27.5 p -78.58 74.1 5.12 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -70.23 57.95 0.17 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.94 2.496 . . . . 0.0 112.011 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.36 47.51 0.35 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.984 1.714 . . . . 0.0 110.761 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -165.19 174.25 41.05 Favored Glycine 0 CA--C 1.527 0.788 0 O-C-N 119.736 -1.852 . . . . 0.0 112.159 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -71.73 162.06 43.22 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.438 2.092 . . . . 0.0 110.57 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 7.8 m -73.95 151.04 40.46 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 126.414 1.886 . . . . 0.0 111.034 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -164.85 165.15 20.72 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.735 1.614 . . . . 0.0 108.267 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.4 mp -79.15 128.02 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 177.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -72.09 -60.56 2.17 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.847 1.659 . . . . 0.0 109.867 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' TRP . . . . . 0.41 ' CE3' ' HD2' ' A' ' 222' ' ' ARG . 28.7 p-90 -140.24 166.56 24.35 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.242 1.417 . . . . 0.0 109.807 -178.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.596 HG13 ' CE1' ' A' ' 229' ' ' TYR . 49.9 t -145.85 133.03 15.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 125.585 1.554 . . . . 0.0 107.012 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.41 ' HD2' ' CE3' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -148.7 127.48 12.56 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.63 0.729 . . . . 0.0 109.362 178.255 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -79.99 87.88 5.38 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.9 p -57.42 -53.94 52.47 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.227 1.011 . . . . 0.0 112.622 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -119.31 -179.23 3.79 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.7 mp -61.27 -27.18 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.244 1.018 . . . . 0.0 110.838 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.8 t -131.64 -30.89 1.61 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.364 0.666 . . . . 0.0 111.765 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 16.7 t -76.31 135.42 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' TYR . . . . . 0.596 ' CE1' HG13 ' A' ' 221' ' ' VAL . 1.6 t80 -129.02 148.35 50.97 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.72 1.608 . . . . 0.0 108.681 -179.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -132.2 136.76 47.26 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 126.524 1.93 . . . . 0.0 107.564 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.72 161.61 38.78 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.751 1.62 . . . . 0.0 110.191 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -134.87 145.19 48.03 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.521 0.729 . . . . 0.0 109.998 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.1 t -124.2 146.12 30.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 125.657 1.583 . . . . 0.0 108.263 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.87 133.14 56.34 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 87.9 mt -134.74 135.99 24.47 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 123.828 0.851 . . . . 0.0 108.911 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.29 -42.38 2.0 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.662 2.241 . . . . 0.0 112.554 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -60.64 -24.9 65.91 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.308 0.643 . . . . 0.0 112.113 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 54.6 mt -68.19 -28.14 67.01 Favored 'General case' 0 C--O 1.225 -0.194 0 O-C-N 121.099 -1.0 . . . . 0.0 110.844 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 39.3 m -63.74 -15.76 59.4 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.763 1.225 . . . . 0.0 113.39 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -68.54 -24.08 64.59 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.41 ' HB2' HD23 ' A' ' 244' ' ' LEU . 41.0 mt -85.38 121.99 28.9 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.693 1.597 . . . . 0.0 107.882 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -50.5 -37.21 37.63 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.6 mp -61.02 -38.59 86.62 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.415 -0.803 . . . . 0.0 109.994 178.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.507 ' C ' ' H ' ' A' ' 246' ' ' LYS . 2.6 mm? -91.89 3.04 56.07 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 127.567 2.347 . . . . 0.0 113.226 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -79.89 36.44 0.33 Allowed 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.507 ' H ' ' C ' ' A' ' 244' ' ' LEU . 57.0 tptt -145.83 136.51 24.28 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 129.347 3.059 . . . . 0.0 108.649 -178.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -174.69 158.98 2.78 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 128.887 2.875 . . . . 0.0 106.329 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -156.57 46.92 0.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.113 0.965 . . . . 0.0 109.178 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.171 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.523 0 N-CA-C 107.297 -2.321 . . . . 0.0 107.297 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.58 -31.73 71.8 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.739 1.769 . . . . 0.0 107.702 177.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 59.7 m 43.53 19.06 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 130.037 3.335 . . . . 0.0 118.038 176.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -57.28 -35.63 70.04 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 120.342 1.428 . . . . 0.0 109.775 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.4 m -63.67 -45.39 90.32 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 119.301 0.955 . . . . 0.0 110.349 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -65.79 -35.31 80.34 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.57 1.148 . . . . 0.0 110.594 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -69.53 -55.06 11.25 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.376 1.07 . . . . 0.0 108.311 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.4 p -60.52 -35.83 76.93 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 123.834 0.854 . . . . 0.0 111.307 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.69 -44.61 81.65 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 119.346 0.975 . . . . 0.0 109.71 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 52.0 tp -62.49 -44.89 95.28 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 118.52 -0.752 . . . . 0.0 109.036 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.7 mt -60.78 -48.27 82.57 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.272 0.942 . . . . 0.0 110.539 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 33.0 m -56.46 -56.5 20.39 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.676 1.19 . . . . 0.0 109.335 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.9 ttpp -58.69 -48.22 81.84 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-O 118.948 -0.548 . . . . 0.0 110.4 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.1 m -52.88 -52.95 55.57 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.231 1.012 . . . . 0.0 110.933 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.546 ' O ' HG23 ' A' ' 106' ' ' VAL . 17.1 tp -57.81 -53.59 56.47 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 118.882 0.765 . . . . 0.0 110.099 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -58.69 -46.72 86.63 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -59.17 -43.44 92.12 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 125.049 1.339 . . . . 0.0 107.832 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.27 -50.53 65.64 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.552 HG22 ' CD2' ' A' ' 172' ' ' PHE . 15.7 t -57.32 -53.49 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 118.69 1.245 . . . . 0.0 110.684 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -32.8 74.22 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.044 0.838 . . . . 0.0 110.979 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.3 m -66.21 -45.71 79.81 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 34.1 mt -60.56 -51.43 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 123.848 0.859 . . . . 0.0 108.79 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.19 -38.97 69.06 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 123.521 0.513 . . . . 0.0 109.978 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -67.58 -54.51 19.22 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 118.808 0.731 . . . . 0.0 110.669 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.11 -17.5 7.32 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 125.874 1.67 . . . . 0.0 114.537 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.6 mp -111.59 -27.86 8.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 119.388 0.995 . . . . 0.0 109.509 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -59.71 -31.07 69.26 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.447 0.567 . . . . 0.0 110.919 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -64.38 -46.04 85.1 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 122.901 0.48 . . . . 0.0 111.348 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -162.95 152.6 15.56 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.996 1.719 . . . . 0.0 110.094 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 55.9 m -75.68 166.79 23.01 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 23.6 pt -125.12 153.29 32.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 124.426 1.091 . . . . 0.0 109.108 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -146.3 168.27 21.5 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.996 -0.44 . . . . 0.0 112.149 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -154.11 121.38 5.74 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.072 0.949 . . . . 0.0 109.665 178.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -81.71 103.96 11.77 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.5 0.72 . . . . 0.0 109.634 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.94 70.83 2.92 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 178.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 67.66 -121.15 14.1 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -69.11 -28.13 66.2 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -107.13 137.5 45.07 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 119.482 1.037 . . . . 0.0 110.056 -178.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.8 mt -112.74 134.13 56.33 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.42 ' CD1' HG11 ' A' ' 221' ' ' VAL . 43.7 m-85 -100.68 129.01 46.53 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 125.124 1.37 . . . . 0.0 107.977 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -123.57 132.5 53.9 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.897 1.279 . . . . 0.0 108.712 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -129.62 112.91 14.17 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.447 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 19.8 m -97.42 159.74 30.44 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-O 118.402 -0.809 . . . . 0.0 111.214 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.2 90.34 0.1 OUTLIER 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 123.989 3.126 . . . . 0.0 113.622 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 56.07 44.69 88.3 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 123.827 0.727 . . . . 0.0 112.751 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 6.5 mt -113.58 -66.89 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.449 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 13.6 pt-20 -171.41 167.56 6.76 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.894 1.278 . . . . 0.0 109.354 178.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.61 122.22 38.32 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 178.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.8 m -137.84 156.5 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -122.09 125.99 47.41 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 177.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -146.91 157.95 43.78 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.442 1.497 . . . . 0.0 110.13 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -88.56 153.25 21.29 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 178.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 174.08 -163.53 34.46 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.241 -1.943 . . . . 0.0 108.241 -178.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.12 137.84 46.45 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.8 146.89 20.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -90.79 98.57 11.85 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.266 1.426 . . . . 0.0 107.425 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.6 t -51.99 -23.87 5.75 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -52.03 -33.59 39.3 Favored 'General case' 0 C--N 1.341 0.198 0 O-C-N 121.268 -0.895 . . . . 0.0 112.762 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.0 t -146.43 -9.6 0.49 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.52 9.75 58.64 Favored Glycine 0 CA--C 1.523 0.572 0 O-C-N 120.591 -1.318 . . . . 0.0 112.714 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -68.65 121.71 17.02 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.401 1.1 . . . . 0.0 110.966 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 65.2 mt -75.67 126.16 36.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 40.8 t -89.69 -55.62 6.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -133.47 152.21 51.88 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.604 0.762 . . . . 0.0 110.241 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -147.04 173.67 12.24 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.604 2.362 . . . . 0.0 108.251 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -162.42 141.31 9.09 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -95.03 -5.49 44.36 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -178.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 21.5 m -83.0 -12.49 57.23 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.752 -1.218 . . . . 0.0 111.343 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.7 tp -131.89 72.94 1.51 Allowed 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.646 1.178 . . . . 0.0 109.322 -178.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 22.1 t -137.06 140.5 42.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.377 1.071 . . . . 0.0 108.23 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -126.14 134.46 51.31 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -85.91 120.88 27.79 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 126.531 1.932 . . . . 0.0 108.576 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 50.7 mt -94.08 -89.03 0.23 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -114.63 145.7 18.64 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -114.9 92.57 30.91 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 83.5 Cg_endo -71.9 179.67 4.62 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.682 2.922 . . . . 0.0 111.387 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -104.08 160.45 14.83 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 124.656 1.182 . . . . 0.0 111.676 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -77.37 -26.53 52.0 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -110.75 136.71 49.41 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.0 p -63.39 -24.11 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 124.147 0.979 . . . . 0.0 112.237 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -81.45 -18.5 45.05 Favored 'General case' 0 C--N 1.335 -0.038 0 C-N-CA 123.314 0.645 . . . . 0.0 112.258 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -71.55 -23.63 61.8 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 122.818 0.447 . . . . 0.0 110.3 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -113.62 168.6 9.63 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.01 1.724 . . . . 0.0 108.352 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -142.12 134.77 28.3 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.552 ' CD2' HG22 ' A' ' 106' ' ' VAL . 8.7 m-30 -101.03 170.86 7.99 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.07 0.948 . . . . 0.0 109.1 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -137.61 129.66 28.98 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 24.8 tp -100.79 98.35 8.88 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.12 -179.73 3.98 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 126.561 1.944 . . . . 0.0 108.775 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -149.64 162.74 39.61 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 122.23 1.014 . . . . 0.0 110.254 178.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -133.14 -179.67 5.64 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.997 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -58.66 -35.7 72.97 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 125.103 1.361 . . . . 0.0 109.092 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 44.7 t -72.05 -62.11 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -177.64 -169.14 38.3 Favored Glycine 0 C--N 1.338 0.679 0 CA-C-N 119.178 0.899 . . . . 0.0 111.234 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -78.4 158.4 28.75 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.997 0.427 . . . . 0.0 111.149 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -158.1 166.36 32.67 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.056 1.343 . . . . 0.0 107.894 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 3.5 mt -114.63 136.09 52.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 7.1 t -110.98 145.34 38.59 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -140.27 120.32 13.69 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 178.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 2.6 tt -114.85 134.55 57.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 178.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.5 mt -129.32 112.42 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 124.063 0.945 . . . . 0.0 110.289 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -104.29 -160.39 24.27 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 126.343 1.925 . . . . 0.0 111.292 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 40.0 m 67.55 60.12 0.48 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.465 1.506 . . . . 0.0 112.633 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -112.24 -119.47 3.73 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -126.28 115.57 19.9 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.496 1.518 . . . . 0.0 107.893 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 46.1 mm -60.26 114.59 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 54.3 m -72.8 100.07 2.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.73 -15.55 20.72 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.833 0.742 . . . . 0.0 112.7 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.46 -36.71 42.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.514 1.526 . . . . 0.0 107.513 177.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 5.0 p -126.49 -30.76 2.81 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 96.57 17.13 34.47 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 127.317 2.389 . . . . 0.0 111.116 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -92.46 166.18 12.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.35 1.075 . . . . 0.0 111.98 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -87.49 146.74 25.68 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.603 178.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -76.8 30.22 0.13 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.367 2.267 . . . . 0.0 110.744 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -74.6 140.93 44.69 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.964 0.888 . . . . 0.0 110.719 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.3 p -109.47 150.04 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.252 -1.34 . . . . 0.0 109.377 -178.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -120.62 130.44 54.15 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.9 mp -120.19 110.01 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 124.929 1.291 . . . . 0.0 108.2 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -96.46 107.07 19.42 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -84.19 124.45 31.18 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.099 0.96 . . . . 0.0 109.426 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 27.9 m -134.9 173.22 14.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 125.1 1.36 . . . . 0.0 110.645 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 2.4 t -86.86 127.55 35.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 177.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -85.44 171.85 46.2 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 118.61 0.641 . . . . 0.0 112.991 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -68.02 -16.13 68.14 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.831 1.205 . . . . 0.0 112.418 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 40.0 t -118.17 119.33 34.4 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -97.22 18.21 15.53 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.796 0.438 . . . . 0.0 111.253 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 91.2 p -138.41 48.33 1.95 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.045 1.738 . . . . 0.0 110.927 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.83 168.08 28.15 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 120.762 -1.211 . . . . 0.0 111.617 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.68 169.96 21.38 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.865 2.377 . . . . 0.0 111.041 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.5 ' O ' HG23 ' A' ' 217' ' ' THR . 78.9 p -68.54 155.05 40.71 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 216' ' ' SER . 0.8 OUTLIER -169.64 154.05 5.32 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 121.66 -0.65 . . . . 0.0 109.611 179.247 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.9 mt -82.06 130.23 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -75.98 -59.42 2.77 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.364 1.065 . . . . 0.0 111.441 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 45.1 p-90 -142.23 165.32 27.76 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.775 1.63 . . . . 0.0 108.222 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.807 HG13 ' CE1' ' A' ' 229' ' ' TYR . 46.3 t -145.24 127.01 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.75 133.76 17.07 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 122.051 0.929 . . . . 0.0 110.801 178.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -82.39 86.52 6.71 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 6.7 p -57.59 -64.76 0.79 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.587 1.155 . . . . 0.0 108.915 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -98.76 -174.49 2.8 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 178.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 34.3 mm -69.71 -43.93 79.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 O-C-N 121.347 -0.846 . . . . 0.0 110.486 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -103.81 -39.72 6.53 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.006 0.522 . . . . 0.0 112.308 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 15.5 t -72.56 130.82 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' TYR . . . . . 0.807 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.2 OUTLIER -127.5 148.88 50.32 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.915 1.686 . . . . 0.0 108.693 -179.207 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -129.02 144.23 51.12 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.804 1.242 . . . . 0.0 109.258 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.67 161.48 40.48 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.269 1.828 . . . . 0.0 108.698 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -131.05 144.88 51.78 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 86.8 t -130.94 135.23 60.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 4.6 p -102.64 142.58 33.56 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 72.9 mt -141.87 131.75 12.6 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-O 118.748 -0.644 . . . . 0.0 109.714 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -71.54 -32.97 11.38 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.514 2.143 . . . . 0.0 112.128 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -69.38 -22.02 63.74 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.029 0.932 . . . . 0.0 111.246 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.6 mp -68.91 -41.2 78.52 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 22.4 m -57.63 -19.76 28.52 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.137 1.375 . . . . 0.0 112.469 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -64.98 -26.38 68.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.247 0.619 . . . . 0.0 110.643 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 25.1 mt -88.03 133.8 33.88 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.704 2.401 . . . . 0.0 108.477 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -54.9 -47.37 74.43 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.935 2.094 . . . . 0.0 113.937 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 8.1 mp -58.91 -34.63 71.92 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.225 -0.922 . . . . 0.0 111.925 -178.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -92.66 3.88 54.75 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.046 1.338 . . . . 0.0 111.476 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -76.78 52.75 0.86 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.259 1.823 . . . . 0.0 110.491 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -153.43 134.77 14.21 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.188 1.395 . . . . 0.0 107.321 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -164.41 178.74 7.23 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.962 1.705 . . . . 0.0 107.921 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 59.56 21.3 9.84 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.079 1.351 . . . . 0.0 113.026 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 36.9 t70 . . . . . 0 C--O 1.252 1.232 0 C-N-CA 124.672 1.189 . . . . 0.0 110.787 -179.455 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.761 0 N-CA-C 108.436 -1.866 . . . . 0.0 108.436 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.37 -5.25 1.82 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.593 1.157 . . . . 0.0 113.499 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.7 t -68.57 155.66 39.55 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -150.08 107.11 3.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.3 m -57.81 -26.39 61.91 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -84.02 -25.72 29.69 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.786 -0.571 . . . . 0.0 110.245 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.6 tptm -67.87 -44.86 76.09 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.1 p -63.54 -40.23 96.46 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.89 95.69 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 40.7 tp -65.61 -44.83 85.32 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.981 0.912 . . . . 0.0 110.041 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 21.4 mt -62.24 -49.02 77.37 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 79.0 m -54.46 -54.22 43.75 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.638 0.775 . . . . 0.0 109.092 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -58.0 -51.36 69.97 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 122.835 0.454 . . . . 0.0 109.989 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 28.3 m -56.52 -42.61 78.7 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.819 0.847 . . . . 0.0 112.548 -178.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.6 tp -66.98 -55.66 13.52 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 119.328 0.967 . . . . 0.0 110.136 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -60.21 -47.15 87.19 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 118.749 0.704 . . . . 0.0 111.971 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -57.79 -49.79 75.43 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.31 -47.18 91.1 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.478 HG13 ' CE1' ' A' ' 172' ' ' PHE . 42.5 t -59.74 -53.55 46.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 126.238 1.815 . . . . 0.0 110.783 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -32.56 74.17 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 119.776 -0.769 . . . . 0.0 109.68 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.6 m -65.36 -44.92 86.14 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.284 0.947 . . . . 0.0 108.63 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.518 HD11 HD12 ' A' ' 183' ' ' ILE . 7.9 mt -53.02 -53.16 23.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.33 -46.87 79.73 Favored 'General case' 0 N--CA 1.436 -1.15 0 O-C-N 124.688 1.243 . . . . 0.0 111.99 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.21 -50.83 71.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.809 0.814 . . . . 0.0 110.023 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -68.46 -8.96 45.52 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.721 1.208 . . . . 0.0 114.059 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.4 mt -115.27 -25.15 8.14 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.416 1.007 . . . . 0.0 111.861 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -61.87 -29.27 70.08 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.125 0.42 . . . . 0.0 110.347 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -69.62 -46.35 66.43 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.883 1.273 . . . . 0.0 109.546 178.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 -160.15 147.45 16.28 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.641 1.576 . . . . 0.0 110.218 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 65.9 m -75.58 177.57 6.66 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 34.0 pt -131.86 150.32 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 O-C-N 121.432 -0.793 . . . . 0.0 109.556 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.59 164.91 28.94 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.961 0.504 . . . . 0.0 110.604 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -147.08 129.13 15.5 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.057 1.743 . . . . 0.0 109.237 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -91.33 102.76 15.46 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.97 66.64 3.62 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.959 1.303 . . . . 0.0 107.791 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.16 -120.28 11.77 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -63.34 -34.9 78.7 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.809 0.844 . . . . 0.0 112.558 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -107.44 148.85 28.61 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 118.743 0.701 . . . . 0.0 110.637 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.0 mt -112.06 151.03 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -125.22 128.4 48.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.246 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -126.33 130.69 51.31 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.846 1.658 . . . . 0.0 108.544 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -125.76 120.97 32.02 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.35 1.46 . . . . 0.0 109.33 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 6.5 m -105.53 160.02 27.51 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.755 1.222 . . . . 0.0 113.89 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.02 86.12 0.49 Allowed 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 124.585 3.524 . . . . 0.0 113.208 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 61.93 54.95 31.11 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.0 mt -130.02 -67.46 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.414 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 20.9 pt-20 -170.29 166.57 8.72 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 126.337 1.855 . . . . 0.0 108.05 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.58 119.07 27.12 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 102.472 -3.159 . . . . 0.0 102.472 177.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.6 m -139.24 148.39 23.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -178.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -113.69 138.02 50.8 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -145.76 158.5 43.85 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.753 1.221 . . . . 0.0 111.158 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -87.81 154.48 20.51 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 152.34 -164.14 30.48 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -132.13 161.29 33.68 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.173 1.389 . . . . 0.0 108.01 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 53.7 t -131.69 136.63 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.579 1.152 . . . . 0.0 109.928 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.89 93.33 5.64 Favored 'General case' 0 N--CA 1.461 0.09 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.2 t -48.13 -27.95 2.65 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -54.42 -30.16 51.46 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.258 1.423 . . . . 0.0 112.498 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.1 t -145.18 -16.69 0.5 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.533 0.606 . . . . 0.0 112.196 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 96.26 4.91 59.55 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 125.191 1.377 . . . . 0.0 113.173 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -68.85 142.46 54.82 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.557 1.178 . . . . 0.0 110.34 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.7 mt -74.76 158.29 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 57.6 t -99.87 -41.97 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 117.798 -1.096 . . . . 0.0 112.127 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -128.56 174.71 9.15 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 120.635 1.562 . . . . 0.0 112.246 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -141.11 58.14 1.54 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.455 1.102 . . . . 0.0 110.468 -178.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.79 106.28 11.69 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 120.536 -1.352 . . . . 0.0 109.343 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -63.91 -12.95 41.55 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.525 1.057 . . . . 0.0 110.963 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.1 t -66.26 -25.84 67.07 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 128.071 2.548 . . . . 0.0 114.366 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 46.8 mt -129.78 76.7 1.74 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.172 0.897 . . . . 0.0 108.696 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.2 t -142.67 138.95 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 126.145 1.778 . . . . 0.0 108.933 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -132.04 153.48 50.36 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 125.215 1.406 . . . . 0.0 110.673 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -95.39 135.96 36.35 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.658 1.583 . . . . 0.0 108.2 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 63.7 mt -115.89 -78.85 0.58 Allowed 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -121.38 154.05 16.6 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt -132.84 90.57 31.74 Favored Pre-proline 0 N--CA 1.456 -0.148 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 48.6 Cg_endo -76.27 -178.99 4.83 Favored 'Trans proline' 0 C--O 1.239 0.529 0 C-N-CA 123.194 2.596 . . . . 0.0 111.951 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -85.59 166.97 15.8 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.24 -37.03 39.03 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -105.33 152.0 23.47 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.375 -0.828 . . . . 0.0 111.67 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.1 p -68.25 -24.68 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.575 0.75 . . . . 0.0 112.393 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -82.82 -8.24 59.6 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.909 1.284 . . . . 0.0 112.372 -178.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -96.79 -11.72 24.58 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.466 1.107 . . . . 0.0 110.258 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -120.53 177.91 4.87 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.83 2.452 . . . . 0.0 111.552 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -142.85 165.78 26.44 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.02 1.728 . . . . 0.0 109.786 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.478 ' CE1' HG13 ' A' ' 106' ' ' VAL . 77.7 m-85 -140.94 168.42 19.84 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.885 1.674 . . . . 0.0 109.28 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -129.97 122.0 27.65 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.638 0.775 . . . . 0.0 109.488 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.0 tt -81.28 105.0 12.12 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 45.7 mt -115.78 -179.89 3.78 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.944 0.897 . . . . 0.0 110.995 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -161.91 156.15 22.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -138.42 -172.83 3.38 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -54.16 -24.2 17.18 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.487 1.915 . . . . 0.0 113.626 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 45.7 t -80.85 -75.5 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -166.68 -168.97 29.67 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.571 ' CE2' HD22 ' A' ' 243' ' ' LEU . 6.3 m-85 -78.16 154.78 30.88 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.249 1.02 . . . . 0.0 111.177 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -160.85 175.38 12.61 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.149 1.78 . . . . 0.0 108.74 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.518 HD12 HD11 ' A' ' 109' ' ' ILE . 15.8 mt -120.01 137.85 52.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 103.063 -2.94 . . . . 0.0 103.063 177.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.4 t -124.88 125.85 44.61 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -128.55 146.02 50.95 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 5.8 tt -121.53 138.2 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.409 HG21 ' HD3' ' A' ' 163' ' ' PRO . 13.8 mt -126.06 109.54 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 125.65 1.58 . . . . 0.0 109.512 -178.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.34 -153.26 24.9 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 41.7 m 75.95 31.67 0.68 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.866 1.267 . . . . 0.0 111.357 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -91.62 -138.22 7.92 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 108.266 -1.934 . . . . 0.0 108.266 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -117.47 121.71 41.77 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 127.229 2.212 . . . . 0.0 110.04 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 10.6 mm -60.79 125.63 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 123.378 0.671 . . . . 0.0 109.839 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 56.6 m -84.64 101.96 12.56 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 103.922 -2.621 . . . . 0.0 103.922 177.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -58.61 -17.79 24.91 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.579 0.627 . . . . 0.0 110.762 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 24.9 t -50.69 -41.56 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 125.526 1.53 . . . . 0.0 109.098 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 7.5 p -125.45 -24.23 3.96 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 96.1 6.21 59.13 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 126.713 2.101 . . . . 0.0 112.441 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -86.23 166.82 15.4 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.038 0.935 . . . . 0.0 110.965 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -90.39 150.87 21.68 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 2.6 tpt85 -76.88 30.69 0.13 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 128.216 2.606 . . . . 0.0 110.789 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.1 ptt? -72.44 149.13 44.5 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -176.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.3 p -121.74 140.78 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 114.616 -1.174 . . . . 0.0 112.218 -176.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -112.57 123.09 49.51 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.365 1.066 . . . . 0.0 110.394 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 2.3 mp -109.04 128.67 64.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 126.115 1.766 . . . . 0.0 111.098 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -106.23 118.69 37.29 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.36 1.064 . . . . 0.0 108.724 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -97.27 115.33 27.43 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.91 0.884 . . . . 0.0 109.61 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 32.8 m -125.54 165.42 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.647 1.579 . . . . 0.0 112.106 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.13 137.33 37.43 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -107.06 128.03 9.08 Favored Glycine 0 C--N 1.334 0.471 0 N-CA-C 108.265 -1.934 . . . . 0.0 108.265 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -42.91 -41.63 4.63 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.592 1.568 . . . . 0.0 113.656 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.4 t -79.49 85.37 5.27 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.414 ' HA ' ' HB3' ' A' ' 236' ' ' PRO . 18.1 p-10 -72.66 9.15 1.17 Allowed 'General case' 0 CA--C 1.549 0.908 0 O-C-N 121.276 -0.89 . . . . 0.0 113.115 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.95 46.51 1.65 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.43 1.892 . . . . 0.0 112.906 -178.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -166.83 159.89 33.38 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 120.299 -1.5 . . . . 0.0 111.993 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.25 166.59 22.82 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.135 2.557 . . . . 0.0 111.825 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 5.2 p -66.22 158.62 28.38 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.827 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.0 p -161.6 165.31 28.58 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.125 1.77 . . . . 0.0 107.376 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.8 mt -85.61 132.1 32.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -78.2 -53.03 7.79 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.787 1.635 . . . . 0.0 110.542 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' TRP . . . . . 0.489 ' CE3' ' HD2' ' A' ' 222' ' ' ARG . 37.9 p-90 -152.16 167.4 28.66 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.38 1.472 . . . . 0.0 108.685 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.717 HG13 ' CE1' ' A' ' 229' ' ' TYR . 47.0 t -146.29 133.88 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 126.253 1.821 . . . . 0.0 106.923 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.489 ' HD2' ' CE3' ' A' ' 220' ' ' TRP . 0.1 OUTLIER -153.75 130.47 10.81 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.912 0.778 . . . . 0.0 111.12 178.082 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -81.73 86.88 6.36 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 6.6 p -65.32 -55.02 20.61 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 127.022 2.129 . . . . 0.0 110.599 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -98.38 -176.51 3.42 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.5 mp -78.79 -29.98 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.8 t -111.61 -54.34 2.62 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.511 0.725 . . . . 0.0 110.898 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.94 149.4 10.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 123.639 0.776 . . . . 0.0 109.283 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' TYR . . . . . 0.717 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.2 OUTLIER -138.24 139.56 39.29 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.213 1.805 . . . . 0.0 109.453 -178.168 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.3 140.34 49.68 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.03 1.332 . . . . 0.0 108.553 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.39 162.32 38.46 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.394 1.877 . . . . 0.0 109.12 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -131.79 149.4 52.48 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 94.3 t -132.55 132.77 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 125.836 1.654 . . . . 0.0 108.887 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.25 144.29 27.2 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 32.7 mt -141.28 136.97 16.21 Favored Pre-proline 0 N--CA 1.454 -0.262 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.414 ' HB3' ' HA ' ' A' ' 212' ' ' ASN . 89.9 Cg_endo -76.75 -40.88 0.46 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.627 1.551 . . . . 0.0 112.338 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -68.27 -17.67 64.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 120.768 -1.208 . . . . 0.0 111.944 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 17.0 mt -66.04 -30.77 71.36 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 176.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 28.9 m -61.11 -13.78 19.71 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.024 1.33 . . . . 0.0 111.167 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -75.37 -32.37 60.81 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 120.142 -1.599 . . . . 0.0 111.534 178.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 40.5 mt -81.31 111.47 17.72 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 126.5 1.92 . . . . 0.0 109.0 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -47.08 -34.11 5.58 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 128.847 2.859 . . . . 0.0 114.878 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.571 HD22 ' CE2' ' A' ' 181' ' ' TYR . 12.5 mt -62.82 -39.62 94.88 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.355 -0.841 . . . . 0.0 111.531 178.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 4.8 mp -91.51 10.33 28.27 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 127.058 2.143 . . . . 0.0 113.5 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -72.09 65.62 0.58 Allowed 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 126.462 1.905 . . . . 0.0 110.694 -178.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -140.7 146.39 37.73 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 130.206 3.403 . . . . 0.0 107.754 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 27.0 m120 67.43 20.25 9.92 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -82.48 85.54 6.92 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 100.414 -3.921 . . . . 0.0 100.414 176.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 18.6 t70 . . . . . 0 C--O 1.247 0.943 0 C-N-CA 126.857 2.063 . . . . 0.0 109.808 -178.935 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.715 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -144.26 -78.7 0.2 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.736 1.214 . . . . 0.0 110.127 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.1 p -72.61 81.29 1.1 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.357 1.063 . . . . 0.0 109.528 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -82.45 -38.76 23.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 118.623 -0.703 . . . . 0.0 112.57 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 63.4 m -57.92 -54.54 45.72 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.955 0.902 . . . . 0.0 111.918 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -62.83 -27.93 69.66 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.554 0.342 . . . . 0.0 111.57 -178.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? -66.67 -57.22 7.6 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.9 p -61.81 -36.17 80.34 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 118.17 0.441 . . . . 0.0 110.415 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.49 -48.17 82.94 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 118.293 0.497 . . . . 0.0 110.096 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 47.1 tp -67.53 -40.2 85.06 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 118.218 -0.896 . . . . 0.0 109.445 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.7 mt -59.35 -52.49 65.43 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.864 1.211 . . . . 0.0 109.266 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.4 m -57.3 -49.57 75.68 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 121.648 -0.657 . . . . 0.0 109.47 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -57.89 -49.1 77.86 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 118.238 0.472 . . . . 0.0 109.776 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 59.6 m -53.05 -52.57 58.09 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.71 1.604 . . . . 0.0 110.422 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 19.0 tp -59.83 -54.3 47.88 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 118.802 -0.618 . . . . 0.0 110.603 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.86 -47.67 79.88 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 118.262 0.483 . . . . 0.0 111.708 -178.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -60.06 -39.74 87.05 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.285 1.034 . . . . 0.0 108.512 178.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.89 -52.83 50.53 Favored Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 40.3 t -56.39 -52.99 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 118.661 1.231 . . . . 0.0 111.165 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -29.67 70.87 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.405 1.002 . . . . 0.0 111.54 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.1 m -75.41 -42.69 53.09 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 118.79 -0.624 . . . . 0.0 110.459 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.427 HD11 HD12 ' A' ' 183' ' ' ILE . 22.6 mt -56.12 -50.87 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.03 -43.19 91.57 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -65.77 -20.51 66.29 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.72 1.208 . . . . 0.0 112.81 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.16 10.36 33.84 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.003 1.321 . . . . 0.0 112.583 178.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.7 mt -135.59 -29.15 1.07 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.497 1.119 . . . . 0.0 113.555 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -51.7 -37.16 49.61 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -178.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -65.45 -40.07 92.79 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 116.069 1.878 . . . . 0.0 116.069 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.9 mmt180 -159.12 147.87 18.25 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.395 1.478 . . . . 0.0 109.243 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 32.2 m -75.72 172.3 12.87 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 32.9 pt -126.31 146.24 32.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.422 ' CD1' HD11 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -144.96 152.65 40.51 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 122.84 0.456 . . . . 0.0 110.889 -178.562 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -137.08 127.71 26.98 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 124.046 0.938 . . . . 0.0 110.455 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -89.15 102.86 15.52 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.57 70.75 4.24 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.08 -115.51 5.5 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -77.27 -28.03 53.37 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.322 1.049 . . . . 0.0 111.794 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -106.65 135.56 47.96 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 119.327 0.967 . . . . 0.0 111.215 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.4 mt -106.82 145.82 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.515 ' CD1' HG11 ' A' ' 221' ' ' VAL . 67.1 m-85 -121.27 128.33 52.26 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.409 1.484 . . . . 0.0 107.627 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -122.94 128.24 50.0 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.676 1.59 . . . . 0.0 110.255 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -121.06 109.97 15.68 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.074 0.95 . . . . 0.0 108.612 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 11.6 m -95.23 158.8 34.15 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 123.226 0.61 . . . . 0.0 110.972 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.5 83.55 0.39 Allowed 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 123.903 3.069 . . . . 0.0 115.658 -178.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.32 51.68 50.47 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 124.205 0.907 . . . . 0.0 111.085 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.8 mt -126.8 -67.17 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.4 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 10.5 pt-20 -170.64 163.35 8.11 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 126.414 1.885 . . . . 0.0 108.362 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.67 121.12 36.64 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 102.154 -3.276 . . . . 0.0 102.154 177.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.4 m -131.5 156.95 43.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 124.548 1.139 . . . . 0.0 111.13 -178.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -125.83 126.39 44.41 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 178.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -143.99 157.53 44.28 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.489 1.115 . . . . 0.0 111.926 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -89.29 153.24 21.05 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 178.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 161.84 -163.03 34.51 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.38 140.86 50.58 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.6 t -123.37 144.54 32.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -94.64 100.41 12.35 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.3 t -57.01 -20.31 23.43 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.676 1.126 . . . . 0.0 112.191 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -46.97 -38.84 11.32 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 126.857 2.063 . . . . 0.0 112.317 178.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.7 t -144.61 -10.65 0.61 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.833 0.853 . . . . 0.0 112.034 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.13 3.81 63.35 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.581 1.563 . . . . 0.0 113.182 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -64.88 143.62 57.82 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.561 1.544 . . . . 0.0 111.149 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.422 HD11 ' CD1' ' A' ' 119' ' ' PHE . 39.7 mt -91.91 139.57 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 60.3 t -85.3 -82.35 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 123.553 0.741 . . . . 0.0 109.351 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -82.26 155.56 24.8 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.877 1.217 . . . . 0.0 109.103 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 62.2 mtp85 -122.33 34.22 5.22 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.301 1.44 . . . . 0.0 110.51 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -49.95 128.93 19.68 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.581 1.552 . . . . 0.0 110.524 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -95.99 -6.01 39.89 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.049 1.739 . . . . 0.0 114.959 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 41.7 p -75.75 -21.52 57.38 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 80.6 mt -128.92 81.81 2.05 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.3 t -142.5 135.12 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.071 1.348 . . . . 0.0 107.838 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -124.31 151.38 44.35 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.087 1.355 . . . . 0.0 111.051 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -96.99 112.64 24.3 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 127.068 2.147 . . . . 0.0 107.449 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.3 mp -93.82 -78.53 0.43 Allowed 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -120.49 144.23 16.95 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -121.52 89.35 47.19 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 52.5 Cg_endo -77.58 173.35 14.32 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.793 2.995 . . . . 0.0 111.608 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -87.88 161.88 17.25 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.184 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -82.97 -37.84 23.51 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.066 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -93.34 132.59 37.42 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 15.0 p -60.65 -31.74 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 123.85 0.86 . . . . 0.0 112.086 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -68.03 -21.36 65.02 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.704 0.684 . . . . 0.0 112.01 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -84.31 -20.31 32.3 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.838 0.455 . . . . 0.0 110.614 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 32.9 mmm-85 -70.72 165.93 21.95 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.748 0.819 . . . . 0.0 109.904 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -134.86 95.98 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.086 0.955 . . . . 0.0 109.241 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -106.68 156.65 18.4 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.946 1.298 . . . . 0.0 108.932 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -140.92 147.49 38.92 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.759 1.224 . . . . 0.0 107.888 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 25.1 tp -107.94 102.64 11.81 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 125.705 1.602 . . . . 0.0 106.875 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.81 179.0 4.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.28 1.432 . . . . 0.0 107.837 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.415 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 20.5 p90 -154.07 163.66 39.74 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -133.81 173.9 11.04 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -63.78 -11.43 26.69 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.403 -0.81 . . . . 0.0 110.61 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 83.7 t -83.76 -66.16 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -176.32 -174.54 42.91 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.415 ' CD2' ' HB3' ' A' ' 176' ' ' TYR . 26.2 m-85 -81.41 156.57 25.33 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 124.798 1.239 . . . . 0.0 111.842 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -162.79 169.96 19.08 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.228 1.011 . . . . 0.0 111.258 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.427 HD12 HD11 ' A' ' 109' ' ' ILE . 7.9 mt -116.57 121.78 68.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 11.8 t -97.69 131.61 44.08 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.704 1.202 . . . . 0.0 110.321 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -137.93 110.14 7.34 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.114 1.766 . . . . 0.0 109.075 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 2.7 tt -103.22 140.23 22.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.2 mt -132.83 113.79 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 123.647 0.779 . . . . 0.0 110.289 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -106.55 -156.87 21.33 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 125.293 1.425 . . . . 0.0 110.897 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 65.69 60.79 0.7 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.109 1.763 . . . . 0.0 111.554 -178.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -116.84 -124.01 3.52 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 104.633 -3.387 . . . . 0.0 104.633 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -127.95 123.58 35.22 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.759 1.224 . . . . 0.0 110.754 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 31.0 mm -64.25 116.96 4.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 71.8 m -73.71 102.09 3.86 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -53.18 -28.8 28.24 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.5 m -52.41 -33.28 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 C-N-CA 125.025 1.33 . . . . 0.0 111.384 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 73.1 p -123.0 -45.79 2.12 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.74 12.43 20.88 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.994 2.235 . . . . 0.0 111.32 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -92.56 169.97 10.11 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.942 1.297 . . . . 0.0 111.488 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -85.17 148.51 26.07 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.589 0.709 . . . . 0.0 111.792 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 18.3 tpt85 -84.05 28.56 0.6 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.676 2.39 . . . . 0.0 109.157 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 3.5 ptt? -73.47 158.77 34.3 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -177.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 1.9 p -125.93 140.1 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.155 -178.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -105.96 115.54 30.4 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 125.84 1.656 . . . . 0.0 107.083 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.6 mp -107.12 131.65 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -118.1 120.15 36.88 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 125.435 1.494 . . . . 0.0 108.511 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -101.05 119.4 38.69 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.42 1.488 . . . . 0.0 112.368 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 17.2 m -127.05 176.34 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.808 1.243 . . . . 0.0 111.8 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.6 t -91.0 124.32 35.15 Favored 'General case' 0 C--N 1.337 0.053 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 178.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.34 155.24 34.03 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.258 -0.496 . . . . 0.0 113.043 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -57.44 -27.22 57.98 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.305 0.955 . . . . 0.0 111.594 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 6.0 m -114.68 93.69 4.44 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -77.55 25.03 0.19 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.967 1.707 . . . . 0.0 112.552 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 27.2 t -131.98 45.48 2.77 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.343 1.857 . . . . 0.0 110.005 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -161.35 166.03 35.69 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-O 118.619 -1.101 . . . . 0.0 111.27 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -71.09 166.75 28.16 Favored 'Trans proline' 0 C--O 1.24 0.589 0 C-N-CA 122.821 2.347 . . . . 0.0 112.413 -178.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 96.7 p -70.38 155.58 40.49 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -166.01 156.11 12.5 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.0 mt -78.87 127.03 39.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -72.01 -51.25 22.71 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.743 1.617 . . . . 0.0 112.139 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' TRP . . . . . 0.441 ' CZ2' ' HB2' ' A' ' 232' ' ' GLN . 20.7 p-90 -152.76 164.92 36.86 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.183 1.393 . . . . 0.0 109.334 -178.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.798 HG13 ' CE1' ' A' ' 229' ' ' TYR . 51.3 t -147.36 120.75 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.42 ' HD3' ' CE3' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -140.15 127.42 21.19 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 178.674 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -80.68 92.26 5.97 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 104.101 -2.555 . . . . 0.0 104.101 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 5.7 p -65.69 -65.65 0.65 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.35 1.46 . . . . 0.0 109.786 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -88.71 -172.83 3.88 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.052 0.941 . . . . 0.0 108.489 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.4 mp -78.71 -40.99 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -106.07 -49.41 3.38 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.106 1.363 . . . . 0.0 112.539 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 2.4 t -68.26 145.54 13.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' TYR . . . . . 0.798 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.2 OUTLIER -137.2 136.1 37.86 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.716 1.606 . . . . 0.0 109.177 -178.413 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.42 139.93 43.78 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 125.047 1.339 . . . . 0.0 108.577 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -142.06 155.1 45.38 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 126.088 1.755 . . . . 0.0 110.136 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.441 ' HB2' ' CZ2' ' A' ' 220' ' ' TRP . 5.0 tt0 -136.25 146.42 46.7 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 1.6 m -137.34 154.56 30.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.1 p -109.08 148.67 30.46 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 123.469 0.708 . . . . 0.0 110.33 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 41.6 mt -142.27 133.35 12.94 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.27 -46.56 0.65 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.772 2.315 . . . . 0.0 112.324 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -62.03 -22.73 65.96 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.953 0.901 . . . . 0.0 113.375 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.8 mp -63.26 -40.06 96.35 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.223 0.92 . . . . 0.0 108.974 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 30.2 m -54.59 -22.53 13.58 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.84 1.656 . . . . 0.0 113.152 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -62.7 -31.47 72.38 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 121.1 -1.0 . . . . 0.0 110.841 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 26.4 mt -79.4 118.88 21.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.7 -35.52 31.52 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.9 mp -58.93 -45.19 90.99 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.336 -0.852 . . . . 0.0 109.599 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.76 5.45 36.31 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.125 1.77 . . . . 0.0 112.62 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -78.18 52.18 1.08 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 119.68 1.127 . . . . 0.0 111.261 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -152.48 155.6 37.79 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.548 1.539 . . . . 0.0 109.069 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -160.91 157.58 26.76 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 125.886 1.675 . . . . 0.0 109.583 177.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.25 -1.46 5.71 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 125.384 1.473 . . . . 0.0 109.826 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 26.3 t0 . . . . . 0 C--O 1.243 0.737 0 CA-C-O 117.385 -1.293 . . . . 0.0 109.192 -179.875 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.284 0 N-CA-C 107.843 -2.103 . . . . 0.0 107.843 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.38 168.95 11.57 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.78 1.29 . . . . 0.0 108.41 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.8 t 57.23 29.67 17.11 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.334 1.054 . . . . 0.0 111.681 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -61.19 161.4 8.87 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.4 m -53.8 -61.08 2.53 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.071 1.349 . . . . 0.0 112.941 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -58.25 -36.64 73.52 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.818 1.19 . . . . 0.0 110.484 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.42 -38.75 74.84 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.6 m -72.69 -47.53 46.46 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.102 1.361 . . . . 0.0 109.28 178.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.05 -38.31 70.44 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.373 0.669 . . . . 0.0 110.659 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.3 tp -60.57 -38.11 83.5 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 119.003 -0.523 . . . . 0.0 110.457 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.497 HD23 HD13 ' A' ' 174' ' ' LEU . 3.4 mt -67.23 -49.51 64.2 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 58.7 m -54.6 -44.57 73.16 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.919 0.888 . . . . 0.0 109.904 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -66.31 -50.78 62.45 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 121.104 -0.998 . . . . 0.0 110.246 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 58.4 m -53.99 -47.43 71.44 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.287 1.435 . . . . 0.0 111.145 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 28.5 tp -63.31 -54.79 31.51 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 119.051 0.841 . . . . 0.0 110.911 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -54.01 -48.99 69.86 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.414 0.686 . . . . 0.0 110.52 -178.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -57.37 -50.79 71.85 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 124.07 0.948 . . . . 0.0 109.051 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -57.04 -49.38 72.13 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-O 119.178 -0.79 . . . . 0.0 111.687 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 72.6 t -58.88 -53.2 50.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 125.343 1.457 . . . . 0.0 110.867 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -31.23 72.34 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 118.573 0.624 . . . . 0.0 110.531 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.8 m -70.44 -46.13 64.47 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.537 HD11 HD12 ' A' ' 183' ' ' ILE . 10.9 mt -53.56 -54.31 19.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.37 -44.04 84.09 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 124.035 0.834 . . . . 0.0 110.81 -178.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -60.41 -52.53 64.82 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.163 0.506 . . . . 0.0 111.6 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -22.19 66.8 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.8 mt -96.04 -27.37 15.14 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 118.823 0.738 . . . . 0.0 110.311 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -61.79 -28.44 69.46 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.186 0.594 . . . . 0.0 110.178 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -66.53 -46.93 74.52 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -165.44 152.75 10.64 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.908 2.083 . . . . 0.0 109.431 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 57.5 m -75.44 171.82 13.58 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 41.6 pt -125.78 147.55 30.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 123.801 0.84 . . . . 0.0 108.981 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.73 156.42 45.01 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 122.78 0.432 . . . . 0.0 110.375 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -142.91 128.02 18.58 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 124.167 0.987 . . . . 0.0 110.195 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -88.71 106.12 18.14 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.29 67.23 0.92 Allowed 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.35 -120.53 7.11 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.173 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -66.73 -32.06 73.12 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.64 1.176 . . . . 0.0 111.345 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -107.64 135.84 48.41 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.463 0.649 . . . . 0.0 111.626 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.459 HD12 ' H ' ' A' ' 140' ' ' GLY . 33.1 mt -105.8 149.72 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 177.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -119.08 134.8 54.98 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.334 -1.757 . . . . 0.0 108.205 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -128.91 130.74 47.19 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.751 1.22 . . . . 0.0 108.495 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -129.4 118.82 22.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.585 1.154 . . . . 0.0 109.219 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 10.6 m -105.41 160.32 26.46 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.668 1.187 . . . . 0.0 113.57 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -63.79 92.82 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 124.858 3.706 . . . . 0.0 113.157 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 52.17 53.06 32.7 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-O 119.579 -0.567 . . . . 0.0 111.846 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.1 mt -124.92 -67.36 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -177.38 174.73 1.55 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.98 1.712 . . . . 0.0 109.203 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.82 124.55 39.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 177.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.9 m -134.42 156.94 41.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 124.379 1.072 . . . . 0.0 110.879 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -124.09 124.12 41.82 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -146.17 156.37 43.37 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.323 1.049 . . . . 0.0 111.615 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -102.21 119.59 39.06 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.459 ' H ' HD12 ' A' ' 126' ' ' ILE . . . -154.44 -165.14 13.54 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.921 1.724 . . . . 0.0 108.962 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.66 136.89 50.28 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.6 p -149.62 153.44 10.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 123.902 0.881 . . . . 0.0 112.319 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -95.18 113.76 25.48 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.7 t -65.03 -16.3 63.29 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 120.721 1.6 . . . . 0.0 111.818 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -71.3 -23.06 61.88 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.934 1.694 . . . . 0.0 114.046 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.2 t -145.07 -23.0 0.49 Allowed 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.559 -0.713 . . . . 0.0 110.679 -178.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.37 15.29 44.62 Favored Glycine 0 C--O 1.223 -0.578 0 C-N-CA 126.011 1.767 . . . . 0.0 110.959 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -71.36 112.08 7.2 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 118.226 1.013 . . . . 0.0 110.267 -178.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 88.1 mt -80.35 107.95 13.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 102.744 -3.058 . . . . 0.0 102.744 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 35.0 t -70.89 -41.56 77.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 126.702 2.001 . . . . 0.0 111.379 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -138.03 139.12 39.43 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 119.121 0.873 . . . . 0.0 110.744 -178.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 56.9 mtm180 -112.78 85.68 2.22 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 125.451 1.5 . . . . 0.0 112.677 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -71.95 134.17 45.81 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -95.56 -6.76 39.64 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.011 1.324 . . . . 0.0 111.593 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.08 -28.42 61.37 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -177.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 93.5 mt -123.27 81.6 1.9 Allowed 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.108 0.963 . . . . 0.0 108.553 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.8 t -134.95 133.95 53.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.044 0.838 . . . . 0.0 108.965 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -130.3 163.4 26.88 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.492 1.517 . . . . 0.0 110.792 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -112.9 143.38 44.28 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 18.5 mt -116.32 -72.92 0.67 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -128.67 148.88 18.19 Favored Glycine 0 C--O 1.241 0.564 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -130.78 91.83 36.0 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.718 1.207 . . . . 0.0 109.286 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.441 ' HD3' HG21 ' A' ' 187' ' ' ILE . 43.5 Cg_endo -74.46 -166.09 0.31 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 125.06 3.84 . . . . 0.0 111.051 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -95.98 168.1 10.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.114 1.366 . . . . 0.0 109.395 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -81.79 -28.45 33.2 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -113.98 162.56 16.27 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 123.328 0.651 . . . . 0.0 110.324 -179.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.8 p -73.63 -34.58 41.96 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 C-N-CA 123.364 0.665 . . . . 0.0 110.379 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -74.37 -16.03 60.91 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.404 -0.81 . . . . 0.0 112.182 -177.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -81.57 -19.66 41.53 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.183 0.993 . . . . 0.0 110.603 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -117.33 177.91 4.56 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.608 1.563 . . . . 0.0 110.985 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -140.51 156.86 46.2 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -133.83 166.99 21.37 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.308 1.843 . . . . 0.0 107.977 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -133.74 123.7 25.38 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 120.498 1.499 . . . . 0.0 112.614 -179.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.497 HD13 HD23 ' A' ' 98' ' ' LEU . 0.7 OUTLIER -82.77 99.08 9.45 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.005 1.322 . . . . 0.0 109.442 179.581 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.43 HD12 ' HB2' ' A' ' 184' ' ' SER . 24.7 mt -108.21 174.02 6.06 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 122.394 1.092 . . . . 0.0 109.516 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -154.52 163.11 40.7 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -141.25 -178.44 5.59 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -52.55 -34.25 49.3 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 125.335 1.454 . . . . 0.0 110.523 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.505 HG13 ' HB2' ' A' ' 248' ' ' GLU . 56.1 t -70.79 -67.78 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 127.005 2.122 . . . . 0.0 109.191 178.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -175.77 -174.69 42.54 Favored Glycine 0 N--CA 1.446 -0.66 0 O-C-N 121.817 -0.552 . . . . 0.0 111.931 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -80.06 158.32 26.49 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.515 1.126 . . . . 0.0 111.973 -178.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -165.69 177.0 7.58 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.457 1.503 . . . . 0.0 108.531 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.537 HD12 HD11 ' A' ' 109' ' ' ILE . 8.9 mt -121.92 126.28 74.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 101.609 -3.478 . . . . 0.0 101.609 177.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.43 ' HB2' HD12 ' A' ' 175' ' ' LEU . 3.2 t -106.4 107.8 19.0 Favored 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 124.325 1.016 . . . . 0.0 109.248 -178.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -111.22 118.78 36.85 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 118.5 -0.762 . . . . 0.0 110.699 -179.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.8 tt -108.95 140.27 28.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.441 HG21 ' HD3' ' A' ' 163' ' ' PRO . 7.5 mt -133.87 113.47 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 C-N-CA 123.997 0.919 . . . . 0.0 110.637 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.68 -162.41 26.01 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 177.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.0 m 84.45 29.19 0.07 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.251 2.221 . . . . 0.0 112.959 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -87.4 -109.15 0.92 Allowed Glycine 0 C--N 1.338 0.649 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -139.11 126.6 21.7 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.337 1.455 . . . . 0.0 109.053 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.5 mm -68.19 122.54 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 120.503 1.501 . . . . 0.0 109.453 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 30.5 p -82.01 117.76 22.46 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 123.156 0.583 . . . . 0.0 111.622 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -71.89 -3.52 22.95 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.115 -0.991 . . . . 0.0 110.718 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 39.6 t -66.98 -42.06 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 125.127 1.371 . . . . 0.0 108.278 178.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.9 p -124.34 -28.57 3.64 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 122.898 0.479 . . . . 0.0 111.613 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.77 30.62 10.22 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -116.55 169.28 9.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.74 1.216 . . . . 0.0 112.289 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -83.83 139.91 32.36 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.351 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 2.9 tpp85 -77.13 30.75 0.14 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 130.013 3.325 . . . . 0.0 109.371 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 12.2 ptt? -73.11 157.11 37.9 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 122.008 0.909 . . . . 0.0 109.329 -176.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.5 p -125.19 146.05 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 114.37 -1.287 . . . . 0.0 111.317 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -112.7 138.6 49.27 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 1.8 mp -125.94 114.38 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 126.455 1.902 . . . . 0.0 107.579 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -99.69 116.28 31.43 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -93.54 118.17 31.01 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 125.242 1.417 . . . . 0.0 111.506 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 32.5 m -129.49 172.21 15.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 124.266 1.026 . . . . 0.0 111.312 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.2 t -78.59 134.96 37.16 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -93.21 122.01 6.79 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -37.68 -61.73 1.06 Allowed Glycine 0 C--N 1.336 0.538 0 C-N-CA 126.74 2.114 . . . . 0.0 111.343 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.8 p -77.66 83.09 4.05 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.483 ' HA ' ' HB3' ' A' ' 236' ' ' PRO . 37.2 p-10 -76.64 66.78 2.66 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.9 p -149.47 19.45 0.94 Allowed 'General case' 0 C--O 1.238 0.458 0 N-CA-C 116.539 2.052 . . . . 0.0 116.539 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -163.95 173.65 40.01 Favored Glycine 0 N--CA 1.47 0.941 0 O-C-N 121.189 -0.945 . . . . 0.0 115.197 -178.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -64.77 164.24 24.97 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.036 2.49 . . . . 0.0 112.535 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 15.8 p -67.31 157.59 33.59 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.368 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 1.7 p -161.27 163.72 30.75 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.417 2.287 . . . . 0.0 106.923 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.5 mt -82.75 134.57 26.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 178.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -81.57 -55.22 4.81 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.052 1.341 . . . . 0.0 111.097 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 26.2 p-90 -147.92 166.54 27.36 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.259 1.424 . . . . 0.0 108.541 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.679 HG13 ' CE1' ' A' ' 229' ' ' TYR . 49.6 t -146.1 131.76 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -179.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.43 133.65 15.25 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.73 0.776 . . . . 0.0 111.223 177.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -81.72 89.3 6.27 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.2 p -66.01 -51.91 54.03 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.082 0.953 . . . . 0.0 111.734 -178.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -103.18 -173.83 2.4 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.0 mp -72.17 -43.54 66.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 3.4 m -111.94 -28.55 7.99 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -177.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 2.1 t -81.78 143.1 12.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' TYR . . . . . 0.679 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.9 OUTLIER -129.04 145.5 51.24 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.31 1.444 . . . . 0.0 110.09 -177.964 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -129.33 142.02 50.93 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 125.442 1.497 . . . . 0.0 108.39 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.28 163.2 37.16 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.296 1.839 . . . . 0.0 110.786 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -126.89 149.15 49.91 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 88.7 t -132.77 134.37 58.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 125.525 1.53 . . . . 0.0 107.803 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.41 143.48 32.63 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.922 0.889 . . . . 0.0 108.877 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 33.8 mt -139.85 138.13 19.36 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 118.251 -0.88 . . . . 0.0 109.215 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.483 ' HB3' ' HA ' ' A' ' 212' ' ' ASN . 72.4 Cg_endo -74.22 -46.16 0.31 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.647 2.231 . . . . 0.0 110.838 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.71 -25.41 62.88 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.996 1.318 . . . . 0.0 110.816 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 238' ' ' LEU . 15.3 mt -65.52 -41.33 93.26 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 24.7 m -58.01 -16.1 11.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.604 1.562 . . . . 0.0 113.061 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -63.19 -43.84 97.07 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.006 0.923 . . . . 0.0 109.143 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.8 mt -71.87 120.04 16.9 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 128.809 2.844 . . . . 0.0 107.049 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -52.67 -35.21 54.75 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.4 mp -58.73 -36.7 74.72 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.602 -0.686 . . . . 0.0 110.897 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -94.41 3.88 54.6 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 125.046 1.338 . . . . 0.0 111.949 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -75.95 40.91 0.21 Allowed 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.506 -0.746 . . . . 0.0 112.384 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 20.6 tptt -153.62 154.28 33.91 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 127.025 2.13 . . . . 0.0 107.36 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -166.19 138.2 3.8 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 125.362 1.465 . . . . 0.0 107.806 177.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' GLU . . . . . 0.505 ' HB2' HG13 ' A' ' 179' ' ' VAL . 5.4 mm-40 -138.7 69.81 1.38 Allowed 'General case' 0 C--O 1.235 0.316 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.9 p30 . . . . . 0 C--O 1.249 1.063 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.537 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.117 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -146.5 -172.91 4.06 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.699 2.0 . . . . 0.0 106.32 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.7 t -138.04 149.34 45.95 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -130.32 14.37 5.59 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 127.977 2.511 . . . . 0.0 110.127 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 26.2 m -49.17 -41.72 37.57 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.265 1.026 . . . . 0.0 113.707 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -67.8 -37.39 81.93 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.706 -0.621 . . . . 0.0 110.187 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -64.83 -48.06 75.71 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.8 p -63.68 -36.08 82.65 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 118.375 -0.821 . . . . 0.0 110.22 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.53 -35.97 77.27 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.715 1.143 . . . . 0.0 110.34 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.22 -45.34 88.69 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.6 mt -63.46 -53.93 44.47 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.494 1.118 . . . . 0.0 109.538 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 55.2 m -54.87 -44.51 74.1 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.637 1.175 . . . . 0.0 110.648 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.1 ttmm -65.97 -49.79 66.6 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.813 -0.613 . . . . 0.0 109.945 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 79.9 m -51.92 -43.28 63.35 Favored 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 124.523 1.129 . . . . 0.0 111.157 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tt -61.79 -56.88 14.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.299 0.5 . . . . 0.0 111.898 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -60.69 -45.71 93.16 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.744 0.817 . . . . 0.0 111.42 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -57.72 -44.28 85.87 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.861 0.864 . . . . 0.0 108.851 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.98 -52.03 54.87 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 94.8 t -55.1 -53.2 36.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 124.977 1.311 . . . . 0.0 111.711 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.04 -33.36 75.58 Favored 'General case' 0 C--N 1.335 -0.052 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.741 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.2 m -67.63 -46.22 73.13 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.453 HD11 HD12 ' A' ' 183' ' ' ILE . 27.9 mt -55.64 -54.31 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 124.606 1.163 . . . . 0.0 108.855 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.02 -43.73 82.13 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.468 -178.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -60.99 -52.96 62.81 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-N 118.78 0.718 . . . . 0.0 110.637 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.68 -15.65 53.48 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.2 mt -101.54 -28.11 12.73 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 119.358 0.981 . . . . 0.0 109.174 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -65.5 -26.22 67.82 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -66.6 -46.23 76.61 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 -161.77 148.56 14.1 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.307 1.843 . . . . 0.0 109.297 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 71.0 m -74.99 164.42 26.57 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 178.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 33.3 pt -119.36 154.98 21.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -145.21 165.39 28.48 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.031 -178.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -151.25 125.34 9.26 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.194 1.397 . . . . 0.0 109.369 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -88.76 117.38 27.7 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -108.41 67.49 0.67 Allowed 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.722 1.209 . . . . 0.0 109.0 178.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.0 -114.09 3.88 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 107.917 -2.073 . . . . 0.0 107.917 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -83.99 -26.5 29.14 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.162 1.385 . . . . 0.0 112.463 179.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -106.38 115.44 30.22 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.409 1.484 . . . . 0.0 112.638 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 51.2 mt -92.57 146.74 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 C-N-CA 125.559 1.543 . . . . 0.0 108.219 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.475 ' CD1' HG11 ' A' ' 221' ' ' VAL . 64.1 m-85 -118.04 135.23 54.3 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.499 -1.228 . . . . 0.0 107.74 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -133.14 126.43 31.69 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.311 1.044 . . . . 0.0 108.772 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -122.85 127.07 48.53 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.595 1.158 . . . . 0.0 111.677 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 17.6 m -114.21 158.66 39.06 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 123.428 0.691 . . . . 0.0 112.351 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.28 92.78 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.625 1 C-N-CA 125.614 4.21 . . . . 0.0 113.858 -178.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 58.91 47.49 90.37 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.1 mt -125.37 -66.86 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.215 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.523 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 20.8 pt-20 -178.13 167.11 1.99 Allowed 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.415 1.486 . . . . 0.0 109.117 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.32 119.28 29.65 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 178.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.6 m -127.2 156.67 38.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 125.252 1.421 . . . . 0.0 110.765 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.36 124.07 41.57 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 103.638 -2.726 . . . . 0.0 103.638 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -146.29 158.79 43.91 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -178.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -89.37 153.64 20.7 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 169.48 -168.46 41.3 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -125.62 138.22 53.91 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.563 1.545 . . . . 0.0 107.075 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.9 p -148.8 152.43 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 119.244 0.929 . . . . 0.0 110.907 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -93.74 105.16 17.22 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.243 1.017 . . . . 0.0 108.353 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.9 t -50.05 -35.5 25.36 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.909 1.231 . . . . 0.0 112.142 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -46.73 -31.45 2.96 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.21 1.804 . . . . 0.0 114.0 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.1 t -146.4 -24.03 0.43 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 101.26 13.73 32.52 Favored Glycine 0 CA--C 1.527 0.842 0 O-C-N 120.984 -1.073 . . . . 0.0 111.237 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -70.08 115.28 9.11 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 23.0 mt -84.96 119.22 33.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 89.0 t -73.55 -72.3 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.34 1.456 . . . . 0.0 107.896 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -127.5 152.92 46.96 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.207 1.803 . . . . 0.0 108.04 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.3 87.88 1.48 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -61.13 118.62 7.04 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.738 1.215 . . . . 0.0 107.775 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -69.96 6.01 1.38 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 -178.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.43 -1.51 58.08 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 120.418 1.463 . . . . 0.0 111.357 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 15.9 mt -138.08 78.08 1.66 Allowed 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -136.2 135.18 50.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -134.49 154.82 51.23 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.96 1.704 . . . . 0.0 108.689 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -107.68 143.19 36.52 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.874 0.87 . . . . 0.0 109.236 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 35.5 mt -113.6 -69.96 0.83 Allowed 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 124.255 0.972 . . . . 0.0 109.432 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -133.57 156.51 22.3 Favored Glycine 0 C--O 1.239 0.422 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -126.78 93.7 41.67 Favored Pre-proline 0 C--O 1.231 0.102 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.523 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 57.3 Cg_endo -76.73 174.69 12.43 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 122.421 2.08 . . . . 0.0 110.068 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -81.32 162.03 23.62 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.47 -28.96 24.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.937 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -103.44 135.48 44.96 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.39 -22.54 28.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -83.28 -14.44 53.08 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 124.865 1.266 . . . . 0.0 111.448 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -84.55 -13.74 50.93 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.404 0.682 . . . . 0.0 110.864 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -117.51 174.56 6.08 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.345 1.858 . . . . 0.0 111.524 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -142.68 154.4 44.29 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.104 1.361 . . . . 0.0 109.511 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -128.96 169.41 14.69 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.874 2.469 . . . . 0.0 108.759 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -131.78 135.84 47.08 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.663 1.185 . . . . 0.0 109.514 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 17.4 tp -89.15 98.76 11.95 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.444 1.097 . . . . 0.0 108.343 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.408 HD12 ' HB2' ' A' ' 184' ' ' SER . 20.6 mt -105.32 178.37 4.58 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.95 0.881 . . . . 0.0 111.341 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -158.58 162.66 37.38 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -138.62 -178.39 5.28 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 125.346 1.459 . . . . 0.0 109.827 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -58.92 -15.59 13.56 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 45.4 t -98.58 -56.32 5.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 C-N-CA 125.569 1.548 . . . . 0.0 108.768 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -169.21 -167.42 29.77 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 119.324 0.966 . . . . 0.0 113.172 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -88.64 156.09 19.23 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 122.192 -0.593 . . . . 0.0 110.848 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -157.64 173.98 16.04 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.162 1.385 . . . . 0.0 107.934 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.453 HD12 HD11 ' A' ' 109' ' ' ILE . 18.9 mt -118.27 140.22 42.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 102.908 -2.997 . . . . 0.0 102.908 178.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.408 ' HB2' HD12 ' A' ' 175' ' ' LEU . 36.1 t -117.94 131.26 56.52 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.6 127.05 18.81 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 178.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.6 tt -115.19 134.74 57.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.5 mt -125.04 111.08 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.681 1.192 . . . . 0.0 111.823 -177.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -100.42 -158.32 27.95 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 108.328 -1.909 . . . . 0.0 108.328 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 9.1 m 69.53 56.95 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 123.93 0.892 . . . . 0.0 109.467 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -114.79 -116.06 3.11 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 105.678 -2.969 . . . . 0.0 105.678 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -135.24 129.05 33.05 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.902 1.681 . . . . 0.0 107.375 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 25.8 mm -67.28 132.73 32.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 29.3 p -80.31 113.48 18.52 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.22 -24.46 66.37 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.863 1.211 . . . . 0.0 111.86 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 3.6 m -57.34 -41.5 78.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 117.251 -1.357 . . . . 0.0 112.634 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 1.3 p -125.41 -21.43 4.54 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 120.612 1.551 . . . . 0.0 112.591 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 89.31 13.45 61.72 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.875 1.702 . . . . 0.0 110.923 -178.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -90.2 169.6 11.0 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.61 1.205 . . . . 0.0 108.98 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.412 ' C ' ' H ' ' A' ' 201' ' ' MET . 17.6 mt-10 -86.31 149.66 24.89 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.049 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -78.44 31.08 0.18 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.112 2.165 . . . . 0.0 107.775 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.412 ' H ' ' C ' ' A' ' 199' ' ' GLU . 11.5 ptt? -71.37 152.14 43.44 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -175.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.7 p -119.47 146.38 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 114.207 -1.361 . . . . 0.0 111.57 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -111.76 132.24 54.79 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 125.145 1.378 . . . . 0.0 107.391 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 2.4 mp -118.13 139.77 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 178.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -122.74 100.21 6.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -81.06 126.53 31.54 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 118.817 0.735 . . . . 0.0 110.198 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 33.0 m -134.79 172.24 16.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 126.014 1.726 . . . . 0.0 111.144 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.7 t -78.75 139.47 38.43 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -107.33 146.87 16.21 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -40.96 -66.14 0.94 Allowed Glycine 0 CA--C 1.522 0.514 0 C-N-CA 126.49 1.995 . . . . 0.0 112.469 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.7 t -70.75 103.72 2.66 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 117.845 0.822 . . . . 0.0 110.557 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -71.59 6.8 1.7 Allowed 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.68 -0.637 . . . . 0.0 111.018 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 73.9 p -126.95 30.72 5.41 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.335 1.854 . . . . 0.0 110.283 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -120.64 170.32 14.38 Favored Glycine 0 N--CA 1.47 0.925 0 CA-C-N 119.675 1.125 . . . . 0.0 115.159 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -79.91 165.75 21.75 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.583 2.188 . . . . 0.0 110.477 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 90.5 p -78.74 152.31 31.58 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.38 164.18 7.01 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.558 1.543 . . . . 0.0 108.215 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.1 mt -84.82 134.53 26.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -79.59 -54.27 6.05 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 125.224 1.409 . . . . 0.0 111.443 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' TRP . . . . . 0.406 ' CZ2' ' HB2' ' A' ' 232' ' ' GLN . 41.1 p-90 -146.94 162.65 38.28 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.71 1.204 . . . . 0.0 108.7 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.87 HG13 ' CE1' ' A' ' 229' ' ' TYR . 44.0 t -148.41 135.34 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 125.943 1.697 . . . . 0.0 107.062 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.07 138.4 10.26 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 177.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -82.51 87.3 6.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 102.564 -3.125 . . . . 0.0 102.564 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.1 p -63.13 -49.65 73.56 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.692 1.597 . . . . 0.0 111.913 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -95.2 -172.37 2.65 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.6 mp -71.51 -46.4 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 4.9 m -113.37 -36.55 4.95 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 2.7 t -70.17 144.63 13.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' TYR . . . . . 0.87 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.1 OUTLIER -127.56 139.76 52.55 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.079 1.752 . . . . 0.0 108.141 -179.028 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -121.94 142.99 49.73 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.895 1.278 . . . . 0.0 109.425 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.69 162.71 36.92 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.624 1.57 . . . . 0.0 110.019 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.406 ' HB2' ' CZ2' ' A' ' 220' ' ' TRP . 15.8 tt0 -129.11 142.93 50.73 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 93.5 t -129.25 137.88 55.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 124.891 1.277 . . . . 0.0 108.192 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.97 139.85 41.99 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 123.849 0.859 . . . . 0.0 111.153 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 26.6 mt -140.33 139.07 19.91 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.259 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.05 -43.98 0.29 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.683 2.256 . . . . 0.0 111.983 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -59.22 -21.21 59.16 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.807 0.843 . . . . 0.0 111.373 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 14.1 mt -69.85 -39.92 76.12 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 117.383 -1.294 . . . . 0.0 109.032 177.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 9.1 m -58.44 -22.13 53.38 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 119.657 1.117 . . . . 0.0 113.386 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -60.78 -32.03 71.37 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.362 0.665 . . . . 0.0 110.301 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 23.7 mt -79.86 118.84 21.99 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -48.33 -35.15 11.82 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 3.6 mp -57.61 -41.4 81.21 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 121.093 -1.004 . . . . 0.0 111.148 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -89.42 1.83 55.31 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.87 1.668 . . . . 0.0 112.905 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -76.01 59.86 1.34 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.418 1.487 . . . . 0.0 108.6 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -147.43 127.16 13.41 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.857 2.063 . . . . 0.0 108.823 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . 0.251 17.3 m120 85.32 9.37 0.35 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 130.408 3.483 . . . . 0.0 112.246 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -73.4 -19.9 60.87 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.657 1.983 . . . . 0.0 108.844 177.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 4.7 t70 . . . . . 0 C--O 1.251 1.164 0 C-N-CA 128.253 2.621 . . . . 0.0 110.647 179.488 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 CA--C 1.534 0.346 0 CA-C-O 119.013 -0.518 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.18 -45.26 77.5 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.03 -39.41 81.89 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.1 mt -63.72 -52.83 58.76 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 19.6 m -54.71 -44.96 73.91 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.876 -0.515 . . . . 0.0 109.618 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -63.77 -51.67 63.79 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.195 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.0 m -58.47 -39.96 81.4 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 120.325 1.42 . . . . 0.0 111.317 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.577 ' O ' HG23 ' A' ' 106' ' ' VAL . 10.3 tp -64.67 -55.48 19.87 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 119.016 0.825 . . . . 0.0 110.072 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -59.65 -46.98 87.38 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -57.58 -44.23 85.21 Favored 'General case' 0 C--O 1.225 -0.204 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.73 -53.39 46.62 Favored Glycine 0 N--CA 1.438 -1.228 0 CA-C-O 118.473 -1.181 . . . . 0.0 111.11 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 102' ' ' LEU . 5.0 t -55.19 -52.96 39.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 119.132 1.466 . . . . 0.0 111.142 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -33.76 76.19 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 118.816 -0.612 . . . . 0.0 111.274 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.0 m -70.04 -45.83 66.33 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.463 HD11 HD12 ' A' ' 183' ' ' ILE . 32.9 mt -56.27 -54.67 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 123.94 0.896 . . . . 0.0 109.814 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.76 -39.64 92.34 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 123.614 0.571 . . . . 0.0 110.266 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -62.86 -44.48 95.99 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.166 0.894 . . . . 0.0 110.526 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -20.32 62.29 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 118.266 -0.873 . . . . 0.0 112.765 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.8 mt -98.77 -28.85 13.31 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 120.34 1.427 . . . . 0.0 111.651 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -59.35 -37.43 77.83 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.91 0.484 . . . . 0.0 110.618 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -64.03 -46.76 83.02 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -156.94 148.32 22.22 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.013 0.925 . . . . 0.0 110.245 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 85.7 m -75.26 174.48 9.45 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 41.4 pt -130.71 148.6 33.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 123.476 0.71 . . . . 0.0 110.074 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.54 168.23 20.26 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.218 0.607 . . . . 0.0 110.038 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -151.43 129.59 11.91 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.906 1.682 . . . . 0.0 109.67 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -95.0 102.33 14.13 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.53 67.41 2.86 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 126.573 1.949 . . . . 0.0 109.384 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.15 -116.85 5.69 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 124.5 1.048 . . . . 0.0 110.803 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -70.2 -30.62 67.77 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.144 0.978 . . . . 0.0 111.443 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -107.33 160.39 15.65 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.865 0.841 . . . . 0.0 110.051 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.6 mt -125.86 151.66 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.432 ' CD1' HG11 ' A' ' 221' ' ' VAL . 40.4 m-85 -123.18 131.56 53.73 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 126.456 1.902 . . . . 0.0 106.749 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -126.35 131.54 51.78 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.849 1.659 . . . . 0.0 108.325 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -128.52 123.65 34.06 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.952 1.301 . . . . 0.0 109.869 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 4.6 m -109.91 160.35 28.43 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.236 1.414 . . . . 0.0 113.718 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.96 90.41 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.13 3.22 . . . . 0.0 113.324 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 59.19 52.07 55.45 Favored Glycine 0 CA--C 1.519 0.34 0 O-C-N 120.957 -1.089 . . . . 0.0 111.743 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.6 mt -127.31 -67.17 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.09 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.411 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 8.7 pt-20 -173.09 167.31 4.94 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 126.13 1.772 . . . . 0.0 109.281 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.22 117.24 24.13 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.0 m -130.57 156.19 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 124.386 1.074 . . . . 0.0 112.706 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -124.79 135.46 52.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 177.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -146.45 157.41 43.75 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.079 0.952 . . . . 0.0 113.35 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 33.5 t60 -88.79 119.72 29.54 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 103.581 -2.748 . . . . 0.0 103.581 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -165.25 -163.14 17.9 Favored Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 111.666 -0.573 . . . . 0.0 111.666 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.3 154.31 51.58 Favored 'General case' 0 CA--C 1.526 0.039 0 C-N-CA 123.505 0.722 . . . . 0.0 109.486 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.4 t . . . . . 0 C--O 1.24 0.603 0 C-N-CA 124.087 0.955 . . . . 0.0 110.716 -179.047 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 . . . . . 0 C--O 1.235 0.299 0 CA-C-O 120.69 0.281 . . . . 0.0 110.363 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 23.4 mt . . . . . 0 CA--C 1.54 0.59 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -179.888 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 89.9 mt . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.3 t -137.17 143.83 33.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 125.745 1.618 . . . . 0.0 106.788 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -140.44 162.63 34.88 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.907 0.883 . . . . 0.0 111.56 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.3 ptp85 -108.34 143.21 37.54 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.926 1.291 . . . . 0.0 110.076 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.3 mp -120.03 -70.2 0.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.375 1.47 . . . . 0.0 107.788 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -132.6 152.98 20.43 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 123.547 0.594 . . . . 0.0 112.589 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -124.43 91.07 50.05 Favored Pre-proline 0 N--CA 1.452 -0.352 0 C-N-CA 126.028 1.731 . . . . 0.0 109.434 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 97.2 Cg_endo -73.55 177.22 8.27 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.014 2.476 . . . . 0.0 111.37 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -91.09 169.13 11.11 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -82.48 -42.67 18.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.948 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -93.27 149.76 20.99 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 122.969 0.508 . . . . 0.0 110.065 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.2 p -69.79 -20.05 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 123.33 0.652 . . . . 0.0 112.45 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -88.96 -20.0 25.03 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.661 1.184 . . . . 0.0 111.656 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -77.34 -19.31 56.51 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.094 0.558 . . . . 0.0 109.793 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -103.56 171.11 7.55 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.15 1.38 . . . . 0.0 109.788 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -137.81 134.6 35.38 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.89 1.276 . . . . 0.0 107.788 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.497 ' CD2' HG22 ' A' ' 106' ' ' VAL . 4.4 m-30 -115.5 164.59 14.08 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.959 1.304 . . . . 0.0 110.672 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -131.67 122.03 25.28 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 124.621 1.168 . . . . 0.0 112.0 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 15.7 tp -85.76 104.34 15.36 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.426 HD12 ' HB2' ' A' ' 184' ' ' SER . 38.8 mt -114.49 177.03 4.79 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 122.139 0.971 . . . . 0.0 110.939 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -156.76 155.67 32.0 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.037 1.335 . . . . 0.0 107.463 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -138.59 -177.15 4.73 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -49.25 -31.33 8.59 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.079 1.352 . . . . 0.0 113.218 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 89.8 t -74.28 -74.37 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -166.53 -162.34 17.81 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.585 ' CZ ' HD22 ' A' ' 243' ' ' LEU . 3.7 m-85 -78.31 161.87 26.91 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.293 0.637 . . . . 0.0 112.06 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -163.15 175.25 11.2 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.854 2.062 . . . . 0.0 108.302 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.463 HD12 HD11 ' A' ' 109' ' ' ILE . 7.2 mt -127.01 121.51 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.426 ' HB2' HD12 ' A' ' 175' ' ' LEU . 39.9 t -91.35 137.81 32.07 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -139.18 120.51 14.87 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.8 tt -114.72 139.81 38.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.3 mt -133.51 112.53 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 123.4 0.68 . . . . 0.0 112.284 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -105.78 -167.69 23.42 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 124.604 1.097 . . . . 0.0 110.956 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.5 t 80.69 47.27 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.307 1.843 . . . . 0.0 110.39 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -97.76 -112.02 3.02 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 105.645 -2.982 . . . . 0.0 105.645 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -141.36 122.61 14.81 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 104.265 -2.494 . . . . 0.0 104.265 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.5 mm -60.17 134.38 25.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 98.8 m -81.58 100.81 9.59 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.98 -19.27 51.35 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.33 0.652 . . . . 0.0 111.325 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.32 -30.24 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 126.141 1.776 . . . . 0.0 110.767 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.3 p -125.01 -36.2 2.57 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 119.601 1.091 . . . . 0.0 112.416 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 96.54 33.81 6.03 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.084 1.326 . . . . 0.0 110.581 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -124.95 171.05 10.51 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.376 1.47 . . . . 0.0 112.058 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -89.1 141.85 28.15 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.558 0.743 . . . . 0.0 112.006 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.17 29.14 0.22 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 128.455 2.702 . . . . 0.0 110.764 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -73.52 142.38 46.73 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 122.282 1.039 . . . . 0.0 109.489 -176.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -104.81 149.58 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 CA-C-N 113.399 -1.728 . . . . 0.0 111.417 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -118.2 124.96 49.2 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.2 mp -115.86 129.86 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 125.806 1.642 . . . . 0.0 106.638 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -114.57 108.97 17.55 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -85.27 119.49 25.7 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.593 0.757 . . . . 0.0 110.602 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 32.0 m -131.43 171.57 17.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 C-N-CA 125.026 1.33 . . . . 0.0 111.796 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.37 133.55 39.91 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -89.7 149.13 20.31 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 123.557 0.599 . . . . 0.0 111.811 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -60.67 -45.02 97.18 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 47.1 t -87.21 98.58 11.4 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -72.21 8.04 1.48 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.385 0.674 . . . . 0.0 109.381 177.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 60.2 m -130.84 38.44 3.69 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.241 1.817 . . . . 0.0 113.267 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.2 165.7 28.16 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 121.475 -0.766 . . . . 0.0 112.161 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.66 168.24 20.57 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.969 2.446 . . . . 0.0 112.492 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 81.0 p -77.26 150.0 35.37 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.78 162.73 23.98 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.174 1.39 . . . . 0.0 107.446 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.1 mp -76.68 141.77 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -84.63 -59.65 2.3 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 -141.58 166.56 24.42 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.171 1.388 . . . . 0.0 108.484 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.729 HG13 ' CE1' ' A' ' 229' ' ' TYR . 47.7 t -145.84 136.39 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 C-N-CA 126.142 1.777 . . . . 0.0 106.391 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.46 121.09 3.71 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.375 0.607 . . . . 0.0 109.862 177.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -81.05 88.14 5.98 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 14.7 p -58.02 -56.8 17.36 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.587 1.555 . . . . 0.0 112.095 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt -99.76 -172.55 2.26 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.239 -1.764 . . . . 0.0 106.239 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 31.2 mm -75.5 -35.22 31.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 O-C-N 121.081 -1.012 . . . . 0.0 109.392 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.98 -54.05 2.54 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.912 0.885 . . . . 0.0 110.861 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 29.2 t -62.56 137.44 24.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 121.41 0.624 . . . . 0.0 109.391 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . 0.729 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.4 OUTLIER -133.08 139.92 47.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.147 1.779 . . . . 0.0 107.048 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -120.6 140.52 51.41 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 125.409 1.484 . . . . 0.0 108.945 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.84 161.41 39.36 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 126.132 1.773 . . . . 0.0 109.745 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -133.02 146.11 51.44 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 99.0 t -131.65 134.14 60.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 124.68 1.192 . . . . 0.0 108.376 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.08 142.06 35.13 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.624 0.77 . . . . 0.0 109.812 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 61.7 mt -139.72 135.68 16.92 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.73 -41.84 0.68 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.881 1.721 . . . . 0.0 112.367 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -62.99 -20.46 65.31 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 16.2 mt -68.52 -33.04 73.42 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 118.174 -0.917 . . . . 0.0 109.882 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 21.0 m -62.88 -13.4 33.64 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -70.37 -36.71 74.32 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.827 0.822 . . . . 0.0 109.152 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 24.0 mt -70.52 114.02 8.21 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -48.16 -33.77 8.91 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.585 HD22 ' CZ ' ' A' ' 181' ' ' TYR . 16.6 mt -61.49 -37.05 82.25 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.257 -0.902 . . . . 0.0 109.817 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 13.0 mt -95.74 9.69 39.55 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 127.505 2.322 . . . . 0.0 113.491 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.761 0 O-C-N 121.564 -0.71 . . . . 0.0 110.457 179.315 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 118.799 -0.619 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.88 -49.55 75.77 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.584 0.707 . . . . 0.0 109.516 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 62.3 tp -55.15 -43.63 74.38 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 125.3 1.44 . . . . 0.0 109.666 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.2 mt -62.52 -53.67 51.23 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.553 1.07 . . . . 0.0 109.506 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 85.2 m -54.36 -52.7 60.8 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.013 0.525 . . . . 0.0 109.826 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -61.9 -42.14 98.72 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 118.488 -0.768 . . . . 0.0 110.801 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.1 m -55.8 -47.8 76.5 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 119.318 0.963 . . . . 0.0 109.771 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 26.6 tp -59.28 -55.8 30.28 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 118.373 0.533 . . . . 0.0 109.765 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -51.21 -52.42 44.65 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 124.778 1.231 . . . . 0.0 110.997 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -55.83 -44.59 78.08 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 125.088 1.355 . . . . 0.0 109.711 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.62 -53.24 39.86 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 125.117 1.341 . . . . 0.0 111.785 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 59.1 t -55.25 -52.92 40.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 119.018 1.409 . . . . 0.0 110.998 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -31.07 72.01 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 118.51 0.596 . . . . 0.0 110.703 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.2 m -69.05 -42.62 76.05 Favored 'General case' 0 CA--C 1.523 -0.093 0 CA-C-N 118.682 0.674 . . . . 0.0 109.403 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.473 HD11 HD12 ' A' ' 183' ' ' ILE . 34.1 mt -58.09 -51.16 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 107.103 -1.444 . . . . 0.0 107.103 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.88 -40.03 94.0 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 118.762 -0.637 . . . . 0.0 111.095 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -59.32 -47.48 85.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.875 0.762 . . . . 0.0 109.375 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -73.51 -19.3 60.96 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.6 mt -102.67 -28.29 12.21 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 119.901 1.228 . . . . 0.0 112.124 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -58.03 -32.46 67.99 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -65.84 -45.58 81.69 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 119.036 -0.507 . . . . 0.0 110.504 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -158.4 156.38 30.34 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.662 1.119 . . . . 0.0 111.203 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 59.9 m -76.09 176.04 8.36 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 34.0 pt -135.7 155.49 36.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.49 163.3 38.18 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.126 0.488 . . . . 0.0 112.137 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -150.92 129.01 11.83 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.22 1.408 . . . . 0.0 110.638 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -92.23 107.6 19.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.57 73.09 3.73 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.627 1.571 . . . . 0.0 107.545 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.59 -115.43 5.93 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -74.15 -27.22 60.74 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.322 1.049 . . . . 0.0 112.638 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -107.13 157.6 17.73 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 118.718 0.69 . . . . 0.0 110.299 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 58.7 mt -123.99 149.41 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.467 ' CD1' HG11 ' A' ' 221' ' ' VAL . 55.5 m-85 -126.15 129.3 48.77 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.219 2.208 . . . . 0.0 107.424 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -127.03 130.96 50.99 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.722 1.609 . . . . 0.0 107.644 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -122.3 115.44 22.34 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.814 1.246 . . . . 0.0 108.594 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 15.6 m -105.02 154.86 38.41 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 123.48 0.712 . . . . 0.0 110.588 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -61.05 90.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.589 1 C-N-CA 125.887 4.391 . . . . 0.0 116.091 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 60.05 33.96 81.58 Favored Glycine 0 CA--C 1.528 0.853 0 O-C-N 121.682 -0.636 . . . . 0.0 112.323 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.0 mt -111.23 -66.36 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.448 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 5.3 pt-20 -180.0 162.52 1.01 Allowed 'General case' 0 C--O 1.24 0.586 0 C-N-CA 126.468 1.907 . . . . 0.0 108.901 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -115.52 122.29 45.26 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 102.544 -3.132 . . . . 0.0 102.544 178.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.4 m -130.32 156.17 42.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 123.358 0.663 . . . . 0.0 111.228 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -125.62 126.43 44.73 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -146.33 158.95 43.94 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.435 1.094 . . . . 0.0 112.435 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -88.39 154.64 20.22 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 177.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 166.0 -163.97 37.15 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -127.82 144.32 51.09 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.624 1.97 . . . . 0.0 106.7 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 C--O 1.236 0.348 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.98 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 . . . . . 0 N--CA 1.447 -0.623 0 CA-C-O 121.199 0.524 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 74.6 mt . . . . . 0 N--CA 1.447 -0.618 0 N-CA-C 103.167 -2.901 . . . . 0.0 103.167 177.65 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 83.7 mt . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 39.6 t -136.78 143.14 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.384 1.074 . . . . 0.0 108.568 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -143.59 147.36 34.28 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.191 1.397 . . . . 0.0 111.714 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.92 123.63 40.68 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 124.809 1.244 . . . . 0.0 108.073 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.5 mp -95.28 -72.47 0.62 Allowed 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -125.76 148.14 16.87 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -128.44 91.97 42.33 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 42.5 Cg_endo -77.01 176.57 9.97 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.615 2.877 . . . . 0.0 110.698 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -83.76 167.73 16.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.177 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.43 -33.62 23.65 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.488 1.115 . . . . 0.0 112.001 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -90.9 142.2 28.02 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 126.402 1.881 . . . . 0.0 106.258 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.3 p -72.96 -28.35 26.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 118.224 0.465 . . . . 0.0 110.078 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -73.1 0.51 11.34 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 127.479 2.311 . . . . 0.0 113.059 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -114.76 -13.12 12.06 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.329 1.852 . . . . 0.0 110.227 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 36.1 mmm-85 -77.25 163.68 26.29 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.824 1.25 . . . . 0.0 108.358 177.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -131.03 95.89 3.92 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.301 0.572 . . . . 0.0 110.134 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -108.53 148.94 29.53 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 125.774 1.629 . . . . 0.0 108.279 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -138.37 134.92 34.79 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.358 1.063 . . . . 0.0 109.791 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.95 98.51 10.41 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.29 1.036 . . . . 0.0 109.515 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.433 HD12 ' HB2' ' A' ' 184' ' ' SER . 35.4 mt -103.77 172.01 7.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.761 0.791 . . . . 0.0 110.195 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -157.37 157.09 33.43 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.246 -0.909 . . . . 0.0 109.503 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -138.83 -179.23 5.71 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -56.79 -11.75 1.56 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.788 2.035 . . . . 0.0 113.026 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 54.8 t -94.07 -67.07 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 126.484 1.914 . . . . 0.0 107.873 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -169.63 -174.11 37.69 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -81.05 158.76 24.98 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 114.606 -0.797 . . . . 0.0 109.044 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -162.61 176.55 10.26 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.546 1.538 . . . . 0.0 108.469 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.473 HD12 HD11 ' A' ' 109' ' ' ILE . 14.3 mt -123.93 133.75 68.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.433 ' HB2' HD12 ' A' ' 175' ' ' LEU . 32.3 t -109.19 122.49 47.42 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -125.58 112.93 16.76 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.9 tt -100.86 130.93 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 11.0 mt -123.36 109.7 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.088 1.355 . . . . 0.0 109.053 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -104.36 -153.04 22.59 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 107.559 -2.217 . . . . 0.0 107.559 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.3 m 74.43 46.07 0.17 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.34 1.456 . . . . 0.0 109.444 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -111.95 -126.95 4.84 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -130.42 124.91 33.18 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.441 1.096 . . . . 0.0 110.986 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 46.1 mm -61.08 137.28 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.82 0.848 . . . . 0.0 112.296 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 74.1 m -94.66 95.36 8.7 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 102.866 -3.013 . . . . 0.0 102.866 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -55.07 -17.79 4.47 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.888 1.275 . . . . 0.0 113.537 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 73.4 t -59.73 -38.18 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 124.878 1.271 . . . . 0.0 109.567 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 20.9 p -125.32 -15.9 6.07 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 78.52 32.94 40.36 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -103.48 159.9 15.19 Favored 'General case' 0 CA--C 1.52 -0.189 0 O-C-N 121.435 -1.038 . . . . 0.0 110.651 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -91.71 142.4 27.64 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.903 1.281 . . . . 0.0 107.725 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -73.46 28.96 0.07 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 127.854 2.461 . . . . 0.0 111.82 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.3 ptt? -73.2 141.0 47.35 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 122.58 1.181 . . . . 0.0 110.04 -175.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 1.5 p -113.06 144.35 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.33 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -112.26 125.25 53.96 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.6 mp -109.67 119.11 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -102.38 106.39 17.14 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -85.36 115.17 22.95 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.37 1.068 . . . . 0.0 110.46 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.8 m -127.93 172.83 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 126.14 1.776 . . . . 0.0 112.277 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.3 t -85.5 133.09 34.1 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.445 1.498 . . . . 0.0 107.313 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -89.67 161.86 29.94 Favored Glycine 0 N--CA 1.47 0.95 0 CA-C-N 119.555 1.071 . . . . 0.0 112.032 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -47.22 -79.61 0.07 OUTLIER Glycine 0 C--N 1.341 0.824 0 C-N-CA 126.315 1.912 . . . . 0.0 110.997 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 25.3 m -70.42 126.3 29.24 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -98.28 35.98 1.68 Allowed 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 8.6 m -143.24 33.19 1.34 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -129.52 179.15 16.95 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 120.361 1.437 . . . . 0.0 113.122 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -75.09 170.06 21.22 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.949 2.432 . . . . 0.0 109.273 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 98.3 p -81.72 156.36 25.04 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.853 -0.529 . . . . 0.0 109.692 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.85 164.69 7.85 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 126.143 1.777 . . . . 0.0 109.276 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.9 mt -79.75 136.09 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.164 1.386 . . . . 0.0 107.37 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -81.21 -54.84 5.16 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 124.574 1.15 . . . . 0.0 109.753 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 19.0 p-90 -148.59 166.54 27.96 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 124.794 1.237 . . . . 0.0 108.761 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.76 HG13 ' CE1' ' A' ' 229' ' ' TYR . 45.3 t -145.28 126.58 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.01 122.05 10.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -75.02 97.92 3.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 2.1 p -66.14 -51.79 54.52 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 118.311 -0.852 . . . . 0.0 111.715 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -120.72 179.11 4.45 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.437 0.695 . . . . 0.0 109.781 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.548 ' H ' HD12 ' A' ' 226' ' ' ILE . 3.8 mp -55.19 -37.82 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 C-N-CA 125.908 1.683 . . . . 0.0 110.666 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.75 -21.04 5.29 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 56.4 t -85.21 124.51 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . 0.76 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.6 OUTLIER -123.68 142.9 50.63 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 179.398 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -129.79 139.95 51.15 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -138.83 160.85 38.69 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.086 1.354 . . . . 0.0 109.505 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -127.28 143.71 51.18 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.0 t -128.53 143.75 40.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 125.084 1.354 . . . . 0.0 107.683 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.45 134.13 55.32 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 124.29 1.036 . . . . 0.0 110.408 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 93.9 mt -136.72 138.36 26.08 Favored Pre-proline 0 C--O 1.236 0.355 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.638 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.08 -43.29 0.25 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.312 2.008 . . . . 0.0 111.944 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -57.32 -26.82 61.52 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.794 0.837 . . . . 0.0 111.278 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 16.9 mt -66.17 -38.72 88.74 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 120.947 -1.096 . . . . 0.0 110.189 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 42.8 m -55.21 -21.85 15.53 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.6 1.56 . . . . 0.0 113.921 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -64.98 -34.44 78.43 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 123.393 0.677 . . . . 0.0 111.192 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 29.9 mt -71.95 117.27 13.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -48.67 -36.11 15.34 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.82 -36.17 78.37 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.527 -0.733 . . . . 0.0 110.254 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -97.84 3.58 49.83 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.389 1.875 . . . . 0.0 113.271 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 178.902 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.9 m . . . . . 0 CA--C 1.537 0.445 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.34 -48.31 82.12 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 119.633 1.106 . . . . 0.0 108.409 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 58.9 tp -56.97 -44.83 83.04 Favored 'General case' 0 C--N 1.343 0.322 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.1 mt -61.4 -50.52 72.52 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.955 0.798 . . . . 0.0 110.577 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 54.9 m -54.97 -52.44 63.06 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.815 1.246 . . . . 0.0 110.669 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -63.96 -42.78 97.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.575 0.75 . . . . 0.0 110.62 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.2 m -54.1 -49.14 69.78 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.155 0.982 . . . . 0.0 109.007 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 41.1 tp -57.38 -54.24 49.09 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.929 0.331 . . . . 0.0 110.72 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -52.65 -50.99 62.08 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 124.428 1.091 . . . . 0.0 111.654 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -56.11 -52.2 65.18 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.393 1.077 . . . . 0.0 108.604 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -55.29 -51.04 56.97 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 96.4 t -57.2 -52.79 51.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 C-N-CA 125.206 1.402 . . . . 0.0 111.809 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -32.3 73.57 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 119.289 0.95 . . . . 0.0 110.313 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.1 m -66.3 -42.02 88.89 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 34.0 mt -61.49 -50.72 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.51 -40.92 72.4 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 117.9 -1.048 . . . . 0.0 110.809 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -62.61 -55.01 31.01 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.305 1.042 . . . . 0.0 110.436 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -62.7 -25.92 68.4 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 11.0 mp -98.07 -26.99 14.42 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.543 1.52 . . . . 0.0 110.848 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -53.88 -29.54 41.97 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.184 0.994 . . . . 0.0 111.233 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -74.49 -46.83 36.97 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 117.965 0.348 . . . . 0.0 110.709 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.2 mmt85 -157.03 151.46 25.33 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.201 -0.937 . . . . 0.0 111.819 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 51.5 m -76.43 160.55 29.44 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 32.8 pt -118.1 152.83 20.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 124.889 1.275 . . . . 0.0 108.592 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -146.16 168.87 19.94 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 122.853 0.461 . . . . 0.0 111.909 -178.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -154.51 127.69 8.37 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.572 1.549 . . . . 0.0 111.286 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -91.52 104.37 16.88 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.52 66.77 5.46 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.424 1.489 . . . . 0.0 107.034 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 66.84 -115.96 7.76 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -66.12 -34.03 77.13 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -107.32 152.76 23.71 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 119.165 0.893 . . . . 0.0 110.247 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.7 mt -121.16 151.97 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -126.93 136.72 52.68 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.714 1.605 . . . . 0.0 108.202 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -131.38 132.45 44.41 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.542 1.537 . . . . 0.0 108.955 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -126.04 117.27 22.87 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.607 1.163 . . . . 0.0 109.737 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 21.9 m -104.22 158.17 32.49 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 124.197 0.999 . . . . 0.0 111.502 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -63.67 84.91 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.621 1 C-N-CA 125.413 4.076 . . . . 0.0 116.101 -178.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.41 29.02 74.24 Favored Glycine 0 CA--C 1.529 0.938 0 O-C-N 121.394 -0.816 . . . . 0.0 111.542 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.1 mt -106.77 -67.25 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.415 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 7.8 pt-20 -172.56 165.31 5.58 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.713 1.205 . . . . 0.0 108.954 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.23 119.87 30.59 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 103.7 -2.704 . . . . 0.0 103.7 177.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.43 156.63 42.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 124.53 1.132 . . . . 0.0 112.02 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -123.81 133.67 53.76 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -146.11 158.25 43.87 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.71 1.204 . . . . 0.0 111.629 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 50.3 t60 -87.94 154.86 20.18 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 157.9 -162.19 31.98 Favored Glycine 0 C--N 1.333 0.409 0 O-C-N 121.21 -0.931 . . . . 0.0 111.28 -178.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.61 145.9 49.07 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 54.2 t . . . . . 0 C--O 1.237 0.413 0 C-N-CA 124.971 1.308 . . . . 0.0 108.3 179.825 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 . . . . . 0 C--O 1.242 0.676 0 CA-C-O 121.009 0.433 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 26.2 mt . . . . . 0 N--CA 1.449 -0.507 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 178.913 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 84.5 mt . . . . . 0 N--CA 1.463 0.175 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.78 147.14 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -142.41 153.04 43.4 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.717 1.207 . . . . 0.0 110.538 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 37.5 mtm105 -101.1 126.32 47.78 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 22.7 mt -101.68 -62.4 1.26 Allowed 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -134.15 153.49 20.97 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.441 ' HB3' ' HB3' ' A' ' 189' ' ' SER . 0.9 OUTLIER -129.22 86.25 57.26 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 126.872 2.069 . . . . 0.0 109.239 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.437 ' HD3' HG21 ' A' ' 187' ' ' ILE . 41.5 Cg_endo -80.47 176.7 8.9 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 123.672 2.915 . . . . 0.0 110.788 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.2 mmmt -92.64 156.45 17.07 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.49 -25.03 41.92 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.015 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -107.29 126.89 53.01 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.58 1.152 . . . . 0.0 108.042 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.4 p -52.9 -34.23 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.834 1.254 . . . . 0.0 111.195 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.428 ' HG3' ' H ' ' A' ' 168' ' ' GLU . 14.1 mt-10 -61.09 -18.26 56.98 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 129.722 3.209 . . . . 0.0 113.521 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -112.32 -4.08 14.39 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.024 1.73 . . . . 0.0 111.736 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 61.2 mtp180 -91.3 176.87 6.42 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.821 0.82 . . . . 0.0 109.777 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -142.68 134.76 27.27 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -144.0 150.07 37.7 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.782 1.633 . . . . 0.0 107.864 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -133.11 131.73 40.87 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.643 1.177 . . . . 0.0 108.5 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 28.1 tp -86.2 99.65 11.68 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 44.0 mt -101.19 175.04 5.72 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.166 0.986 . . . . 0.0 109.613 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.425 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 5.7 p90 -155.93 156.6 34.85 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.866 0.841 . . . . 0.0 109.648 177.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -135.16 -179.73 5.81 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -54.18 -32.09 54.6 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 125.598 1.559 . . . . 0.0 112.298 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 58.2 t -73.9 -59.06 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.222 1.009 . . . . 0.0 109.13 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -178.96 -168.7 38.5 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 124.552 1.072 . . . . 0.0 111.726 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.425 ' CD2' ' HB3' ' A' ' 176' ' ' TYR . 24.4 m-85 -83.35 161.25 21.45 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.681 1.193 . . . . 0.0 112.36 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -168.03 168.97 11.58 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.78 2.032 . . . . 0.0 109.026 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 15.9 mt -114.28 138.37 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.0 t -111.25 123.54 50.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.902 1.281 . . . . 0.0 108.102 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.4 109.94 11.49 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 177.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 2.3 tt -100.82 126.09 54.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.437 HG21 ' HD3' ' A' ' 163' ' ' PRO . 7.2 mt -116.44 112.37 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.144 0.978 . . . . 0.0 110.989 -177.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -108.57 -161.27 20.26 Favored Glycine 0 CA--C 1.522 0.492 0 C-N-CA 124.784 1.183 . . . . 0.0 111.126 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.441 ' HB3' ' HB3' ' A' ' 162' ' ' LYS . 0.4 OUTLIER 74.44 31.86 0.99 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.411 1.485 . . . . 0.0 110.386 -179.265 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -87.97 -102.18 0.91 Allowed Glycine 0 C--N 1.336 0.548 1 N-CA-C 102.788 -4.125 . . . . 0.0 102.788 177.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -145.88 160.54 41.66 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 24.2 mm -92.49 132.71 36.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 125.026 1.33 . . . . 0.0 109.141 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 59.3 m -88.4 93.86 9.67 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 100.329 -3.952 . . . . 0.0 100.329 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -53.42 -24.45 12.6 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -177.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -51.11 -34.32 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 125.99 1.716 . . . . 0.0 111.334 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.1 p -126.08 -25.63 3.53 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.879 0.872 . . . . 0.0 112.36 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 92.57 19.5 37.7 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.803 1.192 . . . . 0.0 111.722 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -95.79 165.18 12.42 Favored 'General case' 0 N--CA 1.454 -0.225 0 O-C-N 121.269 -1.136 . . . . 0.0 110.285 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -96.25 147.22 24.0 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.812 0.845 . . . . 0.0 109.163 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -75.56 28.3 0.1 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.971 2.108 . . . . 0.0 110.286 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.9 ptm -72.62 146.19 46.8 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.507 1.146 . . . . 0.0 108.299 -176.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.3 p -120.1 140.03 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 113.901 -1.5 . . . . 0.0 112.549 -176.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -105.13 131.74 52.23 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.1 mp -115.91 113.98 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -97.31 109.08 21.91 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -85.53 118.05 24.81 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.54 0.736 . . . . 0.0 109.585 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.79 172.89 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 125.732 1.613 . . . . 0.0 112.184 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.6 t -86.38 136.58 33.07 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.108 1.763 . . . . 0.0 108.405 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.93 158.05 32.88 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -63.52 -68.29 1.72 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 108.266 -1.934 . . . . 0.0 108.266 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 17.0 p -81.6 91.5 6.4 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 104.084 -2.561 . . . . 0.0 104.084 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -72.51 37.44 0.07 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.753 2.421 . . . . 0.0 113.487 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.4 m -138.22 46.12 2.06 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 115.097 1.518 . . . . 0.0 115.097 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -156.9 175.08 34.51 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -71.66 165.65 31.86 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.071 1.847 . . . . 0.0 110.733 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 52.0 p -72.93 153.89 40.78 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.338 1.055 . . . . 0.0 110.519 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -169.27 160.71 9.71 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.261 1.424 . . . . 0.0 108.652 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.8 127.83 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -72.24 -60.95 1.97 Allowed 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.868 1.667 . . . . 0.0 109.8 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . 0.412 ' CE3' ' HD2' ' A' ' 222' ' ' ARG . 40.7 p-90 -143.03 168.46 19.66 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.859 2.064 . . . . 0.0 109.091 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.603 HG13 ' CE1' ' A' ' 229' ' ' TYR . 55.9 t -144.2 145.3 21.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 126.283 1.833 . . . . 0.0 106.42 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.412 ' HD2' ' CE3' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -164.34 118.8 1.44 Allowed 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.143 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -75.64 92.2 2.93 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 102.285 -3.228 . . . . 0.0 102.285 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 4.8 p -56.09 -55.2 35.83 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.853 1.261 . . . . 0.0 112.408 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -111.59 -172.54 2.06 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.595 ' H ' HD12 ' A' ' 226' ' ' ILE . 3.8 mp -62.23 -38.67 81.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 O-C-N 121.396 -0.815 . . . . 0.0 110.214 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.76 -41.05 3.26 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.877 0.871 . . . . 0.0 112.285 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 10.0 t -64.49 132.25 30.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . 0.603 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.5 OUTLIER -130.82 141.7 50.35 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.335 1.454 . . . . 0.0 107.288 -179.297 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -127.01 141.83 51.69 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.75 161.8 38.34 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.445 1.498 . . . . 0.0 108.854 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -138.95 147.46 42.28 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 123.583 0.753 . . . . 0.0 109.99 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.4 m -132.76 151.65 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.127 0.571 . . . . 0.0 109.487 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.1 p -113.42 131.87 55.85 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 122.802 0.441 . . . . 0.0 109.814 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 85.3 mt -129.63 136.12 28.61 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.34 -40.34 0.85 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.207 1.938 . . . . 0.0 112.639 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -61.45 -26.22 67.74 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.38 0.672 . . . . 0.0 111.721 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 3.8 mp -66.29 -35.17 79.71 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.762 0.71 . . . . 0.0 109.309 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 44.0 m -59.51 -19.63 49.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.725 1.21 . . . . 0.0 113.234 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -62.85 -34.52 77.52 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.567 0.747 . . . . 0.0 110.581 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 47.9 mt -73.1 118.92 16.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.218 1.407 . . . . 0.0 107.654 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -49.91 -39.75 41.0 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.0 mp -59.98 -34.32 73.15 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.191 -0.943 . . . . 0.0 111.19 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.407 HD22 ' N ' ' A' ' 244' ' ' LEU . 2.5 mm? -101.13 5.54 42.82 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 126.583 1.953 . . . . 0.0 112.495 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.461 0 C-N-CA 123.946 0.898 . . . . 0.0 109.646 179.441 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.1 p . . . . . 0 C--O 1.235 0.31 0 CA-C-O 119.676 -0.202 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.83 -43.61 92.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 48.6 tp -60.65 -48.36 82.13 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 124.034 0.934 . . . . 0.0 108.607 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.9 mt -58.58 -52.05 67.32 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.209 1.004 . . . . 0.0 110.016 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 97.3 m -56.64 -50.28 72.52 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.292 1.037 . . . . 0.0 110.662 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -64.23 -50.94 66.04 Favored 'General case' 0 C--O 1.224 -0.244 0 O-C-N 121.455 -0.778 . . . . 0.0 110.118 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.4 m -51.97 -43.24 63.47 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.411 1.084 . . . . 0.0 111.026 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.6 tt -58.47 -57.08 14.54 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 119.368 0.986 . . . . 0.0 110.122 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -63.64 -38.02 89.52 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -59.9 -36.03 76.12 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.493 ' HA3' HD11 ' A' ' 183' ' ' ILE . . . -66.93 -51.4 40.2 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.1 t -56.07 -52.97 44.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 118.483 1.142 . . . . 0.0 112.4 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.16 -32.66 68.42 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.907 0.776 . . . . 0.0 111.213 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.1 m -75.63 -46.71 30.02 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 122.845 0.458 . . . . 0.0 110.917 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.589 HD11 HD12 ' A' ' 183' ' ' ILE . 24.8 mt -55.75 -52.42 48.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.07 -41.38 83.26 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 123.778 0.674 . . . . 0.0 110.88 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -62.1 -50.63 71.15 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 118.376 0.534 . . . . 0.0 110.929 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.404 ' HE2' ' OE2' ' A' ' 237' ' ' GLU . 0.7 OUTLIER -67.1 -3.55 7.72 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.058 0.943 . . . . 0.0 113.444 -179.303 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.9 mt -115.22 -28.89 6.78 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.676 1.59 . . . . 0.0 110.075 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -62.18 -26.14 68.17 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.238 0.615 . . . . 0.0 110.612 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.09 -46.89 60.93 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.706 0.802 . . . . 0.0 109.289 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -160.85 147.71 15.29 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 125.703 1.601 . . . . 0.0 108.495 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 67.7 m -75.71 173.21 11.38 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.7 pt -128.61 146.75 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 C-N-CA 123.639 0.775 . . . . 0.0 110.59 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -142.01 162.14 36.22 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.549 0.74 . . . . 0.0 111.057 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -146.9 125.03 12.11 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.441 1.096 . . . . 0.0 109.715 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -87.93 102.35 14.63 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.5 67.04 7.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 66.13 -115.09 7.11 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -63.61 -36.96 85.54 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.099 -0.953 . . . . 0.0 113.146 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -107.31 154.2 21.62 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 120.499 1.5 . . . . 0.0 111.613 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 30.2 mt -118.45 135.23 59.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -110.12 127.61 54.99 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 105.55 -2.018 . . . . 0.0 105.55 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -123.11 119.9 31.66 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.408 1.883 . . . . 0.0 111.718 -177.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -119.87 126.07 50.05 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.034 1.334 . . . . 0.0 110.947 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 3.3 m -111.13 160.84 27.52 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.685 1.594 . . . . 0.0 114.624 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -65.6 87.1 0.21 Allowed 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 124.794 3.663 . . . . 0.0 112.417 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 55.93 56.47 23.8 Favored Glycine 0 C--N 1.331 0.29 0 O-C-N 121.216 -0.927 . . . . 0.0 111.727 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.2 mt -128.05 -66.18 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -178.89 173.56 1.2 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.532 1.933 . . . . 0.0 110.982 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.72 118.74 28.77 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 176.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.43 154.97 41.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.984 0.913 . . . . 0.0 111.016 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -117.87 136.2 53.6 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -146.45 156.44 43.29 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.45 1.1 . . . . 0.0 112.413 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -92.19 147.44 22.93 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 162.9 -163.9 35.58 Favored Glycine 0 C--N 1.336 0.554 0 CA-C-N 120.126 1.33 . . . . 0.0 113.231 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -123.24 135.61 54.34 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.922 1.689 . . . . 0.0 110.095 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 CA--C 1.53 0.184 0 C-N-CA 124.502 1.121 . . . . 0.0 108.726 -179.824 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 . . . . . 0 N--CA 1.443 -0.798 0 CA-C-O 121.95 0.881 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 72.2 mt . . . . . 0 C--N 1.326 -0.443 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 179.684 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 49.1 mt . . . . . 0 CA--C 1.515 -0.37 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.6 t -143.4 129.3 16.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -119.74 157.35 28.77 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 122.871 0.468 . . . . 0.0 112.013 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 26.6 mmm-85 -105.58 129.78 53.76 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.152 1.381 . . . . 0.0 107.907 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.9 mp -110.2 -65.66 1.14 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.516 0.726 . . . . 0.0 110.712 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -125.71 154.06 18.52 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -129.72 96.73 25.89 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.228 1.811 . . . . 0.0 108.913 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -74.35 -170.41 0.73 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.638 2.892 . . . . 0.0 108.796 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -100.88 165.38 11.38 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -81.46 -34.09 31.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.668 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -98.95 133.7 42.85 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 118.589 0.631 . . . . 0.0 110.355 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.6 p -58.26 -28.3 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.277 1.031 . . . . 0.0 109.611 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -69.01 -19.11 64.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 128.192 2.597 . . . . 0.0 112.84 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -99.62 -9.8 22.75 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.878 0.871 . . . . 0.0 110.476 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -70.3 161.5 30.26 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -140.35 95.64 2.91 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -101.37 167.38 10.21 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.539 1.136 . . . . 0.0 109.934 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -137.05 132.48 34.25 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.311 1.044 . . . . 0.0 110.12 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.4 tp -90.87 98.56 11.85 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 16.4 mt -107.19 -178.92 3.78 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.629 1.172 . . . . 0.0 109.494 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -155.47 161.66 40.9 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -136.6 -178.3 5.11 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 124.567 1.147 . . . . 0.0 108.437 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -56.34 -23.04 34.68 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.876 1.27 . . . . 0.0 111.511 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 58.6 t -81.67 -66.81 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -174.71 -164.22 29.18 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -77.22 160.03 29.23 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.299 0.64 . . . . 0.0 111.205 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -168.2 161.39 12.31 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.653 1.581 . . . . 0.0 109.381 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.589 HD12 HD11 ' A' ' 109' ' ' ILE . 4.1 mt -106.6 133.47 51.03 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 178.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 4.1 t -108.55 131.68 54.6 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -134.59 124.85 26.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.0 tt -115.38 140.15 38.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.3 mt -135.2 115.7 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 O-C-N 121.699 -0.626 . . . . 0.0 110.971 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -105.33 -168.0 23.83 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.683 1.611 . . . . 0.0 110.015 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.5 t 78.16 58.05 0.03 OUTLIER 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.452 1.901 . . . . 0.0 110.713 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -110.53 -104.21 2.81 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 106.941 -2.464 . . . . 0.0 106.941 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -153.97 119.61 5.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 42.6 mm -60.66 133.95 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 123.963 0.905 . . . . 0.0 109.108 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 58.9 m -86.36 106.52 17.46 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.11 -15.68 5.96 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.307 0.958 . . . . 0.0 112.964 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 49.0 t -58.28 -46.4 88.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.983 1.313 . . . . 0.0 110.34 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.6 p -119.89 -20.88 7.38 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.553 1.141 . . . . 0.0 111.71 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 81.95 13.25 79.83 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 127.14 2.305 . . . . 0.0 112.139 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -85.77 170.59 12.3 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.549 1.54 . . . . 0.0 110.823 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.09 153.54 22.63 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 122.104 0.954 . . . . 0.0 111.536 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 29.9 ttm-85 -92.76 29.97 1.67 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 127.769 2.428 . . . . 0.0 109.463 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.0 ptt? -73.93 154.58 39.31 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.6 p -122.61 144.4 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.453 -177.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -111.57 131.91 54.92 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.7 mp -123.48 119.5 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 125.097 1.359 . . . . 0.0 108.835 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -100.84 120.64 40.43 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.68 0.792 . . . . 0.0 108.951 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -99.4 123.1 43.38 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.838 0.745 . . . . 0.0 110.137 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 14.8 m -135.12 170.08 20.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.9 1.28 . . . . 0.0 111.389 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.1 136.04 41.14 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -92.59 108.17 3.61 Favored Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 107.548 -2.221 . . . . 0.0 107.548 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -34.99 -54.3 0.87 Allowed Glycine 0 C--N 1.338 0.647 0 C-N-CA 126.728 2.109 . . . . 0.0 113.473 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 14.9 m -79.56 71.27 6.15 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -50.15 23.1 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.647 1 C-N-CA 133.767 4.827 . . . . 0.0 118.406 -178.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 7.9 t -145.96 47.39 1.24 Allowed 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.154 -1.591 . . . . 0.0 110.891 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -140.46 166.98 25.68 Favored Glycine 0 C--N 1.336 0.571 0 O-C-N 120.508 -1.37 . . . . 0.0 110.405 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.34 168.92 23.68 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 CA-C-N 119.623 1.711 . . . . 0.0 108.915 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 99.1 p -72.23 153.42 41.59 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.9 p -160.44 165.16 31.54 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.561 1.545 . . . . 0.0 108.18 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.2 mp -84.92 132.08 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -78.95 -55.33 5.22 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 124.804 1.242 . . . . 0.0 111.297 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 33.2 p-90 -146.24 165.45 29.17 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.652 HG13 ' CE1' ' A' ' 229' ' ' TYR . 52.6 t -144.38 139.19 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 126.259 1.824 . . . . 0.0 106.19 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.22 134.86 11.69 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.606 0.717 . . . . 0.0 110.621 178.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -90.54 90.35 7.96 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.3 p -75.32 -46.05 35.76 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.227 1.011 . . . . 0.0 111.584 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -103.52 -179.61 4.0 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.2 mp -78.16 -27.8 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.5 t -118.27 -56.81 2.13 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.288 1.435 . . . . 0.0 111.24 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 3.7 t -60.02 141.42 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . 0.652 ' CE1' HG13 ' A' ' 221' ' ' VAL . 1.2 t80 -125.85 150.5 47.82 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.905 2.082 . . . . 0.0 109.035 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -131.44 138.7 49.16 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.777 1.631 . . . . 0.0 108.837 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.71 162.22 40.19 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.091 1.757 . . . . 0.0 111.745 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -132.38 147.66 52.39 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 89.3 t -129.59 139.07 52.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 126.065 1.746 . . . . 0.0 108.377 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.92 140.77 46.3 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 124.134 0.974 . . . . 0.0 109.678 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 56.9 mt -137.83 140.4 29.42 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.53 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.85 -45.04 0.31 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.049 2.499 . . . . 0.0 112.284 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.404 ' OE2' ' HE2' ' A' ' 112' ' ' LYS . 10.5 mt-10 -61.08 -25.69 67.12 Favored 'General case' 0 N--CA 1.461 0.124 0 O-C-N 121.235 -0.916 . . . . 0.0 111.914 -178.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.2 mp -60.1 -37.66 80.64 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 118.336 -0.84 . . . . 0.0 109.905 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 32.6 m -54.47 -26.7 32.71 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.819 1.648 . . . . 0.0 113.181 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -62.08 -30.15 70.8 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 41.7 mt -76.19 116.21 16.67 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.578 1.151 . . . . 0.0 112.151 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -48.19 -39.96 22.6 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.636 1.974 . . . . 0.0 114.853 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 13.4 mt -61.53 -34.08 74.91 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.183 -0.948 . . . . 0.0 112.968 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 1.9 mp -104.95 7.72 34.28 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.317 0 C-N-CA 129.084 2.954 . . . . 0.0 110.047 -178.523 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.534 0.331 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.8 90.04 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 118.616 0.644 . . . . 0.0 110.683 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 47.6 tp -61.53 -45.75 92.86 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.0 mt -64.5 -52.16 59.31 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.543 0.737 . . . . 0.0 110.484 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 53.3 m -54.89 -51.75 65.02 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.654 -0.654 . . . . 0.0 110.188 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -60.21 -46.59 89.23 Favored 'General case' 0 C--N 1.339 0.116 0 O-C-N 121.656 -0.652 . . . . 0.0 110.64 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.1 m -53.34 -45.96 69.3 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.093 0.957 . . . . 0.0 110.2 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 27.4 tp -59.45 -56.64 19.43 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.611 0.641 . . . . 0.0 110.721 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -56.56 -51.47 68.46 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 118.436 0.562 . . . . 0.0 111.723 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -55.2 -38.92 69.01 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.415 0.686 . . . . 0.0 109.674 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -67.04 -52.79 30.27 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 87.8 t -55.03 -53.32 35.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.734 1.214 . . . . 0.0 111.276 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -31.52 72.68 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 118.64 0.654 . . . . 0.0 110.822 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.0 m -69.71 -46.7 65.41 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.576 HD11 HD12 ' A' ' 183' ' ' ILE . 25.0 mt -57.33 -52.21 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.35 -41.02 88.24 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 119.171 -0.442 . . . . 0.0 111.466 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -60.54 -50.77 72.22 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.19 0.45 . . . . 0.0 110.79 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -71.32 -19.92 62.25 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.2 mp -102.8 -25.72 13.41 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.125 1.329 . . . . 0.0 111.526 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -55.12 -39.21 69.14 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 121.551 -0.718 . . . . 0.0 110.802 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.96 -42.73 89.58 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.487 -0.768 . . . . 0.0 111.184 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 -153.63 147.21 25.07 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 120.224 1.375 . . . . 0.0 112.403 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 60.7 m -76.14 167.88 21.06 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 36.3 pt -128.15 148.42 32.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.74 167.92 20.94 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.222 0.609 . . . . 0.0 112.141 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -151.04 127.43 10.66 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.318 1.447 . . . . 0.0 109.758 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -91.07 102.73 15.49 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.704 0.802 . . . . 0.0 109.176 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.27 66.75 8.53 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.89 -114.96 7.04 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -63.84 -32.87 74.53 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.036 0.934 . . . . 0.0 112.594 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -107.68 159.43 16.48 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 119.663 1.119 . . . . 0.0 111.094 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.6 mt -127.92 147.05 32.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.419 ' CD1' HG11 ' A' ' 221' ' ' VAL . 47.9 m-85 -123.05 128.62 50.4 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.295 1.838 . . . . 0.0 108.776 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -122.2 130.52 53.28 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.619 1.968 . . . . 0.0 110.01 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -124.21 119.41 29.28 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.398 1.479 . . . . 0.0 108.256 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 14.9 m -108.52 157.71 35.86 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 123.45 0.7 . . . . 0.0 111.274 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -65.69 87.41 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.552 1 C-N-CA 125.67 4.246 . . . . 0.0 115.55 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.58 34.42 89.85 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 119.479 -0.623 . . . . 0.0 111.851 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.5 mt -112.44 -67.22 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.487 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 11.7 pt-20 -173.26 168.21 4.7 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.73 1.612 . . . . 0.0 109.379 -178.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.63 120.38 29.37 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 177.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.2 m -138.33 156.56 30.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 124.832 1.253 . . . . 0.0 111.553 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -132.64 127.05 34.05 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.958 0.903 . . . . 0.0 108.835 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.407 ' HB3' ' HB ' ' A' ' 157' ' ' VAL . 7.4 p90 -136.93 159.25 42.44 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 126.909 2.084 . . . . 0.0 113.283 -178.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -87.36 153.3 21.56 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 159.75 -164.98 34.42 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.83 147.35 49.46 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 89.8 t . . . . . 0 C--O 1.235 0.311 0 C-N-CA 124.398 1.079 . . . . 0.0 110.604 -178.895 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 . . . . . 0 N--CA 1.442 -0.832 0 CA-C-O 121.366 0.603 . . . . 0.0 111.479 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 48.7 mt . . . . . 0 N--CA 1.442 -0.84 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 179.41 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 19.2 tp . . . . . 0 CA--C 1.531 0.242 0 CA-C-O 120.681 0.277 . . . . 0.0 110.607 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 138' ' ' PHE . 3.9 p -134.95 154.97 37.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.666 1.586 . . . . 0.0 110.002 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -143.32 151.38 40.42 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.125 1.37 . . . . 0.0 109.846 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 13.9 ptt-85 -99.18 135.49 40.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 125.513 1.525 . . . . 0.0 109.315 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.25 -65.67 1.1 Allowed 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 123.377 0.671 . . . . 0.0 109.722 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -130.73 150.21 19.25 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.75 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 6.5 ttpp -123.25 90.36 50.48 Favored Pre-proline 0 N--CA 1.451 -0.386 0 C-N-CA 125.932 1.693 . . . . 0.0 108.388 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.487 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 93.1 Cg_endo -70.59 175.14 9.19 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.956 2.438 . . . . 0.0 109.275 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -91.28 166.06 13.12 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.334 0.653 . . . . 0.0 110.531 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -77.61 -27.79 51.33 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.987 0.915 . . . . 0.0 113.316 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -112.99 137.89 50.71 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.725 1.21 . . . . 0.0 109.094 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.5 p -60.4 -27.34 39.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.22 1.008 . . . . 0.0 111.823 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -71.93 -8.32 53.78 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 129.128 2.971 . . . . 0.0 112.287 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -112.97 -5.13 13.81 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.676 1.99 . . . . 0.0 110.425 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 45.2 mmm-85 -82.55 165.73 19.87 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -134.24 96.59 3.64 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.421 ' CE2' ' HG3' ' A' ' 185' ' ' GLU . 77.5 m-85 -111.3 139.57 46.6 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.283 1.833 . . . . 0.0 107.459 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -131.03 137.11 49.03 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.272 1.029 . . . . 0.0 109.029 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 43.8 tp -88.52 103.3 15.76 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.468 1.107 . . . . 0.0 109.717 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 7.2 mt -119.63 177.64 4.87 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.845 1.258 . . . . 0.0 108.342 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.4 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 19.8 p90 -157.49 166.85 31.87 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.579 0.751 . . . . 0.0 110.019 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 178' ' ' ASP . 31.6 t70 -136.6 -178.46 5.18 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.427 ' H ' ' CG ' ' A' ' 177' ' ' ASP . 0.5 OUTLIER -54.51 -30.67 54.22 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 125.491 1.516 . . . . 0.0 111.36 179.647 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 20.2 t -77.52 -64.25 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.491 1.116 . . . . 0.0 110.012 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -169.67 -170.83 34.61 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 119.059 0.845 . . . . 0.0 112.491 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.4 ' CD2' ' HB3' ' A' ' 176' ' ' TYR . 8.1 m-85 -87.67 154.77 20.32 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 123.637 0.775 . . . . 0.0 110.816 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -159.72 172.83 17.01 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.719 1.208 . . . . 0.0 107.977 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.576 HD12 HD11 ' A' ' 109' ' ' ILE . 9.1 mt -117.41 137.96 49.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 177.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.2 t -106.0 118.29 36.23 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 124.916 1.385 . . . . 0.0 107.437 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.421 ' HG3' ' CE2' ' A' ' 172' ' ' PHE . 0.6 OUTLIER -123.82 107.78 11.77 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 178.031 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 2.1 tt -101.99 128.33 54.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.1 mt -120.4 111.1 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.955 1.302 . . . . 0.0 111.551 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -104.75 -159.01 23.65 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 125.7 1.619 . . . . 0.0 110.042 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 74.82 36.94 0.53 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.772 1.629 . . . . 0.0 109.735 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -89.89 -126.91 3.18 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 107.576 -2.21 . . . . 0.0 107.576 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -137.35 127.95 26.85 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.9 mm -61.45 129.36 24.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 123.499 0.719 . . . . 0.0 111.784 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 5.1 m -90.0 94.07 9.65 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 101.198 -3.63 . . . . 0.0 101.198 176.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -57.67 -17.72 16.52 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.4 m -53.05 -33.04 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.466 1.507 . . . . 0.0 109.854 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 1.4 p -122.35 -34.01 3.36 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 123.25 0.62 . . . . 0.0 111.33 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 95.46 22.79 20.85 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.284 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -111.1 165.59 11.76 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.299 1.84 . . . . 0.0 109.159 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -87.21 145.48 26.38 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.355 1.462 . . . . 0.0 111.954 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -79.05 29.81 0.21 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.638 2.775 . . . . 0.0 111.06 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.8 ptm -73.12 149.44 43.04 Favored 'General case' 0 C--O 1.239 0.512 0 O-C-N 121.124 -0.985 . . . . 0.0 109.504 -177.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -116.73 146.88 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.607 -177.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -115.05 127.98 55.96 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.7 mp -117.06 116.53 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.109 0.964 . . . . 0.0 108.412 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -100.32 113.69 26.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -92.2 116.78 29.24 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 28.3 m -125.31 169.84 16.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 125.789 1.636 . . . . 0.0 111.806 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -81.37 137.41 35.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -101.24 122.46 7.6 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 107.364 -2.294 . . . . 0.0 107.364 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -45.32 -46.13 11.13 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.37 1.462 . . . . 0.0 113.238 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 8.3 t -81.62 65.2 6.65 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -57.14 28.19 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 130.099 3.36 . . . . 0.0 117.538 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.1 t -138.78 47.1 1.95 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 120.637 1.562 . . . . 0.0 112.486 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -153.24 172.68 32.15 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -73.28 167.1 28.18 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.276 1.984 . . . . 0.0 109.799 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.19 155.71 34.28 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.66 159.77 12.21 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.241 1.416 . . . . 0.0 107.373 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.86 128.89 37.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -72.9 -61.01 1.96 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 124.08 0.952 . . . . 0.0 109.184 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . 0.459 ' CE3' ' HD2' ' A' ' 222' ' ' ARG . 28.6 p-90 -139.64 167.2 22.65 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.595 1.558 . . . . 0.0 109.443 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.742 HG13 ' CE1' ' A' ' 229' ' ' TYR . 24.9 t -144.01 129.15 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.459 ' HD2' ' CE3' ' A' ' 220' ' ' TRP . 0.1 OUTLIER -145.51 118.03 8.55 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.99 0.9 . . . . 0.0 109.417 178.053 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -76.36 94.58 3.64 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 102.714 -3.069 . . . . 0.0 102.714 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 17.4 p -61.45 -66.41 0.54 Allowed 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.274 0.629 . . . . 0.0 109.669 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -101.38 179.12 4.45 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 34.7 mm -62.07 -21.47 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 123.535 0.734 . . . . 0.0 111.871 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.01 -45.57 1.26 Allowed 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.243 0.617 . . . . 0.0 111.228 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 25.2 t -67.29 133.58 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . 0.742 ' CE1' HG13 ' A' ' 221' ' ' VAL . 1.2 t80 -130.09 144.63 51.45 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.752 1.621 . . . . 0.0 108.661 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -123.74 138.38 54.53 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 126.363 1.865 . . . . 0.0 107.944 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.1 156.51 43.94 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.868 1.267 . . . . 0.0 109.91 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -130.9 143.3 50.63 Favored 'General case' 0 CA--C 1.52 -0.211 0 O-C-N 121.344 -0.847 . . . . 0.0 110.673 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 61.1 t -125.61 140.89 47.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.44 1.496 . . . . 0.0 107.419 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.72 136.81 52.44 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 96.6 mt -133.02 143.47 48.67 Favored Pre-proline 0 C--O 1.236 0.385 0 CA-C-O 118.192 -0.909 . . . . 0.0 109.112 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.39 -44.2 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.34 2.026 . . . . 0.0 111.445 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -62.36 -20.3 64.26 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.721 1.208 . . . . 0.0 113.291 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 14.9 mt -69.63 -38.11 77.07 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.047 0.839 . . . . 0.0 109.982 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 34.5 m -54.31 -21.58 9.71 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.433 1.493 . . . . 0.0 113.61 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -61.94 -30.66 71.06 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.391 1.076 . . . . 0.0 110.835 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 52.8 mt -79.09 124.08 27.96 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -48.02 -45.41 31.94 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 126.267 1.827 . . . . 0.0 112.824 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 6.1 mp -60.7 -28.91 68.99 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.271 -0.893 . . . . 0.0 111.512 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -99.91 -0.68 39.05 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.596 1.558 . . . . 0.0 111.627 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.457 0 C-N-CA 125.744 1.618 . . . . 0.0 109.493 -179.808 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.4 p . . . . . 0 C--O 1.237 0.408 0 CA-C-O 119.545 -0.264 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.5 -45.59 93.24 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.415 0.686 . . . . 0.0 110.262 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.1 tp -62.74 -42.86 99.87 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 117.895 -1.05 . . . . 0.0 110.482 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.7 mt -58.99 -53.82 54.12 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.441 1.019 . . . . 0.0 109.123 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.6 m -56.1 -42.03 76.15 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.816 0.447 . . . . 0.0 110.129 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -65.72 -51.07 62.2 Favored 'General case' 0 CA--C 1.527 0.09 0 O-C-N 120.97 -1.082 . . . . 0.0 110.044 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.7 m -53.02 -43.19 66.34 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.182 1.393 . . . . 0.0 110.323 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.405 ' O ' HG23 ' A' ' 106' ' ' VAL . 19.9 tp -60.08 -55.55 32.57 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.943 0.792 . . . . 0.0 111.489 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -65.46 -40.07 92.77 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 118.867 0.758 . . . . 0.0 112.124 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -61.59 -41.46 97.46 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 124.052 0.941 . . . . 0.0 109.851 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.406 ' HA3' HD11 ' A' ' 183' ' ' ILE . . . -66.26 -49.47 57.09 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.412 HG13 ' CE1' ' A' ' 172' ' ' PHE . 62.6 t -54.52 -53.05 34.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 126.036 1.734 . . . . 0.0 111.412 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -32.99 74.77 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 118.133 0.424 . . . . 0.0 110.463 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.09 -42.78 72.28 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 118.324 0.511 . . . . 0.0 110.492 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.418 HD11 HD12 ' A' ' 183' ' ' ILE . 16.6 mt -53.4 -53.5 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.97 -42.36 98.16 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 118.643 -0.694 . . . . 0.0 110.422 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -61.44 -30.04 70.33 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.948 0.794 . . . . 0.0 111.174 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -91.96 -3.81 55.42 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.67 1.188 . . . . 0.0 112.511 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.9 mt -119.75 -29.28 5.05 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.041 1.291 . . . . 0.0 112.586 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -62.07 -24.77 67.3 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.46 0.704 . . . . 0.0 111.313 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -73.45 -46.62 47.29 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.657 1.183 . . . . 0.0 108.565 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -161.33 145.16 13.01 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.034 1.733 . . . . 0.0 108.951 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 33.9 m -76.19 173.73 10.99 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.322 0.649 . . . . 0.0 109.778 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 42.1 pt -125.55 151.56 31.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 123.794 0.838 . . . . 0.0 109.209 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.89 160.89 41.76 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 122.849 0.46 . . . . 0.0 109.901 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -150.95 125.13 9.35 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.568 -0.708 . . . . 0.0 111.278 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -84.58 101.73 12.34 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 178.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.21 67.2 9.55 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.32 -115.68 6.94 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -66.85 -33.74 76.28 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -106.78 160.37 15.53 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.464 1.029 . . . . 0.0 110.363 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 21.3 mt -125.07 133.52 69.25 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 N-CA-C 104.894 -2.262 . . . . 0.0 104.894 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.528 ' CD1' HG11 ' A' ' 221' ' ' VAL . 67.7 m-85 -110.63 131.64 54.88 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -121.49 128.36 52.0 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 125.245 1.418 . . . . 0.0 109.368 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -127.24 108.85 11.23 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 124.288 0.992 . . . . 0.0 112.096 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 1.7 m -98.23 159.28 31.07 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.038 0.935 . . . . 0.0 112.858 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.06 96.34 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.562 1 C-N-CA 125.925 4.417 . . . . 0.0 113.62 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 55.54 49.78 63.42 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-O 119.076 -0.847 . . . . 0.0 111.18 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 5.1 mt -125.95 -68.01 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.613 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -172.64 162.57 5.11 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -123.73 119.76 30.73 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 103.011 -2.959 . . . . 0.0 103.011 177.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.8 m -131.38 155.87 42.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 124.123 0.969 . . . . 0.0 111.166 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -122.51 131.63 53.94 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 177.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -146.11 157.41 43.84 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.972 0.909 . . . . 0.0 111.102 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -89.39 154.4 20.09 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 157.05 -163.62 32.41 Favored Glycine 0 C--N 1.33 0.231 0 O-C-N 120.175 -1.578 . . . . 0.0 110.768 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.09 144.3 51.06 Favored 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.4 p . . . . . 0 C--N 1.328 -0.368 0 C-N-CA 126.106 1.762 . . . . 0.0 106.454 -179.693 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 34.5 mm . . . . . 0 CA--C 1.547 0.832 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.414 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 47.3 mt . . . . . 0 C--O 1.233 0.206 0 N-CA-C 110.713 -0.106 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.9 p -142.8 141.69 27.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -132.5 157.83 43.65 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.605 1.562 . . . . 0.0 109.484 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -107.71 130.66 54.92 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.495 1.118 . . . . 0.0 109.746 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.4 -75.98 0.51 Allowed 'General case' 0 N--CA 1.458 -0.052 0 C-N-CA 124.434 1.093 . . . . 0.0 109.68 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -127.72 153.76 19.41 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -129.45 90.97 42.65 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.441 ' HD3' HG21 ' A' ' 187' ' ' ILE . 54.7 Cg_endo -74.87 173.67 14.06 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.965 2.444 . . . . 0.0 110.984 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -83.16 164.52 20.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.825 0.821 . . . . 0.0 109.493 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -81.92 -24.02 35.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.307 -1.315 . . . . 0.0 113.592 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -102.03 144.1 31.04 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.8 p -72.95 -31.53 36.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 121.426 0.631 . . . . 0.0 110.199 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.55 -21.93 66.65 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.822 2.049 . . . . 0.0 110.571 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -83.48 -18.41 38.65 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.288 -0.883 . . . . 0.0 112.302 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.502 ' HD3' ' CE1' ' A' ' 172' ' ' PHE . 3.0 mtt180 -76.36 172.34 13.07 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.175 0.59 . . . . 0.0 112.304 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -136.75 95.03 3.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.254 1.422 . . . . 0.0 107.988 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.502 ' CE1' ' HD3' ' A' ' 170' ' ' ARG . 85.7 m-85 -99.09 161.61 13.53 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.64 1.176 . . . . 0.0 109.535 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -141.51 129.51 21.97 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 118.671 0.669 . . . . 0.0 110.155 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 21.5 tp -87.88 99.66 12.29 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 26.5 mt -106.84 -179.67 4.0 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.758 1.223 . . . . 0.0 109.556 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 181' ' ' TYR . 4.1 p90 -159.72 159.88 33.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -140.81 -173.53 3.73 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -50.87 -34.03 26.4 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.953 1.701 . . . . 0.0 112.631 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 41.3 t -79.16 -73.47 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -165.65 -169.05 28.75 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 119.366 0.984 . . . . 0.0 111.959 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 176' ' ' TYR . 5.6 m-85 -78.49 156.37 29.35 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.269 0.628 . . . . 0.0 110.789 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -159.55 167.53 28.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.431 1.492 . . . . 0.0 107.616 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.418 HD12 HD11 ' A' ' 109' ' ' ILE . 9.3 mt -114.88 125.13 72.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.3 t -99.18 130.08 45.47 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -137.99 107.06 6.01 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 103.72 -2.696 . . . . 0.0 103.72 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.0 tt -99.65 140.45 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.441 HG21 ' HD3' ' A' ' 163' ' ' PRO . 15.2 mt -129.59 112.28 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 123.291 0.636 . . . . 0.0 110.092 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.34 -159.07 26.07 Favored Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.1 m 72.05 57.99 0.15 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.557 1.543 . . . . 0.0 109.286 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -116.4 -118.78 3.08 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 125.589 1.566 . . . . 0.0 109.501 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -140.59 122.81 15.8 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.366 1.466 . . . . 0.0 109.79 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.6 mm -61.15 119.29 4.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 126.065 1.746 . . . . 0.0 110.497 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 35.2 m -77.58 100.9 6.29 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -48.56 -29.7 4.51 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.737 1.615 . . . . 0.0 113.476 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 27.1 t -53.36 -40.84 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.186 1.394 . . . . 0.0 111.585 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 37.9 p -124.07 -18.4 5.92 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.694 0.759 . . . . 0.0 111.554 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 77.56 15.84 80.92 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 128.68 3.038 . . . . 0.0 111.994 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -86.45 168.9 13.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.068 1.347 . . . . 0.0 110.801 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -85.32 148.15 26.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.252 1.025 . . . . 0.0 108.443 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.91 29.93 0.99 Allowed 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 127.933 2.493 . . . . 0.0 111.232 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 11.9 ptt? -73.18 156.26 38.78 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.18 143.53 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.978 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -106.78 133.23 51.76 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.73 111.81 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 C-N-CA 124.378 1.071 . . . . 0.0 108.373 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -97.12 114.56 26.24 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -91.28 122.92 34.32 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.488 0.715 . . . . 0.0 110.142 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.82 176.49 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 125.864 1.666 . . . . 0.0 110.728 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.9 t -88.09 143.15 27.24 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -107.07 151.84 16.88 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -51.66 -61.55 6.3 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.843 1.687 . . . . 0.0 113.952 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 11.7 m -78.03 92.57 4.36 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 118.568 1.184 . . . . 0.0 108.669 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -66.42 17.36 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.041 2.536 . . . . 0.0 114.166 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 3.8 m -132.78 47.04 2.55 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 -177.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -157.88 175.51 35.12 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 120.647 -1.283 . . . . 0.0 111.552 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.44 162.6 37.89 Favored 'Trans proline' 0 C--O 1.239 0.562 0 C-N-CA 122.661 2.241 . . . . 0.0 110.959 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 12.4 p -69.38 162.09 28.03 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.875 0.87 . . . . 0.0 109.366 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.21 157.25 9.22 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.16 1.384 . . . . 0.0 107.927 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.83 132.32 33.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -81.25 -53.17 6.58 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 125.59 1.556 . . . . 0.0 111.377 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 41.3 p-90 -148.94 165.85 30.35 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 124.135 0.974 . . . . 0.0 108.446 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.749 HG13 ' CE1' ' A' ' 229' ' ' TYR . 49.1 t -145.67 136.39 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 127.146 2.179 . . . . 0.0 105.504 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.02 130.57 10.65 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -78.69 87.93 4.59 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . 0.405 ' HB ' ' HE3' ' A' ' 225' ' ' LYS . 2.6 p -60.45 -53.45 57.41 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.423 0.689 . . . . 0.0 110.989 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.405 ' HE3' ' HB ' ' A' ' 224' ' ' THR . 17.5 mmtp -114.81 179.33 3.98 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.6 mp -66.22 -33.04 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -108.83 -65.05 1.17 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.871 0.868 . . . . 0.0 109.88 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 5.5 t -55.35 138.88 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 124.892 1.277 . . . . 0.0 109.749 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . 0.749 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.3 OUTLIER -133.49 151.03 51.71 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.698 1.999 . . . . 0.0 108.341 -178.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -132.22 141.06 48.91 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 126.109 1.764 . . . . 0.0 108.793 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.01 162.31 37.26 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.429 2.292 . . . . 0.0 111.177 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -134.48 147.64 50.41 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.746 0.818 . . . . 0.0 108.898 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 93.3 t -134.66 135.5 53.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 C-N-CA 124.687 1.195 . . . . 0.0 108.689 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.7 p -102.75 142.19 34.31 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.706 0.802 . . . . 0.0 108.979 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 34.0 mt -139.48 137.61 19.13 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 123.693 0.797 . . . . 0.0 109.9 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.34 -34.66 2.63 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.914 2.41 . . . . 0.0 113.029 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -67.81 -26.46 66.09 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.224 -0.922 . . . . 0.0 110.595 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 3.9 mp -65.9 -34.47 78.21 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 28.3 m -59.13 -11.16 3.35 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.252 1.421 . . . . 0.0 112.98 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -81.96 -30.34 31.76 Favored 'General case' 0 CA--C 1.528 0.098 0 O-C-N 120.16 -1.587 . . . . 0.0 111.142 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 23.8 mt -78.78 111.88 15.35 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.41 -27.87 1.86 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 116.404 2.001 . . . . 0.0 116.404 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 5.2 mp -63.68 -45.03 91.92 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.466 0.706 . . . . 0.0 110.445 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -82.21 3.59 26.76 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 127.002 2.121 . . . . 0.0 113.3 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.32 0 C-N-CA 127.949 2.5 . . . . 0.0 110.584 -177.546 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.9 m . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 118.79 -0.624 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.59 -46.06 84.48 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.662 1.119 . . . . 0.0 110.064 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.9 tp -66.39 -39.74 89.24 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.112 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.2 mt -60.95 -51.75 67.94 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.403 1.002 . . . . 0.0 110.392 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 90.1 m -55.12 -56.45 19.75 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.26 1.424 . . . . 0.0 109.906 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.04 -48.91 78.66 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-O 119.043 -0.503 . . . . 0.0 111.332 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 54.9 m -52.84 -50.39 63.82 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.439 0.695 . . . . 0.0 111.41 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.9 tp -58.59 -54.12 50.7 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.766 -0.635 . . . . 0.0 110.138 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -55.12 -51.54 66.1 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.555 0.742 . . . . 0.0 112.071 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -59.09 -40.08 84.19 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.24 -52.48 52.45 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-O 118.146 -1.363 . . . . 0.0 110.973 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.422 HG22 ' CG ' ' A' ' 172' ' ' PHE . 29.5 t -55.72 -53.19 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 119.255 1.528 . . . . 0.0 111.289 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -35.04 79.13 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.863 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.2 m -64.91 -45.24 86.7 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 41.0 mt -56.66 -54.36 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -56.7 -43.23 80.34 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 123.278 0.361 . . . . 0.0 110.466 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -67.56 -37.63 82.94 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.823 -0.548 . . . . 0.0 112.294 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.86 -1.97 41.45 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.935 0.894 . . . . 0.0 113.235 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.2 mt -119.39 -26.16 5.89 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 119.645 1.111 . . . . 0.0 111.744 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -58.7 -23.57 59.83 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -74.22 -43.17 58.19 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 117.946 -1.026 . . . . 0.0 111.383 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -156.23 150.21 25.19 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.523 1.129 . . . . 0.0 112.376 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 57.4 m -76.02 171.58 14.21 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 23.0 pt -129.38 156.12 41.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 123.955 0.902 . . . . 0.0 109.018 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -151.21 154.03 36.06 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 122.059 -0.401 . . . . 0.0 111.196 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -141.37 127.42 19.51 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 124.118 0.967 . . . . 0.0 110.699 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -87.22 118.13 26.43 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -109.84 67.41 0.65 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.045 2.138 . . . . 0.0 106.105 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.14 -120.8 8.03 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -66.46 -33.07 74.87 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.531 1.132 . . . . 0.0 112.508 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -106.92 145.31 32.37 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 118.737 0.699 . . . . 0.0 109.847 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 10.6 mt -116.06 151.16 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.494 ' CD1' HG11 ' A' ' 221' ' ' VAL . 42.3 m-85 -118.7 135.92 54.22 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 126.057 1.743 . . . . 0.0 106.447 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.63 131.43 48.07 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 125.661 1.584 . . . . 0.0 108.516 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -128.2 109.35 11.41 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.183 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 2.5 m -89.45 160.04 42.97 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 117.832 -1.08 . . . . 0.0 108.709 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -61.49 70.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 125.15 3.9 . . . . 0.0 116.145 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.46 48.74 65.6 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 125.257 1.408 . . . . 0.0 111.772 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.2 mt -114.65 -66.29 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -160.14 160.95 33.57 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.462 1.905 . . . . 0.0 107.915 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -123.46 120.81 34.02 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 102.525 -3.139 . . . . 0.0 102.525 177.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.94 155.52 27.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 123.593 0.757 . . . . 0.0 111.751 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -121.24 135.74 55.08 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -145.97 157.69 43.88 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 125.206 1.402 . . . . 0.0 111.144 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -88.78 151.44 22.39 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 164.68 -163.33 36.21 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.4 139.24 50.63 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.706 2.002 . . . . 0.0 106.268 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 91.5 t . . . . . 0 C--N 1.328 -0.335 0 C-N-CA 125.189 1.396 . . . . 0.0 109.594 -178.81 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 . . . . . 0 N--CA 1.454 -0.257 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 20.2 mt . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 179.784 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 93.3 mt . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.8 t -140.99 141.48 31.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -132.78 144.86 50.53 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.222 1.409 . . . . 0.0 110.084 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.3 mmt85 -93.39 114.19 26.54 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.937 1.295 . . . . 0.0 110.215 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.0 mp -89.85 -79.82 0.33 Allowed 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -118.58 157.23 15.33 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -133.63 88.63 33.18 Favored Pre-proline 0 N--CA 1.454 -0.258 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -77.37 172.2 16.36 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.069 2.513 . . . . 0.0 112.18 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -89.63 165.25 14.35 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 125.1 1.36 . . . . 0.0 111.659 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.95 -43.55 21.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.712 0.768 . . . . 0.0 110.708 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -78.96 130.0 35.1 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.666 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.7 p -64.88 -32.97 60.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 O-C-N 123.286 0.366 . . . . 0.0 110.149 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -67.72 -28.44 67.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.54 1.136 . . . . 0.0 112.049 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -71.81 -33.3 68.41 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -75.06 174.47 9.33 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.835 1.254 . . . . 0.0 109.251 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -143.53 149.28 37.23 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.422 ' CG ' HG22 ' A' ' 106' ' ' VAL . 41.5 m-85 -136.76 146.58 45.93 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.933 1.293 . . . . 0.0 107.966 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.99 123.35 40.18 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.816 1.246 . . . . 0.0 110.115 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 tt -86.6 106.31 17.47 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 45.2 mt -113.45 177.99 4.44 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.597 1.159 . . . . 0.0 110.689 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 181' ' ' TYR . 5.2 p90 -152.66 159.28 43.19 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 177.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -140.65 -178.42 5.51 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.43 -28.47 68.3 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 41.0 t -71.63 -56.66 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.256 1.022 . . . . 0.0 109.754 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 178.24 -173.69 46.11 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.713 ' CE2' HD22 ' A' ' 243' ' ' LEU . 2.5 m-85 -78.05 164.13 25.31 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.068 0.547 . . . . 0.0 109.726 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -164.19 170.55 16.19 Favored 'General case' 0 N--CA 1.461 0.095 0 C-N-CA 125.434 1.493 . . . . 0.0 109.076 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 5.9 mt -118.2 134.67 61.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 103.816 -2.661 . . . . 0.0 103.816 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 21.1 t -110.57 139.61 45.66 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -137.3 112.71 9.3 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 6.3 tt -101.52 140.3 20.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.8 mt -131.46 110.7 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.201 1.0 . . . . 0.0 109.853 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -101.32 -157.68 27.03 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 49.6 m 70.57 55.76 0.27 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.562 1.145 . . . . 0.0 112.205 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -114.42 -126.31 4.24 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -130.01 123.67 31.12 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.911 1.684 . . . . 0.0 107.508 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.0 mm -60.94 146.18 11.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 124.805 1.242 . . . . 0.0 111.371 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 64.4 m -105.92 91.31 3.68 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 103.776 -2.675 . . . . 0.0 103.776 177.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -49.8 -30.78 10.28 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.614 1.166 . . . . 0.0 113.11 -178.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 60.6 t -45.96 -40.2 3.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 127.168 2.187 . . . . 0.0 110.276 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 7.1 p -120.4 -27.36 5.21 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.002 0.521 . . . . 0.0 110.963 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 92.31 22.57 29.18 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.898 1.714 . . . . 0.0 110.724 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -101.6 164.49 11.73 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.666 1.233 . . . . 0.0 112.388 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -89.49 146.47 24.6 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.541 -1.209 . . . . 0.0 107.866 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -77.35 30.84 0.15 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 127.522 2.329 . . . . 0.0 111.203 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -73.61 145.01 45.74 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 1.4 p -112.4 142.3 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 C-N-CA 124.468 1.107 . . . . 0.0 110.058 -177.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -109.51 123.59 49.65 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.2 mp -115.34 121.55 67.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 124.444 1.098 . . . . 0.0 108.822 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -102.37 116.67 33.12 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.47 0.708 . . . . 0.0 109.683 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -96.02 117.94 31.65 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.918 1.287 . . . . 0.0 109.625 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 22.2 m -133.21 167.85 25.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 124.565 1.146 . . . . 0.0 112.035 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.6 t -81.19 128.49 33.83 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 177.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.6 137.11 13.07 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -51.43 -41.84 49.35 Favored Glycine 0 C--N 1.336 0.528 0 CA-C-O 119.014 -0.881 . . . . 0.0 112.385 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 4.7 m -80.71 74.9 7.63 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -71.33 30.88 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.218 2.207 . . . . 0.0 112.939 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 37.8 m -143.96 47.33 1.43 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.208 2.203 . . . . 0.0 108.242 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -155.11 164.2 31.77 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -78.25 172.76 14.88 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.874 2.382 . . . . 0.0 112.354 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 24.2 m -62.25 147.63 47.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.485 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -165.92 156.29 12.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.8 mt -87.6 127.81 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -72.43 -52.95 13.68 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.783 1.233 . . . . 0.0 110.996 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . 0.42 ' CZ2' ' HB2' ' A' ' 232' ' ' GLN . 39.9 p-90 -150.58 166.6 29.76 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.002 1.321 . . . . 0.0 109.395 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.817 HG13 ' CE1' ' A' ' 229' ' ' TYR . 40.4 t -146.46 128.42 7.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 C-N-CA 126.015 1.726 . . . . 0.0 106.795 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.414 ' HD2' ' CE3' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -146.26 124.8 12.43 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.361 0.6 . . . . 0.0 109.898 178.67 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -79.42 93.06 5.3 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 103.08 -2.933 . . . . 0.0 103.08 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.0 p -68.8 -53.59 20.81 Favored 'General case' 0 C--O 1.237 0.424 0 O-C-N 121.667 -0.646 . . . . 0.0 110.348 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -103.33 174.54 5.82 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 25.1 mm -62.94 -27.62 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 O-C-N 121.89 -0.506 . . . . 0.0 111.144 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.89 -52.68 1.99 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.778 0.831 . . . . 0.0 110.697 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 1.7 t -64.94 132.33 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.737 0.815 . . . . 0.0 109.187 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . 0.817 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.3 OUTLIER -124.49 154.77 40.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.327 1.851 . . . . 0.0 109.187 -178.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -131.23 137.77 49.05 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 125.937 1.695 . . . . 0.0 108.784 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -143.61 161.62 38.04 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 126.274 1.83 . . . . 0.0 110.544 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.42 ' HB2' ' CZ2' ' A' ' 220' ' ' TRP . 22.6 tt0 -137.63 143.76 41.57 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.9 m -133.69 146.59 31.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 123.808 0.843 . . . . 0.0 108.97 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.87 143.78 33.54 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.454 0.701 . . . . 0.0 110.08 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 22.9 mt -140.33 134.49 15.46 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.876 0.871 . . . . 0.0 109.135 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.12 -45.63 0.64 Allowed 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.176 1.917 . . . . 0.0 110.9 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -61.73 -21.43 64.5 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.4 mp -64.57 -36.32 83.84 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.685 1.13 . . . . 0.0 109.993 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 50.8 m -56.75 -23.53 43.49 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.022 1.729 . . . . 0.0 113.208 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -64.24 -26.98 68.74 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 121.236 -0.915 . . . . 0.0 112.769 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 28.9 mt -83.19 122.79 28.86 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -48.26 -41.27 27.26 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.95 2.1 . . . . 0.0 113.84 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.713 HD22 ' CE2' ' A' ' 181' ' ' TYR . 49.6 mt -63.52 -37.17 86.26 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.76 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 24.0 mt -97.29 6.67 47.98 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 127.19 2.196 . . . . 0.0 112.788 -177.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.311 0 C-N-CA 126.356 1.863 . . . . 0.0 108.644 179.777 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.9 p . . . . . 0 CA--C 1.532 0.27 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.49 -46.21 89.5 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 59.9 tp -59.65 -49.04 79.31 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.09 0.956 . . . . 0.0 109.098 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.9 mt -59.05 -50.49 73.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.363 1.065 . . . . 0.0 109.778 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 75.0 m -55.77 -52.48 63.83 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.225 1.41 . . . . 0.0 110.231 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -64.47 -41.9 96.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.214 1.006 . . . . 0.0 110.784 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 23.9 m -55.52 -51.69 66.19 Favored 'General case' 0 CA--C 1.523 -0.089 0 C-N-CA 125.284 1.434 . . . . 0.0 109.41 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 106' ' ' VAL . 12.5 tp -56.98 -52.37 65.49 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 118.669 -0.682 . . . . 0.0 109.933 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -56.79 -50.86 71.06 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.478 0.581 . . . . 0.0 111.303 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -55.76 -38.89 70.46 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.546 1.138 . . . . 0.0 109.443 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.64 -53.26 36.17 Favored Glycine 0 N--CA 1.437 -1.25 0 CA-C-O 118.323 -1.265 . . . . 0.0 110.181 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 102' ' ' LEU . 4.1 t -55.88 -53.13 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 119.297 1.548 . . . . 0.0 110.348 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -32.55 72.46 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 118.561 0.618 . . . . 0.0 112.007 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.3 m -68.2 -51.51 44.74 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.45 HD11 HD12 ' A' ' 183' ' ' ILE . 25.4 mt -55.1 -54.26 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.97 -39.14 80.84 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.648 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -61.89 -42.05 98.61 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 118.814 0.734 . . . . 0.0 111.257 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -82.0 -8.22 59.66 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 117.586 -1.197 . . . . 0.0 113.405 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.8 mp -111.65 -33.11 6.45 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 120.941 1.7 . . . . 0.0 110.87 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -53.67 -36.64 62.37 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 122.943 0.497 . . . . 0.0 110.876 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -61.94 -42.57 99.26 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 117.627 -1.178 . . . . 0.0 113.566 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -162.38 150.18 14.18 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 126.696 1.998 . . . . 0.0 111.261 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 31.5 m -75.96 167.27 22.17 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.713 0.805 . . . . 0.0 109.554 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.8 pt -125.55 157.27 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 125.256 1.423 . . . . 0.0 108.592 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.21 168.48 22.36 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.289 0.636 . . . . 0.0 111.667 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -151.68 119.94 6.35 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 124.883 1.273 . . . . 0.0 108.433 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -87.98 102.63 14.93 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.87 67.73 6.19 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.23 -116.2 9.02 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 107.815 -2.114 . . . . 0.0 107.815 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -65.51 -33.42 75.89 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -107.59 121.62 45.04 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 119.081 0.855 . . . . 0.0 111.128 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.5 mt -95.03 150.21 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.403 ' CD1' HG11 ' A' ' 221' ' ' VAL . 45.1 m-85 -119.61 137.87 53.59 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 126.149 1.78 . . . . 0.0 106.354 178.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.19 132.19 41.26 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 125.288 1.435 . . . . 0.0 109.11 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -130.3 112.28 13.17 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 124.893 1.37 . . . . 0.0 109.859 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 6.8 m -96.04 159.38 32.36 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.006 0.922 . . . . 0.0 111.018 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -64.87 88.02 0.18 Allowed 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 123.714 2.942 . . . . 0.0 114.046 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 56.98 54.56 35.96 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.3 mt -126.49 -66.52 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.418 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 8.6 pt-20 -167.5 163.37 14.78 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.178 1.791 . . . . 0.0 108.193 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -124.62 115.75 21.3 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 101.473 -3.529 . . . . 0.0 101.473 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.4 m -130.23 155.55 41.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 123.456 0.702 . . . . 0.0 111.849 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -119.26 126.68 52.07 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 104.961 -2.236 . . . . 0.0 104.961 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -144.91 157.67 44.07 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.885 0.874 . . . . 0.0 112.339 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -89.29 154.59 19.97 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 177.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 166.25 -162.86 36.42 Favored Glycine 0 CA--C 1.521 0.426 0 O-C-N 120.282 -1.511 . . . . 0.0 111.723 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.1 131.72 45.84 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 177.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.4 p . . . . . 0 C--O 1.239 0.529 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 179.952 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 . . . . . 0 N--CA 1.45 -0.459 0 CA-C-O 121.281 0.563 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 47.6 mt . . . . . 0 C--N 1.329 -0.286 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 179.607 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 C--O 1.232 0.174 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.8 t -142.63 132.76 23.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 124.983 1.313 . . . . 0.0 108.452 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -121.7 150.18 42.17 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.926 1.69 . . . . 0.0 109.872 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -101.42 117.07 34.2 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 35.0 mt -89.35 -72.92 0.53 Allowed 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -133.69 152.45 20.49 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -122.7 94.77 47.25 Favored Pre-proline 0 N--CA 1.447 -0.584 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.53 ' HB2' HH22 ' A' ' 170' ' ' ARG . 41.8 Cg_endo -79.13 179.53 6.37 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 122.559 2.173 . . . . 0.0 109.723 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -92.09 173.03 8.04 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -90.59 -41.44 11.35 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.769 0.668 . . . . 0.0 110.268 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -83.35 138.29 33.59 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 125.666 1.586 . . . . 0.0 108.504 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.44 -24.3 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -77.56 -20.73 53.63 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.834 0.853 . . . . 0.0 113.059 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -76.64 -37.28 56.59 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.787 0.804 . . . . 0.0 110.547 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.53 HH22 ' HB2' ' A' ' 163' ' ' PRO . 0.3 OUTLIER -84.72 174.4 9.94 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.531 0.732 . . . . 0.0 110.192 179.563 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -147.6 120.56 8.77 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -96.75 160.01 14.61 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -131.62 122.04 25.36 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.982 0.913 . . . . 0.0 110.966 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 22.0 tp -84.65 103.53 13.84 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.403 HD12 ' HB2' ' A' ' 184' ' ' SER . 36.0 mt -109.75 -179.84 3.92 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.134 1.374 . . . . 0.0 108.854 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.427 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 5.0 p90 -159.03 164.56 35.37 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.19 -0.944 . . . . 0.0 109.918 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -140.71 -178.29 5.46 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.1 -20.63 64.24 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.675 1.19 . . . . 0.0 110.641 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 74.0 t -79.65 -65.74 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -173.29 -172.27 38.65 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.122 1.344 . . . . 0.0 110.01 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.427 ' CD2' ' HB3' ' A' ' 176' ' ' TYR . 29.3 m-85 -83.69 164.47 19.62 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.538 0.735 . . . . 0.0 111.433 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -168.08 165.92 13.22 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.638 1.575 . . . . 0.0 109.247 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.45 HD12 HD11 ' A' ' 109' ' ' ILE . 4.8 mt -112.46 128.97 68.83 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.403 ' HB2' HD12 ' A' ' 175' ' ' LEU . 40.3 t -97.11 130.78 44.34 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 126.155 1.782 . . . . 0.0 108.205 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -138.15 107.48 6.12 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 7.6 tt -100.53 140.53 19.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 5.6 mt -131.76 111.26 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 123.72 0.808 . . . . 0.0 110.532 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.72 -161.21 25.85 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 178.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 50.6 m 71.38 50.08 0.29 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.234 1.814 . . . . 0.0 112.206 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -105.5 -95.2 2.38 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 107.514 -2.234 . . . . 0.0 107.514 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -154.48 123.78 6.45 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.553 1.541 . . . . 0.0 110.854 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.4 mm -65.6 116.87 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 119.616 1.098 . . . . 0.0 108.886 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 19.8 p -69.83 119.84 14.66 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 122.524 0.33 . . . . 0.0 110.908 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -70.72 -8.47 52.36 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.581 -0.699 . . . . 0.0 110.145 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 23.1 t -65.23 -42.93 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 126.359 1.864 . . . . 0.0 109.042 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 6.7 p -125.88 -27.88 3.27 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.948 0.795 . . . . 0.0 112.814 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 97.74 19.28 25.16 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 126.801 2.143 . . . . 0.0 110.036 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -107.25 168.3 9.31 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 119.2 1.5 . . . . 0.0 112.45 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.45 163.0 27.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 122.289 1.042 . . . . 0.0 111.401 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -99.3 29.09 4.12 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 126.514 1.926 . . . . 0.0 108.059 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -73.08 148.08 44.36 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.781 0.8 . . . . 0.0 110.433 -175.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.2 p -116.02 141.53 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.542 -177.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -110.65 124.52 52.06 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.6 mp -113.3 128.03 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 125.649 1.58 . . . . 0.0 109.059 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -108.4 107.7 18.36 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.581 1.152 . . . . 0.0 108.578 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -84.0 122.47 28.81 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 107.886 -1.154 . . . . 0.0 107.886 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 23.0 m -131.45 169.86 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 125.767 1.627 . . . . 0.0 112.527 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -83.11 144.05 30.13 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.633 -1.292 . . . . 0.0 107.735 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -113.39 123.62 6.23 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -32.04 -62.2 0.29 Allowed Glycine 0 CA--C 1.523 0.55 0 C-N-CA 128.954 3.169 . . . . 0.0 114.765 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 2.0 p -78.02 89.79 4.18 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -67.33 35.09 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.107 2.163 . . . . 0.0 115.488 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.4 m -148.5 45.82 1.04 Allowed 'General case' 0 CA--C 1.54 0.559 0 O-C-N 119.837 -1.789 . . . . 0.0 111.161 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.54 162.59 28.48 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.02 169.86 20.34 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.849 2.366 . . . . 0.0 112.036 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 10.3 m -70.7 156.09 39.93 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -168.45 155.88 7.87 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.8 mt -77.73 134.17 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -74.14 -61.43 1.86 Allowed 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 41.7 p-90 -140.25 166.47 24.61 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 125.812 1.645 . . . . 0.0 109.121 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.586 HG13 ' CE1' ' A' ' 229' ' ' TYR . 53.3 t -147.5 134.6 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.19 131.35 11.08 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -85.69 86.37 7.37 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 101.629 -3.471 . . . . 0.0 101.629 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 8.6 p -61.2 -58.09 9.73 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.88 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 56.3 mmtt -91.61 -172.82 3.35 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.7 mp -74.54 -36.61 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 121.021 -1.049 . . . . 0.0 109.492 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 4.6 m -120.91 -43.08 2.47 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.468 0.707 . . . . 0.0 111.835 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 1.1 t -67.7 136.11 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . 0.586 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.7 OUTLIER -124.11 148.02 47.48 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.41 2.284 . . . . 0.0 110.011 -178.01 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -126.18 138.21 53.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.369 2.268 . . . . 0.0 106.655 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.95 161.98 38.84 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.943 1.697 . . . . 0.0 111.065 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -138.35 149.67 45.82 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.453 0.701 . . . . 0.0 109.962 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 72.2 t -133.18 135.96 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.593 1.157 . . . . 0.0 109.306 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.37 130.0 53.57 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.171 1.389 . . . . 0.0 111.26 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 33.4 mt -133.56 138.49 31.29 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-O 118.612 -0.708 . . . . 0.0 110.522 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.76 -43.9 1.63 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.213 2.609 . . . . 0.0 112.467 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -63.57 -20.44 65.64 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 37.1 mt -72.01 -35.28 69.38 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-O 118.828 -0.606 . . . . 0.0 110.037 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 48.2 m -56.3 -21.67 25.53 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.393 1.477 . . . . 0.0 113.149 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -65.98 -31.39 72.27 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.626 0.77 . . . . 0.0 112.115 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 64.4 mt -77.02 116.46 17.7 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -48.1 -37.12 14.56 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.5 mp -63.73 -36.76 84.94 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.01 -1.056 . . . . 0.0 110.028 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -91.87 3.21 55.69 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.746 2.019 . . . . 0.0 112.704 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.714 0 C-N-CA 123.779 0.832 . . . . 0.0 111.002 179.688 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 43.4 p . . . . . 0 CA--C 1.528 0.114 0 CA-C-O 119.395 -0.336 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.94 -48.81 75.05 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.908 0.883 . . . . 0.0 108.774 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 41.6 tp -57.71 -46.76 83.95 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.9 mt -59.1 -53.22 60.79 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.458 0.703 . . . . 0.0 109.704 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 38.6 m -55.1 -43.64 74.21 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.132 1.373 . . . . 0.0 110.803 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.75 -51.52 33.38 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 117.843 -1.075 . . . . 0.0 109.013 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 42.0 m -54.36 -44.26 72.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 119.701 1.137 . . . . 0.0 110.971 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.3 tp -60.12 -55.51 32.96 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 118.686 0.675 . . . . 0.0 109.612 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -56.72 -49.55 74.84 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.779 1.232 . . . . 0.0 110.598 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -57.35 -49.81 74.95 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.722 1.209 . . . . 0.0 108.543 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.78 -46.45 94.48 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 49.9 t -58.8 -52.23 62.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 C-N-CA 126.096 1.758 . . . . 0.0 111.133 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -32.66 74.45 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 119.552 1.069 . . . . 0.0 109.732 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.5 m -66.85 -43.27 84.11 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 34.7 mt -59.16 -51.89 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -35.68 72.27 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.98 -0.533 . . . . 0.0 111.297 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -66.89 -56.56 9.73 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.244 0.929 . . . . 0.0 109.953 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.89 -24.12 66.74 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -178.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 80.5 mt -94.31 -27.93 15.84 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 119.045 0.839 . . . . 0.0 109.955 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -64.1 -27.33 69.02 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 121.663 -0.648 . . . . 0.0 109.709 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -63.74 -46.89 83.3 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.346 1.058 . . . . 0.0 109.012 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -163.37 156.46 18.87 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 126.073 1.749 . . . . 0.0 110.487 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 76.8 m -75.84 176.2 8.03 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 34.1 pt -135.58 149.78 28.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.69 168.13 20.92 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.091 0.556 . . . . 0.0 111.337 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -154.96 128.54 8.55 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.339 1.056 . . . . 0.0 112.16 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -92.45 102.61 15.07 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.4 0.68 . . . . 0.0 109.35 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.92 67.63 8.23 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.461 1.904 . . . . 0.0 106.558 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 67.21 -115.36 7.08 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -68.25 -33.22 73.98 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 118.789 -0.624 . . . . 0.0 112.188 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -106.25 154.18 21.1 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 119.794 1.179 . . . . 0.0 111.603 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.7 mt -121.36 149.94 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.529 ' CD1' HG11 ' A' ' 221' ' ' VAL . 53.1 m-85 -126.76 129.08 47.66 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 127.014 2.125 . . . . 0.0 107.993 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -125.3 125.21 43.16 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 127.104 2.162 . . . . 0.0 109.13 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -122.68 126.67 48.05 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.978 1.311 . . . . 0.0 109.637 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.445 ' HB3' HD12 ' A' ' 133' ' ' ILE . 17.8 m -113.72 157.24 42.19 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.641 0.776 . . . . 0.0 112.77 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -60.29 90.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.354 0.845 1 C-N-CA 126.163 4.575 . . . . 0.0 115.976 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 62.21 31.05 77.71 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.874 -0.491 . . . . 0.0 111.874 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.445 HD12 ' HB3' ' A' ' 130' ' ' CYS . 4.9 mt -110.64 -66.08 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.252 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.52 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 9.4 pt-20 179.67 164.74 1.08 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.753 1.621 . . . . 0.0 109.689 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.35 123.12 38.7 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.2 m -131.23 155.85 42.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 124.385 1.074 . . . . 0.0 111.747 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -123.29 122.72 39.04 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.908 1.683 . . . . 0.0 108.144 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -146.45 156.71 43.49 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.364 1.066 . . . . 0.0 111.404 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -93.15 153.53 18.59 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 168.18 -163.71 37.39 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -116.18 142.9 46.21 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.234 0.25 0 C-N-CA 124.004 0.922 . . . . 0.0 108.886 -179.141 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 . . . . . 0 C--O 1.237 0.397 0 CA-C-O 120.641 0.257 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.3 mt . . . . . 0 C--N 1.328 -0.349 0 N-CA-C 103.66 -2.719 . . . . 0.0 103.66 178.339 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 76.9 mt . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 41.9 t -137.96 138.12 44.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -141.56 153.51 44.88 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.364 1.465 . . . . 0.0 108.33 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -109.88 127.92 55.02 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.508 1.523 . . . . 0.0 110.513 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -90.66 -71.16 0.64 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -133.59 160.66 24.08 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 124.137 0.875 . . . . 0.0 111.759 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -130.36 90.6 40.91 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 126.167 1.787 . . . . 0.0 107.879 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.52 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 54.6 Cg_endo -75.95 -175.55 2.56 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 124.471 3.447 . . . . 0.0 110.288 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -110.75 161.19 16.03 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.915 0.886 . . . . 0.0 110.314 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.15 -29.55 57.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.731 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -99.11 133.79 42.89 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.6 p -67.18 -26.43 36.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 122.917 0.487 . . . . 0.0 110.349 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -74.0 -16.19 61.07 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.145 1.778 . . . . 0.0 112.548 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -91.94 -13.69 30.74 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.63 1.572 . . . . 0.0 108.744 177.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -107.15 175.25 5.56 Favored 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 126.961 2.104 . . . . 0.0 107.786 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -148.07 152.34 37.2 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -138.6 165.52 26.68 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.784 1.234 . . . . 0.0 107.819 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -139.37 122.59 16.97 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.477 1.111 . . . . 0.0 109.296 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 25.7 tp -88.89 100.16 12.96 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 54.1 mt -106.29 -179.55 3.97 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.281 2.233 . . . . 0.0 110.504 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -156.54 151.8 26.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.137 0.975 . . . . 0.0 109.035 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -134.32 -174.54 3.59 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.066 1.746 . . . . 0.0 106.621 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -54.87 -31.4 59.7 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.997 2.119 . . . . 0.0 112.035 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 73.0 t -69.81 -67.53 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -177.61 -163.6 29.71 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.534 ' CE2' HD22 ' A' ' 243' ' ' LEU . 3.3 m-85 -78.19 160.95 27.68 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.421 0.688 . . . . 0.0 109.397 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -165.84 168.4 15.97 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.27 1.428 . . . . 0.0 109.453 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.0 mt -117.45 124.85 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.3 t -102.16 133.44 47.01 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -137.04 111.57 8.63 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.6 tt -101.1 127.82 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 5.8 mt -120.39 114.13 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.29 1.036 . . . . 0.0 111.522 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.0 -172.81 27.64 Favored Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 125.17 1.367 . . . . 0.0 111.455 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.2 t 84.57 58.52 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 128.242 2.617 . . . . 0.0 110.808 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -110.23 -127.4 5.28 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 107.656 -2.178 . . . . 0.0 107.656 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -126.82 118.79 25.34 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 19.1 mm -59.82 134.53 25.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 18.9 p -89.25 106.73 18.63 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -63.66 -12.22 32.18 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 119.104 0.865 . . . . 0.0 110.385 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 29.0 t -60.73 -42.01 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 126.937 2.095 . . . . 0.0 109.767 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 3.5 p -125.23 -24.06 4.05 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.856 0.753 . . . . 0.0 112.504 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 87.51 29.31 22.08 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 108.499 -1.84 . . . . 0.0 108.499 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -108.15 164.55 12.2 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 122.545 1.165 . . . . 0.0 111.283 178.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -91.51 138.41 31.59 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 1.8 mtt85 -70.69 29.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 129.921 3.288 . . . . 0.0 112.784 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 16.0 ptt? -72.46 148.81 44.77 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.018 0.913 . . . . 0.0 110.552 -174.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -115.91 143.39 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.369 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -108.26 133.61 52.25 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.41 110.17 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -95.21 108.4 20.53 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.656 0.782 . . . . 0.0 109.814 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -84.68 126.85 33.73 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.054 0.542 . . . . 0.0 109.726 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 32.3 m -139.27 175.65 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 125.877 1.671 . . . . 0.0 112.315 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.9 t -93.0 126.16 37.94 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.533 1.533 . . . . 0.0 107.563 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.12 164.82 44.57 Favored Glycine 0 N--CA 1.467 0.756 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -54.12 -76.12 0.2 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 125.094 1.33 . . . . 0.0 110.394 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 47.8 m -70.85 145.73 50.08 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 34.0 p30 -117.26 33.26 5.71 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 29.6 m -134.78 47.33 2.38 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.733 1.213 . . . . 0.0 113.433 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -153.54 165.71 31.53 Favored Glycine 0 CA--C 1.524 0.615 0 O-C-N 120.451 -1.405 . . . . 0.0 110.333 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -70.82 163.99 37.18 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.038 1.825 . . . . 0.0 110.327 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 14.1 p -67.24 155.83 37.86 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.236 1.014 . . . . 0.0 109.137 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -169.02 159.42 9.25 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.67 1.188 . . . . 0.0 108.711 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.6 mp -76.74 134.03 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -78.11 -55.34 5.36 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 125.973 1.709 . . . . 0.0 109.934 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . 0.402 ' CE3' ' CD ' ' A' ' 222' ' ' ARG . 27.9 p-90 -145.69 165.05 29.9 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 124.755 1.222 . . . . 0.0 108.686 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.766 HG13 ' CE1' ' A' ' 229' ' ' TYR . 39.0 t -144.47 127.39 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.402 ' CD ' ' CE3' ' A' ' 220' ' ' TRP . 0.3 OUTLIER -153.82 118.69 5.01 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 124.107 0.879 . . . . 0.0 109.189 179.355 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -74.64 95.2 2.79 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 102.626 -3.102 . . . . 0.0 102.626 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.7 p -63.73 -57.77 8.95 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.81 0.844 . . . . 0.0 111.69 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -100.87 -178.51 3.79 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.435 ' H ' HD12 ' A' ' 226' ' ' ILE . 4.4 mp -58.2 -41.55 81.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 O-C-N 121.79 -0.569 . . . . 0.0 110.022 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -123.52 -10.1 7.93 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -177.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 59.0 t -91.74 130.5 40.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . 0.766 ' CE1' HG13 ' A' ' 221' ' ' VAL . 1.1 t80 -123.38 143.51 50.07 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.218 1.007 . . . . 0.0 108.354 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -127.3 140.92 51.87 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 125.609 1.564 . . . . 0.0 107.451 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -139.7 159.04 43.09 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.272 1.829 . . . . 0.0 108.042 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -131.48 144.62 51.28 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 99.6 t -132.55 133.44 59.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.2 p -104.66 141.0 37.22 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 43.6 mt -137.36 137.12 21.55 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -72.99 -39.28 2.35 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.065 1.843 . . . . 0.0 112.127 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -60.52 -34.61 74.35 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.587 0.63 . . . . 0.0 111.338 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 5.1 mp -59.45 -29.95 68.15 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-O 118.745 -0.645 . . . . 0.0 111.428 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 57.2 m -63.57 -19.35 64.75 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.935 0.894 . . . . 0.0 112.618 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -67.46 -38.58 84.66 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.169 0.588 . . . . 0.0 111.086 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 49.6 mt -67.0 117.45 9.08 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.352 1.061 . . . . 0.0 108.539 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -48.36 -37.87 17.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.347 1.459 . . . . 0.0 114.874 -178.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.534 HD22 ' CE2' ' A' ' 181' ' ' TYR . 17.9 mt -62.72 -33.55 75.35 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.578 -0.702 . . . . 0.0 110.015 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -98.21 2.42 48.35 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.986 2.115 . . . . 0.0 113.064 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.517 0 C-N-CA 124.534 1.134 . . . . 0.0 107.998 179.036 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.9 p . . . . . 0 CA--C 1.535 0.376 0 CA-C-O 119.726 -0.178 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.68 -45.21 91.13 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.479 -0.763 . . . . 0.0 108.971 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 45.8 tp -58.42 -44.79 89.22 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.707 1.203 . . . . 0.0 108.434 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 11.5 mt -64.05 -54.92 26.59 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.238 1.015 . . . . 0.0 110.184 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.3 m -57.14 -44.24 83.19 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.03 -1.044 . . . . 0.0 110.784 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -62.31 -50.46 71.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 120.977 -1.077 . . . . 0.0 108.441 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.0 m -56.0 -40.77 73.85 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.144 0.977 . . . . 0.0 110.477 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.503 ' O ' HG23 ' A' ' 106' ' ' VAL . 13.6 tp -62.29 -53.33 56.64 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.726 0.694 . . . . 0.0 109.136 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.34 -48.33 80.9 Favored 'General case' 0 C--N 1.335 -0.064 0 C-N-CA 123.43 0.692 . . . . 0.0 110.616 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -60.86 -42.88 98.73 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.374 1.47 . . . . 0.0 110.269 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.11 -47.11 85.13 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 102' ' ' LEU . 94.5 t -57.87 -53.07 50.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 118.566 1.183 . . . . 0.0 110.125 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -31.4 72.55 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 119.177 0.899 . . . . 0.0 110.488 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.6 m -65.75 -48.11 72.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 40.8 mt -58.78 -53.02 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 C-N-CA 123.886 0.875 . . . . 0.0 108.805 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.47 -36.57 73.92 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.326 0.512 . . . . 0.0 111.31 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -63.58 -54.5 35.0 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.536 1.062 . . . . 0.0 108.318 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.21 10.59 0.55 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 128.399 2.68 . . . . 0.0 114.825 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.6 mt -132.68 -32.85 1.25 Allowed 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 124.636 1.174 . . . . 0.0 108.278 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -61.39 -34.43 75.33 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -59.14 -45.05 91.95 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.92 1.688 . . . . 0.0 111.922 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -166.72 153.04 8.52 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.593 1.957 . . . . 0.0 109.683 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.0 m -76.48 174.76 9.9 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 27.5 pt -131.66 152.16 36.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -146.75 165.05 30.82 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 122.91 0.484 . . . . 0.0 110.786 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -150.34 128.48 11.95 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.539 1.536 . . . . 0.0 110.595 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -94.27 102.8 14.82 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.463 1.105 . . . . 0.0 109.707 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.77 66.87 6.16 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.52 -115.47 7.67 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -63.6 -35.26 79.92 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.325 1.05 . . . . 0.0 112.213 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -107.14 153.45 22.63 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 119.211 0.914 . . . . 0.0 110.502 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.2 mt -119.92 152.68 22.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -124.97 132.47 53.27 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 127.182 2.193 . . . . 0.0 107.31 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -126.96 132.93 50.71 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 125.87 1.668 . . . . 0.0 107.376 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -129.49 111.52 12.84 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 6.6 m -100.37 159.0 30.92 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 123.814 0.846 . . . . 0.0 111.236 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -61.46 92.97 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 124.442 3.428 . . . . 0.0 114.121 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 54.95 39.28 67.97 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.062 -0.854 . . . . 0.0 112.217 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.4 mt -109.9 -66.94 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.412 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 9.7 pt-20 -171.32 161.34 6.47 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.982 1.713 . . . . 0.0 106.917 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -119.91 121.7 39.6 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 101.625 -3.472 . . . . 0.0 101.625 177.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.1 m -137.39 155.06 31.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 123.506 0.722 . . . . 0.0 111.725 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -119.91 132.6 55.59 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 177.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -146.34 158.19 43.86 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.235 1.014 . . . . 0.0 113.032 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -88.8 148.46 23.9 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 165.64 -162.93 36.3 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -178.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.95 147.04 50.81 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 124.497 1.119 . . . . 0.0 108.186 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 C--N 1.325 -0.478 0 C-N-CA 124.988 1.315 . . . . 0.0 107.813 179.78 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 . . . . . 0 N--CA 1.448 -0.551 0 CA-C-O 120.471 0.177 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 56.3 mt . . . . . 0 CA--C 1.549 0.928 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 177.414 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 43.3 mt . . . . . 0 C--O 1.231 0.096 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 12.2 t -140.91 135.44 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.924 1.29 . . . . 0.0 109.351 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -119.64 176.27 5.46 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.735 1.214 . . . . 0.0 110.972 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -128.31 120.31 26.82 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 26.2 mt -96.77 -67.37 0.85 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.738 1.215 . . . . 0.0 109.807 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -127.25 149.2 17.73 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 189' ' ' SER . 26.7 tttp -124.89 83.54 59.59 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 125.969 1.708 . . . . 0.0 108.261 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 63.8 Cg_endo -75.58 173.61 14.2 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.403 2.069 . . . . 0.0 109.928 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -92.89 161.57 14.43 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.554 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -80.68 -22.98 39.91 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.742 0.817 . . . . 0.0 112.929 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -112.35 147.51 36.22 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.157 0.983 . . . . 0.0 108.456 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.2 p -71.25 -32.14 46.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -74.14 -12.87 60.72 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -177.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -84.68 -18.67 34.56 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.474 0.309 . . . . 0.0 110.289 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -111.84 171.84 7.25 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.662 1.185 . . . . 0.0 111.983 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -138.69 117.14 12.03 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.445 1.098 . . . . 0.0 109.471 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.408 ' CD2' HG22 ' A' ' 106' ' ' VAL . 3.3 m-30 -96.76 158.29 15.5 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -130.55 126.6 37.18 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.081 0.553 . . . . 0.0 112.159 -177.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.2 tt -90.28 101.8 14.52 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.332 0.653 . . . . 0.0 110.504 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 5.2 mt -115.03 174.81 5.79 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.87 1.668 . . . . 0.0 108.333 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -143.02 163.96 31.37 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 120.345 -1.472 . . . . 0.0 109.069 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -137.94 -176.38 4.41 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.902 1.681 . . . . 0.0 110.388 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -69.39 5.28 1.37 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.401 1.88 . . . . 0.0 115.076 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 41.5 t -118.9 -63.98 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -162.51 -160.86 11.47 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 119.812 1.187 . . . . 0.0 111.888 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.547 ' CE2' HD22 ' A' ' 243' ' ' LEU . 3.1 m-85 -91.13 160.85 15.36 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -164.84 171.88 13.61 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 7.4 mt -121.07 133.57 67.28 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 4.4 t -111.13 132.11 54.55 Favored 'General case' 0 N--CA 1.439 -1.002 0 O-C-N 124.579 1.175 . . . . 0.0 108.752 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -133.64 111.57 10.72 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.8 tt -96.79 132.78 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.5 mt -124.32 111.4 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 124.501 1.121 . . . . 0.0 111.03 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -103.34 -158.54 25.01 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.468 ' HB3' ' HB3' ' A' ' 162' ' ' LYS . 1.6 t 70.69 28.29 3.5 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 127.062 2.145 . . . . 0.0 112.286 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -81.28 -90.45 0.56 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 103.611 -3.796 . . . . 0.0 103.611 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -157.14 165.97 34.54 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 29.2 mm -94.36 145.5 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 126.235 1.814 . . . . 0.0 108.448 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.8 p -107.71 98.41 8.01 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 106.114 -1.809 . . . . 0.0 106.114 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -63.22 -7.62 6.42 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 120.28 1.4 . . . . 0.0 112.444 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 86.0 t -63.65 -38.43 82.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 126.499 1.92 . . . . 0.0 108.147 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 21.0 p -119.45 -32.5 4.32 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.213 1.005 . . . . 0.0 110.539 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 88.72 32.95 10.47 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -118.01 -176.93 3.15 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.643 1.577 . . . . 0.0 109.116 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -102.89 148.34 25.77 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.878 0.871 . . . . 0.0 110.228 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.04 29.62 0.08 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 129.317 3.047 . . . . 0.0 111.312 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -72.74 151.48 42.12 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 120.819 -1.176 . . . . 0.0 110.967 -174.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.3 p -121.95 149.12 25.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.771 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -114.95 130.35 56.9 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.6 mp -117.63 111.91 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -96.04 108.39 20.8 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.651 1.18 . . . . 0.0 108.835 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -87.83 121.15 29.9 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.115 0.966 . . . . 0.0 111.677 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.71 163.86 36.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 126.085 1.754 . . . . 0.0 111.002 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.17 139.8 40.01 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -94.85 178.23 36.11 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -89.77 -39.14 6.29 Favored Glycine 0 CA--C 1.525 0.699 0 O-C-N 121.909 -0.759 . . . . 0.0 111.513 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.8 t -82.62 94.8 7.61 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.48 ' HA ' ' HB3' ' A' ' 236' ' ' PRO . 5.6 p30 -77.64 39.8 0.28 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.066 0.546 . . . . 0.0 111.246 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 41.0 p -156.7 26.26 0.33 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -138.18 176.99 20.39 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 118.676 0.671 . . . . 0.0 112.562 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.47 164.33 28.7 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.298 2.666 . . . . 0.0 112.098 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 8.6 t -70.91 159.58 34.41 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.89 161.85 7.22 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 126.079 1.752 . . . . 0.0 107.452 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.8 mp -82.2 130.08 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -71.15 -59.22 2.89 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.539 1.135 . . . . 0.0 110.351 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 29.6 p-90 -143.55 166.04 25.92 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 125.244 1.418 . . . . 0.0 108.552 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.653 HG13 ' CE1' ' A' ' 229' ' ' TYR . 42.7 t -145.55 127.74 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.82 118.23 8.48 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 177.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -77.81 91.27 4.1 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 101.002 -3.703 . . . . 0.0 101.002 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.7 p -56.75 -53.13 61.37 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.871 1.669 . . . . 0.0 113.513 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.495 ' HB2' ' H ' ' A' ' 228' ' ' VAL . 71.6 mmtt -116.14 176.63 5.01 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 16.9 mm -61.72 -30.52 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -122.69 -24.28 4.92 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.495 ' H ' ' HB2' ' A' ' 225' ' ' LYS . 21.8 t -90.28 135.67 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . 0.653 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.8 OUTLIER -131.81 142.13 49.64 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -179.517 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -127.17 140.04 52.53 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 125.111 1.364 . . . . 0.0 108.615 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -140.72 159.12 42.88 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.462 1.505 . . . . 0.0 109.042 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -130.56 139.63 50.46 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 79.7 t -122.06 146.74 26.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 124.503 1.121 . . . . 0.0 108.313 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.52 130.4 54.23 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 123.122 0.569 . . . . 0.0 109.98 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 63.4 mt -132.19 137.94 31.18 Favored Pre-proline 0 C--O 1.236 0.383 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.193 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.48 ' HB3' ' HA ' ' A' ' 212' ' ' ASN . 81.3 Cg_endo -74.89 -44.88 0.32 Allowed 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.188 1.926 . . . . 0.0 112.478 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.84 -25.76 21.15 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.681 1.192 . . . . 0.0 113.261 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 88.6 mt -67.49 -34.38 77.02 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-N 118.651 0.659 . . . . 0.0 112.762 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 19.0 m -57.66 -17.75 16.6 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.879 1.272 . . . . 0.0 114.312 -178.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -64.12 -29.02 70.17 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.941 -0.475 . . . . 0.0 110.363 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 30.0 mt -80.29 113.44 18.47 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -49.61 -30.74 9.31 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.547 HD22 ' CE2' ' A' ' 181' ' ' TYR . 17.5 mt -62.74 -36.18 82.18 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.756 -0.59 . . . . 0.0 109.535 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -95.28 2.96 54.96 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 126.888 2.075 . . . . 0.0 114.586 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.597 0 C-N-CA 126.58 1.952 . . . . 0.0 109.101 179.551 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.4 p . . . . . 0 CA--C 1.531 0.237 0 CA-C-O 118.858 -0.591 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.48 -45.56 92.48 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.001 0.819 . . . . 0.0 110.03 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.7 tp -60.95 -40.66 94.16 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 118.947 0.794 . . . . 0.0 109.449 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.4 mt -60.65 -54.38 46.02 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 55.9 m -54.2 -44.88 72.0 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.499 1.12 . . . . 0.0 111.534 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.2 ttmt -62.78 -50.99 68.85 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 m -56.88 -42.91 80.68 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 117.815 -1.088 . . . . 0.0 111.156 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.438 ' O ' HG23 ' A' ' 106' ' ' VAL . 20.9 tp -62.66 -53.48 53.93 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 119.881 1.219 . . . . 0.0 109.504 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -55.38 -52.41 63.62 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 123.91 0.884 . . . . 0.0 111.198 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -55.22 -50.48 69.31 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 125.008 1.323 . . . . 0.0 108.496 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.421 ' HA3' HD11 ' A' ' 183' ' ' ILE . . . -58.05 -50.27 67.57 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 123.91 0.767 . . . . 0.0 112.081 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 102' ' ' LEU . 89.9 t -59.18 -53.23 50.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 124.215 1.006 . . . . 0.0 110.136 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -30.86 71.9 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 118.983 0.811 . . . . 0.0 110.6 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.4 m -66.49 -45.15 80.6 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.426 HD11 HD12 ' A' ' 183' ' ' ILE . 31.0 mt -58.28 -53.84 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.21 -37.59 83.53 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.183 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -60.74 -44.46 96.63 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.215 1.006 . . . . 0.0 109.472 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.86 -19.29 44.81 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 71.0 mt -100.74 -25.06 14.26 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 121.132 1.787 . . . . 0.0 112.793 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -59.36 -21.12 59.37 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -71.2 -46.09 61.98 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.77 2.428 . . . . 0.0 110.542 179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -162.28 153.29 17.68 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 125.558 1.543 . . . . 0.0 112.456 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.6 m -76.36 159.92 30.06 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 175.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 24.7 pt -117.63 154.64 19.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -147.09 165.86 28.66 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.294 0.569 . . . . 0.0 111.217 -178.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -151.1 134.56 16.23 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.094 1.357 . . . . 0.0 109.555 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -97.45 105.39 17.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 123.52 0.728 . . . . 0.0 109.813 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.84 67.33 9.79 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.104 1.361 . . . . 0.0 107.609 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 69.76 -115.18 6.07 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -66.83 -32.4 73.66 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.028 1.331 . . . . 0.0 112.679 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -106.09 162.84 13.26 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 119.036 0.835 . . . . 0.0 111.89 -177.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 45.3 mt -130.66 149.43 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -125.49 129.81 50.53 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.182 2.193 . . . . 0.0 108.255 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -125.98 129.6 49.54 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.333 1.853 . . . . 0.0 109.392 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -124.03 117.16 24.08 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.941 1.696 . . . . 0.0 109.666 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 19.8 m -99.35 159.7 29.43 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.574 1.15 . . . . 0.0 111.056 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -62.78 87.24 0.11 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 124.797 3.665 . . . . 0.0 113.687 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 57.61 45.77 92.85 Favored Glycine 0 CA--C 1.527 0.814 0 O-C-N 121.201 -0.937 . . . . 0.0 112.0 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.5 mt -118.26 -66.74 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 118.607 1.203 . . . . 0.0 108.435 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -166.02 159.81 15.93 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 126.954 2.102 . . . . 0.0 107.885 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -123.92 117.65 25.27 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 102.072 -3.307 . . . . 0.0 102.072 177.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.0 m -128.9 156.24 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.43 1.092 . . . . 0.0 111.979 -178.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -127.26 127.51 44.5 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 178.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -146.4 159.4 43.43 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.201 1.4 . . . . 0.0 113.04 -178.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -88.7 153.58 20.98 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 177.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 163.2 -163.81 35.7 Favored Glycine 0 C--O 1.241 0.579 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -178.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.53 139.28 53.33 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 126.102 1.761 . . . . 0.0 106.607 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 C--N 1.323 -0.569 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 179.358 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 N--CA 1.445 -0.675 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.8 mt . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 178.493 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.5 mt . . . . . 0 N--CA 1.464 0.26 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.3 t -142.73 142.41 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 123.508 0.723 . . . . 0.0 109.88 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -139.95 159.26 42.59 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.367 1.467 . . . . 0.0 109.197 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.2 124.99 51.64 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.99 -62.54 1.54 Allowed 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 124.631 1.172 . . . . 0.0 109.557 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -139.92 158.29 25.66 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.9 ttpp -126.03 89.7 51.79 Favored Pre-proline 0 N--CA 1.452 -0.334 0 C-N-CA 124.875 1.27 . . . . 0.0 108.467 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -75.4 177.36 8.75 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.982 2.455 . . . . 0.0 109.502 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -91.63 155.57 18.24 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 121.788 -0.57 . . . . 0.0 111.588 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.42 -24.15 61.19 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 125.036 1.334 . . . . 0.0 113.277 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -109.61 148.49 31.21 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.753 1.621 . . . . 0.0 108.777 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.1 p -73.32 -32.87 39.16 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 C-N-CA 121.987 0.115 . . . . 0.0 111.267 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -72.95 -21.98 60.78 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 120.454 -1.404 . . . . 0.0 113.465 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -79.68 -17.72 53.01 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.295 0.638 . . . . 0.0 111.626 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.96 176.56 5.23 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.245 1.018 . . . . 0.0 111.15 178.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -146.76 137.1 23.67 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.712 1.205 . . . . 0.0 108.612 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.401 ' CD2' HG22 ' A' ' 106' ' ' VAL . 3.5 m-30 -127.05 159.67 33.44 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.706 2.803 . . . . 0.0 106.777 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -136.08 131.65 35.12 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.276 0.63 . . . . 0.0 112.165 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 35.2 tp -85.23 101.65 12.68 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.613 1.565 . . . . 0.0 108.413 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.43 HD12 ' HB2' ' A' ' 184' ' ' SER . 27.8 mt -113.55 -179.15 3.56 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.605 1.562 . . . . 0.0 109.603 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -153.46 158.07 40.82 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 52.4 p30 -134.8 -173.37 3.28 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 127.596 2.358 . . . . 0.0 107.094 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.55 -22.76 66.15 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.107 -1.621 . . . . 0.0 113.469 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 74.6 t -78.31 -53.48 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 178.3 -163.09 30.9 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-O 122.023 0.791 . . . . 0.0 112.368 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.475 ' CE2' HD22 ' A' ' 243' ' ' LEU . 3.0 m-85 -82.7 159.9 22.49 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -167.43 165.83 14.68 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.939 0.896 . . . . 0.0 109.684 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.426 HD12 HD11 ' A' ' 109' ' ' ILE . 5.8 mt -109.92 136.47 45.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 177.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.43 ' HB2' HD12 ' A' ' 175' ' ' LEU . 0.6 OUTLIER -110.96 116.74 31.73 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 125.106 1.362 . . . . 0.0 107.818 -179.153 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -116.3 108.67 16.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.2 tt -99.65 140.19 19.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.5 mt -135.66 107.43 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 124.335 1.054 . . . . 0.0 111.153 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -101.45 -157.19 26.87 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 18.1 m 68.23 34.26 3.98 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.759 0.424 . . . . 0.0 112.075 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -89.84 -96.34 1.12 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 103.812 -3.715 . . . . 0.0 103.812 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -150.54 170.58 18.79 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.99 1.716 . . . . 0.0 107.575 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 23.5 mm -100.64 123.06 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 126.365 1.866 . . . . 0.0 107.946 178.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 8.1 m -88.1 94.39 9.79 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 101.505 -3.517 . . . . 0.0 101.505 177.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -57.89 -15.63 9.26 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 3.1 m -55.91 -35.62 41.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.003 0.921 . . . . 0.0 108.87 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 75.0 p -114.87 -24.45 8.65 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.569 1.148 . . . . 0.0 110.275 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 81.91 34.44 24.39 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -129.85 169.68 14.87 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.052 1.341 . . . . 0.0 110.939 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -83.02 145.76 29.12 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 12.2 ttt85 -76.82 29.17 0.13 Allowed 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 129.913 3.285 . . . . 0.0 112.384 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -72.19 144.1 48.64 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 122.351 1.072 . . . . 0.0 111.959 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -110.8 155.67 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 113.489 -1.687 . . . . 0.0 111.493 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -123.87 128.46 49.52 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.021 1.728 . . . . 0.0 106.972 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.5 mp -118.09 119.79 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 124.968 1.307 . . . . 0.0 107.723 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -102.5 113.81 27.48 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -94.1 116.75 29.21 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 33.6 m -126.4 169.35 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 125.298 1.439 . . . . 0.0 112.096 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -85.48 135.78 33.7 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 177.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -101.56 156.08 18.91 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 118.936 0.789 . . . . 0.0 111.608 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -51.01 -68.21 1.6 Allowed Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.902 1.715 . . . . 0.0 112.145 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 13.3 p -75.66 80.24 2.64 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 117.913 0.856 . . . . 0.0 108.776 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -67.46 36.23 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.132 2.573 . . . . 0.0 115.777 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 14.3 m -148.05 46.65 1.08 Allowed 'General case' 0 CA--C 1.536 0.408 0 O-C-N 119.932 -1.73 . . . . 0.0 113.093 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -148.28 -178.58 23.54 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.63 164.9 32.79 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.862 2.375 . . . . 0.0 110.417 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 60.6 p -81.42 151.95 27.65 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.934 0.894 . . . . 0.0 108.706 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.32 163.6 17.57 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.274 1.429 . . . . 0.0 107.454 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.3 mp -77.36 130.07 36.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -72.38 -61.07 1.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.968 1.707 . . . . 0.0 110.222 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -142.26 167.85 21.14 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 125.689 1.596 . . . . 0.0 108.804 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.609 HG13 ' CE1' ' A' ' 229' ' ' TYR . 28.7 t -145.69 137.63 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.97 117.8 3.3 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -77.16 92.7 3.83 Favored 'General case' 0 C--N 1.328 -0.357 1 N-CA-C 99.715 -4.18 . . . . 0.0 99.715 177.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 2.0 p -58.42 -61.38 2.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.875 1.27 . . . . 0.0 112.348 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -98.78 -172.72 2.36 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 28.2 mm -63.25 -46.1 96.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 O-C-N 121.256 -0.902 . . . . 0.0 111.089 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 9.1 t -109.72 -16.89 13.81 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 16.2 t -87.32 140.56 15.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 123.928 0.891 . . . . 0.0 108.874 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . 0.609 ' CE1' HG13 ' A' ' 221' ' ' VAL . 2.3 t80 -133.78 140.64 47.07 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.126 0.971 . . . . 0.0 109.038 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -127.98 138.48 52.63 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.02 161.44 39.39 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.524 1.529 . . . . 0.0 109.71 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -133.46 149.85 51.75 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 123.334 0.654 . . . . 0.0 110.355 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 60.5 t -128.29 144.98 36.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 125.511 1.524 . . . . 0.0 107.554 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.66 133.03 56.43 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 83.0 mt -134.75 137.58 27.76 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.056 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.34 -43.19 1.1 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.169 2.579 . . . . 0.0 112.708 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -57.76 -33.78 68.85 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.072 0.549 . . . . 0.0 111.081 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 55.6 mt -61.81 -33.79 74.76 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.891 0.769 . . . . 0.0 111.898 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 53.1 m -61.84 -17.16 55.32 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.017 0.927 . . . . 0.0 113.133 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -69.31 -17.98 63.77 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 123.923 0.889 . . . . 0.0 112.896 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 45.1 mt -90.74 120.73 32.02 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 126.235 1.814 . . . . 0.0 107.017 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.14 -41.79 49.53 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.898 1.279 . . . . 0.0 113.055 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.475 HD22 ' CE2' ' A' ' 181' ' ' TYR . 31.7 mt -56.39 -34.8 67.04 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.416 0.687 . . . . 0.0 110.193 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -100.88 4.53 42.8 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 126.791 2.036 . . . . 0.0 113.84 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.463 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.787 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.6 m . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.7 -39.11 87.33 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-N 118.622 0.646 . . . . 0.0 109.841 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.9 tp -64.6 -44.89 89.16 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mt -59.11 -51.07 71.62 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.0 m -55.17 -44.75 75.52 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.34 1.056 . . . . 0.0 111.083 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -67.23 -51.17 56.48 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 121.548 -0.72 . . . . 0.0 110.232 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 21.8 m -54.82 -42.07 71.43 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 118.153 -0.927 . . . . 0.0 110.506 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.8 tp -61.01 -56.15 24.43 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 120.051 1.296 . . . . 0.0 110.034 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -57.23 -49.49 75.85 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.987 0.812 . . . . 0.0 111.602 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -56.85 -44.48 82.2 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.334 0.654 . . . . 0.0 109.269 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.542 ' HA3' HD11 ' A' ' 183' ' ' ILE . . . -63.52 -47.2 89.25 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 79.7 t -58.18 -52.99 51.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.671 1.189 . . . . 0.0 109.838 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -31.1 72.05 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.14 0.882 . . . . 0.0 110.315 178.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -68.53 -47.96 65.56 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.637 HD11 HD12 ' A' ' 183' ' ' ILE . 24.3 mt -57.06 -54.72 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 123.075 0.55 . . . . 0.0 109.583 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.52 -41.24 80.45 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 124.188 0.93 . . . . 0.0 110.23 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -64.64 -43.98 91.96 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.079 0.466 . . . . 0.0 111.894 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.31 -13.08 61.05 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 73.9 mt -106.75 -26.85 11.12 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 119.488 1.04 . . . . 0.0 111.945 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -57.15 -28.19 62.52 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.178 0.591 . . . . 0.0 111.625 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -68.52 -45.88 71.07 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.342 1.457 . . . . 0.0 111.096 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -161.07 149.55 16.08 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.978 1.311 . . . . 0.0 109.896 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 60.3 m -75.38 163.16 27.72 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 177.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 28.2 pt -118.24 148.7 20.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.8 154.58 44.34 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 122.673 0.389 . . . . 0.0 110.689 -177.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -143.13 124.96 15.07 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 124.439 1.096 . . . . 0.0 110.143 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -87.63 102.86 15.03 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.6 67.32 6.41 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.52 -115.95 6.26 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -66.4 -33.15 75.08 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.479 0.712 . . . . 0.0 112.59 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -106.64 160.29 15.56 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 122.153 0.977 . . . . 0.0 110.947 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.0 mt -124.57 147.99 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 178.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -121.64 134.53 54.99 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -130.49 125.25 33.88 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 126.629 1.972 . . . . 0.0 108.221 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -126.39 119.07 26.35 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 125.043 1.337 . . . . 0.0 109.799 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 12.5 m -102.88 160.52 25.97 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 124.76 1.224 . . . . 0.0 113.229 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.88 80.64 0.64 Allowed 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 124.47 3.447 . . . . 0.0 113.506 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.76 52.19 35.66 Favored Glycine 0 C--O 1.237 0.324 0 O-C-N 121.546 -0.721 . . . . 0.0 111.505 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.3 mt -129.17 -67.09 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -174.41 160.19 3.17 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.17 1.388 . . . . 0.0 108.987 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.91 120.23 38.51 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 176.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.18 154.86 40.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 118.758 0.708 . . . . 0.0 111.083 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -123.04 130.32 52.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 127.897 2.479 . . . . 0.0 106.579 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -146.37 156.92 43.67 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.357 1.063 . . . . 0.0 110.198 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 56.3 t60 -89.2 153.83 20.62 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 156.21 -164.14 32.26 Favored Glycine 0 CA--C 1.523 0.537 0 O-C-N 120.829 -1.169 . . . . 0.0 111.59 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.16 150.05 45.61 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 124.388 1.075 . . . . 0.0 110.517 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 CA--C 1.535 0.392 0 C-N-CA 125.091 1.357 . . . . 0.0 108.205 179.285 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.5 mt . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 179.172 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 84.3 mt . . . . . 0 C--O 1.23 0.061 0 CA-C-O 119.399 -0.334 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 9.8 t -136.69 152.8 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.802 1.241 . . . . 0.0 108.585 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -145.44 171.8 14.12 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 126.286 1.835 . . . . 0.0 110.112 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -125.9 125.59 43.04 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.118 1.767 . . . . 0.0 109.55 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 22.1 mt -102.89 -72.83 0.68 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.227 1.011 . . . . 0.0 109.395 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -124.0 149.18 16.88 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -132.37 89.14 37.6 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.01 0.924 . . . . 0.0 110.443 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -77.5 -179.15 5.16 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 125.049 3.833 . . . . 0.0 113.293 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -90.05 161.67 15.71 Favored 'General case' 0 C--O 1.231 0.084 0 C-N-CA 124.069 0.948 . . . . 0.0 110.211 178.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.19 -24.81 57.87 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -118.99 157.91 26.82 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 123.629 0.771 . . . . 0.0 109.331 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 5.2 p -73.97 -33.02 35.21 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 C-N-CA 124.633 1.173 . . . . 0.0 112.095 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -75.13 -7.05 52.69 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.22 1.808 . . . . 0.0 112.93 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -94.2 -14.99 25.0 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.115 1.366 . . . . 0.0 109.708 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -124.35 179.32 4.96 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 128.665 2.786 . . . . 0.0 112.811 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -138.17 166.76 23.35 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.414 2.286 . . . . 0.0 107.817 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -141.06 159.34 42.42 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.864 2.066 . . . . 0.0 107.612 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -124.38 124.54 42.58 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.755 1.222 . . . . 0.0 111.309 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 21.6 tp -90.02 100.77 13.53 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 22.6 mt -107.21 -178.72 3.72 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.308 1.843 . . . . 0.0 108.754 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -158.81 159.89 35.62 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.61 -175.67 4.03 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -48.2 -35.78 12.48 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.979 1.711 . . . . 0.0 111.307 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 60.0 t -77.77 -67.63 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 126.193 1.797 . . . . 0.0 111.27 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -167.46 -170.22 32.0 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -178.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.478 ' CE2' HD22 ' A' ' 243' ' ' LEU . 3.6 m-85 -78.81 152.79 31.15 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.469 1.108 . . . . 0.0 112.037 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -162.49 156.56 21.15 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.005 1.322 . . . . 0.0 109.971 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.637 HD12 HD11 ' A' ' 109' ' ' ILE . 7.4 mt -102.04 140.08 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 177.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 4.3 t -121.98 136.35 54.92 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -142.62 119.18 11.01 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 176.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.8 tt -97.28 140.39 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.7 mt -130.51 112.59 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 O-C-N 120.742 -1.224 . . . . 0.0 110.161 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.18 -155.57 25.83 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 107.89 -2.084 . . . . 0.0 107.89 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 49.1 m 73.16 44.43 0.33 Allowed 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.095 1.358 . . . . 0.0 108.586 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -99.91 -121.9 4.74 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 125.158 1.361 . . . . 0.0 110.026 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -136.29 122.61 20.58 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.368 1.867 . . . . 0.0 108.774 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 14.1 mm -60.95 136.57 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 119.736 1.153 . . . . 0.0 110.155 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 28.5 p -90.58 111.58 22.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -68.13 -10.69 56.02 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 120.475 1.489 . . . . 0.0 110.391 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 40.6 t -60.33 -45.33 96.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 126.709 2.004 . . . . 0.0 108.808 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 1.3 p -125.41 -20.57 4.75 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 92.49 10.31 60.69 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.75 2.119 . . . . 0.0 112.255 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -94.32 169.66 10.06 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.544 1.138 . . . . 0.0 112.157 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -88.28 156.08 19.38 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 122.159 0.981 . . . . 0.0 109.707 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -79.52 30.21 0.24 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 128.97 2.908 . . . . 0.0 111.286 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 1.9 ptm -72.39 150.46 43.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.958 0.885 . . . . 0.0 110.428 -175.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.1 p -120.23 149.01 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 114.341 -1.3 . . . . 0.0 111.699 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -112.77 127.92 56.28 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.945 1.698 . . . . 0.0 106.853 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.1 mp -119.93 115.97 49.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.248 1.019 . . . . 0.0 108.454 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -101.19 116.43 32.79 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.338 0.655 . . . . 0.0 110.64 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -92.4 114.41 26.95 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.047 1.339 . . . . 0.0 110.104 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 27.4 m -127.38 172.28 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 126.197 1.799 . . . . 0.0 111.801 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -85.7 142.65 28.87 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -113.55 144.88 18.27 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-O 118.583 -1.12 . . . . 0.0 110.878 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -32.94 -73.98 0.07 OUTLIER Glycine 0 C--N 1.337 0.631 0 C-N-CA 128.724 3.059 . . . . 0.0 113.233 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 39.6 t -70.72 94.09 0.99 Allowed 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -74.39 21.12 0.11 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.312 1.845 . . . . 0.0 111.667 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 37.5 m -135.82 40.48 2.74 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.909 1.684 . . . . 0.0 112.578 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -150.94 166.95 30.5 Favored Glycine 0 CA--C 1.526 0.748 0 O-C-N 120.682 -1.261 . . . . 0.0 111.505 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.46 167.03 25.21 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.492 2.128 . . . . 0.0 112.128 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 51.0 m -76.87 155.19 33.1 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.979 178.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.0 p -162.05 163.63 28.63 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 126.55 1.94 . . . . 0.0 107.216 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.3 mp -81.45 129.23 37.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . 0.459 ' HG3' HG23 ' A' ' 234' ' ' THR . 64.9 mm-40 -79.23 -47.08 16.59 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.493 0.717 . . . . 0.0 112.635 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 40.0 p-90 -151.99 166.98 29.87 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.696 HG13 ' CE1' ' A' ' 229' ' ' TYR . 46.8 t -144.77 138.92 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 C-N-CA 125.719 1.608 . . . . 0.0 106.808 -178.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.96 134.34 4.27 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.621 0.724 . . . . 0.0 112.104 177.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -86.96 93.11 9.25 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 78.2 p -67.53 -56.42 9.57 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.576 0.703 . . . . 0.0 110.693 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -95.03 -175.04 3.41 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.983 1.713 . . . . 0.0 107.591 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.6 mp -74.71 -39.17 46.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 O-C-N 121.713 -0.617 . . . . 0.0 109.706 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 5.4 m -115.69 -18.91 10.73 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 3.5 t -85.13 152.82 3.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . 0.696 ' CE1' HG13 ' A' ' 221' ' ' VAL . 3.3 t80 -135.41 139.85 44.48 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.604 1.162 . . . . 0.0 108.585 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -120.84 135.43 55.17 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.035 1.334 . . . . 0.0 108.57 -178.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -138.46 161.13 37.8 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.93 1.692 . . . . 0.0 109.751 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -138.53 144.13 39.8 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 66.6 t -131.72 133.55 61.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 125.624 1.57 . . . . 0.0 109.449 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . 0.459 HG23 ' HG3' ' A' ' 219' ' ' GLN . 1.9 p -99.49 146.6 26.19 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 13.4 mt -142.99 136.18 13.96 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.277 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -72.55 -44.69 0.68 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.433 2.089 . . . . 0.0 111.492 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -58.93 -20.82 55.61 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.13 0.972 . . . . 0.0 112.289 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 2.2 mp -71.69 -39.16 70.39 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.783 0.833 . . . . 0.0 108.987 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 29.2 m -58.3 -30.5 66.7 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.453 1.501 . . . . 0.0 111.979 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -60.2 -38.17 82.5 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.577 0.351 . . . . 0.0 110.788 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 23.8 mt -72.64 117.04 13.83 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -47.92 -34.34 8.91 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -177.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.478 HD22 ' CE2' ' A' ' 181' ' ' TYR . 20.1 mt -64.13 -40.86 97.08 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.941 0.792 . . . . 0.0 110.661 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 4.8 mp -99.58 9.38 43.28 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 125.295 1.438 . . . . 0.0 113.798 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.723 0 C-N-CA 126.533 1.933 . . . . 0.0 111.231 179.623 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.534 0.345 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.57 -40.57 95.8 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.2 tp -62.22 -45.69 92.2 Favored 'General case' 0 C--O 1.221 -0.396 0 C-N-CA 124.31 1.044 . . . . 0.0 109.148 178.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 mt -59.66 -51.3 70.37 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.173 0.989 . . . . 0.0 109.457 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.1 m -55.0 -55.48 30.43 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.553 1.141 . . . . 0.0 109.626 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -61.23 -46.33 90.87 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.12 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.1 m -52.23 -51.71 56.69 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 119.608 1.095 . . . . 0.0 110.196 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.2 tp -56.56 -55.31 35.5 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 119.229 0.922 . . . . 0.0 108.826 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.61 -49.6 67.48 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.803 1.241 . . . . 0.0 113.507 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -42.2 93.36 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.914 1.686 . . . . 0.0 108.525 179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.39 -50.23 69.91 Favored Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.84 -53.14 49.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 118.793 1.297 . . . . 0.0 111.109 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -31.78 72.0 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.206 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 m -66.08 -48.23 71.65 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.435 HD11 HD12 ' A' ' 183' ' ' ILE . 27.1 mt -58.36 -54.64 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.733 0.813 . . . . 0.0 110.318 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.77 -31.8 71.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 123.036 0.21 . . . . 0.0 111.525 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -73.64 -46.62 45.6 Favored 'General case' 0 C--O 1.225 -0.211 0 O-C-N 121.526 -0.734 . . . . 0.0 109.059 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.18 5.18 5.74 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.692 1.997 . . . . 0.0 113.887 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.3 mt -123.42 -30.43 3.66 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 125.516 1.526 . . . . 0.0 109.199 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -62.01 -28.5 69.62 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.158 0.435 . . . . 0.0 109.961 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -62.89 -47.16 84.51 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.706 0.802 . . . . 0.0 109.262 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -164.35 150.29 10.7 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.275 1.83 . . . . 0.0 109.883 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 64.2 m -75.27 171.75 13.65 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.3 pt -128.39 147.66 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 O-C-N 121.395 -0.815 . . . . 0.0 110.318 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.84 167.91 20.96 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.565 0.746 . . . . 0.0 110.894 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -153.71 124.88 7.41 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.65 1.58 . . . . 0.0 110.594 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -87.04 102.31 14.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.14 67.36 6.91 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.149 1.78 . . . . 0.0 109.608 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.8 -115.26 4.66 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -73.29 -27.77 61.73 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.245 1.818 . . . . 0.0 112.883 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -107.66 161.85 14.5 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 118.945 0.793 . . . . 0.0 110.293 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 24.1 mt -128.23 141.01 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 104.154 -2.535 . . . . 0.0 104.154 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.423 ' CD1' HG11 ' A' ' 221' ' ' VAL . 53.3 m-85 -116.73 135.18 53.98 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 124.786 1.234 . . . . 0.0 107.776 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.38 130.44 46.03 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.625 1.57 . . . . 0.0 108.488 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -128.24 121.73 30.05 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.615 1.166 . . . . 0.0 110.622 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 4.2 m -108.73 159.19 31.85 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 123.956 0.902 . . . . 0.0 112.231 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -65.7 95.13 0.28 Allowed 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 125.259 3.973 . . . . 0.0 114.562 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 57.94 39.69 92.15 Favored Glycine 0 CA--C 1.525 0.67 0 O-C-N 121.554 -0.716 . . . . 0.0 111.636 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.8 mt -115.16 -65.17 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.462 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 5.7 pt-20 179.4 169.51 1.05 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.894 2.078 . . . . 0.0 108.695 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.45 124.6 40.5 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.9 m -135.01 156.95 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 125.479 1.511 . . . . 0.0 111.189 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -124.03 133.63 53.61 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 103.327 -2.842 . . . . 0.0 103.327 176.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -146.25 156.62 43.51 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.902 0.881 . . . . 0.0 110.575 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -89.47 153.82 20.51 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 155.68 -162.82 31.4 Favored Glycine 0 CA--C 1.519 0.292 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.95 152.59 50.1 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.251 1.02 . . . . 0.0 108.355 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 93.3 t . . . . . 0 C--O 1.237 0.411 0 C-N-CA 124.408 1.083 . . . . 0.0 109.559 179.556 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 . . . . . 0 C--O 1.234 0.255 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 38.0 mm . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 179.124 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.7 mt . . . . . 0 CA--C 1.521 -0.14 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.2 143.26 28.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 124.74 1.216 . . . . 0.0 108.186 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -134.88 155.65 50.32 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.785 1.234 . . . . 0.0 109.256 178.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 28.9 ttp180 -97.06 130.23 44.39 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 128.021 2.528 . . . . 0.0 108.331 -178.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 27.5 mt -112.54 -69.88 0.84 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.415 1.007 . . . . 0.0 108.666 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -139.58 141.8 12.08 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-O 121.446 0.47 . . . . 0.0 112.979 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -110.88 92.9 15.71 Favored Pre-proline 0 N--CA 1.447 -0.582 0 C-N-CA 127.366 2.266 . . . . 0.0 110.637 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.462 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 75.5 Cg_endo -75.53 -177.16 3.36 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.646 2.897 . . . . 0.0 109.358 178.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -96.81 157.96 15.65 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.14 -26.51 56.39 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 124.901 1.376 . . . . 0.0 114.15 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -108.97 139.63 43.57 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 124.164 0.986 . . . . 0.0 108.466 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.4 p -62.97 -31.04 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -61.88 -26.7 68.31 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.727 1.611 . . . . 0.0 112.542 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -94.6 -2.33 51.62 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -79.62 163.56 24.5 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.434 -0.791 . . . . 0.0 110.297 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -137.58 95.1 3.0 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -102.35 160.2 14.75 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -135.63 143.86 45.77 Favored 'General case' 0 C--O 1.227 -0.11 0 C-N-CA 124.304 1.042 . . . . 0.0 110.221 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 36.3 tp -110.07 97.85 7.26 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.443 HD23 ' HB2' ' A' ' 184' ' ' SER . 0.5 OUTLIER -109.48 174.23 5.96 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.417 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 6.1 p90 -150.67 162.63 40.31 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 121.401 -0.812 . . . . 0.0 110.486 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -140.71 -175.3 4.24 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.4 1.062 . . . . 0.0 109.185 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -57.04 -20.3 23.84 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.155 1.382 . . . . 0.0 113.991 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 97.4 t -81.09 -65.66 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 178.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 175.57 -170.16 43.09 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.417 ' CD2' ' HB3' ' A' ' 176' ' ' TYR . 15.6 m-85 -78.52 159.13 28.35 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.721 0.772 . . . . 0.0 109.911 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -156.21 176.2 12.98 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.53 1.932 . . . . 0.0 106.805 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.435 HD12 HD11 ' A' ' 109' ' ' ILE . 18.8 mt -121.1 114.46 43.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 178.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.443 ' HB2' HD23 ' A' ' 175' ' ' LEU . 4.7 t -90.46 141.58 28.6 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -146.29 107.01 4.09 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.6 tt -98.68 140.44 18.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.9 mt -133.97 113.71 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 123.869 0.868 . . . . 0.0 110.847 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -107.85 -156.73 19.5 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 124.754 1.169 . . . . 0.0 110.275 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 68.5 m 73.09 37.55 0.76 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.775 1.23 . . . . 0.0 109.983 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -94.16 -108.35 2.04 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 126.858 2.17 . . . . 0.0 108.336 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -140.07 120.99 14.54 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.638 1.175 . . . . 0.0 107.921 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 17.7 mm -60.58 121.59 8.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 124.336 1.054 . . . . 0.0 109.272 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 77.6 m -82.22 96.42 7.85 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 125.735 1.614 . . . . 0.0 109.923 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.09 -18.47 58.09 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -59.3 -31.48 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.674 1.189 . . . . 0.0 110.76 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 44.8 p -125.07 -35.0 2.7 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.777 0.831 . . . . 0.0 111.799 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.92 32.93 5.7 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 126.43 1.966 . . . . 0.0 110.779 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -124.13 171.12 10.05 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.372 1.869 . . . . 0.0 112.174 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -83.33 148.7 27.19 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 122.322 1.058 . . . . 0.0 110.439 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -82.98 30.77 0.44 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 130.8 3.64 . . . . 0.0 109.251 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.5 ptt? -74.28 150.83 40.03 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.688 1.195 . . . . 0.0 110.334 -175.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -113.32 146.79 17.49 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.355 -177.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -114.42 116.39 28.81 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.8 mp -106.26 130.66 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -117.85 103.76 10.28 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.719 0.807 . . . . 0.0 110.108 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -83.02 125.31 31.3 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 15.5 m -135.96 171.09 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.44 1.496 . . . . 0.0 110.974 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 2.1 t -81.61 140.5 34.39 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -118.43 109.21 1.73 Allowed Glycine 0 C--N 1.34 0.752 0 CA-C-O 117.836 -1.536 . . . . 0.0 113.217 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 4.71 -92.15 0.0 OUTLIER Glycine 0 C--N 1.34 0.803 0 C-N-CA 129.626 3.489 . . . . 0.0 114.07 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.0 100.0 0.39 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -72.11 29.13 0.05 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.486 1.914 . . . . 0.0 113.169 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 14.8 t -119.29 47.2 1.73 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.685 1.994 . . . . 0.0 114.19 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -166.08 162.99 36.5 Favored Glycine 0 C--N 1.339 0.717 0 C-N-CA 118.014 -2.041 . . . . 0.0 117.523 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -66.64 164.81 27.59 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.355 2.704 . . . . 0.0 110.321 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 28.8 m -64.47 155.46 32.66 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.473 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -168.88 157.16 7.94 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 126.025 1.73 . . . . 0.0 108.111 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.9 mt -83.38 133.81 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -74.95 -55.27 5.94 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 125.061 1.345 . . . . 0.0 111.772 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 52.1 p-90 -149.94 165.93 31.15 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.218 1.407 . . . . 0.0 108.347 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.8 HG13 ' CE1' ' A' ' 229' ' ' TYR . 39.6 t -148.34 130.42 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 125.198 1.399 . . . . 0.0 107.62 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.37 140.65 16.59 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -92.16 90.23 7.24 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 102.365 -3.198 . . . . 0.0 102.365 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 2.0 p -61.31 -65.15 0.74 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.767 1.627 . . . . 0.0 110.747 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -86.88 -172.59 4.06 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.501 ' H ' HD12 ' A' ' 226' ' ' ILE . 3.6 mp -58.97 -41.53 83.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 118.322 -0.846 . . . . 0.0 110.163 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 7.3 m -129.86 -8.91 4.45 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 25.1 t -71.87 121.72 22.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 103.927 -2.62 . . . . 0.0 103.927 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . 0.8 ' CE1' HG13 ' A' ' 221' ' ' VAL . 1.0 OUTLIER -110.17 124.63 51.9 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 179.323 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -114.33 135.16 54.38 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -139.79 158.29 44.33 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.04 1.736 . . . . 0.0 109.621 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -130.69 146.21 52.12 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 85.1 t -131.95 135.48 58.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.77 138.25 40.65 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.726 0.81 . . . . 0.0 110.376 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 48.4 mt -139.81 137.05 17.91 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 124.052 0.941 . . . . 0.0 109.594 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.59 -32.77 2.67 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.722 2.948 . . . . 0.0 113.11 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -69.19 -23.81 63.96 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.717 1.207 . . . . 0.0 112.146 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 37.4 mt -66.28 -36.54 83.24 Favored 'General case' 0 C--O 1.226 -0.139 0 O-C-N 121.238 -0.914 . . . . 0.0 110.292 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 3.7 m -56.39 -19.23 13.85 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.893 1.277 . . . . 0.0 113.553 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -62.85 -31.98 73.12 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.23 1.412 . . . . 0.0 110.358 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 26.8 mt -84.11 120.14 25.82 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.44 -37.8 57.74 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.715 0.689 . . . . 0.0 112.072 -178.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 6.0 mp -57.6 -38.84 75.59 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.485 -0.76 . . . . 0.0 111.248 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -97.35 6.08 48.85 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.071 1.748 . . . . 0.0 111.675 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.259 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 179.27 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 CA--C 1.535 0.383 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.93 -45.81 89.48 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 66.7 tp -62.62 -41.34 98.95 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.413 0.685 . . . . 0.0 110.272 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.8 mt -60.08 -54.28 47.8 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.983 0.913 . . . . 0.0 109.762 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 45.2 m -56.21 -51.79 66.78 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.228 1.011 . . . . 0.0 110.748 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -58.03 -49.55 76.47 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.7 m -53.94 -49.55 68.45 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 118.425 -0.798 . . . . 0.0 110.598 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.521 ' O ' HG23 ' A' ' 106' ' ' VAL . 9.2 tp -56.77 -54.91 40.83 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.967 0.803 . . . . 0.0 109.579 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -55.29 -53.64 53.62 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.684 0.793 . . . . 0.0 111.492 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -57.37 -33.51 67.88 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.315 1.446 . . . . 0.0 110.363 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -69.43 -53.38 17.41 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 102' ' ' LEU . 3.4 t -56.55 -52.1 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 118.799 1.3 . . . . 0.0 111.706 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -37.24 79.76 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 118.89 -0.576 . . . . 0.0 110.779 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.4 m -67.43 -48.11 68.23 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.497 HD11 HD12 ' A' ' 183' ' ' ILE . 43.8 mt -53.5 -52.97 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 123.978 0.911 . . . . 0.0 109.575 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.54 -39.45 83.99 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 122.187 0.195 . . . . 0.0 111.234 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -69.73 -33.93 73.17 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.294 -0.879 . . . . 0.0 111.461 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.24 10.25 15.25 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.569 1.548 . . . . 0.0 112.239 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.3 mt -133.35 -33.35 1.12 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.841 1.256 . . . . 0.0 110.557 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -56.26 -31.23 63.39 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 123.693 0.797 . . . . 0.0 111.57 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -69.47 -45.96 67.79 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 118.668 -0.682 . . . . 0.0 112.465 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -157.26 143.65 18.0 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 125.336 1.454 . . . . 0.0 108.244 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 30.5 m -75.87 172.08 13.31 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 122.906 0.482 . . . . 0.0 110.959 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 25.6 pt -125.9 154.91 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.591 1.156 . . . . 0.0 111.418 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.62 167.69 21.64 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.738 0.815 . . . . 0.0 109.956 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -150.53 117.75 6.0 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.772 1.629 . . . . 0.0 109.935 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -82.54 102.14 11.19 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.0 66.8 3.62 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.474 -0.766 . . . . 0.0 110.472 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.19 -113.06 3.74 Favored Glycine 0 C--N 1.339 0.697 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -77.39 -38.33 50.11 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -106.65 126.44 52.28 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.874 1.215 . . . . 0.0 113.503 -178.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.0 mt -90.6 147.8 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.484 ' CD1' HG11 ' A' ' 221' ' ' VAL . 66.2 m-85 -115.11 135.8 53.81 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 178.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.72 123.91 27.14 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.789 1.236 . . . . 0.0 109.337 -177.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -126.8 119.51 27.05 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.824 1.249 . . . . 0.0 111.743 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 1.4 m -100.62 160.81 25.85 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 125.391 1.477 . . . . 0.0 112.477 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -64.13 88.86 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 124.249 3.299 . . . . 0.0 112.288 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 53.48 57.46 15.49 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 123.934 0.778 . . . . 0.0 111.274 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 15.6 mt -124.94 -65.67 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.509 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 15.6 pt-20 -176.15 168.92 2.86 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 127.621 2.368 . . . . 0.0 109.677 177.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -123.52 124.15 42.2 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.5 155.76 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.301 1.041 . . . . 0.0 112.256 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -119.82 126.24 50.51 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -146.48 157.67 43.78 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.093 0.861 . . . . 0.0 112.065 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -88.68 148.63 23.91 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 160.32 -162.17 33.09 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 108.871 -1.691 . . . . 0.0 108.871 -177.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.4 ttm-85 -125.63 164.15 21.22 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.34 1.456 . . . . 0.0 111.104 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 84.5 t . . . . . 0 C--O 1.24 0.571 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.749 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 . . . . . 0 N--CA 1.46 0.04 0 CA-C-O 121.202 0.525 . . . . 0.0 111.461 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.6 mp . . . . . 0 C--O 1.236 0.382 0 C-N-CA 123.853 0.861 . . . . 0.0 108.801 178.654 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 76.6 mt . . . . . 0 N--CA 1.456 -0.172 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.8 t -135.84 142.54 38.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.534 1.134 . . . . 0.0 108.054 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -137.61 158.62 43.99 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 126.348 1.859 . . . . 0.0 109.049 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -113.01 130.43 56.14 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.437 1.095 . . . . 0.0 110.196 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.96 -75.19 0.53 Allowed 'General case' 0 C--O 1.226 -0.153 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -134.68 152.39 20.68 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 116.255 -0.43 . . . . 0.0 112.73 -178.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -116.49 94.39 42.93 Favored Pre-proline 0 N--CA 1.453 -0.32 0 C-N-CA 125.271 1.428 . . . . 0.0 108.601 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.509 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 88.1 Cg_endo -73.48 -175.82 2.21 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.343 2.695 . . . . 0.0 109.555 178.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.457 ' HE2' ' OE2' ' A' ' 169' ' ' GLU . 25.3 mmmt -97.53 161.1 13.94 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.16 0.584 . . . . 0.0 112.238 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -78.26 -24.21 46.96 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.87 1.668 . . . . 0.0 113.362 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -116.37 147.75 41.3 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.5 p -73.06 -27.23 24.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -79.68 -12.73 59.8 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.296 0.639 . . . . 0.0 112.445 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.457 ' OE2' ' HE2' ' A' ' 164' ' ' LYS . 4.3 mm-40 -79.62 -21.5 44.84 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.865 0.466 . . . . 0.0 110.864 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -107.3 172.1 7.01 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.744 1.618 . . . . 0.0 110.652 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -134.29 131.31 38.26 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 124.186 0.994 . . . . 0.0 109.434 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -107.86 162.29 14.14 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -130.11 120.86 25.28 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.056 -1.028 . . . . 0.0 109.738 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 48.4 tp -87.24 100.6 12.81 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 39.5 mt -105.32 -179.21 3.88 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 126.207 1.803 . . . . 0.0 109.972 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 181' ' ' TYR . 4.6 p90 -157.09 157.07 33.87 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 124.458 1.103 . . . . 0.0 109.596 177.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -137.51 -179.36 5.69 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.143 2.177 . . . . 0.0 108.604 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -58.53 -26.41 63.49 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.445 1.098 . . . . 0.0 113.533 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 59.8 t -79.62 -62.81 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -172.99 -164.41 28.34 Favored Glycine 0 C--N 1.339 0.725 0 CA-C-N 119.031 0.832 . . . . 0.0 111.366 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.508 ' CE2' HD13 ' A' ' 243' ' ' LEU . 2.9 m-85 -78.21 166.38 22.8 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.193 -0.593 . . . . 0.0 109.982 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -167.62 162.09 13.97 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.508 1.523 . . . . 0.0 108.145 178.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.497 HD12 HD11 ' A' ' 109' ' ' ILE . 3.6 mt -113.97 121.43 66.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.154 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.2 t -95.96 135.03 38.25 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -138.57 133.63 32.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 178.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.9 tt -121.45 141.37 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 124.679 1.191 . . . . 0.0 109.072 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.4 mt -137.14 115.14 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 122.596 0.358 . . . . 0.0 111.705 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -103.74 -166.96 25.28 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 126.497 1.999 . . . . 0.0 110.125 178.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 69.3 m 73.23 60.41 0.1 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.624 1.569 . . . . 0.0 109.056 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -108.13 -95.58 2.4 Favored Glycine 0 CA--C 1.519 0.286 0 N-CA-C 104.513 -3.435 . . . . 0.0 104.513 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -155.59 125.23 6.41 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 18.0 mm -60.25 121.29 7.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.2 99.94 10.27 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 125.839 1.656 . . . . 0.0 110.153 -178.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -60.94 -20.49 62.28 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.364 0.602 . . . . 0.0 111.51 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.5 m -57.18 -32.64 41.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.642 1.577 . . . . 0.0 112.235 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 67.0 p -125.17 -29.22 3.32 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.078 1.351 . . . . 0.0 112.017 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 88.22 32.37 12.34 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -178.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -126.82 -179.72 4.96 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.915 1.686 . . . . 0.0 111.322 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -91.86 148.15 22.44 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.298 0.639 . . . . 0.0 109.496 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 45.2 ttm-85 -79.32 30.12 0.23 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.287 2.635 . . . . 0.0 109.729 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.7 ptm -72.87 153.96 40.8 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 122.064 0.935 . . . . 0.0 110.075 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 6.0 p -122.97 148.93 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 113.876 -1.511 . . . . 0.0 113.696 -176.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -114.09 137.46 51.7 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.5 mp -126.03 118.41 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 127.516 2.326 . . . . 0.0 107.921 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -106.88 104.28 13.92 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.554 1.141 . . . . 0.0 110.42 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -80.95 129.53 34.58 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 120.523 -1.361 . . . . 0.0 111.8 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 33.9 m -137.8 172.15 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.643 1.177 . . . . 0.0 112.634 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.4 137.64 37.35 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.176 0.991 . . . . 0.0 108.352 178.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -105.38 117.95 5.69 Favored Glycine 0 C--N 1.332 0.352 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -42.34 -46.8 5.56 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 126.239 1.876 . . . . 0.0 113.283 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.42 ' C ' ' H ' ' A' ' 213' ' ' SER . 1.8 p -76.45 80.73 3.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -65.02 21.46 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 130.317 3.447 . . . . 0.0 113.329 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . 0.42 ' H ' ' C ' ' A' ' 211' ' ' SER . 23.4 t -142.49 47.24 1.58 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 129.567 3.147 . . . . 0.0 107.642 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -149.61 159.3 28.02 Favored Glycine 0 C--N 1.34 0.771 0 O-C-N 119.668 -1.895 . . . . 0.0 114.6 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.93 173.47 13.51 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.851 3.034 . . . . 0.0 111.015 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 49.0 m -75.28 152.13 38.26 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -168.39 152.59 5.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 178.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.1 mt -78.66 134.68 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . 0.462 ' HG3' HE21 ' A' ' 232' ' ' GLN . 14.7 mm100 -77.63 -51.81 10.03 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.007 0.923 . . . . 0.0 111.794 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 55.9 p-90 -149.66 165.55 31.99 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.244 1.418 . . . . 0.0 108.439 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.812 HG13 ' CE1' ' A' ' 229' ' ' TYR . 24.5 t -147.42 134.16 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 126.228 1.811 . . . . 0.0 106.883 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.68 124.75 6.15 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 177.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -78.96 86.99 4.79 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 103.517 -2.771 . . . . 0.0 103.517 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 8.6 p -53.14 -52.55 58.34 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.904 1.682 . . . . 0.0 112.606 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -107.05 -177.36 3.34 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . 0.253 2.6 mp -68.24 -18.95 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 118.882 -1.127 . . . . 0.0 110.603 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -132.31 -39.6 1.03 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.519 1.054 . . . . 0.0 112.614 178.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 11.8 t -63.47 135.3 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . 0.812 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.2 OUTLIER -133.34 139.65 46.96 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.43 1.092 . . . . 0.0 109.9 -178.07 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -121.03 140.57 51.74 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.478 1.511 . . . . 0.0 111.755 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -142.94 161.31 38.46 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 128.183 2.593 . . . . 0.0 109.723 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.462 HE21 ' HG3' ' A' ' 219' ' ' GLN . 38.7 tt0 -137.22 146.67 45.12 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.034 1.334 . . . . 0.0 107.496 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 98.5 t -131.92 134.68 59.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 125.294 1.438 . . . . 0.0 107.862 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.64 134.56 45.8 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.234 1.014 . . . . 0.0 110.577 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 69.6 mt -131.74 138.47 32.64 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.71 -46.2 0.89 Allowed 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.542 2.828 . . . . 0.0 111.553 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.98 -27.48 66.88 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.947 1.299 . . . . 0.0 111.79 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 3.5 mp -61.68 -31.62 71.77 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 117.871 -1.061 . . . . 0.0 110.477 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 8.3 m -65.64 -19.16 65.8 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.978 1.263 . . . . 0.0 113.158 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -63.54 -29.82 71.02 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.051 0.941 . . . . 0.0 111.419 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 50.7 mt -82.34 113.78 20.36 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -48.2 -31.2 5.47 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.508 HD13 ' CE2' ' A' ' 181' ' ' TYR . 21.2 mt -67.58 -36.5 81.02 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.162 -0.961 . . . . 0.0 110.338 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 17.9 mt -100.06 8.89 43.63 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 127.341 2.256 . . . . 0.0 111.204 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 178.574 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 CA--C 1.536 0.418 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.15 -45.04 96.3 Favored 'General case' 0 C--N 1.337 0.06 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 67.7 tp -58.3 -44.01 88.37 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.081 -0.961 . . . . 0.0 108.87 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.2 mt -61.24 -53.92 50.66 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.243 0.929 . . . . 0.0 109.388 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 51.6 m -55.13 -48.58 73.48 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.806 0.842 . . . . 0.0 111.198 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -62.87 -46.3 88.51 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 120.403 -1.436 . . . . 0.0 110.214 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 52.9 m -54.18 -46.04 72.28 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.576 1.15 . . . . 0.0 109.915 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.479 ' O ' HG23 ' A' ' 106' ' ' VAL . 22.0 tp -58.6 -54.08 51.14 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.761 0.709 . . . . 0.0 110.452 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 25.4 t30 -57.47 -46.93 83.12 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.263 0.483 . . . . 0.0 111.526 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -55.52 -46.64 77.01 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.974 0.91 . . . . 0.0 109.169 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.449 ' HA3' HD11 ' A' ' 183' ' ' ILE . . . -64.04 -46.47 91.21 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 102' ' ' LEU . 93.2 t -59.01 -53.22 51.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.047 1.339 . . . . 0.0 110.393 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -32.52 73.49 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.775 1.17 . . . . 0.0 110.16 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.2 m -67.22 -46.46 73.77 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.437 HD11 HD12 ' A' ' 183' ' ' ILE . 33.8 mt -59.64 -51.6 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.99 -35.72 77.56 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 118.659 -0.686 . . . . 0.0 110.217 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.27 -48.42 75.79 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 119.708 1.14 . . . . 0.0 110.357 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.14 -27.65 60.95 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 -178.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.8 mp -85.72 -28.37 24.67 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 120.19 1.359 . . . . 0.0 109.336 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -60.53 -19.47 57.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.127 0.571 . . . . 0.0 111.452 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.36 -46.64 54.53 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.19 0.596 . . . . 0.0 110.868 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -165.54 155.63 13.0 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.586 1.554 . . . . 0.0 108.258 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 33.5 m -75.77 162.85 27.83 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.3 pt -117.68 156.23 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.22 163.23 38.23 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 120.712 0.292 . . . . 0.0 111.191 -177.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -152.31 127.63 9.9 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.739 1.616 . . . . 0.0 109.816 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -89.14 104.43 16.98 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.17 67.66 5.9 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.43 -115.03 4.92 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.491 -1.043 . . . . 0.0 110.491 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -73.82 -34.26 64.5 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -106.38 138.2 42.98 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 119.355 0.98 . . . . 0.0 110.976 -178.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.2 mt -102.89 149.69 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -122.24 133.79 54.7 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 126.406 1.882 . . . . 0.0 106.223 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.47 132.72 44.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.101 1.761 . . . . 0.0 107.945 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -126.46 117.84 23.72 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.424 1.089 . . . . 0.0 110.959 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 8.7 m -102.64 155.99 35.84 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.008 0.923 . . . . 0.0 112.924 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.34 92.21 0.28 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 125.069 3.846 . . . . 0.0 116.164 -178.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 62.64 36.27 93.01 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.3 mt -116.68 -66.99 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.461 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 7.2 pt-20 176.96 166.62 0.53 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.075 1.75 . . . . 0.0 109.58 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -117.62 129.63 55.87 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 104.278 -2.49 . . . . 0.0 104.278 177.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.1 m -138.32 155.46 28.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.922 0.889 . . . . 0.0 110.725 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -121.12 131.44 54.25 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -145.96 157.84 43.88 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.418 1.087 . . . . 0.0 111.479 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -88.61 154.27 20.46 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 165.34 -163.66 36.7 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.64 142.04 50.81 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.235 0.341 0 CA-C-N 118.777 0.717 . . . . 0.0 109.709 -178.803 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 14.1 mt . . . . . 0 C--N 1.326 -0.433 0 C-N-CA 127.504 2.322 . . . . 0.0 106.672 -179.323 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 23.5 mt . . . . . 0 CA--C 1.515 -0.377 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.5 p -143.18 152.52 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.848 0.859 . . . . 0.0 109.872 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -142.38 145.56 33.99 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.913 1.685 . . . . 0.0 108.124 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -95.58 135.15 37.62 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.522 1.129 . . . . 0.0 108.676 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.4 mp -102.15 -69.69 0.78 Allowed 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 123.122 0.569 . . . . 0.0 110.486 -178.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -127.96 165.83 20.82 Favored Glycine 0 C--O 1.243 0.681 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -132.32 89.12 37.87 Favored Pre-proline 0 N--CA 1.448 -0.569 0 C-N-CA 125.428 1.491 . . . . 0.0 109.52 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 90.9 Cg_endo -74.93 176.63 9.63 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 123.201 2.601 . . . . 0.0 108.02 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -94.8 155.37 16.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.916 0.865 . . . . 0.0 111.443 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.28 -20.25 61.55 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 126.074 1.75 . . . . 0.0 113.317 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -122.97 136.83 55.01 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.466 1.506 . . . . 0.0 109.91 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.9 p -61.37 -27.76 42.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.536 0.684 . . . . 0.0 110.691 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -71.06 -6.44 39.09 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 127.755 2.422 . . . . 0.0 113.013 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -112.35 -20.11 11.94 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.561 1.144 . . . . 0.0 112.721 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.27 165.78 13.26 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -145.79 112.71 6.04 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -101.56 170.14 8.38 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.999 1.32 . . . . 0.0 110.522 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -131.81 125.82 32.8 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.481 1.512 . . . . 0.0 110.836 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 24.4 tp -86.51 104.46 15.99 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 61.2 mt -107.47 177.0 4.96 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.21 1.404 . . . . 0.0 110.78 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.464 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 12.0 p90 -162.37 166.53 25.03 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 122.813 1.292 . . . . 0.0 110.766 178.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -140.85 177.42 8.05 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 126.125 1.77 . . . . 0.0 106.759 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.28 -31.67 69.33 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 125.379 1.471 . . . . 0.0 107.948 177.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 38.7 t -66.1 -62.11 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 125.756 1.623 . . . . 0.0 107.791 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 178.9 -171.97 44.15 Favored Glycine 0 C--N 1.339 0.745 0 C-N-CA 124.392 0.996 . . . . 0.0 113.158 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.464 ' CD2' ' HB3' ' A' ' 176' ' ' TYR . 32.9 m-85 -90.27 155.05 19.27 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.692 1.197 . . . . 0.0 111.789 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -164.87 162.05 20.61 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.416 1.887 . . . . 0.0 109.171 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.449 HD11 ' HA3' ' A' ' 105' ' ' GLY . 8.6 mt -106.3 141.68 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 177.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 5.3 t -122.77 132.75 54.36 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -132.9 120.55 21.63 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 177.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.9 tt -105.91 128.0 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 5.5 mt -120.71 107.28 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 124.312 1.045 . . . . 0.0 110.653 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -99.7 -156.62 28.48 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 107.146 -2.382 . . . . 0.0 107.146 177.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 46.8 m 70.22 51.72 0.38 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.547 0.689 . . . . 0.0 110.757 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -115.71 -119.93 3.26 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 107.244 -2.342 . . . . 0.0 107.244 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -129.39 141.75 50.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.544 1.138 . . . . 0.0 108.793 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 24.5 mm -79.55 128.89 38.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 16.7 m -90.53 104.42 17.0 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 101.908 -3.367 . . . . 0.0 101.908 176.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -55.45 -16.04 3.31 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -177.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 3.0 m -59.05 -39.7 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.207 1.003 . . . . 0.0 110.246 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 1.2 p -125.21 -17.95 5.54 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.627 1.103 . . . . 0.0 111.551 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 85.94 5.48 83.52 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.685 0.659 . . . . 0.0 113.549 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -83.93 160.83 21.0 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.271 1.429 . . . . 0.0 108.351 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -86.61 152.11 22.87 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -74.96 29.84 0.09 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 127.415 2.286 . . . . 0.0 109.962 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.3 ptt? -72.1 149.3 44.91 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 122.025 0.917 . . . . 0.0 109.838 -175.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.6 p -123.08 144.12 33.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.252 -176.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -108.35 130.18 55.21 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 178.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.1 mp -118.38 112.42 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 124.744 1.217 . . . . 0.0 108.225 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -95.33 116.79 29.25 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -94.53 116.38 28.7 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.326 0.65 . . . . 0.0 110.305 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 32.2 m -126.57 171.61 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 125.518 1.527 . . . . 0.0 111.955 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -85.86 135.8 33.56 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.783 1.633 . . . . 0.0 106.991 177.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -91.57 154.66 22.84 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 119.195 0.907 . . . . 0.0 111.406 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -62.61 -60.79 7.26 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 27.5 p -78.58 74.1 5.12 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -70.23 57.95 0.17 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.94 2.496 . . . . 0.0 112.011 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.36 47.51 0.35 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.984 1.714 . . . . 0.0 110.761 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -165.19 174.25 41.05 Favored Glycine 0 CA--C 1.527 0.788 0 O-C-N 119.736 -1.852 . . . . 0.0 112.159 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -71.73 162.06 43.22 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.438 2.092 . . . . 0.0 110.57 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 7.8 m -73.95 151.04 40.46 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 126.414 1.886 . . . . 0.0 111.034 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -164.85 165.15 20.72 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.735 1.614 . . . . 0.0 108.267 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.4 mp -79.15 128.02 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 177.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -72.09 -60.56 2.17 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.847 1.659 . . . . 0.0 109.867 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . 0.41 ' CE3' ' HD2' ' A' ' 222' ' ' ARG . 28.7 p-90 -140.24 166.56 24.35 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.242 1.417 . . . . 0.0 109.807 -178.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.596 HG13 ' CE1' ' A' ' 229' ' ' TYR . 49.9 t -145.85 133.03 15.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 125.585 1.554 . . . . 0.0 107.012 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.41 ' HD2' ' CE3' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -148.7 127.48 12.56 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.63 0.729 . . . . 0.0 109.362 178.255 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -79.99 87.88 5.38 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.9 p -57.42 -53.94 52.47 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.227 1.011 . . . . 0.0 112.622 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -119.31 -179.23 3.79 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.7 mp -61.27 -27.18 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.244 1.018 . . . . 0.0 110.838 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.8 t -131.64 -30.89 1.61 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.364 0.666 . . . . 0.0 111.765 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 16.7 t -76.31 135.42 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . 0.596 ' CE1' HG13 ' A' ' 221' ' ' VAL . 1.6 t80 -129.02 148.35 50.97 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.72 1.608 . . . . 0.0 108.681 -179.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -132.2 136.76 47.26 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 126.524 1.93 . . . . 0.0 107.564 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.72 161.61 38.78 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.751 1.62 . . . . 0.0 110.191 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -134.87 145.19 48.03 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.521 0.729 . . . . 0.0 109.998 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.1 t -124.2 146.12 30.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 125.657 1.583 . . . . 0.0 108.263 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.87 133.14 56.34 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 87.9 mt -134.74 135.99 24.47 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 123.828 0.851 . . . . 0.0 108.911 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.29 -42.38 2.0 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.662 2.241 . . . . 0.0 112.554 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -60.64 -24.9 65.91 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.308 0.643 . . . . 0.0 112.113 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 54.6 mt -68.19 -28.14 67.01 Favored 'General case' 0 C--O 1.225 -0.194 0 O-C-N 121.099 -1.0 . . . . 0.0 110.844 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 39.3 m -63.74 -15.76 59.4 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.763 1.225 . . . . 0.0 113.39 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -68.54 -24.08 64.59 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.41 ' HB2' HD23 ' A' ' 244' ' ' LEU . 41.0 mt -85.38 121.99 28.9 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.693 1.597 . . . . 0.0 107.882 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -50.5 -37.21 37.63 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.6 mp -61.02 -38.59 86.62 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.415 -0.803 . . . . 0.0 109.994 178.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.41 HD23 ' HB2' ' A' ' 241' ' ' LEU . 2.6 mm? -91.89 3.04 56.07 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 127.567 2.347 . . . . 0.0 113.226 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.673 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.569 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.4 p . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.307 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.69 -44.61 81.65 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 119.346 0.975 . . . . 0.0 109.71 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 52.0 tp -62.49 -44.89 95.28 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 118.52 -0.752 . . . . 0.0 109.036 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.7 mt -60.78 -48.27 82.57 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.272 0.942 . . . . 0.0 110.539 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 33.0 m -56.46 -56.5 20.39 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.676 1.19 . . . . 0.0 109.335 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.9 ttpp -58.69 -48.22 81.84 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-O 118.948 -0.548 . . . . 0.0 110.4 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.1 m -52.88 -52.95 55.57 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.231 1.012 . . . . 0.0 110.933 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.546 ' O ' HG23 ' A' ' 106' ' ' VAL . 17.1 tp -57.81 -53.59 56.47 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 118.882 0.765 . . . . 0.0 110.099 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -58.69 -46.72 86.63 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -59.17 -43.44 92.12 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 125.049 1.339 . . . . 0.0 107.832 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.27 -50.53 65.64 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.552 HG22 ' CD2' ' A' ' 172' ' ' PHE . 15.7 t -57.32 -53.49 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 118.69 1.245 . . . . 0.0 110.684 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -32.8 74.22 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.044 0.838 . . . . 0.0 110.979 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.3 m -66.21 -45.71 79.81 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 34.1 mt -60.56 -51.43 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 123.848 0.859 . . . . 0.0 108.79 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.19 -38.97 69.06 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 123.521 0.513 . . . . 0.0 109.978 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -67.58 -54.51 19.22 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 118.808 0.731 . . . . 0.0 110.669 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.11 -17.5 7.32 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 125.874 1.67 . . . . 0.0 114.537 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.6 mp -111.59 -27.86 8.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 119.388 0.995 . . . . 0.0 109.509 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -59.71 -31.07 69.26 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.447 0.567 . . . . 0.0 110.919 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -64.38 -46.04 85.1 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 122.901 0.48 . . . . 0.0 111.348 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -162.95 152.6 15.56 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.996 1.719 . . . . 0.0 110.094 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 55.9 m -75.68 166.79 23.01 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 23.6 pt -125.12 153.29 32.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 124.426 1.091 . . . . 0.0 109.108 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -146.3 168.27 21.5 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.996 -0.44 . . . . 0.0 112.149 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -154.11 121.38 5.74 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.072 0.949 . . . . 0.0 109.665 178.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -81.71 103.96 11.77 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.5 0.72 . . . . 0.0 109.634 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.94 70.83 2.92 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 178.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 67.66 -121.15 14.1 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -69.11 -28.13 66.2 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -107.13 137.5 45.07 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 119.482 1.037 . . . . 0.0 110.056 -178.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.8 mt -112.74 134.13 56.33 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.42 ' CD1' HG11 ' A' ' 221' ' ' VAL . 43.7 m-85 -100.68 129.01 46.53 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 125.124 1.37 . . . . 0.0 107.977 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -123.57 132.5 53.9 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.897 1.279 . . . . 0.0 108.712 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -129.62 112.91 14.17 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.447 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 19.8 m -97.42 159.74 30.44 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-O 118.402 -0.809 . . . . 0.0 111.214 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.2 90.34 0.1 OUTLIER 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 123.989 3.126 . . . . 0.0 113.622 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 56.07 44.69 88.3 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 123.827 0.727 . . . . 0.0 112.751 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 6.5 mt -113.58 -66.89 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.449 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 13.6 pt-20 -171.41 167.56 6.76 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.894 1.278 . . . . 0.0 109.354 178.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.61 122.22 38.32 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 178.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.8 m -137.84 156.5 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -122.09 125.99 47.41 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 177.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -146.91 157.95 43.78 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.442 1.497 . . . . 0.0 110.13 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -88.56 153.25 21.29 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 178.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 174.08 -163.53 34.46 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.241 -1.943 . . . . 0.0 108.241 -178.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.12 137.84 46.45 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.325 -0.488 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 . . . . . 0 C--O 1.235 0.292 0 CA-C-O 120.818 0.342 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 65.2 mt . . . . . 0 C--N 1.328 -0.365 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 179.376 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.7 tp . . . . . 0 C--O 1.233 0.187 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 22.1 t -137.06 140.5 42.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.377 1.071 . . . . 0.0 108.23 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -126.14 134.46 51.31 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -85.91 120.88 27.79 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 126.531 1.932 . . . . 0.0 108.576 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 50.7 mt -94.08 -89.03 0.23 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -114.63 145.7 18.64 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -114.9 92.57 30.91 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 83.5 Cg_endo -71.9 179.67 4.62 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.682 2.922 . . . . 0.0 111.387 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -104.08 160.45 14.83 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 124.656 1.182 . . . . 0.0 111.676 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -77.37 -26.53 52.0 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -110.75 136.71 49.41 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.0 p -63.39 -24.11 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 124.147 0.979 . . . . 0.0 112.237 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -81.45 -18.5 45.05 Favored 'General case' 0 C--N 1.335 -0.038 0 C-N-CA 123.314 0.645 . . . . 0.0 112.258 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -71.55 -23.63 61.8 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 122.818 0.447 . . . . 0.0 110.3 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -113.62 168.6 9.63 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.01 1.724 . . . . 0.0 108.352 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -142.12 134.77 28.3 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.552 ' CD2' HG22 ' A' ' 106' ' ' VAL . 8.7 m-30 -101.03 170.86 7.99 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.07 0.948 . . . . 0.0 109.1 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -137.61 129.66 28.98 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 24.8 tp -100.79 98.35 8.88 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.12 -179.73 3.98 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 126.561 1.944 . . . . 0.0 108.775 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -149.64 162.74 39.61 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 122.23 1.014 . . . . 0.0 110.254 178.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -133.14 -179.67 5.64 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.997 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -58.66 -35.7 72.97 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 125.103 1.361 . . . . 0.0 109.092 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 44.7 t -72.05 -62.11 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -177.64 -169.14 38.3 Favored Glycine 0 C--N 1.338 0.679 0 CA-C-N 119.178 0.899 . . . . 0.0 111.234 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -78.4 158.4 28.75 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.997 0.427 . . . . 0.0 111.149 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -158.1 166.36 32.67 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.056 1.343 . . . . 0.0 107.894 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 3.5 mt -114.63 136.09 52.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 7.1 t -110.98 145.34 38.59 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -140.27 120.32 13.69 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 178.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 2.6 tt -114.85 134.55 57.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 178.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.5 mt -129.32 112.42 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 124.063 0.945 . . . . 0.0 110.289 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -104.29 -160.39 24.27 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 126.343 1.925 . . . . 0.0 111.292 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 40.0 m 67.55 60.12 0.48 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.465 1.506 . . . . 0.0 112.633 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -112.24 -119.47 3.73 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -126.28 115.57 19.9 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.496 1.518 . . . . 0.0 107.893 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 46.1 mm -60.26 114.59 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 54.3 m -72.8 100.07 2.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.73 -15.55 20.72 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.833 0.742 . . . . 0.0 112.7 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.46 -36.71 42.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.514 1.526 . . . . 0.0 107.513 177.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 5.0 p -126.49 -30.76 2.81 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 96.57 17.13 34.47 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 127.317 2.389 . . . . 0.0 111.116 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -92.46 166.18 12.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.35 1.075 . . . . 0.0 111.98 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -87.49 146.74 25.68 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.603 178.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -76.8 30.22 0.13 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.367 2.267 . . . . 0.0 110.744 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -74.6 140.93 44.69 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.964 0.888 . . . . 0.0 110.719 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.3 p -109.47 150.04 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.252 -1.34 . . . . 0.0 109.377 -178.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -120.62 130.44 54.15 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.9 mp -120.19 110.01 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 124.929 1.291 . . . . 0.0 108.2 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -96.46 107.07 19.42 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -84.19 124.45 31.18 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.099 0.96 . . . . 0.0 109.426 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 27.9 m -134.9 173.22 14.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 125.1 1.36 . . . . 0.0 110.645 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 2.4 t -86.86 127.55 35.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 177.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -85.44 171.85 46.2 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 118.61 0.641 . . . . 0.0 112.991 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -68.02 -16.13 68.14 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.831 1.205 . . . . 0.0 112.418 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 40.0 t -118.17 119.33 34.4 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -97.22 18.21 15.53 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.796 0.438 . . . . 0.0 111.253 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 91.2 p -138.41 48.33 1.95 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.045 1.738 . . . . 0.0 110.927 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.83 168.08 28.15 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 120.762 -1.211 . . . . 0.0 111.617 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.68 169.96 21.38 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.865 2.377 . . . . 0.0 111.041 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.5 ' O ' HG23 ' A' ' 217' ' ' THR . 78.9 p -68.54 155.05 40.71 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 216' ' ' SER . 0.8 OUTLIER -169.64 154.05 5.32 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 121.66 -0.65 . . . . 0.0 109.611 179.247 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.9 mt -82.06 130.23 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -75.98 -59.42 2.77 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.364 1.065 . . . . 0.0 111.441 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 45.1 p-90 -142.23 165.32 27.76 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.775 1.63 . . . . 0.0 108.222 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.807 HG13 ' CE1' ' A' ' 229' ' ' TYR . 46.3 t -145.24 127.01 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.75 133.76 17.07 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 122.051 0.929 . . . . 0.0 110.801 178.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -82.39 86.52 6.71 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 6.7 p -57.59 -64.76 0.79 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.587 1.155 . . . . 0.0 108.915 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -98.76 -174.49 2.8 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 178.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 34.3 mm -69.71 -43.93 79.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 O-C-N 121.347 -0.846 . . . . 0.0 110.486 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -103.81 -39.72 6.53 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.006 0.522 . . . . 0.0 112.308 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 15.5 t -72.56 130.82 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . 0.807 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.2 OUTLIER -127.5 148.88 50.32 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.915 1.686 . . . . 0.0 108.693 -179.207 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -129.02 144.23 51.12 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.804 1.242 . . . . 0.0 109.258 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.67 161.48 40.48 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.269 1.828 . . . . 0.0 108.698 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -131.05 144.88 51.78 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 86.8 t -130.94 135.23 60.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 4.6 p -102.64 142.58 33.56 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 72.9 mt -141.87 131.75 12.6 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-O 118.748 -0.644 . . . . 0.0 109.714 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -71.54 -32.97 11.38 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.514 2.143 . . . . 0.0 112.128 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -69.38 -22.02 63.74 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.029 0.932 . . . . 0.0 111.246 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.6 mp -68.91 -41.2 78.52 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 22.4 m -57.63 -19.76 28.52 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.137 1.375 . . . . 0.0 112.469 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -64.98 -26.38 68.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.247 0.619 . . . . 0.0 110.643 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 25.1 mt -88.03 133.8 33.88 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.704 2.401 . . . . 0.0 108.477 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -54.9 -47.37 74.43 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.935 2.094 . . . . 0.0 113.937 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 8.1 mp -58.91 -34.63 71.92 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.225 -0.922 . . . . 0.0 111.925 -178.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -92.66 3.88 54.75 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.046 1.338 . . . . 0.0 111.476 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.37 0 C-N-CA 126.259 1.823 . . . . 0.0 110.491 -179.479 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.89 95.69 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 40.7 tp -65.61 -44.83 85.32 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.981 0.912 . . . . 0.0 110.041 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 21.4 mt -62.24 -49.02 77.37 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 79.0 m -54.46 -54.22 43.75 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.638 0.775 . . . . 0.0 109.092 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -58.0 -51.36 69.97 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 122.835 0.454 . . . . 0.0 109.989 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 28.3 m -56.52 -42.61 78.7 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.819 0.847 . . . . 0.0 112.548 -178.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.6 tp -66.98 -55.66 13.52 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 119.328 0.967 . . . . 0.0 110.136 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -60.21 -47.15 87.19 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 118.749 0.704 . . . . 0.0 111.971 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -57.79 -49.79 75.43 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.31 -47.18 91.1 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.478 HG13 ' CE1' ' A' ' 172' ' ' PHE . 42.5 t -59.74 -53.55 46.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 126.238 1.815 . . . . 0.0 110.783 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -32.56 74.17 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 119.776 -0.769 . . . . 0.0 109.68 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.6 m -65.36 -44.92 86.14 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.284 0.947 . . . . 0.0 108.63 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.518 HD11 HD12 ' A' ' 183' ' ' ILE . 7.9 mt -53.02 -53.16 23.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.33 -46.87 79.73 Favored 'General case' 0 N--CA 1.436 -1.15 0 O-C-N 124.688 1.243 . . . . 0.0 111.99 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.21 -50.83 71.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.809 0.814 . . . . 0.0 110.023 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -68.46 -8.96 45.52 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.721 1.208 . . . . 0.0 114.059 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.4 mt -115.27 -25.15 8.14 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.416 1.007 . . . . 0.0 111.861 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -61.87 -29.27 70.08 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.125 0.42 . . . . 0.0 110.347 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -69.62 -46.35 66.43 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.883 1.273 . . . . 0.0 109.546 178.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 -160.15 147.45 16.28 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.641 1.576 . . . . 0.0 110.218 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 65.9 m -75.58 177.57 6.66 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 34.0 pt -131.86 150.32 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 O-C-N 121.432 -0.793 . . . . 0.0 109.556 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.59 164.91 28.94 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.961 0.504 . . . . 0.0 110.604 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -147.08 129.13 15.5 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.057 1.743 . . . . 0.0 109.237 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -91.33 102.76 15.46 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.97 66.64 3.62 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.959 1.303 . . . . 0.0 107.791 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.16 -120.28 11.77 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -63.34 -34.9 78.7 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.809 0.844 . . . . 0.0 112.558 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -107.44 148.85 28.61 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 118.743 0.701 . . . . 0.0 110.637 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.0 mt -112.06 151.03 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -125.22 128.4 48.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.246 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -126.33 130.69 51.31 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.846 1.658 . . . . 0.0 108.544 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -125.76 120.97 32.02 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.35 1.46 . . . . 0.0 109.33 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 6.5 m -105.53 160.02 27.51 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.755 1.222 . . . . 0.0 113.89 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.02 86.12 0.49 Allowed 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 124.585 3.524 . . . . 0.0 113.208 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 61.93 54.95 31.11 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.0 mt -130.02 -67.46 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.414 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 20.9 pt-20 -170.29 166.57 8.72 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 126.337 1.855 . . . . 0.0 108.05 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.58 119.07 27.12 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 102.472 -3.159 . . . . 0.0 102.472 177.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.6 m -139.24 148.39 23.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -178.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -113.69 138.02 50.8 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -145.76 158.5 43.85 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.753 1.221 . . . . 0.0 111.158 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -87.81 154.48 20.51 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 152.34 -164.14 30.48 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -132.13 161.29 33.68 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.173 1.389 . . . . 0.0 108.01 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 53.7 t . . . . . 0 N--CA 1.467 0.397 0 C-N-CA 124.579 1.152 . . . . 0.0 109.928 -179.309 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 . . . . . 0 C--O 1.235 0.303 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.7 mt . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 179.516 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 46.8 mt . . . . . 0 C--O 1.234 0.258 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.2 t -142.67 138.95 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 126.145 1.778 . . . . 0.0 108.933 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -132.04 153.48 50.36 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 125.215 1.406 . . . . 0.0 110.673 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -95.39 135.96 36.35 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.658 1.583 . . . . 0.0 108.2 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 63.7 mt -115.89 -78.85 0.58 Allowed 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -121.38 154.05 16.6 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt -132.84 90.57 31.74 Favored Pre-proline 0 N--CA 1.456 -0.148 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 48.6 Cg_endo -76.27 -178.99 4.83 Favored 'Trans proline' 0 C--O 1.239 0.529 0 C-N-CA 123.194 2.596 . . . . 0.0 111.951 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -85.59 166.97 15.8 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.24 -37.03 39.03 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -105.33 152.0 23.47 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.375 -0.828 . . . . 0.0 111.67 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.1 p -68.25 -24.68 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.575 0.75 . . . . 0.0 112.393 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -82.82 -8.24 59.6 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.909 1.284 . . . . 0.0 112.372 -178.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -96.79 -11.72 24.58 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.466 1.107 . . . . 0.0 110.258 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -120.53 177.91 4.87 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.83 2.452 . . . . 0.0 111.552 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -142.85 165.78 26.44 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.02 1.728 . . . . 0.0 109.786 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.478 ' CE1' HG13 ' A' ' 106' ' ' VAL . 77.7 m-85 -140.94 168.42 19.84 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.885 1.674 . . . . 0.0 109.28 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -129.97 122.0 27.65 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.638 0.775 . . . . 0.0 109.488 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.0 tt -81.28 105.0 12.12 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 45.7 mt -115.78 -179.89 3.78 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.944 0.897 . . . . 0.0 110.995 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -161.91 156.15 22.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -138.42 -172.83 3.38 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -54.16 -24.2 17.18 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.487 1.915 . . . . 0.0 113.626 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 45.7 t -80.85 -75.5 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -166.68 -168.97 29.67 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.571 ' CE2' HD22 ' A' ' 243' ' ' LEU . 6.3 m-85 -78.16 154.78 30.88 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.249 1.02 . . . . 0.0 111.177 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -160.85 175.38 12.61 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.149 1.78 . . . . 0.0 108.74 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.518 HD12 HD11 ' A' ' 109' ' ' ILE . 15.8 mt -120.01 137.85 52.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 103.063 -2.94 . . . . 0.0 103.063 177.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.4 t -124.88 125.85 44.61 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -128.55 146.02 50.95 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 5.8 tt -121.53 138.2 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.409 HG21 ' HD3' ' A' ' 163' ' ' PRO . 13.8 mt -126.06 109.54 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 125.65 1.58 . . . . 0.0 109.512 -178.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.34 -153.26 24.9 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 41.7 m 75.95 31.67 0.68 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.866 1.267 . . . . 0.0 111.357 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -91.62 -138.22 7.92 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 108.266 -1.934 . . . . 0.0 108.266 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -117.47 121.71 41.77 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 127.229 2.212 . . . . 0.0 110.04 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 10.6 mm -60.79 125.63 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 123.378 0.671 . . . . 0.0 109.839 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 56.6 m -84.64 101.96 12.56 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 103.922 -2.621 . . . . 0.0 103.922 177.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -58.61 -17.79 24.91 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.579 0.627 . . . . 0.0 110.762 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 24.9 t -50.69 -41.56 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 125.526 1.53 . . . . 0.0 109.098 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 7.5 p -125.45 -24.23 3.96 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 96.1 6.21 59.13 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 126.713 2.101 . . . . 0.0 112.441 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -86.23 166.82 15.4 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.038 0.935 . . . . 0.0 110.965 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -90.39 150.87 21.68 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 2.6 tpt85 -76.88 30.69 0.13 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 128.216 2.606 . . . . 0.0 110.789 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.1 ptt? -72.44 149.13 44.5 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -176.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.3 p -121.74 140.78 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 114.616 -1.174 . . . . 0.0 112.218 -176.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -112.57 123.09 49.51 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.365 1.066 . . . . 0.0 110.394 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 2.3 mp -109.04 128.67 64.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 126.115 1.766 . . . . 0.0 111.098 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -106.23 118.69 37.29 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.36 1.064 . . . . 0.0 108.724 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -97.27 115.33 27.43 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.91 0.884 . . . . 0.0 109.61 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 32.8 m -125.54 165.42 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.647 1.579 . . . . 0.0 112.106 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.13 137.33 37.43 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -107.06 128.03 9.08 Favored Glycine 0 C--N 1.334 0.471 0 N-CA-C 108.265 -1.934 . . . . 0.0 108.265 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -42.91 -41.63 4.63 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.592 1.568 . . . . 0.0 113.656 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.4 t -79.49 85.37 5.27 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.414 ' HA ' ' HB3' ' A' ' 236' ' ' PRO . 18.1 p-10 -72.66 9.15 1.17 Allowed 'General case' 0 CA--C 1.549 0.908 0 O-C-N 121.276 -0.89 . . . . 0.0 113.115 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.95 46.51 1.65 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.43 1.892 . . . . 0.0 112.906 -178.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -166.83 159.89 33.38 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 120.299 -1.5 . . . . 0.0 111.993 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.25 166.59 22.82 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.135 2.557 . . . . 0.0 111.825 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 5.2 p -66.22 158.62 28.38 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.827 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.0 p -161.6 165.31 28.58 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.125 1.77 . . . . 0.0 107.376 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.8 mt -85.61 132.1 32.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -78.2 -53.03 7.79 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.787 1.635 . . . . 0.0 110.542 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . 0.489 ' CE3' ' HD2' ' A' ' 222' ' ' ARG . 37.9 p-90 -152.16 167.4 28.66 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.38 1.472 . . . . 0.0 108.685 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.717 HG13 ' CE1' ' A' ' 229' ' ' TYR . 47.0 t -146.29 133.88 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 126.253 1.821 . . . . 0.0 106.923 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.489 ' HD2' ' CE3' ' A' ' 220' ' ' TRP . 0.1 OUTLIER -153.75 130.47 10.81 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.912 0.778 . . . . 0.0 111.12 178.082 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -81.73 86.88 6.36 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 6.6 p -65.32 -55.02 20.61 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 127.022 2.129 . . . . 0.0 110.599 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -98.38 -176.51 3.42 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.5 mp -78.79 -29.98 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.8 t -111.61 -54.34 2.62 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.511 0.725 . . . . 0.0 110.898 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.94 149.4 10.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 123.639 0.776 . . . . 0.0 109.283 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . 0.717 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.2 OUTLIER -138.24 139.56 39.29 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.213 1.805 . . . . 0.0 109.453 -178.168 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.3 140.34 49.68 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.03 1.332 . . . . 0.0 108.553 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.39 162.32 38.46 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.394 1.877 . . . . 0.0 109.12 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -131.79 149.4 52.48 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 94.3 t -132.55 132.77 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 125.836 1.654 . . . . 0.0 108.887 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.25 144.29 27.2 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 32.7 mt -141.28 136.97 16.21 Favored Pre-proline 0 N--CA 1.454 -0.262 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.414 ' HB3' ' HA ' ' A' ' 212' ' ' ASN . 89.9 Cg_endo -76.75 -40.88 0.46 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.627 1.551 . . . . 0.0 112.338 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -68.27 -17.67 64.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 120.768 -1.208 . . . . 0.0 111.944 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 17.0 mt -66.04 -30.77 71.36 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 176.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 28.9 m -61.11 -13.78 19.71 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.024 1.33 . . . . 0.0 111.167 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -75.37 -32.37 60.81 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 120.142 -1.599 . . . . 0.0 111.534 178.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 40.5 mt -81.31 111.47 17.72 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 126.5 1.92 . . . . 0.0 109.0 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -47.08 -34.11 5.58 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 128.847 2.859 . . . . 0.0 114.878 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.571 HD22 ' CE2' ' A' ' 181' ' ' TYR . 12.5 mt -62.82 -39.62 94.88 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.355 -0.841 . . . . 0.0 111.531 178.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 4.8 mp -91.51 10.33 28.27 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 127.058 2.143 . . . . 0.0 113.5 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.164 0 C-N-CA 126.462 1.905 . . . . 0.0 110.694 -178.289 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.9 p . . . . . 0 CA--C 1.528 0.115 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.49 -48.17 82.94 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 118.293 0.497 . . . . 0.0 110.096 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 47.1 tp -67.53 -40.2 85.06 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 118.218 -0.896 . . . . 0.0 109.445 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.7 mt -59.35 -52.49 65.43 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.864 1.211 . . . . 0.0 109.266 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.4 m -57.3 -49.57 75.68 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 121.648 -0.657 . . . . 0.0 109.47 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -57.89 -49.1 77.86 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 118.238 0.472 . . . . 0.0 109.776 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 59.6 m -53.05 -52.57 58.09 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.71 1.604 . . . . 0.0 110.422 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 19.0 tp -59.83 -54.3 47.88 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 118.802 -0.618 . . . . 0.0 110.603 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.86 -47.67 79.88 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 118.262 0.483 . . . . 0.0 111.708 -178.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -60.06 -39.74 87.05 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.285 1.034 . . . . 0.0 108.512 178.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.89 -52.83 50.53 Favored Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 40.3 t -56.39 -52.99 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 118.661 1.231 . . . . 0.0 111.165 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -29.67 70.87 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.405 1.002 . . . . 0.0 111.54 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.1 m -75.41 -42.69 53.09 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 118.79 -0.624 . . . . 0.0 110.459 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.427 HD11 HD12 ' A' ' 183' ' ' ILE . 22.6 mt -56.12 -50.87 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.03 -43.19 91.57 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -65.77 -20.51 66.29 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.72 1.208 . . . . 0.0 112.81 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.16 10.36 33.84 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.003 1.321 . . . . 0.0 112.583 178.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.7 mt -135.59 -29.15 1.07 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.497 1.119 . . . . 0.0 113.555 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -51.7 -37.16 49.61 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -178.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -65.45 -40.07 92.79 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 116.069 1.878 . . . . 0.0 116.069 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.9 mmt180 -159.12 147.87 18.25 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.395 1.478 . . . . 0.0 109.243 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 32.2 m -75.72 172.3 12.87 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 32.9 pt -126.31 146.24 32.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.422 ' CD1' HD11 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -144.96 152.65 40.51 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 122.84 0.456 . . . . 0.0 110.889 -178.562 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -137.08 127.71 26.98 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 124.046 0.938 . . . . 0.0 110.455 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -89.15 102.86 15.52 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.57 70.75 4.24 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.08 -115.51 5.5 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -77.27 -28.03 53.37 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.322 1.049 . . . . 0.0 111.794 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -106.65 135.56 47.96 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 119.327 0.967 . . . . 0.0 111.215 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.4 mt -106.82 145.82 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.515 ' CD1' HG11 ' A' ' 221' ' ' VAL . 67.1 m-85 -121.27 128.33 52.26 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.409 1.484 . . . . 0.0 107.627 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -122.94 128.24 50.0 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.676 1.59 . . . . 0.0 110.255 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -121.06 109.97 15.68 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.074 0.95 . . . . 0.0 108.612 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 11.6 m -95.23 158.8 34.15 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 123.226 0.61 . . . . 0.0 110.972 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.5 83.55 0.39 Allowed 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 123.903 3.069 . . . . 0.0 115.658 -178.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.32 51.68 50.47 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 124.205 0.907 . . . . 0.0 111.085 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.8 mt -126.8 -67.17 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.4 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 10.5 pt-20 -170.64 163.35 8.11 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 126.414 1.885 . . . . 0.0 108.362 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.67 121.12 36.64 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 102.154 -3.276 . . . . 0.0 102.154 177.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.4 m -131.5 156.95 43.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 124.548 1.139 . . . . 0.0 111.13 -178.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -125.83 126.39 44.41 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 178.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -143.99 157.53 44.28 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.489 1.115 . . . . 0.0 111.926 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -89.29 153.24 21.05 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 178.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 161.84 -163.03 34.51 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.38 140.86 50.58 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.6 t . . . . . 0 C--N 1.332 -0.186 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.829 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 . . . . . 0 C--O 1.234 0.258 0 CA-C-O 121.408 0.623 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.422 HD11 ' CD1' ' A' ' 119' ' ' PHE . 39.7 mt . . . . . 0 N--CA 1.45 -0.438 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 80.6 mt . . . . . 0 C--O 1.233 0.235 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.3 t -142.5 135.12 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.071 1.348 . . . . 0.0 107.838 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -124.31 151.38 44.35 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.087 1.355 . . . . 0.0 111.051 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -96.99 112.64 24.3 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 127.068 2.147 . . . . 0.0 107.449 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.3 mp -93.82 -78.53 0.43 Allowed 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -120.49 144.23 16.95 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -121.52 89.35 47.19 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 52.5 Cg_endo -77.58 173.35 14.32 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.793 2.995 . . . . 0.0 111.608 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -87.88 161.88 17.25 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.184 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -82.97 -37.84 23.51 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.066 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -93.34 132.59 37.42 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 15.0 p -60.65 -31.74 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 123.85 0.86 . . . . 0.0 112.086 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -68.03 -21.36 65.02 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.704 0.684 . . . . 0.0 112.01 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -84.31 -20.31 32.3 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.838 0.455 . . . . 0.0 110.614 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 32.9 mmm-85 -70.72 165.93 21.95 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.748 0.819 . . . . 0.0 109.904 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -134.86 95.98 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.086 0.955 . . . . 0.0 109.241 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -106.68 156.65 18.4 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.946 1.298 . . . . 0.0 108.932 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -140.92 147.49 38.92 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.759 1.224 . . . . 0.0 107.888 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 25.1 tp -107.94 102.64 11.81 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 125.705 1.602 . . . . 0.0 106.875 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.81 179.0 4.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.28 1.432 . . . . 0.0 107.837 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.415 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 20.5 p90 -154.07 163.66 39.74 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -133.81 173.9 11.04 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -63.78 -11.43 26.69 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.403 -0.81 . . . . 0.0 110.61 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 83.7 t -83.76 -66.16 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -176.32 -174.54 42.91 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.415 ' CD2' ' HB3' ' A' ' 176' ' ' TYR . 26.2 m-85 -81.41 156.57 25.33 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 124.798 1.239 . . . . 0.0 111.842 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -162.79 169.96 19.08 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.228 1.011 . . . . 0.0 111.258 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.427 HD12 HD11 ' A' ' 109' ' ' ILE . 7.9 mt -116.57 121.78 68.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 11.8 t -97.69 131.61 44.08 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.704 1.202 . . . . 0.0 110.321 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -137.93 110.14 7.34 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.114 1.766 . . . . 0.0 109.075 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 2.7 tt -103.22 140.23 22.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.2 mt -132.83 113.79 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 123.647 0.779 . . . . 0.0 110.289 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -106.55 -156.87 21.33 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 125.293 1.425 . . . . 0.0 110.897 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 65.69 60.79 0.7 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.109 1.763 . . . . 0.0 111.554 -178.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -116.84 -124.01 3.52 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 104.633 -3.387 . . . . 0.0 104.633 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -127.95 123.58 35.22 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.759 1.224 . . . . 0.0 110.754 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 31.0 mm -64.25 116.96 4.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 71.8 m -73.71 102.09 3.86 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -53.18 -28.8 28.24 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.5 m -52.41 -33.28 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 C-N-CA 125.025 1.33 . . . . 0.0 111.384 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 73.1 p -123.0 -45.79 2.12 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.74 12.43 20.88 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.994 2.235 . . . . 0.0 111.32 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -92.56 169.97 10.11 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.942 1.297 . . . . 0.0 111.488 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -85.17 148.51 26.07 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.589 0.709 . . . . 0.0 111.792 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 18.3 tpt85 -84.05 28.56 0.6 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.676 2.39 . . . . 0.0 109.157 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 3.5 ptt? -73.47 158.77 34.3 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -177.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 1.9 p -125.93 140.1 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.155 -178.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -105.96 115.54 30.4 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 125.84 1.656 . . . . 0.0 107.083 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.6 mp -107.12 131.65 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -118.1 120.15 36.88 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 125.435 1.494 . . . . 0.0 108.511 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -101.05 119.4 38.69 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.42 1.488 . . . . 0.0 112.368 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 17.2 m -127.05 176.34 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.808 1.243 . . . . 0.0 111.8 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.6 t -91.0 124.32 35.15 Favored 'General case' 0 C--N 1.337 0.053 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 178.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.34 155.24 34.03 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.258 -0.496 . . . . 0.0 113.043 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -57.44 -27.22 57.98 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.305 0.955 . . . . 0.0 111.594 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 6.0 m -114.68 93.69 4.44 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -77.55 25.03 0.19 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.967 1.707 . . . . 0.0 112.552 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 27.2 t -131.98 45.48 2.77 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.343 1.857 . . . . 0.0 110.005 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -161.35 166.03 35.69 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-O 118.619 -1.101 . . . . 0.0 111.27 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -71.09 166.75 28.16 Favored 'Trans proline' 0 C--O 1.24 0.589 0 C-N-CA 122.821 2.347 . . . . 0.0 112.413 -178.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 96.7 p -70.38 155.58 40.49 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -166.01 156.11 12.5 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.0 mt -78.87 127.03 39.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -72.01 -51.25 22.71 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.743 1.617 . . . . 0.0 112.139 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . 0.441 ' CZ2' ' HB2' ' A' ' 232' ' ' GLN . 20.7 p-90 -152.76 164.92 36.86 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.183 1.393 . . . . 0.0 109.334 -178.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.798 HG13 ' CE1' ' A' ' 229' ' ' TYR . 51.3 t -147.36 120.75 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.42 ' HD3' ' CE3' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -140.15 127.42 21.19 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 178.674 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -80.68 92.26 5.97 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 104.101 -2.555 . . . . 0.0 104.101 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 5.7 p -65.69 -65.65 0.65 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.35 1.46 . . . . 0.0 109.786 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -88.71 -172.83 3.88 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.052 0.941 . . . . 0.0 108.489 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.4 mp -78.71 -40.99 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -106.07 -49.41 3.38 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.106 1.363 . . . . 0.0 112.539 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 2.4 t -68.26 145.54 13.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . 0.798 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.2 OUTLIER -137.2 136.1 37.86 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.716 1.606 . . . . 0.0 109.177 -178.413 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.42 139.93 43.78 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 125.047 1.339 . . . . 0.0 108.577 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -142.06 155.1 45.38 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 126.088 1.755 . . . . 0.0 110.136 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.441 ' HB2' ' CZ2' ' A' ' 220' ' ' TRP . 5.0 tt0 -136.25 146.42 46.7 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 1.6 m -137.34 154.56 30.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.1 p -109.08 148.67 30.46 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 123.469 0.708 . . . . 0.0 110.33 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 41.6 mt -142.27 133.35 12.94 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.27 -46.56 0.65 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.772 2.315 . . . . 0.0 112.324 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -62.03 -22.73 65.96 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.953 0.901 . . . . 0.0 113.375 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.8 mp -63.26 -40.06 96.35 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.223 0.92 . . . . 0.0 108.974 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 30.2 m -54.59 -22.53 13.58 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.84 1.656 . . . . 0.0 113.152 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -62.7 -31.47 72.38 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 121.1 -1.0 . . . . 0.0 110.841 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 26.4 mt -79.4 118.88 21.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.7 -35.52 31.52 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.9 mp -58.93 -45.19 90.99 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.336 -0.852 . . . . 0.0 109.599 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.76 5.45 36.31 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.125 1.77 . . . . 0.0 112.62 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.526 0 CA-C-N 119.68 1.127 . . . . 0.0 111.261 -179.549 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.6 m . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.05 -38.31 70.44 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.373 0.669 . . . . 0.0 110.659 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.3 tp -60.57 -38.11 83.5 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 119.003 -0.523 . . . . 0.0 110.457 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.497 HD23 HD13 ' A' ' 174' ' ' LEU . 3.4 mt -67.23 -49.51 64.2 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 58.7 m -54.6 -44.57 73.16 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.919 0.888 . . . . 0.0 109.904 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -66.31 -50.78 62.45 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 121.104 -0.998 . . . . 0.0 110.246 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 58.4 m -53.99 -47.43 71.44 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.287 1.435 . . . . 0.0 111.145 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 28.5 tp -63.31 -54.79 31.51 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 119.051 0.841 . . . . 0.0 110.911 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -54.01 -48.99 69.86 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.414 0.686 . . . . 0.0 110.52 -178.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -57.37 -50.79 71.85 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 124.07 0.948 . . . . 0.0 109.051 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -57.04 -49.38 72.13 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-O 119.178 -0.79 . . . . 0.0 111.687 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 72.6 t -58.88 -53.2 50.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 125.343 1.457 . . . . 0.0 110.867 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -31.23 72.34 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 118.573 0.624 . . . . 0.0 110.531 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.8 m -70.44 -46.13 64.47 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.537 HD11 HD12 ' A' ' 183' ' ' ILE . 10.9 mt -53.56 -54.31 19.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.37 -44.04 84.09 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 124.035 0.834 . . . . 0.0 110.81 -178.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -60.41 -52.53 64.82 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.163 0.506 . . . . 0.0 111.6 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -22.19 66.8 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.8 mt -96.04 -27.37 15.14 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 118.823 0.738 . . . . 0.0 110.311 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -61.79 -28.44 69.46 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.186 0.594 . . . . 0.0 110.178 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -66.53 -46.93 74.52 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -165.44 152.75 10.64 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.908 2.083 . . . . 0.0 109.431 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 57.5 m -75.44 171.82 13.58 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 41.6 pt -125.78 147.55 30.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 123.801 0.84 . . . . 0.0 108.981 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.73 156.42 45.01 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 122.78 0.432 . . . . 0.0 110.375 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -142.91 128.02 18.58 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 124.167 0.987 . . . . 0.0 110.195 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -88.71 106.12 18.14 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.29 67.23 0.92 Allowed 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.35 -120.53 7.11 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.173 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -66.73 -32.06 73.12 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.64 1.176 . . . . 0.0 111.345 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -107.64 135.84 48.41 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.463 0.649 . . . . 0.0 111.626 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.459 HD12 ' H ' ' A' ' 140' ' ' GLY . 33.1 mt -105.8 149.72 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 177.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -119.08 134.8 54.98 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.334 -1.757 . . . . 0.0 108.205 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -128.91 130.74 47.19 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.751 1.22 . . . . 0.0 108.495 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -129.4 118.82 22.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.585 1.154 . . . . 0.0 109.219 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 10.6 m -105.41 160.32 26.46 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.668 1.187 . . . . 0.0 113.57 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -63.79 92.82 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 124.858 3.706 . . . . 0.0 113.157 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 52.17 53.06 32.7 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-O 119.579 -0.567 . . . . 0.0 111.846 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.1 mt -124.92 -67.36 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -177.38 174.73 1.55 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.98 1.712 . . . . 0.0 109.203 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.82 124.55 39.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 177.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.9 m -134.42 156.94 41.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 124.379 1.072 . . . . 0.0 110.879 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -124.09 124.12 41.82 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -146.17 156.37 43.37 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.323 1.049 . . . . 0.0 111.615 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -102.21 119.59 39.06 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.459 ' H ' HD12 ' A' ' 126' ' ' ILE . . . -154.44 -165.14 13.54 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.921 1.724 . . . . 0.0 108.962 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.66 136.89 50.28 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 C--O 1.237 0.417 0 C-N-CA 123.902 0.881 . . . . 0.0 112.319 -179.193 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 . . . . . 0 N--CA 1.445 -0.715 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 88.1 mt . . . . . 0 C--N 1.326 -0.442 0 N-CA-C 102.744 -3.058 . . . . 0.0 102.744 178.863 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 N--CA 1.456 -0.144 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.8 t -134.95 133.95 53.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.044 0.838 . . . . 0.0 108.965 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -130.3 163.4 26.88 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.492 1.517 . . . . 0.0 110.792 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -112.9 143.38 44.28 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 18.5 mt -116.32 -72.92 0.67 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -128.67 148.88 18.19 Favored Glycine 0 C--O 1.241 0.564 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -130.78 91.83 36.0 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.718 1.207 . . . . 0.0 109.286 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.441 ' HD3' HG21 ' A' ' 187' ' ' ILE . 43.5 Cg_endo -74.46 -166.09 0.31 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 125.06 3.84 . . . . 0.0 111.051 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -95.98 168.1 10.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.114 1.366 . . . . 0.0 109.395 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -81.79 -28.45 33.2 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -113.98 162.56 16.27 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 123.328 0.651 . . . . 0.0 110.324 -179.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.8 p -73.63 -34.58 41.96 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 C-N-CA 123.364 0.665 . . . . 0.0 110.379 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -74.37 -16.03 60.91 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.404 -0.81 . . . . 0.0 112.182 -177.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -81.57 -19.66 41.53 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.183 0.993 . . . . 0.0 110.603 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -117.33 177.91 4.56 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.608 1.563 . . . . 0.0 110.985 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -140.51 156.86 46.2 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -133.83 166.99 21.37 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.308 1.843 . . . . 0.0 107.977 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -133.74 123.7 25.38 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 120.498 1.499 . . . . 0.0 112.614 -179.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.497 HD13 HD23 ' A' ' 98' ' ' LEU . 0.7 OUTLIER -82.77 99.08 9.45 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.005 1.322 . . . . 0.0 109.442 179.581 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.43 HD12 ' HB2' ' A' ' 184' ' ' SER . 24.7 mt -108.21 174.02 6.06 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 122.394 1.092 . . . . 0.0 109.516 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -154.52 163.11 40.7 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -141.25 -178.44 5.59 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -52.55 -34.25 49.3 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 125.335 1.454 . . . . 0.0 110.523 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 56.1 t -70.79 -67.78 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 127.005 2.122 . . . . 0.0 109.191 178.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -175.77 -174.69 42.54 Favored Glycine 0 N--CA 1.446 -0.66 0 O-C-N 121.817 -0.552 . . . . 0.0 111.931 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -80.06 158.32 26.49 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.515 1.126 . . . . 0.0 111.973 -178.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -165.69 177.0 7.58 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.457 1.503 . . . . 0.0 108.531 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.537 HD12 HD11 ' A' ' 109' ' ' ILE . 8.9 mt -121.92 126.28 74.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 101.609 -3.478 . . . . 0.0 101.609 177.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.43 ' HB2' HD12 ' A' ' 175' ' ' LEU . 3.2 t -106.4 107.8 19.0 Favored 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 124.325 1.016 . . . . 0.0 109.248 -178.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -111.22 118.78 36.85 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 118.5 -0.762 . . . . 0.0 110.699 -179.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.8 tt -108.95 140.27 28.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.441 HG21 ' HD3' ' A' ' 163' ' ' PRO . 7.5 mt -133.87 113.47 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 C-N-CA 123.997 0.919 . . . . 0.0 110.637 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.68 -162.41 26.01 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 177.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.0 m 84.45 29.19 0.07 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.251 2.221 . . . . 0.0 112.959 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -87.4 -109.15 0.92 Allowed Glycine 0 C--N 1.338 0.649 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -139.11 126.6 21.7 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.337 1.455 . . . . 0.0 109.053 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.5 mm -68.19 122.54 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 120.503 1.501 . . . . 0.0 109.453 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 30.5 p -82.01 117.76 22.46 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 123.156 0.583 . . . . 0.0 111.622 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -71.89 -3.52 22.95 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.115 -0.991 . . . . 0.0 110.718 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 39.6 t -66.98 -42.06 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 125.127 1.371 . . . . 0.0 108.278 178.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.9 p -124.34 -28.57 3.64 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 122.898 0.479 . . . . 0.0 111.613 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.77 30.62 10.22 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -116.55 169.28 9.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.74 1.216 . . . . 0.0 112.289 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -83.83 139.91 32.36 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.351 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 2.9 tpp85 -77.13 30.75 0.14 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 130.013 3.325 . . . . 0.0 109.371 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 12.2 ptt? -73.11 157.11 37.9 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 122.008 0.909 . . . . 0.0 109.329 -176.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.5 p -125.19 146.05 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 114.37 -1.287 . . . . 0.0 111.317 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -112.7 138.6 49.27 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 1.8 mp -125.94 114.38 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 126.455 1.902 . . . . 0.0 107.579 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -99.69 116.28 31.43 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -93.54 118.17 31.01 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 125.242 1.417 . . . . 0.0 111.506 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 32.5 m -129.49 172.21 15.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 124.266 1.026 . . . . 0.0 111.312 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.2 t -78.59 134.96 37.16 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -93.21 122.01 6.79 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -37.68 -61.73 1.06 Allowed Glycine 0 C--N 1.336 0.538 0 C-N-CA 126.74 2.114 . . . . 0.0 111.343 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.8 p -77.66 83.09 4.05 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.483 ' HA ' ' HB3' ' A' ' 236' ' ' PRO . 37.2 p-10 -76.64 66.78 2.66 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.9 p -149.47 19.45 0.94 Allowed 'General case' 0 C--O 1.238 0.458 0 N-CA-C 116.539 2.052 . . . . 0.0 116.539 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -163.95 173.65 40.01 Favored Glycine 0 N--CA 1.47 0.941 0 O-C-N 121.189 -0.945 . . . . 0.0 115.197 -178.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -64.77 164.24 24.97 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.036 2.49 . . . . 0.0 112.535 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 15.8 p -67.31 157.59 33.59 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.368 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 1.7 p -161.27 163.72 30.75 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.417 2.287 . . . . 0.0 106.923 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.5 mt -82.75 134.57 26.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 178.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -81.57 -55.22 4.81 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.052 1.341 . . . . 0.0 111.097 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 26.2 p-90 -147.92 166.54 27.36 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.259 1.424 . . . . 0.0 108.541 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.679 HG13 ' CE1' ' A' ' 229' ' ' TYR . 49.6 t -146.1 131.76 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -179.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.43 133.65 15.25 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.73 0.776 . . . . 0.0 111.223 177.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -81.72 89.3 6.27 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.2 p -66.01 -51.91 54.03 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.082 0.953 . . . . 0.0 111.734 -178.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -103.18 -173.83 2.4 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.0 mp -72.17 -43.54 66.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 3.4 m -111.94 -28.55 7.99 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -177.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 2.1 t -81.78 143.1 12.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . 0.679 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.9 OUTLIER -129.04 145.5 51.24 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.31 1.444 . . . . 0.0 110.09 -177.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -129.33 142.02 50.93 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 125.442 1.497 . . . . 0.0 108.39 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.28 163.2 37.16 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.296 1.839 . . . . 0.0 110.786 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -126.89 149.15 49.91 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 88.7 t -132.77 134.37 58.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 125.525 1.53 . . . . 0.0 107.803 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.41 143.48 32.63 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.922 0.889 . . . . 0.0 108.877 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 33.8 mt -139.85 138.13 19.36 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 118.251 -0.88 . . . . 0.0 109.215 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.483 ' HB3' ' HA ' ' A' ' 212' ' ' ASN . 72.4 Cg_endo -74.22 -46.16 0.31 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.647 2.231 . . . . 0.0 110.838 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.71 -25.41 62.88 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.996 1.318 . . . . 0.0 110.816 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 238' ' ' LEU . 15.3 mt -65.52 -41.33 93.26 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 24.7 m -58.01 -16.1 11.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.604 1.562 . . . . 0.0 113.061 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -63.19 -43.84 97.07 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.006 0.923 . . . . 0.0 109.143 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.8 mt -71.87 120.04 16.9 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 128.809 2.844 . . . . 0.0 107.049 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -52.67 -35.21 54.75 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.4 mp -58.73 -36.7 74.72 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.602 -0.686 . . . . 0.0 110.897 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -94.41 3.88 54.6 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 125.046 1.338 . . . . 0.0 111.949 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.718 0 O-C-N 121.506 -0.746 . . . . 0.0 112.384 -179.346 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.446 -0.672 0 CA-C-O 118.375 -0.821 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.53 -35.97 77.27 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.715 1.143 . . . . 0.0 110.34 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.22 -45.34 88.69 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.6 mt -63.46 -53.93 44.47 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.494 1.118 . . . . 0.0 109.538 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 55.2 m -54.87 -44.51 74.1 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.637 1.175 . . . . 0.0 110.648 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.1 ttmm -65.97 -49.79 66.6 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.813 -0.613 . . . . 0.0 109.945 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 79.9 m -51.92 -43.28 63.35 Favored 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 124.523 1.129 . . . . 0.0 111.157 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tt -61.79 -56.88 14.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.299 0.5 . . . . 0.0 111.898 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -60.69 -45.71 93.16 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.744 0.817 . . . . 0.0 111.42 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -57.72 -44.28 85.87 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.861 0.864 . . . . 0.0 108.851 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.98 -52.03 54.87 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 94.8 t -55.1 -53.2 36.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 124.977 1.311 . . . . 0.0 111.711 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.04 -33.36 75.58 Favored 'General case' 0 C--N 1.335 -0.052 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.741 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.2 m -67.63 -46.22 73.13 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.453 HD11 HD12 ' A' ' 183' ' ' ILE . 27.9 mt -55.64 -54.31 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 124.606 1.163 . . . . 0.0 108.855 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.02 -43.73 82.13 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.468 -178.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -60.99 -52.96 62.81 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-N 118.78 0.718 . . . . 0.0 110.637 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.68 -15.65 53.48 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.2 mt -101.54 -28.11 12.73 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 119.358 0.981 . . . . 0.0 109.174 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -65.5 -26.22 67.82 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -66.6 -46.23 76.61 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 -161.77 148.56 14.1 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.307 1.843 . . . . 0.0 109.297 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 71.0 m -74.99 164.42 26.57 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 178.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 33.3 pt -119.36 154.98 21.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -145.21 165.39 28.48 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.031 -178.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -151.25 125.34 9.26 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.194 1.397 . . . . 0.0 109.369 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -88.76 117.38 27.7 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -108.41 67.49 0.67 Allowed 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.722 1.209 . . . . 0.0 109.0 178.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.0 -114.09 3.88 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 107.917 -2.073 . . . . 0.0 107.917 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -83.99 -26.5 29.14 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.162 1.385 . . . . 0.0 112.463 179.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -106.38 115.44 30.22 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.409 1.484 . . . . 0.0 112.638 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 51.2 mt -92.57 146.74 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 C-N-CA 125.559 1.543 . . . . 0.0 108.219 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.475 ' CD1' HG11 ' A' ' 221' ' ' VAL . 64.1 m-85 -118.04 135.23 54.3 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.499 -1.228 . . . . 0.0 107.74 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -133.14 126.43 31.69 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.311 1.044 . . . . 0.0 108.772 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -122.85 127.07 48.53 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.595 1.158 . . . . 0.0 111.677 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 17.6 m -114.21 158.66 39.06 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 123.428 0.691 . . . . 0.0 112.351 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.28 92.78 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.625 1 C-N-CA 125.614 4.21 . . . . 0.0 113.858 -178.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 58.91 47.49 90.37 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.1 mt -125.37 -66.86 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.215 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.523 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 20.8 pt-20 -178.13 167.11 1.99 Allowed 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.415 1.486 . . . . 0.0 109.117 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.32 119.28 29.65 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 178.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.6 m -127.2 156.67 38.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 125.252 1.421 . . . . 0.0 110.765 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.36 124.07 41.57 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 103.638 -2.726 . . . . 0.0 103.638 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -146.29 158.79 43.91 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -178.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -89.37 153.64 20.7 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 169.48 -168.46 41.3 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -125.62 138.22 53.91 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.563 1.545 . . . . 0.0 107.075 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.467 0.402 0 CA-C-N 119.244 0.929 . . . . 0.0 110.907 -178.857 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 . . . . . 0 C--O 1.236 0.365 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 23.0 mt . . . . . 0 C--O 1.237 0.434 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 179.111 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 15.9 mt . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -136.2 135.18 50.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -134.49 154.82 51.23 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.96 1.704 . . . . 0.0 108.689 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -107.68 143.19 36.52 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.874 0.87 . . . . 0.0 109.236 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 35.5 mt -113.6 -69.96 0.83 Allowed 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 124.255 0.972 . . . . 0.0 109.432 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -133.57 156.51 22.3 Favored Glycine 0 C--O 1.239 0.422 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -126.78 93.7 41.67 Favored Pre-proline 0 C--O 1.231 0.102 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.523 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 57.3 Cg_endo -76.73 174.69 12.43 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 122.421 2.08 . . . . 0.0 110.068 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -81.32 162.03 23.62 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.47 -28.96 24.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.937 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -103.44 135.48 44.96 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.39 -22.54 28.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -83.28 -14.44 53.08 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 124.865 1.266 . . . . 0.0 111.448 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -84.55 -13.74 50.93 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.404 0.682 . . . . 0.0 110.864 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -117.51 174.56 6.08 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.345 1.858 . . . . 0.0 111.524 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -142.68 154.4 44.29 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.104 1.361 . . . . 0.0 109.511 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -128.96 169.41 14.69 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.874 2.469 . . . . 0.0 108.759 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -131.78 135.84 47.08 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.663 1.185 . . . . 0.0 109.514 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 17.4 tp -89.15 98.76 11.95 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.444 1.097 . . . . 0.0 108.343 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.408 HD12 ' HB2' ' A' ' 184' ' ' SER . 20.6 mt -105.32 178.37 4.58 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.95 0.881 . . . . 0.0 111.341 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -158.58 162.66 37.38 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -138.62 -178.39 5.28 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 125.346 1.459 . . . . 0.0 109.827 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -58.92 -15.59 13.56 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 45.4 t -98.58 -56.32 5.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 C-N-CA 125.569 1.548 . . . . 0.0 108.768 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -169.21 -167.42 29.77 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 119.324 0.966 . . . . 0.0 113.172 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -88.64 156.09 19.23 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 122.192 -0.593 . . . . 0.0 110.848 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -157.64 173.98 16.04 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.162 1.385 . . . . 0.0 107.934 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.453 HD12 HD11 ' A' ' 109' ' ' ILE . 18.9 mt -118.27 140.22 42.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 102.908 -2.997 . . . . 0.0 102.908 178.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.408 ' HB2' HD12 ' A' ' 175' ' ' LEU . 36.1 t -117.94 131.26 56.52 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.6 127.05 18.81 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 178.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.6 tt -115.19 134.74 57.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.5 mt -125.04 111.08 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.681 1.192 . . . . 0.0 111.823 -177.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -100.42 -158.32 27.95 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 108.328 -1.909 . . . . 0.0 108.328 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 9.1 m 69.53 56.95 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 123.93 0.892 . . . . 0.0 109.467 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -114.79 -116.06 3.11 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 105.678 -2.969 . . . . 0.0 105.678 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -135.24 129.05 33.05 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.902 1.681 . . . . 0.0 107.375 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 25.8 mm -67.28 132.73 32.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 29.3 p -80.31 113.48 18.52 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.22 -24.46 66.37 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.863 1.211 . . . . 0.0 111.86 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 3.6 m -57.34 -41.5 78.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 117.251 -1.357 . . . . 0.0 112.634 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 1.3 p -125.41 -21.43 4.54 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 120.612 1.551 . . . . 0.0 112.591 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 89.31 13.45 61.72 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.875 1.702 . . . . 0.0 110.923 -178.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -90.2 169.6 11.0 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.61 1.205 . . . . 0.0 108.98 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.412 ' C ' ' H ' ' A' ' 201' ' ' MET . 17.6 mt-10 -86.31 149.66 24.89 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -78.44 31.08 0.18 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.112 2.165 . . . . 0.0 107.775 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.412 ' H ' ' C ' ' A' ' 199' ' ' GLU . 11.5 ptt? -71.37 152.14 43.44 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -175.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.7 p -119.47 146.38 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 114.207 -1.361 . . . . 0.0 111.57 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -111.76 132.24 54.79 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 125.145 1.378 . . . . 0.0 107.391 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 2.4 mp -118.13 139.77 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 178.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -122.74 100.21 6.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -81.06 126.53 31.54 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 118.817 0.735 . . . . 0.0 110.198 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 33.0 m -134.79 172.24 16.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 126.014 1.726 . . . . 0.0 111.144 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.7 t -78.75 139.47 38.43 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -107.33 146.87 16.21 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -40.96 -66.14 0.94 Allowed Glycine 0 CA--C 1.522 0.514 0 C-N-CA 126.49 1.995 . . . . 0.0 112.469 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.7 t -70.75 103.72 2.66 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 117.845 0.822 . . . . 0.0 110.557 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -71.59 6.8 1.7 Allowed 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.68 -0.637 . . . . 0.0 111.018 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 73.9 p -126.95 30.72 5.41 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.335 1.854 . . . . 0.0 110.283 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -120.64 170.32 14.38 Favored Glycine 0 N--CA 1.47 0.925 0 CA-C-N 119.675 1.125 . . . . 0.0 115.159 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -79.91 165.75 21.75 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.583 2.188 . . . . 0.0 110.477 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 90.5 p -78.74 152.31 31.58 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.38 164.18 7.01 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.558 1.543 . . . . 0.0 108.215 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.1 mt -84.82 134.53 26.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -79.59 -54.27 6.05 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 125.224 1.409 . . . . 0.0 111.443 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . 0.406 ' CZ2' ' HB2' ' A' ' 232' ' ' GLN . 41.1 p-90 -146.94 162.65 38.28 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.71 1.204 . . . . 0.0 108.7 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.87 HG13 ' CE1' ' A' ' 229' ' ' TYR . 44.0 t -148.41 135.34 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 125.943 1.697 . . . . 0.0 107.062 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.07 138.4 10.26 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 177.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -82.51 87.3 6.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 102.564 -3.125 . . . . 0.0 102.564 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.1 p -63.13 -49.65 73.56 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.692 1.597 . . . . 0.0 111.913 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -95.2 -172.37 2.65 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.6 mp -71.51 -46.4 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 4.9 m -113.37 -36.55 4.95 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 2.7 t -70.17 144.63 13.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . 0.87 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.1 OUTLIER -127.56 139.76 52.55 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.079 1.752 . . . . 0.0 108.141 -179.028 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -121.94 142.99 49.73 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.895 1.278 . . . . 0.0 109.425 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.69 162.71 36.92 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.624 1.57 . . . . 0.0 110.019 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.406 ' HB2' ' CZ2' ' A' ' 220' ' ' TRP . 15.8 tt0 -129.11 142.93 50.73 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 93.5 t -129.25 137.88 55.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 124.891 1.277 . . . . 0.0 108.192 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.97 139.85 41.99 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 123.849 0.859 . . . . 0.0 111.153 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 26.6 mt -140.33 139.07 19.91 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.259 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.05 -43.98 0.29 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.683 2.256 . . . . 0.0 111.983 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -59.22 -21.21 59.16 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.807 0.843 . . . . 0.0 111.373 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 14.1 mt -69.85 -39.92 76.12 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 117.383 -1.294 . . . . 0.0 109.032 177.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 9.1 m -58.44 -22.13 53.38 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 119.657 1.117 . . . . 0.0 113.386 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -60.78 -32.03 71.37 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.362 0.665 . . . . 0.0 110.301 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 23.7 mt -79.86 118.84 21.99 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -48.33 -35.15 11.82 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 3.6 mp -57.61 -41.4 81.21 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 121.093 -1.004 . . . . 0.0 111.148 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -89.42 1.83 55.31 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.87 1.668 . . . . 0.0 112.905 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.418 0 C-N-CA 125.418 1.487 . . . . 0.0 108.6 -179.876 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.221 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -150.94 177.54 10.04 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.172 1.789 . . . . 0.0 106.867 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 m -117.3 165.32 13.6 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.997 1.319 . . . . 0.0 108.457 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -126.26 36.6 4.47 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.645 0.778 . . . . 0.0 109.267 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.1 m -52.5 -50.63 62.39 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.671 1.188 . . . . 0.0 111.872 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -55.97 -31.8 63.32 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.317 1.047 . . . . 0.0 113.079 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.45 -44.13 89.1 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 123.478 0.711 . . . . 0.0 109.765 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.7 m -66.54 -36.21 82.11 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.781 -0.575 . . . . 0.0 110.248 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.18 -45.26 77.5 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.03 -39.41 81.89 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.1 mt -63.72 -52.83 58.76 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 19.6 m -54.71 -44.96 73.91 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.876 -0.515 . . . . 0.0 109.618 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -63.77 -51.67 63.79 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.195 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.0 m -58.47 -39.96 81.4 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 120.325 1.42 . . . . 0.0 111.317 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.577 ' O ' HG23 ' A' ' 106' ' ' VAL . 10.3 tp -64.67 -55.48 19.87 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 119.016 0.825 . . . . 0.0 110.072 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -59.65 -46.98 87.38 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -57.58 -44.23 85.21 Favored 'General case' 0 C--O 1.225 -0.204 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.73 -53.39 46.62 Favored Glycine 0 N--CA 1.438 -1.228 0 CA-C-O 118.473 -1.181 . . . . 0.0 111.11 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 102' ' ' LEU . 5.0 t -55.19 -52.96 39.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 119.132 1.466 . . . . 0.0 111.142 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -33.76 76.19 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 118.816 -0.612 . . . . 0.0 111.274 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.0 m -70.04 -45.83 66.33 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.463 HD11 HD12 ' A' ' 183' ' ' ILE . 32.9 mt -56.27 -54.67 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 123.94 0.896 . . . . 0.0 109.814 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.76 -39.64 92.34 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 123.614 0.571 . . . . 0.0 110.266 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -62.86 -44.48 95.99 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.166 0.894 . . . . 0.0 110.526 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -20.32 62.29 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 118.266 -0.873 . . . . 0.0 112.765 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.8 mt -98.77 -28.85 13.31 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 120.34 1.427 . . . . 0.0 111.651 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -59.35 -37.43 77.83 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.91 0.484 . . . . 0.0 110.618 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -64.03 -46.76 83.02 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -156.94 148.32 22.22 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.013 0.925 . . . . 0.0 110.245 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 85.7 m -75.26 174.48 9.45 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 41.4 pt -130.71 148.6 33.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 123.476 0.71 . . . . 0.0 110.074 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.54 168.23 20.26 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.218 0.607 . . . . 0.0 110.038 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -151.43 129.59 11.91 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.906 1.682 . . . . 0.0 109.67 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -95.0 102.33 14.13 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.53 67.41 2.86 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 126.573 1.949 . . . . 0.0 109.384 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.15 -116.85 5.69 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 124.5 1.048 . . . . 0.0 110.803 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -70.2 -30.62 67.77 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.144 0.978 . . . . 0.0 111.443 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -107.33 160.39 15.65 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.865 0.841 . . . . 0.0 110.051 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.6 mt -125.86 151.66 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.432 ' CD1' HG11 ' A' ' 221' ' ' VAL . 40.4 m-85 -123.18 131.56 53.73 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 126.456 1.902 . . . . 0.0 106.749 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -126.35 131.54 51.78 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.849 1.659 . . . . 0.0 108.325 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -128.52 123.65 34.06 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.952 1.301 . . . . 0.0 109.869 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 4.6 m -109.91 160.35 28.43 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.236 1.414 . . . . 0.0 113.718 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.96 90.41 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.13 3.22 . . . . 0.0 113.324 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 59.19 52.07 55.45 Favored Glycine 0 CA--C 1.519 0.34 0 O-C-N 120.957 -1.089 . . . . 0.0 111.743 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.6 mt -127.31 -67.17 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.09 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.411 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 8.7 pt-20 -173.09 167.31 4.94 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 126.13 1.772 . . . . 0.0 109.281 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.22 117.24 24.13 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.0 m -130.57 156.19 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 124.386 1.074 . . . . 0.0 112.706 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -124.79 135.46 52.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 177.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -146.45 157.41 43.75 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.079 0.952 . . . . 0.0 113.35 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 33.5 t60 -88.79 119.72 29.54 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 103.581 -2.748 . . . . 0.0 103.581 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -165.25 -163.14 17.9 Favored Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 111.666 -0.573 . . . . 0.0 111.666 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.3 154.31 51.58 Favored 'General case' 0 CA--C 1.526 0.039 0 C-N-CA 123.505 0.722 . . . . 0.0 109.486 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.4 t -128.59 154.36 39.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 124.087 0.955 . . . . 0.0 110.716 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -102.41 93.83 5.37 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 127.6 2.36 . . . . 0.0 105.851 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.2 t -48.75 -27.38 2.91 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.953 1.301 . . . . 0.0 113.875 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -55.89 -26.57 47.93 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.4 t -146.47 -18.21 0.43 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.682 0.674 . . . . 0.0 111.621 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 97.87 3.72 58.04 Favored Glycine 0 C--O 1.22 -0.729 0 C-N-CA 124.998 1.285 . . . . 0.0 111.738 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -64.21 147.81 51.52 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.018 1.409 . . . . 0.0 110.363 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 23.4 mt -87.45 158.75 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 84.5 t -103.44 143.24 15.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 124.565 1.146 . . . . 0.0 107.939 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -58.0 110.35 0.91 Allowed 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -137.06 164.63 27.95 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.42 1.088 . . . . 0.0 110.272 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.65 137.54 58.17 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.038 1.735 . . . . 0.0 109.866 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -95.59 15.06 20.88 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.881 2.073 . . . . 0.0 113.196 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.22 -10.17 58.73 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 120.224 -1.547 . . . . 0.0 112.553 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 89.9 mt -120.62 72.7 0.97 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.767 1.627 . . . . 0.0 106.636 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.3 t -137.17 143.83 33.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 125.745 1.618 . . . . 0.0 106.788 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -140.44 162.63 34.88 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.907 0.883 . . . . 0.0 111.56 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.3 ptp85 -108.34 143.21 37.54 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.926 1.291 . . . . 0.0 110.076 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.3 mp -120.03 -70.2 0.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.375 1.47 . . . . 0.0 107.788 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -132.6 152.98 20.43 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 123.547 0.594 . . . . 0.0 112.589 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -124.43 91.07 50.05 Favored Pre-proline 0 N--CA 1.452 -0.352 0 C-N-CA 126.028 1.731 . . . . 0.0 109.434 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 97.2 Cg_endo -73.55 177.22 8.27 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.014 2.476 . . . . 0.0 111.37 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -91.09 169.13 11.11 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -82.48 -42.67 18.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.948 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -93.27 149.76 20.99 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 122.969 0.508 . . . . 0.0 110.065 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.2 p -69.79 -20.05 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 123.33 0.652 . . . . 0.0 112.45 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -88.96 -20.0 25.03 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.661 1.184 . . . . 0.0 111.656 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -77.34 -19.31 56.51 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.094 0.558 . . . . 0.0 109.793 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -103.56 171.11 7.55 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.15 1.38 . . . . 0.0 109.788 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -137.81 134.6 35.38 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.89 1.276 . . . . 0.0 107.788 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.497 ' CD2' HG22 ' A' ' 106' ' ' VAL . 4.4 m-30 -115.5 164.59 14.08 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.959 1.304 . . . . 0.0 110.672 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -131.67 122.03 25.28 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 124.621 1.168 . . . . 0.0 112.0 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 15.7 tp -85.76 104.34 15.36 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.426 HD12 ' HB2' ' A' ' 184' ' ' SER . 38.8 mt -114.49 177.03 4.79 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 122.139 0.971 . . . . 0.0 110.939 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -156.76 155.67 32.0 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.037 1.335 . . . . 0.0 107.463 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -138.59 -177.15 4.73 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -49.25 -31.33 8.59 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.079 1.352 . . . . 0.0 113.218 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 89.8 t -74.28 -74.37 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -166.53 -162.34 17.81 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.585 ' CZ ' HD22 ' A' ' 243' ' ' LEU . 3.7 m-85 -78.31 161.87 26.91 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.293 0.637 . . . . 0.0 112.06 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -163.15 175.25 11.2 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.854 2.062 . . . . 0.0 108.302 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.463 HD12 HD11 ' A' ' 109' ' ' ILE . 7.2 mt -127.01 121.51 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.426 ' HB2' HD12 ' A' ' 175' ' ' LEU . 39.9 t -91.35 137.81 32.07 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -139.18 120.51 14.87 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.8 tt -114.72 139.81 38.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.3 mt -133.51 112.53 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 123.4 0.68 . . . . 0.0 112.284 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -105.78 -167.69 23.42 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 124.604 1.097 . . . . 0.0 110.956 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.5 t 80.69 47.27 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.307 1.843 . . . . 0.0 110.39 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -97.76 -112.02 3.02 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 105.645 -2.982 . . . . 0.0 105.645 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -141.36 122.61 14.81 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 104.265 -2.494 . . . . 0.0 104.265 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.5 mm -60.17 134.38 25.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 98.8 m -81.58 100.81 9.59 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.98 -19.27 51.35 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.33 0.652 . . . . 0.0 111.325 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.32 -30.24 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 126.141 1.776 . . . . 0.0 110.767 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.3 p -125.01 -36.2 2.57 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 119.601 1.091 . . . . 0.0 112.416 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 96.54 33.81 6.03 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.084 1.326 . . . . 0.0 110.581 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -124.95 171.05 10.51 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.376 1.47 . . . . 0.0 112.058 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -89.1 141.85 28.15 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.558 0.743 . . . . 0.0 112.006 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.17 29.14 0.22 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 128.455 2.702 . . . . 0.0 110.764 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -73.52 142.38 46.73 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 122.282 1.039 . . . . 0.0 109.489 -176.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -104.81 149.58 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 CA-C-N 113.399 -1.728 . . . . 0.0 111.417 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -118.2 124.96 49.2 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.2 mp -115.86 129.86 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 125.806 1.642 . . . . 0.0 106.638 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -114.57 108.97 17.55 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -85.27 119.49 25.7 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.593 0.757 . . . . 0.0 110.602 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 32.0 m -131.43 171.57 17.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 C-N-CA 125.026 1.33 . . . . 0.0 111.796 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.37 133.55 39.91 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -89.7 149.13 20.31 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 123.557 0.599 . . . . 0.0 111.811 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -60.67 -45.02 97.18 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 47.1 t -87.21 98.58 11.4 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -72.21 8.04 1.48 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.385 0.674 . . . . 0.0 109.381 177.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 60.2 m -130.84 38.44 3.69 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.241 1.817 . . . . 0.0 113.267 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.2 165.7 28.16 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 121.475 -0.766 . . . . 0.0 112.161 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.66 168.24 20.57 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.969 2.446 . . . . 0.0 112.492 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 81.0 p -77.26 150.0 35.37 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.78 162.73 23.98 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.174 1.39 . . . . 0.0 107.446 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.1 mp -76.68 141.77 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -84.63 -59.65 2.3 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 -141.58 166.56 24.42 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.171 1.388 . . . . 0.0 108.484 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.729 HG13 ' CE1' ' A' ' 229' ' ' TYR . 47.7 t -145.84 136.39 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 C-N-CA 126.142 1.777 . . . . 0.0 106.391 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.46 121.09 3.71 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.375 0.607 . . . . 0.0 109.862 177.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -81.05 88.14 5.98 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 14.7 p -58.02 -56.8 17.36 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.587 1.555 . . . . 0.0 112.095 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt -99.76 -172.55 2.26 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.239 -1.764 . . . . 0.0 106.239 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 31.2 mm -75.5 -35.22 31.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 O-C-N 121.081 -1.012 . . . . 0.0 109.392 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.98 -54.05 2.54 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.912 0.885 . . . . 0.0 110.861 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 29.2 t -62.56 137.44 24.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 121.41 0.624 . . . . 0.0 109.391 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . 0.729 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.4 OUTLIER -133.08 139.92 47.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.147 1.779 . . . . 0.0 107.048 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -120.6 140.52 51.41 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 125.409 1.484 . . . . 0.0 108.945 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.84 161.41 39.36 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 126.132 1.773 . . . . 0.0 109.745 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -133.02 146.11 51.44 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 99.0 t -131.65 134.14 60.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 124.68 1.192 . . . . 0.0 108.376 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.08 142.06 35.13 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.624 0.77 . . . . 0.0 109.812 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 61.7 mt -139.72 135.68 16.92 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.73 -41.84 0.68 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.881 1.721 . . . . 0.0 112.367 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -62.99 -20.46 65.31 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 16.2 mt -68.52 -33.04 73.42 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 118.174 -0.917 . . . . 0.0 109.882 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 21.0 m -62.88 -13.4 33.64 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -70.37 -36.71 74.32 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.827 0.822 . . . . 0.0 109.152 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 24.0 mt -70.52 114.02 8.21 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -48.16 -33.77 8.91 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.585 HD22 ' CZ ' ' A' ' 181' ' ' TYR . 16.6 mt -61.49 -37.05 82.25 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.257 -0.902 . . . . 0.0 109.817 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 13.0 mt -95.74 9.69 39.55 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 127.505 2.322 . . . . 0.0 113.491 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -77.21 41.4 0.3 Allowed 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.564 -0.71 . . . . 0.0 110.457 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -150.38 130.53 13.57 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.158 1.383 . . . . 0.0 110.206 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -172.54 -179.41 2.18 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.944 2.898 . . . . 0.0 106.716 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 62.24 7.68 2.35 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.029 2.131 . . . . 0.0 114.105 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 7.9 t70 . . . . . 0 C--O 1.25 1.12 0 C-N-CA 124.645 1.178 . . . . 0.0 112.613 -179.255 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.588 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -130.04 -169.09 2.06 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.603 1.161 . . . . 0.0 110.384 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.5 t -153.81 -160.11 1.06 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.853 1.261 . . . . 0.0 108.512 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -62.54 118.95 8.28 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.962 1.305 . . . . 0.0 108.619 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.8 m -46.02 -51.67 13.21 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.041 1.737 . . . . 0.0 114.039 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -58.56 -50.31 74.27 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 122.334 0.254 . . . . 0.0 110.393 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -58.78 -47.72 83.72 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 118.092 -0.956 . . . . 0.0 110.387 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p -60.12 -43.78 95.39 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 119.944 1.247 . . . . 0.0 111.875 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.88 -49.55 75.77 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.584 0.707 . . . . 0.0 109.516 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 62.3 tp -55.15 -43.63 74.38 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 125.3 1.44 . . . . 0.0 109.666 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.2 mt -62.52 -53.67 51.23 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.553 1.07 . . . . 0.0 109.506 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 85.2 m -54.36 -52.7 60.8 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.013 0.525 . . . . 0.0 109.826 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -61.9 -42.14 98.72 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 118.488 -0.768 . . . . 0.0 110.801 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.1 m -55.8 -47.8 76.5 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 119.318 0.963 . . . . 0.0 109.771 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 26.6 tp -59.28 -55.8 30.28 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 118.373 0.533 . . . . 0.0 109.765 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -51.21 -52.42 44.65 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 124.778 1.231 . . . . 0.0 110.997 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -55.83 -44.59 78.08 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 125.088 1.355 . . . . 0.0 109.711 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.62 -53.24 39.86 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 125.117 1.341 . . . . 0.0 111.785 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 59.1 t -55.25 -52.92 40.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 119.018 1.409 . . . . 0.0 110.998 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -31.07 72.01 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 118.51 0.596 . . . . 0.0 110.703 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.2 m -69.05 -42.62 76.05 Favored 'General case' 0 CA--C 1.523 -0.093 0 CA-C-N 118.682 0.674 . . . . 0.0 109.403 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.473 HD11 HD12 ' A' ' 183' ' ' ILE . 34.1 mt -58.09 -51.16 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 107.103 -1.444 . . . . 0.0 107.103 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.88 -40.03 94.0 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 118.762 -0.637 . . . . 0.0 111.095 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -59.32 -47.48 85.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.875 0.762 . . . . 0.0 109.375 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -73.51 -19.3 60.96 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.6 mt -102.67 -28.29 12.21 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 119.901 1.228 . . . . 0.0 112.124 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -58.03 -32.46 67.99 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -65.84 -45.58 81.69 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 119.036 -0.507 . . . . 0.0 110.504 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -158.4 156.38 30.34 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.662 1.119 . . . . 0.0 111.203 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 59.9 m -76.09 176.04 8.36 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 34.0 pt -135.7 155.49 36.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.49 163.3 38.18 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.126 0.488 . . . . 0.0 112.137 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -150.92 129.01 11.83 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.22 1.408 . . . . 0.0 110.638 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -92.23 107.6 19.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.57 73.09 3.73 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.627 1.571 . . . . 0.0 107.545 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.59 -115.43 5.93 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -74.15 -27.22 60.74 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.322 1.049 . . . . 0.0 112.638 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -107.13 157.6 17.73 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 118.718 0.69 . . . . 0.0 110.299 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 58.7 mt -123.99 149.41 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.467 ' CD1' HG11 ' A' ' 221' ' ' VAL . 55.5 m-85 -126.15 129.3 48.77 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.219 2.208 . . . . 0.0 107.424 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -127.03 130.96 50.99 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.722 1.609 . . . . 0.0 107.644 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -122.3 115.44 22.34 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.814 1.246 . . . . 0.0 108.594 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 15.6 m -105.02 154.86 38.41 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 123.48 0.712 . . . . 0.0 110.588 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -61.05 90.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.589 1 C-N-CA 125.887 4.391 . . . . 0.0 116.091 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 60.05 33.96 81.58 Favored Glycine 0 CA--C 1.528 0.853 0 O-C-N 121.682 -0.636 . . . . 0.0 112.323 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.0 mt -111.23 -66.36 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.448 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 5.3 pt-20 -180.0 162.52 1.01 Allowed 'General case' 0 C--O 1.24 0.586 0 C-N-CA 126.468 1.907 . . . . 0.0 108.901 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -115.52 122.29 45.26 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 102.544 -3.132 . . . . 0.0 102.544 178.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.4 m -130.32 156.17 42.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 123.358 0.663 . . . . 0.0 111.228 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -125.62 126.43 44.73 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -146.33 158.95 43.94 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.435 1.094 . . . . 0.0 112.435 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -88.39 154.64 20.22 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 177.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 166.0 -163.97 37.15 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -127.82 144.32 51.09 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.624 1.97 . . . . 0.0 106.7 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.9 p -155.16 148.2 12.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -97.13 91.05 5.37 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 103.564 -2.754 . . . . 0.0 103.564 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.9 t -51.2 -27.37 8.73 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -52.17 -28.45 18.18 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.553 1.541 . . . . 0.0 113.138 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.403 HG23 ' H ' ' A' ' 148' ' ' GLU . 1.8 t -131.49 -28.02 1.9 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.265 1.426 . . . . 0.0 109.499 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 98.56 7.55 55.6 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 126.095 1.807 . . . . 0.0 109.427 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.403 ' H ' HG23 ' A' ' 146' ' ' THR . 18.4 mt-10 -65.54 113.57 4.28 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 119.067 1.433 . . . . 0.0 110.849 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 74.6 mt -73.53 138.06 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 103.167 -2.901 . . . . 0.0 103.167 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 78.2 t -93.82 162.87 2.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 125.008 1.323 . . . . 0.0 107.644 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -52.63 122.19 8.53 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.73 -175.47 3.97 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.248 0.619 . . . . 0.0 112.083 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -106.31 129.87 54.25 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -88.72 24.16 2.09 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.696 1.198 . . . . 0.0 111.093 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -81.54 -14.34 56.99 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 121.304 -0.873 . . . . 0.0 111.271 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 83.7 mt -124.2 82.27 2.01 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.776 1.631 . . . . 0.0 107.619 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 39.6 t -136.78 143.14 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.384 1.074 . . . . 0.0 108.568 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -143.59 147.36 34.28 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.191 1.397 . . . . 0.0 111.714 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.92 123.63 40.68 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 124.809 1.244 . . . . 0.0 108.073 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.5 mp -95.28 -72.47 0.62 Allowed 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -125.76 148.14 16.87 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -128.44 91.97 42.33 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 42.5 Cg_endo -77.01 176.57 9.97 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.615 2.877 . . . . 0.0 110.698 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -83.76 167.73 16.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.177 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.43 -33.62 23.65 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.488 1.115 . . . . 0.0 112.001 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -90.9 142.2 28.02 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 126.402 1.881 . . . . 0.0 106.258 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.3 p -72.96 -28.35 26.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 118.224 0.465 . . . . 0.0 110.078 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -73.1 0.51 11.34 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 127.479 2.311 . . . . 0.0 113.059 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -114.76 -13.12 12.06 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.329 1.852 . . . . 0.0 110.227 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 36.1 mmm-85 -77.25 163.68 26.29 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.824 1.25 . . . . 0.0 108.358 177.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -131.03 95.89 3.92 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.301 0.572 . . . . 0.0 110.134 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -108.53 148.94 29.53 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 125.774 1.629 . . . . 0.0 108.279 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -138.37 134.92 34.79 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.358 1.063 . . . . 0.0 109.791 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.95 98.51 10.41 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.29 1.036 . . . . 0.0 109.515 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.433 HD12 ' HB2' ' A' ' 184' ' ' SER . 35.4 mt -103.77 172.01 7.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.761 0.791 . . . . 0.0 110.195 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -157.37 157.09 33.43 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.246 -0.909 . . . . 0.0 109.503 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -138.83 -179.23 5.71 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -56.79 -11.75 1.56 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.788 2.035 . . . . 0.0 113.026 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 54.8 t -94.07 -67.07 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 126.484 1.914 . . . . 0.0 107.873 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -169.63 -174.11 37.69 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -81.05 158.76 24.98 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 114.606 -0.797 . . . . 0.0 109.044 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -162.61 176.55 10.26 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.546 1.538 . . . . 0.0 108.469 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.473 HD12 HD11 ' A' ' 109' ' ' ILE . 14.3 mt -123.93 133.75 68.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.433 ' HB2' HD12 ' A' ' 175' ' ' LEU . 32.3 t -109.19 122.49 47.42 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -125.58 112.93 16.76 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.9 tt -100.86 130.93 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 11.0 mt -123.36 109.7 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.088 1.355 . . . . 0.0 109.053 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -104.36 -153.04 22.59 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 107.559 -2.217 . . . . 0.0 107.559 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.3 m 74.43 46.07 0.17 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.34 1.456 . . . . 0.0 109.444 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -111.95 -126.95 4.84 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -130.42 124.91 33.18 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.441 1.096 . . . . 0.0 110.986 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 46.1 mm -61.08 137.28 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.82 0.848 . . . . 0.0 112.296 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 74.1 m -94.66 95.36 8.7 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 102.866 -3.013 . . . . 0.0 102.866 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -55.07 -17.79 4.47 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.888 1.275 . . . . 0.0 113.537 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 73.4 t -59.73 -38.18 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 124.878 1.271 . . . . 0.0 109.567 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 20.9 p -125.32 -15.9 6.07 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 78.52 32.94 40.36 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -103.48 159.9 15.19 Favored 'General case' 0 CA--C 1.52 -0.189 0 O-C-N 121.435 -1.038 . . . . 0.0 110.651 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -91.71 142.4 27.64 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.903 1.281 . . . . 0.0 107.725 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -73.46 28.96 0.07 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 127.854 2.461 . . . . 0.0 111.82 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.3 ptt? -73.2 141.0 47.35 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 122.58 1.181 . . . . 0.0 110.04 -175.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 1.5 p -113.06 144.35 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.33 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -112.26 125.25 53.96 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.6 mp -109.67 119.11 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -102.38 106.39 17.14 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -85.36 115.17 22.95 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.37 1.068 . . . . 0.0 110.46 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.8 m -127.93 172.83 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 126.14 1.776 . . . . 0.0 112.277 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.3 t -85.5 133.09 34.1 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.445 1.498 . . . . 0.0 107.313 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -89.67 161.86 29.94 Favored Glycine 0 N--CA 1.47 0.95 0 CA-C-N 119.555 1.071 . . . . 0.0 112.032 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -47.22 -79.61 0.07 OUTLIER Glycine 0 C--N 1.341 0.824 0 C-N-CA 126.315 1.912 . . . . 0.0 110.997 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 25.3 m -70.42 126.3 29.24 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -98.28 35.98 1.68 Allowed 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 8.6 m -143.24 33.19 1.34 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -129.52 179.15 16.95 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 120.361 1.437 . . . . 0.0 113.122 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -75.09 170.06 21.22 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.949 2.432 . . . . 0.0 109.273 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 98.3 p -81.72 156.36 25.04 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.853 -0.529 . . . . 0.0 109.692 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.85 164.69 7.85 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 126.143 1.777 . . . . 0.0 109.276 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.9 mt -79.75 136.09 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.164 1.386 . . . . 0.0 107.37 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -81.21 -54.84 5.16 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 124.574 1.15 . . . . 0.0 109.753 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 19.0 p-90 -148.59 166.54 27.96 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 124.794 1.237 . . . . 0.0 108.761 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.76 HG13 ' CE1' ' A' ' 229' ' ' TYR . 45.3 t -145.28 126.58 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.01 122.05 10.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -75.02 97.92 3.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 2.1 p -66.14 -51.79 54.52 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 118.311 -0.852 . . . . 0.0 111.715 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -120.72 179.11 4.45 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.437 0.695 . . . . 0.0 109.781 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.548 ' H ' HD12 ' A' ' 226' ' ' ILE . 3.8 mp -55.19 -37.82 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 C-N-CA 125.908 1.683 . . . . 0.0 110.666 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.75 -21.04 5.29 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 56.4 t -85.21 124.51 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . 0.76 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.6 OUTLIER -123.68 142.9 50.63 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 179.398 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -129.79 139.95 51.15 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -138.83 160.85 38.69 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.086 1.354 . . . . 0.0 109.505 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -127.28 143.71 51.18 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.0 t -128.53 143.75 40.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 125.084 1.354 . . . . 0.0 107.683 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.45 134.13 55.32 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 124.29 1.036 . . . . 0.0 110.408 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 93.9 mt -136.72 138.36 26.08 Favored Pre-proline 0 C--O 1.236 0.355 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.638 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.08 -43.29 0.25 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.312 2.008 . . . . 0.0 111.944 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -57.32 -26.82 61.52 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.794 0.837 . . . . 0.0 111.278 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 16.9 mt -66.17 -38.72 88.74 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 120.947 -1.096 . . . . 0.0 110.189 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 42.8 m -55.21 -21.85 15.53 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.6 1.56 . . . . 0.0 113.921 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -64.98 -34.44 78.43 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 123.393 0.677 . . . . 0.0 111.192 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 29.9 mt -71.95 117.27 13.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -48.67 -36.11 15.34 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.82 -36.17 78.37 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.527 -0.733 . . . . 0.0 110.254 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -97.84 3.58 49.83 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.389 1.875 . . . . 0.0 113.271 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -79.02 47.64 0.79 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -157.78 144.34 17.8 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 127.811 2.444 . . . . 0.0 107.35 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -171.35 159.45 5.72 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 128.768 2.827 . . . . 0.0 105.88 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.6 68.55 1.28 Allowed 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.4 t70 . . . . . 0 C--O 1.25 1.13 0 CA-C-N 113.856 -1.52 . . . . 0.0 108.806 179.38 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.919 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -151.97 150.21 29.76 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.6 p -165.96 166.78 17.17 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.429 1.092 . . . . 0.0 108.947 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -111.63 175.85 5.26 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.219 1.408 . . . . 0.0 110.702 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.5 m -72.88 -45.85 56.03 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.875 1.27 . . . . 0.0 114.109 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -57.83 -34.59 69.85 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.816 0.735 . . . . 0.0 110.784 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -59.13 -47.43 85.31 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.9 m -65.92 -35.68 81.29 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.34 -48.31 82.12 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 119.633 1.106 . . . . 0.0 108.409 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 58.9 tp -56.97 -44.83 83.04 Favored 'General case' 0 C--N 1.343 0.322 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.1 mt -61.4 -50.52 72.52 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.955 0.798 . . . . 0.0 110.577 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 54.9 m -54.97 -52.44 63.06 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.815 1.246 . . . . 0.0 110.669 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -63.96 -42.78 97.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.575 0.75 . . . . 0.0 110.62 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.2 m -54.1 -49.14 69.78 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.155 0.982 . . . . 0.0 109.007 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 41.1 tp -57.38 -54.24 49.09 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.929 0.331 . . . . 0.0 110.72 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -52.65 -50.99 62.08 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 124.428 1.091 . . . . 0.0 111.654 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -56.11 -52.2 65.18 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.393 1.077 . . . . 0.0 108.604 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -55.29 -51.04 56.97 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 96.4 t -57.2 -52.79 51.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 C-N-CA 125.206 1.402 . . . . 0.0 111.809 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -32.3 73.57 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 119.289 0.95 . . . . 0.0 110.313 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.1 m -66.3 -42.02 88.89 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 34.0 mt -61.49 -50.72 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.51 -40.92 72.4 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 117.9 -1.048 . . . . 0.0 110.809 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -62.61 -55.01 31.01 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.305 1.042 . . . . 0.0 110.436 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -62.7 -25.92 68.4 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 11.0 mp -98.07 -26.99 14.42 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.543 1.52 . . . . 0.0 110.848 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -53.88 -29.54 41.97 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.184 0.994 . . . . 0.0 111.233 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -74.49 -46.83 36.97 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 117.965 0.348 . . . . 0.0 110.709 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.2 mmt85 -157.03 151.46 25.33 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.201 -0.937 . . . . 0.0 111.819 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 51.5 m -76.43 160.55 29.44 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 32.8 pt -118.1 152.83 20.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 124.889 1.275 . . . . 0.0 108.592 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -146.16 168.87 19.94 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 122.853 0.461 . . . . 0.0 111.909 -178.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -154.51 127.69 8.37 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.572 1.549 . . . . 0.0 111.286 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -91.52 104.37 16.88 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.52 66.77 5.46 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.424 1.489 . . . . 0.0 107.034 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 66.84 -115.96 7.76 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -66.12 -34.03 77.13 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -107.32 152.76 23.71 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 119.165 0.893 . . . . 0.0 110.247 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.7 mt -121.16 151.97 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -126.93 136.72 52.68 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.714 1.605 . . . . 0.0 108.202 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -131.38 132.45 44.41 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.542 1.537 . . . . 0.0 108.955 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -126.04 117.27 22.87 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.607 1.163 . . . . 0.0 109.737 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 21.9 m -104.22 158.17 32.49 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 124.197 0.999 . . . . 0.0 111.502 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -63.67 84.91 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.621 1 C-N-CA 125.413 4.076 . . . . 0.0 116.101 -178.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.41 29.02 74.24 Favored Glycine 0 CA--C 1.529 0.938 0 O-C-N 121.394 -0.816 . . . . 0.0 111.542 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.1 mt -106.77 -67.25 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.415 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 7.8 pt-20 -172.56 165.31 5.58 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.713 1.205 . . . . 0.0 108.954 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.23 119.87 30.59 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 103.7 -2.704 . . . . 0.0 103.7 177.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.43 156.63 42.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 124.53 1.132 . . . . 0.0 112.02 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -123.81 133.67 53.76 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -146.11 158.25 43.87 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.71 1.204 . . . . 0.0 111.629 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 50.3 t60 -87.94 154.86 20.18 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 157.9 -162.19 31.98 Favored Glycine 0 C--N 1.333 0.409 0 O-C-N 121.21 -0.931 . . . . 0.0 111.28 -178.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.61 145.9 49.07 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 54.2 t -128.95 153.82 39.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 124.971 1.308 . . . . 0.0 108.3 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -106.99 94.96 5.38 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.8 t -54.72 -12.68 0.82 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 120.154 1.343 . . . . 0.0 112.169 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -55.72 -30.5 61.27 Favored 'General case' 0 C--N 1.344 0.363 0 O-C-N 120.79 -1.194 . . . . 0.0 110.296 177.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.86 -43.31 0.23 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.308 1.443 . . . . 0.0 108.712 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 121.01 11.21 6.42 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 126.329 1.919 . . . . 0.0 110.985 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -64.99 127.56 32.09 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 118.924 1.362 . . . . 0.0 110.17 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 26.2 mt -73.92 128.31 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.17 -74.18 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.39 117.42 24.3 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 125.946 1.698 . . . . 0.0 107.646 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.26 37.09 4.2 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.839 1.256 . . . . 0.0 111.435 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -61.55 133.14 55.34 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.206 2.202 . . . . 0.0 111.4 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -75.19 6.14 4.67 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 t -85.15 -16.88 38.97 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.24 1.382 . . . . 0.0 113.332 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 84.5 mt -133.06 79.63 1.85 Allowed 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 119.7 1.137 . . . . 0.0 109.735 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.78 147.14 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -142.41 153.04 43.4 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.717 1.207 . . . . 0.0 110.538 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 37.5 mtm105 -101.1 126.32 47.78 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 22.7 mt -101.68 -62.4 1.26 Allowed 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -134.15 153.49 20.97 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.441 ' HB3' ' HB3' ' A' ' 189' ' ' SER . 0.9 OUTLIER -129.22 86.25 57.26 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 126.872 2.069 . . . . 0.0 109.239 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.437 ' HD3' HG21 ' A' ' 187' ' ' ILE . 41.5 Cg_endo -80.47 176.7 8.9 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 123.672 2.915 . . . . 0.0 110.788 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.2 mmmt -92.64 156.45 17.07 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.49 -25.03 41.92 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.015 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -107.29 126.89 53.01 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.58 1.152 . . . . 0.0 108.042 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.4 p -52.9 -34.23 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.834 1.254 . . . . 0.0 111.195 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.428 ' HG3' ' H ' ' A' ' 168' ' ' GLU . 14.1 mt-10 -61.09 -18.26 56.98 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 129.722 3.209 . . . . 0.0 113.521 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -112.32 -4.08 14.39 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.024 1.73 . . . . 0.0 111.736 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 61.2 mtp180 -91.3 176.87 6.42 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.821 0.82 . . . . 0.0 109.777 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -142.68 134.76 27.27 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -144.0 150.07 37.7 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.782 1.633 . . . . 0.0 107.864 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -133.11 131.73 40.87 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.643 1.177 . . . . 0.0 108.5 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 28.1 tp -86.2 99.65 11.68 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 44.0 mt -101.19 175.04 5.72 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.166 0.986 . . . . 0.0 109.613 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.425 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 5.7 p90 -155.93 156.6 34.85 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.866 0.841 . . . . 0.0 109.648 177.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -135.16 -179.73 5.81 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -54.18 -32.09 54.6 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 125.598 1.559 . . . . 0.0 112.298 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 58.2 t -73.9 -59.06 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.222 1.009 . . . . 0.0 109.13 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -178.96 -168.7 38.5 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 124.552 1.072 . . . . 0.0 111.726 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.425 ' CD2' ' HB3' ' A' ' 176' ' ' TYR . 24.4 m-85 -83.35 161.25 21.45 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.681 1.193 . . . . 0.0 112.36 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -168.03 168.97 11.58 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.78 2.032 . . . . 0.0 109.026 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 15.9 mt -114.28 138.37 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.0 t -111.25 123.54 50.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.902 1.281 . . . . 0.0 108.102 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.4 109.94 11.49 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 177.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 2.3 tt -100.82 126.09 54.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.437 HG21 ' HD3' ' A' ' 163' ' ' PRO . 7.2 mt -116.44 112.37 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.144 0.978 . . . . 0.0 110.989 -177.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -108.57 -161.27 20.26 Favored Glycine 0 CA--C 1.522 0.492 0 C-N-CA 124.784 1.183 . . . . 0.0 111.126 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.441 ' HB3' ' HB3' ' A' ' 162' ' ' LYS . 0.4 OUTLIER 74.44 31.86 0.99 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.411 1.485 . . . . 0.0 110.386 -179.265 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -87.97 -102.18 0.91 Allowed Glycine 0 C--N 1.336 0.548 1 N-CA-C 102.788 -4.125 . . . . 0.0 102.788 177.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -145.88 160.54 41.66 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 24.2 mm -92.49 132.71 36.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 125.026 1.33 . . . . 0.0 109.141 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 59.3 m -88.4 93.86 9.67 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 100.329 -3.952 . . . . 0.0 100.329 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -53.42 -24.45 12.6 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -177.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -51.11 -34.32 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 125.99 1.716 . . . . 0.0 111.334 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.1 p -126.08 -25.63 3.53 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.879 0.872 . . . . 0.0 112.36 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 92.57 19.5 37.7 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.803 1.192 . . . . 0.0 111.722 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -95.79 165.18 12.42 Favored 'General case' 0 N--CA 1.454 -0.225 0 O-C-N 121.269 -1.136 . . . . 0.0 110.285 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -96.25 147.22 24.0 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.812 0.845 . . . . 0.0 109.163 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -75.56 28.3 0.1 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.971 2.108 . . . . 0.0 110.286 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.9 ptm -72.62 146.19 46.8 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.507 1.146 . . . . 0.0 108.299 -176.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.3 p -120.1 140.03 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 113.901 -1.5 . . . . 0.0 112.549 -176.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -105.13 131.74 52.23 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.1 mp -115.91 113.98 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -97.31 109.08 21.91 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -85.53 118.05 24.81 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.54 0.736 . . . . 0.0 109.585 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.79 172.89 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 125.732 1.613 . . . . 0.0 112.184 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.6 t -86.38 136.58 33.07 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.108 1.763 . . . . 0.0 108.405 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.93 158.05 32.88 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -63.52 -68.29 1.72 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 108.266 -1.934 . . . . 0.0 108.266 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 17.0 p -81.6 91.5 6.4 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 104.084 -2.561 . . . . 0.0 104.084 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -72.51 37.44 0.07 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.753 2.421 . . . . 0.0 113.487 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.4 m -138.22 46.12 2.06 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 115.097 1.518 . . . . 0.0 115.097 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -156.9 175.08 34.51 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -71.66 165.65 31.86 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.071 1.847 . . . . 0.0 110.733 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 52.0 p -72.93 153.89 40.78 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.338 1.055 . . . . 0.0 110.519 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -169.27 160.71 9.71 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.261 1.424 . . . . 0.0 108.652 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.8 127.83 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -72.24 -60.95 1.97 Allowed 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.868 1.667 . . . . 0.0 109.8 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . 0.412 ' CE3' ' HD2' ' A' ' 222' ' ' ARG . 40.7 p-90 -143.03 168.46 19.66 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.859 2.064 . . . . 0.0 109.091 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.603 HG13 ' CE1' ' A' ' 229' ' ' TYR . 55.9 t -144.2 145.3 21.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 126.283 1.833 . . . . 0.0 106.42 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.412 ' HD2' ' CE3' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -164.34 118.8 1.44 Allowed 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.143 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -75.64 92.2 2.93 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 102.285 -3.228 . . . . 0.0 102.285 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 4.8 p -56.09 -55.2 35.83 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.853 1.261 . . . . 0.0 112.408 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -111.59 -172.54 2.06 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.595 ' H ' HD12 ' A' ' 226' ' ' ILE . 3.8 mp -62.23 -38.67 81.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 O-C-N 121.396 -0.815 . . . . 0.0 110.214 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.76 -41.05 3.26 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.877 0.871 . . . . 0.0 112.285 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 10.0 t -64.49 132.25 30.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . 0.603 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.5 OUTLIER -130.82 141.7 50.35 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.335 1.454 . . . . 0.0 107.288 -179.297 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -127.01 141.83 51.69 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.75 161.8 38.34 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.445 1.498 . . . . 0.0 108.854 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -138.95 147.46 42.28 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 123.583 0.753 . . . . 0.0 109.99 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.4 m -132.76 151.65 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.127 0.571 . . . . 0.0 109.487 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.1 p -113.42 131.87 55.85 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 122.802 0.441 . . . . 0.0 109.814 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 85.3 mt -129.63 136.12 28.61 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.34 -40.34 0.85 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.207 1.938 . . . . 0.0 112.639 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -61.45 -26.22 67.74 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.38 0.672 . . . . 0.0 111.721 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 3.8 mp -66.29 -35.17 79.71 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.762 0.71 . . . . 0.0 109.309 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 44.0 m -59.51 -19.63 49.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.725 1.21 . . . . 0.0 113.234 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -62.85 -34.52 77.52 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.567 0.747 . . . . 0.0 110.581 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 47.9 mt -73.1 118.92 16.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.218 1.407 . . . . 0.0 107.654 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -49.91 -39.75 41.0 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.0 mp -59.98 -34.32 73.15 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.191 -0.943 . . . . 0.0 111.19 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.434 ' C ' ' H ' ' A' ' 246' ' ' LYS . 2.5 mm? -101.13 5.54 42.82 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 126.583 1.953 . . . . 0.0 112.495 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -75.58 38.51 0.15 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.946 0.898 . . . . 0.0 109.646 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.434 ' H ' ' C ' ' A' ' 244' ' ' LEU . 42.6 tptt -134.7 129.57 34.96 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 129.429 3.091 . . . . 0.0 105.74 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 39.5 p30 -150.91 167.32 27.92 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.484 1.914 . . . . 0.0 106.53 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -149.15 66.64 1.03 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 . . . . . 0 C--O 1.247 0.93 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.797 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 40.23 36.46 0.33 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 127.1 2.16 . . . . 0.0 114.446 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 73.5 m -94.82 164.57 12.87 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.974 0.91 . . . . 0.0 110.05 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -124.27 177.78 5.69 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.922 1.689 . . . . 0.0 107.291 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.3 m -44.81 -55.15 5.62 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -63.0 -46.56 87.07 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.017 0.437 . . . . 0.0 111.492 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -59.23 -48.87 79.99 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 124.797 1.239 . . . . 0.0 110.677 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.1 p -63.55 -35.87 81.91 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 122.008 -0.433 . . . . 0.0 110.697 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.83 -43.61 92.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 48.6 tp -60.65 -48.36 82.13 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 124.034 0.934 . . . . 0.0 108.607 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.9 mt -58.58 -52.05 67.32 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.209 1.004 . . . . 0.0 110.016 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 97.3 m -56.64 -50.28 72.52 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.292 1.037 . . . . 0.0 110.662 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -64.23 -50.94 66.04 Favored 'General case' 0 C--O 1.224 -0.244 0 O-C-N 121.455 -0.778 . . . . 0.0 110.118 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.4 m -51.97 -43.24 63.47 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.411 1.084 . . . . 0.0 111.026 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.6 tt -58.47 -57.08 14.54 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 119.368 0.986 . . . . 0.0 110.122 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -63.64 -38.02 89.52 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -59.9 -36.03 76.12 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.493 ' HA3' HD11 ' A' ' 183' ' ' ILE . . . -66.93 -51.4 40.2 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.1 t -56.07 -52.97 44.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 118.483 1.142 . . . . 0.0 112.4 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.16 -32.66 68.42 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.907 0.776 . . . . 0.0 111.213 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.1 m -75.63 -46.71 30.02 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 122.845 0.458 . . . . 0.0 110.917 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.589 HD11 HD12 ' A' ' 183' ' ' ILE . 24.8 mt -55.75 -52.42 48.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.07 -41.38 83.26 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 123.778 0.674 . . . . 0.0 110.88 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -62.1 -50.63 71.15 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 118.376 0.534 . . . . 0.0 110.929 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.404 ' HE2' ' OE2' ' A' ' 237' ' ' GLU . 0.7 OUTLIER -67.1 -3.55 7.72 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.058 0.943 . . . . 0.0 113.444 -179.303 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.9 mt -115.22 -28.89 6.78 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.676 1.59 . . . . 0.0 110.075 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -62.18 -26.14 68.17 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.238 0.615 . . . . 0.0 110.612 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.09 -46.89 60.93 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.706 0.802 . . . . 0.0 109.289 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -160.85 147.71 15.29 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 125.703 1.601 . . . . 0.0 108.495 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 67.7 m -75.71 173.21 11.38 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.7 pt -128.61 146.75 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 C-N-CA 123.639 0.775 . . . . 0.0 110.59 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -142.01 162.14 36.22 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.549 0.74 . . . . 0.0 111.057 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -146.9 125.03 12.11 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.441 1.096 . . . . 0.0 109.715 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -87.93 102.35 14.63 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.5 67.04 7.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 66.13 -115.09 7.11 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -63.61 -36.96 85.54 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.099 -0.953 . . . . 0.0 113.146 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -107.31 154.2 21.62 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 120.499 1.5 . . . . 0.0 111.613 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 30.2 mt -118.45 135.23 59.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -110.12 127.61 54.99 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 105.55 -2.018 . . . . 0.0 105.55 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -123.11 119.9 31.66 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.408 1.883 . . . . 0.0 111.718 -177.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -119.87 126.07 50.05 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.034 1.334 . . . . 0.0 110.947 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 3.3 m -111.13 160.84 27.52 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.685 1.594 . . . . 0.0 114.624 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -65.6 87.1 0.21 Allowed 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 124.794 3.663 . . . . 0.0 112.417 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 55.93 56.47 23.8 Favored Glycine 0 C--N 1.331 0.29 0 O-C-N 121.216 -0.927 . . . . 0.0 111.727 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.2 mt -128.05 -66.18 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -178.89 173.56 1.2 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.532 1.933 . . . . 0.0 110.982 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.72 118.74 28.77 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 176.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.43 154.97 41.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.984 0.913 . . . . 0.0 111.016 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -117.87 136.2 53.6 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -146.45 156.44 43.29 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.45 1.1 . . . . 0.0 112.413 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -92.19 147.44 22.93 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 162.9 -163.9 35.58 Favored Glycine 0 C--N 1.336 0.554 0 CA-C-N 120.126 1.33 . . . . 0.0 113.231 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -123.24 135.61 54.34 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.922 1.689 . . . . 0.0 110.095 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.2 p -152.33 151.16 12.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 124.502 1.121 . . . . 0.0 108.726 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -96.1 96.3 8.75 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 125.367 1.467 . . . . 0.0 107.182 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.9 t -55.71 -12.27 1.21 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -73.38 -24.93 60.38 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 120.293 1.406 . . . . 0.0 112.793 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.0 t -135.84 -20.84 1.5 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.104 1.361 . . . . 0.0 110.665 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 90.65 12.97 60.22 Favored Glycine 0 C--O 1.222 -0.6 0 C-N-CA 125.503 1.525 . . . . 0.0 110.461 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -69.69 113.19 6.73 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 118.209 1.004 . . . . 0.0 109.688 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 72.2 mt -74.43 111.29 9.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 58.9 t -65.46 -45.07 93.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 126.575 1.95 . . . . 0.0 110.659 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -145.21 160.9 40.76 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.658 1.183 . . . . 0.0 109.525 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -136.76 155.39 49.89 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.351 1.461 . . . . 0.0 107.287 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -150.31 142.0 23.63 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -95.79 -2.14 48.24 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.7 t -66.29 -43.13 87.21 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.976 1.31 . . . . 0.0 113.423 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 49.1 mt -119.23 89.08 3.06 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.085 0.954 . . . . 0.0 109.417 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.6 t -143.4 129.3 16.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -119.74 157.35 28.77 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 122.871 0.468 . . . . 0.0 112.013 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 26.6 mmm-85 -105.58 129.78 53.76 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.152 1.381 . . . . 0.0 107.907 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.9 mp -110.2 -65.66 1.14 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.516 0.726 . . . . 0.0 110.712 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -125.71 154.06 18.52 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -129.72 96.73 25.89 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.228 1.811 . . . . 0.0 108.913 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -74.35 -170.41 0.73 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.638 2.892 . . . . 0.0 108.796 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -100.88 165.38 11.38 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -81.46 -34.09 31.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.668 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -98.95 133.7 42.85 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 118.589 0.631 . . . . 0.0 110.355 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.6 p -58.26 -28.3 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.277 1.031 . . . . 0.0 109.611 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -69.01 -19.11 64.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 128.192 2.597 . . . . 0.0 112.84 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -99.62 -9.8 22.75 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.878 0.871 . . . . 0.0 110.476 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -70.3 161.5 30.26 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -140.35 95.64 2.91 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -101.37 167.38 10.21 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.539 1.136 . . . . 0.0 109.934 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -137.05 132.48 34.25 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.311 1.044 . . . . 0.0 110.12 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.4 tp -90.87 98.56 11.85 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 16.4 mt -107.19 -178.92 3.78 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.629 1.172 . . . . 0.0 109.494 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -155.47 161.66 40.9 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -136.6 -178.3 5.11 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 124.567 1.147 . . . . 0.0 108.437 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -56.34 -23.04 34.68 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.876 1.27 . . . . 0.0 111.511 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 58.6 t -81.67 -66.81 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -174.71 -164.22 29.18 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -77.22 160.03 29.23 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.299 0.64 . . . . 0.0 111.205 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -168.2 161.39 12.31 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.653 1.581 . . . . 0.0 109.381 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.589 HD12 HD11 ' A' ' 109' ' ' ILE . 4.1 mt -106.6 133.47 51.03 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 178.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 4.1 t -108.55 131.68 54.6 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -134.59 124.85 26.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.0 tt -115.38 140.15 38.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.3 mt -135.2 115.7 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 O-C-N 121.699 -0.626 . . . . 0.0 110.971 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -105.33 -168.0 23.83 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.683 1.611 . . . . 0.0 110.015 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.5 t 78.16 58.05 0.03 OUTLIER 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.452 1.901 . . . . 0.0 110.713 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -110.53 -104.21 2.81 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 106.941 -2.464 . . . . 0.0 106.941 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -153.97 119.61 5.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 42.6 mm -60.66 133.95 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 123.963 0.905 . . . . 0.0 109.108 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 58.9 m -86.36 106.52 17.46 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.11 -15.68 5.96 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.307 0.958 . . . . 0.0 112.964 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 49.0 t -58.28 -46.4 88.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.983 1.313 . . . . 0.0 110.34 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.6 p -119.89 -20.88 7.38 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.553 1.141 . . . . 0.0 111.71 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 81.95 13.25 79.83 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 127.14 2.305 . . . . 0.0 112.139 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -85.77 170.59 12.3 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.549 1.54 . . . . 0.0 110.823 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.09 153.54 22.63 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 122.104 0.954 . . . . 0.0 111.536 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 29.9 ttm-85 -92.76 29.97 1.67 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 127.769 2.428 . . . . 0.0 109.463 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.0 ptt? -73.93 154.58 39.31 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.6 p -122.61 144.4 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.453 -177.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -111.57 131.91 54.92 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.7 mp -123.48 119.5 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 125.097 1.359 . . . . 0.0 108.835 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -100.84 120.64 40.43 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.68 0.792 . . . . 0.0 108.951 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -99.4 123.1 43.38 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.838 0.745 . . . . 0.0 110.137 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 14.8 m -135.12 170.08 20.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.9 1.28 . . . . 0.0 111.389 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.1 136.04 41.14 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -92.59 108.17 3.61 Favored Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 107.548 -2.221 . . . . 0.0 107.548 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -34.99 -54.3 0.87 Allowed Glycine 0 C--N 1.338 0.647 0 C-N-CA 126.728 2.109 . . . . 0.0 113.473 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 14.9 m -79.56 71.27 6.15 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -50.15 23.1 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.647 1 C-N-CA 133.767 4.827 . . . . 0.0 118.406 -178.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 7.9 t -145.96 47.39 1.24 Allowed 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.154 -1.591 . . . . 0.0 110.891 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -140.46 166.98 25.68 Favored Glycine 0 C--N 1.336 0.571 0 O-C-N 120.508 -1.37 . . . . 0.0 110.405 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.34 168.92 23.68 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 CA-C-N 119.623 1.711 . . . . 0.0 108.915 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 99.1 p -72.23 153.42 41.59 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.9 p -160.44 165.16 31.54 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.561 1.545 . . . . 0.0 108.18 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.2 mp -84.92 132.08 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -78.95 -55.33 5.22 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 124.804 1.242 . . . . 0.0 111.297 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 33.2 p-90 -146.24 165.45 29.17 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.652 HG13 ' CE1' ' A' ' 229' ' ' TYR . 52.6 t -144.38 139.19 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 126.259 1.824 . . . . 0.0 106.19 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.22 134.86 11.69 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.606 0.717 . . . . 0.0 110.621 178.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -90.54 90.35 7.96 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.3 p -75.32 -46.05 35.76 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.227 1.011 . . . . 0.0 111.584 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -103.52 -179.61 4.0 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.2 mp -78.16 -27.8 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.5 t -118.27 -56.81 2.13 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.288 1.435 . . . . 0.0 111.24 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 3.7 t -60.02 141.42 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . 0.652 ' CE1' HG13 ' A' ' 221' ' ' VAL . 1.2 t80 -125.85 150.5 47.82 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.905 2.082 . . . . 0.0 109.035 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -131.44 138.7 49.16 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.777 1.631 . . . . 0.0 108.837 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.71 162.22 40.19 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.091 1.757 . . . . 0.0 111.745 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -132.38 147.66 52.39 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 89.3 t -129.59 139.07 52.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 126.065 1.746 . . . . 0.0 108.377 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.92 140.77 46.3 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 124.134 0.974 . . . . 0.0 109.678 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 56.9 mt -137.83 140.4 29.42 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.53 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.85 -45.04 0.31 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.049 2.499 . . . . 0.0 112.284 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.404 ' OE2' ' HE2' ' A' ' 112' ' ' LYS . 10.5 mt-10 -61.08 -25.69 67.12 Favored 'General case' 0 N--CA 1.461 0.124 0 O-C-N 121.235 -0.916 . . . . 0.0 111.914 -178.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.2 mp -60.1 -37.66 80.64 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 118.336 -0.84 . . . . 0.0 109.905 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 32.6 m -54.47 -26.7 32.71 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.819 1.648 . . . . 0.0 113.181 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -62.08 -30.15 70.8 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 41.7 mt -76.19 116.21 16.67 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.578 1.151 . . . . 0.0 112.151 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -48.19 -39.96 22.6 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.636 1.974 . . . . 0.0 114.853 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 13.4 mt -61.53 -34.08 74.91 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.183 -0.948 . . . . 0.0 112.968 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 1.9 mp -104.95 7.72 34.28 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -68.07 70.26 0.15 Allowed 'General case' 0 C--O 1.235 0.317 0 C-N-CA 129.084 2.954 . . . . 0.0 110.047 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -141.67 158.45 43.8 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 130.572 3.549 . . . . 0.0 107.819 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 29.0 m120 62.55 15.88 8.29 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.381 1.872 . . . . 0.0 115.67 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -80.3 72.51 7.15 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 2.9 p30 . . . . . 0 C--O 1.247 0.972 0 C-N-CA 126.955 2.102 . . . . 0.0 109.774 179.664 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.972 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.9 -33.82 76.43 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 117.992 0.896 . . . . 0.0 111.506 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.4 m -67.55 76.19 0.18 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.766 1.627 . . . . 0.0 112.53 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -60.13 -36.05 76.63 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.635 -1.291 . . . . 0.0 110.527 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 58.0 m -60.13 -41.8 93.43 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.08 0.952 . . . . 0.0 111.193 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -68.98 -29.73 68.0 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.768 -0.826 . . . . 0.0 108.768 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -50.88 65.97 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.2 p -61.59 -39.93 92.95 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.8 90.04 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 118.616 0.644 . . . . 0.0 110.683 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 47.6 tp -61.53 -45.75 92.86 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.0 mt -64.5 -52.16 59.31 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.543 0.737 . . . . 0.0 110.484 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 53.3 m -54.89 -51.75 65.02 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.654 -0.654 . . . . 0.0 110.188 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -60.21 -46.59 89.23 Favored 'General case' 0 C--N 1.339 0.116 0 O-C-N 121.656 -0.652 . . . . 0.0 110.64 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.1 m -53.34 -45.96 69.3 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.093 0.957 . . . . 0.0 110.2 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 27.4 tp -59.45 -56.64 19.43 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.611 0.641 . . . . 0.0 110.721 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -56.56 -51.47 68.46 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 118.436 0.562 . . . . 0.0 111.723 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -55.2 -38.92 69.01 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.415 0.686 . . . . 0.0 109.674 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -67.04 -52.79 30.27 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 87.8 t -55.03 -53.32 35.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.734 1.214 . . . . 0.0 111.276 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -31.52 72.68 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 118.64 0.654 . . . . 0.0 110.822 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.0 m -69.71 -46.7 65.41 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.576 HD11 HD12 ' A' ' 183' ' ' ILE . 25.0 mt -57.33 -52.21 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.35 -41.02 88.24 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 119.171 -0.442 . . . . 0.0 111.466 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -60.54 -50.77 72.22 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.19 0.45 . . . . 0.0 110.79 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -71.32 -19.92 62.25 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.2 mp -102.8 -25.72 13.41 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.125 1.329 . . . . 0.0 111.526 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -55.12 -39.21 69.14 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 121.551 -0.718 . . . . 0.0 110.802 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.96 -42.73 89.58 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.487 -0.768 . . . . 0.0 111.184 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 -153.63 147.21 25.07 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 120.224 1.375 . . . . 0.0 112.403 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 60.7 m -76.14 167.88 21.06 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 36.3 pt -128.15 148.42 32.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.74 167.92 20.94 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.222 0.609 . . . . 0.0 112.141 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -151.04 127.43 10.66 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.318 1.447 . . . . 0.0 109.758 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -91.07 102.73 15.49 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.704 0.802 . . . . 0.0 109.176 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.27 66.75 8.53 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.89 -114.96 7.04 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -63.84 -32.87 74.53 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.036 0.934 . . . . 0.0 112.594 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -107.68 159.43 16.48 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 119.663 1.119 . . . . 0.0 111.094 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.6 mt -127.92 147.05 32.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.419 ' CD1' HG11 ' A' ' 221' ' ' VAL . 47.9 m-85 -123.05 128.62 50.4 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.295 1.838 . . . . 0.0 108.776 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -122.2 130.52 53.28 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.619 1.968 . . . . 0.0 110.01 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -124.21 119.41 29.28 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.398 1.479 . . . . 0.0 108.256 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 14.9 m -108.52 157.71 35.86 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 123.45 0.7 . . . . 0.0 111.274 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -65.69 87.41 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.552 1 C-N-CA 125.67 4.246 . . . . 0.0 115.55 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.58 34.42 89.85 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 119.479 -0.623 . . . . 0.0 111.851 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.5 mt -112.44 -67.22 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.487 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 11.7 pt-20 -173.26 168.21 4.7 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.73 1.612 . . . . 0.0 109.379 -178.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.63 120.38 29.37 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 177.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.2 m -138.33 156.56 30.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 124.832 1.253 . . . . 0.0 111.553 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -132.64 127.05 34.05 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.958 0.903 . . . . 0.0 108.835 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.407 ' HB3' ' HB ' ' A' ' 157' ' ' VAL . 7.4 p90 -136.93 159.25 42.44 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 126.909 2.084 . . . . 0.0 113.283 -178.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -87.36 153.3 21.56 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 159.75 -164.98 34.42 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.83 147.35 49.46 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 89.8 t -121.54 156.16 25.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 124.398 1.079 . . . . 0.0 110.604 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -101.69 89.42 3.69 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 103.541 -2.763 . . . . 0.0 103.541 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 8.8 t -49.98 -21.78 1.33 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.485 1.114 . . . . 0.0 112.399 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -56.69 -26.74 57.35 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.89 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.51 -30.05 0.38 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.209 0.913 . . . . 0.0 111.88 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 114.55 -0.0 23.36 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 126.48 1.991 . . . . 0.0 110.259 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -56.06 128.56 35.98 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 126.046 1.739 . . . . 0.0 111.479 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 48.7 mt -67.34 129.04 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 47.7 t -76.3 -51.47 19.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 O-C-N 120.641 -1.287 . . . . 0.0 110.197 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 -138.61 152.25 47.97 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.52 -2.029 . . . . 0.0 105.52 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -144.14 139.69 28.96 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.934 0.894 . . . . 0.0 110.544 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -151.33 153.71 35.32 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -95.48 24.97 4.75 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.125 0.57 . . . . 0.0 109.9 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.7 t -83.69 -30.22 26.96 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 120.287 -1.508 . . . . 0.0 111.311 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 19.2 tp -140.88 72.74 1.4 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.558 0.617 . . . . 0.0 110.607 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 138' ' ' PHE . 3.9 p -134.95 154.97 37.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.666 1.586 . . . . 0.0 110.002 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -143.32 151.38 40.42 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.125 1.37 . . . . 0.0 109.846 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 13.9 ptt-85 -99.18 135.49 40.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 125.513 1.525 . . . . 0.0 109.315 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.25 -65.67 1.1 Allowed 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 123.377 0.671 . . . . 0.0 109.722 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -130.73 150.21 19.25 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.75 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 6.5 ttpp -123.25 90.36 50.48 Favored Pre-proline 0 N--CA 1.451 -0.386 0 C-N-CA 125.932 1.693 . . . . 0.0 108.388 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.487 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 93.1 Cg_endo -70.59 175.14 9.19 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.956 2.438 . . . . 0.0 109.275 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -91.28 166.06 13.12 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.334 0.653 . . . . 0.0 110.531 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -77.61 -27.79 51.33 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.987 0.915 . . . . 0.0 113.316 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -112.99 137.89 50.71 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.725 1.21 . . . . 0.0 109.094 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.5 p -60.4 -27.34 39.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.22 1.008 . . . . 0.0 111.823 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -71.93 -8.32 53.78 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 129.128 2.971 . . . . 0.0 112.287 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -112.97 -5.13 13.81 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.676 1.99 . . . . 0.0 110.425 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 45.2 mmm-85 -82.55 165.73 19.87 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -134.24 96.59 3.64 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.421 ' CE2' ' HG3' ' A' ' 185' ' ' GLU . 77.5 m-85 -111.3 139.57 46.6 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.283 1.833 . . . . 0.0 107.459 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -131.03 137.11 49.03 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.272 1.029 . . . . 0.0 109.029 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 43.8 tp -88.52 103.3 15.76 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.468 1.107 . . . . 0.0 109.717 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 7.2 mt -119.63 177.64 4.87 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.845 1.258 . . . . 0.0 108.342 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.4 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 19.8 p90 -157.49 166.85 31.87 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.579 0.751 . . . . 0.0 110.019 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 178' ' ' ASP . 31.6 t70 -136.6 -178.46 5.18 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.427 ' H ' ' CG ' ' A' ' 177' ' ' ASP . 0.5 OUTLIER -54.51 -30.67 54.22 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 125.491 1.516 . . . . 0.0 111.36 179.647 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 20.2 t -77.52 -64.25 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.491 1.116 . . . . 0.0 110.012 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -169.67 -170.83 34.61 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 119.059 0.845 . . . . 0.0 112.491 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.4 ' CD2' ' HB3' ' A' ' 176' ' ' TYR . 8.1 m-85 -87.67 154.77 20.32 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 123.637 0.775 . . . . 0.0 110.816 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -159.72 172.83 17.01 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.719 1.208 . . . . 0.0 107.977 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.576 HD12 HD11 ' A' ' 109' ' ' ILE . 9.1 mt -117.41 137.96 49.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 177.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.2 t -106.0 118.29 36.23 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 124.916 1.385 . . . . 0.0 107.437 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.421 ' HG3' ' CE2' ' A' ' 172' ' ' PHE . 0.6 OUTLIER -123.82 107.78 11.77 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 178.031 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 2.1 tt -101.99 128.33 54.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.1 mt -120.4 111.1 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.955 1.302 . . . . 0.0 111.551 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -104.75 -159.01 23.65 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 125.7 1.619 . . . . 0.0 110.042 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 74.82 36.94 0.53 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.772 1.629 . . . . 0.0 109.735 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -89.89 -126.91 3.18 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 107.576 -2.21 . . . . 0.0 107.576 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -137.35 127.95 26.85 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.9 mm -61.45 129.36 24.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 123.499 0.719 . . . . 0.0 111.784 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 5.1 m -90.0 94.07 9.65 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 101.198 -3.63 . . . . 0.0 101.198 176.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -57.67 -17.72 16.52 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.4 m -53.05 -33.04 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.466 1.507 . . . . 0.0 109.854 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 1.4 p -122.35 -34.01 3.36 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 123.25 0.62 . . . . 0.0 111.33 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 95.46 22.79 20.85 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.284 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -111.1 165.59 11.76 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.299 1.84 . . . . 0.0 109.159 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -87.21 145.48 26.38 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.355 1.462 . . . . 0.0 111.954 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -79.05 29.81 0.21 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.638 2.775 . . . . 0.0 111.06 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.8 ptm -73.12 149.44 43.04 Favored 'General case' 0 C--O 1.239 0.512 0 O-C-N 121.124 -0.985 . . . . 0.0 109.504 -177.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -116.73 146.88 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.607 -177.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -115.05 127.98 55.96 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.7 mp -117.06 116.53 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.109 0.964 . . . . 0.0 108.412 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -100.32 113.69 26.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -92.2 116.78 29.24 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 28.3 m -125.31 169.84 16.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 125.789 1.636 . . . . 0.0 111.806 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -81.37 137.41 35.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -101.24 122.46 7.6 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 107.364 -2.294 . . . . 0.0 107.364 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -45.32 -46.13 11.13 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.37 1.462 . . . . 0.0 113.238 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 8.3 t -81.62 65.2 6.65 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -57.14 28.19 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 130.099 3.36 . . . . 0.0 117.538 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.1 t -138.78 47.1 1.95 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 120.637 1.562 . . . . 0.0 112.486 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -153.24 172.68 32.15 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -73.28 167.1 28.18 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.276 1.984 . . . . 0.0 109.799 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.19 155.71 34.28 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.66 159.77 12.21 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.241 1.416 . . . . 0.0 107.373 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.86 128.89 37.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -72.9 -61.01 1.96 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 124.08 0.952 . . . . 0.0 109.184 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . 0.459 ' CE3' ' HD2' ' A' ' 222' ' ' ARG . 28.6 p-90 -139.64 167.2 22.65 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.595 1.558 . . . . 0.0 109.443 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.742 HG13 ' CE1' ' A' ' 229' ' ' TYR . 24.9 t -144.01 129.15 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.459 ' HD2' ' CE3' ' A' ' 220' ' ' TRP . 0.1 OUTLIER -145.51 118.03 8.55 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.99 0.9 . . . . 0.0 109.417 178.053 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -76.36 94.58 3.64 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 102.714 -3.069 . . . . 0.0 102.714 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 17.4 p -61.45 -66.41 0.54 Allowed 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.274 0.629 . . . . 0.0 109.669 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -101.38 179.12 4.45 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 34.7 mm -62.07 -21.47 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 123.535 0.734 . . . . 0.0 111.871 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.01 -45.57 1.26 Allowed 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.243 0.617 . . . . 0.0 111.228 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 25.2 t -67.29 133.58 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . 0.742 ' CE1' HG13 ' A' ' 221' ' ' VAL . 1.2 t80 -130.09 144.63 51.45 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.752 1.621 . . . . 0.0 108.661 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -123.74 138.38 54.53 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 126.363 1.865 . . . . 0.0 107.944 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.1 156.51 43.94 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.868 1.267 . . . . 0.0 109.91 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -130.9 143.3 50.63 Favored 'General case' 0 CA--C 1.52 -0.211 0 O-C-N 121.344 -0.847 . . . . 0.0 110.673 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 61.1 t -125.61 140.89 47.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.44 1.496 . . . . 0.0 107.419 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.72 136.81 52.44 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 96.6 mt -133.02 143.47 48.67 Favored Pre-proline 0 C--O 1.236 0.385 0 CA-C-O 118.192 -0.909 . . . . 0.0 109.112 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.39 -44.2 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.34 2.026 . . . . 0.0 111.445 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -62.36 -20.3 64.26 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.721 1.208 . . . . 0.0 113.291 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 14.9 mt -69.63 -38.11 77.07 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.047 0.839 . . . . 0.0 109.982 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 34.5 m -54.31 -21.58 9.71 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.433 1.493 . . . . 0.0 113.61 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -61.94 -30.66 71.06 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.391 1.076 . . . . 0.0 110.835 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 52.8 mt -79.09 124.08 27.96 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -48.02 -45.41 31.94 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 126.267 1.827 . . . . 0.0 112.824 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 6.1 mp -60.7 -28.91 68.99 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.271 -0.893 . . . . 0.0 111.512 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -99.91 -0.68 39.05 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.596 1.558 . . . . 0.0 111.627 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -78.1 37.97 0.27 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.744 1.618 . . . . 0.0 109.493 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -144.3 132.96 22.29 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 127.681 2.392 . . . . 0.0 107.113 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -163.14 153.85 16.54 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 126.82 2.048 . . . . 0.0 105.516 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -172.93 -22.98 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.535 1.534 . . . . 0.0 112.949 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 21.8 t0 . . . . . 0 C--O 1.25 1.114 0 C-N-CA 127.377 2.271 . . . . 0.0 110.885 179.699 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.741 0 N-CA-C 108.761 -1.735 . . . . 0.0 108.761 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.44 -26.61 68.81 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.485 1.143 . . . . 0.0 110.453 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.8 m -136.45 170.86 15.36 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.955 1.702 . . . . 0.0 108.481 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 61.7 21.96 12.59 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.313 1.445 . . . . 0.0 114.418 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.7 m -64.6 -34.47 78.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 122.923 1.344 . . . . 0.0 111.29 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -72.55 -35.26 67.98 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 125.02 1.328 . . . . 0.0 107.737 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -68.29 -49.62 59.24 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.549 1.54 . . . . 0.0 108.26 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.4 p -57.0 -45.58 82.93 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 120.247 1.385 . . . . 0.0 110.879 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.5 -45.59 93.24 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.415 0.686 . . . . 0.0 110.262 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.1 tp -62.74 -42.86 99.87 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 117.895 -1.05 . . . . 0.0 110.482 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.7 mt -58.99 -53.82 54.12 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.441 1.019 . . . . 0.0 109.123 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.6 m -56.1 -42.03 76.15 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.816 0.447 . . . . 0.0 110.129 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -65.72 -51.07 62.2 Favored 'General case' 0 CA--C 1.527 0.09 0 O-C-N 120.97 -1.082 . . . . 0.0 110.044 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.7 m -53.02 -43.19 66.34 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.182 1.393 . . . . 0.0 110.323 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.405 ' O ' HG23 ' A' ' 106' ' ' VAL . 19.9 tp -60.08 -55.55 32.57 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.943 0.792 . . . . 0.0 111.489 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -65.46 -40.07 92.77 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 118.867 0.758 . . . . 0.0 112.124 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -61.59 -41.46 97.46 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 124.052 0.941 . . . . 0.0 109.851 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.406 ' HA3' HD11 ' A' ' 183' ' ' ILE . . . -66.26 -49.47 57.09 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.412 HG13 ' CE1' ' A' ' 172' ' ' PHE . 62.6 t -54.52 -53.05 34.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 126.036 1.734 . . . . 0.0 111.412 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -32.99 74.77 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 118.133 0.424 . . . . 0.0 110.463 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.09 -42.78 72.28 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 118.324 0.511 . . . . 0.0 110.492 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.418 HD11 HD12 ' A' ' 183' ' ' ILE . 16.6 mt -53.4 -53.5 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.97 -42.36 98.16 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 118.643 -0.694 . . . . 0.0 110.422 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -61.44 -30.04 70.33 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.948 0.794 . . . . 0.0 111.174 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -91.96 -3.81 55.42 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.67 1.188 . . . . 0.0 112.511 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.9 mt -119.75 -29.28 5.05 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.041 1.291 . . . . 0.0 112.586 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -62.07 -24.77 67.3 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.46 0.704 . . . . 0.0 111.313 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -73.45 -46.62 47.29 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.657 1.183 . . . . 0.0 108.565 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -161.33 145.16 13.01 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.034 1.733 . . . . 0.0 108.951 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 33.9 m -76.19 173.73 10.99 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.322 0.649 . . . . 0.0 109.778 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 42.1 pt -125.55 151.56 31.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 123.794 0.838 . . . . 0.0 109.209 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.89 160.89 41.76 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 122.849 0.46 . . . . 0.0 109.901 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -150.95 125.13 9.35 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.568 -0.708 . . . . 0.0 111.278 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -84.58 101.73 12.34 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 178.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.21 67.2 9.55 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.32 -115.68 6.94 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -66.85 -33.74 76.28 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -106.78 160.37 15.53 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.464 1.029 . . . . 0.0 110.363 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 21.3 mt -125.07 133.52 69.25 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 N-CA-C 104.894 -2.262 . . . . 0.0 104.894 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.528 ' CD1' HG11 ' A' ' 221' ' ' VAL . 67.7 m-85 -110.63 131.64 54.88 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -121.49 128.36 52.0 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 125.245 1.418 . . . . 0.0 109.368 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -127.24 108.85 11.23 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 124.288 0.992 . . . . 0.0 112.096 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 1.7 m -98.23 159.28 31.07 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.038 0.935 . . . . 0.0 112.858 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.06 96.34 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.562 1 C-N-CA 125.925 4.417 . . . . 0.0 113.62 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 55.54 49.78 63.42 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-O 119.076 -0.847 . . . . 0.0 111.18 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 5.1 mt -125.95 -68.01 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.613 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -172.64 162.57 5.11 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -123.73 119.76 30.73 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 103.011 -2.959 . . . . 0.0 103.011 177.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.8 m -131.38 155.87 42.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 124.123 0.969 . . . . 0.0 111.166 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -122.51 131.63 53.94 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 177.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -146.11 157.41 43.84 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.972 0.909 . . . . 0.0 111.102 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -89.39 154.4 20.09 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 157.05 -163.62 32.41 Favored Glycine 0 C--N 1.33 0.231 0 O-C-N 120.175 -1.578 . . . . 0.0 110.768 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.09 144.3 51.06 Favored 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.4 p -154.87 147.52 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 126.106 1.762 . . . . 0.0 106.454 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -89.16 83.15 6.5 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 101.06 -3.682 . . . . 0.0 101.06 177.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.4 t -52.63 -14.82 0.57 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.117 1.367 . . . . 0.0 114.499 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.464 ' HA ' ' HE2' ' A' ' 145' ' ' LYS . 11.3 mmpt? -69.62 -35.78 75.56 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.636 1.975 . . . . 0.0 111.557 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.4 t -119.76 -21.52 7.21 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.61 1.564 . . . . 0.0 111.321 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 88.08 35.03 9.2 Favored Glycine 0 C--O 1.224 -0.487 0 O-C-N 121.4 -0.813 . . . . 0.0 111.224 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -101.67 119.97 39.61 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 34.5 mm -69.4 158.33 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 13.4 t -131.44 -16.92 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.884 1.274 . . . . 0.0 110.809 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -143.44 148.06 35.52 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.854 1.261 . . . . 0.0 108.281 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -134.3 35.39 3.24 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.168 0.987 . . . . 0.0 110.365 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -51.81 121.31 6.38 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -86.84 -0.14 55.91 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.611 1.165 . . . . 0.0 112.833 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.4 t -76.81 -42.34 40.89 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 125.097 1.359 . . . . 0.0 111.097 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 47.3 mt -110.72 73.45 0.83 Allowed 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.863 0.865 . . . . 0.0 110.713 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.9 p -142.8 141.69 27.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -132.5 157.83 43.65 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.605 1.562 . . . . 0.0 109.484 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -107.71 130.66 54.92 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.495 1.118 . . . . 0.0 109.746 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.4 -75.98 0.51 Allowed 'General case' 0 N--CA 1.458 -0.052 0 C-N-CA 124.434 1.093 . . . . 0.0 109.68 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -127.72 153.76 19.41 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -129.45 90.97 42.65 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.441 ' HD3' HG21 ' A' ' 187' ' ' ILE . 54.7 Cg_endo -74.87 173.67 14.06 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.965 2.444 . . . . 0.0 110.984 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -83.16 164.52 20.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.825 0.821 . . . . 0.0 109.493 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -81.92 -24.02 35.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.307 -1.315 . . . . 0.0 113.592 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -102.03 144.1 31.04 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.8 p -72.95 -31.53 36.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 121.426 0.631 . . . . 0.0 110.199 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.55 -21.93 66.65 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.822 2.049 . . . . 0.0 110.571 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -83.48 -18.41 38.65 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.288 -0.883 . . . . 0.0 112.302 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.502 ' HD3' ' CE1' ' A' ' 172' ' ' PHE . 3.0 mtt180 -76.36 172.34 13.07 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.175 0.59 . . . . 0.0 112.304 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -136.75 95.03 3.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.254 1.422 . . . . 0.0 107.988 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.502 ' CE1' ' HD3' ' A' ' 170' ' ' ARG . 85.7 m-85 -99.09 161.61 13.53 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.64 1.176 . . . . 0.0 109.535 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -141.51 129.51 21.97 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 118.671 0.669 . . . . 0.0 110.155 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 21.5 tp -87.88 99.66 12.29 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 26.5 mt -106.84 -179.67 4.0 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.758 1.223 . . . . 0.0 109.556 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 181' ' ' TYR . 4.1 p90 -159.72 159.88 33.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -140.81 -173.53 3.73 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -50.87 -34.03 26.4 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.953 1.701 . . . . 0.0 112.631 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.432 ' O ' ' HE3' ' A' ' 246' ' ' LYS . 41.3 t -79.16 -73.47 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -165.65 -169.05 28.75 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 119.366 0.984 . . . . 0.0 111.959 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 176' ' ' TYR . 5.6 m-85 -78.49 156.37 29.35 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.269 0.628 . . . . 0.0 110.789 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -159.55 167.53 28.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.431 1.492 . . . . 0.0 107.616 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.418 HD12 HD11 ' A' ' 109' ' ' ILE . 9.3 mt -114.88 125.13 72.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.3 t -99.18 130.08 45.47 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -137.99 107.06 6.01 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 103.72 -2.696 . . . . 0.0 103.72 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.0 tt -99.65 140.45 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.441 HG21 ' HD3' ' A' ' 163' ' ' PRO . 15.2 mt -129.59 112.28 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 123.291 0.636 . . . . 0.0 110.092 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.34 -159.07 26.07 Favored Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.1 m 72.05 57.99 0.15 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.557 1.543 . . . . 0.0 109.286 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -116.4 -118.78 3.08 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 125.589 1.566 . . . . 0.0 109.501 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -140.59 122.81 15.8 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.366 1.466 . . . . 0.0 109.79 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.6 mm -61.15 119.29 4.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 126.065 1.746 . . . . 0.0 110.497 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 35.2 m -77.58 100.9 6.29 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -48.56 -29.7 4.51 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.737 1.615 . . . . 0.0 113.476 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 27.1 t -53.36 -40.84 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.186 1.394 . . . . 0.0 111.585 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 37.9 p -124.07 -18.4 5.92 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.694 0.759 . . . . 0.0 111.554 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 77.56 15.84 80.92 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 128.68 3.038 . . . . 0.0 111.994 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -86.45 168.9 13.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.068 1.347 . . . . 0.0 110.801 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -85.32 148.15 26.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.252 1.025 . . . . 0.0 108.443 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.91 29.93 0.99 Allowed 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 127.933 2.493 . . . . 0.0 111.232 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 11.9 ptt? -73.18 156.26 38.78 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.18 143.53 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.978 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -106.78 133.23 51.76 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.73 111.81 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 C-N-CA 124.378 1.071 . . . . 0.0 108.373 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -97.12 114.56 26.24 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -91.28 122.92 34.32 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.488 0.715 . . . . 0.0 110.142 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.82 176.49 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 125.864 1.666 . . . . 0.0 110.728 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.9 t -88.09 143.15 27.24 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -107.07 151.84 16.88 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -51.66 -61.55 6.3 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.843 1.687 . . . . 0.0 113.952 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 11.7 m -78.03 92.57 4.36 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 118.568 1.184 . . . . 0.0 108.669 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -66.42 17.36 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.041 2.536 . . . . 0.0 114.166 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 3.8 m -132.78 47.04 2.55 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 -177.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -157.88 175.51 35.12 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 120.647 -1.283 . . . . 0.0 111.552 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.44 162.6 37.89 Favored 'Trans proline' 0 C--O 1.239 0.562 0 C-N-CA 122.661 2.241 . . . . 0.0 110.959 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 12.4 p -69.38 162.09 28.03 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.875 0.87 . . . . 0.0 109.366 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.21 157.25 9.22 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.16 1.384 . . . . 0.0 107.927 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.83 132.32 33.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -81.25 -53.17 6.58 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 125.59 1.556 . . . . 0.0 111.377 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 41.3 p-90 -148.94 165.85 30.35 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 124.135 0.974 . . . . 0.0 108.446 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.749 HG13 ' CE1' ' A' ' 229' ' ' TYR . 49.1 t -145.67 136.39 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 127.146 2.179 . . . . 0.0 105.504 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.02 130.57 10.65 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -78.69 87.93 4.59 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.405 ' HB ' ' HE3' ' A' ' 225' ' ' LYS . 2.6 p -60.45 -53.45 57.41 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.423 0.689 . . . . 0.0 110.989 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.405 ' HE3' ' HB ' ' A' ' 224' ' ' THR . 17.5 mmtp -114.81 179.33 3.98 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.6 mp -66.22 -33.04 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -108.83 -65.05 1.17 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.871 0.868 . . . . 0.0 109.88 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 5.5 t -55.35 138.88 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 124.892 1.277 . . . . 0.0 109.749 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . 0.749 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.3 OUTLIER -133.49 151.03 51.71 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.698 1.999 . . . . 0.0 108.341 -178.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -132.22 141.06 48.91 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 126.109 1.764 . . . . 0.0 108.793 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.01 162.31 37.26 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.429 2.292 . . . . 0.0 111.177 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -134.48 147.64 50.41 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.746 0.818 . . . . 0.0 108.898 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 93.3 t -134.66 135.5 53.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 C-N-CA 124.687 1.195 . . . . 0.0 108.689 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.7 p -102.75 142.19 34.31 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.706 0.802 . . . . 0.0 108.979 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 34.0 mt -139.48 137.61 19.13 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 123.693 0.797 . . . . 0.0 109.9 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.34 -34.66 2.63 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.914 2.41 . . . . 0.0 113.029 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -67.81 -26.46 66.09 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.224 -0.922 . . . . 0.0 110.595 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 3.9 mp -65.9 -34.47 78.21 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 28.3 m -59.13 -11.16 3.35 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.252 1.421 . . . . 0.0 112.98 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -81.96 -30.34 31.76 Favored 'General case' 0 CA--C 1.528 0.098 0 O-C-N 120.16 -1.587 . . . . 0.0 111.142 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 23.8 mt -78.78 111.88 15.35 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.41 -27.87 1.86 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 116.404 2.001 . . . . 0.0 116.404 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 5.2 mp -63.68 -45.03 91.92 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.466 0.706 . . . . 0.0 110.445 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -82.21 3.59 26.76 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 127.002 2.121 . . . . 0.0 113.3 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -74.02 64.2 1.0 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 127.949 2.5 . . . . 0.0 110.584 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.432 ' HE3' ' O ' ' A' ' 179' ' ' VAL . 4.8 tptp -135.34 146.39 48.37 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 128.673 2.789 . . . . 0.0 108.404 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 18.4 m120 67.86 11.66 8.47 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.785 1.634 . . . . 0.0 112.614 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -85.82 73.58 10.34 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 178.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 39.0 t70 . . . . . 0 C--O 1.245 0.859 0 CA-C-O 118.49 -0.767 . . . . 0.0 109.891 179.655 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.171 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -144.71 171.87 13.8 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.852 1.661 . . . . 0.0 107.637 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.1 m -153.51 -172.34 4.2 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.121 0.969 . . . . 0.0 109.452 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 55.55 35.66 25.6 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.608 1.563 . . . . 0.0 113.622 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 63.9 m -55.41 -53.68 53.25 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 121.363 -0.836 . . . . 0.0 111.929 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -59.85 -39.55 85.54 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.143 0.577 . . . . 0.0 111.974 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -57.14 -52.37 65.58 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.9 m -65.31 -36.03 82.8 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 118.79 -0.624 . . . . 0.0 110.422 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.59 -46.06 84.48 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.662 1.119 . . . . 0.0 110.064 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.9 tp -66.39 -39.74 89.24 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.112 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.2 mt -60.95 -51.75 67.94 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.403 1.002 . . . . 0.0 110.392 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 90.1 m -55.12 -56.45 19.75 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.26 1.424 . . . . 0.0 109.906 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.04 -48.91 78.66 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-O 119.043 -0.503 . . . . 0.0 111.332 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 54.9 m -52.84 -50.39 63.82 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.439 0.695 . . . . 0.0 111.41 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.9 tp -58.59 -54.12 50.7 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.766 -0.635 . . . . 0.0 110.138 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -55.12 -51.54 66.1 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.555 0.742 . . . . 0.0 112.071 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -59.09 -40.08 84.19 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.24 -52.48 52.45 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-O 118.146 -1.363 . . . . 0.0 110.973 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.422 HG22 ' CG ' ' A' ' 172' ' ' PHE . 29.5 t -55.72 -53.19 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 119.255 1.528 . . . . 0.0 111.289 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -35.04 79.13 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.863 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.2 m -64.91 -45.24 86.7 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 41.0 mt -56.66 -54.36 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -56.7 -43.23 80.34 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 123.278 0.361 . . . . 0.0 110.466 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -67.56 -37.63 82.94 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.823 -0.548 . . . . 0.0 112.294 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.86 -1.97 41.45 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.935 0.894 . . . . 0.0 113.235 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.2 mt -119.39 -26.16 5.89 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 119.645 1.111 . . . . 0.0 111.744 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -58.7 -23.57 59.83 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -74.22 -43.17 58.19 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 117.946 -1.026 . . . . 0.0 111.383 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -156.23 150.21 25.19 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.523 1.129 . . . . 0.0 112.376 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 57.4 m -76.02 171.58 14.21 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 23.0 pt -129.38 156.12 41.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 123.955 0.902 . . . . 0.0 109.018 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -151.21 154.03 36.06 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 122.059 -0.401 . . . . 0.0 111.196 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -141.37 127.42 19.51 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 124.118 0.967 . . . . 0.0 110.699 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -87.22 118.13 26.43 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -109.84 67.41 0.65 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.045 2.138 . . . . 0.0 106.105 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.14 -120.8 8.03 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -66.46 -33.07 74.87 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.531 1.132 . . . . 0.0 112.508 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -106.92 145.31 32.37 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 118.737 0.699 . . . . 0.0 109.847 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 10.6 mt -116.06 151.16 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.494 ' CD1' HG11 ' A' ' 221' ' ' VAL . 42.3 m-85 -118.7 135.92 54.22 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 126.057 1.743 . . . . 0.0 106.447 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.63 131.43 48.07 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 125.661 1.584 . . . . 0.0 108.516 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -128.2 109.35 11.41 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.183 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 2.5 m -89.45 160.04 42.97 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 117.832 -1.08 . . . . 0.0 108.709 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -61.49 70.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 125.15 3.9 . . . . 0.0 116.145 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.46 48.74 65.6 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 125.257 1.408 . . . . 0.0 111.772 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.2 mt -114.65 -66.29 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -160.14 160.95 33.57 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.462 1.905 . . . . 0.0 107.915 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -123.46 120.81 34.02 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 102.525 -3.139 . . . . 0.0 102.525 177.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.94 155.52 27.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 123.593 0.757 . . . . 0.0 111.751 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -121.24 135.74 55.08 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -145.97 157.69 43.88 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 125.206 1.402 . . . . 0.0 111.144 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -88.78 151.44 22.39 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 164.68 -163.33 36.21 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.4 139.24 50.63 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.706 2.002 . . . . 0.0 106.268 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 91.5 t -116.8 153.19 18.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 125.189 1.396 . . . . 0.0 109.594 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -105.98 93.44 4.63 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 127.427 2.291 . . . . 0.0 105.559 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.7 t -57.56 -13.84 4.36 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 119.271 0.942 . . . . 0.0 112.812 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -50.71 -40.32 53.88 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 125.125 1.37 . . . . 0.0 109.803 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.4 t -145.8 -11.46 0.51 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.265 0.626 . . . . 0.0 111.355 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 105.46 5.49 39.62 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.598 1.57 . . . . 0.0 114.097 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -61.14 160.53 10.07 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.568 1.947 . . . . 0.0 112.637 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 20.2 mt -106.98 124.74 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.7 t -72.22 -54.72 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 118.147 -0.93 . . . . 0.0 112.642 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -125.54 103.03 7.65 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.64 1.564 . . . . 0.0 109.636 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -76.0 129.05 36.29 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -142.21 142.8 32.69 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 118.554 0.616 . . . . 0.0 109.623 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -95.92 -6.16 39.76 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.87 1.268 . . . . 0.0 111.887 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 62.7 p -63.1 -36.59 84.09 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 93.3 mt -127.66 86.42 2.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.782 1.233 . . . . 0.0 109.455 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.8 t -140.99 141.48 31.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -132.78 144.86 50.53 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.222 1.409 . . . . 0.0 110.084 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.3 mmt85 -93.39 114.19 26.54 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.937 1.295 . . . . 0.0 110.215 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.0 mp -89.85 -79.82 0.33 Allowed 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -118.58 157.23 15.33 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -133.63 88.63 33.18 Favored Pre-proline 0 N--CA 1.454 -0.258 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -77.37 172.2 16.36 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.069 2.513 . . . . 0.0 112.18 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -89.63 165.25 14.35 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 125.1 1.36 . . . . 0.0 111.659 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.95 -43.55 21.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.712 0.768 . . . . 0.0 110.708 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -78.96 130.0 35.1 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.666 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.7 p -64.88 -32.97 60.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 O-C-N 123.286 0.366 . . . . 0.0 110.149 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -67.72 -28.44 67.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.54 1.136 . . . . 0.0 112.049 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -71.81 -33.3 68.41 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -75.06 174.47 9.33 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.835 1.254 . . . . 0.0 109.251 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -143.53 149.28 37.23 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.422 ' CG ' HG22 ' A' ' 106' ' ' VAL . 41.5 m-85 -136.76 146.58 45.93 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.933 1.293 . . . . 0.0 107.966 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.99 123.35 40.18 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.816 1.246 . . . . 0.0 110.115 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 tt -86.6 106.31 17.47 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 45.2 mt -113.45 177.99 4.44 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.597 1.159 . . . . 0.0 110.689 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 181' ' ' TYR . 5.2 p90 -152.66 159.28 43.19 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 177.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -140.65 -178.42 5.51 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.43 -28.47 68.3 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 41.0 t -71.63 -56.66 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.256 1.022 . . . . 0.0 109.754 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 178.24 -173.69 46.11 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.713 ' CE2' HD22 ' A' ' 243' ' ' LEU . 2.5 m-85 -78.05 164.13 25.31 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.068 0.547 . . . . 0.0 109.726 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -164.19 170.55 16.19 Favored 'General case' 0 N--CA 1.461 0.095 0 C-N-CA 125.434 1.493 . . . . 0.0 109.076 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 5.9 mt -118.2 134.67 61.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 103.816 -2.661 . . . . 0.0 103.816 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 21.1 t -110.57 139.61 45.66 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -137.3 112.71 9.3 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 6.3 tt -101.52 140.3 20.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.8 mt -131.46 110.7 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.201 1.0 . . . . 0.0 109.853 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -101.32 -157.68 27.03 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 49.6 m 70.57 55.76 0.27 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.562 1.145 . . . . 0.0 112.205 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -114.42 -126.31 4.24 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -130.01 123.67 31.12 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.911 1.684 . . . . 0.0 107.508 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.0 mm -60.94 146.18 11.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 124.805 1.242 . . . . 0.0 111.371 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 64.4 m -105.92 91.31 3.68 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 103.776 -2.675 . . . . 0.0 103.776 177.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -49.8 -30.78 10.28 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.614 1.166 . . . . 0.0 113.11 -178.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 60.6 t -45.96 -40.2 3.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 127.168 2.187 . . . . 0.0 110.276 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 7.1 p -120.4 -27.36 5.21 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.002 0.521 . . . . 0.0 110.963 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 92.31 22.57 29.18 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.898 1.714 . . . . 0.0 110.724 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -101.6 164.49 11.73 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.666 1.233 . . . . 0.0 112.388 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -89.49 146.47 24.6 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.541 -1.209 . . . . 0.0 107.866 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -77.35 30.84 0.15 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 127.522 2.329 . . . . 0.0 111.203 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -73.61 145.01 45.74 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 1.4 p -112.4 142.3 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 C-N-CA 124.468 1.107 . . . . 0.0 110.058 -177.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -109.51 123.59 49.65 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.2 mp -115.34 121.55 67.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 124.444 1.098 . . . . 0.0 108.822 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -102.37 116.67 33.12 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.47 0.708 . . . . 0.0 109.683 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -96.02 117.94 31.65 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.918 1.287 . . . . 0.0 109.625 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 22.2 m -133.21 167.85 25.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 124.565 1.146 . . . . 0.0 112.035 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.6 t -81.19 128.49 33.83 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 177.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.6 137.11 13.07 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -51.43 -41.84 49.35 Favored Glycine 0 C--N 1.336 0.528 0 CA-C-O 119.014 -0.881 . . . . 0.0 112.385 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 4.7 m -80.71 74.9 7.63 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -71.33 30.88 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.218 2.207 . . . . 0.0 112.939 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 37.8 m -143.96 47.33 1.43 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.208 2.203 . . . . 0.0 108.242 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -155.11 164.2 31.77 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -78.25 172.76 14.88 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.874 2.382 . . . . 0.0 112.354 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 24.2 m -62.25 147.63 47.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.485 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -165.92 156.29 12.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.8 mt -87.6 127.81 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -72.43 -52.95 13.68 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.783 1.233 . . . . 0.0 110.996 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . 0.42 ' CZ2' ' HB2' ' A' ' 232' ' ' GLN . 39.9 p-90 -150.58 166.6 29.76 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.002 1.321 . . . . 0.0 109.395 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.817 HG13 ' CE1' ' A' ' 229' ' ' TYR . 40.4 t -146.46 128.42 7.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 C-N-CA 126.015 1.726 . . . . 0.0 106.795 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.414 ' HD2' ' CE3' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -146.26 124.8 12.43 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.361 0.6 . . . . 0.0 109.898 178.67 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -79.42 93.06 5.3 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 103.08 -2.933 . . . . 0.0 103.08 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.0 p -68.8 -53.59 20.81 Favored 'General case' 0 C--O 1.237 0.424 0 O-C-N 121.667 -0.646 . . . . 0.0 110.348 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -103.33 174.54 5.82 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 25.1 mm -62.94 -27.62 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 O-C-N 121.89 -0.506 . . . . 0.0 111.144 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.89 -52.68 1.99 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.778 0.831 . . . . 0.0 110.697 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 1.7 t -64.94 132.33 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.737 0.815 . . . . 0.0 109.187 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . 0.817 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.3 OUTLIER -124.49 154.77 40.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.327 1.851 . . . . 0.0 109.187 -178.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -131.23 137.77 49.05 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 125.937 1.695 . . . . 0.0 108.784 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -143.61 161.62 38.04 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 126.274 1.83 . . . . 0.0 110.544 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.42 ' HB2' ' CZ2' ' A' ' 220' ' ' TRP . 22.6 tt0 -137.63 143.76 41.57 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.9 m -133.69 146.59 31.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 123.808 0.843 . . . . 0.0 108.97 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.87 143.78 33.54 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.454 0.701 . . . . 0.0 110.08 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 22.9 mt -140.33 134.49 15.46 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.876 0.871 . . . . 0.0 109.135 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.12 -45.63 0.64 Allowed 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.176 1.917 . . . . 0.0 110.9 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -61.73 -21.43 64.5 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.4 mp -64.57 -36.32 83.84 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.685 1.13 . . . . 0.0 109.993 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 50.8 m -56.75 -23.53 43.49 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.022 1.729 . . . . 0.0 113.208 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -64.24 -26.98 68.74 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 121.236 -0.915 . . . . 0.0 112.769 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 28.9 mt -83.19 122.79 28.86 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -48.26 -41.27 27.26 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.95 2.1 . . . . 0.0 113.84 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.713 HD22 ' CE2' ' A' ' 181' ' ' TYR . 49.6 mt -63.52 -37.17 86.26 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.76 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 24.0 mt -97.29 6.67 47.98 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 127.19 2.196 . . . . 0.0 112.788 -177.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -80.46 54.7 2.1 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.356 1.863 . . . . 0.0 108.644 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -150.47 133.57 16.15 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.977 0.911 . . . . 0.0 109.944 -178.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -160.44 163.35 33.11 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -141.9 70.86 1.34 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.404 1.082 . . . . 0.0 109.567 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 116.316 -1.802 . . . . 0.0 107.878 178.261 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.083 0 N-CA-C 107.975 -2.05 . . . . 0.0 107.975 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.51 123.96 23.6 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.7 m -137.08 136.62 38.51 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -139.69 87.15 2.15 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.2 m -47.26 -46.87 24.93 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 124.506 1.123 . . . . 0.0 112.212 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -58.97 -40.41 84.7 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.349 0.66 . . . . 0.0 112.464 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.58 -43.92 83.63 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 119.652 1.114 . . . . 0.0 108.192 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.9 p -63.41 -36.13 82.71 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.533 0.606 . . . . 0.0 110.121 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.49 -46.21 89.5 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 59.9 tp -59.65 -49.04 79.31 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.09 0.956 . . . . 0.0 109.098 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.9 mt -59.05 -50.49 73.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.363 1.065 . . . . 0.0 109.778 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 75.0 m -55.77 -52.48 63.83 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.225 1.41 . . . . 0.0 110.231 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -64.47 -41.9 96.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.214 1.006 . . . . 0.0 110.784 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 23.9 m -55.52 -51.69 66.19 Favored 'General case' 0 CA--C 1.523 -0.089 0 C-N-CA 125.284 1.434 . . . . 0.0 109.41 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 106' ' ' VAL . 12.5 tp -56.98 -52.37 65.49 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 118.669 -0.682 . . . . 0.0 109.933 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -56.79 -50.86 71.06 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.478 0.581 . . . . 0.0 111.303 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -55.76 -38.89 70.46 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.546 1.138 . . . . 0.0 109.443 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.64 -53.26 36.17 Favored Glycine 0 N--CA 1.437 -1.25 0 CA-C-O 118.323 -1.265 . . . . 0.0 110.181 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 102' ' ' LEU . 4.1 t -55.88 -53.13 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 119.297 1.548 . . . . 0.0 110.348 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -32.55 72.46 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 118.561 0.618 . . . . 0.0 112.007 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.3 m -68.2 -51.51 44.74 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.45 HD11 HD12 ' A' ' 183' ' ' ILE . 25.4 mt -55.1 -54.26 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.97 -39.14 80.84 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.648 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -61.89 -42.05 98.61 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 118.814 0.734 . . . . 0.0 111.257 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -82.0 -8.22 59.66 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 117.586 -1.197 . . . . 0.0 113.405 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.8 mp -111.65 -33.11 6.45 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 120.941 1.7 . . . . 0.0 110.87 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -53.67 -36.64 62.37 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 122.943 0.497 . . . . 0.0 110.876 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -61.94 -42.57 99.26 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 117.627 -1.178 . . . . 0.0 113.566 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -162.38 150.18 14.18 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 126.696 1.998 . . . . 0.0 111.261 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 31.5 m -75.96 167.27 22.17 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.713 0.805 . . . . 0.0 109.554 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.8 pt -125.55 157.27 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 125.256 1.423 . . . . 0.0 108.592 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.21 168.48 22.36 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.289 0.636 . . . . 0.0 111.667 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -151.68 119.94 6.35 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 124.883 1.273 . . . . 0.0 108.433 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -87.98 102.63 14.93 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.87 67.73 6.19 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.23 -116.2 9.02 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 107.815 -2.114 . . . . 0.0 107.815 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -65.51 -33.42 75.89 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -107.59 121.62 45.04 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 119.081 0.855 . . . . 0.0 111.128 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.5 mt -95.03 150.21 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.403 ' CD1' HG11 ' A' ' 221' ' ' VAL . 45.1 m-85 -119.61 137.87 53.59 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 126.149 1.78 . . . . 0.0 106.354 178.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.19 132.19 41.26 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 125.288 1.435 . . . . 0.0 109.11 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -130.3 112.28 13.17 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 124.893 1.37 . . . . 0.0 109.859 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 6.8 m -96.04 159.38 32.36 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.006 0.922 . . . . 0.0 111.018 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -64.87 88.02 0.18 Allowed 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 123.714 2.942 . . . . 0.0 114.046 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 56.98 54.56 35.96 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.3 mt -126.49 -66.52 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.418 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 8.6 pt-20 -167.5 163.37 14.78 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.178 1.791 . . . . 0.0 108.193 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -124.62 115.75 21.3 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 101.473 -3.529 . . . . 0.0 101.473 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.4 m -130.23 155.55 41.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 123.456 0.702 . . . . 0.0 111.849 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -119.26 126.68 52.07 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 104.961 -2.236 . . . . 0.0 104.961 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -144.91 157.67 44.07 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.885 0.874 . . . . 0.0 112.339 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -89.29 154.59 19.97 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 177.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 166.25 -162.86 36.42 Favored Glycine 0 CA--C 1.521 0.426 0 O-C-N 120.282 -1.511 . . . . 0.0 111.723 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.1 131.72 45.84 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 177.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.4 p -142.43 159.45 19.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -106.26 96.27 6.35 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.711 1.605 . . . . 0.0 108.161 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.2 t -54.86 -11.56 0.64 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.647 1.579 . . . . 0.0 115.065 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.8 mmtp -71.45 -23.33 61.82 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.71 1.204 . . . . 0.0 111.982 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.5 t -146.22 -20.29 0.44 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.625 0.77 . . . . 0.0 111.191 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 97.49 11.7 50.43 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 125.177 1.37 . . . . 0.0 112.074 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -72.2 115.19 11.14 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 117.862 0.831 . . . . 0.0 110.333 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 47.6 mt -72.69 118.24 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 28.1 t -79.39 -54.03 12.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 124.636 1.175 . . . . 0.0 108.512 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -141.52 153.31 44.81 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.512 1.125 . . . . 0.0 108.603 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 29.2 ptt85 -148.93 170.48 18.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.897 2.079 . . . . 0.0 108.772 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -153.13 151.9 30.69 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -92.93 -8.15 44.06 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.309 0.643 . . . . 0.0 111.452 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.4 p -72.5 -21.5 61.19 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 83.9 mt -129.99 80.4 1.95 Allowed 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.8 t -142.63 132.76 23.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 124.983 1.313 . . . . 0.0 108.452 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -121.7 150.18 42.17 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.926 1.69 . . . . 0.0 109.872 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -101.42 117.07 34.2 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 35.0 mt -89.35 -72.92 0.53 Allowed 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -133.69 152.45 20.49 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -122.7 94.77 47.25 Favored Pre-proline 0 N--CA 1.447 -0.584 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.53 ' HB2' HH22 ' A' ' 170' ' ' ARG . 41.8 Cg_endo -79.13 179.53 6.37 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 122.559 2.173 . . . . 0.0 109.723 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -92.09 173.03 8.04 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -90.59 -41.44 11.35 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.769 0.668 . . . . 0.0 110.268 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -83.35 138.29 33.59 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 125.666 1.586 . . . . 0.0 108.504 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.44 -24.3 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -77.56 -20.73 53.63 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.834 0.853 . . . . 0.0 113.059 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -76.64 -37.28 56.59 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.787 0.804 . . . . 0.0 110.547 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.53 HH22 ' HB2' ' A' ' 163' ' ' PRO . 0.3 OUTLIER -84.72 174.4 9.94 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.531 0.732 . . . . 0.0 110.192 179.563 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -147.6 120.56 8.77 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -96.75 160.01 14.61 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -131.62 122.04 25.36 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.982 0.913 . . . . 0.0 110.966 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 22.0 tp -84.65 103.53 13.84 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.403 HD12 ' HB2' ' A' ' 184' ' ' SER . 36.0 mt -109.75 -179.84 3.92 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.134 1.374 . . . . 0.0 108.854 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.427 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 5.0 p90 -159.03 164.56 35.37 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.19 -0.944 . . . . 0.0 109.918 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -140.71 -178.29 5.46 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.1 -20.63 64.24 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.675 1.19 . . . . 0.0 110.641 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 74.0 t -79.65 -65.74 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -173.29 -172.27 38.65 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.122 1.344 . . . . 0.0 110.01 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.427 ' CD2' ' HB3' ' A' ' 176' ' ' TYR . 29.3 m-85 -83.69 164.47 19.62 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.538 0.735 . . . . 0.0 111.433 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -168.08 165.92 13.22 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.638 1.575 . . . . 0.0 109.247 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.45 HD12 HD11 ' A' ' 109' ' ' ILE . 4.8 mt -112.46 128.97 68.83 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.403 ' HB2' HD12 ' A' ' 175' ' ' LEU . 40.3 t -97.11 130.78 44.34 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 126.155 1.782 . . . . 0.0 108.205 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -138.15 107.48 6.12 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 7.6 tt -100.53 140.53 19.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 5.6 mt -131.76 111.26 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 123.72 0.808 . . . . 0.0 110.532 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.72 -161.21 25.85 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 178.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 50.6 m 71.38 50.08 0.29 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.234 1.814 . . . . 0.0 112.206 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -105.5 -95.2 2.38 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 107.514 -2.234 . . . . 0.0 107.514 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -154.48 123.78 6.45 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.553 1.541 . . . . 0.0 110.854 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.4 mm -65.6 116.87 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 119.616 1.098 . . . . 0.0 108.886 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 19.8 p -69.83 119.84 14.66 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 122.524 0.33 . . . . 0.0 110.908 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -70.72 -8.47 52.36 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.581 -0.699 . . . . 0.0 110.145 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 23.1 t -65.23 -42.93 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 126.359 1.864 . . . . 0.0 109.042 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 6.7 p -125.88 -27.88 3.27 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.948 0.795 . . . . 0.0 112.814 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 97.74 19.28 25.16 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 126.801 2.143 . . . . 0.0 110.036 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -107.25 168.3 9.31 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 119.2 1.5 . . . . 0.0 112.45 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.45 163.0 27.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 122.289 1.042 . . . . 0.0 111.401 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -99.3 29.09 4.12 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 126.514 1.926 . . . . 0.0 108.059 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -73.08 148.08 44.36 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.781 0.8 . . . . 0.0 110.433 -175.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.2 p -116.02 141.53 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.542 -177.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -110.65 124.52 52.06 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.6 mp -113.3 128.03 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 125.649 1.58 . . . . 0.0 109.059 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -108.4 107.7 18.36 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.581 1.152 . . . . 0.0 108.578 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -84.0 122.47 28.81 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 107.886 -1.154 . . . . 0.0 107.886 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 23.0 m -131.45 169.86 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 125.767 1.627 . . . . 0.0 112.527 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -83.11 144.05 30.13 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.633 -1.292 . . . . 0.0 107.735 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -113.39 123.62 6.23 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -32.04 -62.2 0.29 Allowed Glycine 0 CA--C 1.523 0.55 0 C-N-CA 128.954 3.169 . . . . 0.0 114.765 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 2.0 p -78.02 89.79 4.18 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -67.33 35.09 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.107 2.163 . . . . 0.0 115.488 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.4 m -148.5 45.82 1.04 Allowed 'General case' 0 CA--C 1.54 0.559 0 O-C-N 119.837 -1.789 . . . . 0.0 111.161 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.54 162.59 28.48 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.02 169.86 20.34 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.849 2.366 . . . . 0.0 112.036 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 10.3 m -70.7 156.09 39.93 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -168.45 155.88 7.87 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.8 mt -77.73 134.17 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -74.14 -61.43 1.86 Allowed 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 41.7 p-90 -140.25 166.47 24.61 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 125.812 1.645 . . . . 0.0 109.121 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.586 HG13 ' CE1' ' A' ' 229' ' ' TYR . 53.3 t -147.5 134.6 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.19 131.35 11.08 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -85.69 86.37 7.37 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 101.629 -3.471 . . . . 0.0 101.629 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 8.6 p -61.2 -58.09 9.73 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.88 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 56.3 mmtt -91.61 -172.82 3.35 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.7 mp -74.54 -36.61 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 121.021 -1.049 . . . . 0.0 109.492 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 4.6 m -120.91 -43.08 2.47 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.468 0.707 . . . . 0.0 111.835 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 1.1 t -67.7 136.11 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . 0.586 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.7 OUTLIER -124.11 148.02 47.48 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.41 2.284 . . . . 0.0 110.011 -178.01 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -126.18 138.21 53.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.369 2.268 . . . . 0.0 106.655 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.95 161.98 38.84 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.943 1.697 . . . . 0.0 111.065 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -138.35 149.67 45.82 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.453 0.701 . . . . 0.0 109.962 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 72.2 t -133.18 135.96 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.593 1.157 . . . . 0.0 109.306 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.37 130.0 53.57 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.171 1.389 . . . . 0.0 111.26 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 33.4 mt -133.56 138.49 31.29 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-O 118.612 -0.708 . . . . 0.0 110.522 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.76 -43.9 1.63 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.213 2.609 . . . . 0.0 112.467 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -63.57 -20.44 65.64 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 37.1 mt -72.01 -35.28 69.38 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-O 118.828 -0.606 . . . . 0.0 110.037 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 48.2 m -56.3 -21.67 25.53 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.393 1.477 . . . . 0.0 113.149 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -65.98 -31.39 72.27 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.626 0.77 . . . . 0.0 112.115 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 64.4 mt -77.02 116.46 17.7 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -48.1 -37.12 14.56 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.5 mp -63.73 -36.76 84.94 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.01 -1.056 . . . . 0.0 110.028 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -91.87 3.21 55.69 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.746 2.019 . . . . 0.0 112.704 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -78.21 34.05 0.2 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.779 0.832 . . . . 0.0 111.002 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -153.04 128.04 9.66 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.796 1.638 . . . . 0.0 109.46 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -170.81 162.03 7.43 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.954 1.702 . . . . 0.0 107.751 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 53.36 33.63 16.18 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.608 1.163 . . . . 0.0 112.926 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.986 0 C-N-CA 127.523 2.329 . . . . 0.0 113.323 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.469 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.59 164.38 25.0 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 117.919 0.859 . . . . 0.0 110.537 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.6 p -156.19 171.27 20.46 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 125.877 1.671 . . . . 0.0 108.479 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -137.2 153.59 50.38 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.452 1.501 . . . . 0.0 108.109 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.9 m -45.09 -44.75 10.62 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 128.472 2.709 . . . . 0.0 114.45 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -60.56 -45.2 94.79 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 121.872 -0.517 . . . . 0.0 111.316 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -73.9 -44.75 54.2 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.167 0.587 . . . . 0.0 110.588 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 43.4 p -61.53 -35.91 79.07 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 118.52 0.6 . . . . 0.0 110.243 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.94 -48.81 75.05 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.908 0.883 . . . . 0.0 108.774 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 41.6 tp -57.71 -46.76 83.95 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.9 mt -59.1 -53.22 60.79 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.458 0.703 . . . . 0.0 109.704 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 38.6 m -55.1 -43.64 74.21 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.132 1.373 . . . . 0.0 110.803 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.75 -51.52 33.38 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 117.843 -1.075 . . . . 0.0 109.013 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 42.0 m -54.36 -44.26 72.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 119.701 1.137 . . . . 0.0 110.971 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.3 tp -60.12 -55.51 32.96 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 118.686 0.675 . . . . 0.0 109.612 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -56.72 -49.55 74.84 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.779 1.232 . . . . 0.0 110.598 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -57.35 -49.81 74.95 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.722 1.209 . . . . 0.0 108.543 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.78 -46.45 94.48 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 49.9 t -58.8 -52.23 62.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 C-N-CA 126.096 1.758 . . . . 0.0 111.133 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -32.66 74.45 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 119.552 1.069 . . . . 0.0 109.732 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.5 m -66.85 -43.27 84.11 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 34.7 mt -59.16 -51.89 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -35.68 72.27 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.98 -0.533 . . . . 0.0 111.297 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -66.89 -56.56 9.73 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.244 0.929 . . . . 0.0 109.953 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.89 -24.12 66.74 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -178.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 80.5 mt -94.31 -27.93 15.84 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 119.045 0.839 . . . . 0.0 109.955 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -64.1 -27.33 69.02 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 121.663 -0.648 . . . . 0.0 109.709 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -63.74 -46.89 83.3 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.346 1.058 . . . . 0.0 109.012 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -163.37 156.46 18.87 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 126.073 1.749 . . . . 0.0 110.487 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 76.8 m -75.84 176.2 8.03 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 34.1 pt -135.58 149.78 28.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.69 168.13 20.92 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.091 0.556 . . . . 0.0 111.337 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -154.96 128.54 8.55 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.339 1.056 . . . . 0.0 112.16 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -92.45 102.61 15.07 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.4 0.68 . . . . 0.0 109.35 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.92 67.63 8.23 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.461 1.904 . . . . 0.0 106.558 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 67.21 -115.36 7.08 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -68.25 -33.22 73.98 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 118.789 -0.624 . . . . 0.0 112.188 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -106.25 154.18 21.1 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 119.794 1.179 . . . . 0.0 111.603 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.7 mt -121.36 149.94 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.529 ' CD1' HG11 ' A' ' 221' ' ' VAL . 53.1 m-85 -126.76 129.08 47.66 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 127.014 2.125 . . . . 0.0 107.993 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -125.3 125.21 43.16 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 127.104 2.162 . . . . 0.0 109.13 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -122.68 126.67 48.05 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.978 1.311 . . . . 0.0 109.637 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.445 ' HB3' HD12 ' A' ' 133' ' ' ILE . 17.8 m -113.72 157.24 42.19 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.641 0.776 . . . . 0.0 112.77 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -60.29 90.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.354 0.845 1 C-N-CA 126.163 4.575 . . . . 0.0 115.976 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 62.21 31.05 77.71 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.874 -0.491 . . . . 0.0 111.874 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.445 HD12 ' HB3' ' A' ' 130' ' ' CYS . 4.9 mt -110.64 -66.08 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.252 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.52 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 9.4 pt-20 179.67 164.74 1.08 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.753 1.621 . . . . 0.0 109.689 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.35 123.12 38.7 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.2 m -131.23 155.85 42.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 124.385 1.074 . . . . 0.0 111.747 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -123.29 122.72 39.04 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.908 1.683 . . . . 0.0 108.144 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -146.45 156.71 43.49 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.364 1.066 . . . . 0.0 111.404 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -93.15 153.53 18.59 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 168.18 -163.71 37.39 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -116.18 142.9 46.21 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.9 p -154.79 140.67 11.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 124.004 0.922 . . . . 0.0 108.886 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -82.78 95.85 8.02 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.0 t -56.54 -17.22 7.72 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.102 1.319 . . . . 0.0 112.479 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -62.78 -23.56 67.28 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.835 2.454 . . . . 0.0 112.654 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.439 HG23 ' H ' ' A' ' 148' ' ' GLU . 1.5 t -141.77 -33.09 0.51 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.215 1.406 . . . . 0.0 110.79 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 106.99 0.64 35.98 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.963 1.744 . . . . 0.0 110.371 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.439 ' H ' HG23 ' A' ' 146' ' ' THR . 77.3 mt-10 -63.89 113.07 3.21 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.434 1.617 . . . . 0.0 110.415 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.3 mt -71.57 139.31 20.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 103.66 -2.719 . . . . 0.0 103.66 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 15.0 t -103.3 -36.16 4.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 123.748 0.819 . . . . 0.0 110.71 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -147.43 126.94 13.22 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 119.199 0.908 . . . . 0.0 109.057 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -108.05 104.68 14.17 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.115 1.766 . . . . 0.0 108.424 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.33 150.76 46.98 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.193 0.997 . . . . 0.0 109.362 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -97.41 -22.81 16.39 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 118.271 2.693 . . . . 0.0 118.271 -178.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 10.5 t -96.67 -43.03 7.73 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 120.559 1.527 . . . . 0.0 112.091 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 76.9 mt -83.24 72.43 10.17 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 41.9 t -137.96 138.12 44.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -141.56 153.51 44.88 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.364 1.465 . . . . 0.0 108.33 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -109.88 127.92 55.02 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.508 1.523 . . . . 0.0 110.513 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -90.66 -71.16 0.64 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -133.59 160.66 24.08 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 124.137 0.875 . . . . 0.0 111.759 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -130.36 90.6 40.91 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 126.167 1.787 . . . . 0.0 107.879 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.52 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 54.6 Cg_endo -75.95 -175.55 2.56 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 124.471 3.447 . . . . 0.0 110.288 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -110.75 161.19 16.03 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.915 0.886 . . . . 0.0 110.314 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.15 -29.55 57.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.731 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -99.11 133.79 42.89 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.6 p -67.18 -26.43 36.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 122.917 0.487 . . . . 0.0 110.349 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -74.0 -16.19 61.07 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.145 1.778 . . . . 0.0 112.548 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -91.94 -13.69 30.74 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.63 1.572 . . . . 0.0 108.744 177.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -107.15 175.25 5.56 Favored 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 126.961 2.104 . . . . 0.0 107.786 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -148.07 152.34 37.2 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -138.6 165.52 26.68 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.784 1.234 . . . . 0.0 107.819 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -139.37 122.59 16.97 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.477 1.111 . . . . 0.0 109.296 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 25.7 tp -88.89 100.16 12.96 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 54.1 mt -106.29 -179.55 3.97 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.281 2.233 . . . . 0.0 110.504 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -156.54 151.8 26.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.137 0.975 . . . . 0.0 109.035 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -134.32 -174.54 3.59 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.066 1.746 . . . . 0.0 106.621 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -54.87 -31.4 59.7 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.997 2.119 . . . . 0.0 112.035 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 73.0 t -69.81 -67.53 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -177.61 -163.6 29.71 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.534 ' CE2' HD22 ' A' ' 243' ' ' LEU . 3.3 m-85 -78.19 160.95 27.68 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.421 0.688 . . . . 0.0 109.397 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -165.84 168.4 15.97 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.27 1.428 . . . . 0.0 109.453 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.0 mt -117.45 124.85 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.3 t -102.16 133.44 47.01 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -137.04 111.57 8.63 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.6 tt -101.1 127.82 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 5.8 mt -120.39 114.13 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.29 1.036 . . . . 0.0 111.522 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.0 -172.81 27.64 Favored Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 125.17 1.367 . . . . 0.0 111.455 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.2 t 84.57 58.52 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 128.242 2.617 . . . . 0.0 110.808 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -110.23 -127.4 5.28 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 107.656 -2.178 . . . . 0.0 107.656 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -126.82 118.79 25.34 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 19.1 mm -59.82 134.53 25.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 18.9 p -89.25 106.73 18.63 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -63.66 -12.22 32.18 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 119.104 0.865 . . . . 0.0 110.385 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 29.0 t -60.73 -42.01 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 126.937 2.095 . . . . 0.0 109.767 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 3.5 p -125.23 -24.06 4.05 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.856 0.753 . . . . 0.0 112.504 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 87.51 29.31 22.08 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 108.499 -1.84 . . . . 0.0 108.499 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -108.15 164.55 12.2 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 122.545 1.165 . . . . 0.0 111.283 178.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -91.51 138.41 31.59 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 1.8 mtt85 -70.69 29.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 129.921 3.288 . . . . 0.0 112.784 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 16.0 ptt? -72.46 148.81 44.77 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.018 0.913 . . . . 0.0 110.552 -174.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -115.91 143.39 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.369 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -108.26 133.61 52.25 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.41 110.17 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -95.21 108.4 20.53 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.656 0.782 . . . . 0.0 109.814 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -84.68 126.85 33.73 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.054 0.542 . . . . 0.0 109.726 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 32.3 m -139.27 175.65 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 125.877 1.671 . . . . 0.0 112.315 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.9 t -93.0 126.16 37.94 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.533 1.533 . . . . 0.0 107.563 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.12 164.82 44.57 Favored Glycine 0 N--CA 1.467 0.756 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -54.12 -76.12 0.2 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 125.094 1.33 . . . . 0.0 110.394 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 47.8 m -70.85 145.73 50.08 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 34.0 p30 -117.26 33.26 5.71 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 29.6 m -134.78 47.33 2.38 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.733 1.213 . . . . 0.0 113.433 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -153.54 165.71 31.53 Favored Glycine 0 CA--C 1.524 0.615 0 O-C-N 120.451 -1.405 . . . . 0.0 110.333 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -70.82 163.99 37.18 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.038 1.825 . . . . 0.0 110.327 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 14.1 p -67.24 155.83 37.86 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.236 1.014 . . . . 0.0 109.137 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -169.02 159.42 9.25 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.67 1.188 . . . . 0.0 108.711 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.6 mp -76.74 134.03 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -78.11 -55.34 5.36 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 125.973 1.709 . . . . 0.0 109.934 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . 0.402 ' CE3' ' CD ' ' A' ' 222' ' ' ARG . 27.9 p-90 -145.69 165.05 29.9 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 124.755 1.222 . . . . 0.0 108.686 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.766 HG13 ' CE1' ' A' ' 229' ' ' TYR . 39.0 t -144.47 127.39 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.402 ' CD ' ' CE3' ' A' ' 220' ' ' TRP . 0.3 OUTLIER -153.82 118.69 5.01 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 124.107 0.879 . . . . 0.0 109.189 179.355 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -74.64 95.2 2.79 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 102.626 -3.102 . . . . 0.0 102.626 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.7 p -63.73 -57.77 8.95 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.81 0.844 . . . . 0.0 111.69 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -100.87 -178.51 3.79 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.435 ' H ' HD12 ' A' ' 226' ' ' ILE . 4.4 mp -58.2 -41.55 81.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 O-C-N 121.79 -0.569 . . . . 0.0 110.022 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -123.52 -10.1 7.93 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -177.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 59.0 t -91.74 130.5 40.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . 0.766 ' CE1' HG13 ' A' ' 221' ' ' VAL . 1.1 t80 -123.38 143.51 50.07 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.218 1.007 . . . . 0.0 108.354 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -127.3 140.92 51.87 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 125.609 1.564 . . . . 0.0 107.451 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -139.7 159.04 43.09 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.272 1.829 . . . . 0.0 108.042 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -131.48 144.62 51.28 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 99.6 t -132.55 133.44 59.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.2 p -104.66 141.0 37.22 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 43.6 mt -137.36 137.12 21.55 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -72.99 -39.28 2.35 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.065 1.843 . . . . 0.0 112.127 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -60.52 -34.61 74.35 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.587 0.63 . . . . 0.0 111.338 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 5.1 mp -59.45 -29.95 68.15 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-O 118.745 -0.645 . . . . 0.0 111.428 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 57.2 m -63.57 -19.35 64.75 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.935 0.894 . . . . 0.0 112.618 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -67.46 -38.58 84.66 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.169 0.588 . . . . 0.0 111.086 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 49.6 mt -67.0 117.45 9.08 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.352 1.061 . . . . 0.0 108.539 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -48.36 -37.87 17.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.347 1.459 . . . . 0.0 114.874 -178.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.534 HD22 ' CE2' ' A' ' 181' ' ' TYR . 17.9 mt -62.72 -33.55 75.35 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.578 -0.702 . . . . 0.0 110.015 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -98.21 2.42 48.35 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.986 2.115 . . . . 0.0 113.064 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -81.48 49.41 1.3 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.534 1.134 . . . . 0.0 107.998 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -155.17 140.11 17.29 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 131.383 3.873 . . . . 0.0 106.478 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -167.77 167.96 12.76 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 127.859 2.463 . . . . 0.0 106.209 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -142.75 55.92 1.41 Allowed 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 27.1 t70 . . . . . 0 C--O 1.252 1.209 0 O-C-N 120.872 -1.143 . . . . 0.0 109.882 179.264 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.768 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -111.19 165.9 11.53 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.728 1.611 . . . . 0.0 110.496 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.0 p -98.52 -29.56 13.02 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.664 0.786 . . . . 0.0 110.699 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -145.7 119.52 9.27 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 72.0 m -53.67 -52.88 58.57 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.462 0.705 . . . . 0.0 111.361 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -53.24 -46.25 69.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.802 1.241 . . . . 0.0 111.409 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -58.79 -51.04 71.68 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 122.797 0.439 . . . . 0.0 110.246 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.9 p -62.82 -39.82 95.51 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 117.652 0.206 . . . . 0.0 111.221 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.68 -45.21 91.13 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.479 -0.763 . . . . 0.0 108.971 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 45.8 tp -58.42 -44.79 89.22 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.707 1.203 . . . . 0.0 108.434 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 11.5 mt -64.05 -54.92 26.59 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.238 1.015 . . . . 0.0 110.184 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.3 m -57.14 -44.24 83.19 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.03 -1.044 . . . . 0.0 110.784 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -62.31 -50.46 71.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 120.977 -1.077 . . . . 0.0 108.441 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.0 m -56.0 -40.77 73.85 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.144 0.977 . . . . 0.0 110.477 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.503 ' O ' HG23 ' A' ' 106' ' ' VAL . 13.6 tp -62.29 -53.33 56.64 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.726 0.694 . . . . 0.0 109.136 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.34 -48.33 80.9 Favored 'General case' 0 C--N 1.335 -0.064 0 C-N-CA 123.43 0.692 . . . . 0.0 110.616 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -60.86 -42.88 98.73 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.374 1.47 . . . . 0.0 110.269 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.11 -47.11 85.13 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 102' ' ' LEU . 94.5 t -57.87 -53.07 50.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 118.566 1.183 . . . . 0.0 110.125 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -31.4 72.55 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 119.177 0.899 . . . . 0.0 110.488 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.6 m -65.75 -48.11 72.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 40.8 mt -58.78 -53.02 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 C-N-CA 123.886 0.875 . . . . 0.0 108.805 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.47 -36.57 73.92 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.326 0.512 . . . . 0.0 111.31 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -63.58 -54.5 35.0 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.536 1.062 . . . . 0.0 108.318 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.21 10.59 0.55 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 128.399 2.68 . . . . 0.0 114.825 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.6 mt -132.68 -32.85 1.25 Allowed 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 124.636 1.174 . . . . 0.0 108.278 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -61.39 -34.43 75.33 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -59.14 -45.05 91.95 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.92 1.688 . . . . 0.0 111.922 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -166.72 153.04 8.52 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.593 1.957 . . . . 0.0 109.683 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.0 m -76.48 174.76 9.9 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 27.5 pt -131.66 152.16 36.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -146.75 165.05 30.82 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 122.91 0.484 . . . . 0.0 110.786 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -150.34 128.48 11.95 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.539 1.536 . . . . 0.0 110.595 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -94.27 102.8 14.82 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.463 1.105 . . . . 0.0 109.707 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.77 66.87 6.16 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.52 -115.47 7.67 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -63.6 -35.26 79.92 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.325 1.05 . . . . 0.0 112.213 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -107.14 153.45 22.63 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 119.211 0.914 . . . . 0.0 110.502 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.2 mt -119.92 152.68 22.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -124.97 132.47 53.27 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 127.182 2.193 . . . . 0.0 107.31 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -126.96 132.93 50.71 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 125.87 1.668 . . . . 0.0 107.376 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -129.49 111.52 12.84 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 6.6 m -100.37 159.0 30.92 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 123.814 0.846 . . . . 0.0 111.236 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -61.46 92.97 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 124.442 3.428 . . . . 0.0 114.121 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 54.95 39.28 67.97 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.062 -0.854 . . . . 0.0 112.217 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.4 mt -109.9 -66.94 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.412 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 9.7 pt-20 -171.32 161.34 6.47 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.982 1.713 . . . . 0.0 106.917 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -119.91 121.7 39.6 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 101.625 -3.472 . . . . 0.0 101.625 177.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.1 m -137.39 155.06 31.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 123.506 0.722 . . . . 0.0 111.725 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -119.91 132.6 55.59 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 177.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -146.34 158.19 43.86 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.235 1.014 . . . . 0.0 113.032 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -88.8 148.46 23.9 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 165.64 -162.93 36.3 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -178.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.95 147.04 50.81 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 124.497 1.119 . . . . 0.0 108.186 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.2 p -152.81 162.74 2.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 124.988 1.315 . . . . 0.0 107.813 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -105.82 107.41 18.39 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.923 1.689 . . . . 0.0 107.122 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.1 t -62.49 -22.47 66.29 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 121.051 1.751 . . . . 0.0 110.827 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -58.1 -25.18 61.04 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.515 1.526 . . . . 0.0 114.154 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.9 t -146.68 -23.6 0.42 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.33 0.968 . . . . 0.0 111.558 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 101.52 6.91 49.71 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.863 1.697 . . . . 0.0 110.052 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -67.26 114.85 6.31 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 118.897 1.349 . . . . 0.0 110.927 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 56.3 mt -71.74 158.34 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 19.4 t -135.58 -34.67 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 O-C-N 120.955 -1.091 . . . . 0.0 110.998 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -131.4 122.96 27.21 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 104.262 -2.496 . . . . 0.0 104.262 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -141.33 54.51 1.54 Allowed 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.163 1.385 . . . . 0.0 111.27 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -59.46 120.62 9.71 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.225 1.41 . . . . 0.0 110.196 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -69.87 1.86 4.01 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.22 -10.24 59.64 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.357 -1.465 . . . . 0.0 112.699 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 43.3 mt -136.45 77.97 1.68 Allowed 'General case' 0 C--O 1.231 0.096 0 C-N-CA 124.053 0.941 . . . . 0.0 108.733 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 12.2 t -140.91 135.44 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.924 1.29 . . . . 0.0 109.351 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -119.64 176.27 5.46 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.735 1.214 . . . . 0.0 110.972 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -128.31 120.31 26.82 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 26.2 mt -96.77 -67.37 0.85 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.738 1.215 . . . . 0.0 109.807 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -127.25 149.2 17.73 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 189' ' ' SER . 26.7 tttp -124.89 83.54 59.59 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 125.969 1.708 . . . . 0.0 108.261 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 63.8 Cg_endo -75.58 173.61 14.2 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.403 2.069 . . . . 0.0 109.928 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -92.89 161.57 14.43 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.554 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -80.68 -22.98 39.91 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.742 0.817 . . . . 0.0 112.929 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -112.35 147.51 36.22 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.157 0.983 . . . . 0.0 108.456 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.2 p -71.25 -32.14 46.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -74.14 -12.87 60.72 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -177.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -84.68 -18.67 34.56 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.474 0.309 . . . . 0.0 110.289 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -111.84 171.84 7.25 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.662 1.185 . . . . 0.0 111.983 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -138.69 117.14 12.03 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.445 1.098 . . . . 0.0 109.471 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.408 ' CD2' HG22 ' A' ' 106' ' ' VAL . 3.3 m-30 -96.76 158.29 15.5 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -130.55 126.6 37.18 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.081 0.553 . . . . 0.0 112.159 -177.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.2 tt -90.28 101.8 14.52 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.332 0.653 . . . . 0.0 110.504 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 5.2 mt -115.03 174.81 5.79 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.87 1.668 . . . . 0.0 108.333 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -143.02 163.96 31.37 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 120.345 -1.472 . . . . 0.0 109.069 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -137.94 -176.38 4.41 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.902 1.681 . . . . 0.0 110.388 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -69.39 5.28 1.37 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.401 1.88 . . . . 0.0 115.076 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 41.5 t -118.9 -63.98 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -162.51 -160.86 11.47 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 119.812 1.187 . . . . 0.0 111.888 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.547 ' CE2' HD22 ' A' ' 243' ' ' LEU . 3.1 m-85 -91.13 160.85 15.36 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -164.84 171.88 13.61 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 7.4 mt -121.07 133.57 67.28 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 4.4 t -111.13 132.11 54.55 Favored 'General case' 0 N--CA 1.439 -1.002 0 O-C-N 124.579 1.175 . . . . 0.0 108.752 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -133.64 111.57 10.72 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.8 tt -96.79 132.78 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.5 mt -124.32 111.4 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 124.501 1.121 . . . . 0.0 111.03 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -103.34 -158.54 25.01 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.468 ' HB3' ' HB3' ' A' ' 162' ' ' LYS . 1.6 t 70.69 28.29 3.5 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 127.062 2.145 . . . . 0.0 112.286 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -81.28 -90.45 0.56 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 103.611 -3.796 . . . . 0.0 103.611 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -157.14 165.97 34.54 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 29.2 mm -94.36 145.5 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 126.235 1.814 . . . . 0.0 108.448 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.8 p -107.71 98.41 8.01 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 106.114 -1.809 . . . . 0.0 106.114 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -63.22 -7.62 6.42 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 120.28 1.4 . . . . 0.0 112.444 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 86.0 t -63.65 -38.43 82.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 126.499 1.92 . . . . 0.0 108.147 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 21.0 p -119.45 -32.5 4.32 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.213 1.005 . . . . 0.0 110.539 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 88.72 32.95 10.47 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -118.01 -176.93 3.15 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.643 1.577 . . . . 0.0 109.116 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -102.89 148.34 25.77 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.878 0.871 . . . . 0.0 110.228 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.04 29.62 0.08 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 129.317 3.047 . . . . 0.0 111.312 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -72.74 151.48 42.12 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 120.819 -1.176 . . . . 0.0 110.967 -174.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.3 p -121.95 149.12 25.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.771 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -114.95 130.35 56.9 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.6 mp -117.63 111.91 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -96.04 108.39 20.8 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.651 1.18 . . . . 0.0 108.835 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -87.83 121.15 29.9 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.115 0.966 . . . . 0.0 111.677 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.71 163.86 36.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 126.085 1.754 . . . . 0.0 111.002 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.17 139.8 40.01 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -94.85 178.23 36.11 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -89.77 -39.14 6.29 Favored Glycine 0 CA--C 1.525 0.699 0 O-C-N 121.909 -0.759 . . . . 0.0 111.513 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.8 t -82.62 94.8 7.61 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.48 ' HA ' ' HB3' ' A' ' 236' ' ' PRO . 5.6 p30 -77.64 39.8 0.28 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.066 0.546 . . . . 0.0 111.246 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 41.0 p -156.7 26.26 0.33 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -138.18 176.99 20.39 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 118.676 0.671 . . . . 0.0 112.562 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.47 164.33 28.7 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.298 2.666 . . . . 0.0 112.098 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 8.6 t -70.91 159.58 34.41 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.89 161.85 7.22 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 126.079 1.752 . . . . 0.0 107.452 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.8 mp -82.2 130.08 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -71.15 -59.22 2.89 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.539 1.135 . . . . 0.0 110.351 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 29.6 p-90 -143.55 166.04 25.92 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 125.244 1.418 . . . . 0.0 108.552 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.653 HG13 ' CE1' ' A' ' 229' ' ' TYR . 42.7 t -145.55 127.74 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.82 118.23 8.48 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 177.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -77.81 91.27 4.1 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 101.002 -3.703 . . . . 0.0 101.002 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.7 p -56.75 -53.13 61.37 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.871 1.669 . . . . 0.0 113.513 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.495 ' HB2' ' H ' ' A' ' 228' ' ' VAL . 71.6 mmtt -116.14 176.63 5.01 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 16.9 mm -61.72 -30.52 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -122.69 -24.28 4.92 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.495 ' H ' ' HB2' ' A' ' 225' ' ' LYS . 21.8 t -90.28 135.67 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . 0.653 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.8 OUTLIER -131.81 142.13 49.64 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -179.517 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -127.17 140.04 52.53 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 125.111 1.364 . . . . 0.0 108.615 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -140.72 159.12 42.88 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.462 1.505 . . . . 0.0 109.042 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -130.56 139.63 50.46 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 79.7 t -122.06 146.74 26.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 124.503 1.121 . . . . 0.0 108.313 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.52 130.4 54.23 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 123.122 0.569 . . . . 0.0 109.98 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 63.4 mt -132.19 137.94 31.18 Favored Pre-proline 0 C--O 1.236 0.383 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.193 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.48 ' HB3' ' HA ' ' A' ' 212' ' ' ASN . 81.3 Cg_endo -74.89 -44.88 0.32 Allowed 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.188 1.926 . . . . 0.0 112.478 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.84 -25.76 21.15 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.681 1.192 . . . . 0.0 113.261 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 88.6 mt -67.49 -34.38 77.02 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-N 118.651 0.659 . . . . 0.0 112.762 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 19.0 m -57.66 -17.75 16.6 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.879 1.272 . . . . 0.0 114.312 -178.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -64.12 -29.02 70.17 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.941 -0.475 . . . . 0.0 110.363 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 30.0 mt -80.29 113.44 18.47 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -49.61 -30.74 9.31 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.547 HD22 ' CE2' ' A' ' 181' ' ' TYR . 17.5 mt -62.74 -36.18 82.18 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.756 -0.59 . . . . 0.0 109.535 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -95.28 2.96 54.96 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 126.888 2.075 . . . . 0.0 114.586 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -73.09 59.68 0.53 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.58 1.952 . . . . 0.0 109.101 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -134.1 153.23 51.94 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 128.757 2.823 . . . . 0.0 109.804 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 39.9 m-20 53.0 36.05 21.03 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.135 2.174 . . . . 0.0 111.557 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -112.79 -3.39 14.2 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 129.363 3.065 . . . . 0.0 111.797 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 . . . . . 0 C--O 1.245 0.853 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.16 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.185 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.35 164.32 30.16 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.3 p -141.14 104.83 4.71 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 58.77 10.58 1.52 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.6 m -49.77 -49.05 49.9 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 125.146 1.378 . . . . 0.0 111.945 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -62.69 -15.07 50.85 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -91.18 -53.7 4.25 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.4 p -59.34 -36.46 75.74 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.858 -0.591 . . . . 0.0 110.774 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.48 -45.56 92.48 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.001 0.819 . . . . 0.0 110.03 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.7 tp -60.95 -40.66 94.16 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 118.947 0.794 . . . . 0.0 109.449 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.4 mt -60.65 -54.38 46.02 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 55.9 m -54.2 -44.88 72.0 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.499 1.12 . . . . 0.0 111.534 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.2 ttmt -62.78 -50.99 68.85 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 m -56.88 -42.91 80.68 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 117.815 -1.088 . . . . 0.0 111.156 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.438 ' O ' HG23 ' A' ' 106' ' ' VAL . 20.9 tp -62.66 -53.48 53.93 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 119.881 1.219 . . . . 0.0 109.504 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -55.38 -52.41 63.62 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 123.91 0.884 . . . . 0.0 111.198 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -55.22 -50.48 69.31 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 125.008 1.323 . . . . 0.0 108.496 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.421 ' HA3' HD11 ' A' ' 183' ' ' ILE . . . -58.05 -50.27 67.57 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 123.91 0.767 . . . . 0.0 112.081 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 102' ' ' LEU . 89.9 t -59.18 -53.23 50.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 124.215 1.006 . . . . 0.0 110.136 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -30.86 71.9 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 118.983 0.811 . . . . 0.0 110.6 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.4 m -66.49 -45.15 80.6 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.426 HD11 HD12 ' A' ' 183' ' ' ILE . 31.0 mt -58.28 -53.84 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.21 -37.59 83.53 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.183 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -60.74 -44.46 96.63 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.215 1.006 . . . . 0.0 109.472 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.86 -19.29 44.81 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 71.0 mt -100.74 -25.06 14.26 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 121.132 1.787 . . . . 0.0 112.793 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -59.36 -21.12 59.37 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -71.2 -46.09 61.98 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.77 2.428 . . . . 0.0 110.542 179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -162.28 153.29 17.68 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 125.558 1.543 . . . . 0.0 112.456 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.6 m -76.36 159.92 30.06 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 175.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 24.7 pt -117.63 154.64 19.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -147.09 165.86 28.66 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.294 0.569 . . . . 0.0 111.217 -178.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -151.1 134.56 16.23 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.094 1.357 . . . . 0.0 109.555 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -97.45 105.39 17.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 123.52 0.728 . . . . 0.0 109.813 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.84 67.33 9.79 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.104 1.361 . . . . 0.0 107.609 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 69.76 -115.18 6.07 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -66.83 -32.4 73.66 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.028 1.331 . . . . 0.0 112.679 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -106.09 162.84 13.26 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 119.036 0.835 . . . . 0.0 111.89 -177.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 45.3 mt -130.66 149.43 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -125.49 129.81 50.53 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.182 2.193 . . . . 0.0 108.255 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -125.98 129.6 49.54 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.333 1.853 . . . . 0.0 109.392 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -124.03 117.16 24.08 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.941 1.696 . . . . 0.0 109.666 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 19.8 m -99.35 159.7 29.43 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.574 1.15 . . . . 0.0 111.056 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -62.78 87.24 0.11 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 124.797 3.665 . . . . 0.0 113.687 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 57.61 45.77 92.85 Favored Glycine 0 CA--C 1.527 0.814 0 O-C-N 121.201 -0.937 . . . . 0.0 112.0 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.5 mt -118.26 -66.74 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 118.607 1.203 . . . . 0.0 108.435 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -166.02 159.81 15.93 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 126.954 2.102 . . . . 0.0 107.885 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -123.92 117.65 25.27 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 102.072 -3.307 . . . . 0.0 102.072 177.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.0 m -128.9 156.24 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.43 1.092 . . . . 0.0 111.979 -178.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -127.26 127.51 44.5 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 178.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -146.4 159.4 43.43 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.201 1.4 . . . . 0.0 113.04 -178.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -88.7 153.58 20.98 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 177.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 163.2 -163.81 35.7 Favored Glycine 0 C--O 1.241 0.579 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -178.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.53 139.28 53.33 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 126.102 1.761 . . . . 0.0 106.607 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.5 p -146.12 147.56 18.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.56 96.44 10.08 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 104.274 -2.491 . . . . 0.0 104.274 178.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.5 t -54.12 -24.75 18.92 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 120.436 1.471 . . . . 0.0 111.126 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -59.91 -22.74 62.81 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 129.59 3.156 . . . . 0.0 114.7 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.418 HG23 ' H ' ' A' ' 148' ' ' GLU . 6.4 t -142.96 -24.14 0.62 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.488 1.115 . . . . 0.0 111.036 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 100.4 -3.9 56.68 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 127.105 2.288 . . . . 0.0 111.737 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.418 ' H ' HG23 ' A' ' 146' ' ' THR . 39.2 mt-10 -70.41 115.68 9.87 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 124.12 0.968 . . . . 0.0 112.998 -178.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.66 140.11 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 39.7 t -99.71 -43.18 11.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 124.751 1.22 . . . . 0.0 108.095 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -167.32 161.13 14.04 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 126.025 1.73 . . . . 0.0 108.009 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -150.47 168.25 24.75 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.64 1.976 . . . . 0.0 106.756 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -121.54 154.09 37.13 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -93.38 -10.68 34.41 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.432 0.693 . . . . 0.0 110.911 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.29 -24.78 32.05 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.968 -1.082 . . . . 0.0 113.097 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.5 mt -117.88 80.93 1.58 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.146 1.378 . . . . 0.0 109.252 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.3 t -142.73 142.41 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 123.508 0.723 . . . . 0.0 109.88 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -139.95 159.26 42.59 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.367 1.467 . . . . 0.0 109.197 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.2 124.99 51.64 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.99 -62.54 1.54 Allowed 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 124.631 1.172 . . . . 0.0 109.557 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -139.92 158.29 25.66 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.9 ttpp -126.03 89.7 51.79 Favored Pre-proline 0 N--CA 1.452 -0.334 0 C-N-CA 124.875 1.27 . . . . 0.0 108.467 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -75.4 177.36 8.75 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.982 2.455 . . . . 0.0 109.502 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -91.63 155.57 18.24 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 121.788 -0.57 . . . . 0.0 111.588 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.42 -24.15 61.19 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 125.036 1.334 . . . . 0.0 113.277 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -109.61 148.49 31.21 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.753 1.621 . . . . 0.0 108.777 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.1 p -73.32 -32.87 39.16 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 C-N-CA 121.987 0.115 . . . . 0.0 111.267 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -72.95 -21.98 60.78 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 120.454 -1.404 . . . . 0.0 113.465 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -79.68 -17.72 53.01 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.295 0.638 . . . . 0.0 111.626 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.96 176.56 5.23 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.245 1.018 . . . . 0.0 111.15 178.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -146.76 137.1 23.67 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.712 1.205 . . . . 0.0 108.612 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.401 ' CD2' HG22 ' A' ' 106' ' ' VAL . 3.5 m-30 -127.05 159.67 33.44 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.706 2.803 . . . . 0.0 106.777 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -136.08 131.65 35.12 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.276 0.63 . . . . 0.0 112.165 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 35.2 tp -85.23 101.65 12.68 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.613 1.565 . . . . 0.0 108.413 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.43 HD12 ' HB2' ' A' ' 184' ' ' SER . 27.8 mt -113.55 -179.15 3.56 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.605 1.562 . . . . 0.0 109.603 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -153.46 158.07 40.82 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 52.4 p30 -134.8 -173.37 3.28 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 127.596 2.358 . . . . 0.0 107.094 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.55 -22.76 66.15 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.107 -1.621 . . . . 0.0 113.469 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 74.6 t -78.31 -53.48 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 178.3 -163.09 30.9 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-O 122.023 0.791 . . . . 0.0 112.368 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.475 ' CE2' HD22 ' A' ' 243' ' ' LEU . 3.0 m-85 -82.7 159.9 22.49 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -167.43 165.83 14.68 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.939 0.896 . . . . 0.0 109.684 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.426 HD12 HD11 ' A' ' 109' ' ' ILE . 5.8 mt -109.92 136.47 45.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 177.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.43 ' HB2' HD12 ' A' ' 175' ' ' LEU . 0.6 OUTLIER -110.96 116.74 31.73 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 125.106 1.362 . . . . 0.0 107.818 -179.153 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -116.3 108.67 16.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.2 tt -99.65 140.19 19.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.5 mt -135.66 107.43 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 124.335 1.054 . . . . 0.0 111.153 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -101.45 -157.19 26.87 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 18.1 m 68.23 34.26 3.98 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.759 0.424 . . . . 0.0 112.075 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -89.84 -96.34 1.12 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 103.812 -3.715 . . . . 0.0 103.812 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -150.54 170.58 18.79 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.99 1.716 . . . . 0.0 107.575 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 23.5 mm -100.64 123.06 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 126.365 1.866 . . . . 0.0 107.946 178.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 8.1 m -88.1 94.39 9.79 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 101.505 -3.517 . . . . 0.0 101.505 177.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -57.89 -15.63 9.26 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 3.1 m -55.91 -35.62 41.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.003 0.921 . . . . 0.0 108.87 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 75.0 p -114.87 -24.45 8.65 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.569 1.148 . . . . 0.0 110.275 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 81.91 34.44 24.39 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -129.85 169.68 14.87 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.052 1.341 . . . . 0.0 110.939 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -83.02 145.76 29.12 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 12.2 ttt85 -76.82 29.17 0.13 Allowed 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 129.913 3.285 . . . . 0.0 112.384 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -72.19 144.1 48.64 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 122.351 1.072 . . . . 0.0 111.959 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -110.8 155.67 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 113.489 -1.687 . . . . 0.0 111.493 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -123.87 128.46 49.52 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.021 1.728 . . . . 0.0 106.972 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.5 mp -118.09 119.79 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 124.968 1.307 . . . . 0.0 107.723 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -102.5 113.81 27.48 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -94.1 116.75 29.21 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 33.6 m -126.4 169.35 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 125.298 1.439 . . . . 0.0 112.096 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -85.48 135.78 33.7 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 177.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -101.56 156.08 18.91 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 118.936 0.789 . . . . 0.0 111.608 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -51.01 -68.21 1.6 Allowed Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.902 1.715 . . . . 0.0 112.145 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 13.3 p -75.66 80.24 2.64 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 117.913 0.856 . . . . 0.0 108.776 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -67.46 36.23 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.132 2.573 . . . . 0.0 115.777 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 14.3 m -148.05 46.65 1.08 Allowed 'General case' 0 CA--C 1.536 0.408 0 O-C-N 119.932 -1.73 . . . . 0.0 113.093 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -148.28 -178.58 23.54 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.63 164.9 32.79 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.862 2.375 . . . . 0.0 110.417 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 60.6 p -81.42 151.95 27.65 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.934 0.894 . . . . 0.0 108.706 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.32 163.6 17.57 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.274 1.429 . . . . 0.0 107.454 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.3 mp -77.36 130.07 36.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -72.38 -61.07 1.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.968 1.707 . . . . 0.0 110.222 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -142.26 167.85 21.14 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 125.689 1.596 . . . . 0.0 108.804 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.609 HG13 ' CE1' ' A' ' 229' ' ' TYR . 28.7 t -145.69 137.63 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.97 117.8 3.3 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -77.16 92.7 3.83 Favored 'General case' 0 C--N 1.328 -0.357 1 N-CA-C 99.715 -4.18 . . . . 0.0 99.715 177.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 2.0 p -58.42 -61.38 2.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.875 1.27 . . . . 0.0 112.348 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -98.78 -172.72 2.36 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 28.2 mm -63.25 -46.1 96.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 O-C-N 121.256 -0.902 . . . . 0.0 111.089 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 9.1 t -109.72 -16.89 13.81 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 16.2 t -87.32 140.56 15.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 123.928 0.891 . . . . 0.0 108.874 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . 0.609 ' CE1' HG13 ' A' ' 221' ' ' VAL . 2.3 t80 -133.78 140.64 47.07 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.126 0.971 . . . . 0.0 109.038 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -127.98 138.48 52.63 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.02 161.44 39.39 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.524 1.529 . . . . 0.0 109.71 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -133.46 149.85 51.75 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 123.334 0.654 . . . . 0.0 110.355 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 60.5 t -128.29 144.98 36.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 125.511 1.524 . . . . 0.0 107.554 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.66 133.03 56.43 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 83.0 mt -134.75 137.58 27.76 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.056 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.34 -43.19 1.1 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.169 2.579 . . . . 0.0 112.708 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -57.76 -33.78 68.85 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.072 0.549 . . . . 0.0 111.081 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 55.6 mt -61.81 -33.79 74.76 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.891 0.769 . . . . 0.0 111.898 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 53.1 m -61.84 -17.16 55.32 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.017 0.927 . . . . 0.0 113.133 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -69.31 -17.98 63.77 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 123.923 0.889 . . . . 0.0 112.896 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 45.1 mt -90.74 120.73 32.02 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 126.235 1.814 . . . . 0.0 107.017 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.14 -41.79 49.53 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.898 1.279 . . . . 0.0 113.055 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.475 HD22 ' CE2' ' A' ' 181' ' ' TYR . 31.7 mt -56.39 -34.8 67.04 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.416 0.687 . . . . 0.0 110.193 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -100.88 4.53 42.8 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 126.791 2.036 . . . . 0.0 113.84 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -77.69 45.22 0.49 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -158.39 144.76 17.27 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 128.694 2.797 . . . . 0.0 107.593 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -167.91 178.38 5.2 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 127.079 2.152 . . . . 0.0 107.043 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 58.34 -19.96 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 118.842 2.904 . . . . 0.0 118.842 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 38.1 t70 . . . . . 0 N--CA 1.482 1.16 0 C-N-CA 131.267 3.827 . . . . 0.0 110.142 179.544 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.797 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.01 157.64 45.94 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 126.293 1.837 . . . . 0.0 107.975 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.9 m -60.7 -32.17 71.41 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.185 0.594 . . . . 0.0 112.101 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -82.51 24.83 0.67 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 117.385 -1.293 . . . . 0.0 113.537 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.0 m -47.5 -43.21 24.36 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 121.522 1.964 . . . . 0.0 111.956 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -56.83 -38.47 72.67 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.282 1.033 . . . . 0.0 112.75 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -63.26 -44.75 94.25 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.6 m -63.14 -42.8 99.54 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.7 -39.11 87.33 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-N 118.622 0.646 . . . . 0.0 109.841 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.9 tp -64.6 -44.89 89.16 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mt -59.11 -51.07 71.62 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.0 m -55.17 -44.75 75.52 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.34 1.056 . . . . 0.0 111.083 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -67.23 -51.17 56.48 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 121.548 -0.72 . . . . 0.0 110.232 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 21.8 m -54.82 -42.07 71.43 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 118.153 -0.927 . . . . 0.0 110.506 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.8 tp -61.01 -56.15 24.43 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 120.051 1.296 . . . . 0.0 110.034 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -57.23 -49.49 75.85 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.987 0.812 . . . . 0.0 111.602 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -56.85 -44.48 82.2 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.334 0.654 . . . . 0.0 109.269 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.542 ' HA3' HD11 ' A' ' 183' ' ' ILE . . . -63.52 -47.2 89.25 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 79.7 t -58.18 -52.99 51.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.671 1.189 . . . . 0.0 109.838 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -31.1 72.05 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.14 0.882 . . . . 0.0 110.315 178.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -68.53 -47.96 65.56 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.637 HD11 HD12 ' A' ' 183' ' ' ILE . 24.3 mt -57.06 -54.72 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 123.075 0.55 . . . . 0.0 109.583 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.52 -41.24 80.45 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 124.188 0.93 . . . . 0.0 110.23 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -64.64 -43.98 91.96 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.079 0.466 . . . . 0.0 111.894 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.31 -13.08 61.05 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 73.9 mt -106.75 -26.85 11.12 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 119.488 1.04 . . . . 0.0 111.945 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -57.15 -28.19 62.52 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.178 0.591 . . . . 0.0 111.625 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -68.52 -45.88 71.07 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.342 1.457 . . . . 0.0 111.096 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -161.07 149.55 16.08 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.978 1.311 . . . . 0.0 109.896 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 60.3 m -75.38 163.16 27.72 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 177.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 28.2 pt -118.24 148.7 20.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.8 154.58 44.34 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 122.673 0.389 . . . . 0.0 110.689 -177.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -143.13 124.96 15.07 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 124.439 1.096 . . . . 0.0 110.143 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -87.63 102.86 15.03 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.6 67.32 6.41 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.52 -115.95 6.26 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -66.4 -33.15 75.08 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.479 0.712 . . . . 0.0 112.59 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -106.64 160.29 15.56 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 122.153 0.977 . . . . 0.0 110.947 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.0 mt -124.57 147.99 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 178.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -121.64 134.53 54.99 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -130.49 125.25 33.88 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 126.629 1.972 . . . . 0.0 108.221 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -126.39 119.07 26.35 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 125.043 1.337 . . . . 0.0 109.799 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 12.5 m -102.88 160.52 25.97 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 124.76 1.224 . . . . 0.0 113.229 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.88 80.64 0.64 Allowed 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 124.47 3.447 . . . . 0.0 113.506 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.76 52.19 35.66 Favored Glycine 0 C--O 1.237 0.324 0 O-C-N 121.546 -0.721 . . . . 0.0 111.505 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.3 mt -129.17 -67.09 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -174.41 160.19 3.17 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.17 1.388 . . . . 0.0 108.987 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.91 120.23 38.51 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 176.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.18 154.86 40.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 118.758 0.708 . . . . 0.0 111.083 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -123.04 130.32 52.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 127.897 2.479 . . . . 0.0 106.579 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -146.37 156.92 43.67 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.357 1.063 . . . . 0.0 110.198 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 56.3 t60 -89.2 153.83 20.62 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 156.21 -164.14 32.26 Favored Glycine 0 CA--C 1.523 0.537 0 O-C-N 120.829 -1.169 . . . . 0.0 111.59 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.41 ' CD ' HG21 ' A' ' 150' ' ' VAL . 0.0 OUTLIER -124.16 150.05 45.61 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 124.388 1.075 . . . . 0.0 110.517 179.753 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.96 156.81 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.091 1.357 . . . . 0.0 108.205 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -101.39 99.2 9.51 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.138 1.775 . . . . 0.0 107.869 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.6 t -52.79 -23.32 6.63 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.158 1.383 . . . . 0.0 112.714 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -64.44 -27.25 68.86 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.7 t -146.55 -10.32 0.47 Allowed 'General case' 0 CA--C 1.539 0.536 0 O-C-N 124.401 1.063 . . . . 0.0 111.557 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.69 36.41 16.34 Favored Glycine 0 C--N 1.339 0.739 0 O-C-N 121.076 -1.015 . . . . 0.0 110.993 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -107.24 133.18 52.19 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.886 1.275 . . . . 0.0 107.786 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.5 mt -70.73 149.2 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.41 HG21 ' CD ' ' A' ' 141' ' ' ARG . 67.3 t -100.95 -35.14 4.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 123.935 0.894 . . . . 0.0 112.048 -178.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -141.74 139.01 32.75 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -118.37 73.98 0.93 Allowed 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 124.953 1.301 . . . . 0.0 107.89 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -71.87 136.9 47.12 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.995 1.318 . . . . 0.0 109.832 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -96.62 -4.24 41.42 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.788 1.235 . . . . 0.0 111.993 178.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 2.5 t -72.51 -42.57 64.68 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.701 1.137 . . . . 0.0 111.653 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 84.3 mt -115.03 87.48 2.66 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 123.873 0.869 . . . . 0.0 111.14 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 9.8 t -136.69 152.8 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.802 1.241 . . . . 0.0 108.585 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -145.44 171.8 14.12 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 126.286 1.835 . . . . 0.0 110.112 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -125.9 125.59 43.04 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.118 1.767 . . . . 0.0 109.55 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 22.1 mt -102.89 -72.83 0.68 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.227 1.011 . . . . 0.0 109.395 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -124.0 149.18 16.88 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -132.37 89.14 37.6 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.01 0.924 . . . . 0.0 110.443 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -77.5 -179.15 5.16 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 125.049 3.833 . . . . 0.0 113.293 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -90.05 161.67 15.71 Favored 'General case' 0 C--O 1.231 0.084 0 C-N-CA 124.069 0.948 . . . . 0.0 110.211 178.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.19 -24.81 57.87 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -118.99 157.91 26.82 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 123.629 0.771 . . . . 0.0 109.331 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 5.2 p -73.97 -33.02 35.21 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 C-N-CA 124.633 1.173 . . . . 0.0 112.095 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -75.13 -7.05 52.69 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.22 1.808 . . . . 0.0 112.93 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -94.2 -14.99 25.0 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.115 1.366 . . . . 0.0 109.708 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -124.35 179.32 4.96 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 128.665 2.786 . . . . 0.0 112.811 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -138.17 166.76 23.35 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.414 2.286 . . . . 0.0 107.817 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -141.06 159.34 42.42 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.864 2.066 . . . . 0.0 107.612 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -124.38 124.54 42.58 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.755 1.222 . . . . 0.0 111.309 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 21.6 tp -90.02 100.77 13.53 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 22.6 mt -107.21 -178.72 3.72 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.308 1.843 . . . . 0.0 108.754 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -158.81 159.89 35.62 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.61 -175.67 4.03 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -48.2 -35.78 12.48 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.979 1.711 . . . . 0.0 111.307 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 60.0 t -77.77 -67.63 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 126.193 1.797 . . . . 0.0 111.27 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -167.46 -170.22 32.0 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -178.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.478 ' CE2' HD22 ' A' ' 243' ' ' LEU . 3.6 m-85 -78.81 152.79 31.15 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.469 1.108 . . . . 0.0 112.037 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -162.49 156.56 21.15 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.005 1.322 . . . . 0.0 109.971 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.637 HD12 HD11 ' A' ' 109' ' ' ILE . 7.4 mt -102.04 140.08 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 177.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 4.3 t -121.98 136.35 54.92 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -142.62 119.18 11.01 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 176.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.8 tt -97.28 140.39 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.7 mt -130.51 112.59 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 O-C-N 120.742 -1.224 . . . . 0.0 110.161 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.18 -155.57 25.83 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 107.89 -2.084 . . . . 0.0 107.89 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 49.1 m 73.16 44.43 0.33 Allowed 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.095 1.358 . . . . 0.0 108.586 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -99.91 -121.9 4.74 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 125.158 1.361 . . . . 0.0 110.026 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -136.29 122.61 20.58 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.368 1.867 . . . . 0.0 108.774 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 14.1 mm -60.95 136.57 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 119.736 1.153 . . . . 0.0 110.155 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 28.5 p -90.58 111.58 22.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -68.13 -10.69 56.02 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 120.475 1.489 . . . . 0.0 110.391 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 40.6 t -60.33 -45.33 96.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 126.709 2.004 . . . . 0.0 108.808 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 1.3 p -125.41 -20.57 4.75 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 92.49 10.31 60.69 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.75 2.119 . . . . 0.0 112.255 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -94.32 169.66 10.06 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.544 1.138 . . . . 0.0 112.157 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -88.28 156.08 19.38 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 122.159 0.981 . . . . 0.0 109.707 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -79.52 30.21 0.24 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 128.97 2.908 . . . . 0.0 111.286 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 1.9 ptm -72.39 150.46 43.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.958 0.885 . . . . 0.0 110.428 -175.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.1 p -120.23 149.01 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 114.341 -1.3 . . . . 0.0 111.699 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -112.77 127.92 56.28 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.945 1.698 . . . . 0.0 106.853 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.1 mp -119.93 115.97 49.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.248 1.019 . . . . 0.0 108.454 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -101.19 116.43 32.79 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.338 0.655 . . . . 0.0 110.64 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -92.4 114.41 26.95 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.047 1.339 . . . . 0.0 110.104 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 27.4 m -127.38 172.28 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 126.197 1.799 . . . . 0.0 111.801 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -85.7 142.65 28.87 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -113.55 144.88 18.27 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-O 118.583 -1.12 . . . . 0.0 110.878 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -32.94 -73.98 0.07 OUTLIER Glycine 0 C--N 1.337 0.631 0 C-N-CA 128.724 3.059 . . . . 0.0 113.233 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 39.6 t -70.72 94.09 0.99 Allowed 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -74.39 21.12 0.11 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.312 1.845 . . . . 0.0 111.667 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 37.5 m -135.82 40.48 2.74 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.909 1.684 . . . . 0.0 112.578 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -150.94 166.95 30.5 Favored Glycine 0 CA--C 1.526 0.748 0 O-C-N 120.682 -1.261 . . . . 0.0 111.505 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.46 167.03 25.21 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.492 2.128 . . . . 0.0 112.128 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 51.0 m -76.87 155.19 33.1 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.979 178.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.0 p -162.05 163.63 28.63 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 126.55 1.94 . . . . 0.0 107.216 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.3 mp -81.45 129.23 37.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . 0.459 ' HG3' HG23 ' A' ' 234' ' ' THR . 64.9 mm-40 -79.23 -47.08 16.59 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.493 0.717 . . . . 0.0 112.635 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 40.0 p-90 -151.99 166.98 29.87 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.696 HG13 ' CE1' ' A' ' 229' ' ' TYR . 46.8 t -144.77 138.92 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 C-N-CA 125.719 1.608 . . . . 0.0 106.808 -178.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.96 134.34 4.27 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.621 0.724 . . . . 0.0 112.104 177.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -86.96 93.11 9.25 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 78.2 p -67.53 -56.42 9.57 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.576 0.703 . . . . 0.0 110.693 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -95.03 -175.04 3.41 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.983 1.713 . . . . 0.0 107.591 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.6 mp -74.71 -39.17 46.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 O-C-N 121.713 -0.617 . . . . 0.0 109.706 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 5.4 m -115.69 -18.91 10.73 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 3.5 t -85.13 152.82 3.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . 0.696 ' CE1' HG13 ' A' ' 221' ' ' VAL . 3.3 t80 -135.41 139.85 44.48 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.604 1.162 . . . . 0.0 108.585 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -120.84 135.43 55.17 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.035 1.334 . . . . 0.0 108.57 -178.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -138.46 161.13 37.8 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.93 1.692 . . . . 0.0 109.751 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -138.53 144.13 39.8 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 66.6 t -131.72 133.55 61.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 125.624 1.57 . . . . 0.0 109.449 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . 0.459 HG23 ' HG3' ' A' ' 219' ' ' GLN . 1.9 p -99.49 146.6 26.19 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 13.4 mt -142.99 136.18 13.96 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.277 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -72.55 -44.69 0.68 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.433 2.089 . . . . 0.0 111.492 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -58.93 -20.82 55.61 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.13 0.972 . . . . 0.0 112.289 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 2.2 mp -71.69 -39.16 70.39 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.783 0.833 . . . . 0.0 108.987 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 29.2 m -58.3 -30.5 66.7 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.453 1.501 . . . . 0.0 111.979 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -60.2 -38.17 82.5 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.577 0.351 . . . . 0.0 110.788 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 23.8 mt -72.64 117.04 13.83 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -47.92 -34.34 8.91 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -177.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.478 HD22 ' CE2' ' A' ' 181' ' ' TYR . 20.1 mt -64.13 -40.86 97.08 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.941 0.792 . . . . 0.0 110.661 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 4.8 mp -99.58 9.38 43.28 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 125.295 1.438 . . . . 0.0 113.798 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -72.05 48.3 0.17 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.533 1.933 . . . . 0.0 111.231 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -130.69 142.82 50.44 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 127.707 2.403 . . . . 0.0 108.029 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 81.51 4.99 1.34 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.635 2.774 . . . . 0.0 114.054 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.7 7.63 4.44 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.933 2.093 . . . . 0.0 109.965 177.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 38.5 t70 . . . . . 0 C--O 1.245 0.849 0 C-N-CA 126.688 1.995 . . . . 0.0 111.978 -179.458 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.965 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.11 2.09 16.22 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.327 1.451 . . . . 0.0 113.228 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.6 m -126.94 144.71 50.92 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.366 1.866 . . . . 0.0 107.211 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -144.57 145.25 31.71 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.649 1.98 . . . . 0.0 108.562 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.7 m -65.17 -44.54 88.17 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.483 1.513 . . . . 0.0 113.357 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.57 -32.69 74.22 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.394 -0.816 . . . . 0.0 111.139 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.472 ' HE3' HD11 ' A' ' 243' ' ' LEU . 21.2 tptm -64.46 -39.14 93.25 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.81 -41.74 91.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 118.702 0.683 . . . . 0.0 109.681 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.57 -40.57 95.8 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.2 tp -62.22 -45.69 92.2 Favored 'General case' 0 C--O 1.221 -0.396 0 C-N-CA 124.31 1.044 . . . . 0.0 109.148 178.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 mt -59.66 -51.3 70.37 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.173 0.989 . . . . 0.0 109.457 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.1 m -55.0 -55.48 30.43 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.553 1.141 . . . . 0.0 109.626 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -61.23 -46.33 90.87 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.12 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.1 m -52.23 -51.71 56.69 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 119.608 1.095 . . . . 0.0 110.196 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.2 tp -56.56 -55.31 35.5 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 119.229 0.922 . . . . 0.0 108.826 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.61 -49.6 67.48 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.803 1.241 . . . . 0.0 113.507 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -42.2 93.36 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.914 1.686 . . . . 0.0 108.525 179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.39 -50.23 69.91 Favored Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.84 -53.14 49.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 118.793 1.297 . . . . 0.0 111.109 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -31.78 72.0 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.206 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 m -66.08 -48.23 71.65 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.435 HD11 HD12 ' A' ' 183' ' ' ILE . 27.1 mt -58.36 -54.64 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.733 0.813 . . . . 0.0 110.318 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.77 -31.8 71.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 123.036 0.21 . . . . 0.0 111.525 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -73.64 -46.62 45.6 Favored 'General case' 0 C--O 1.225 -0.211 0 O-C-N 121.526 -0.734 . . . . 0.0 109.059 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.18 5.18 5.74 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.692 1.997 . . . . 0.0 113.887 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.3 mt -123.42 -30.43 3.66 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 125.516 1.526 . . . . 0.0 109.199 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -62.01 -28.5 69.62 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.158 0.435 . . . . 0.0 109.961 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -62.89 -47.16 84.51 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.706 0.802 . . . . 0.0 109.262 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -164.35 150.29 10.7 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.275 1.83 . . . . 0.0 109.883 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 64.2 m -75.27 171.75 13.65 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.3 pt -128.39 147.66 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 O-C-N 121.395 -0.815 . . . . 0.0 110.318 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.84 167.91 20.96 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.565 0.746 . . . . 0.0 110.894 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -153.71 124.88 7.41 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.65 1.58 . . . . 0.0 110.594 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -87.04 102.31 14.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.14 67.36 6.91 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.149 1.78 . . . . 0.0 109.608 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.8 -115.26 4.66 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -73.29 -27.77 61.73 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.245 1.818 . . . . 0.0 112.883 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -107.66 161.85 14.5 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 118.945 0.793 . . . . 0.0 110.293 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 24.1 mt -128.23 141.01 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 104.154 -2.535 . . . . 0.0 104.154 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.423 ' CD1' HG11 ' A' ' 221' ' ' VAL . 53.3 m-85 -116.73 135.18 53.98 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 124.786 1.234 . . . . 0.0 107.776 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.38 130.44 46.03 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.625 1.57 . . . . 0.0 108.488 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -128.24 121.73 30.05 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.615 1.166 . . . . 0.0 110.622 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 4.2 m -108.73 159.19 31.85 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 123.956 0.902 . . . . 0.0 112.231 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -65.7 95.13 0.28 Allowed 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 125.259 3.973 . . . . 0.0 114.562 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 57.94 39.69 92.15 Favored Glycine 0 CA--C 1.525 0.67 0 O-C-N 121.554 -0.716 . . . . 0.0 111.636 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.8 mt -115.16 -65.17 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.462 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 5.7 pt-20 179.4 169.51 1.05 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.894 2.078 . . . . 0.0 108.695 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.45 124.6 40.5 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.9 m -135.01 156.95 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 125.479 1.511 . . . . 0.0 111.189 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -124.03 133.63 53.61 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 103.327 -2.842 . . . . 0.0 103.327 176.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -146.25 156.62 43.51 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.902 0.881 . . . . 0.0 110.575 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -89.47 153.82 20.51 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 155.68 -162.82 31.4 Favored Glycine 0 CA--C 1.519 0.292 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.405 ' HD3' HG21 ' A' ' 150' ' ' VAL . 0.0 OUTLIER -130.95 152.59 50.1 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.251 1.02 . . . . 0.0 108.355 179.103 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 93.3 t -120.34 145.88 26.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 124.408 1.083 . . . . 0.0 109.559 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -93.61 94.92 8.89 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 178.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 8.9 t -47.2 -26.53 1.2 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.837 1.655 . . . . 0.0 113.801 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -52.03 -38.17 56.04 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 119.066 0.848 . . . . 0.0 111.632 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.2 t -147.02 -10.67 0.44 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 99.67 7.72 53.09 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.316 1.436 . . . . 0.0 112.344 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -62.46 135.86 57.63 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 119.494 1.647 . . . . 0.0 110.307 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 38.0 mm -73.6 134.35 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.405 HG21 ' HD3' ' A' ' 141' ' ' ARG . 7.5 t -93.32 -23.74 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.074 0.95 . . . . 0.0 112.065 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -145.72 109.09 4.66 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? -89.11 17.06 6.23 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.677 1.591 . . . . 0.0 114.147 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -44.31 133.36 5.5 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.047 1.339 . . . . 0.0 111.578 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -95.0 6.01 50.31 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 74.6 m -81.74 -3.39 53.63 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.7 mt -144.83 77.23 1.52 Allowed 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.2 143.26 28.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 124.74 1.216 . . . . 0.0 108.186 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -134.88 155.65 50.32 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.785 1.234 . . . . 0.0 109.256 178.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 28.9 ttp180 -97.06 130.23 44.39 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 128.021 2.528 . . . . 0.0 108.331 -178.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 27.5 mt -112.54 -69.88 0.84 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.415 1.007 . . . . 0.0 108.666 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -139.58 141.8 12.08 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-O 121.446 0.47 . . . . 0.0 112.979 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -110.88 92.9 15.71 Favored Pre-proline 0 N--CA 1.447 -0.582 0 C-N-CA 127.366 2.266 . . . . 0.0 110.637 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.462 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 75.5 Cg_endo -75.53 -177.16 3.36 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.646 2.897 . . . . 0.0 109.358 178.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -96.81 157.96 15.65 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.14 -26.51 56.39 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 124.901 1.376 . . . . 0.0 114.15 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -108.97 139.63 43.57 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 124.164 0.986 . . . . 0.0 108.466 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.4 p -62.97 -31.04 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -61.88 -26.7 68.31 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.727 1.611 . . . . 0.0 112.542 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -94.6 -2.33 51.62 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -79.62 163.56 24.5 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.434 -0.791 . . . . 0.0 110.297 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -137.58 95.1 3.0 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -102.35 160.2 14.75 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -135.63 143.86 45.77 Favored 'General case' 0 C--O 1.227 -0.11 0 C-N-CA 124.304 1.042 . . . . 0.0 110.221 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 36.3 tp -110.07 97.85 7.26 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.443 HD23 ' HB2' ' A' ' 184' ' ' SER . 0.5 OUTLIER -109.48 174.23 5.96 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.417 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 6.1 p90 -150.67 162.63 40.31 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 121.401 -0.812 . . . . 0.0 110.486 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -140.71 -175.3 4.24 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.4 1.062 . . . . 0.0 109.185 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -57.04 -20.3 23.84 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.155 1.382 . . . . 0.0 113.991 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 97.4 t -81.09 -65.66 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 178.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 175.57 -170.16 43.09 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.417 ' CD2' ' HB3' ' A' ' 176' ' ' TYR . 15.6 m-85 -78.52 159.13 28.35 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.721 0.772 . . . . 0.0 109.911 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -156.21 176.2 12.98 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.53 1.932 . . . . 0.0 106.805 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.435 HD12 HD11 ' A' ' 109' ' ' ILE . 18.8 mt -121.1 114.46 43.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 178.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.443 ' HB2' HD23 ' A' ' 175' ' ' LEU . 4.7 t -90.46 141.58 28.6 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -146.29 107.01 4.09 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.6 tt -98.68 140.44 18.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.9 mt -133.97 113.71 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 123.869 0.868 . . . . 0.0 110.847 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -107.85 -156.73 19.5 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 124.754 1.169 . . . . 0.0 110.275 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 68.5 m 73.09 37.55 0.76 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.775 1.23 . . . . 0.0 109.983 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -94.16 -108.35 2.04 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 126.858 2.17 . . . . 0.0 108.336 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -140.07 120.99 14.54 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.638 1.175 . . . . 0.0 107.921 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 17.7 mm -60.58 121.59 8.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 124.336 1.054 . . . . 0.0 109.272 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 77.6 m -82.22 96.42 7.85 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 125.735 1.614 . . . . 0.0 109.923 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.09 -18.47 58.09 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -59.3 -31.48 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.674 1.189 . . . . 0.0 110.76 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 44.8 p -125.07 -35.0 2.7 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.777 0.831 . . . . 0.0 111.799 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.92 32.93 5.7 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 126.43 1.966 . . . . 0.0 110.779 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -124.13 171.12 10.05 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.372 1.869 . . . . 0.0 112.174 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -83.33 148.7 27.19 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 122.322 1.058 . . . . 0.0 110.439 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -82.98 30.77 0.44 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 130.8 3.64 . . . . 0.0 109.251 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.5 ptt? -74.28 150.83 40.03 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.688 1.195 . . . . 0.0 110.334 -175.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.4 p -113.32 146.79 17.49 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.355 -177.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -114.42 116.39 28.81 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.8 mp -106.26 130.66 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -117.85 103.76 10.28 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.719 0.807 . . . . 0.0 110.108 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -83.02 125.31 31.3 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 15.5 m -135.96 171.09 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.44 1.496 . . . . 0.0 110.974 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 2.1 t -81.61 140.5 34.39 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -118.43 109.21 1.73 Allowed Glycine 0 C--N 1.34 0.752 0 CA-C-O 117.836 -1.536 . . . . 0.0 113.217 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 4.71 -92.15 0.0 OUTLIER Glycine 0 C--N 1.34 0.803 0 C-N-CA 129.626 3.489 . . . . 0.0 114.07 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.0 100.0 0.39 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -72.11 29.13 0.05 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.486 1.914 . . . . 0.0 113.169 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 14.8 t -119.29 47.2 1.73 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.685 1.994 . . . . 0.0 114.19 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -166.08 162.99 36.5 Favored Glycine 0 C--N 1.339 0.717 0 C-N-CA 118.014 -2.041 . . . . 0.0 117.523 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -66.64 164.81 27.59 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.355 2.704 . . . . 0.0 110.321 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 28.8 m -64.47 155.46 32.66 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.473 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -168.88 157.16 7.94 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 126.025 1.73 . . . . 0.0 108.111 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.9 mt -83.38 133.81 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -74.95 -55.27 5.94 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 125.061 1.345 . . . . 0.0 111.772 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 52.1 p-90 -149.94 165.93 31.15 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.218 1.407 . . . . 0.0 108.347 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.8 HG13 ' CE1' ' A' ' 229' ' ' TYR . 39.6 t -148.34 130.42 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 125.198 1.399 . . . . 0.0 107.62 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.37 140.65 16.59 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -92.16 90.23 7.24 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 102.365 -3.198 . . . . 0.0 102.365 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 2.0 p -61.31 -65.15 0.74 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.767 1.627 . . . . 0.0 110.747 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -86.88 -172.59 4.06 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.501 ' H ' HD12 ' A' ' 226' ' ' ILE . 3.6 mp -58.97 -41.53 83.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 118.322 -0.846 . . . . 0.0 110.163 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 7.3 m -129.86 -8.91 4.45 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 25.1 t -71.87 121.72 22.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 103.927 -2.62 . . . . 0.0 103.927 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . 0.8 ' CE1' HG13 ' A' ' 221' ' ' VAL . 1.0 OUTLIER -110.17 124.63 51.9 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 179.323 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -114.33 135.16 54.38 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -139.79 158.29 44.33 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.04 1.736 . . . . 0.0 109.621 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -130.69 146.21 52.12 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 85.1 t -131.95 135.48 58.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.77 138.25 40.65 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.726 0.81 . . . . 0.0 110.376 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 48.4 mt -139.81 137.05 17.91 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 124.052 0.941 . . . . 0.0 109.594 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.59 -32.77 2.67 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.722 2.948 . . . . 0.0 113.11 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -69.19 -23.81 63.96 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.717 1.207 . . . . 0.0 112.146 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 37.4 mt -66.28 -36.54 83.24 Favored 'General case' 0 C--O 1.226 -0.139 0 O-C-N 121.238 -0.914 . . . . 0.0 110.292 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 3.7 m -56.39 -19.23 13.85 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.893 1.277 . . . . 0.0 113.553 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -62.85 -31.98 73.12 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.23 1.412 . . . . 0.0 110.358 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 26.8 mt -84.11 120.14 25.82 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.44 -37.8 57.74 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.715 0.689 . . . . 0.0 112.072 -178.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.472 HD11 ' HE3' ' A' ' 94' ' ' LYS . 6.0 mp -57.6 -38.84 75.59 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.485 -0.76 . . . . 0.0 111.248 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -97.35 6.08 48.85 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.071 1.748 . . . . 0.0 111.675 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -79.21 64.96 4.25 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -139.81 153.39 47.08 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 126.783 2.033 . . . . 0.0 108.302 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 62.04 7.44 2.13 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.42 1.488 . . . . 0.0 114.61 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -73.48 -4.56 34.54 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 128.91 2.884 . . . . 0.0 112.303 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 C--O 1.251 1.161 0 C-N-CA 127.973 2.509 . . . . 0.0 113.315 -178.601 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.895 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.64 170.34 5.25 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.843 0.857 . . . . 0.0 112.103 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.3 m 61.84 70.42 0.59 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.871 2.069 . . . . 0.0 111.908 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -145.25 146.85 31.85 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.594 -0.691 . . . . 0.0 111.121 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 68.1 m -54.95 -39.86 69.37 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 126.755 2.022 . . . . 0.0 113.409 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -64.03 -20.25 65.78 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 121.853 -0.529 . . . . 0.0 112.316 -178.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -70.57 -43.11 70.13 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.7 m -66.43 -41.51 89.09 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.036 0.934 . . . . 0.0 108.896 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.93 -45.81 89.48 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 66.7 tp -62.62 -41.34 98.95 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.413 0.685 . . . . 0.0 110.272 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.8 mt -60.08 -54.28 47.8 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.983 0.913 . . . . 0.0 109.762 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 45.2 m -56.21 -51.79 66.78 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.228 1.011 . . . . 0.0 110.748 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -58.03 -49.55 76.47 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.7 m -53.94 -49.55 68.45 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 118.425 -0.798 . . . . 0.0 110.598 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.521 ' O ' HG23 ' A' ' 106' ' ' VAL . 9.2 tp -56.77 -54.91 40.83 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.967 0.803 . . . . 0.0 109.579 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -55.29 -53.64 53.62 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.684 0.793 . . . . 0.0 111.492 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -57.37 -33.51 67.88 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.315 1.446 . . . . 0.0 110.363 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -69.43 -53.38 17.41 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 102' ' ' LEU . 3.4 t -56.55 -52.1 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 118.799 1.3 . . . . 0.0 111.706 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -37.24 79.76 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 118.89 -0.576 . . . . 0.0 110.779 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.4 m -67.43 -48.11 68.23 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.497 HD11 HD12 ' A' ' 183' ' ' ILE . 43.8 mt -53.5 -52.97 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 123.978 0.911 . . . . 0.0 109.575 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.54 -39.45 83.99 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 122.187 0.195 . . . . 0.0 111.234 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -69.73 -33.93 73.17 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.294 -0.879 . . . . 0.0 111.461 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.24 10.25 15.25 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.569 1.548 . . . . 0.0 112.239 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.3 mt -133.35 -33.35 1.12 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.841 1.256 . . . . 0.0 110.557 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -56.26 -31.23 63.39 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 123.693 0.797 . . . . 0.0 111.57 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -69.47 -45.96 67.79 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 118.668 -0.682 . . . . 0.0 112.465 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -157.26 143.65 18.0 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 125.336 1.454 . . . . 0.0 108.244 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 30.5 m -75.87 172.08 13.31 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 122.906 0.482 . . . . 0.0 110.959 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 25.6 pt -125.9 154.91 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.591 1.156 . . . . 0.0 111.418 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.62 167.69 21.64 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.738 0.815 . . . . 0.0 109.956 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -150.53 117.75 6.0 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.772 1.629 . . . . 0.0 109.935 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -82.54 102.14 11.19 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.0 66.8 3.62 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.474 -0.766 . . . . 0.0 110.472 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.19 -113.06 3.74 Favored Glycine 0 C--N 1.339 0.697 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -77.39 -38.33 50.11 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -106.65 126.44 52.28 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.874 1.215 . . . . 0.0 113.503 -178.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.0 mt -90.6 147.8 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.484 ' CD1' HG11 ' A' ' 221' ' ' VAL . 66.2 m-85 -115.11 135.8 53.81 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 178.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.72 123.91 27.14 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.789 1.236 . . . . 0.0 109.337 -177.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -126.8 119.51 27.05 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.824 1.249 . . . . 0.0 111.743 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 1.4 m -100.62 160.81 25.85 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 125.391 1.477 . . . . 0.0 112.477 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -64.13 88.86 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 124.249 3.299 . . . . 0.0 112.288 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 53.48 57.46 15.49 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 123.934 0.778 . . . . 0.0 111.274 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 15.6 mt -124.94 -65.67 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.509 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 15.6 pt-20 -176.15 168.92 2.86 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 127.621 2.368 . . . . 0.0 109.677 177.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -123.52 124.15 42.2 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.5 155.76 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.301 1.041 . . . . 0.0 112.256 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -119.82 126.24 50.51 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -146.48 157.67 43.78 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.093 0.861 . . . . 0.0 112.065 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -88.68 148.63 23.91 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 160.32 -162.17 33.09 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 108.871 -1.691 . . . . 0.0 108.871 -177.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.4 ttm-85 -125.63 164.15 21.22 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.34 1.456 . . . . 0.0 111.104 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 84.5 t -137.27 135.17 47.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -81.13 89.82 6.01 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 127.925 2.49 . . . . 0.0 107.737 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.9 t -54.3 -17.2 2.7 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.697 1.199 . . . . 0.0 113.714 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -64.11 -24.28 67.64 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 120.902 -1.124 . . . . 0.0 112.681 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 t -142.9 -31.1 0.51 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.673 0.789 . . . . 0.0 110.455 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 106.34 19.61 9.82 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 125.503 1.525 . . . . 0.0 111.3 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -85.27 155.75 21.24 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 119.289 1.544 . . . . 0.0 111.461 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.6 mp -71.79 154.54 7.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 123.853 0.861 . . . . 0.0 108.801 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.3 p -162.91 157.94 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.507 1.523 . . . . 0.0 108.733 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 12.7 t30 24.94 83.34 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 129.753 3.221 . . . . 0.0 113.213 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.97 177.77 5.17 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.934 1.294 . . . . 0.0 112.886 -178.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.23 142.58 39.93 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 125.531 1.532 . . . . 0.0 107.157 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -95.58 0.7 53.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 111.344 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 t -86.28 -10.67 54.1 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.666 1.586 . . . . 0.0 111.789 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 76.6 mt -128.82 79.21 1.9 Allowed 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.8 t -135.84 142.54 38.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.534 1.134 . . . . 0.0 108.054 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -137.61 158.62 43.99 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 126.348 1.859 . . . . 0.0 109.049 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -113.01 130.43 56.14 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.437 1.095 . . . . 0.0 110.196 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.96 -75.19 0.53 Allowed 'General case' 0 C--O 1.226 -0.153 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -134.68 152.39 20.68 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 116.255 -0.43 . . . . 0.0 112.73 -178.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -116.49 94.39 42.93 Favored Pre-proline 0 N--CA 1.453 -0.32 0 C-N-CA 125.271 1.428 . . . . 0.0 108.601 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.509 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 88.1 Cg_endo -73.48 -175.82 2.21 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.343 2.695 . . . . 0.0 109.555 178.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.457 ' HE2' ' OE2' ' A' ' 169' ' ' GLU . 25.3 mmmt -97.53 161.1 13.94 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.16 0.584 . . . . 0.0 112.238 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -78.26 -24.21 46.96 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.87 1.668 . . . . 0.0 113.362 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -116.37 147.75 41.3 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.5 p -73.06 -27.23 24.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -79.68 -12.73 59.8 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.296 0.639 . . . . 0.0 112.445 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.457 ' OE2' ' HE2' ' A' ' 164' ' ' LYS . 4.3 mm-40 -79.62 -21.5 44.84 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.865 0.466 . . . . 0.0 110.864 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -107.3 172.1 7.01 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.744 1.618 . . . . 0.0 110.652 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -134.29 131.31 38.26 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 124.186 0.994 . . . . 0.0 109.434 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -107.86 162.29 14.14 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -130.11 120.86 25.28 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.056 -1.028 . . . . 0.0 109.738 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 48.4 tp -87.24 100.6 12.81 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 39.5 mt -105.32 -179.21 3.88 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 126.207 1.803 . . . . 0.0 109.972 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 181' ' ' TYR . 4.6 p90 -157.09 157.07 33.87 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 124.458 1.103 . . . . 0.0 109.596 177.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -137.51 -179.36 5.69 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.143 2.177 . . . . 0.0 108.604 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -58.53 -26.41 63.49 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.445 1.098 . . . . 0.0 113.533 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 59.8 t -79.62 -62.81 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -172.99 -164.41 28.34 Favored Glycine 0 C--N 1.339 0.725 0 CA-C-N 119.031 0.832 . . . . 0.0 111.366 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.508 ' CE2' HD13 ' A' ' 243' ' ' LEU . 2.9 m-85 -78.21 166.38 22.8 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.193 -0.593 . . . . 0.0 109.982 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -167.62 162.09 13.97 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.508 1.523 . . . . 0.0 108.145 178.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.497 HD12 HD11 ' A' ' 109' ' ' ILE . 3.6 mt -113.97 121.43 66.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.154 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.2 t -95.96 135.03 38.25 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -138.57 133.63 32.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 178.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.9 tt -121.45 141.37 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 124.679 1.191 . . . . 0.0 109.072 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.4 mt -137.14 115.14 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 122.596 0.358 . . . . 0.0 111.705 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -103.74 -166.96 25.28 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 126.497 1.999 . . . . 0.0 110.125 178.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 69.3 m 73.23 60.41 0.1 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.624 1.569 . . . . 0.0 109.056 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -108.13 -95.58 2.4 Favored Glycine 0 CA--C 1.519 0.286 0 N-CA-C 104.513 -3.435 . . . . 0.0 104.513 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -155.59 125.23 6.41 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 18.0 mm -60.25 121.29 7.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.2 99.94 10.27 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 125.839 1.656 . . . . 0.0 110.153 -178.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -60.94 -20.49 62.28 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.364 0.602 . . . . 0.0 111.51 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.5 m -57.18 -32.64 41.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.642 1.577 . . . . 0.0 112.235 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 67.0 p -125.17 -29.22 3.32 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.078 1.351 . . . . 0.0 112.017 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 88.22 32.37 12.34 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -178.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -126.82 -179.72 4.96 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.915 1.686 . . . . 0.0 111.322 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -91.86 148.15 22.44 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.298 0.639 . . . . 0.0 109.496 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 45.2 ttm-85 -79.32 30.12 0.23 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.287 2.635 . . . . 0.0 109.729 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.7 ptm -72.87 153.96 40.8 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 122.064 0.935 . . . . 0.0 110.075 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 6.0 p -122.97 148.93 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 113.876 -1.511 . . . . 0.0 113.696 -176.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -114.09 137.46 51.7 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.5 mp -126.03 118.41 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 127.516 2.326 . . . . 0.0 107.921 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -106.88 104.28 13.92 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.554 1.141 . . . . 0.0 110.42 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -80.95 129.53 34.58 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 120.523 -1.361 . . . . 0.0 111.8 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 33.9 m -137.8 172.15 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.643 1.177 . . . . 0.0 112.634 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.4 137.64 37.35 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.176 0.991 . . . . 0.0 108.352 178.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -105.38 117.95 5.69 Favored Glycine 0 C--N 1.332 0.352 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -42.34 -46.8 5.56 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 126.239 1.876 . . . . 0.0 113.283 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.42 ' C ' ' H ' ' A' ' 213' ' ' SER . 1.8 p -76.45 80.73 3.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -65.02 21.46 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 130.317 3.447 . . . . 0.0 113.329 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.42 ' H ' ' C ' ' A' ' 211' ' ' SER . 23.4 t -142.49 47.24 1.58 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 129.567 3.147 . . . . 0.0 107.642 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -149.61 159.3 28.02 Favored Glycine 0 C--N 1.34 0.771 0 O-C-N 119.668 -1.895 . . . . 0.0 114.6 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.93 173.47 13.51 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.851 3.034 . . . . 0.0 111.015 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 49.0 m -75.28 152.13 38.26 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -168.39 152.59 5.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 178.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.1 mt -78.66 134.68 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . 0.462 ' HG3' HE21 ' A' ' 232' ' ' GLN . 14.7 mm100 -77.63 -51.81 10.03 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.007 0.923 . . . . 0.0 111.794 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 55.9 p-90 -149.66 165.55 31.99 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.244 1.418 . . . . 0.0 108.439 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.812 HG13 ' CE1' ' A' ' 229' ' ' TYR . 24.5 t -147.42 134.16 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 126.228 1.811 . . . . 0.0 106.883 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.68 124.75 6.15 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 177.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -78.96 86.99 4.79 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 103.517 -2.771 . . . . 0.0 103.517 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 8.6 p -53.14 -52.55 58.34 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.904 1.682 . . . . 0.0 112.606 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -107.05 -177.36 3.34 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . 0.253 2.6 mp -68.24 -18.95 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 118.882 -1.127 . . . . 0.0 110.603 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -132.31 -39.6 1.03 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.519 1.054 . . . . 0.0 112.614 178.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 11.8 t -63.47 135.3 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . 0.812 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.2 OUTLIER -133.34 139.65 46.96 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.43 1.092 . . . . 0.0 109.9 -178.07 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -121.03 140.57 51.74 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.478 1.511 . . . . 0.0 111.755 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -142.94 161.31 38.46 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 128.183 2.593 . . . . 0.0 109.723 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.462 HE21 ' HG3' ' A' ' 219' ' ' GLN . 38.7 tt0 -137.22 146.67 45.12 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.034 1.334 . . . . 0.0 107.496 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 98.5 t -131.92 134.68 59.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 125.294 1.438 . . . . 0.0 107.862 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.64 134.56 45.8 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.234 1.014 . . . . 0.0 110.577 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 69.6 mt -131.74 138.47 32.64 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.71 -46.2 0.89 Allowed 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.542 2.828 . . . . 0.0 111.553 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.98 -27.48 66.88 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.947 1.299 . . . . 0.0 111.79 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 3.5 mp -61.68 -31.62 71.77 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 117.871 -1.061 . . . . 0.0 110.477 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 8.3 m -65.64 -19.16 65.8 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.978 1.263 . . . . 0.0 113.158 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -63.54 -29.82 71.02 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.051 0.941 . . . . 0.0 111.419 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 50.7 mt -82.34 113.78 20.36 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -48.2 -31.2 5.47 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.508 HD13 ' CE2' ' A' ' 181' ' ' TYR . 21.2 mt -67.58 -36.5 81.02 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.162 -0.961 . . . . 0.0 110.338 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 17.9 mt -100.06 8.89 43.63 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 127.341 2.256 . . . . 0.0 111.204 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -80.69 68.75 7.04 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 20.6 tptp -144.63 137.88 26.98 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 126.204 1.802 . . . . 0.0 107.858 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 21.0 m120 72.05 29.34 2.37 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 126.12 1.768 . . . . 0.0 112.17 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -73.83 37.48 0.1 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 128.218 2.607 . . . . 0.0 108.971 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 . . . . . 0 C--O 1.247 0.922 0 C-N-CA 127.072 2.149 . . . . 0.0 110.046 -177.75 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.713 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.94 20.92 3.81 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.993 0.917 . . . . 0.0 112.815 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.0 p -156.6 -59.91 0.09 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.245 0.929 . . . . 0.0 112.408 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -75.48 59.06 1.06 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.566 1.146 . . . . 0.0 110.834 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.6 m -47.18 -58.54 3.95 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 126.52 1.928 . . . . 0.0 112.782 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -52.59 -53.04 52.06 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.815 0.734 . . . . 0.0 111.921 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -58.75 -40.46 83.91 Favored 'General case' 0 C--O 1.225 -0.207 0 O-C-N 121.872 -0.517 . . . . 0.0 110.314 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.9 m -65.67 -43.61 88.8 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.15 -45.04 96.3 Favored 'General case' 0 C--N 1.337 0.06 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 67.7 tp -58.3 -44.01 88.37 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.081 -0.961 . . . . 0.0 108.87 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.2 mt -61.24 -53.92 50.66 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.243 0.929 . . . . 0.0 109.388 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 51.6 m -55.13 -48.58 73.48 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.806 0.842 . . . . 0.0 111.198 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -62.87 -46.3 88.51 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 120.403 -1.436 . . . . 0.0 110.214 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 52.9 m -54.18 -46.04 72.28 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.576 1.15 . . . . 0.0 109.915 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.479 ' O ' HG23 ' A' ' 106' ' ' VAL . 22.0 tp -58.6 -54.08 51.14 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.761 0.709 . . . . 0.0 110.452 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 25.4 t30 -57.47 -46.93 83.12 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.263 0.483 . . . . 0.0 111.526 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -55.52 -46.64 77.01 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.974 0.91 . . . . 0.0 109.169 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.449 ' HA3' HD11 ' A' ' 183' ' ' ILE . . . -64.04 -46.47 91.21 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 102' ' ' LEU . 93.2 t -59.01 -53.22 51.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.047 1.339 . . . . 0.0 110.393 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -32.52 73.49 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.775 1.17 . . . . 0.0 110.16 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.2 m -67.22 -46.46 73.77 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.437 HD11 HD12 ' A' ' 183' ' ' ILE . 33.8 mt -59.64 -51.6 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.99 -35.72 77.56 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 118.659 -0.686 . . . . 0.0 110.217 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.27 -48.42 75.79 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 119.708 1.14 . . . . 0.0 110.357 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.14 -27.65 60.95 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 -178.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.8 mp -85.72 -28.37 24.67 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 120.19 1.359 . . . . 0.0 109.336 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -60.53 -19.47 57.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.127 0.571 . . . . 0.0 111.452 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.36 -46.64 54.53 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.19 0.596 . . . . 0.0 110.868 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -165.54 155.63 13.0 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.586 1.554 . . . . 0.0 108.258 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 33.5 m -75.77 162.85 27.83 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.3 pt -117.68 156.23 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.22 163.23 38.23 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 120.712 0.292 . . . . 0.0 111.191 -177.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -152.31 127.63 9.9 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.739 1.616 . . . . 0.0 109.816 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -89.14 104.43 16.98 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.17 67.66 5.9 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.43 -115.03 4.92 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.491 -1.043 . . . . 0.0 110.491 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -73.82 -34.26 64.5 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -106.38 138.2 42.98 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 119.355 0.98 . . . . 0.0 110.976 -178.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.2 mt -102.89 149.69 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -122.24 133.79 54.7 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 126.406 1.882 . . . . 0.0 106.223 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.47 132.72 44.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.101 1.761 . . . . 0.0 107.945 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -126.46 117.84 23.72 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.424 1.089 . . . . 0.0 110.959 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 8.7 m -102.64 155.99 35.84 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.008 0.923 . . . . 0.0 112.924 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.34 92.21 0.28 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 125.069 3.846 . . . . 0.0 116.164 -178.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 62.64 36.27 93.01 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.3 mt -116.68 -66.99 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.461 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 7.2 pt-20 176.96 166.62 0.53 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.075 1.75 . . . . 0.0 109.58 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -117.62 129.63 55.87 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 104.278 -2.49 . . . . 0.0 104.278 177.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.1 m -138.32 155.46 28.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.922 0.889 . . . . 0.0 110.725 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -121.12 131.44 54.25 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -145.96 157.84 43.88 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.418 1.087 . . . . 0.0 111.479 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -88.61 154.27 20.46 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 165.34 -163.66 36.7 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.429 ' HD2' HG21 ' A' ' 150' ' ' VAL . 0.0 OUTLIER -129.64 142.04 50.81 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 179.457 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.7 p -152.88 159.19 3.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 118.777 0.717 . . . . 0.0 109.709 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -102.59 112.77 25.67 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.654 1.182 . . . . 0.0 109.466 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.1 t -57.72 -19.09 24.95 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.742 1.155 . . . . 0.0 113.575 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -59.26 -35.43 73.7 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.469 1.108 . . . . 0.0 113.533 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.2 t -143.82 -20.35 0.58 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.489 0.716 . . . . 0.0 111.629 -178.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 97.16 17.62 31.46 Favored Glycine 0 C--O 1.223 -0.588 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -71.0 114.55 9.17 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 118.4 1.1 . . . . 0.0 108.281 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 14.1 mt -81.73 120.14 32.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 127.504 2.322 . . . . 0.0 106.672 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.429 HG21 ' HD2' ' A' ' 141' ' ' ARG . 42.2 t -79.47 -81.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 126.038 1.735 . . . . 0.0 108.918 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -78.47 123.99 27.64 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 46.8 mtm105 -117.62 101.68 8.55 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 101.852 -3.388 . . . . 0.0 101.852 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -120.44 112.68 19.27 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.18 1.392 . . . . 0.0 109.995 -177.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -73.08 10.51 0.91 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.138 1.375 . . . . 0.0 113.27 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 3.5 t -89.49 -42.49 11.44 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 120.48 -1.388 . . . . 0.0 111.775 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 23.5 mt -105.94 81.24 1.62 Allowed 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 119.131 0.878 . . . . 0.0 109.491 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.5 p -143.18 152.52 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.848 0.859 . . . . 0.0 109.872 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -142.38 145.56 33.99 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.913 1.685 . . . . 0.0 108.124 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -95.58 135.15 37.62 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.522 1.129 . . . . 0.0 108.676 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.4 mp -102.15 -69.69 0.78 Allowed 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 123.122 0.569 . . . . 0.0 110.486 -178.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -127.96 165.83 20.82 Favored Glycine 0 C--O 1.243 0.681 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -132.32 89.12 37.87 Favored Pre-proline 0 N--CA 1.448 -0.569 0 C-N-CA 125.428 1.491 . . . . 0.0 109.52 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 90.9 Cg_endo -74.93 176.63 9.63 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 123.201 2.601 . . . . 0.0 108.02 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -94.8 155.37 16.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.916 0.865 . . . . 0.0 111.443 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.28 -20.25 61.55 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 126.074 1.75 . . . . 0.0 113.317 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -122.97 136.83 55.01 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.466 1.506 . . . . 0.0 109.91 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.9 p -61.37 -27.76 42.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.536 0.684 . . . . 0.0 110.691 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -71.06 -6.44 39.09 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 127.755 2.422 . . . . 0.0 113.013 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -112.35 -20.11 11.94 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.561 1.144 . . . . 0.0 112.721 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.27 165.78 13.26 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -145.79 112.71 6.04 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -101.56 170.14 8.38 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.999 1.32 . . . . 0.0 110.522 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -131.81 125.82 32.8 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.481 1.512 . . . . 0.0 110.836 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 24.4 tp -86.51 104.46 15.99 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 61.2 mt -107.47 177.0 4.96 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.21 1.404 . . . . 0.0 110.78 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.464 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 12.0 p90 -162.37 166.53 25.03 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 122.813 1.292 . . . . 0.0 110.766 178.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -140.85 177.42 8.05 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 126.125 1.77 . . . . 0.0 106.759 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.28 -31.67 69.33 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 125.379 1.471 . . . . 0.0 107.948 177.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 38.7 t -66.1 -62.11 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 125.756 1.623 . . . . 0.0 107.791 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 178.9 -171.97 44.15 Favored Glycine 0 C--N 1.339 0.745 0 C-N-CA 124.392 0.996 . . . . 0.0 113.158 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.464 ' CD2' ' HB3' ' A' ' 176' ' ' TYR . 32.9 m-85 -90.27 155.05 19.27 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.692 1.197 . . . . 0.0 111.789 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -164.87 162.05 20.61 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.416 1.887 . . . . 0.0 109.171 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.449 HD11 ' HA3' ' A' ' 105' ' ' GLY . 8.6 mt -106.3 141.68 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 177.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 5.3 t -122.77 132.75 54.36 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -132.9 120.55 21.63 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 177.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.9 tt -105.91 128.0 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 5.5 mt -120.71 107.28 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 124.312 1.045 . . . . 0.0 110.653 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -99.7 -156.62 28.48 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 107.146 -2.382 . . . . 0.0 107.146 177.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 46.8 m 70.22 51.72 0.38 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.547 0.689 . . . . 0.0 110.757 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -115.71 -119.93 3.26 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 107.244 -2.342 . . . . 0.0 107.244 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -129.39 141.75 50.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.544 1.138 . . . . 0.0 108.793 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 24.5 mm -79.55 128.89 38.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 16.7 m -90.53 104.42 17.0 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 101.908 -3.367 . . . . 0.0 101.908 176.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -55.45 -16.04 3.31 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -177.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 3.0 m -59.05 -39.7 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.207 1.003 . . . . 0.0 110.246 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 1.2 p -125.21 -17.95 5.54 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.627 1.103 . . . . 0.0 111.551 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 85.94 5.48 83.52 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.685 0.659 . . . . 0.0 113.549 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -83.93 160.83 21.0 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.271 1.429 . . . . 0.0 108.351 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -86.61 152.11 22.87 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -74.96 29.84 0.09 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 127.415 2.286 . . . . 0.0 109.962 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.3 ptt? -72.1 149.3 44.91 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 122.025 0.917 . . . . 0.0 109.838 -175.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.6 p -123.08 144.12 33.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.252 -176.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -108.35 130.18 55.21 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 178.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.1 mp -118.38 112.42 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 124.744 1.217 . . . . 0.0 108.225 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -95.33 116.79 29.25 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -94.53 116.38 28.7 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.326 0.65 . . . . 0.0 110.305 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 32.2 m -126.57 171.61 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 125.518 1.527 . . . . 0.0 111.955 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -85.86 135.8 33.56 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.783 1.633 . . . . 0.0 106.991 177.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -91.57 154.66 22.84 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 119.195 0.907 . . . . 0.0 111.406 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -62.61 -60.79 7.26 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 27.5 p -78.58 74.1 5.12 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -70.23 57.95 0.17 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.94 2.496 . . . . 0.0 112.011 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.36 47.51 0.35 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.984 1.714 . . . . 0.0 110.761 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -165.19 174.25 41.05 Favored Glycine 0 CA--C 1.527 0.788 0 O-C-N 119.736 -1.852 . . . . 0.0 112.159 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -71.73 162.06 43.22 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.438 2.092 . . . . 0.0 110.57 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 7.8 m -73.95 151.04 40.46 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 126.414 1.886 . . . . 0.0 111.034 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -164.85 165.15 20.72 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.735 1.614 . . . . 0.0 108.267 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.4 mp -79.15 128.02 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 177.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -72.09 -60.56 2.17 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.847 1.659 . . . . 0.0 109.867 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . 0.41 ' CE3' ' HD2' ' A' ' 222' ' ' ARG . 28.7 p-90 -140.24 166.56 24.35 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.242 1.417 . . . . 0.0 109.807 -178.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.596 HG13 ' CE1' ' A' ' 229' ' ' TYR . 49.9 t -145.85 133.03 15.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 125.585 1.554 . . . . 0.0 107.012 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.41 ' HD2' ' CE3' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -148.7 127.48 12.56 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.63 0.729 . . . . 0.0 109.362 178.255 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -79.99 87.88 5.38 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.9 p -57.42 -53.94 52.47 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.227 1.011 . . . . 0.0 112.622 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -119.31 -179.23 3.79 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.7 mp -61.27 -27.18 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.244 1.018 . . . . 0.0 110.838 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.8 t -131.64 -30.89 1.61 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.364 0.666 . . . . 0.0 111.765 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 16.7 t -76.31 135.42 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . 0.596 ' CE1' HG13 ' A' ' 221' ' ' VAL . 1.6 t80 -129.02 148.35 50.97 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.72 1.608 . . . . 0.0 108.681 -179.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -132.2 136.76 47.26 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 126.524 1.93 . . . . 0.0 107.564 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.72 161.61 38.78 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.751 1.62 . . . . 0.0 110.191 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -134.87 145.19 48.03 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.521 0.729 . . . . 0.0 109.998 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.1 t -124.2 146.12 30.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 125.657 1.583 . . . . 0.0 108.263 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.87 133.14 56.34 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 87.9 mt -134.74 135.99 24.47 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 123.828 0.851 . . . . 0.0 108.911 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.29 -42.38 2.0 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.662 2.241 . . . . 0.0 112.554 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -60.64 -24.9 65.91 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.308 0.643 . . . . 0.0 112.113 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 54.6 mt -68.19 -28.14 67.01 Favored 'General case' 0 C--O 1.225 -0.194 0 O-C-N 121.099 -1.0 . . . . 0.0 110.844 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 39.3 m -63.74 -15.76 59.4 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.763 1.225 . . . . 0.0 113.39 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -68.54 -24.08 64.59 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.41 ' HB2' HD23 ' A' ' 244' ' ' LEU . 41.0 mt -85.38 121.99 28.9 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.693 1.597 . . . . 0.0 107.882 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -50.5 -37.21 37.63 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.6 mp -61.02 -38.59 86.62 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.415 -0.803 . . . . 0.0 109.994 178.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.507 ' C ' ' H ' ' A' ' 246' ' ' LYS . 2.6 mm? -91.89 3.04 56.07 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 127.567 2.347 . . . . 0.0 113.226 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -79.89 36.44 0.33 Allowed 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.507 ' H ' ' C ' ' A' ' 244' ' ' LEU . 57.0 tptt -145.83 136.51 24.28 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 129.347 3.059 . . . . 0.0 108.649 -178.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -174.69 158.98 2.78 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 128.887 2.875 . . . . 0.0 106.329 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -156.57 46.92 0.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.113 0.965 . . . . 0.0 109.178 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.171 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.523 0 N-CA-C 107.297 -2.321 . . . . 0.0 107.297 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.58 -31.73 71.8 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.739 1.769 . . . . 0.0 107.702 177.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 59.7 m 43.53 19.06 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 130.037 3.335 . . . . 0.0 118.038 176.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -57.28 -35.63 70.04 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 120.342 1.428 . . . . 0.0 109.775 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.4 m -63.67 -45.39 90.32 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 119.301 0.955 . . . . 0.0 110.349 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -65.79 -35.31 80.34 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.57 1.148 . . . . 0.0 110.594 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -69.53 -55.06 11.25 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.376 1.07 . . . . 0.0 108.311 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.4 p -60.52 -35.83 76.93 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 123.834 0.854 . . . . 0.0 111.307 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.69 -44.61 81.65 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 119.346 0.975 . . . . 0.0 109.71 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 52.0 tp -62.49 -44.89 95.28 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 118.52 -0.752 . . . . 0.0 109.036 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.7 mt -60.78 -48.27 82.57 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.272 0.942 . . . . 0.0 110.539 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 33.0 m -56.46 -56.5 20.39 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.676 1.19 . . . . 0.0 109.335 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.9 ttpp -58.69 -48.22 81.84 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-O 118.948 -0.548 . . . . 0.0 110.4 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.1 m -52.88 -52.95 55.57 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.231 1.012 . . . . 0.0 110.933 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.546 ' O ' HG23 ' A' ' 106' ' ' VAL . 17.1 tp -57.81 -53.59 56.47 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 118.882 0.765 . . . . 0.0 110.099 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -58.69 -46.72 86.63 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -59.17 -43.44 92.12 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 125.049 1.339 . . . . 0.0 107.832 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.27 -50.53 65.64 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.552 HG22 ' CD2' ' A' ' 172' ' ' PHE . 15.7 t -57.32 -53.49 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 118.69 1.245 . . . . 0.0 110.684 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -32.8 74.22 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.044 0.838 . . . . 0.0 110.979 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.3 m -66.21 -45.71 79.81 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 34.1 mt -60.56 -51.43 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 123.848 0.859 . . . . 0.0 108.79 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.19 -38.97 69.06 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 123.521 0.513 . . . . 0.0 109.978 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -67.58 -54.51 19.22 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 118.808 0.731 . . . . 0.0 110.669 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.11 -17.5 7.32 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 125.874 1.67 . . . . 0.0 114.537 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.6 mp -111.59 -27.86 8.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 119.388 0.995 . . . . 0.0 109.509 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -59.71 -31.07 69.26 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.447 0.567 . . . . 0.0 110.919 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -64.38 -46.04 85.1 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 122.901 0.48 . . . . 0.0 111.348 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -162.95 152.6 15.56 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.996 1.719 . . . . 0.0 110.094 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 55.9 m -75.68 166.79 23.01 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 23.6 pt -125.12 153.29 32.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 124.426 1.091 . . . . 0.0 109.108 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -146.3 168.27 21.5 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.996 -0.44 . . . . 0.0 112.149 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -154.11 121.38 5.74 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.072 0.949 . . . . 0.0 109.665 178.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -81.71 103.96 11.77 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.5 0.72 . . . . 0.0 109.634 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.94 70.83 2.92 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 178.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 67.66 -121.15 14.1 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -69.11 -28.13 66.2 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -107.13 137.5 45.07 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 119.482 1.037 . . . . 0.0 110.056 -178.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.8 mt -112.74 134.13 56.33 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.42 ' CD1' HG11 ' A' ' 221' ' ' VAL . 43.7 m-85 -100.68 129.01 46.53 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 125.124 1.37 . . . . 0.0 107.977 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -123.57 132.5 53.9 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.897 1.279 . . . . 0.0 108.712 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -129.62 112.91 14.17 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.447 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 19.8 m -97.42 159.74 30.44 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-O 118.402 -0.809 . . . . 0.0 111.214 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.2 90.34 0.1 OUTLIER 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 123.989 3.126 . . . . 0.0 113.622 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 56.07 44.69 88.3 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 123.827 0.727 . . . . 0.0 112.751 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 6.5 mt -113.58 -66.89 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.449 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 13.6 pt-20 -171.41 167.56 6.76 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.894 1.278 . . . . 0.0 109.354 178.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.61 122.22 38.32 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 178.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.8 m -137.84 156.5 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -122.09 125.99 47.41 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 177.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -146.91 157.95 43.78 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.442 1.497 . . . . 0.0 110.13 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -88.56 153.25 21.29 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 178.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 174.08 -163.53 34.46 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.241 -1.943 . . . . 0.0 108.241 -178.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.12 137.84 46.45 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.8 146.89 20.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -90.79 98.57 11.85 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.266 1.426 . . . . 0.0 107.425 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.6 t -51.99 -23.87 5.75 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -52.03 -33.59 39.3 Favored 'General case' 0 C--N 1.341 0.198 0 O-C-N 121.268 -0.895 . . . . 0.0 112.762 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.0 t -146.43 -9.6 0.49 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.52 9.75 58.64 Favored Glycine 0 CA--C 1.523 0.572 0 O-C-N 120.591 -1.318 . . . . 0.0 112.714 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -68.65 121.71 17.02 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.401 1.1 . . . . 0.0 110.966 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 65.2 mt -75.67 126.16 36.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 40.8 t -89.69 -55.62 6.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -133.47 152.21 51.88 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.604 0.762 . . . . 0.0 110.241 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -147.04 173.67 12.24 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.604 2.362 . . . . 0.0 108.251 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -162.42 141.31 9.09 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -95.03 -5.49 44.36 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -178.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 21.5 m -83.0 -12.49 57.23 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.752 -1.218 . . . . 0.0 111.343 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.7 tp -131.89 72.94 1.51 Allowed 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.646 1.178 . . . . 0.0 109.322 -178.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 22.1 t -137.06 140.5 42.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.377 1.071 . . . . 0.0 108.23 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -126.14 134.46 51.31 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -85.91 120.88 27.79 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 126.531 1.932 . . . . 0.0 108.576 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 50.7 mt -94.08 -89.03 0.23 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -114.63 145.7 18.64 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -114.9 92.57 30.91 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 83.5 Cg_endo -71.9 179.67 4.62 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.682 2.922 . . . . 0.0 111.387 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -104.08 160.45 14.83 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 124.656 1.182 . . . . 0.0 111.676 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -77.37 -26.53 52.0 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -110.75 136.71 49.41 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.0 p -63.39 -24.11 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 124.147 0.979 . . . . 0.0 112.237 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -81.45 -18.5 45.05 Favored 'General case' 0 C--N 1.335 -0.038 0 C-N-CA 123.314 0.645 . . . . 0.0 112.258 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -71.55 -23.63 61.8 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 122.818 0.447 . . . . 0.0 110.3 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -113.62 168.6 9.63 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.01 1.724 . . . . 0.0 108.352 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -142.12 134.77 28.3 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.552 ' CD2' HG22 ' A' ' 106' ' ' VAL . 8.7 m-30 -101.03 170.86 7.99 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.07 0.948 . . . . 0.0 109.1 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -137.61 129.66 28.98 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 24.8 tp -100.79 98.35 8.88 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.12 -179.73 3.98 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 126.561 1.944 . . . . 0.0 108.775 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -149.64 162.74 39.61 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 122.23 1.014 . . . . 0.0 110.254 178.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -133.14 -179.67 5.64 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.997 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -58.66 -35.7 72.97 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 125.103 1.361 . . . . 0.0 109.092 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 44.7 t -72.05 -62.11 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -177.64 -169.14 38.3 Favored Glycine 0 C--N 1.338 0.679 0 CA-C-N 119.178 0.899 . . . . 0.0 111.234 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -78.4 158.4 28.75 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.997 0.427 . . . . 0.0 111.149 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -158.1 166.36 32.67 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.056 1.343 . . . . 0.0 107.894 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 3.5 mt -114.63 136.09 52.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 7.1 t -110.98 145.34 38.59 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -140.27 120.32 13.69 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 178.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 2.6 tt -114.85 134.55 57.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 178.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.5 mt -129.32 112.42 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 124.063 0.945 . . . . 0.0 110.289 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -104.29 -160.39 24.27 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 126.343 1.925 . . . . 0.0 111.292 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 40.0 m 67.55 60.12 0.48 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.465 1.506 . . . . 0.0 112.633 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -112.24 -119.47 3.73 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -126.28 115.57 19.9 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.496 1.518 . . . . 0.0 107.893 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 46.1 mm -60.26 114.59 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 54.3 m -72.8 100.07 2.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.73 -15.55 20.72 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.833 0.742 . . . . 0.0 112.7 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.46 -36.71 42.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.514 1.526 . . . . 0.0 107.513 177.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 5.0 p -126.49 -30.76 2.81 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 96.57 17.13 34.47 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 127.317 2.389 . . . . 0.0 111.116 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -92.46 166.18 12.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.35 1.075 . . . . 0.0 111.98 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -87.49 146.74 25.68 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.603 178.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -76.8 30.22 0.13 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.367 2.267 . . . . 0.0 110.744 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -74.6 140.93 44.69 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.964 0.888 . . . . 0.0 110.719 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.3 p -109.47 150.04 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.252 -1.34 . . . . 0.0 109.377 -178.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -120.62 130.44 54.15 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.9 mp -120.19 110.01 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 124.929 1.291 . . . . 0.0 108.2 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -96.46 107.07 19.42 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -84.19 124.45 31.18 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.099 0.96 . . . . 0.0 109.426 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 27.9 m -134.9 173.22 14.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 125.1 1.36 . . . . 0.0 110.645 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 2.4 t -86.86 127.55 35.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 177.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -85.44 171.85 46.2 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 118.61 0.641 . . . . 0.0 112.991 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -68.02 -16.13 68.14 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.831 1.205 . . . . 0.0 112.418 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 40.0 t -118.17 119.33 34.4 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -97.22 18.21 15.53 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.796 0.438 . . . . 0.0 111.253 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 91.2 p -138.41 48.33 1.95 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.045 1.738 . . . . 0.0 110.927 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.83 168.08 28.15 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 120.762 -1.211 . . . . 0.0 111.617 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.68 169.96 21.38 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.865 2.377 . . . . 0.0 111.041 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.5 ' O ' HG23 ' A' ' 217' ' ' THR . 78.9 p -68.54 155.05 40.71 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 216' ' ' SER . 0.8 OUTLIER -169.64 154.05 5.32 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 121.66 -0.65 . . . . 0.0 109.611 179.247 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.9 mt -82.06 130.23 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -75.98 -59.42 2.77 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.364 1.065 . . . . 0.0 111.441 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 45.1 p-90 -142.23 165.32 27.76 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.775 1.63 . . . . 0.0 108.222 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.807 HG13 ' CE1' ' A' ' 229' ' ' TYR . 46.3 t -145.24 127.01 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.75 133.76 17.07 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 122.051 0.929 . . . . 0.0 110.801 178.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -82.39 86.52 6.71 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 6.7 p -57.59 -64.76 0.79 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.587 1.155 . . . . 0.0 108.915 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -98.76 -174.49 2.8 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 178.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 34.3 mm -69.71 -43.93 79.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 O-C-N 121.347 -0.846 . . . . 0.0 110.486 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -103.81 -39.72 6.53 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.006 0.522 . . . . 0.0 112.308 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 15.5 t -72.56 130.82 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . 0.807 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.2 OUTLIER -127.5 148.88 50.32 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.915 1.686 . . . . 0.0 108.693 -179.207 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -129.02 144.23 51.12 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.804 1.242 . . . . 0.0 109.258 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.67 161.48 40.48 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.269 1.828 . . . . 0.0 108.698 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -131.05 144.88 51.78 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 86.8 t -130.94 135.23 60.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 4.6 p -102.64 142.58 33.56 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 72.9 mt -141.87 131.75 12.6 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-O 118.748 -0.644 . . . . 0.0 109.714 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -71.54 -32.97 11.38 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.514 2.143 . . . . 0.0 112.128 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -69.38 -22.02 63.74 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.029 0.932 . . . . 0.0 111.246 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.6 mp -68.91 -41.2 78.52 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 22.4 m -57.63 -19.76 28.52 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.137 1.375 . . . . 0.0 112.469 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -64.98 -26.38 68.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.247 0.619 . . . . 0.0 110.643 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 25.1 mt -88.03 133.8 33.88 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.704 2.401 . . . . 0.0 108.477 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -54.9 -47.37 74.43 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.935 2.094 . . . . 0.0 113.937 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 8.1 mp -58.91 -34.63 71.92 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.225 -0.922 . . . . 0.0 111.925 -178.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -92.66 3.88 54.75 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.046 1.338 . . . . 0.0 111.476 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -76.78 52.75 0.86 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.259 1.823 . . . . 0.0 110.491 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -153.43 134.77 14.21 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.188 1.395 . . . . 0.0 107.321 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -164.41 178.74 7.23 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.962 1.705 . . . . 0.0 107.921 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 59.56 21.3 9.84 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.079 1.351 . . . . 0.0 113.026 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 36.9 t70 . . . . . 0 C--O 1.252 1.232 0 C-N-CA 124.672 1.189 . . . . 0.0 110.787 -179.455 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.761 0 N-CA-C 108.436 -1.866 . . . . 0.0 108.436 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.37 -5.25 1.82 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.593 1.157 . . . . 0.0 113.499 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.7 t -68.57 155.66 39.55 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -150.08 107.11 3.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.3 m -57.81 -26.39 61.91 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -84.02 -25.72 29.69 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.786 -0.571 . . . . 0.0 110.245 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.6 tptm -67.87 -44.86 76.09 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.1 p -63.54 -40.23 96.46 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.89 95.69 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 40.7 tp -65.61 -44.83 85.32 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.981 0.912 . . . . 0.0 110.041 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 21.4 mt -62.24 -49.02 77.37 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 79.0 m -54.46 -54.22 43.75 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.638 0.775 . . . . 0.0 109.092 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -58.0 -51.36 69.97 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 122.835 0.454 . . . . 0.0 109.989 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 28.3 m -56.52 -42.61 78.7 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.819 0.847 . . . . 0.0 112.548 -178.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.6 tp -66.98 -55.66 13.52 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 119.328 0.967 . . . . 0.0 110.136 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -60.21 -47.15 87.19 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 118.749 0.704 . . . . 0.0 111.971 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -57.79 -49.79 75.43 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.31 -47.18 91.1 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.478 HG13 ' CE1' ' A' ' 172' ' ' PHE . 42.5 t -59.74 -53.55 46.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 126.238 1.815 . . . . 0.0 110.783 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -32.56 74.17 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 119.776 -0.769 . . . . 0.0 109.68 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.6 m -65.36 -44.92 86.14 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.284 0.947 . . . . 0.0 108.63 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.518 HD11 HD12 ' A' ' 183' ' ' ILE . 7.9 mt -53.02 -53.16 23.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.33 -46.87 79.73 Favored 'General case' 0 N--CA 1.436 -1.15 0 O-C-N 124.688 1.243 . . . . 0.0 111.99 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.21 -50.83 71.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.809 0.814 . . . . 0.0 110.023 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -68.46 -8.96 45.52 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.721 1.208 . . . . 0.0 114.059 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.4 mt -115.27 -25.15 8.14 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.416 1.007 . . . . 0.0 111.861 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -61.87 -29.27 70.08 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.125 0.42 . . . . 0.0 110.347 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -69.62 -46.35 66.43 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.883 1.273 . . . . 0.0 109.546 178.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 -160.15 147.45 16.28 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.641 1.576 . . . . 0.0 110.218 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 65.9 m -75.58 177.57 6.66 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 34.0 pt -131.86 150.32 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 O-C-N 121.432 -0.793 . . . . 0.0 109.556 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.59 164.91 28.94 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.961 0.504 . . . . 0.0 110.604 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -147.08 129.13 15.5 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.057 1.743 . . . . 0.0 109.237 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -91.33 102.76 15.46 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.97 66.64 3.62 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.959 1.303 . . . . 0.0 107.791 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.16 -120.28 11.77 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -63.34 -34.9 78.7 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.809 0.844 . . . . 0.0 112.558 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -107.44 148.85 28.61 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 118.743 0.701 . . . . 0.0 110.637 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.0 mt -112.06 151.03 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -125.22 128.4 48.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.246 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -126.33 130.69 51.31 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.846 1.658 . . . . 0.0 108.544 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -125.76 120.97 32.02 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.35 1.46 . . . . 0.0 109.33 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 6.5 m -105.53 160.02 27.51 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.755 1.222 . . . . 0.0 113.89 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.02 86.12 0.49 Allowed 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 124.585 3.524 . . . . 0.0 113.208 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 61.93 54.95 31.11 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.0 mt -130.02 -67.46 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.414 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 20.9 pt-20 -170.29 166.57 8.72 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 126.337 1.855 . . . . 0.0 108.05 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.58 119.07 27.12 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 102.472 -3.159 . . . . 0.0 102.472 177.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.6 m -139.24 148.39 23.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -178.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -113.69 138.02 50.8 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -145.76 158.5 43.85 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.753 1.221 . . . . 0.0 111.158 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -87.81 154.48 20.51 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 152.34 -164.14 30.48 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -132.13 161.29 33.68 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.173 1.389 . . . . 0.0 108.01 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 53.7 t -131.69 136.63 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.579 1.152 . . . . 0.0 109.928 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.89 93.33 5.64 Favored 'General case' 0 N--CA 1.461 0.09 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.2 t -48.13 -27.95 2.65 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -54.42 -30.16 51.46 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.258 1.423 . . . . 0.0 112.498 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.1 t -145.18 -16.69 0.5 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.533 0.606 . . . . 0.0 112.196 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 96.26 4.91 59.55 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 125.191 1.377 . . . . 0.0 113.173 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -68.85 142.46 54.82 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.557 1.178 . . . . 0.0 110.34 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.7 mt -74.76 158.29 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 57.6 t -99.87 -41.97 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 117.798 -1.096 . . . . 0.0 112.127 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -128.56 174.71 9.15 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 120.635 1.562 . . . . 0.0 112.246 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -141.11 58.14 1.54 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.455 1.102 . . . . 0.0 110.468 -178.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.79 106.28 11.69 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 120.536 -1.352 . . . . 0.0 109.343 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -63.91 -12.95 41.55 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.525 1.057 . . . . 0.0 110.963 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.1 t -66.26 -25.84 67.07 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 128.071 2.548 . . . . 0.0 114.366 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 46.8 mt -129.78 76.7 1.74 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.172 0.897 . . . . 0.0 108.696 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.2 t -142.67 138.95 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 126.145 1.778 . . . . 0.0 108.933 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -132.04 153.48 50.36 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 125.215 1.406 . . . . 0.0 110.673 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -95.39 135.96 36.35 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.658 1.583 . . . . 0.0 108.2 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 63.7 mt -115.89 -78.85 0.58 Allowed 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -121.38 154.05 16.6 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt -132.84 90.57 31.74 Favored Pre-proline 0 N--CA 1.456 -0.148 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 48.6 Cg_endo -76.27 -178.99 4.83 Favored 'Trans proline' 0 C--O 1.239 0.529 0 C-N-CA 123.194 2.596 . . . . 0.0 111.951 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -85.59 166.97 15.8 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.24 -37.03 39.03 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -105.33 152.0 23.47 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.375 -0.828 . . . . 0.0 111.67 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.1 p -68.25 -24.68 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.575 0.75 . . . . 0.0 112.393 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -82.82 -8.24 59.6 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.909 1.284 . . . . 0.0 112.372 -178.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -96.79 -11.72 24.58 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.466 1.107 . . . . 0.0 110.258 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -120.53 177.91 4.87 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.83 2.452 . . . . 0.0 111.552 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -142.85 165.78 26.44 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.02 1.728 . . . . 0.0 109.786 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.478 ' CE1' HG13 ' A' ' 106' ' ' VAL . 77.7 m-85 -140.94 168.42 19.84 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.885 1.674 . . . . 0.0 109.28 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -129.97 122.0 27.65 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.638 0.775 . . . . 0.0 109.488 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.0 tt -81.28 105.0 12.12 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 45.7 mt -115.78 -179.89 3.78 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.944 0.897 . . . . 0.0 110.995 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -161.91 156.15 22.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -138.42 -172.83 3.38 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -54.16 -24.2 17.18 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.487 1.915 . . . . 0.0 113.626 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 45.7 t -80.85 -75.5 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -166.68 -168.97 29.67 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.571 ' CE2' HD22 ' A' ' 243' ' ' LEU . 6.3 m-85 -78.16 154.78 30.88 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.249 1.02 . . . . 0.0 111.177 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -160.85 175.38 12.61 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.149 1.78 . . . . 0.0 108.74 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.518 HD12 HD11 ' A' ' 109' ' ' ILE . 15.8 mt -120.01 137.85 52.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 103.063 -2.94 . . . . 0.0 103.063 177.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.4 t -124.88 125.85 44.61 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -128.55 146.02 50.95 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 5.8 tt -121.53 138.2 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.409 HG21 ' HD3' ' A' ' 163' ' ' PRO . 13.8 mt -126.06 109.54 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 125.65 1.58 . . . . 0.0 109.512 -178.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.34 -153.26 24.9 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 41.7 m 75.95 31.67 0.68 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.866 1.267 . . . . 0.0 111.357 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -91.62 -138.22 7.92 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 108.266 -1.934 . . . . 0.0 108.266 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -117.47 121.71 41.77 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 127.229 2.212 . . . . 0.0 110.04 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 10.6 mm -60.79 125.63 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 123.378 0.671 . . . . 0.0 109.839 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 56.6 m -84.64 101.96 12.56 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 103.922 -2.621 . . . . 0.0 103.922 177.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -58.61 -17.79 24.91 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.579 0.627 . . . . 0.0 110.762 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 24.9 t -50.69 -41.56 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 125.526 1.53 . . . . 0.0 109.098 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 7.5 p -125.45 -24.23 3.96 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 96.1 6.21 59.13 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 126.713 2.101 . . . . 0.0 112.441 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -86.23 166.82 15.4 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.038 0.935 . . . . 0.0 110.965 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -90.39 150.87 21.68 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 2.6 tpt85 -76.88 30.69 0.13 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 128.216 2.606 . . . . 0.0 110.789 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.1 ptt? -72.44 149.13 44.5 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -176.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.3 p -121.74 140.78 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 114.616 -1.174 . . . . 0.0 112.218 -176.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -112.57 123.09 49.51 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.365 1.066 . . . . 0.0 110.394 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 2.3 mp -109.04 128.67 64.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 126.115 1.766 . . . . 0.0 111.098 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -106.23 118.69 37.29 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.36 1.064 . . . . 0.0 108.724 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -97.27 115.33 27.43 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.91 0.884 . . . . 0.0 109.61 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 32.8 m -125.54 165.42 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.647 1.579 . . . . 0.0 112.106 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.13 137.33 37.43 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -107.06 128.03 9.08 Favored Glycine 0 C--N 1.334 0.471 0 N-CA-C 108.265 -1.934 . . . . 0.0 108.265 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -42.91 -41.63 4.63 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.592 1.568 . . . . 0.0 113.656 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.4 t -79.49 85.37 5.27 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.414 ' HA ' ' HB3' ' A' ' 236' ' ' PRO . 18.1 p-10 -72.66 9.15 1.17 Allowed 'General case' 0 CA--C 1.549 0.908 0 O-C-N 121.276 -0.89 . . . . 0.0 113.115 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.95 46.51 1.65 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.43 1.892 . . . . 0.0 112.906 -178.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -166.83 159.89 33.38 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 120.299 -1.5 . . . . 0.0 111.993 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.25 166.59 22.82 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.135 2.557 . . . . 0.0 111.825 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 5.2 p -66.22 158.62 28.38 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.827 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.0 p -161.6 165.31 28.58 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.125 1.77 . . . . 0.0 107.376 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.8 mt -85.61 132.1 32.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -78.2 -53.03 7.79 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.787 1.635 . . . . 0.0 110.542 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . 0.489 ' CE3' ' HD2' ' A' ' 222' ' ' ARG . 37.9 p-90 -152.16 167.4 28.66 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.38 1.472 . . . . 0.0 108.685 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.717 HG13 ' CE1' ' A' ' 229' ' ' TYR . 47.0 t -146.29 133.88 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 126.253 1.821 . . . . 0.0 106.923 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.489 ' HD2' ' CE3' ' A' ' 220' ' ' TRP . 0.1 OUTLIER -153.75 130.47 10.81 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.912 0.778 . . . . 0.0 111.12 178.082 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -81.73 86.88 6.36 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 6.6 p -65.32 -55.02 20.61 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 127.022 2.129 . . . . 0.0 110.599 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -98.38 -176.51 3.42 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.5 mp -78.79 -29.98 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.8 t -111.61 -54.34 2.62 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.511 0.725 . . . . 0.0 110.898 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.94 149.4 10.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 123.639 0.776 . . . . 0.0 109.283 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . 0.717 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.2 OUTLIER -138.24 139.56 39.29 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.213 1.805 . . . . 0.0 109.453 -178.168 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.3 140.34 49.68 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.03 1.332 . . . . 0.0 108.553 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.39 162.32 38.46 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.394 1.877 . . . . 0.0 109.12 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -131.79 149.4 52.48 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 94.3 t -132.55 132.77 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 125.836 1.654 . . . . 0.0 108.887 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.25 144.29 27.2 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 32.7 mt -141.28 136.97 16.21 Favored Pre-proline 0 N--CA 1.454 -0.262 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.414 ' HB3' ' HA ' ' A' ' 212' ' ' ASN . 89.9 Cg_endo -76.75 -40.88 0.46 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.627 1.551 . . . . 0.0 112.338 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -68.27 -17.67 64.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 120.768 -1.208 . . . . 0.0 111.944 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 17.0 mt -66.04 -30.77 71.36 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 176.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 28.9 m -61.11 -13.78 19.71 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.024 1.33 . . . . 0.0 111.167 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -75.37 -32.37 60.81 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 120.142 -1.599 . . . . 0.0 111.534 178.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 40.5 mt -81.31 111.47 17.72 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 126.5 1.92 . . . . 0.0 109.0 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -47.08 -34.11 5.58 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 128.847 2.859 . . . . 0.0 114.878 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.571 HD22 ' CE2' ' A' ' 181' ' ' TYR . 12.5 mt -62.82 -39.62 94.88 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.355 -0.841 . . . . 0.0 111.531 178.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 4.8 mp -91.51 10.33 28.27 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 127.058 2.143 . . . . 0.0 113.5 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -72.09 65.62 0.58 Allowed 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 126.462 1.905 . . . . 0.0 110.694 -178.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -140.7 146.39 37.73 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 130.206 3.403 . . . . 0.0 107.754 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 27.0 m120 67.43 20.25 9.92 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -82.48 85.54 6.92 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 100.414 -3.921 . . . . 0.0 100.414 176.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 18.6 t70 . . . . . 0 C--O 1.247 0.943 0 C-N-CA 126.857 2.063 . . . . 0.0 109.808 -178.935 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.715 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -144.26 -78.7 0.2 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.736 1.214 . . . . 0.0 110.127 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.1 p -72.61 81.29 1.1 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.357 1.063 . . . . 0.0 109.528 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -82.45 -38.76 23.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 118.623 -0.703 . . . . 0.0 112.57 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 63.4 m -57.92 -54.54 45.72 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.955 0.902 . . . . 0.0 111.918 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -62.83 -27.93 69.66 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.554 0.342 . . . . 0.0 111.57 -178.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? -66.67 -57.22 7.6 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.9 p -61.81 -36.17 80.34 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 118.17 0.441 . . . . 0.0 110.415 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.49 -48.17 82.94 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 118.293 0.497 . . . . 0.0 110.096 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 47.1 tp -67.53 -40.2 85.06 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 118.218 -0.896 . . . . 0.0 109.445 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.7 mt -59.35 -52.49 65.43 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.864 1.211 . . . . 0.0 109.266 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.4 m -57.3 -49.57 75.68 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 121.648 -0.657 . . . . 0.0 109.47 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -57.89 -49.1 77.86 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 118.238 0.472 . . . . 0.0 109.776 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 59.6 m -53.05 -52.57 58.09 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.71 1.604 . . . . 0.0 110.422 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 19.0 tp -59.83 -54.3 47.88 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 118.802 -0.618 . . . . 0.0 110.603 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.86 -47.67 79.88 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 118.262 0.483 . . . . 0.0 111.708 -178.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -60.06 -39.74 87.05 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.285 1.034 . . . . 0.0 108.512 178.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.89 -52.83 50.53 Favored Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 40.3 t -56.39 -52.99 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 118.661 1.231 . . . . 0.0 111.165 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -29.67 70.87 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.405 1.002 . . . . 0.0 111.54 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.1 m -75.41 -42.69 53.09 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 118.79 -0.624 . . . . 0.0 110.459 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.427 HD11 HD12 ' A' ' 183' ' ' ILE . 22.6 mt -56.12 -50.87 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.03 -43.19 91.57 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -65.77 -20.51 66.29 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.72 1.208 . . . . 0.0 112.81 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.16 10.36 33.84 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.003 1.321 . . . . 0.0 112.583 178.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.7 mt -135.59 -29.15 1.07 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.497 1.119 . . . . 0.0 113.555 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -51.7 -37.16 49.61 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -178.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -65.45 -40.07 92.79 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 116.069 1.878 . . . . 0.0 116.069 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.9 mmt180 -159.12 147.87 18.25 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.395 1.478 . . . . 0.0 109.243 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 32.2 m -75.72 172.3 12.87 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 32.9 pt -126.31 146.24 32.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.422 ' CD1' HD11 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -144.96 152.65 40.51 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 122.84 0.456 . . . . 0.0 110.889 -178.562 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -137.08 127.71 26.98 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 124.046 0.938 . . . . 0.0 110.455 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -89.15 102.86 15.52 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.57 70.75 4.24 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.08 -115.51 5.5 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -77.27 -28.03 53.37 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.322 1.049 . . . . 0.0 111.794 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -106.65 135.56 47.96 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 119.327 0.967 . . . . 0.0 111.215 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.4 mt -106.82 145.82 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.515 ' CD1' HG11 ' A' ' 221' ' ' VAL . 67.1 m-85 -121.27 128.33 52.26 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.409 1.484 . . . . 0.0 107.627 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -122.94 128.24 50.0 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.676 1.59 . . . . 0.0 110.255 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -121.06 109.97 15.68 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.074 0.95 . . . . 0.0 108.612 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 11.6 m -95.23 158.8 34.15 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 123.226 0.61 . . . . 0.0 110.972 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.5 83.55 0.39 Allowed 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 123.903 3.069 . . . . 0.0 115.658 -178.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.32 51.68 50.47 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 124.205 0.907 . . . . 0.0 111.085 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.8 mt -126.8 -67.17 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.4 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 10.5 pt-20 -170.64 163.35 8.11 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 126.414 1.885 . . . . 0.0 108.362 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.67 121.12 36.64 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 102.154 -3.276 . . . . 0.0 102.154 177.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.4 m -131.5 156.95 43.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 124.548 1.139 . . . . 0.0 111.13 -178.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -125.83 126.39 44.41 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 178.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -143.99 157.53 44.28 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.489 1.115 . . . . 0.0 111.926 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -89.29 153.24 21.05 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 178.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 161.84 -163.03 34.51 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.38 140.86 50.58 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.6 t -123.37 144.54 32.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -94.64 100.41 12.35 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.3 t -57.01 -20.31 23.43 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.676 1.126 . . . . 0.0 112.191 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -46.97 -38.84 11.32 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 126.857 2.063 . . . . 0.0 112.317 178.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.7 t -144.61 -10.65 0.61 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.833 0.853 . . . . 0.0 112.034 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.13 3.81 63.35 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.581 1.563 . . . . 0.0 113.182 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -64.88 143.62 57.82 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.561 1.544 . . . . 0.0 111.149 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.422 HD11 ' CD1' ' A' ' 119' ' ' PHE . 39.7 mt -91.91 139.57 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 60.3 t -85.3 -82.35 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 123.553 0.741 . . . . 0.0 109.351 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -82.26 155.56 24.8 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.877 1.217 . . . . 0.0 109.103 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 62.2 mtp85 -122.33 34.22 5.22 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.301 1.44 . . . . 0.0 110.51 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -49.95 128.93 19.68 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.581 1.552 . . . . 0.0 110.524 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -95.99 -6.01 39.89 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.049 1.739 . . . . 0.0 114.959 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 41.7 p -75.75 -21.52 57.38 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 80.6 mt -128.92 81.81 2.05 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.3 t -142.5 135.12 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.071 1.348 . . . . 0.0 107.838 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -124.31 151.38 44.35 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.087 1.355 . . . . 0.0 111.051 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -96.99 112.64 24.3 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 127.068 2.147 . . . . 0.0 107.449 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.3 mp -93.82 -78.53 0.43 Allowed 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -120.49 144.23 16.95 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -121.52 89.35 47.19 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 52.5 Cg_endo -77.58 173.35 14.32 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.793 2.995 . . . . 0.0 111.608 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -87.88 161.88 17.25 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.184 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -82.97 -37.84 23.51 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.066 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -93.34 132.59 37.42 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 15.0 p -60.65 -31.74 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 123.85 0.86 . . . . 0.0 112.086 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -68.03 -21.36 65.02 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.704 0.684 . . . . 0.0 112.01 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -84.31 -20.31 32.3 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.838 0.455 . . . . 0.0 110.614 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 32.9 mmm-85 -70.72 165.93 21.95 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.748 0.819 . . . . 0.0 109.904 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -134.86 95.98 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.086 0.955 . . . . 0.0 109.241 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -106.68 156.65 18.4 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.946 1.298 . . . . 0.0 108.932 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -140.92 147.49 38.92 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.759 1.224 . . . . 0.0 107.888 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 25.1 tp -107.94 102.64 11.81 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 125.705 1.602 . . . . 0.0 106.875 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.81 179.0 4.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.28 1.432 . . . . 0.0 107.837 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.415 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 20.5 p90 -154.07 163.66 39.74 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -133.81 173.9 11.04 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -63.78 -11.43 26.69 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.403 -0.81 . . . . 0.0 110.61 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 83.7 t -83.76 -66.16 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -176.32 -174.54 42.91 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.415 ' CD2' ' HB3' ' A' ' 176' ' ' TYR . 26.2 m-85 -81.41 156.57 25.33 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 124.798 1.239 . . . . 0.0 111.842 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -162.79 169.96 19.08 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.228 1.011 . . . . 0.0 111.258 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.427 HD12 HD11 ' A' ' 109' ' ' ILE . 7.9 mt -116.57 121.78 68.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 11.8 t -97.69 131.61 44.08 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.704 1.202 . . . . 0.0 110.321 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -137.93 110.14 7.34 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.114 1.766 . . . . 0.0 109.075 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 2.7 tt -103.22 140.23 22.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.2 mt -132.83 113.79 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 123.647 0.779 . . . . 0.0 110.289 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -106.55 -156.87 21.33 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 125.293 1.425 . . . . 0.0 110.897 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 65.69 60.79 0.7 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.109 1.763 . . . . 0.0 111.554 -178.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -116.84 -124.01 3.52 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 104.633 -3.387 . . . . 0.0 104.633 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -127.95 123.58 35.22 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.759 1.224 . . . . 0.0 110.754 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 31.0 mm -64.25 116.96 4.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 71.8 m -73.71 102.09 3.86 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -53.18 -28.8 28.24 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.5 m -52.41 -33.28 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 C-N-CA 125.025 1.33 . . . . 0.0 111.384 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 73.1 p -123.0 -45.79 2.12 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.74 12.43 20.88 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.994 2.235 . . . . 0.0 111.32 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -92.56 169.97 10.11 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.942 1.297 . . . . 0.0 111.488 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -85.17 148.51 26.07 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.589 0.709 . . . . 0.0 111.792 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 18.3 tpt85 -84.05 28.56 0.6 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.676 2.39 . . . . 0.0 109.157 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 3.5 ptt? -73.47 158.77 34.3 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -177.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 1.9 p -125.93 140.1 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.155 -178.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -105.96 115.54 30.4 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 125.84 1.656 . . . . 0.0 107.083 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 4.6 mp -107.12 131.65 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -118.1 120.15 36.88 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 125.435 1.494 . . . . 0.0 108.511 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -101.05 119.4 38.69 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.42 1.488 . . . . 0.0 112.368 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 17.2 m -127.05 176.34 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.808 1.243 . . . . 0.0 111.8 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.6 t -91.0 124.32 35.15 Favored 'General case' 0 C--N 1.337 0.053 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 178.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.34 155.24 34.03 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.258 -0.496 . . . . 0.0 113.043 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -57.44 -27.22 57.98 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.305 0.955 . . . . 0.0 111.594 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 6.0 m -114.68 93.69 4.44 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -77.55 25.03 0.19 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.967 1.707 . . . . 0.0 112.552 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 27.2 t -131.98 45.48 2.77 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.343 1.857 . . . . 0.0 110.005 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -161.35 166.03 35.69 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-O 118.619 -1.101 . . . . 0.0 111.27 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -71.09 166.75 28.16 Favored 'Trans proline' 0 C--O 1.24 0.589 0 C-N-CA 122.821 2.347 . . . . 0.0 112.413 -178.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 96.7 p -70.38 155.58 40.49 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -166.01 156.11 12.5 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.0 mt -78.87 127.03 39.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -72.01 -51.25 22.71 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.743 1.617 . . . . 0.0 112.139 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . 0.441 ' CZ2' ' HB2' ' A' ' 232' ' ' GLN . 20.7 p-90 -152.76 164.92 36.86 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.183 1.393 . . . . 0.0 109.334 -178.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.798 HG13 ' CE1' ' A' ' 229' ' ' TYR . 51.3 t -147.36 120.75 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.42 ' HD3' ' CE3' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -140.15 127.42 21.19 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 178.674 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -80.68 92.26 5.97 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 104.101 -2.555 . . . . 0.0 104.101 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 5.7 p -65.69 -65.65 0.65 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.35 1.46 . . . . 0.0 109.786 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -88.71 -172.83 3.88 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.052 0.941 . . . . 0.0 108.489 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.4 mp -78.71 -40.99 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -106.07 -49.41 3.38 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.106 1.363 . . . . 0.0 112.539 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 2.4 t -68.26 145.54 13.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . 0.798 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.2 OUTLIER -137.2 136.1 37.86 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.716 1.606 . . . . 0.0 109.177 -178.413 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.42 139.93 43.78 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 125.047 1.339 . . . . 0.0 108.577 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -142.06 155.1 45.38 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 126.088 1.755 . . . . 0.0 110.136 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.441 ' HB2' ' CZ2' ' A' ' 220' ' ' TRP . 5.0 tt0 -136.25 146.42 46.7 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 1.6 m -137.34 154.56 30.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.1 p -109.08 148.67 30.46 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 123.469 0.708 . . . . 0.0 110.33 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 41.6 mt -142.27 133.35 12.94 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.27 -46.56 0.65 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.772 2.315 . . . . 0.0 112.324 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -62.03 -22.73 65.96 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.953 0.901 . . . . 0.0 113.375 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.8 mp -63.26 -40.06 96.35 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.223 0.92 . . . . 0.0 108.974 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 30.2 m -54.59 -22.53 13.58 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.84 1.656 . . . . 0.0 113.152 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -62.7 -31.47 72.38 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 121.1 -1.0 . . . . 0.0 110.841 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 26.4 mt -79.4 118.88 21.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.7 -35.52 31.52 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.9 mp -58.93 -45.19 90.99 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.336 -0.852 . . . . 0.0 109.599 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.76 5.45 36.31 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.125 1.77 . . . . 0.0 112.62 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -78.18 52.18 1.08 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 119.68 1.127 . . . . 0.0 111.261 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -152.48 155.6 37.79 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.548 1.539 . . . . 0.0 109.069 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -160.91 157.58 26.76 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 125.886 1.675 . . . . 0.0 109.583 177.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.25 -1.46 5.71 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 125.384 1.473 . . . . 0.0 109.826 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 26.3 t0 . . . . . 0 C--O 1.243 0.737 0 CA-C-O 117.385 -1.293 . . . . 0.0 109.192 -179.875 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.284 0 N-CA-C 107.843 -2.103 . . . . 0.0 107.843 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.38 168.95 11.57 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.78 1.29 . . . . 0.0 108.41 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.8 t 57.23 29.67 17.11 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.334 1.054 . . . . 0.0 111.681 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -61.19 161.4 8.87 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.4 m -53.8 -61.08 2.53 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.071 1.349 . . . . 0.0 112.941 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -58.25 -36.64 73.52 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.818 1.19 . . . . 0.0 110.484 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.42 -38.75 74.84 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.6 m -72.69 -47.53 46.46 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.102 1.361 . . . . 0.0 109.28 178.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.05 -38.31 70.44 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.373 0.669 . . . . 0.0 110.659 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.3 tp -60.57 -38.11 83.5 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 119.003 -0.523 . . . . 0.0 110.457 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.497 HD23 HD13 ' A' ' 174' ' ' LEU . 3.4 mt -67.23 -49.51 64.2 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 58.7 m -54.6 -44.57 73.16 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.919 0.888 . . . . 0.0 109.904 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -66.31 -50.78 62.45 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 121.104 -0.998 . . . . 0.0 110.246 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 58.4 m -53.99 -47.43 71.44 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.287 1.435 . . . . 0.0 111.145 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 28.5 tp -63.31 -54.79 31.51 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 119.051 0.841 . . . . 0.0 110.911 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -54.01 -48.99 69.86 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.414 0.686 . . . . 0.0 110.52 -178.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -57.37 -50.79 71.85 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 124.07 0.948 . . . . 0.0 109.051 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -57.04 -49.38 72.13 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-O 119.178 -0.79 . . . . 0.0 111.687 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 72.6 t -58.88 -53.2 50.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 125.343 1.457 . . . . 0.0 110.867 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -31.23 72.34 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 118.573 0.624 . . . . 0.0 110.531 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.8 m -70.44 -46.13 64.47 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.537 HD11 HD12 ' A' ' 183' ' ' ILE . 10.9 mt -53.56 -54.31 19.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.37 -44.04 84.09 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 124.035 0.834 . . . . 0.0 110.81 -178.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -60.41 -52.53 64.82 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.163 0.506 . . . . 0.0 111.6 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -22.19 66.8 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.8 mt -96.04 -27.37 15.14 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 118.823 0.738 . . . . 0.0 110.311 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -61.79 -28.44 69.46 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.186 0.594 . . . . 0.0 110.178 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -66.53 -46.93 74.52 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -165.44 152.75 10.64 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.908 2.083 . . . . 0.0 109.431 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 57.5 m -75.44 171.82 13.58 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 41.6 pt -125.78 147.55 30.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 123.801 0.84 . . . . 0.0 108.981 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.73 156.42 45.01 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 122.78 0.432 . . . . 0.0 110.375 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -142.91 128.02 18.58 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 124.167 0.987 . . . . 0.0 110.195 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -88.71 106.12 18.14 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.29 67.23 0.92 Allowed 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.35 -120.53 7.11 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.173 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -66.73 -32.06 73.12 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.64 1.176 . . . . 0.0 111.345 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -107.64 135.84 48.41 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.463 0.649 . . . . 0.0 111.626 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.459 HD12 ' H ' ' A' ' 140' ' ' GLY . 33.1 mt -105.8 149.72 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 177.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -119.08 134.8 54.98 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.334 -1.757 . . . . 0.0 108.205 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -128.91 130.74 47.19 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.751 1.22 . . . . 0.0 108.495 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -129.4 118.82 22.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.585 1.154 . . . . 0.0 109.219 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 10.6 m -105.41 160.32 26.46 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.668 1.187 . . . . 0.0 113.57 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -63.79 92.82 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 124.858 3.706 . . . . 0.0 113.157 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 52.17 53.06 32.7 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-O 119.579 -0.567 . . . . 0.0 111.846 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.1 mt -124.92 -67.36 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -177.38 174.73 1.55 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.98 1.712 . . . . 0.0 109.203 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.82 124.55 39.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 177.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.9 m -134.42 156.94 41.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 124.379 1.072 . . . . 0.0 110.879 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -124.09 124.12 41.82 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -146.17 156.37 43.37 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.323 1.049 . . . . 0.0 111.615 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -102.21 119.59 39.06 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.459 ' H ' HD12 ' A' ' 126' ' ' ILE . . . -154.44 -165.14 13.54 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.921 1.724 . . . . 0.0 108.962 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.66 136.89 50.28 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.6 p -149.62 153.44 10.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 123.902 0.881 . . . . 0.0 112.319 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -95.18 113.76 25.48 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.7 t -65.03 -16.3 63.29 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 120.721 1.6 . . . . 0.0 111.818 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -71.3 -23.06 61.88 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.934 1.694 . . . . 0.0 114.046 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.2 t -145.07 -23.0 0.49 Allowed 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.559 -0.713 . . . . 0.0 110.679 -178.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.37 15.29 44.62 Favored Glycine 0 C--O 1.223 -0.578 0 C-N-CA 126.011 1.767 . . . . 0.0 110.959 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -71.36 112.08 7.2 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 118.226 1.013 . . . . 0.0 110.267 -178.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 88.1 mt -80.35 107.95 13.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 102.744 -3.058 . . . . 0.0 102.744 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 35.0 t -70.89 -41.56 77.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 126.702 2.001 . . . . 0.0 111.379 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -138.03 139.12 39.43 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 119.121 0.873 . . . . 0.0 110.744 -178.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 56.9 mtm180 -112.78 85.68 2.22 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 125.451 1.5 . . . . 0.0 112.677 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -71.95 134.17 45.81 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -95.56 -6.76 39.64 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.011 1.324 . . . . 0.0 111.593 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.08 -28.42 61.37 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -177.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 93.5 mt -123.27 81.6 1.9 Allowed 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.108 0.963 . . . . 0.0 108.553 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.8 t -134.95 133.95 53.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.044 0.838 . . . . 0.0 108.965 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -130.3 163.4 26.88 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.492 1.517 . . . . 0.0 110.792 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -112.9 143.38 44.28 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 18.5 mt -116.32 -72.92 0.67 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -128.67 148.88 18.19 Favored Glycine 0 C--O 1.241 0.564 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -130.78 91.83 36.0 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.718 1.207 . . . . 0.0 109.286 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.441 ' HD3' HG21 ' A' ' 187' ' ' ILE . 43.5 Cg_endo -74.46 -166.09 0.31 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 125.06 3.84 . . . . 0.0 111.051 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -95.98 168.1 10.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.114 1.366 . . . . 0.0 109.395 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -81.79 -28.45 33.2 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -113.98 162.56 16.27 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 123.328 0.651 . . . . 0.0 110.324 -179.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.8 p -73.63 -34.58 41.96 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 C-N-CA 123.364 0.665 . . . . 0.0 110.379 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -74.37 -16.03 60.91 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.404 -0.81 . . . . 0.0 112.182 -177.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -81.57 -19.66 41.53 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.183 0.993 . . . . 0.0 110.603 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -117.33 177.91 4.56 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.608 1.563 . . . . 0.0 110.985 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -140.51 156.86 46.2 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -133.83 166.99 21.37 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.308 1.843 . . . . 0.0 107.977 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -133.74 123.7 25.38 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 120.498 1.499 . . . . 0.0 112.614 -179.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.497 HD13 HD23 ' A' ' 98' ' ' LEU . 0.7 OUTLIER -82.77 99.08 9.45 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.005 1.322 . . . . 0.0 109.442 179.581 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.43 HD12 ' HB2' ' A' ' 184' ' ' SER . 24.7 mt -108.21 174.02 6.06 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 122.394 1.092 . . . . 0.0 109.516 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -154.52 163.11 40.7 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -141.25 -178.44 5.59 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -52.55 -34.25 49.3 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 125.335 1.454 . . . . 0.0 110.523 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.505 HG13 ' HB2' ' A' ' 248' ' ' GLU . 56.1 t -70.79 -67.78 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 127.005 2.122 . . . . 0.0 109.191 178.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -175.77 -174.69 42.54 Favored Glycine 0 N--CA 1.446 -0.66 0 O-C-N 121.817 -0.552 . . . . 0.0 111.931 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -80.06 158.32 26.49 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.515 1.126 . . . . 0.0 111.973 -178.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -165.69 177.0 7.58 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.457 1.503 . . . . 0.0 108.531 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.537 HD12 HD11 ' A' ' 109' ' ' ILE . 8.9 mt -121.92 126.28 74.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 101.609 -3.478 . . . . 0.0 101.609 177.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.43 ' HB2' HD12 ' A' ' 175' ' ' LEU . 3.2 t -106.4 107.8 19.0 Favored 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 124.325 1.016 . . . . 0.0 109.248 -178.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -111.22 118.78 36.85 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 118.5 -0.762 . . . . 0.0 110.699 -179.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.8 tt -108.95 140.27 28.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.441 HG21 ' HD3' ' A' ' 163' ' ' PRO . 7.5 mt -133.87 113.47 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 C-N-CA 123.997 0.919 . . . . 0.0 110.637 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.68 -162.41 26.01 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 177.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.0 m 84.45 29.19 0.07 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.251 2.221 . . . . 0.0 112.959 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -87.4 -109.15 0.92 Allowed Glycine 0 C--N 1.338 0.649 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -139.11 126.6 21.7 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.337 1.455 . . . . 0.0 109.053 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.5 mm -68.19 122.54 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 120.503 1.501 . . . . 0.0 109.453 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 30.5 p -82.01 117.76 22.46 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 123.156 0.583 . . . . 0.0 111.622 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -71.89 -3.52 22.95 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.115 -0.991 . . . . 0.0 110.718 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 39.6 t -66.98 -42.06 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 125.127 1.371 . . . . 0.0 108.278 178.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.9 p -124.34 -28.57 3.64 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 122.898 0.479 . . . . 0.0 111.613 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.77 30.62 10.22 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -116.55 169.28 9.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.74 1.216 . . . . 0.0 112.289 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -83.83 139.91 32.36 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.351 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 2.9 tpp85 -77.13 30.75 0.14 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 130.013 3.325 . . . . 0.0 109.371 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 12.2 ptt? -73.11 157.11 37.9 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 122.008 0.909 . . . . 0.0 109.329 -176.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.5 p -125.19 146.05 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 114.37 -1.287 . . . . 0.0 111.317 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -112.7 138.6 49.27 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 1.8 mp -125.94 114.38 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 126.455 1.902 . . . . 0.0 107.579 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -99.69 116.28 31.43 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -93.54 118.17 31.01 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 125.242 1.417 . . . . 0.0 111.506 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 32.5 m -129.49 172.21 15.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 124.266 1.026 . . . . 0.0 111.312 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.2 t -78.59 134.96 37.16 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -93.21 122.01 6.79 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -37.68 -61.73 1.06 Allowed Glycine 0 C--N 1.336 0.538 0 C-N-CA 126.74 2.114 . . . . 0.0 111.343 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.8 p -77.66 83.09 4.05 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.483 ' HA ' ' HB3' ' A' ' 236' ' ' PRO . 37.2 p-10 -76.64 66.78 2.66 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.9 p -149.47 19.45 0.94 Allowed 'General case' 0 C--O 1.238 0.458 0 N-CA-C 116.539 2.052 . . . . 0.0 116.539 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -163.95 173.65 40.01 Favored Glycine 0 N--CA 1.47 0.941 0 O-C-N 121.189 -0.945 . . . . 0.0 115.197 -178.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -64.77 164.24 24.97 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.036 2.49 . . . . 0.0 112.535 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 15.8 p -67.31 157.59 33.59 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.368 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 1.7 p -161.27 163.72 30.75 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.417 2.287 . . . . 0.0 106.923 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.5 mt -82.75 134.57 26.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 178.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -81.57 -55.22 4.81 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.052 1.341 . . . . 0.0 111.097 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 26.2 p-90 -147.92 166.54 27.36 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.259 1.424 . . . . 0.0 108.541 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.679 HG13 ' CE1' ' A' ' 229' ' ' TYR . 49.6 t -146.1 131.76 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -179.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.43 133.65 15.25 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.73 0.776 . . . . 0.0 111.223 177.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -81.72 89.3 6.27 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.2 p -66.01 -51.91 54.03 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.082 0.953 . . . . 0.0 111.734 -178.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -103.18 -173.83 2.4 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.0 mp -72.17 -43.54 66.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 3.4 m -111.94 -28.55 7.99 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -177.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 2.1 t -81.78 143.1 12.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . 0.679 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.9 OUTLIER -129.04 145.5 51.24 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.31 1.444 . . . . 0.0 110.09 -177.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -129.33 142.02 50.93 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 125.442 1.497 . . . . 0.0 108.39 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.28 163.2 37.16 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.296 1.839 . . . . 0.0 110.786 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -126.89 149.15 49.91 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 88.7 t -132.77 134.37 58.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 125.525 1.53 . . . . 0.0 107.803 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.41 143.48 32.63 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.922 0.889 . . . . 0.0 108.877 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 33.8 mt -139.85 138.13 19.36 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 118.251 -0.88 . . . . 0.0 109.215 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.483 ' HB3' ' HA ' ' A' ' 212' ' ' ASN . 72.4 Cg_endo -74.22 -46.16 0.31 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.647 2.231 . . . . 0.0 110.838 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.71 -25.41 62.88 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.996 1.318 . . . . 0.0 110.816 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 238' ' ' LEU . 15.3 mt -65.52 -41.33 93.26 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 24.7 m -58.01 -16.1 11.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.604 1.562 . . . . 0.0 113.061 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -63.19 -43.84 97.07 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.006 0.923 . . . . 0.0 109.143 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.8 mt -71.87 120.04 16.9 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 128.809 2.844 . . . . 0.0 107.049 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -52.67 -35.21 54.75 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.4 mp -58.73 -36.7 74.72 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.602 -0.686 . . . . 0.0 110.897 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -94.41 3.88 54.6 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 125.046 1.338 . . . . 0.0 111.949 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -75.95 40.91 0.21 Allowed 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.506 -0.746 . . . . 0.0 112.384 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 20.6 tptt -153.62 154.28 33.91 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 127.025 2.13 . . . . 0.0 107.36 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -166.19 138.2 3.8 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 125.362 1.465 . . . . 0.0 107.806 177.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . 0.505 ' HB2' HG13 ' A' ' 179' ' ' VAL . 5.4 mm-40 -138.7 69.81 1.38 Allowed 'General case' 0 C--O 1.235 0.316 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.9 p30 . . . . . 0 C--O 1.249 1.063 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.537 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.117 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -146.5 -172.91 4.06 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.699 2.0 . . . . 0.0 106.32 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.7 t -138.04 149.34 45.95 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -130.32 14.37 5.59 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 127.977 2.511 . . . . 0.0 110.127 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 26.2 m -49.17 -41.72 37.57 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.265 1.026 . . . . 0.0 113.707 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -67.8 -37.39 81.93 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.706 -0.621 . . . . 0.0 110.187 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -64.83 -48.06 75.71 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.8 p -63.68 -36.08 82.65 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 118.375 -0.821 . . . . 0.0 110.22 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.53 -35.97 77.27 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.715 1.143 . . . . 0.0 110.34 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.22 -45.34 88.69 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.6 mt -63.46 -53.93 44.47 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.494 1.118 . . . . 0.0 109.538 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 55.2 m -54.87 -44.51 74.1 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.637 1.175 . . . . 0.0 110.648 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.1 ttmm -65.97 -49.79 66.6 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.813 -0.613 . . . . 0.0 109.945 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 79.9 m -51.92 -43.28 63.35 Favored 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 124.523 1.129 . . . . 0.0 111.157 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tt -61.79 -56.88 14.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.299 0.5 . . . . 0.0 111.898 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -60.69 -45.71 93.16 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.744 0.817 . . . . 0.0 111.42 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -57.72 -44.28 85.87 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.861 0.864 . . . . 0.0 108.851 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.98 -52.03 54.87 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 94.8 t -55.1 -53.2 36.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 124.977 1.311 . . . . 0.0 111.711 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.04 -33.36 75.58 Favored 'General case' 0 C--N 1.335 -0.052 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.741 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.2 m -67.63 -46.22 73.13 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.453 HD11 HD12 ' A' ' 183' ' ' ILE . 27.9 mt -55.64 -54.31 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 124.606 1.163 . . . . 0.0 108.855 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.02 -43.73 82.13 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.468 -178.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -60.99 -52.96 62.81 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-N 118.78 0.718 . . . . 0.0 110.637 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.68 -15.65 53.48 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.2 mt -101.54 -28.11 12.73 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 119.358 0.981 . . . . 0.0 109.174 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -65.5 -26.22 67.82 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -66.6 -46.23 76.61 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 -161.77 148.56 14.1 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.307 1.843 . . . . 0.0 109.297 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 71.0 m -74.99 164.42 26.57 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 178.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 33.3 pt -119.36 154.98 21.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -145.21 165.39 28.48 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.031 -178.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -151.25 125.34 9.26 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.194 1.397 . . . . 0.0 109.369 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -88.76 117.38 27.7 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -108.41 67.49 0.67 Allowed 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.722 1.209 . . . . 0.0 109.0 178.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.0 -114.09 3.88 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 107.917 -2.073 . . . . 0.0 107.917 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -83.99 -26.5 29.14 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.162 1.385 . . . . 0.0 112.463 179.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -106.38 115.44 30.22 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.409 1.484 . . . . 0.0 112.638 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 51.2 mt -92.57 146.74 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 C-N-CA 125.559 1.543 . . . . 0.0 108.219 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.475 ' CD1' HG11 ' A' ' 221' ' ' VAL . 64.1 m-85 -118.04 135.23 54.3 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.499 -1.228 . . . . 0.0 107.74 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -133.14 126.43 31.69 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.311 1.044 . . . . 0.0 108.772 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -122.85 127.07 48.53 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.595 1.158 . . . . 0.0 111.677 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 17.6 m -114.21 158.66 39.06 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 123.428 0.691 . . . . 0.0 112.351 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.28 92.78 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.625 1 C-N-CA 125.614 4.21 . . . . 0.0 113.858 -178.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 58.91 47.49 90.37 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.1 mt -125.37 -66.86 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.215 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.523 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 20.8 pt-20 -178.13 167.11 1.99 Allowed 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.415 1.486 . . . . 0.0 109.117 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.32 119.28 29.65 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 178.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.6 m -127.2 156.67 38.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 125.252 1.421 . . . . 0.0 110.765 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.36 124.07 41.57 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 103.638 -2.726 . . . . 0.0 103.638 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -146.29 158.79 43.91 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -178.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -89.37 153.64 20.7 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 169.48 -168.46 41.3 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -125.62 138.22 53.91 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.563 1.545 . . . . 0.0 107.075 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.9 p -148.8 152.43 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 119.244 0.929 . . . . 0.0 110.907 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -93.74 105.16 17.22 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.243 1.017 . . . . 0.0 108.353 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.9 t -50.05 -35.5 25.36 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.909 1.231 . . . . 0.0 112.142 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -46.73 -31.45 2.96 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.21 1.804 . . . . 0.0 114.0 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.1 t -146.4 -24.03 0.43 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 101.26 13.73 32.52 Favored Glycine 0 CA--C 1.527 0.842 0 O-C-N 120.984 -1.073 . . . . 0.0 111.237 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -70.08 115.28 9.11 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 23.0 mt -84.96 119.22 33.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 89.0 t -73.55 -72.3 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.34 1.456 . . . . 0.0 107.896 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -127.5 152.92 46.96 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.207 1.803 . . . . 0.0 108.04 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.3 87.88 1.48 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -61.13 118.62 7.04 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.738 1.215 . . . . 0.0 107.775 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -69.96 6.01 1.38 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 -178.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.43 -1.51 58.08 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 120.418 1.463 . . . . 0.0 111.357 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 15.9 mt -138.08 78.08 1.66 Allowed 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -136.2 135.18 50.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -134.49 154.82 51.23 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.96 1.704 . . . . 0.0 108.689 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -107.68 143.19 36.52 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.874 0.87 . . . . 0.0 109.236 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 35.5 mt -113.6 -69.96 0.83 Allowed 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 124.255 0.972 . . . . 0.0 109.432 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -133.57 156.51 22.3 Favored Glycine 0 C--O 1.239 0.422 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -126.78 93.7 41.67 Favored Pre-proline 0 C--O 1.231 0.102 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.523 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 57.3 Cg_endo -76.73 174.69 12.43 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 122.421 2.08 . . . . 0.0 110.068 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -81.32 162.03 23.62 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.47 -28.96 24.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.937 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -103.44 135.48 44.96 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.39 -22.54 28.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -83.28 -14.44 53.08 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 124.865 1.266 . . . . 0.0 111.448 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -84.55 -13.74 50.93 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.404 0.682 . . . . 0.0 110.864 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -117.51 174.56 6.08 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.345 1.858 . . . . 0.0 111.524 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -142.68 154.4 44.29 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.104 1.361 . . . . 0.0 109.511 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -128.96 169.41 14.69 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.874 2.469 . . . . 0.0 108.759 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -131.78 135.84 47.08 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.663 1.185 . . . . 0.0 109.514 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 17.4 tp -89.15 98.76 11.95 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.444 1.097 . . . . 0.0 108.343 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.408 HD12 ' HB2' ' A' ' 184' ' ' SER . 20.6 mt -105.32 178.37 4.58 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.95 0.881 . . . . 0.0 111.341 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -158.58 162.66 37.38 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -138.62 -178.39 5.28 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 125.346 1.459 . . . . 0.0 109.827 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -58.92 -15.59 13.56 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 45.4 t -98.58 -56.32 5.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 C-N-CA 125.569 1.548 . . . . 0.0 108.768 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -169.21 -167.42 29.77 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 119.324 0.966 . . . . 0.0 113.172 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -88.64 156.09 19.23 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 122.192 -0.593 . . . . 0.0 110.848 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -157.64 173.98 16.04 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.162 1.385 . . . . 0.0 107.934 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.453 HD12 HD11 ' A' ' 109' ' ' ILE . 18.9 mt -118.27 140.22 42.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 102.908 -2.997 . . . . 0.0 102.908 178.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.408 ' HB2' HD12 ' A' ' 175' ' ' LEU . 36.1 t -117.94 131.26 56.52 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.6 127.05 18.81 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 178.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.6 tt -115.19 134.74 57.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.5 mt -125.04 111.08 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.681 1.192 . . . . 0.0 111.823 -177.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -100.42 -158.32 27.95 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 108.328 -1.909 . . . . 0.0 108.328 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 9.1 m 69.53 56.95 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 123.93 0.892 . . . . 0.0 109.467 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -114.79 -116.06 3.11 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 105.678 -2.969 . . . . 0.0 105.678 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -135.24 129.05 33.05 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.902 1.681 . . . . 0.0 107.375 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 25.8 mm -67.28 132.73 32.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 29.3 p -80.31 113.48 18.52 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.22 -24.46 66.37 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.863 1.211 . . . . 0.0 111.86 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 3.6 m -57.34 -41.5 78.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 117.251 -1.357 . . . . 0.0 112.634 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 1.3 p -125.41 -21.43 4.54 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 120.612 1.551 . . . . 0.0 112.591 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 89.31 13.45 61.72 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.875 1.702 . . . . 0.0 110.923 -178.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -90.2 169.6 11.0 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.61 1.205 . . . . 0.0 108.98 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.412 ' C ' ' H ' ' A' ' 201' ' ' MET . 17.6 mt-10 -86.31 149.66 24.89 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -78.44 31.08 0.18 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.112 2.165 . . . . 0.0 107.775 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.412 ' H ' ' C ' ' A' ' 199' ' ' GLU . 11.5 ptt? -71.37 152.14 43.44 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -175.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.7 p -119.47 146.38 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 114.207 -1.361 . . . . 0.0 111.57 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -111.76 132.24 54.79 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 125.145 1.378 . . . . 0.0 107.391 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 2.4 mp -118.13 139.77 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 178.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -122.74 100.21 6.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -81.06 126.53 31.54 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 118.817 0.735 . . . . 0.0 110.198 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 33.0 m -134.79 172.24 16.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 126.014 1.726 . . . . 0.0 111.144 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.7 t -78.75 139.47 38.43 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -107.33 146.87 16.21 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -40.96 -66.14 0.94 Allowed Glycine 0 CA--C 1.522 0.514 0 C-N-CA 126.49 1.995 . . . . 0.0 112.469 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.7 t -70.75 103.72 2.66 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 117.845 0.822 . . . . 0.0 110.557 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -71.59 6.8 1.7 Allowed 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.68 -0.637 . . . . 0.0 111.018 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 73.9 p -126.95 30.72 5.41 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.335 1.854 . . . . 0.0 110.283 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -120.64 170.32 14.38 Favored Glycine 0 N--CA 1.47 0.925 0 CA-C-N 119.675 1.125 . . . . 0.0 115.159 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -79.91 165.75 21.75 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.583 2.188 . . . . 0.0 110.477 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 90.5 p -78.74 152.31 31.58 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.38 164.18 7.01 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.558 1.543 . . . . 0.0 108.215 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.1 mt -84.82 134.53 26.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -79.59 -54.27 6.05 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 125.224 1.409 . . . . 0.0 111.443 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . 0.406 ' CZ2' ' HB2' ' A' ' 232' ' ' GLN . 41.1 p-90 -146.94 162.65 38.28 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.71 1.204 . . . . 0.0 108.7 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.87 HG13 ' CE1' ' A' ' 229' ' ' TYR . 44.0 t -148.41 135.34 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 125.943 1.697 . . . . 0.0 107.062 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.07 138.4 10.26 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 177.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -82.51 87.3 6.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 102.564 -3.125 . . . . 0.0 102.564 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.1 p -63.13 -49.65 73.56 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.692 1.597 . . . . 0.0 111.913 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -95.2 -172.37 2.65 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.6 mp -71.51 -46.4 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 4.9 m -113.37 -36.55 4.95 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 2.7 t -70.17 144.63 13.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . 0.87 ' CE1' HG13 ' A' ' 221' ' ' VAL . 0.1 OUTLIER -127.56 139.76 52.55 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.079 1.752 . . . . 0.0 108.141 -179.028 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -121.94 142.99 49.73 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.895 1.278 . . . . 0.0 109.425 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.69 162.71 36.92 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.624 1.57 . . . . 0.0 110.019 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.406 ' HB2' ' CZ2' ' A' ' 220' ' ' TRP . 15.8 tt0 -129.11 142.93 50.73 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 93.5 t -129.25 137.88 55.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 124.891 1.277 . . . . 0.0 108.192 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.97 139.85 41.99 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 123.849 0.859 . . . . 0.0 111.153 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 26.6 mt -140.33 139.07 19.91 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.259 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.05 -43.98 0.29 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.683 2.256 . . . . 0.0 111.983 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -59.22 -21.21 59.16 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.807 0.843 . . . . 0.0 111.373 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 14.1 mt -69.85 -39.92 76.12 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 117.383 -1.294 . . . . 0.0 109.032 177.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 9.1 m -58.44 -22.13 53.38 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 119.657 1.117 . . . . 0.0 113.386 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -60.78 -32.03 71.37 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.362 0.665 . . . . 0.0 110.301 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 23.7 mt -79.86 118.84 21.99 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -48.33 -35.15 11.82 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 3.6 mp -57.61 -41.4 81.21 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 121.093 -1.004 . . . . 0.0 111.148 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -89.42 1.83 55.31 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.87 1.668 . . . . 0.0 112.905 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -76.01 59.86 1.34 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.418 1.487 . . . . 0.0 108.6 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -147.43 127.16 13.41 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.857 2.063 . . . . 0.0 108.823 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . 0.251 17.3 m120 85.32 9.37 0.35 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 130.408 3.483 . . . . 0.0 112.246 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -73.4 -19.9 60.87 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.657 1.983 . . . . 0.0 108.844 177.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 4.7 t70 . . . . . 0 C--O 1.251 1.164 0 C-N-CA 128.253 2.621 . . . . 0.0 110.647 179.488 . . . . . . . . 0 0 . 1 stop_ save_